PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lagakos, SW				Lagakos, SW			Time-to-event analyses for long-term treatments - The APPROVe trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Lagakos, SW (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Griffin BA, 2006, J AM STAT ASSOC, V101, P510, DOI 10.1198/016214505000000880; LAGAKOS SW, 1984, BIOMETRICS, V40, P1037, DOI 10.2307/2531154; Park Y, 2006, BIOSTATISTICS, V7, P252, DOI 10.1093/biostatistics/kxj005; Parzen MI, 1997, SCAND J STAT, V24, P309, DOI 10.1111/1467-9469.t01-1-00065	5	53	54	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					113	117		10.1056/NEJMp068137	http://dx.doi.org/10.1056/NEJMp068137			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16801354				2022-12-28	WOS:000238970600001
J	Muotri, AR; Gage, FH				Muotri, Alysson R.; Gage, Fred H.			Generation of neuronal variability and complexity	NATURE			English	Article							PRE-MESSENGER-RNA; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ACTIVITY-DEPENDENT REGULATION; RECEPTOR ION CHANNELS; L1 RETROTRANSPOSITION; HUMAN BRAIN; ALTERNATIVE POLYADENYLATION; CAENORHABDITIS-ELEGANS; EXPRESSION PROFILES	The production of specialized differentiated neurons derived from stem cells has been proposed as a revolutionary technology for regenerative medicine. However, few examples of specific neuronal cell differentiation have been described so far. Although stem-cell tissue replacement might be seemingly straightforward in other cases, the high degree of complexity of the nervous system raises the challenge of tissue replacement substantially. Understanding mechanisms of neuronal diversification will not only be relevant for therapeutic purposes but might also shed light on the differences in cognitive abilities, personality traits and psychiatric conditions observed in humans.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu						ABELIOVICH A, 1992, SCIENCE, V257, P404, DOI 10.1126/science.1631561; AKBARIAN S, 1995, BRAIN RES, V699, P297, DOI 10.1016/0006-8993(95)00922-D; ANGEVINE JB, 1970, J COMP NEUROL, V139, P129, DOI 10.1002/cne.901390202; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Branchi I, 2004, BEHAV PHARMACOL, V15, P353, DOI 10.1097/00008877-200409000-00006; Burgess N, 2003, TRENDS COGN SCI, V7, P517, DOI 10.1016/j.tics.2003.10.014; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; FERRER I, 1992, PROG NEUROBIOL, V39, P1, DOI 10.1016/0301-0082(92)90029-E; FINLAY BL, 1983, SCIENCE, V219, P1349, DOI 10.1126/science.6828866; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Frank O, 2005, J VIROL, V79, P10890, DOI 10.1128/JVI.79.17.10890-10901.2005; Fuller CE, 2002, BRAIN PATHOL, V12, P67; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gottesman II, 2005, ANNU REV PSYCHOL, V56, P263, DOI 10.1146/annurev.psych.56.091103.070208; Gotz M, 2005, DEVELOPMENT, V132, P3327, DOI 10.1242/dev.01931; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Grant SGN, 2006, BIOCHEM SOC T, V34, P59, DOI 10.1042/BST0340059; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Kan PX, 2004, SCHIZOPHR RES, V67, P95, DOI 10.1016/j.schres.2003.09.004; Karlsson H, 2001, P NATL ACAD SCI USA, V98, P4634, DOI 10.1073/pnas.061021998; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keegan LP, 2000, SCIENCE, V290, P1707, DOI 10.1126/science.290.5497.1707; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Kim HS, 1999, J GEN VIROL, V80, P2613, DOI 10.1099/0022-1317-80-10-2613; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Koch C, 1999, SCIENCE, V284, P96, DOI 10.1126/science.284.5411.96; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; MATSUOKA M, 1991, SCIENCE, V254, P81, DOI 10.1126/science.1925563; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers SJ, 1999, ANNU REV PHARMACOL, V39, P221, DOI 10.1146/annurev.pharmtox.39.1.221; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Ogasawara M, 2000, FERTIL STERIL, V73, P300, DOI 10.1016/S0015-0282(99)00495-1; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Pathak S, 2006, EXP SUPPL, V96, P49; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Pelka GJ, 2005, GENOMICS, V85, P441, DOI 10.1016/j.ygeno.2004.12.002; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Roy-Engel AM, 2005, CYTOGENET GENOME RES, V110, P365, DOI 10.1159/000084968; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Vezzani A, 1995, EUR J NEUROSCI, V7, P2513, DOI 10.1111/j.1460-9568.1995.tb01050.x; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wang ZH, 1996, RNA, V2, P1241; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Williams RW, 2000, RES PRO CEL, V30, P21; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yang AH, 2003, J NEUROSCI, V23, P10454; Yee F, 1997, BIOL PSYCHIAT, V41, P759, DOI 10.1016/S0006-3223(96)00553-7; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yolken RH, 2000, BRAIN RES REV, V31, P193, DOI 10.1016/S0165-0173(99)00037-5; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	96	188	194	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1087	1093		10.1038/nature04959	http://dx.doi.org/10.1038/nature04959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810244				2022-12-28	WOS:000238615500036
J	Darnill, S; Gamage, B				Darnill, Stephanie; Gamage, Bernadette			The patient's journey: palliative care - a parent's view	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Paediat Palliat Care, Lifeforce Team, London NW1 0PE, England		Gamage, B (corresponding author), Paediat Palliat Care, Lifeforce Team, London NW1 0PE, England.	bernigamage@hotmail.com							0	7	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1494	1495		10.1136/bmj.332.7556.1494	http://dx.doi.org/10.1136/bmj.332.7556.1494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793812	Green Published			2022-12-28	WOS:000238820200020
J	Deeks, SG				Deeks, Steven G.			Antiretroviral treatment of HIV infected adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RECOMMENDATIONS; LAMIVUDINE; THERAPY; ZIDOVUDINE; EFAVIRENZ; INDINAVIR; DISEASE		Univ Calif San Francisco, San Francisco, CA 94110 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Deeks, SG (corresponding author), Univ Calif San Francisco, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu						Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; *DHHS, 2006, GUID US ANT AG HIV I; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gazzard B, 2005, HIV MED, V6, P1, DOI 10.1111/j.1468-1293.2005.0311b.x; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Johnson Victoria A, 2005, Top HIV Med, V13, P125; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; Opravil M, 2002, J INFECT DIS, V185, P1251, DOI 10.1086/340312; Schambelan M, 2002, JAIDS-J ACQ IMM DEF, V31, P257, DOI 10.1097/00126334-200211010-00001; *SMART STUD, 2006, 13 C RETR OPP INF 5; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Vandamme AM, 2004, ANTIVIR THER, V9, P829; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	25	35	42	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1489	1493		10.1136/bmj.332.7556.1489	http://dx.doi.org/10.1136/bmj.332.7556.1489			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793811	Green Published			2022-12-28	WOS:000238820200019
J	Andersen, M; Kragstrup, J; Sondergaard, J				Andersen, Morten; Kragstrup, Jakob; Sondergaard, Jens			How conducting a clinical trial affects physicians' guideline adherence and drug preferences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; COMMERCIAL SOURCES; BEHAVIOR; ADOPTION; IMPACT	Context General practitioners are frequently involved in clinical trials sponsored by pharmaceutical companies but the effects of participation on their prescribing patterns have not been evaluated. Objective To determine how conducting a company-sponsored clinical trial influenced physicians' adherence to international treatment recommendations and their prescribing of the pharmaceutical company's drugs. Design, Setting, and Patients Observational cohort study in Funen County, Denmark, comparing 10 practices that were conducting a trial on asthma medicine with 165 control ( non - trial-conducting) practices. The study population included 5439 patients treated with asthma drugs from the trial-conducting practices and 59 574 patients from the control practices. Practices conducted the trial between April 26, 2001, and October 7, 2002. Main Outcome Measures Adherence to guidelines measured as use of inhaled corticosteroids among asthma patients. Prevalence of use of the company's drugs and the trial sponsor's share of the total volume of asthma drugs prescribed. Results The baseline proportion of asthma patients using inhaled corticosteroids was 68.5% in trial-conducting and 69.1% in control practices. Conducting the trial did not influence guideline adherence ( odds ratio [ OR] after 2 years, 1.00; 95% confidence interval [CI], 0.84-1.19). In trial-conducting practices, the sponsoring company's share of the total prescribed volume of asthma drugs increased compared with control practices (6.7%; 95% CI, 3.0%-11.7%). This could be attributed to a significantly higher preference for the company's inhaled corticosteroids ( OR, 1.26; 95% CI, 1.04-1.54) and trends toward increased prescribing of the company's other asthma drugs. Conclusion Conducting a trial sponsored by a pharmaceutical company had no significant impact on physicians' adherence to international treatment recommendations but increased their use of the trial sponsor's drugs.	Univ So Denmark, Res Unit Gen Practice, DK-5000 Odense C, Denmark; Univ Aarhus, Res Unit Gen Practice, Aarhus, Denmark	University of Southern Denmark; Aarhus University	Andersen, M (corresponding author), Univ So Denmark, Res Unit Gen Practice, JB Winslows Vej 9A, DK-5000 Odense C, Denmark.	mandersen@health.sdu.dk	Søndergaard, Jens js/F-3031-2013; Andersen, Morten/H-3555-2011	Søndergaard, Jens js/0000-0002-1629-1864; Andersen, Morten/0000-0001-7029-2860				AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; DENIG P, 1991, EUR J CLIN PHARMACOL, V41, P325, DOI 10.1007/BF00314961; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Freemantle N, 2000, BRIT J CLIN PHARMACO, V49, P174, DOI 10.1046/j.1365-2125.2000.00126.x; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; MACKOWIAK JI, 1985, SOC SCI MED, V20, P1191, DOI 10.1016/0277-9536(85)90197-2; PEAY MY, 1988, SOC SCI MED, V26, P1183, DOI 10.1016/0277-9536(88)90149-9; Sondergaard J, 2002, EUR J CLIN PHARMACOL, V58, P127, DOI 10.1007/s00228-002-0454-5; Stovring H, 2003, LANCET, V362, P537, DOI 10.1016/S0140-6736(03)14116-5; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; *WHO COLL CTR DRUG, 2005, IND ATC DDDS 2004; *WHO NAT HEART LUN, 1995, GLOB IN ASTHM GLOB S	15	57	57	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2759	2764		10.1001/jama.295.23.2759	http://dx.doi.org/10.1001/jama.295.23.2759			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16788131	Bronze			2022-12-28	WOS:000238389700031
J	Sheth, U; Parker, R				Sheth, Ujwal; Parker, Roy			Targeting of aberrant mRNAs to cytoplasmic processing bodies	CELL			English	Article							NONSENSE-MEDIATED DECAY; ENDONUCLEOLYTIC CLEAVAGE; YEAST; TRANSLATION; DEGRADATION; UPF1P; SURVEILLANCE; TERMINATION; IDENTIFICATION; DEADENYLATION	In eukaryotes, a specialized pathway of mRNA degradation termed nonsense-mediated decay (NMD) functions in mRNA quality control by recognizing and degrading mRNAs with aberrant termination codons. We demonstrate that NMD in yeast targets premature termination codon (PTC)-containing mRNA to P-bodies. Upf1p is sufficient for targeting mRNAs to P-bodies, whereas Upf2p and Upf3p act, at least in part, downstream of P-body targeting to trigger decapping. The ATPase activity of Upf1p is required for NMD after the targeting of mRNAs to P-bodies. Moreover, Upf1p can target normal mRNAs to P-bodies but not promote their degradation. These observations lead us to propose a new model for NMD wherein two successive steps are used to distinguish normal and aberrant mRNAs.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Sheth, U (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			NIGMS NIH HHS [R01 GM045443, R37 GM045443, GM45443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443, R01GM045443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; ATKIN AL, 1995, MOL BIOL CELL, V6, P611; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Cao D, 2003, CELL, V113, P533, DOI 10.1016/S0092-8674(03)00353-2; Chen CYA, 2003, MOL CELL BIOL, V23, P4805, DOI 10.1128/MCB.23.14.4805-4813.2003; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Page MF, 1999, MOL CELL BIOL, V19, P5943; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shirley RL, 1998, J CELL SCI, V111, P3129; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Takahashi S, 2003, EMBO J, V22, P3951, DOI 10.1093/emboj/cdg374; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	47	226	232	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1095	1109		10.1016/j.cell.2006.04.037	http://dx.doi.org/10.1016/j.cell.2006.04.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777600	Bronze, Green Accepted			2022-12-28	WOS:000238602700015
J	Allen, SA				Allen, SA			Dining with Wilkey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2583	2584		10.1001/jama.295.22.2583	http://dx.doi.org/10.1001/jama.295.22.2583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772612				2022-12-28	WOS:000238224000001
J	Markowitz, AJ; McPhee, SJ				Markowitz, AJ; McPhee, SJ			Integrating palliative care for liver transplant candidates - "Too well for transplant, too sick for life"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Larson AM, 2006, JAMA-J AM MED ASSOC, V295, P2168, DOI 10.1001/jama.295.18.2168	1	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2655	2655		10.1001/jama.295.22.2655	http://dx.doi.org/10.1001/jama.295.22.2655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772629				2022-12-28	WOS:000238224000028
J	Ong, MEH; Ornato, JP; Edwards, DP; Dhindsa, HS; Best, AM; Ines, CS; Hickey, S; Clark, B; Williams, DC; Powell, RG; Overton, JL; Peberdy, MA				Ong, Marcus Eng Hock; Ornato, Joseph P.; Edwards, David P.; Dhindsa, Harinder S.; Best, Al M.; Ines, Caesar S.; Hickey, Scott; Clark, Bryan; Williams, Dean C.; Powell, Robert G.; Overton, Jerry L.; Peberdy, Mary Ann			Use of an automated, load-distributing band chest compression device for out-of-hospital cardiac arrest resuscitation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; PROLONGED CARDIOPULMONARY-RESUSCITATION; INTERNATIONAL LIAISON COMMITTEE; CORONARY PERFUSION-PRESSURE; HEALTH-CARE PROFESSIONALS; VENTRICULAR-FIBRILLATION; STROKE-FOUNDATION; TASK-FORCE; RECOMMENDED GUIDELINES; MYOCARDIAL PERFUSION	Context Only 1% to 8% of adults with out-of-hospital cardiac arrest survive to hospital discharge. Objective To compare resuscitation outcomes before and after an urban emergency medical services ( EMS) system switched from manual cardiopulmonary resuscitation ( CPR) to load-distributing band ( LDB) CPR. Design, Setting, and Patients A phased, observational cohort evaluation with intention-to-treat analysis of 783 adults with out-of-hospital, nontraumatic cardiac arrest. A total of 499 patients were included in the manual CPR phase ( January 1, 2001, to March 31, 2003) and 284 patients in the LDB-CPR phase ( December 20, 2003, to March 31, 2005); of these patients, the LDB device was applied in 210 patients. Intervention Urban EMS system change from manual CPR to LDB-CPR. Main Outcome Measures Return of spontaneous circulation ( ROSC), with secondary outcome measures of survival to hospital admission and hospital discharge, and neurological outcome at discharge. Results Patients in the manual CPR and LDB-CPR phases were comparable except for a faster response time interval ( mean difference, 26 seconds) and more EMS-witnessed arrests ( 18.7% vs 12.6%) with LDB. Rates for ROSC and survival were increased with LDB-CPR compared with manual CPR ( for ROSC, 34.5%; 95% confidence interval [ CI], 29.2%-40.3% vs 20.2%; 95% CI, 16.9%-24.0%; adjusted odds ratio [ OR], 1.94; 95% CI, 1.38-2.72; for survival to hospital admission, 20.9%; 95% CI, 16.6%-26.1% vs 11.1%; 95% CI, 8.6%-14.2%; adjusted OR, 1.88; 95% CI, 1.23-2.86; and for survival to hospital discharge, 9.7%; 95% CI, 6.7%-13.8% vs 2.9%; 95% CI, 1.7%-4.8%; adjusted OR, 2.27; 95% CI, 1.11-4.77). In secondary analysis of the 210 patients in whom the LDB device was applied, 38 patients ( 18.1%) survived to hospital admission ( 95% CI, 13.4%-23.9%) and 12 patients ( 5.7%) survived to hospital discharge ( 95% CI, 3.0%9.3%). Among patients in the manual CPR and LDB-CPR groups who survived to hospital discharge, there was no significant difference between groups in Cerebral Performance Category ( P=. 36) or Overall Performance Category ( P=. 40). The number needed to treat for the adjusted outcome survival to discharge was 15 ( 95% CI, 9-33). Conclusion Compared with resuscitation using manual CPR, a resuscitation strategy using LDB-CPR on EMS ambulances is associated with improved survival to hospital discharge in adults with out-of-hospital nontraumatic cardiac arrest.	Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA; Virginia Commonwealth Univ Hlth Syst, Dept Emergency Med, Richmond, VA USA; Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Div Cardiol, Richmond, VA USA; Virginia Commonwealth Univ Hlth Syst, Dept Emergency Med, Richmond, VA USA; Virginia Commonwealth Univ Hlth Syst, Virginia Commonwealth Univ Reanimat Engn & Shock, Richmond, VA USA; Richmond Ambulance Author, Richmond, VA USA; Chippenham & Johnston Willis Hosp, Dept Emergency Med, Richmond, VA USA; Richmond Community Hosp, Dept Emergency Med, Richmond, VA USA; St Marys Hosp, Dept Emergency Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ornato, JP (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Emergency Med, 1250E Marshall St,2nd Floor, Richmond, VA 23298 USA.	ornato@aol.com	Best, Al/F-6425-2012	Best, Al/0000-0002-6300-3925				Abella BS, 2005, CIRCULATION, V111, P428, DOI 10.1161/01.CIR.0000153811.84257.59; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; BECKER LB, 1993, ANN EMERG MED, V22, P86, DOI 10.1016/S0196-0644(05)80257-4; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Casner Michael, 2005, Prehosp Emerg Care, V9, P61, DOI 10.1080/10903120590891714; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Eftestol T, 2004, CIRCULATION, V110, P10, DOI 10.1161/01.CIR.0000133323.15565.75; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; Halperin HR, 2002, CIRCULATION, V106, P538; HALPERIN HR, 1986, CIRCULATION, V74, P1407, DOI 10.1161/01.CIR.74.6.1407; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; KELSEY SF, 1991, CONTROL CLIN TRIALS, V12, P525; KERN KB, 1988, RESUSCITATION, V16, P241, DOI 10.1016/0300-9572(88)90111-6; Kern KB, 2000, BAILLIERE CLIN ANAES, V14, P591; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; MCDONALD JL, 1983, ANN EMERG MED, V12, P144; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; OMATO JP, 2003, RESUSCITATION, V56, P135; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; RALSTON SH, 1984, ANN EMERG MED, V13, P79, DOI 10.1016/S0196-0644(84)80566-1; SANDERS AB, 1985, AM J EMERG MED, V3, P11, DOI 10.1016/0735-6757(85)90003-8; SANDERS AB, 1984, CRIT CARE MED, V12, P871, DOI 10.1097/00003246-198410000-00007; Timerman S, 2004, RESUSCITATION, V61, P273, DOI 10.1016/j.resuscitation.2004.01.025; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; White RD, 1998, RESUSCITATION, V39, P145, DOI 10.1016/S0300-9572(98)00135-X; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; WOLFE JA, 1988, J THORAC CARDIOV SUR, V95, P523; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	36	164	180	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2629	2637		10.1001/jama.295.22.2629	http://dx.doi.org/10.1001/jama.295.22.2629			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772626	Bronze			2022-12-28	WOS:000238224000025
J	Ohenjo, N; Willis, R; Jackson, D; Nettleton, C; Good, K; Mugarura, B				Ohenjo, Nyang'ori; Willis, Ruth; Jackson, Dorothy; Nettleton, Clive; Good, Kenneth; Mugarura, Benon			Indigenous health 3 - Health of Indigenous people in Africa	LANCET			English	Article							HEPATITIS-C VIRUS; PYGMY POPULATION; CAMEROON; PREVALENCE; YAWS; INFECTION; AMERICA; FOREST; EBOLA; SAN	Our paper is part of a series focusing on Indigenous peoples' health in different world regions. Indigenous peoples worldwide are subject to marginalisation and discrimination, systematically experiencing poorer health than do majority groups. In Africa, poor health in the general population is widely recognised, but the consistently lower health position and social status of indigenous peoples are rarely noted. Disputed conceptual understandings of indigeneity, a history of discriminatory colonial and post-colonial policies, and non-recognition of Indigenous groups by some governments complicate the situation. We discuss two case studies, of the central African Pygmy peoples and the San of southern Africa, to illustrate recurring issues in Indigenous health in the continent. We make recommendations for the recognition of Indigenous peoples in Africa and improvements needed in the collection of health data and the provision of services. Finally, we argue that wider changes are needed to address the social determinants of Indigenous peoples' health.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Hlth Unltd, London, England; Univ Melbourne, Sch Anthropol Geog & Environm Studies, Parkville, Vic 3052, Australia	University of London; London School of Hygiene & Tropical Medicine; University of Melbourne	Nettleton, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	clive.nettleton@lshtm.ac.uk		Willis, Ruth/0000-0001-9570-7436				African Commission on Human and Peoples' Rights & International Work Group for Indigenous Affairs, 2005, REP AFR COMM WORK GR; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; [Anonymous], REDEFINING LEGITIMAT; [Anonymous], 2004, WORKSH DAT COLL DIS; [Anonymous], 2005, HUM DEV REP 2005; Balenger S., 2005, FOREST FARM IDENTIFY; BANDA F, 2004, MINORITIES INDIGENOU; Baquillon G, 1992, Acta Leprol, V8, P71; Barume A.K., 2000, HEADING EXTINCTION I; Betti J.L., 2004, AFRICAN STUDY MONOGR, V25, P1, DOI DOI 10.14989/68229; Biesbrouck K., 1999, CHALLENGING ELUSIVEN; BORCHERT M, 2005, EMERG INFECT DIS, V11; BOUREE P, 1983, AM J TROP MED HYG, V32, P1465, DOI 10.4269/ajtmh.1983.32.1465; *CAURA FOR PEOPL P, 2004, COND VIE POP BATW RW; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; CIRERA P, 1977, B SOC PATHOL EXOT, V70, P32; Colchester M., 2003, Nomadic Peoples, V7, P33, DOI 10.3167/082279403782088840; *COMM POL STUD UN, 2003, REC PROT IND PEOPL R; Commission for Africa, 2005, OUR COMMON INTEREST; CORPUZ VT, 2005, 58 ANN DPI NGO C UN; CORPUZ VT, 2005, MILLENIUM DEV GOALS; ELOBEID S, 2001, HLTH NAMIBIA PROGR C; *EP MED MISS FDN, MAK DIFF UG; *FOR PEOPL PROGR O, 2005, 1 UOBDU FOR PEOPL PR; Froment A, 2001, BIOSOCIAL S, V13, P239; Gonzalez JP, 2000, MICROBES INFECT, V2, P39, DOI 10.1016/S1286-4579(00)00287-2; Good K, 1999, J MOD AFR STUD, V37, P185, DOI 10.1017/S0022278X99003043; Good K, 2003, BUSHMEN DIAMONDS UNC; HERVE V, 1992, B SOC PATHOL EXOT, V85, P342; HEWLETT B, AKA PYGMIES W CONGO; Hewlett B. S., 1996, CULTURAL DIVERSITY 2, P215; Hewlett BS, 1986, AFRICAN PYGMIES, P45; HEWLETT BS, NGOTTO RESERVE FORAG; HEYMER A, 1985, B SOC PATHOL EXOT, V78, P226; HITCHCOCK ROBERT, 2004, INDIGENOUS PEOPLESRI; HODGESON D, IN PRESS TRANSNATION; Hodgson DL, 2002, AM ANTHROPOL, V104, P1037, DOI 10.1525/aa.2002.104.4.1037; *HUM RIGHTS WATCH, 2003, IT COV BLOOD ETHN TA, V15; International Labor Organization, CONV 169 IND TRIB PE; INTERNATIONAL WORK GROUP FOR INDIGENOUS AFFAIRS, 2004, IND WORLD 2004; Jackson D., 2005, OUR KNOWLEDGE OUR KN, VI, P150; Jackson D., 2003, TWA WOMEN TWA RIGHTS; JOHNSON ED, 1993, T ROY SOC TROP MED H, V87, P536, DOI 10.1016/0035-9203(93)90077-4; Kabananukye K., 1996, REPORT STUDY ABAYAND; Kenrick J., 2001, RACISM INDIGENOUS PE, P312; Kitanishi K., 1996, AFRICAN STUDY MONOGR, V17, P35, DOI [10.14989/68141, DOI 10.14989/68141]; Knight J, 2003, AFR STUDY MONOGR S, V28, P81; KOWO MP, 1995, T ROY SOC TROP MED H, V89, P484, DOI 10.1016/0035-9203(95)90076-4; KRETSINGER A, 1993, RECOMMENDATIONS FURT; Kuper A, 2005, LANCET, V366, P983, DOI 10.1016/S0140-6736(05)67374-6; LATTIMER M, 2004, ERASING BOARD REP IN; Lewis, 1995, TWA RWANDA ASSESSMEN; LEWIS I, 1999, THESIS U LONDON; Lewis J, 2000, BATWA PYGMIES GREAT; Lewis J., 2002, FOREST HUNTER GATHER; Lewis-Williams J. D., 1990, DISCOVERING SO AFRIC; LILLY AA, 2005, COMMENSALISM CONFLIC, P60; LOUIS FJ, 1994, T ROY SOC TROP MED H, V88, P53, DOI 10.1016/0035-9203(94)90494-4; MACDONALD D, 1999, ALCOHOL PELASURE HLT, P1; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; MARTIN PMV, 1988, J CLIN MICROBIOL, V26, P2432, DOI 10.1128/JCM.26.11.2432-2433.1988; Maybury-Lewis D., 1997, CULTURAL SURVIVAL ST; MCCASKILL D, 1997, DEV DOMESTICATION IN; Meheus A., 1992, World Health Statistics Quarterly, V45, P228; MERCIER K, 2005, COMMUNICATION; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; MOULIAPELAT JP, 1992, MED AFRIQUE NOIRE, V39, P140; Ndembi N, 2003, AIDS RES HUM RETROV, V19, P435, DOI 10.1089/088922203765551773; NDUMBE PM, 1993, MED MICROBIOL IMMUN, V182, P281, DOI 10.1007/BF00191943; Nelson J, 2003, PRINCIPLES PRACTICE; NOIREAU F, 1992, T ROY SOC TROP MED H, V86, P329, DOI 10.1016/0035-9203(92)90334-9; *OCDH, 2004, SIT PYGM REP CONG RA; PAMPIGLIONE S, 1975, BRIT J VENER DIS, V51, P165; Panter-Brick C., 2001, HUNTER GATHERERS INT; Pennington R, 2001, BIOSOCIAL S, V13, P170; PHORORO H, 2004, FUNDING FIGHT BUDGET; PRB (Population Reference Bureau), 2005, 2005 WORLD POP DAT S; Robins S., 2001, ASSESSMENT STATUS SA; SALOMONE G, 2000, LUTTE GRANDES ENDEMI; Sarno Louis, 1993, SONG FOREST MY LIFE; SAUGESTED S, 2001, INCONVENIENT INDIGEN; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Suzman J., 2001, REGIONAL ASSESSMENT; Sylvain R, 2002, AM ANTHROPOL, V104, P1074, DOI 10.1525/aa.2002.104.4.1074; SYLVAIN R, 2002, INDIGENOUS WOMEN, V1, P8; Tchoumba Belmond, 2005, INDIGENOUS TRIBAL PE; *UN, 2005, ADV UN DRAFT PROGR A; *UN HIGH COMM HU, 1994, DRAFT UN DECL RIGHT; *UNAIDS U, 2004, EP FACT SHEETS HIV A; UNDP, 1998, HUM DEV REP 1998 CON; UNDP, 1996, HUM DEV REP 1996 EC; *US DEP STAT, 1997, CONG COUNTR REP HUM; Vinding Diane, 2005, INDIGENOUS WORLD 200; WALKER PL, 1990, AM ANTHROPOL, V92, P383, DOI 10.1525/aa.1990.92.2.02a00080; WILKIE DS, 2005, CULTURAL SURVIVAL Q, P29; WILLIS R, 2004, RIGHT HLTH INDIGENOU; *WORLD BANK, 2005, GLOB MON REP MILL GO	97	99	99	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 10	2006	367	9526					1937	1946		10.1016/S0140-6736(06)68849-1	http://dx.doi.org/10.1016/S0140-6736(06)68849-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XG	16765763				2022-12-28	WOS:000238194400033
J	Karakozova, M; Kozak, M; Wong, CCL; Bailey, AO; Yates, JR; Mogilner, A; Zebroski, H; Kashina, A				Karakozova, Marina; Kozak, Marina; Wong, Catherine C. L.; Bailey, Aaron O.; Yates, John R., III; Mogilner, Alexander; Zebroski, Henry; Kashina, Anna			Arginylation of beta-actin regulates actin cytoskeleton and cell motility	SCIENCE			English	Article							AMINO; POLYMERIZATION; MUTATION; REMOVAL; PROTEIN; INVIVO	Posttranslational arginylation is critical for mouse embryogenesis, cardiovascular development, and angiogenesis, but its molecular effects and the identity of proteins arginylated in vivo are unknown. We found that beta-actin was arginylated in vivo to regulate actin filament properties, beta-actin localization, and lamella formation in motile cells. Arginylation of beta-actin apparently represents a critical step in the actin N-terminal processing needed for actin functioning in vivo. Thus, posttranslational arginylation of a single protein target can regulate its intracellular function, inducing global changes on the cellular level, and may contribute to cardiovascular development and angiogenesis.	Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Univ Calif Davis, Davis, CA 95616 USA; Rockefeller Univ, New York, NY 10021 USA	University of Pennsylvania; Scripps Research Institute; University of California System; University of California Davis; Rockefeller University	Kashina, A (corresponding author), Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA.	akashina@vet.upenn.edu	Mogilner, Alex/A-3135-2008; Bailey, Aaron/ABB-8522-2021; Karakozova, Marina/Q-9008-2019	Bailey, Aaron/0000-0001-8063-3032; Wong, Catherine CL/0000-0001-7270-980X	NCRR NIH HHS [P41 RR11823-09] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1990, J BIOL CHEM, V265, P7464; Condeelis J, 2005, BIOL CELL, V97, P97; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; HENNESSEY ES, 1991, EUR J BIOCHEM, V197, P345, DOI 10.1111/j.1432-1033.1991.tb15917.x; Hofer D, 1997, J CELL SCI, V110, P765; HOLMES KC, 1993, ADV EXP MED BIOL, V332, P15; KAJI H, 1968, BIOCHEMISTRY-US, V7, P3844, DOI 10.1021/bi00851a009; KAJI H, 1963, Biochim Biophys Acta, V76, P474; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MARTIN DJ, 1987, J BIOL CHEM, V262, P6350; OTEY CA, 1986, J CELL BIOL, V102, P1726, DOI 10.1083/jcb.102.5.1726; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P3961; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P1354; RUBENSTEIN PA, 1977, P NATL ACAD SCI USA, V74, P120, DOI 10.1073/pnas.74.1.120; Schmitz S, 2000, J MOL BIOL, V295, P1201, DOI 10.1006/jmbi.1999.3407; SHEFF DR, 1989, J BIOL CHEM, V264, P11491	19	194	196	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					192	196		10.1126/science.1129344	http://dx.doi.org/10.1126/science.1129344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16794040				2022-12-28	WOS:000239008000035
J	Aravin, A; Gaidatzis, D; Pfeffer, S; Lagos-Quintana, M; Landgraf, P; Iovino, N; Morris, P; Brownstein, MJ; Kuramochi-Miyagawa, S; Nakano, T; Chien, MC; Russo, JJ; Ju, JY; Sheridan, R; Sander, C; Zavolan, M; Tuschl, T				Aravin, Alexei; Gaidatzis, Dimos; Pfeffer, Sebastien; Lagos-Quintana, Mariana; Landgraf, Pablo; Iovino, Nicola; Morris, Patricia; Brownstein, Michael J.; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Chien, Minchen; Russo, James J.; Ju, Jingyue; Sheridan, Robert; Sander, Chris; Zavolan, Mihaela; Tuschl, Thomas			A novel class of small RNAs bind to MILI protein in mouse testes	NATURE			English	Article							MICRORNA GENES; IDENTIFICATION; PIWI; GENOMES; FAMILY; CELLS; SPERMATOGENESIS; VERTEBRATE; PROFILE; WORLD	Small RNAs bound to Argonaute proteins recognize partially or fully complementary nucleic acid targets in diverse gene-silencing processes(1-4). A subgroup of the Argonaute proteins - known as the 'Piwi family'(5) - is required for germ- and stem-cell development in invertebrates(6,7), and two Piwi members - MILI and MIWI - are essential for spermatogenesis in mouse(8,9). Here we describe a new class of small RNAs that bind to MILI in mouse male germ cells, where they accumulate at the onset of meiosis. The sequences of the over 1,000 identified unique molecules share a strong preference for a 50 uridine, but otherwise cannot be readily classified into sequence families. Genomic mapping of these small RNAs reveals a limited number of clusters, suggesting that these RNAs are processed from long primary transcripts. The small RNAs are 26 - 31 nucleotides (nt) in length - clearly distinct from the 21 - 23 nt of microRNAs ( miRNAs) or short interfering RNAs (siRNAs) - and we refer to them as 'Piwi-interacting RNAs' or piRNAs. Orthologous human chromosomal regions also give rise to small RNAs with the characteristics of piRNAs, but the cloned sequences are distinct. The identification of this new class of small RNAs provides an important starting point to determine the molecular function of Piwi proteins in mammalian spermatogenesis.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland; Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; Rockefeller Univ, Populat Council, New York, NY 10021 USA; J Craig Venter Inst, Rockville, MD 20850 USA; Osaka Univ, Grad Sch Frontier Biosci, Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	University of Basel; Howard Hughes Medical Institute; Rockefeller University; Population Council; Rockefeller University; J. Craig Venter Institute; Osaka University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center	Tuschl, T (corresponding author), Univ Basel, Bioctr, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	ttuschl@rockefeller.edu	Pfeffer, Sébastien/H-3212-2019; Pfeffer, Sebastien/A-6512-2010; Zavolan, Mihaela/S-3888-2016; Sander, Chris/H-1452-2011; Quintana, Mariana Lagos/A-7919-2010	Pfeffer, Sébastien/0000-0002-8458-348X; Pfeffer, Sebastien/0000-0002-8458-348X; Sander, Chris/0000-0001-6059-6270; Zavolan, Mihaela/0000-0002-8832-2041	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039024] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD039024] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Jenab S, 1998, ENDOCRINOLOGY, V139, P1883, DOI 10.1210/en.139.4.1883; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	25	1053	1141	9	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					203	207		10.1038/nature04916	http://dx.doi.org/10.1038/nature04916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16751777				2022-12-28	WOS:000238979700048
J	Lambais, MR; Crowley, DE; Cury, JC; Bull, RC; Rodrigues, RR				Lambais, M. R.; Crowley, D. E.; Cury, J. C.; Buell, R. C.; Rodrigues, R. R.			Bacterial diversity in tree canopies of the Atlantic forest	SCIENCE			English	Article							PHYLLOSPHERE		Univ Sao Paulo, Dept Soils & Soil Sci, Sao Paulo, Brazil; Univ Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil; Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92591 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of California System; University of California Riverside	Lambais, MR (corresponding author), Univ Sao Paulo, Dept Soils & Soil Sci, Sao Paulo, Brazil.	mlambais@esalq.usp-br; crowley@ucr.edu	Rodrigues, Ricardo Ribeiro/D-5557-2012; Lambais, Marcio R/C-1319-2012; Crowley, David/C-1216-2014	Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; Lambais, Marcio R/0000-0002-7218-3665; Cury, Juliano/0000-0002-1450-5726; Crowley, David/0000-0002-1805-8599				Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; RUINEN J, 1956, NATURE, V177, P220, DOI 10.1038/177220a0; Yadav RKP, 2005, MICROB ECOL, V50, P185, DOI 10.1007/s00248-004-0171-y; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	6	155	162	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1917	1917		10.1126/science.1124696	http://dx.doi.org/10.1126/science.1124696			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809531				2022-12-28	WOS:000238848100049
J	Juul, AB				Juul, A. B.		DIPOM Trial Grp	Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTOPERATIVE MORTALITY; MYOCARDIAL-INFARCTION; RISK; METAANALYSIS; GUIDELINES; MORBIDITY; BLOCKERS; ATENOLOL; THERAPY	Objectives To evaluate the long term effects of perioperative beta blockade on mortality and cardiac morbidity in patients with diabetes undergoing major non-cardiac surgery. Design Randomised placebo controlled and blinded multicentre trial. Analyses were by intention to treat. Setting University anaesthesia and surgical centres and one coordinating centre. Participants 921 patients aged > 39 scheduled for major non-cardiac surgery. Interventions 100 mg metoprolol controlled and extended release or placebo administered from the day before surgery to a maximum of eight perioperative days. Main outcome measures The composite primary outcome measure was time to all cause mortality, acute myocardial infarction, unstable angina, or congestive heart failure. Secondary outcome measures were time to all cause mortality, cardiac mortality, and non-fatal cardiac morbidity. Results Mean duration of intervention was 4.6 days in the metoprolol group and 4.9 days in the placebo group. Metoprolol significantly reduced the mean heart rate by 11% (95% confidence interval 9% to 13%) and mean blood pressure by 3% (1% to 5%). The primary outcome occurred in 99 of 462 patients in the metoprolol group (21%) and 93 of 459 patients in the placebo group (20%) (hazard ratio 1.06, 0.80 to 1.41) during a median follow-up of 18 months (range 6-30). All cause mortality was 16% (74/462) in the metoprolol group and 16% (72/459) in the placebo group (1.03,0.74 to 1.42). The difference in risk for the proportion of patients with serious adverse events was 2.4% (- 0.8% to 5.6%). Conclusions Perioperative metoprolol did not significantly affect mortality and cardiac morbidity in these patients with diabetes. Confidence intervals, however, were wide, and the issue needs reassessment.	Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Juul, AB (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark.	anne.j@ctu.rh.dk	Wetterslev, Jørn/ABF-1251-2020; Gluud, Christian/AAY-1027-2021	Wetterslev, Jørn/0000-0001-7778-1771; Gluud, Christian/0000-0002-8861-0799; Bestle, Morten/0000-0001-6585-2659				Ali MJ, 2000, CAN J ANAESTH, V47, P10, DOI 10.1007/BF03020725; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HARRIS MI, 1985, DIABETES CARE, V8, P562, DOI 10.2337/diacare.8.6.562; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; *INT C HARM TECHN, 2002, ICH HARM TRIP GUID G; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Juul AB, 2004, AM HEART J, V147, P677, DOI 10.1016/j.ahj.2003.10.030; Juul AB, 2004, EUR J ANAESTH, V21, P523, DOI 10.1017/S0265021504007045; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Leslie K, 2004, ANESTHESIOLOGY, V101, P803, DOI 10.1097/00000542-200409000-00040; Lindenauer PK, 2004, ARCH INTERN MED, V164, P762, DOI 10.1001/archinte.164.7.762; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; MANGANO DT, 1992, JAMA-J AM MED ASSOC, V268, P233, DOI 10.1001/jama.268.2.233; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Omvik Per, 1994, Am J Ther, V1, P65, DOI 10.1097/00045391-199406000-00011; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Powell JT, 2005, J VASC SURG, V41, P602, DOI 10.1016/j.jvs.2005.01.048; Redelmeier DA, 2005, BRIT MED J, V331, P932, DOI 10.1136/bmj.38603.746944.3A; Shammash JB, 2001, AM HEART J, V141, P148, DOI 10.1067/mhj.2001.111547; Siddiqui AK, 2004, ARCH INTERN MED, V164, P664, DOI 10.1001/archinte.164.6.664; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005	24	235	244	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1482	1485		10.1136/bmj.332.7556.1482	http://dx.doi.org/10.1136/bmj.332.7556.1482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793810	Green Published, Bronze			2022-12-28	WOS:000238820200017
J	Montagna, P; McCulloch, M; Taviani, M; Mazzoli, C; Vendrell, B				Montagna, Paolo; McCulloch, Malcolm; Taviani, Marco; Mazzoli, Claudio; Vendrell, Begona			Phosphorus in cold-water corals as a proxy for seawater nutrient chemistry	SCIENCE			English	Article							MARINE-SEDIMENTS; SEA; ACCUMULATION; SKELETONS; CARBONATE; PRIMNOA; BARIUM	Phosphorus is a key macronutrient being strongly enriched in the deep ocean as a result of continuous export and remineralization of biomass from primary production. We show that phosphorus incorporated within the skeletons of the cosmopolitan cold-water coral Desmophyllum dianthus is directly proportional to the ambient seawater phosphorus concentration and thus may serve as a paleo-oceanographic proxy for variations in ocean productivity as well as changes in the residence times and sources of deep-water masses. The application of this tool to fossil specimens from the Mediterranean reveals phosphorus-enriched bottom waters at the end of the Younger Dryas period.	ICRAM, I-00166 Rome, Italy; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; CNR, Ist Sci Marine, I-40129 Bologna, Italy; Univ Padua, Dipartimento Mineral & Petrol, I-35137 Padua, Italy; CNR, Ist Geosci & Georisorse, I-35137 Padua, Italy; CSIC, Inst Ciencias Mar, E-08003 Barcelona, Spain	Australian National University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Montagna, P (corresponding author), ICRAM, Via Casalotti 300, I-00166 Rome, Italy.	p.montagna@icram.org	Montagna, Paolo/H-9632-2015; McCulloch, Malcolm T/C-3651-2009; Taviani, Marco/AAF-2168-2020; Mazzoli, Claudio/H-9651-2015; Montagna, Paolo/F-3457-2010; CNR, Ismar/P-1247-2014	Montagna, Paolo/0000-0001-5598-2214; McCulloch, Malcolm T/0000-0003-1538-1558; Taviani, Marco/0000-0003-0414-4274; Mazzoli, Claudio/0000-0002-0374-8415; CNR, Ismar/0000-0001-5351-1486				Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Barcena MA, 2001, PALAEOGEOGR PALAEOCL, V167, P337, DOI 10.1016/S0031-0182(00)00246-7; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BERTRAND P, 1993, NATURE, V364, P786, DOI 10.1038/364786a0; Bethoux JP, 1998, MAR CHEM, V63, P155, DOI 10.1016/S0304-4203(98)00059-0; CAIRNS SD, 1981, 4TH P INT COR REEF S, V1, P611; Cheng H, 2000, GEOCHIM COSMOCHIM AC, V64, P2401, DOI 10.1016/S0016-7037(99)00422-6; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; DODGE RE, 1984, MAR POLLUT BULL, V15, P178, DOI 10.1016/0025-326X(84)90317-5; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; Forsterra G., 2003, ZOOL VERH, V345, P117; Heikoop JM, 2002, HYDROBIOLOGIA, V471, P117, DOI 10.1023/A:1016505421115; Marchitto TM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000753; McCulloch M., 2005, 3 INT S DEEP SEA COR, P191; McManus J, 1998, GEOCHIM COSMOCHIM AC, V62, P3453, DOI 10.1016/S0016-7037(98)00248-8; Montagna P, 2005, ERLANGEN EARTH C SER, P1109, DOI 10.1007/3-540-27673-4_56; MONTAGNA P, 2005, 3 INT S DEEP SEA COR, P193; NORAMBUENA F, 2002, THESIS U AUSTRAL CHI; RASMUSSEN CE, 1990, P 4 PAC C MAR SCI TE, V1, P13; Rickaby REM, 1999, PALEOCEANOGRAPHY, V14, P293, DOI 10.1029/1999PA900007; Sherwood OA, 2005, MAR ECOL PROG SER, V301, P135, DOI 10.3354/meps301135; SHOTYK W, 1995, J CHROMATOGR A, V706, P209, DOI 10.1016/0021-9673(94)01153-6; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; WAKEHAM SG, 1993, ORG GEOCHEM, P145, DOI DOI 10.1007/978-1-4615-2890-6_6	29	74	76	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1788	1791		10.1126/science.1125781	http://dx.doi.org/10.1126/science.1125781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794077				2022-12-28	WOS:000238452800056
J	Hall, WD				Hall, WD			How have the SSRI antidepressants affected suicide risk?	LANCET			English	Editorial Material							SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; TIME-SERIES ANALYSIS; ADOLESCENTS; DEPRESSION; METAANALYSIS; ASSOCIATION; MEDICATION; EFFICACY; PLACEBO		Univ Queensland, Sch Populat Hlth, Herston, Qld 4066, Australia	University of Queensland	Hall, WD (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4066, Australia.	w.hall@sph.uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				Barbui C, 1999, SOC PSYCH PSYCH EPID, V34, P152, DOI 10.1007/s001270050127; Carlsten A, 2001, PHARMACOEPIDEM DR S, V10, P525, DOI 10.1002/pds.618; Ernst CL, 2004, HARVARD REV PSYCHIAT, V12, P14, DOI 10.1080/10673220490425924; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Grunebaum MF, 2004, J CLIN PSYCHIAT, V65, P1456, DOI 10.4088/JCP.v65n1103; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hall WD, 2003, BRIT MED J, V326, P1008, DOI 10.1136/bmj.326.7397.1008; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Healy D, 2003, PSYCHOTHER PSYCHOSOM, V72, P71, DOI 10.1159/000068691; Helgason T, 2004, BRIT J PSYCHIAT, V184, P157, DOI 10.1192/bjp.184.2.157; Isacsson G, 2005, ACTA PSYCHIAT SCAND, V111, P286, DOI 10.1111/j.1600-0447.2004.00504.x; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Kelly CB, 2003, EUR PSYCHIAT, V18, P325, DOI 10.1016/j.eurpsy.2003.03.005; Ludwig J, 2005, J POLICY ANAL MANAG, V24, P249, DOI 10.1002/pam.20089; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; Mann JJ, 2006, NEUROPSYCHOPHARMACOL, V31, P473, DOI 10.1038/sj.npp.1300958; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Ohberg A, 1998, J AFFECT DISORDERS, V50, P225, DOI 10.1016/S0165-0327(98)00114-1; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; Rihmer Z, 2003, PSYCHOTHER PSYCHOSOM, V72, P357, DOI 10.1159/000073033; Sondergard L, 2006, EUR CHILD ADOLES PSY, V15, P232, DOI 10.1007/s00787-006-0527-6; Valuck RJ, 2004, CNS DRUGS, V18, P1119, DOI 10.2165/00023210-200418150-00006; van Praag H M, 2002, Crisis, V23, P77	27	34	35	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2006	367	9527					1959	1962		10.1016/S0140-6736(06)68860-0	http://dx.doi.org/10.1016/S0140-6736(06)68860-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782468				2022-12-28	WOS:000238488900007
J	Goodnow, CC				Goodnow, CC			Discriminating microbe from self suffers a double toll	SCIENCE			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVATE B-CELLS; AUTOANTIBODY PRODUCTION; DNA; RECOGNITION; RECEPTORS; AUTOIMMUNITY; ENGAGEMENT; ORIGIN; MICE		Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; Australian Natl Univ, Australian Phenom Facil, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 0200, Australia.	chris.goodnow@anu.edu.au	Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Martin DA, 2005, J EXP MED, V202, P1465, DOI 10.1084/jem.20052228; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Sekiguchi DR, 2006, J IMMUNOL, V176, P6879, DOI 10.4049/jimmunol.176.11.6879; Vallin H, 1999, J IMMUNOL, V163, P6306; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	23	16	18	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1606	1608		10.1126/science.1129797	http://dx.doi.org/10.1126/science.1129797			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778043				2022-12-28	WOS:000238288600031
J	Daw, ND; O'Doherty, JP; Dayan, P; Seymour, B; Dolan, RJ				Daw, Nathaniel D.; O'Doherty, John P.; Dayan, Peter; Seymour, Ben; Dolan, Raymond J.			Cortical substrates for exploratory decisions in humans	NATURE			English	Article							PREFRONTAL CORTEX; PARIETAL CORTEX; ORBITOFRONTAL CORTEX; HUMAN BRAIN; REWARD; PREDICTION; DOPAMINE; STRIATUM; SYSTEMS; REPRESENTATIONS	Decision making in an uncertain environment poses a conflict between the opposing demands of gathering and exploiting information. In a classic illustration of this 'exploration-exploitation' dilemma(1), a gambler choosing between multiple slot machines balances the desire to select what seems, on the basis of accumulated experience, the richest option, against the desire to choose a less familiar option that might turn out more advantageous ( and thereby provide information for improving future decisions). Far from representing idle curiosity, such exploration is often critical for organisms to discover how best to harvest resources such as food and water. In appetitive choice, substantial experimental evidence, underpinned by computational reinforcement learning(2) (RL) theory, indicates that a dopaminergic(3,4), striatal(5-9) and medial prefrontal network mediates learning to exploit. In contrast, although exploration has been well studied from both theoretical(1) and ethological(10) perspectives, its neural substrates are much less clear. Here we show, in a gambling task, that human subjects' choices can be characterized by a computationally well-regarded strategy for addressing the explore/exploit dilemma. Furthermore, using this characterization to classify decisions as exploratory or exploitative, we employ functional magnetic resonance imaging to show that the frontopolar cortex and intraparietal sulcus are preferentially active during exploratory decisions. In contrast, regions of striatum and ventromedial prefrontal cortex exhibit activity characteristic of an involvement in value-based exploitative decision making. The results suggest a model of action selection under uncertainty that involves switching between exploratory and exploitative behavioural modes, and provide a computationally precise characterization of the contribution of key decision-related brain systems to each of these functions.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	O'Doherty, JP (corresponding author), UCL, Gatsby Computat Neurosci Unit, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	jdoherty@hss.caltech.edu	O'Doherty, John P/F-1204-2013	Dayan, Peter/0000-0003-3476-1839; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Gittins J., 1974, PROGR STAT, P241; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Kaelbling L.P., 1993, LEARNING EMBEDDED SY; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549	30	1279	1287	11	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					876	879		10.1038/nature04766	http://dx.doi.org/10.1038/nature04766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778890	Green Accepted, Green Published			2022-12-28	WOS:000238254100043
J	Mello, MM; Studdert, DM; Brennan, TA				Mello, MM; Studdert, DM; Brennan, TA			Obesity - The new frontier of public health law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							YOUTH SMOKING; CHILDHOOD OBESITY; TELEVISION COMMERCIALS; PHYSICAL-ACTIVITY; FOOD MESSAGES; UNITED-STATES; SOFT DRINKS; IMPACT; SCHOOLS; TAXES		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Aetna, Hartford, CT USA	Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 665 Huntington Ave, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270				*AM BEV ASS, 2006, SCH BEV GUID Q A; [Anonymous], 1981, FED REG; [Anonymous], 2001, SURG GEN CALL ACT PR; Bayer R, 2002, JAMA-J AM MED ASSOC, V287, P2990, DOI 10.1001/jama.287.22.2990; Bloche MG, 2005, GEORGETOWN LAW J, V93, P1335; Borzekowski DLG, 2001, J AM DIET ASSOC, V101, P42, DOI 10.1016/S0002-8223(01)00012-8; Byrd-Bredbenner C, 2000, J SCHOOL HEALTH, V70, P61, DOI 10.1111/j.1746-1561.2000.tb07245.x; Carter RC, 2002, JAMA-J AM MED ASSOC, V288, P2180, DOI 10.1001/jama.288.17.2180; Centers for Disease Control and Prevention, 2004, YOUTH RISK BEH SURV; Chou S.-Y., 2005, FAST FOOD RESTAURANT; Critser G., 2003, FAT LAND AM BECAME F; *CTR CONS FREED, 2002, FIT FAT WER FIR; DeCicca P, 2002, J POLIT ECON, V110, P144, DOI 10.1086/324386; *DEP HLTH HUM SERV, 2006, PERSP MARK SELF REG; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Emery S, 2005, ARCH PEDIAT ADOL MED, V159, P639, DOI 10.1001/archpedi.159.7.639; ENGLE MK, 2003, I MED WORKSH PREV CH; ENGLE PC, 1978, WASHINGTON POST 0308, pA14; Epstein RA, 2005, GEORGETOWN LAW J, V93, P1361; Evans WD, 2005, AM J PREV MED, V28, P26, DOI 10.1016/j.amepre.2004.09.008; Farrelly MC, 2005, AM J PUBLIC HEALTH, V95, P425, DOI 10.2105/AJPH.2004.049692; *FDA, 2005, FDA ASK PUBL COMM FO; Food and Drug Administration, 2003, FOOD LAB TRANS FATT; Food and Drug Administration, 2004, CAL COUNT REP WORK G; Food Labeling; Health Messages and Label Statements, 1990, FED REGISTER, V55, P5176; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Fried EJ, 2002, JAMA-J AM MED ASSOC, V288, P2181, DOI 10.1001/jama.288.17.2181; *FTC, 2002, 02N0209 FED TRAD COM; *FTC, 1978, FED REGISTER, V43, P17967; General Accounting Office, 2000, GAOHEHS00156; GORN GJ, 1982, J CONSUM RES, V9, P200, DOI 10.1086/208913; Gostin LO, 2002, AM J PUBLIC HEALTH, V92, P352, DOI 10.2105/AJPH.92.3.352; Gostin LO, 2001, MILBANK Q, V79, P547, DOI 10.1111/1468-0009.00221; Gostin LO, 2000, PUBLIC HLTH LAW POWE; *HARR INT, 2005, WALL STREET J   0215, P1; Harrison K, 2005, HEALTH COMMUN, V17, P117, DOI 10.1207/s15327027hc1702_1; HAWKES C., 2004, MARKETING FOOD CHILD; Jacobson MF, 2000, AM J PUBLIC HEALTH, V90, P854, DOI 10.2105/AJPH.90.6.854; Kersh R, 2002, HEALTH AFFAIR, V21, P142, DOI 10.1377/hlthaff.21.6.142; Koplan J., 2005, PREVENTING CHILDHOOD; Kunkel D., 2004, REPORT APA TASK FORC; Kunkel D., 2001, HDB CHILDREN MEDIA, P375; Mathios AD, 2000, J LAW ECON, V43, P651, DOI 10.1086/467468; MCCANN MA, 2004, WISC LAW REV, V4, P1161; McGinnis J.M., 2006, FOOD MARKETING CHILD; Mello MM, 2003, HEALTH AFFAIR, V22, P207, DOI 10.1377/hlthaff.22.6.207; Mensah George A, 2004, Prev Chronic Dis, V1, pA11; *NAT C STAT LEG, HLTH PROM PROGR STAT; *NAT REST ASS, 2005, STAT BILL TRACK NUTR; Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12; NESTLE M, 2013, FOOD POLITICS FOOD I; Noah Lars, 1995, FLA L REV, V47, P80; Obesity as a Public Health Issue: A look at Solutions, 2003, OBESITY PUBLIC HLTH; *OFF SURG GEN, 2000, RED TOB US REP SURG; OLIVER JE, 2002, RWP02017 KSG JF KENN; Ross H, 2003, HEALTH ECON, V12, P217, DOI 10.1002/hec.709; Schlosser Eric, 2002, FAST FOOD NATION DAR; Signorielli N, 1997, HEALTH COMMUN, V9, P289, DOI 10.1207/s15327027hc0904_1; Story Mary, 2004, Int J Behav Nutr Phys Act, V1, P3, DOI 10.1186/1479-5868-1-3; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; TARANTINO LM, 2004, COMMUNICATION    MAR; TARAS HL, 1989, J DEV BEHAV PEDIATR, V10, P176, DOI 10.1097/00004703-198908000-00003; Tillotson JE, 2004, ANNU REV NUTR, V24, P617, DOI 10.1146/annurev.nutr.24.012003.132434; WARNER M, 2005, NY TIMES        1207; WESTBROOK C, 2004, BBC NEWS ONLINE 0910; WESTEN T, 2005, LOYOL LAW SCH S FOOD; World Health Organization, 2004, GLOB STRAT DIET PHYS; 1999, MMWR MORB MORTAL WKL, V48, P241; 2005, NUTR STANDARDS FOODS; 2005, OBESITY POLICY REPOR, V3	70	147	150	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2601	2610		10.1056/NEJMhpr060227	http://dx.doi.org/10.1056/NEJMhpr060227			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052KU	16775242				2022-12-28	WOS:000238233400014
J	Crowcroft, NS; Pebody, RG				Crowcroft, Natasha S.; Pebody, Richard G.			Recent developments in pertussis	LANCET			English	Review							FIELD GEL-ELECTROPHORESIS; HEALTH-CARE WORKERS; WHOLE-CELL VACCINE; BORDETELLA-PERTUSSIS; UNITED-STATES; ACELLULAR VACCINE; ECONOMIC-EVALUATION; HOUSEHOLD EXPOSURE; CONTROLLED-TRIAL; ADULT PERTUSSIS	Pertussis causes nearly 300 000 deaths in children every year. Most deaths take place in developing countries, but the infection remains a priority everywhere. Pertussis vaccination protects infants and children against death and admission to hospital, but breakthrough disease in vaccinated people can happen. In high-mortality countries, the challenge is to improve timeliness and coverage of childhood vaccination and surveillance. In regions with low mortality and highest coverage, pertussis is frequently the least well-controlled disease in childhood vaccination programmes. Some countries have reported a rise in pertussis in adolescents, adults, and pre-vaccination infants, but how much these changes are real or a result of improved recognition and surveillance remains uncertain. In response, several countries have introduced adolescent and adult acellular pertussis vaccine boosters. The effect so far is unknown; assessment is impeded by poor data. Uncertainties still persist about key variables needed to model and design vaccination programmes, such as risk of transmission from adults and adolescents to infants. New vaccination strategies under investigation include vaccination of neonates, family members, and pregnant women.	Hlth Protect Agcy Ctr Infect, Immunisat Dept, London NW9 5EQ, England	Health Protection Agency	Crowcroft, NS (corresponding author), Hlth Protect Agcy Ctr Infect, Immunisat Dept, London NW9 5EQ, England.	Natasha.Crowcroft@HPA.org.uk		Pebody, Richard/0000-0002-9069-2885				Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; Bartkus JM, 2003, J CLIN MICROBIOL, V41, P1167, DOI 10.1128/JCM.41.3.1167-1172.2003; BASS JW, 1994, PEDIATR INFECT DIS J, V13, P343, DOI 10.1097/00006454-199405000-00002; Baughman AL, 2004, CLIN DIAGN LAB IMMUN, V11, P1045, DOI 10.1128/CDLI.11.6.1045-1053.2004; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; BLENNOW M, 1988, BRIT MED J, V296, P1570, DOI 10.1136/bmj.296.6636.1570; Broutin H, 2005, AM J EPIDEMIOL, V161, P1159, DOI 10.1093/aje/kwi141; Campins-Marti M, 2001, VACCINE, V20, P641, DOI 10.1016/S0264-410X(01)00393-0; Caro V, 2005, MICROBES INFECT, V7, P976, DOI 10.1016/j.micinf.2005.04.005; Casey JR, 2005, DRUGS, V65, P1367, DOI 10.2165/00003495-200565100-00005; *CDC, 1996, MMWR-MORBID MORTAL W, V46, P822; Cherry James D, 2005, Pediatr Infect Dis J, V24, pS25, DOI 10.1097/01.inf.0000160926.89577.3b; Cherry JD, 1999, CLIN INFECT DIS, V28, pS112, DOI 10.1086/515058; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cherry JD, 2003, PEDIATRICS, V112, P405, DOI 10.1542/peds.112.2.405; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Cordova S P, 2000, Commun Dis Intell, V24, P375; Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; De Schutter I, 2003, CLIN INFECT DIS, V36, P1391, DOI 10.1086/375071; De Serres G, 2000, J INFECT DIS, V182, P174, DOI 10.1086/315648; Dworkin MS, 2005, ANN INTERN MED, V142, P832, DOI 10.7326/0003-4819-142-10-200505170-00008; Edmunds WJ, 2002, VACCINE, V20, P1316, DOI 10.1016/S0264-410X(01)00473-X; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; Fine PEM, 1997, BIOLOGICALS, V25, P195, DOI 10.1006/biol.1997.0083; FINE PEM, 1986, INT J EPIDEMIOL, V15, P237, DOI 10.1093/ije/15.2.237; FINE PEM, 1987, REV INFECT DIS, V9, P866; FINE PEM, 1988, INT J EPIDEMIOL, V17, P635, DOI 10.1093/ije/17.3.635; Forsyth KD, 2004, CLIN INFECT DIS, V39, P1802, DOI 10.1086/426020; Forsyth Kevin, 2005, Pediatr Infect Dis J, V24, pS69, DOI 10.1097/01.inf.0000160917.29723.03; Fry NK, 2004, J MED MICROBIOL, V53, P519, DOI 10.1099/jmm.0.45624-0; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gay NJ, 2000, LANCET, V355, P1553, DOI 10.1016/S0140-6736(05)74603-1; Gehanno JF, 1999, INFECT CONT HOSP EP, V20, P549, DOI 10.1086/501667; Giammanco A, 2003, VACCINE, V22, P112, DOI 10.1016/S0264-410X(03)00514-0; Gil A, 2001, VACCINE, V19, P4791, DOI 10.1016/S0264-410X(01)00213-4; Gilberg S, 2002, J INFECT DIS, V186, P415, DOI 10.1086/341511; GORDON JE, 1951, AM J MED SCI, V222, P333, DOI 10.1097/00000441-195109000-00011; GRANSTROM G, 1987, J INFECT DIS, V155, P1210, DOI 10.1093/infdis/155.6.1210; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Grimprel E, 1999, LANCET, V354, P1699, DOI 10.1016/S0140-6736(99)01576-7; GRIMPREL E, 1993, J CLIN MICROBIOL, V31, P2745, DOI 10.1128/JCM.31.10.2745-2750.1993; Grimprel E, 1997, CLIN DIAGN LAB IMMUN, V4, P723, DOI 10.1128/CDLI.4.6.723-726.1997; Grimprel E, 1996, CLIN DIAGN LAB IMMUN, V3, P93, DOI 10.1128/CDLI.3.1.93-97.1996; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; GURIS D, 1999, MANUAL SURVEILLANCE, P1; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Gzyl A, 2001, VACCINE, V20, P299, DOI 10.1016/S0264-410X(01)00356-5; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; Hallander HO, 1999, CLIN INFECT DIS, V28, pS99, DOI 10.1086/515056; HALPERIN SA, 1989, J CLIN MICROBIOL, V27, P752, DOI 10.1128/JCM.27.4.752-757.1989; Halperin SA, 1997, PEDIATRICS, V100, P65, DOI 10.1542/peds.100.1.65; He QS, 2003, J INFECT DIS, V187, P1200, DOI 10.1086/368412; HEININGER U, 1993, PEDIATR INFECT DIS J, V12, P504, DOI 10.1097/00006454-199306000-00009; Heininger U, 2001, CURR OPIN INFECT DIS, V14, P329, DOI 10.1097/00001432-200106000-00014; Heininger U, 1996, EUR J PEDIATR, V155, P551, DOI 10.1007/s004310050440; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hethcote HW, 1999, MATH BIOSCI, V158, P47, DOI 10.1016/S0025-5564(99)00004-8; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; *HLTH CAN, 2003, CAN COMMUN DIS REP, V2953, P1; Howson CP, 1991, ADVERSE EFFECTS PERT; Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025; Iskedjian M, 2001, PHARMACOECONOMICS, V19, P551, DOI 10.2165/00019053-200119050-00009; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Kosters K, 2001, J MED MICROBIOL, V50, P436, DOI 10.1099/0022-1317-50-5-436; Langley JM, 2004, PEDIATRICS, V114, pE96, DOI 10.1542/peds.114.1.e96; Lebel MH, 2001, PEDIATR INFECT DIS J, V20, P1149, DOI 10.1097/00006454-200112000-00011; Lee GM, 2005, PEDIATRICS, V115, P1675, DOI 10.1542/peds.2004-2509; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; Lievano FA, 2002, J CLIN MICROBIOL, V40, P2801, DOI 10.1128/JCM.40.8.2801-2805.2002; MARCHANT CD, 1994, J INFECT DIS, V169, P1297, DOI 10.1093/infdis/169.6.1297; Mastrantonio P, 1999, MICROBIOL-UK, V145, P2069, DOI 10.1099/13500872-145-8-2069; Mazengia E, 2000, J CLIN MICROBIOL, V38, P2330; MEADE BD, 1995, PEDIATRICS, V96, P570; MILLER E, 1991, LANCET, V337, P70, DOI 10.1016/0140-6736(91)90735-8; Miller E, 2000, Commun Dis Public Health, V3, P132; Miller E, 2001, VACCINE, V19, P3904, DOI 10.1016/S0264-410X(01)00123-2; Miller E, 1999, BIOLOGICALS, V27, P79, DOI 10.1006/biol.1999.0184; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Murray CJ, GLOBAL BURDEN DIS CO; Muyldermans G, 2005, J CLIN MICROBIOL, V43, P30, DOI 10.1128/JCM.43.1.30-35.2005; Nardone A, 2004, VACCINE, V22, P1314, DOI 10.1016/j.vaccine.2003.08.039; Nennig ME, 1996, JAMA-J AM MED ASSOC, V275, P1672, DOI 10.1001/jama.275.21.1672; NIELSEN A, 1994, INT J EPIDEMIOL, V23, P1300, DOI 10.1093/ije/23.6.1300; Njamkepo E, 2002, VACCINE, V20, P1290, DOI 10.1016/S0264-410X(01)00479-0; Ntezayabo B, 2003, PEDIATR INFECT DIS J, V22, P22, DOI 10.1097/00006454-200301000-00009; Olin P, 2003, VACCINE, V21, P2015, DOI 10.1016/S0264-410X(02)00777-6; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PATRIARCA PA, 1988, AM J PUBLIC HEALTH, V78, P833, DOI 10.2105/AJPH.78.7.833; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Peppler MS, 2003, J CLIN MICROBIOL, V41, P3344, DOI 10.1128/JCM.41.7.3344-3347.2003; Plotkin SA, 1997, PEDIATR INFECT DIS J, V16, P913, DOI 10.1097/00006454-199709000-00021; POSTELSMULTANI S, 1995, INFECTION, V23, P139, DOI 10.1007/BF01793853; Poynten IM, 2002, EPIDEMIOL INFECT, V128, P161, DOI 10.1017/S0950268801006598; Preziosi MP, 2003, VACCINE, V21, P1853, DOI 10.1016/S0264-410X(03)00007-0; Purdy KW, 2004, CLIN INFECT DIS, V39, P20, DOI 10.1086/421091; RAMSAY MEB, 1993, EPIDEMIOL INFECT, V111, P41, DOI 10.1017/S095026880005665X; Reizenstein E, 1996, J CLIN MICROBIOL, V34, P810, DOI 10.1128/JCM.34.4.810-815.1996; Rennels MB, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e12; Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005; ROSENTHAL S, 1995, J INFECT DIS, V171, P1650, DOI 10.1093/infdis/171.6.1650; Rothstein Edward, 2005, Pediatr Infect Dis J, V24, pS44, DOI 10.1097/01.inf.0000160912.58660.87; Salmaso S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e81; Schellekens Joop, 2005, Pediatr Infect Dis J, V24, pS19, DOI 10.1097/01.inf.0000160909.24879.e6; Schmitt HJ, 1996, JAMA-J AM MED ASSOC, V275, P37, DOI 10.1001/jama.275.1.37; Scuffham PA, 2004, VACCINE, V22, P2953, DOI 10.1016/j.vaccine.2003.11.057; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; Smith RE, 1936, Q J MED, V5, P307; Stehr K, 1998, PEDIATRICS, V101, P1, DOI 10.1542/peds.101.1.1; STEKETEE RW, 1988, J INFECT DIS, V157, P434, DOI 10.1093/infdis/157.3.434; Stocks P, 1933, LANCET, V1, P265; Storsaeter J, 2003, VACCINE, V21, P3542, DOI 10.1016/S0264-410X(03)00407-9; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; Strebel P, 2001, J INFECT DIS, V183, P1353, DOI 10.1086/319853; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS83, DOI 10.1097/01.inf.0000160919.94330.1a; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS10, DOI 10.1097/01.inf.0000160708.43944.99; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Taranger J, 2001, CLIN INFECT DIS, V33, P1004, DOI 10.1086/322639; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Thomas PF, 2000, MED J AUSTRALIA, V173, P74, DOI 10.5694/j.1326-5377.2000.tb139246.x; Tormans G, 1998, EUR J PEDIATR, V157, P395, DOI 10.1007/s004310050837; TROLLFORS B, 1981, BRIT MED J, V283, P696, DOI 10.1136/bmj.283.6293.696; van Boven M, 2000, MATH BIOSCI, V164, P161, DOI 10.1016/S0025-5564(00)00009-2; Van Buynder PG, 1999, EPIDEMIOL INFECT, V123, P403, DOI 10.1017/S0950268899003052; van Loo IHM, 1999, J INFECT DIS, V179, P915, DOI 10.1086/314690; Van Rie Annelies, 2005, Pediatr Infect Dis J, V24, pS62, DOI 10.1097/01.inf.0000160915.93979.8f; VANSAVAGE J, 1990, J INFECT DIS, V161, P487, DOI 10.1093/infdis/161.3.487; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; Vincent JM, 2000, CLIN INFECT DIS, V30, P534, DOI 10.1086/313707; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; von Konig Carl-Heinz Wirsing, 2005, Pediatr Infect Dis J, V24, pS66, DOI 10.1097/01.inf.0000160916.47479.22; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; Ward A, 2005, INFECT CONT HOSP EP, V26, P288, DOI 10.1086/502541; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; White J., 1996, COMMUNICAB DIS REP, V6, P86; *WHO, 2001, PERT SURV GLOB M GEN; Wirsing von Konig Carl-Heinz, 2005, Pediatr Infect Dis J, V24, pS87, DOI 10.1097/01.inf.0000160920.75623.a3; World Health Organization, 2005, WORLD HLTH REP 2005; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044; Yih WK, 1999, EMERG INFECT DIS, V5, P441, DOI 10.3201/eid0503.990317; Yih WK, 2000, J INFECT DIS, V182, P1409, DOI 10.1086/315863	149	182	192	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1926	1936		10.1016/S0140-6736(06)68848-X	http://dx.doi.org/10.1016/S0140-6736(06)68848-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765762				2022-12-28	WOS:000238194400032
J	Crowder, R				Crowder, Richard			Applied physics - Toward robots that can sense texture by touch	SCIENCE			English	Editorial Material									Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	University of Southampton	Crowder, R (corresponding author), Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England.	rmc@ecs.soton.ac.uk						BICCHI A, 2000, P IEEE INT C ROB AUT, P328; Brown M., 1994, NEUROFUZZY ADAPTIVE; CROWDER RM, 2000, HDB INT AUTOMATION, P377; Dominguez-Lopez JA, 2004, IEEE SYS MAN CYBERN, P3193, DOI 10.1109/ICSMC.2004.1400831; FUENTAS O, 1996, IEEE SICE RSJ INT C, P342; HUANG G, 2006, NEW SCI         0204, V46; Lee MH, 2000, INT J ROBOT RES, V19, P636, DOI 10.1177/027836490001900702; Maheshwari V, 2006, SCIENCE, V312, P1501, DOI 10.1126/science.1126216	8	20	20	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1478	1479		10.1126/science.1129110	http://dx.doi.org/10.1126/science.1129110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763135	Green Accepted			2022-12-28	WOS:000238124100031
J	Avorn, J; Shrank, W				Avorn, J; Shrank, W			Highlights and a hidden hazard - The FDA's new labeling regulations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							*FOOD DRUG ADM, 2006, NEW REQ PRESCR INF; *GOV ACC OFF, 2006, IMPR NEED FDAS POSTM; HARRIS G, 2006, NY TIMES        0119, pA20; Lasser KE, 2006, ARCH INTERN MED, V166, P338, DOI 10.1001/archinte.166.3.338; 2006, FED REG, V71, P3922	5	15	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2409	2411		10.1056/NEJMp068119	http://dx.doi.org/10.1056/NEJMp068119			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760439				2022-12-28	WOS:000238100800001
J	Marek, PE; Bond, JE				Marek, Paul E.; Bond, Jason E.			Rediscovery of the world's leggiest animal	NATURE			English	Article							MILLIPEDES DIPLOPODA		E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Marek, PE (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	pm0623@ecu.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875				COOK O. F., 1928, PROC U S NAT MUS, V72, P1; Edgecombe GD, 1998, NATURE, V394, P172, DOI 10.1038/28156; ENGHOFF H, 1993, ZOOL J LINN SOC-LOND, V109, P103, DOI 10.1111/j.1096-3642.1993.tb00305.x; Hoffman R.L., 2002, P505; Hoffman RL, 1979, CLASSIFICATION DIPLO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Shear William A., 2003, Zootaxa, V243, P1; Shelley Rowland M., 1996, Myriapodologica, V4, P21; Sierwald P, 2003, J ZOOL SYST EVOL RES, V41, P87, DOI 10.1046/j.1439-0469.2003.00202.x; Wilson HM, 2004, J PALEONTOL, V78, P169, DOI 10.1666/0022-3360(2004)078<0169:MATOPM>2.0.CO;2	12	14	16	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					707	707		10.1038/441707a	http://dx.doi.org/10.1038/441707a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760967	Bronze			2022-12-28	WOS:000238095100041
J	Tani, K; Stoltz, BM				Tani, Kousuke; Stoltz, Brian M.			Synthesis and structural analysis of 2-quinuclidonium tetrafluoroborate	NATURE			English	Article							DISTORTED AMIDES; TWISTED AMIDE; LACTAMS; HYDROLYSIS; BOND; EXPRESSION; MECHANISM; RESONANCE; PROFILE; BASE	The amide functional group is one of the most fundamental motifs found in chemistry and biology, and it has been studied extensively for the past century(1). Typical acyclic amides are planar. But the amide groups of bicyclic bridgehead lactams(1,2) are highly twisted, and this distortion from planarity can dramatically affect the stability and reactivity of these amides; it also increases the basicity of the nitrogen so that it often behaves more like an amine than a typical planar amide. As a result, the structures and reactivity profiles of these 'anti-Bredt' amides(3) differ significantly from those of planar amides. It is possible that this twisting phenomenon is not exclusive to cyclic systems - non-planarity may also be a critical biological design element that leads to amide ground-state destabilization and alters the reactivity, selectivity and mechanism of various protein and enzymatic processes ( such as amide hydrolysis(1,4-10)). The intriguing qualities of these twisted amides were first recognized in 1938 ( ref. 11), wherein one of the simplest families was introduced - molecules containing the 1-azabicyclo[ 2.2.2]octan-2-one system. But the parent member of this group, 2-quinuclidone ( molecule 1 in this paper), has not yet been unambiguously synthesized. Here, we report the chemical synthesis, isolation and full characterization of the HBF4 salt of 1. Critical to the success of the synthesis and isolation was the decision to generate 1 by a route other than classical amide bond formation. We anticipate that these results will provide a greater understanding of the properties of amide bonds.	CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Stoltz, BM (corresponding author), CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Div Chem & Chem Engn, 1200 E Calif Blvd,M-C 164-30, Pasadena, CA 91125 USA.	stoltz@caltech.edu						[Anonymous], TETRAHEDRON; AUBE J, 1991, J AM CHEM SOC, V113, P8965, DOI 10.1021/ja00023a065; BENNET AJ, 1990, J AM CHEM SOC, V112, P6383, DOI 10.1021/ja00173a029; Blackburn G. M., 1980, J CHEM RES MINIPRINT, P3650; BOIVIN J, 1990, TETRAHEDRON LETT, V31, P2281, DOI 10.1016/0040-4039(90)80206-2; Bredt J, 1924, LIEBIGS ANN CHEM, V437, P1; BROWN RS, 1992, ACCOUNTS CHEM RES, V25, P481, DOI 10.1021/ar00023a001; BUCHANAN GL, 1983, J CHEM SOC PERK T 2, P1709, DOI 10.1039/p29830001709; DUNITZ JD, 1975, ACTA CRYSTALLOGR B, V31, P251, DOI 10.1107/S0567740875002427; GREENBERG A, 1993, J AM CHEM SOC, V115, P6951, DOI 10.1021/ja00068a064; GREENBERG A, 1993, STRUCT CHEM, V4, P127, DOI 10.1007/BF00677372; Greenberg A, 1996, J AM CHEM SOC, V118, P8658, DOI 10.1021/ja960294h; Greenberg A., 2000, AMIDE LINKAGE STRUCT; GREENFIELD C, 1988, EMBO J, V7, P139, DOI 10.1002/j.1460-2075.1988.tb02793.x; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Johnson J. R., 1949, CHEM PENICILLIN, P440; Kirby AJ, 1998, ANGEW CHEM INT EDIT, V37, P785, DOI 10.1002/(SICI)1521-3773(19980403)37:6<785::AID-ANIE785>3.0.CO;2-J; Lei Y, 2005, J AM CHEM SOC, V127, P4552, DOI 10.1021/ja050214m; LEVKOEVA EI, 1970, DOKL AKAD NAUK SSSR+, V192, P342; LIU J, 1990, P NATL ACAD SCI USA, V87, P2304, DOI 10.1073/pnas.87.6.2304; Lukes R., 1938, COLLECT CZECH CHEM C, V10, P148, DOI DOI 10.1135/CCCC19380148; MOCK WL, 1976, BIOORG CHEM, V5, P403, DOI 10.1016/0045-2068(76)90025-0; Mujika JI, 2005, J AM CHEM SOC, V127, P4445, DOI 10.1021/ja044873v; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; WANG QP, 1990, CAN J CHEM, V68, P1732, DOI 10.1139/v90-269; WASSERMAN HH, 1977, HETEROCYCLES, V7, P1; WIBERG KB, 1987, J AM CHEM SOC, V109, P5935, DOI 10.1021/ja00254a006; WILLIAMS RM, 1986, J AM CHEM SOC, V108, P6431, DOI 10.1021/ja00280a075; Yakhontov L. N., 1957, J GEN CHEM USSR, V27, P83	30	201	215	8	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					731	734		10.1038/nature04842	http://dx.doi.org/10.1038/nature04842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	050NL	16760973				2022-12-28	WOS:000238095100049
J	Aoyama, H; Shirato, H; Tago, M; Nakagawa, K; Toyoda, T; Hatano, K; Kenjyo, M; Oya, N; Hirota, S; Shioura, H; Kunieda, E; Inomata, T; Hayakawa, K; Katoh, N; Kobashi, G				Aoyama, Hidefumi; Shirato, Hiroki; Tago, Masao; Nakagawa, Keiichi; Toyoda, Tatsuya; Hatano, Kazuo; Kenjyo, Masahiro; Oya, Natsuo; Hirota, Saeko; Shioura, Hiroki; Kunieda, Etsuo; Inomata, Taisuke; Hayakawa, Kazushige; Katoh, Norio; Kobashi, Gen			Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	40th Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 05-08, 2004	New Orleans, LA	Amer Soc Clin Oncol			RECURSIVE PARTITIONING ANALYSIS; SINGLE METASTASES; RADIOTHERAPY; MANAGEMENT; IRRADIATION; SOLITARY; SURGERY	Context In patients with brain metastases, it is unclear whether adding up-front whole-brain radiation therapy (WBRT) to stereotactic radiosurgery (SRS) has beneficial effects on mortality or neurologic function compared with SRS alone. Objective To determine if WBRT combined with SRS results in improvements in survival, brain tumor control, functional preservation rate, and frequency of neurologic death. Design, Setting, and Patients Randomized controlled trial of 132 patients with 1 to 4 brain metastases, each less than 3 cm in diameter, enrolled at 11 hospitals in Japan between October 1999 and December 2003. Interventions Patients were randomly assigned to receive WBRT plus SRS ( 65 patients) or SRS alone ( 67 patients). Main Outcome Measures The primary end point was overall survival; secondary end points were brain tumor recurrence, salvage brain treatment, functional preservation, toxic effects of radiation, and cause of death. Results The median survival time and the 1-year actuarial survival rate were 7.5 months and 38.5% (95% confidence interval, 26.7%-50.3%) in the WBRT + SRS group and 8.0 months and 28.4% (95% confidence interval, 17.6%-39.2%) for SRS alone (P=. 42). The 12-month brain tumor recurrence rate was 46.8% in the WBRT + SRS group and 76.4% for SRS alone group ( P <. 001). Salvage brain treatment was less frequently required in the WBRT + SRS group (n = 10) than with SRS alone ( n = 29) ( P <. 001). Death was attributed to neurologic causes in 22.8% of patients in the WBRT + SRS group and in 19.3% of those treated with SRS alone ( P=. 64). There were no significant differences in systemic and neurologic functional preservation and toxic effects of radiation. Conclusions Compared with SRS alone, the use of WBRT plus SRS did not improve survival for patients with 1 to 4 brain metastases, but intracranial relapse occurred considerably more frequently in those who did not receive WBRT. Consequently, salvage treatment is frequently required when up-front WBRT is not used.	Hokkaido Univ, Grad Sch Med, Dept Radiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Grad Sch Med, Dept Global Hlth & Epidemiol, Div Prevent Med, Sapporo, Hokkaido 0608638, Japan; Tokyo Univ Hosp, Dept Radiol, Tokyo 113, Japan; Kanto Med Ctr NTT EC, Dept Radiol, Tokyo, Japan; Chiba Canc Ctr, Dept Radiol, Chiba, Japan; Hiroshima Univ, Sch Med, Dept Radiol, Hiroshima, Japan; Kyoto Univ, Sch Med, Dept Radiol, Kyoto 606, Japan; Hyogo Med Ctr Adults, Dept Radiol, Akashi, Hyogo, Japan; Izumisano Gen Hosp, Dept Radiol, Izumisano, Japan; Keio Univ, Sch Med, Dept Radiol, Tokyo, Japan; Osaka Med Coll, Dept Radiol, Osaka, Japan; Kitazato Med Sch, Dept Radiol, Sagamihara, Kanagawa, Japan	Hokkaido University; Hokkaido University; University of Tokyo; Kanto Medical Center NTT EC; Chiba Cancer Center; Hiroshima University; Kyoto University; Keio University; Osaka Medical College; Kitasato University	Aoyama, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Radiol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	h-aoyama@umin.ac.jp	Katoh, Norio/A-5488-2012; Shirato, Hiroki/A-7068-2010; Aoyama, Hidefumi/D-3635-2016	Katoh, Norio/0000-0003-3959-2114; Aoyama, Hidefumi/0000-0002-8437-7491				Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Aoyama HI, 2003, INT J RADIAT ONCOL, V56, P793, DOI 10.1016/S0360-3016(03)00014-2; Bradley KA, 2004, SEMIN ONCOL, V31, P693, DOI 10.1053/j.seminoncol.2004.07.012; Chidel MA, 2000, INT J RADIAT ONCOL, V47, P993, DOI 10.1016/S0360-3016(00)00527-7; COX DR, 1972, J R STAT SOC B, V34, P187; DEANGELIS LM, 1989, NEUROLOGY, V39, P789, DOI 10.1212/WNL.39.6.789; FLICKINGER JC, 1994, INT J RADIAT ONCOL, V28, P797, DOI 10.1016/0360-3016(94)90098-1; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Joseph J, 1996, J CLIN ONCOL, V14, P1085, DOI 10.1200/JCO.1996.14.4.1085; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kondziolka D, 1999, INT J RADIAT ONCOL, V45, P427, DOI 10.1016/S0360-3016(99)00198-4; LEKSELL L, 1951, ACTA CHIR SCAND, V102, P316; Mintz AH, 1996, CANCER, V78, P1470, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; PATCHELL RA, 1990, NEW ENGL J MED, V322, P494, DOI 10.1056/NEJM199002223220802; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Pirzkall A, 1998, J CLIN ONCOL, V16, P3563, DOI 10.1200/JCO.1998.16.11.3563; Regine WF, 2002, INT J RADIAT ONCOL, V52, P333, DOI 10.1016/S0360-3016(01)02645-1; Shaw E, 1996, INT J RADIAT ONCOL, V34, P647, DOI 10.1016/0360-3016(95)02106-X; Shirato H, 1997, INT J RADIAT ONCOL, V37, P385, DOI 10.1016/S0360-3016(96)00488-9; Sneed PK, 2002, INT J RADIAT ONCOL, V53, P519, DOI 10.1016/S0360-3016(02)02770-0; The Radiation Therapy Oncology Group, RTOG EORTC LAT RAD M; Trotti A, 2000, INT J RADIAT ONCOL, V47, P13, DOI 10.1016/S0360-3016(99)00559-3; VECHT CJ, 1993, ANN NEUROL, V33, P583, DOI 10.1002/ana.410330605	24	1562	1629	1	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2483	2491		10.1001/jama.295.21.2483	http://dx.doi.org/10.1001/jama.295.21.2483			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	049ZQ	16757720				2022-12-28	WOS:000238057300023
J	Kearon, C; Ginsberg, JS; Douketis, J; Turpie, AG; Bates, SM; Lee, AY; Crowther, MA; Weitz, JI; Brill-Edwards, P; Wells, P; Anderson, DR; Kovacs, MJ; Linkins, LA; Julian, JA; Bonilla, LR; Gent, M				Kearon, Clive; Ginsberg, Jeffrey S.; Douketis, James; Turpie, Alexander G.; Bates, Shannon M.; Lee, Agnes Y.; Crowther, Mark A.; Weitz, Jeffrey I.; Brill-Edwards, Patrick; Wells, Philip; Anderson, David R.; Kovacs, Michael J.; Linkins, Lori-Ann; Julian, Jim A.; Bonilla, Laura R.; Gent, Michael		CANPEDS Grp	An evaluation of D-dimer in the diagnosis of pulmonary embolism - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							SIMPLE CLINICAL-MODEL; COMPUTED-TOMOGRAPHY; VENOUS THROMBOEMBOLISM; NONINVASIVE DIAGNOSIS; PROBABILITY; MANAGEMENT; THROMBOSIS	Background: It may be safe to omit additional diagnostic testing in selected patients with suspected pulmonary embolism (PE) who have a negative D-climer test, but this approach has never been evaluated in a randomized, controlled trial. Objective: To determine if additional diagnostic testing can be safely withheld in patients with suspected PE who have negative erythrocyte agglutination D-climer test results. Design: Randomized comparisons in 2 subgroups of a prospective multicenter study. Setting: 7 university hospitals. Patients: 1126 outpatients or inpatients with suspected PE; of these, 456 patients with negative erythrocyte agglutination D-climer test results were randomly assigned to the intervention groups. Patients were classified into 2 clinical probability groups: those with a low clinical probability of PE (low-probability group) and those with a moderate or high clinical probability of PE, a nondiagnostic ventilation-perfusion lung scan, and no evidence of proximal deep venous thrombosis on bilateral ultrasonography (moderate- or high-probability group). Interventions: The experimental intervention for both probability groups was no further diagnostic testing for PE. The control intervention for the low-probability group was a ventilation-perfusion lung scan followed by ultrasonography of the proximal deep veins of the legs on the same day. if the lung scan was nondiagnostic, ultrasonography of the legs was repeated 7 and 14 days later. The control intervention for the moderate- or high-probability group was ultrasonography of the proximal deep veins of the legs after 7 and 14 days. In the control and experimental groups, anticoagulation was withheld or withdrawn if PE was not diagnosed. Measurements: Symptomatic venous thromboembolism (VTE) during 6 months of follow-up. Results: Prevalence of VTE was 15.2% in the 1126 enrolled patients. In the low-probability group, VTE occurred during follow-up in 0 of 182 patients who had no additional diagnostic testing and in 1 of 185 patients who had additional testing (difference, -0.5 percentage point [95% Cl, -3.0 to 1.6 percentage points]). in the moderate- or high-probability group, VTE occurred during follow-up in 1 of 41 patients who had no additional diagnostic testing and in 0 of 41 patients who had additional testing (difference, 2.4 percentage points [CI, -6.4 to 12.6 percentage points]). Limitations: The authors could not enroll 2000 patients as originally planned; 3 randomly assigned patients did not receive the allocated intervention, and 7 received inadequate follow-up. Personnel who performed follow-up evaluations were not blinded to the results of diagnostic testing at enrollment or to allocation group assignments. Conclusion: In patients with a low probability of PE who have negative D-climer results, additional diagnostic testing can be withheld without increasing the frequency of VTE during follow-up. Low clinical probability and negative D-dimer results occur in 50% of outpatients and in 20% of inpatients with suspected PE.	McMaster Univ, Hamilton, ON, Canada; Henderson Res Ctr, Hamilton, ON, Canada; Univ Ottawa, Ottawa, ON, Canada; Dalhousie Univ, Halifax, NS, Canada; Univ Western Ontario, London, ON, Canada	McMaster University; University of Ottawa; Dalhousie University; Western University (University of Western Ontario)	Kearon, C (corresponding author), Hamilton Hlth Sci, Henderson Div, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	kearonc@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019; Douketis, James/AAO-5659-2021; Kovacs, Michael/G-3315-2011; ginsberg, jeffrey s/ABC-1065-2020	Weitz, Jeffrey/0000-0002-1092-7550; Anderson, David/0000-0003-0845-1722				de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; Ginsberg JS, 1998, ANN INTERN MED, V129, P1006, DOI 10.7326/0003-4819-129-12-199812150-00003; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Quiroz R, 2005, JAMA-J AM MED ASSOC, V293, P2012, DOI 10.1001/jama.293.16.2012; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Van Strijen MJL, 2005, J THROMB HAEMOST, V3, P2449; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	18	124	129	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					812	821		10.7326/0003-4819-144-11-200606060-00007	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZN	16754923				2022-12-28	WOS:000238057000004
J	Kagan, JC; Medzhitov, R				Kagan, Jonathan C.; Medzhitov, Ruslan			Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling	CELL			English	Article							GENE-EXPRESSION; INTERFERON-BETA; PATHWAY; MOLECULE; PROTEIN; SALMONELLA; TIRAP; CELLS; PTDINS(4,5)P-2; IDENTIFICATION	Toll-like receptors (TLRs) play a critical role in the immune system as sensors of microbial infection. Signaling downstream from TLRs is initiated by the recruitment of adaptor proteins, including MyD88 and TRAP. These adaptors play essential roles in TLR signaling, but the mechanism of their function is currently unknown. Here we demonstrate that TRAP and MyD88 have distinct functions and describe a mechanism of recruitment of TRAP and MyD88 to TLR4. We find that TRAP contains a phosphatidylinositol 4,5-bisphosphate (PIP2) binding domain, which mediates TRAP recruitment to the plasma membrane. TRAP then functions to facilitate MyD88 delivery to activated TLR4 to initiate signal transduction. These results establish that phosphoinositide-mediated adaptor recruitment initiates a specific signal-transduction pathway.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu			NIAID NIH HHS [AI-46688, AI07019, K99 AI072955] Funding Source: Medline; PHS HHS [U01A161360-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019, R01AI046688, K99AI072955, R37AI046688] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Bhat N, 1999, J IMMUNOL, V162, P7335; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flo TH, 2000, INFECT IMMUN, V68, P6770, DOI 10.1128/IAI.68.12.6770-6776.2000; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	35	650	680	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					943	955		10.1016/j.cell.2006.03.047	http://dx.doi.org/10.1016/j.cell.2006.03.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751103	Bronze			2022-12-28	WOS:000238116400020
J	Nabi, H; Gueguen, A; Chiron, M; Lafont, S; Zins, M; Lagarde, E				Nabi, Hermann; Gueguen, Alice; Chiron, Mireille; Lafont, Sylviane; Zins, Marie; Lagarde, Emmanuel			Awareness of driving while sleepy and road traffic accidents: prospective study in GAZEL cohort	BRITISH MEDICAL JOURNAL			English	Article							DRIVER SLEEPINESS; FATIGUE; CRASHES; POPULATION; BEHAVIORS	Objectives To examine the association between self assessed driving while sleep), and the risk of serious road traffic accidents (RTAs). Design Prospective cohort study. Setting France. Participants 13 299 of the 19 894 living members of die GAZEL cohort, workers and recent retirees of a French national utility company followed up since 1989. Main outcome measures Frequency of driving while sleepy in the previous 12 months, reported in 2001; rate ratios for serious RTAs in 2001-3, estimated by using generalised linear Poisson regression models with time dependent covariates. Results The risk of serious RTAs increased proportionally with the frequency of self reported driving while sleepy After adjustment for graphic characteristics driving behaviour variables, work conditions, retirement, medical conditions mid treatments, depressive symptoms, and sleep disorders, the adjusted rate ratios of serious RTAs for participants who reported driving while sleep), in the previous 12 months "a few times" or "once a month or more often" were 1.5 (95% confidence interval 1.2 to 2.0) and 2.9 (1.3 to 6.3) respectively compared with those who reported not driving while sleepy over the same period. These associations were not explained by any reported sleep disorders. Conclusions Self assessed driving while sleepy was a powerful predictor of serious RTAs, suggesting that drivers' awareness of their sleepiness while driving is not sufficient to prevent them from having RTAs. Messages on prevention should therefore focus on convincing sleepy drivers to Stop driving and sleep before resuming their journey.	INSERM, U687, IFR69, F-94415 St Maurice, France; UMRESTTE, Inst Natl Rech Transports & Leur Secur, F-69675 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS)	Lagarde, E (corresponding author), Univ Bordeaux 2, INSERM, U593, Equipe Avenir Sante & Insecur Routiere, Case 11,146 Rue Leo Saignat, F-33076 Bordeaux, France.	emmanuel.lagarde@isped.u-bordeaux2.fr	Zins, Marie/AAX-6551-2021; Lafont, Sylviane/AAD-4464-2019; Lagarde, Emmanuel/F-7132-2013	Lafont, Sylviane/0000-0003-0483-6238; Nabi, Hermann/0000-0002-7832-0413; Lagarde, Emmanuel/0000-0001-8031-7400				Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; Dalziel JR, 1997, ACCIDENT ANAL PREV, V29, P489, DOI 10.1016/S0001-4575(97)00028-6; Drake C, 2005, SLEEP AM POLL SUMMAR; Drobnich D, 2005, IND HEALTH, V43, P197, DOI 10.2486/indhealth.43.197; Fergusson D, 2003, AUST NZ J PUBL HEAL, V27, P337, DOI 10.1111/j.1467-842X.2003.tb00404.x; Horne J., 2001, TRANSP RES F, V4, P63, DOI [10.1016/s1369-8478(01)00014-6, DOI 10.1016/S1369-8478(01)00014-6]; Knipling RR., 1994, CRASHES FATALITIES R; Lagarde E, 2005, J CLIN EPIDEMIOL, V58, P524, DOI 10.1016/j.jclinepi.2004.09.008; Lagarde E, 2004, J EPIDEMIOL COMMUN H, V58, P562, DOI 10.1136/jech.2003.011833; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; MacLean AW, 2003, SLEEP MED REV, V7, P507, DOI 10.1016/S1087-0792(03)90004-9; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Nabi H, 2005, AM J EPIDEMIOL, V161, P864, DOI 10.1093/aje/kwi110; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Pierce RJ, 1999, AUST NZ J MED, V29, P658, DOI 10.1111/j.1445-5994.1999.tb01613.x; Reyner LA, 1998, INT J LEGAL MED, V111, P120, DOI 10.1007/s004140050131; Rosen Ilene M, 2005, J Clin Sleep Med, V1, P337; Rothman K., 1998, MODERN EPIDEMIOLOGY; Smith S, 2005, ACCIDENT ANAL PREV, V37, P1066, DOI 10.1016/j.aap.2005.06.008; *TNS SOFR, 2004, FRANC SOMN RES ET	22	72	76	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2006	333	7558					75	77		10.1136/bmj.38863.638194.AE	http://dx.doi.org/10.1136/bmj.38863.638194.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065BA	16798754	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000239133200017
J	Kinder, DR				Kinder, Donald R.			Politics and the life cycle	SCIENCE			English	Editorial Material							ORIENTATIONS	The study of politics and the life cycle began with a rather single-minded focus on childhood and the family-on the idea, as Tocqueville famously put it, that the entire person could be "seen in the cradle of the child:" Politics does begin in childhood, and parents do influence their offspring, but change takes place over the entire span of life. I take up the early emergence of partisanship and essentialism, the formation of generations, politically consequential transitions in adulthood, and the rising of politics and its final decline.	Univ Michigan, Dept Polit Sci, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan	Kinder, DR (corresponding author), Univ Michigan, Dept Polit Sci, Ann Arbor, MI 48106 USA.	drkinder@umich.edu						Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Bandura A., 1969, HDB SOCIALIZATION TH, P213, DOI [10.1080/19371918.2011.591629, DOI 10.1080/19371918.2011.591629]; CAMPBELL A, 1960, AM VOTER, P151; Converse P.E., 1976, DYNAMICS PARTY SUPPO, VVol. 35; CONVERSE PE, 1969, COMP POLIT STUD, V2, P139, DOI 10.1177/001041406900200201; CONVERSE PE, 1964, IDEOLOGY DISCONTENT; DAVIS JA, 1992, PUBLIC OPIN QUART, V56, P261, DOI 10.1086/269322; Eaves L, 1989, GENES CULTURE PERSON; Gelman S. A., 2003, ESSENTIAL CHILD; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; GREEN D, 2002, PORTISON HEARTS MIND; GREEN DP, 1992, J POLIT, V54, P471, DOI 10.2307/2132035; GREEN DP, 1992, AM POLIT SCI REV, V86, P128, DOI 10.2307/1964020; Greenstein F.I., 1965, CHILD POLIT; Hirschfeld L.A., 1996, RACE MAKING COGNITIO; Huckfeldt R.R., 1995, CITIZENS POLITICS SO; Jennings M. K., 1974, POLITICAL CHARACTER; JENNINGS MK, 1979, AM J POLIT SCI, V23, P755, DOI 10.2307/2110805; JENNINGS MK, 1984, AM POLIT SCI REV, V78, P1000, DOI 10.2307/1955804; JENNINGS MK, 2005, AGING GENERATIONS DE; Kagan J., 1998, 3 SEDUCTIVE IDEAS; Kinder D., 1998, HDB SOCIAL PSYCHOL P, VVolume 2, P778; KINDER DR, 2003, ELECTORAL DEMOCRACY, P13; Maccoby EE, 2000, ANNU REV PSYCHOL, V51, P1, DOI 10.1146/annurev.psych.51.1.1; Mannheim K., 1927, ESSAYS SOCIOL KNOW, P276, DOI DOI 10.1016/S0168-8227(00)00198-4; MAYHEW DR, 2005, ELECTOROL REALIGNMEN; Putnam RD., 2000, BOWLING ALONE COLLAP; Rosenstone Steven., 1993, MOBILIZATION PARTICI; Rubin DC, 1998, MEM COGNITION, V26, P3, DOI 10.3758/BF03211366; SCHUMAN H, 1998, AM SOCIOL REV, V57, P315; Sears D.O., 1982, TAX REVOLT SOMETHING; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; SEARS DO, 1975, HDB POLITICAL SCI, V2, P96; STOKER L, 1995, AM POLIT SCI REV, V89, P421, DOI 10.2307/2082435; Tilly Charles, 1978, MOBILIZATION REVOLUT; Verba S., 2005, SOCIAL LOGIC POLITIC, P95; Verba S., 1995, VOICE EQUALITY CIVIC	37	32	33	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1905	1908		10.1126/science.1127891	http://dx.doi.org/10.1126/science.1127891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061CF	16809527				2022-12-28	WOS:000238848100045
J	Culley, AI; Lang, AS; Suttle, CA				Culley, Alexander I.; Lang, Andrew S.; Suttle, Curtis A.			Metagenomic analysis of coastal RNA virus communities	SCIENCE			English	Article							HETEROSIGMA-AKASHIWO; NUCLEOTIDE-SEQUENCE; VIRAL COMMUNITIES; GENOME SEQUENCES; DIVERSITY; HARNAV; SEA	RNA viruses infect marine organisms from bacteria to whales, but RNA virus communities in the sea remain essentially unknown. Reverse-transcribed whole-genome shotgun sequencing was used to characterize the diversity of uncultivated marine RNA virus assemblages. A diverse assemblage of RNA viruses, including a broad group of marine picorna-like viruses, and distant relatives of viruses infecting arthropods and higher plants were found. Communities were dominated by distinct genotypes with small genome sizes, and we completely assembled the genomes of several hitherto undiscovered viruses. Our results show that the oceans are a reservoir of previously unknown RNA viruses.	Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA	University of British Columbia; University of British Columbia; University of British Columbia; University of Alaska System; University of Alaska Fairbanks	Suttle, CA (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, 1461-6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	csuttle@eos.ubc.ca	suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008	suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033; Lang, Andrew/0000-0002-4510-7683				Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; BORSHEIM KY, 1993, FEMS MICROBIOL ECOL, V102, P141, DOI 10.1016/0378-1097(93)90197-A; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard CPD, 2004, VIROLOGY, V319, P280, DOI 10.1016/j.virol.2003.10.033; CHRISTIAN P, 2005, MICR CHANG WORLD M I; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Kim DH, 2005, VIRUS RES, V107, P1, DOI 10.1016/j.virusres.2004.06.004; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Lang AS, 2004, VIROLOGY, V320, P206, DOI 10.1016/j.virol.2003.10.015; LOMMEL SA, 2004, VIRUS TAXONOMY 8 REP, P907; Mari J, 2002, J GEN VIROL, V83, P915, DOI 10.1099/0022-1317-83-4-915; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P8888, DOI 10.1128/AEM.71.12.8888-8894.2005; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; Rima BK, 2005, VIRUS GENES, V30, P113, DOI 10.1007/s11262-004-4588-7; Swofford D., 2002, PAUP 4 0B10; Tai V, 2003, J PHYCOL, V39, P343, DOI 10.1046/j.1529-8817.2003.01162.x; TALIANSKY ME, 2004, VIRUS TAXONOMY 8 REP, P901; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vetten HJ, 2004, VIRUS TAXONOMY, P343; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P241; Yokoi T, 2003, VIROLOGY, V311, P394, DOI 10.1016/S0042-6822(03)00183-1	29	261	276	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1795	1798		10.1126/science.1127404	http://dx.doi.org/10.1126/science.1127404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794078				2022-12-28	WOS:000238452800058
J	Bahar, R; Hartmann, CH; Rodriguez, KA; Denny, AD; Busuttil, RA; Dolle, MET; Calder, RB; Chisholm, GB; Pollock, BH; Klein, CA; Vijg, J				Bahar, Rumana; Hartmann, Claudia H.; Rodriguez, Karl A.; Denny, Ashley D.; Busuttil, Rita A.; Dolle, Martijn E. T.; Calder, R. Brent; Chisholm, Gary B.; Pollock, Brad H.; Klein, Christoph A.; Vijg, Jan			Increased cell-to-cell variation in gene expression in ageing mouse heart	NATURE			English	Article							IN-VIVO MUTATIONS; MODEL; AGE	The accumulation of somatic DNA damage has been implicated as a cause of ageing in metazoa(1,2). One possible mechanism by which increased DNA damage could lead to cellular degeneration and death is by stochastic deregulation of gene expression. Here we directly test for increased transcriptional noise in aged tissue by dissociating single cardiomyocytes from fresh heart samples of both young and old mice, followed by global mRNA amplification and quantification of mRNA levels in a panel of housekeeping and heart-specific genes. Although gene expression levels already varied among cardiomyocytes from young heart, this heterogeneity was significantly elevated at old age. We had demonstrated previously an increased load of genome rearrangements and other mutations in the heart of aged mice(3,4). To confirm that increased stochasticity of gene expression could be a result of increased genome damage, we treated mouse embryonic fibroblasts in culture with hydrogen peroxide. Such treatment resulted in a significant increase in cell-to-cell variation in gene expression, which was found to parallel the induction and persistence of genome rearrangement mutations at a lacZ reporter locus. These results underscore the stochastic nature of the ageing process, and could provide a mechanism for age-related cellular degeneration and death in tissues of multicellular organisms.	Buck Inst Age Res, Novato, CA 94945 USA; Univ Munich, Inst Immunol, D-80336 Munich, Germany; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78245 USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Buck Institute for Research on Aging; University of Munich; University of Texas System; University of Texas Health San Antonio; Netherlands National Institute for Public Health & the Environment	Vijg, J (corresponding author), Buck Inst Age Res, Novato, CA 94945 USA.	jvijg@buckinstitute.org	Rodriguez, Karl A/F-2689-2012	Klein, Christoph A./0000-0001-7128-1725	NIA NIH HHS [R36 AG033401] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R36AG033401] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Dolle MET, 1996, MUTAGENESIS, V11, P111, DOI 10.1093/mutage/11.1.111; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Finch C, 2000, CHANCE DEV AGING; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3	19	390	401	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					1011	1014		10.1038/nature04844	http://dx.doi.org/10.1038/nature04844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791200	Green Submitted			2022-12-28	WOS:000238422300049
J	Donley-Hayes, K				Donley-Hayes, Karen			At face value	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											No Org, W Farmington, OH 44491 USA.	kdonley@bright.net							0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2701	2702		10.1001/jama.295.23.2701	http://dx.doi.org/10.1001/jama.295.23.2701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16788117				2022-12-28	WOS:000238389700001
J	Land, SR; Wickerham, DL; Costantino, JP; Ritter, MW; Vogel, VG; Lee, M; Pajon, ER; Wade, JL; Dakhil, S; Lockhart, JB; Wolmark, N; Ganz, PA				Land, Stephanie R.; Wickerham, D. Lawrence; Costantino, Joseph P.; Ritter, Marcie W.; Vogel, Victor G.; Lee, Myoungkeun; Pajon, Eduardo R.; Wade, James L., III; Dakhil, Shaker; Lockhart, James B., Jr.; Wolmark, Norman; Ganz, Patricia A.			Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGICAL ADJUVANT BREAST; HEALTH SURVEY SF-36; POSTMENOPAUSAL WOMEN; RISK; DEPRESSION; PROGESTIN; OUTCOMES; DISEASE; IMPACT; TESTS	Context Tamoxifen has been approved for breast cancer risk reduction in high-risk women, but how raloxifene compares with tamoxifen is unknown. Objective To compare the differences in patient-reported outcomes, quality of life [QOL], and symptoms in Study of Tamoxifen and Raloxifene ( STAR) participants by treatment assignment. Design, Setting, Participants, and Interventions STAR was a double-blind, randomized phase 3 prevention trial designed to evaluate the relative efficacy of raloxifene vs tamoxifen in reducing the incidence of invasive breast cancer in high-risk postmenopausal women. Between July 1, 1999, and November 4, 2004, 19 747 participants were enrolled at centers throughout North America, with a median potential follow-up time of 4.6 years ( range, 1.2-6.5 years). Patient-reported symptoms were collected from all participants using a 36-item symptom checklist. Quality of life was measured with the Medical Outcomes Study Short-Form Health Survey (SF-36), the Center for Epidemiologic Studies-Depression (CES-D), and the Medical Outcomes Study Sexual Activity Questionnaire in a substudy of 1983 participants, median potential follow-up 5.4 years ( range, 4.6-6.0 years). Questionnaires were administered before treatment, every 6 months for 60 months and at 72 months. Main Outcome Measures Primary QOL end points were the SF-36 physical (PCS) and mental (MCS) component summaries. Results Among women in the QOL analysis, mean PCS, MCS, and CES-D scores worsened modestly over the study's 60 months, with no significant difference between the tamoxifen ( n = 973) and raloxifene ( n = 1010) groups ( P >. 2). Sexual function was slightly better for participants assigned to tamoxifen ( age-adjusted repeated measure odds ratio, 1.22%; 95% CI, 1.01-1.46). Of the women in the symptom assessment analyses, the 9769 in the raloxifene group reported greater mean symptom severity over 60 months of assessments than the 9743 in the tamoxifen group for musculoskeletal problems (1.15 vs 1.10, P=.002), dyspareunia (0.78 vs 0.68, P <. 001), and weight gain (0.82 vs 0.76, P <. 001). Women in the tamoxifen group reported greater mean symptom severity for gynecological problems (0.29 vs 0.19, P <. 001), vasomotor symptoms (0.96 vs 0.85, P <. 001), leg cramps ( 1.10 vs 0.91, P <. 001), and bladder control symptoms (0.88 vs 0.73, P <. 001). Conclusions No significant differences existed between the tamoxifen and raloxifene groups in patient-reported outcomes for physical health, mental health, and depression, although the tamoxifen group reported better sexual function. Although mean symptom severity was low among these postmenopausal women, those in the tamoxifen group reported more gynecological problems, vasomotor symptoms, leg cramps, and bladder control problems, whereas women in the raloxifene group reported more musculoskeletal problems, dyspareunia, and weight gain.	Natl Surg Adjuvant Breast & Bowel Project Operat, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Inst Canc, Allegheny Gen Hosp, Pittsburgh, PA 15260 USA; Magee Womens Hosp, Pittsburgh, PA USA; Colorado Canc Res Program, Denver, CO USA; Decatur Mem Hosp, Community Clin Oncol Program Cent Illinois, Decatur, IL USA; Community Clin Oncol Program Wichita, Wichita, KS USA; Warren Canc Res Fdn, Oklahoma Community Clin Oncol Program, Tulsa, OK USA; Univ Calif Los Angeles, Sch Publ Hlth, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Land, SR (corresponding author), 201 N Craig St,Suite 350, Pittsburgh, PA 15213 USA.	land@pitt.edu			NATIONAL CANCER INSTITUTE [U10CA012027, U10CA037377, U10CA069974, U10CA069651] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aldrighi JM, 2004, AM J OBSTET GYNECOL, V191, P1979, DOI 10.1016/j.ajog.2004.04.042; Alfano CM, 2006, PSYCHO-ONCOLOGY, V15, P985, DOI 10.1002/pon.1033; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Davies GC, 1999, OBSTET GYNECOL, V93, P558, DOI 10.1016/S0029-7844(98)00476-1; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Day R, 2001, ANN NY ACAD SCI, V949, P143; Day R, 2001, J NATL CANCER I, V93, P1615, DOI 10.1093/jnci/93.21.1615; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fallowfield L, 2001, J CLIN ONCOL, V19, P1885, DOI 10.1200/JCO.2001.19.7.1885; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2000, LANCET, V355, P1017, DOI 10.1016/S0140-6736(05)74761-9; Gail MH, 2001, J NATL CANCER I, V93, P334, DOI 10.1093/jnci/93.5.334; GAIL MH, 1994, J NATL CANCER I, V86, P573, DOI 10.1093/jnci/86.8.573; GANZ PA, 1995, JNCI-J NATL CANCER I, V87, P1372, DOI 10.1093/jnci/87.18.1372; Gordon S, 2004, OBSTET GYNECOL, V103, P267, DOI 10.1097/01.AOG.0000110247.98588.ff; GREENDALE GA, 1996, J WOMENS HEALTH, V5, P445; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Kroenke CH, 2004, J CLIN ONCOL, V22, P1849, DOI 10.1200/JCO.2004.04.173; LAND SR, 2003, MANAGING BCR; Land SR, 2002, STAT DESIGN MEASUREM, P71; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; *MED EC PROD CO, 1995, PHYS DESK REF, V49; MYERS JK, 1980, AM J PSYCHIAT, V137, P1081; Nickelsen T, 1999, PSYCHONEUROENDOCRINO, V24, P115, DOI 10.1016/S0306-4530(98)00041-9; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; Sherbourne CD, 1992, MEASURING FUNCTIONIN, P194; Stanton AL, 2005, JNCI-J NATL CANCER I, V97, P448, DOI 10.1093/jnci/dji069; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Waetjen LE, 2004, OBSTET GYNECOL, V103, P261, DOI 10.1097/01.AOG.0000109429.67671.d1; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE Jr, 1993, SF 36 HLTH SURVEY MA; Wyrwich KW, 2003, J GEN INTERN MED, V18, P196, DOI 10.1046/j.1525-1497.2003.20203.x; Yaffe K, 2005, AM J PSYCHIAT, V162, P683, DOI 10.1176/appi.ajp.162.4.683	40	184	189	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2742	2751		10.1001/jama.295.23.joc60075	http://dx.doi.org/10.1001/jama.295.23.joc60075			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16754728				2022-12-28	WOS:000238389700029
J	Wilson, JF				Wilson, Jennifer Fisher			The rocky road to useful cancer biomarkers	ANNALS OF INTERNAL MEDICINE			English	News Item							OVARIAN-CANCER; SERUM					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Baggerly KA, 2005, JNCI-J NATL CANCER I, V97, P307, DOI 10.1093/jnci/dji008; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	4	13	13	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					945	948		10.7326/0003-4819-144-12-200606200-00022	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00022			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785487				2022-12-28	WOS:000238555500017
J	Duret, L; Chureau, C; Samain, S; Weissenbach, J; Avner, P				Duret, L; Chureau, C; Samain, S; Weissenbach, J; Avner, P			The Xist RNA gene evolved in eutherians by pseudogenization of a protein-coding gene	SCIENCE			English	Article							HUMAN-X-CHROMOSOME; MAMMALIAN-X; SEQUENCE; INACTIVATION; EVOLUTION; LOCATION; ORIGINS; GENOME; MOUSE	The Xist noncoding RNA is the key initiator of the process of X chromosome inactivation in eutherian mammals, but its precise function and origin remain unknown. Although Xist is well conserved among eutherians, until now, no homolog has been identified in other mammals. We show here that Xist evolved, at least partly, from a protein-coding gene and that the loss of protein-coding function of the proto-Xist coincides with the four flanking protein genes becoming pseudogenes. This event occurred after the divergence between eutherians and marsupials, which suggests that mechanisms of dosage compensation have evolved independently in both lineages.	CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; Univ Lyon 1, F-69622 Villeurbanne, France; Inst Pasteur, CNRS, URA 1947, Unite Genet Mol Murine, F-75015 Paris, France; Ctr Natl Sequencage, F-91057 Evry, France; CNRS, UMR8030, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Duret, L (corresponding author), CNRS, Lab Biometrie & Biol Evolut, UMR 5558, 16 Rue Raphael Dubois, F-69622 Villeurbanne, France.	duret@biomserv.univ-lyon1.fr		Duret, Laurent/0000-0003-2836-3463				Caparros ML, 2002, CYTOGENET GENOME RES, V99, P99, DOI 10.1159/000071580; CHANDRA HS, 1985, P NATL ACAD SCI USA, V82, P6947, DOI 10.1073/pnas.82.20.6947; CHARLESWORTH B, 1978, P NATL ACAD SCI USA, V75, P5618, DOI 10.1073/pnas.75.11.5618; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Cunningham DB, 1998, DEV BIOL, V204, P345, DOI 10.1006/dbio.1998.9004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Grutzner F, 2004, CURR OPIN GENET DEV, V14, P642, DOI 10.1016/j.gde.2004.09.006; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Koina E, 2005, CHROMOSOME RES, V13, P687, DOI 10.1007/s10577-005-1006-5; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P3354, DOI 10.1073/pnas.0408539102; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Waters PD, 2005, CHROMOSOME RES, V13, P401, DOI 10.1007/s10577-005-0978-5; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	17	317	337	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1653	1655		10.1126/science.1126316	http://dx.doi.org/10.1126/science.1126316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778056				2022-12-28	WOS:000238288600046
J	el Moussaoui, R; de Borgie, CAJM; van den Broek, P; Hustinx, WN; Bresser, P; van den Berk, GEL; Poley, JW; van den Berg, B; Krouwels, FH; Bonten, MJM; Weenink, C; Bossuyt, PMM; Speelman, P; Opmeer, BC; Prins, JM				el Moussaoui, Rachida; de Borgie, Corianne A. J. M.; van den Broek, Peterhans; Hustinx, Willem N.; Bresser, Paul; van den Berk, Guido E. L.; Poley, Jan-Werner; van den Berg, Bob; Krouwels, Frans H.; Bonten, Marc J. M.; Weenink, Carla; Bossuyt, Patrick M. M.; Speelman, Peter; Opmeer, Brent C.; Prins, Jan M.			Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL MOXIFLOXACIN; CONTROLLED-TRIAL; AMOXICILLIN; EFFICACY; TOLERABILITY; ADULTS	Objective To compare the effectiveness of discontinuing treatment with amoxicillin after three days or eight days in adults admitted to hospital with mild to moderate-severe community acquired pneumonia who substantially improved after an initial three days' treatment. Design Randomised, double blind, placebo controlled non-inferiority trial. Setting Nine secondary and tertiary care hospitals in the Netherlands. Participants Adults with mild to moderate-severe community acquired pneumonia (pneumonia severity index score <= 110). Interventions Patients who had substantially improved after three days' treatment with intravenous amoxicillin were randomly assigned to oral amoxicillin (n = 63) or placebo (n = 56) three times daily for five days. Main outcome measures The primary outcome measure was the clinical success rate at day 10. Secondary outcome measures were the clinical success rate at day 28, symptom resolution, radiological success rates at days 10 and 28, and adverse events. Results Baseline characteristics were comparable, with the exception of symptom severity, which was worse in the three day treatment group. In the three day and eight day treatment groups the clinical success rate at day 10 was 93% for both (difference 0.1%, 95% confidence interval - 9% to 10%) and at day 28 was 90% compared with 88% (difference 2.0%, - 9% to 15%). Both groups had similar resolution of symptoms. Radiological success rates were 86% compared with 83% at day 10 (difference 3%, - 10% to 16%) and 86% compared with 79% at day 28 (difference 6%, - 7% to 20%). Six patients (11%) in the placebo group and 13 patients (21%) in the active treatment group reported adverse events (P = 0.1). Conclusions Discontinuing amoxicillin treatment after three days is not inferior to discontinuing it after eight days in adults admitted to hospital with mild to moderate-severe community acquired pneumonia who substantially improved after an initial three days' treatment.	Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands; Diaconessenhuis, Dept Internal Med, Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; St Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; St Lucas Andreas Hosp, Dept Pulmonol, Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Pulmonol, Amsterdam, Netherlands; Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; Kennemer Gasthuis, Dept Pulmonol, Haarlem, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Sint Lucas Andreas Hospital; Sint Lucas Andreas Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Utrecht University; Utrecht University Medical Center; Spaarne Hospital	Prins, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.prins@amc.uva.nl	Prins, Jan M./AAF-4945-2020; Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128				Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; CHOW AW, 1992, CLIN INFECT DIS   S1, V15, P62; Dunbar LM, 2003, CLIN INFECT DIS, V37, P752, DOI 10.1086/377539; El Moussaoui R, 2004, THORAX, V59, P591, DOI 10.1136/thx.2003.015107; Felmingham D, 2000, J ANTIMICROB CHEMOTH, V45, P191, DOI 10.1093/jac/45.2.191; Finch R, 2002, ANTIMICROB AGENTS CH, V46, P1746, DOI 10.1128/AAC.46.6.1746-1754.2002; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Hagberg L, 2002, INFECTION, V30, P378, DOI 10.1007/s15010-002-2096-z; Hazir T, 2002, LANCET, V360, P835; Ortiz-Ruiz G, 2002, CLIN INFECT DIS, V34, P1076, DOI 10.1086/339543; Petitpretz P, 2001, CHEST, V119, P185, DOI 10.1378/chest.119.1.185; Schouten JA, 2005, NETH J MED, V63, P323; Vetter N, 2002, CLIN THER, V24, P1770, DOI 10.1016/S0149-2918(02)80078-9	13	183	186	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2006	332	7554					1355	1358		10.1136/bmj.332.7554.1355	http://dx.doi.org/10.1136/bmj.332.7554.1355			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763247	Green Published, Green Submitted			2022-12-28	WOS:000238587000014
J	Lloyd, C				Lloyd, C			Plant science - Microtubules make tracks for cellulose	SCIENCE			English	Editorial Material							CELLS		John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lloyd, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	clive.lloyd@bbsrc.ac.uk						GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; HEATH IB, 1974, J THEOR BIOL, V48, P445, DOI 10.1016/S0022-5193(74)80011-1; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; NEVILLE AC, 1976, PROTOPLASMA, V90, P307, DOI 10.1007/BF01275682; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050	8	15	15	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1482	1483		10.1126/science.1128903	http://dx.doi.org/10.1126/science.1128903			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763138				2022-12-28	WOS:000238124100034
J	Braun, BI; Wineman, NV; Finn, NL; Barbera, JA; Schmaltz, SP; Loeb, JM				Braun, Barbara I.; Wineman, Nicole V.; Finn, Nicole L.; Barbera, Joseph A.; Schmaltz, Stephen P.; Loeb, Jerod M.			Integrating hospitals into community emergency preparedness planning	ANNALS OF INTERNAL MEDICINE			English	Article							SELF-ASSESSMENTS	Background: Strong community linkages are essential to a health care organization's overall preparedness for emergencies. Objective: To assess community emergency preparedness linkages among hospitals, public health officials, and first responders and to investigate the influence of community hazards, previous preparation for an event requiring national security oversight, and experience responding to actual disasters. Design: With expert advice from an advisory panel, a mailed questionnaire was used to assess linkage issues related to training and drills, equipment, surveillance, laboratory testing, surge capacity, incident management, and communication. Setting: A simple random sample of 1750 U.S. medical-surgical hospitals. Participants: Of 678 hospital representatives that agreed to participate, 575 (33%) completed the questionnaire in early 2004. Respondents were hospital personnel responsible for environmental safety, emergency management, infection control, administration, emergency services, and security. Measurements: Prevalence and breadth of participation in community-wide planning; examination of 17 basic elements in a weighted analysis. Results: In a weighted analysis, most hospitals (88.2% [95% Cl, 84.1 % to 92.3 %]) engaged in community-wide drills and exercises, and most (82.2% [Cl, 77.8% to 86.5%]) conducted a collaborative threat and vulnerability analysis with community responders. Of all respondents, 57.3% (Cl, 52.1% to 62.5%) reported that their community plans addressed the hospital's need for additional supplies and equipment, and 73.0% (Cl, 68.1% to 77.9%) reported that decontamination capacity needs were addressed. Fewer reported a direct link to the Health Alert Network (54.4% [Cl, 49.3% to 59.5%]) and around-the-clock access to a live voice from a public health department (40.0% [Cl, 35.0% to 45.0%]). Performance on many of 17 basic elements was better in large and urban hospitals and was associated with a high number of perceived hazards, previous national security event preparation, and experience in actual response. Limitations: Responses reflect hospitals' self-perception of linkages. The quality of linkages and the extent of possible biases favoring positive responses were not assessed. Conclusions: In this baseline assessment, most hospitals reported substantial integration. However, results suggest that relationships between hospitals, public health departments, and other critical response entities are not adequately robust. Suggestions for enhancing linkages are discussed.	Joint Commiss Accreditat Healthcare Org, Div Res, Oak Brook Terrace, IL 60181 USA; George Washington Univ, Inst Crisis Disaster & Risk Management, Washington, DC USA	George Washington University	Wineman, NV (corresponding author), Joint Commiss Accreditat Healthcare Org, Div Res, 1 Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.	nwineman@jcaho.org			AHRQ HHS [1U 18HS18808-01] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM HOSP ASS, 2004, ANN SURV DAT FISC YE; *ASS STAT TERR HLT, 2005, PUBL HLTH PREP; Barbera J. A., 2004, MED SURGE CAPACITY C; BARBERA JA, ESDP200107 JF KENN S; Braun BI, 2004, AM J INFECT CONTROL, V32, P317, DOI 10.1016/j.ajic.2004.01.003; *CENT FDN, 2005, BREATH EAS REP CENT; Clizbe JA, 2004, BIOSECUR BIOTERROR, V2, P294, DOI 10.1089/bsp.2004.2.294; DAVIS LM, 2002, ARE LOCAL HLTH RESPO; FALKENRATH RA, 200028 JF KENN SCH G; Flowers LK, 2002, EMERG MED CLIN N AM, V20, P457, DOI 10.1016/S0733-8627(01)00009-8; FRICKER RD, MEASURING EVALUATING; *GILM COMM, 2002, 4 ANN REP PRES C ADV; GORDON MJ, 1991, ACAD MED, V66, P762, DOI 10.1097/00001888-199112000-00012; GURSKY E, 2004, PROGR PER BIOT PREP; Gursky Elin A., 2004, HOMETOWN HOSP WEAKES; Health Resources and Services Administration, NAT BIOT HOSP PREP P; Hick JL, 2004, ANN EMERG MED, V44, P253, DOI 10.1016/j.annemergmed.2004.04.011; HOARD ML, 2002, PREPARING LOCAL LEVE; *HOUS SEL COMM HOM, 2004, BIOT AM STILL UNPR; *JOINT COMM RES AC, 2001, COMPR ACCR MAN HOSP; Joint Commission on Accreditation of Healthcare Organizations, 2003, HLTH CAR CROSSR STRA; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LURIE N, LOCAL VARIATION PUBL; McHugh M, 2004, HEALTH AFFAIR, V23, P201, DOI 10.1377/hlthaff.23.3.201; Mothershead JL, 2002, EMERG MED CLIN N AM, V20, P477, DOI 10.1016/S0733-8627(02)00004-4; O'Leary M., 2004, 1 72 HOURS COMMUNITY; O'Leary M., 2004, MEASURING DISASTER P; PEAR R, 2005, NY TIMES        0118, pA17; Perry RW, 2003, DISASTERS, V27, P336, DOI 10.1111/j.0361-3666.2003.00237.x; RUBIN JN, 2004, RECURRING PITFALLS H; Schultz CH, 2002, EMERG MED CLIN N AM, V20, P437, DOI 10.1016/S0733-8627(02)00003-2; *TRUST AM HLTH, 2004, READ NOT PROT PUBL H; TURNOCK BJ, 2004, PUBLIC HLTH PREPARED; *US DEP HHS, FISC YEAR 2006 BUDG; *US GEN ACC OFF, HOM SEC COORD PLANN; *US GEN ACC OFF, 2003, HOSP PREP MOST URB H; *US GEN ACC OFF, 2003, SARS OUTBR IMPR PUBL; WOODRUFF RS, 1971, J AM STAT ASSOC, V66, P411, DOI 10.2307/2283947; Wray RJ, 2004, FAM COMMUNITY HEALTH, V27, P232, DOI 10.1097/00003727-200407000-00010	39	39	42	2	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					799	811		10.7326/0003-4819-144-11-200606060-00006	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049ZN	16754922				2022-12-28	WOS:000238057000003
J	Nayak, S; Olkin, I; Liu, H; Grabe, M; Gould, MK; Allen, IE; Owens, DK; Bravata, DM				Nayak, Smita; Olkin, Ingram; Liu, Hau; Grabe, Michael; Gould, Michael K.; Allen, I. Elaine; Owens, Douglas K.; Bravata, Dena M.			Meta-analysis: Accuracy of quantitative ultrasound for identifying patients with osteoporosis	ANNALS OF INTERNAL MEDICINE			English	Review							X-RAY ABSORPTIOMETRY; BONE-MINERAL DENSITY; COST-EFFECTIVENESS-ANALYSIS; RANDOMIZED CLINICAL-TRIAL; VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; HIP FRACTURE; CALCANEAL ULTRASOUND; HEEL ULTRASOUND; SKELETAL SITES	Background: There is increased interest in quantitative ultrasound for osteoporosis screening because it predicts fracture risk, is portable, and is relatively inexpensive. However, there is no consensus regarding its accuracy for identifying patients with osteoporosis. Purpose: To determine the sensitivity and specificity of calcaneal quantitative ultrasound for identifying patients who meet the World Health Organization's diagnostic criteria for osteoporosis. Dual-energy x-ray absorptiometry (DXA) was used as the reference standard. Data Sources: MEDLINE (1966 to October 2005), EMBASE (1993 to May 2004), Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (1952 to March 2004), and the Science Citation Index (1945 to April 2004). Study Selection: English-language articles that evaluated the sensitivity and specificity of calcaneal quantitative ultrasound for identifying adults with DXA T-scores of -2.5 or less at the hip or spine. Data Extraction: Two authors independently reviewed articles and abstracted data. Data Synthesis: The authors identified 1908 potentially relevant articles, of which 25 met the inclusion criteria, and calculated the sensitivity and specificity of quantitative ultrasound over a range of thresholds. For the quantitative ultrasound index parameter T-score cutoff threshold of -1, sensitivity was 79% (95% Cl, 69% to 86%) and specificity was 58% (Cl, 44% to 70%) for identifying individuals with DXA T-scores of -2.5 or less at the hip or spine. For a T-score threshold of 0, sensitivity improved to 93% (Cl, 87% to 97%) but specificity decreased to 24% (Cl, 10% to 47%). At a pretest probability of 22% (for example, a 65-year-old white woman at average risk), the post-test probability of DXA-determined osteoporosis was 34% (Cl, 26% to 41%) after a positive result and 10% (Cl, 5% to 12%) after a negative result when using a T-score cutoff threshold of -1. Analysis of other quantitative ultrasound parameters (for example, broadband ultrasound attenuation) revealed similar estimates of accuracy. Limitations: The relatively small number of included studies limited the authors' ability to evaluate the effects of heterogeneous study characteristics on the diagnostic accuracy of quantitative ultrasound. Conclusions: The currently available literature suggests that results of calcaneal quantitative ultrasound at commonly used cutoff thresholds do not definitively exclude or confirm DXA-determined osteoporosis. Additional research is needed before use of this test can be recommended in evidence-based screening programs for osteoporosis.	Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Babson Coll, Babson Pk, MA 02157 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California San Francisco; Babson College	Nayak, S (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	smitanayak@stanford.edu	Grabe, Michael/B-3705-2009		AHRQ HHS [HS000028-18] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028, F32HS000028] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Adler RR, 2001, J CLIN DENSITOM, V4, P225, DOI 10.1385/JCD:4:3:225; Alenfeld FE, 2002, BRIT J RADIOL, V75, P895, DOI 10.1259/bjr.75.899.750895; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; *AM COLL RAD, 2001, EXP PAN MUSC IM OST; Ayers M, 2000, J BONE MINER RES, V15, P1850, DOI 10.1359/jbmr.2000.15.9.1850; Bachman DM, 2002, J CLIN DENSITOM, V5, P131, DOI 10.1385/JCD:5:2:131; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Boonen S, 2005, OSTEOPOROSIS INT, V16, P93, DOI 10.1007/s00198-004-1660-z; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Brunader R, 2002, AM FAM PHYSICIAN, V65, P1357; Cetin A, 2001, RHEUMATOL INT, V20, P55, DOI 10.1007/PL00006857; Cook RB, 2005, OSTEOPOROSIS INT, V16, P1565, DOI 10.1007/s00198-005-1864-x; Cook RB, 2005, ULTRASOUND MED BIOL, V31, P625, DOI 10.1016/j.ultrasmedbio.2005.02.003; Damilakis J, 2001, CALCIFIED TISSUE INT, V68, P219, DOI 10.1007/s002230020014; Danese R D, 2001, Curr Rheumatol Rep, V3, P245, DOI 10.1007/s11926-001-0025-2; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Deng HW, 1998, J GROUP THEORY, V1, P339, DOI 10.1515/jgth.1998.024; Diez-Perez A, 2003, J CLIN DENSITOM, V6, P237, DOI 10.1385/JCD:6:3:237; Dubois EFL, 2001, NETH J MED, V58, P62, DOI 10.1016/S0300-2977(00)00102-9; El-Desouki MI, 2005, SAUDI MED J, V26, P1346; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Falgarone G, 2004, JOINT BONE SPINE, V71, P419, DOI 10.1016/j.jbspin.2003.09.011; Faulkner KG, 1996, OSTEOPOROSIS INT, V6, P432, DOI 10.1007/BF01629574; Faulkner KG, 2001, RHEUM DIS CLIN N AM, V27, P81, DOI 10.1016/S0889-857X(05)70188-5; Frost ML, 2000, OSTEOPOROSIS INT, V11, P321, DOI 10.1007/s001980070121; GENANT HK, 1994, J BONE MINER RES, V9, P1503; Genant HK, 1996, J BONE MINER RES, V11, P707; Gluer CC, 1999, OSTEOPOROSIS INT, V9, P193, DOI 10.1007/s001980050135; Goemaere S, 2002, J CLIN DENSITOM, V5, P219, DOI 10.1385/JCD:5:3:219; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; Greenspan SL, 2001, OSTEOPOROSIS INT, V12, P391, DOI 10.1007/s001980170108; Gregg EW, 1997, OSTEOPOROSIS INT, V7, P89, DOI 10.1007/BF01623682; Hamdy Ronald C, 2002, J Clin Densitom, V5 Suppl, pS11, DOI 10.1385/JCD:5:3S:S11; Hans D, 1997, EUR RADIOL, V7, pS43, DOI 10.1007/PL00006863; Hans D, 2003, OSTEOPOROSIS INT, V14, P251, DOI 10.1007/s00198-002-1358-z; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hedges LV, 2014, STAT METHODS META AN; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Hodson J, 2003, BRIT MED J, V326, P1250, DOI 10.1136/bmj.326.7401.1250; *HOL, 2003, CLIN US ULTR; Ikeda Y, 2002, CALCIFIED TISSUE INT, V71, P1, DOI 10.1007/S00223-001-2079-6; Jorgensen HL, 2001, CLIN PHYSIOL, V21, P51, DOI 10.1046/j.1365-2281.2001.00298.x; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1; KRAEMER DF, 2006, OSTEOPOROS INT  0512, P68; Kung AWC, 2005, OSTEOPOROSIS INT, V16, P849, DOI 10.1007/s00198-004-1778-z; Kung AWC, 2003, OSTEOPOROSIS INT, V14, P716, DOI 10.1007/s00198-003-1428-x; LAI KC, 1992, CALCIFIED TISSUE INT, V50, P203, DOI 10.1007/BF00296283; Langton C M, 1997, Technol Health Care, V5, P235; Langton C M, 1999, Technol Health Care, V7, P319; Langton CM, 2000, BRIT J RADIOL, V73, P31, DOI 10.1259/bjr.73.865.10721317; Leib ES, 2004, J CLIN DENSITOM, V7, P1, DOI 10.1385/JCD:7:1:1; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2; Lippuner K, 2000, J CLIN DENSITOM, V3, P241, DOI 10.1385/JCD:3:3:241; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; Lopez-Rodriguez F, 2003, BONE, V32, P571, DOI 10.1016/S8756-3282(03)00058-9; Marin F, 2004, CALCIFIED TISSUE INT, V74, P277, DOI 10.1007/s00223-003-0135-0; MASSIE A, 1993, OSTEOPOROSIS INT, V3, P107, DOI 10.1007/BF01623382; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MELTON LJ, 1995, J BONE MINER RES, V10, P175; Meunier PJ, 1999, CLIN THER, V21, P1025, DOI 10.1016/S0149-2918(99)80022-8; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Naganathan V, 1999, MED J AUSTRALIA, V171, P297, DOI 10.5694/j.1326-5377.1999.tb123659.x; Nairus J, 2000, J CLIN DENSITOM, V3, P141, DOI 10.1385/JCD:3:2:141; National Osteoporosis Foundation, 2005, OST FAST FACTS; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Njeh CF, 2000, OSTEOPOROSIS INT, V11, P1051; Njeh CF, 1997, OSTEOPOROSIS INT, V7, P7, DOI 10.1007/BF01623454; Orwin R.G., 1994, HDB RES SYNTHESIS; Pearson D, 2003, J CLIN DENSITOM, V6, P345, DOI 10.1385/JCD:6:4:345; PECK WA, 1993, AM J MED, V94, P646; Pluijm SMF, 1999, OSTEOPOROSIS INT, V9, P550, DOI 10.1007/s001980050275; Pocock NA, 2000, MED J AUSTRALIA, V173, P355, DOI 10.5694/j.1326-5377.2000.tb125686.x; POCOCK NA, 1992, J BONE MINER RES, V7, P1081; Prins SH, 1998, CLIN PHYSIOL, V18, P3; ROSS P, 1995, BONE, V16, P325, DOI 10.1016/8756-3282(94)00045-X; Roux C, 1996, J BONE MINER RES, V11, P1112; SALAMONE LM, 1994, CALCIFIED TISSUE INT, V54, P87, DOI 10.1007/BF00296056; Sim M F, 2000, Technol Health Care, V8, P277; Sim M F V, 2005, Technol Health Care, V13, P75; Sorensen HA, 2001, J CLIN DENSITOM, V4, P97, DOI 10.1385/JCD:4:2:097; Sox HC, 1988, MED DECISION MAKING; Stafford RS, 2004, ARCH INTERN MED, V164, P1525, DOI 10.1001/archinte.164.14.1525; Stewart A, 2000, BONE, V27, P139, DOI 10.1016/S8756-3282(00)00304-5; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; TRUSCOTT JG, 1992, CLIN PHYS PHYSIOL M, V13, P29, DOI 10.1088/0143-0815/13/1/003; TURNER CH, 1995, OSTEOPOROSIS INT, V5, P130, DOI 10.1007/BF01623314; VANDAELE PLA, 1994, J BONE MINER RES, V9, P1751; Varney LF, 1999, J CLIN DENSITOM, V2, P275, DOI 10.1385/JCD:2:3:275; Working H., 1929, J AM STAT ASSOC, V24, P73, DOI [10.2307/2277011, DOI 10.2307/2277011]; Wuster C, 1998, EXP CLIN ENDOCR DIAB, V106, P277; YOUNG H, 1993, OSTEOPOROSIS INT, V3, P160, DOI 10.1007/BF01623278; Zochling J, 2004, OSTEOPOROSIS INT, V15, P619, DOI 10.1007/s00198-004-1594-5; 2000, NIH CONSEN STATEMENT, V17, P1; 2002, TEC B, V19, P25	99	92	97	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					832	841		10.7326/0003-4819-144-11-200606060-00009	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZN	16754925				2022-12-28	WOS:000238057000006
J	Boehm, T				Boehm, Thomas			Quality control in self/nonself discrimination	CELL			English	Review							CLASS-I MOLECULES; SELF-INCOMPATIBILITY; IMMUNE-SYSTEM; PROTOCHORDATE ALLORECOGNITION; SOMATIC DIVERSIFICATION; ARABIDOPSIS-THALIANA; RECEPTOR REPERTOIRE; S-RNASE; RECOGNITION; CELL		Max Planck Inst Immunobiol, Dept Dev Immunol, Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunobiol, Dept Dev Immunol, Freiburg, Germany.	boehm@immunbio.mpg.de						Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; Arai M, 2001, MICROBIOL IMMUNOL, V45, P857, DOI 10.1111/j.1348-0421.2001.tb01326.x; Austen K F, 1979, Adv Exp Med Biol, V120B, P3; Ban S, 2005, DEV BIOL, V286, P440, DOI 10.1016/j.ydbio.2005.08.004; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Chookajorn T, 2004, P NATL ACAD SCI USA, V101, P911, DOI 10.1073/pnas.2637116100; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Eason DD, 2004, SEMIN IMMUNOL, V16, P215, DOI 10.1016/j.smim.2004.08.001; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; FUJII T, 1983, CELL TISSUE RES, V231, P301; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Grosberg RK, 2000, SCIENCE, V289, P2111, DOI 10.1126/science.289.5487.2111; GROSBERG RK, 1986, NATURE, V322, P456, DOI 10.1038/322456a0; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jozsi M, 2004, HISTOL HISTOPATHOL, V19, P251, DOI 10.14670/HH-19.251; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Klein J, 2005, P NATL ACAD SCI USA, V102, P169, DOI 10.1073/pnas.0408480102; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Kuboto A, 1999, J IMMUNOL, V163, P212; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Landsteiner K, 1928, J EXP MED, V48, P315, DOI 10.1084/jem.48.3.315; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Matton DP, 1999, PLANT CELL, V11, P2087, DOI 10.1105/tpc.11.11.2087; McClure B, 2004, PLANT CELL, V16, P2840, DOI 10.1105/tpc.104.161130; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Moretta L, 2004, TRENDS IMMUNOL, V25, P670, DOI 10.1016/j.it.2004.09.008; Nasrallah JB, 2005, TRENDS IMMUNOL, V26, P412, DOI 10.1016/j.it.2005.06.005; Nasrallah JB, 2002, SCIENCE, V296, P305, DOI 10.1126/science.296.5566.305; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Nasrallah ME, 2004, P NATL ACAD SCI USA, V101, P16070, DOI 10.1073/pnas.0406970101; Niedermann G, 1997, J EXP MED, V186, P209, DOI 10.1084/jem.186.2.209; Olesnicky NS, 2000, GENETICS, V156, P1025; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; RAMMENSEE HG, 1997, MHC LIGANDS REPTIDE; Riquelme M, 2005, GENETICS, V170, P1105, DOI 10.1534/genetics.105.040774; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sawada H, 2004, P NATL ACAD SCI USA, V101, P15615, DOI 10.1073/pnas.0401928101; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uyenoyama MK, 2000, PLANT CELL, V12, P310, DOI 10.1105/tpc.12.3.310; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	74	78	83	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					845	858		10.1016/j.cell.2006.05.017	http://dx.doi.org/10.1016/j.cell.2006.05.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751096	hybrid			2022-12-28	WOS:000238116400013
J	Wallrath, LL; Geyer, PK				Wallrath, Lori L.; Geyer, Pamela K.			TFIIIC boxes in the genome	CELL			English	Editorial Material							TRANSCRIPTION		Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Geyer, PK (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	pamela-geyer@uiowa.edu		Wallrath, Lori/0000-0002-4391-7199; Geyer, Pamela/0000-0001-9275-1407				Cam H, 2004, COLD SPRING HARB SYM, V69, P419, DOI 10.1101/sqb.2004.69.419; Donze D, 2002, BIOESSAYS, V24, P344, DOI 10.1002/bies.10072; Kuhn EJ, 2003, CURR OPIN CELL BIOL, V15, P259, DOI 10.1016/S0955-0674(03)00039-5; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; NOMA K, 2006, CELL; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; WALLRATH LL, 2004, ENCY BIOL CHEM, P105; Willoughby DA, 2000, J BIOL CHEM, V275, P759, DOI 10.1074/jbc.275.2.759	10	6	6	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					829	831		10.1016/j.cell.2006.05.016	http://dx.doi.org/10.1016/j.cell.2006.05.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751090	Bronze			2022-12-28	WOS:000238116400007
J	Marzari, F				Marzari, Francesco			Puzzling Neptune Trojans	SCIENCE			English	Editorial Material							SOLAR-SYSTEM; ASTEROIDS		Univ Padua, Dept Phys, I-35131 Padua, Italy	University of Padua	Marzari, F (corresponding author), Univ Padua, Dept Phys, Via Marzolo 8, I-35131 Padua, Italy.	francesco.marzari@pd.infn.it	Marzari, Francesco/X-2440-2019					Chiang EI, 2005, ASTROPHYS J, V628, P520, DOI 10.1086/430825; Jewitt DC, 2000, ASTRON J, V120, P1140, DOI 10.1086/301453; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Sheppard SS, 2006, SCIENCE, V313, P511, DOI 10.1126/science.1127173; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539	5	6	6	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					451	452		10.1126/science.1129458	http://dx.doi.org/10.1126/science.1129458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16778020				2022-12-28	WOS:000239308600026
J	Duffy, PE; Mutabingwa, TK				Duffy, Patrick E.; Mutabingwa, Theonest K.			Artemisinin combination therapies	LANCET			English	Editorial Material							ARTESUNATE PLUS AMODIAQUINE; PLASMODIUM-FALCIPARUM MALARIA; ARTEMETHER-LUMEFANTRINE; SULFADOXINE-PYRIMETHAMINE; MEFLOQUINE; EFFICACY; MONOTHERAPY; THAILAND		Seattle Biomed Res Inst, Malaria Program, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA; Natl Inst Med Res, Dar Es Salaam, Tanzania	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; National Institute of Medical Research	Duffy, PE (corresponding author), Seattle Biomed Res Inst, Malaria Program, 4 Nickerson St, Seattle, WA 98109 USA.	patrick.duffy@sbri.org						Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Durrani N, 2005, TROP MED INT HEALTH, V10, P521, DOI 10.1111/j.1365-3156.2005.01429.x; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Meremikwu M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-43; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Vijaykadga S, 2006, TROP MED INT HEALTH, V11, P211, DOI 10.1111/j.1365-3156.2005.01557.x; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190	11	37	38	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2037	2039		10.1016/S0140-6736(06)68900-9	http://dx.doi.org/10.1016/S0140-6736(06)68900-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798368				2022-12-28	WOS:000238657400005
J	Okada, K; Inoue, A; Okada, M; Murata, Y; Kakuta, S; Jigami, T; Kubo, S; Shiraishi, H; Eguchi, K; Motomura, M; Akiyama, T; Iwakura, Y; Higuchi, O; Yamanashi, Y				Okada, Kumiko; Inoue, Akane; Okada, Momoko; Murata, Yoji; Kakuta, Shigeru; Jigami, Takafumi; Kubo, Sachiko; Shiraishi, Hirokazu; Eguchi, Katsumi; Motomura, Masakatsu; Akiyama, Tetsu; Iwakura, Yoichiro; Higuchi, Osamu; Yamanashi, Yuji			The muscle protein Dok-7 is essential for neuromuscular synaptogenesis	SCIENCE			English	Article							TYROSINE KINASE MUSK; ACETYLCHOLINE-RECEPTOR; SYNAPSE FORMATION; MUTANT MICE; IN-VIVO; JUNCTION; NEUROTRANSMITTER; DIFFERENTIATION	The formation of the neuromuscular synapse requires muscle-specific receptor kinase (MuSK) to orchestrate postsynaptic differentiation, including the clustering of receptors for the neurotransmitter acetylcholine. Upon innervation, neural agrin activates MuSK to establish the postsynaptic apparatus, although agrin-independent formation of neuromuscular synapses can also occur experimentally in the absence of neurotransmission. Dok-7, a MuSK-interacting cytoplasmic protein, is essential for MuSK activation in cultured myotubes; in particular, the Dok-7 phosphotyrosine-binding domain and its target in MuSK are indispensable. Mice lacking Dok-7 formed neither acetylcholine receptor clusters nor neuromuscular synapses. Thus, Dok-7 is essential for neuromuscular synaptogenesis through its interaction with MuSK.	Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo 1138510, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo 1130032, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med 1, Nagasaki 8528501, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Nagasaki University	Higuchi, O (corresponding author), Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Tokyo 1138510, Japan.	higuchi.creg@mri.tmd.ac.jp; yamanashi.creg@mri.tmd.ac.jp	Kakuta, Shigeru/L-2241-2018; Iwakura, Yoichiro/E-5457-2011	Kakuta, Shigeru/0000-0002-5900-1425; Iwakura, Yoichiro/0000-0002-9934-5775; Murata, Yoji/0000-0002-9576-7030				Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gillespie SKH, 1996, NEURON, V16, P953, DOI 10.1016/S0896-6273(00)80118-X; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sugiyama JE, 1997, J CELL BIOL, V139, P181, DOI 10.1083/jcb.139.1.181; Vincent A, 2003, ANN NY ACAD SCI, V998, P324, DOI 10.1196/annals.1254.036; Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	25	290	308	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1802	1805		10.1126/science.1127142	http://dx.doi.org/10.1126/science.1127142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794080				2022-12-28	WOS:000238452800060
J	Miller, JM; Raymond, J; Fabian, A; Steeghs, D; Homan, J; Reynolds, C; van der Klis, M; Wijnands, R				Miller, Jon M.; Raymond, John; Fabian, Andy; Steeghs, Danny; Homan, Jeroen; Reynolds, Chris; van der Klis, Michiel; Wijnands, Rudy			The magnetic nature of disk accretion onto black holes	NATURE			English	Article							DRIVEN; WINDS; MASS; SIMULATIONS; INSTABILITY; LINE	Although disk accretion onto compact objects - white dwarfs, neutron stars and black holes - is central to much of high-energy astrophysics, the mechanisms that enable this process have remained observationally difficult to determine. Accretion disks must transfer angular momentum in order for matter to travel radially inward onto the compact object(1). Internal viscosity from magnetic processes(1-4) and disk winds(5) can both in principle transfer angular momentum, but hitherto we lacked evidence that either occurs. Here we report that an X-ray-absorbing wind discovered in an observation of the stellar-mass black hole binary GRO J1655-40 ( ref. 6) must be powered by a magnetic process that can also drive accretion through the disk. Detailed spectral analysis and modelling of the wind shows that it can only be powered by pressure generated by magnetic viscosity internal to the disk or magnetocentrifugal forces. This result demonstrates that disk accretion onto black holes is a fundamentally magnetic process.	Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands	University of Michigan System; University of Michigan; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Cambridge; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park; University of Amsterdam	Miller, JM (corresponding author), Univ Michigan, Dept Astron, 500 Church St, Ann Arbor, MI 48109 USA.	jonmm@umich.edu	Steeghs, Danny T/C-5468-2009	Steeghs, Danny T/0000-0003-0771-4746; Reynolds, Christopher/0000-0002-1510-4860; Wijnands, Rudi/0000-0002-3516-2152; Miller, Jon/0000-0003-2869-7682; Raymond, John/0000-0002-7868-1622				Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; BEGELMAN MC, 1983, ASTROPHYS J, V271, P70, DOI 10.1086/161178; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; CALVET N, 1993, ASTROPHYS J, V402, P623, DOI 10.1086/172164; Chelouche D, 2005, ASTROPHYS J, V625, P95, DOI 10.1086/429580; Colgan J, 2004, ASTRON ASTROPHYS, V417, P1183, DOI 10.1051/0004-6361:20034197; Everett JE, 2005, ASTROPHYS J, V631, P689, DOI 10.1086/432678; Grevesse N, 1998, SPACE SCI REV, V85, P161, DOI 10.1023/A:1005161325181; HAWLEY JF, 1995, ASTROPHYS J, V440, P742, DOI 10.1086/175311; HJELLMING RM, 1995, NATURE, V375, P464, DOI 10.1038/375464a0; Houck JC, 2000, ASTR SOC P, V216, P591; KONIGL A, 1994, ASTROPHYS J, V434, P446, DOI 10.1086/174746; Mauche CW, 2000, ASTROPHYS J, V541, P924, DOI 10.1086/309489; Miller JM, 2004, ASTROPHYS J, V601, P450, DOI 10.1086/380196; Miller KA, 2000, ASTROPHYS J, V534, P398, DOI 10.1086/308736; Nahar SN, 1999, ASTRON ASTROPHYS SUP, V135, P347, DOI 10.1051/aas:1999447; Orosz JA, 1997, ASTROPHYS J, V477, P876, DOI 10.1086/303741; Proga D, 2003, ASTROPHYS J, V585, P406, DOI 10.1086/345897; Proga D, 2000, ASTROPHYS J, V543, P686, DOI 10.1086/317154; RAYMOND JC, 1993, ASTROPHYS J, V412, P267, DOI 10.1086/172917; Schulz NS, 2002, ASTROPHYS J, V572, P971, DOI 10.1086/340369; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Spitzer L., 1978, PHYS PROCESSES INTER; Spruit HC, 1996, NATO ADV SCI INST SE, V477, P249; Verner DA, 1996, ATOM DATA NUCL DATA, V64, P1, DOI 10.1006/adnd.1996.0018; VRTILEK SD, 1990, ASTRON ASTROPHYS, V235, P162	28	208	210	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					953	955		10.1038/nature04912	http://dx.doi.org/10.1038/nature04912			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791188	Green Published			2022-12-28	WOS:000238422300035
J	Bhopal, R				Bhopal, Raj			Racism, socioeconomic deprivation, and health in New Zealand	LANCET			English	Editorial Material							INEQUALITIES		Univ Edinburgh, Div Community Hlth Sci, Publ Hlth Sci Sect, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Bhopal, R (corresponding author), Univ Edinburgh, Div Community Hlth Sci, Publ Hlth Sci Sect, Edinburgh EH8 9AG, Midlothian, Scotland.	Raj.Bhopal@ed.ac.uk						Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; Bhopal R, 1998, BMJ-BRIT MED J, V316, P1970, DOI 10.1136/bmj.316.7149.1970; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Bramley D, 2005, AM J PUBLIC HEALTH, V95, P844, DOI 10.2105/AJPH.2004.040907; GILL PS, IN PRESS HLTH CARE N; Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; 2001, BMJ, V322, P1503	8	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					1958	1959		10.1016/S0140-6736(06)68859-4	http://dx.doi.org/10.1016/S0140-6736(06)68859-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782467				2022-12-28	WOS:000238488900006
J	Hubbard, SR				Hubbard, SR			EGF receptor activation: Push comes to shove	CELL			English	Editorial Material							TYROSINE KINASES; INHIBITOR; COMPLEX	A study by Zhang et al. (2006) in this issue of Cell provides compelling evidence that the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) is activated by the formation of an asymmetric dimer, with one kinase domain in the EGF-mediated dimer activating the other through an allosteric mechanism.	NYU, Sch Med, Struct Biol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University	Hubbard, SR (corresponding author), NYU, Sch Med, Struct Biol Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	hubbard@saturn.med.nyu.edu		Hubbard, Stevan/0000-0002-2707-9383				Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Minna JD, 2004, SCIENCE, V304, P1458, DOI 10.1126/science.1099578; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	10	24	25	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1029	1031		10.1016/j.cell.2006.05.028	http://dx.doi.org/10.1016/j.cell.2006.05.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777592	Bronze			2022-12-28	WOS:000238602700007
J	Kantarjian, H; Giles, F; Wunderle, L; Bhalla, K; O'Brien, S; Wassmann, B; Tanaka, C; Manley, P; Rae, P; Mietlowski, W; Bochinski, K; Hochhaus, A; Griffin, JD; Hoelzer, D; Albitar, M; Dugan, M; Cortes, J; Alland, L; Ottmann, OG				Kantarjian, Hagop; Giles, Francis; Wunderle, Lydia; Bhalla, Kapil; O'Brien, Susan; Wassmann, Barbara; Tanaka, Chiaki; Manley, Paul; Rae, Patricia; Mietlowski, William; Bochinski, Kathy; Hochhaus, Andreas; Griffin, James D.; Hoelzer, Dieter; Albitar, Maher; Dugan, Margaret; Cortes, Jorge; Alland, Leila; Ottmann, Oliver G.			Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; IN-VITRO ACTIVITY; BCR-ABL; AMINOPYRIMIDINE INHIBITOR; MESYLATE ST1571; BLAST CRISIS; AMN107; CHEMOTHERAPY; RESPONSES; THERAPY	BACKGROUND: Resistance to imatinib mesylate can occur in chronic myelogenous leukemia (CML). Preclinical in vitro studies have shown that nilotinib (AMN107), a new BCR-ABL tyrosine kinase inhibitor, is more potent than imatinib against CML cells by a factor of 20 to 50. METHODS: In a phase 1 dose-escalation study, we assigned 119 patients with imatinib-resistant CML or acute lymphoblastic leukemia (ALL) to receive nilotinib orally at doses of 50 mg, 100 mg, 200 mg, 400 mg, 600 mg, 800 mg, and 1200 mg once daily and at 400 mg and 600 mg twice daily. RESULTS: Common adverse events were myelosuppression, transient indirect hyperbilirubinemia, and rashes. Of 33 patients with the blastic phase of disease, 13 had a hematologic response and 9 had a cytogenetic response; of 46 patients with the accelerated phase, 33 had a hematologic response and 22 had a cytogenetic response; 11 of 12 patients with the chronic phase had a complete hematologic remission. CONCLUSIONS: Nilotinib has a relatively favorable safety profile and is active in imatinib-resistant CML.	Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Unit 428, Houston, TX 77230 USA; Goethe Univ Frankfurt, D-6000 Frankfurt, Germany; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; Novartis Pharmaceut, E Hanover, NJ USA; Quest Diagnost, San Juan Capistrano, CA USA; Heidelberg Univ, Fak Klin Med Mannheim, Mannheim, Germany; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Goethe University Frankfurt; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Novartis; Ruprecht Karls University Heidelberg; Harvard University; Dana-Farber Cancer Institute	Kantarjian, H (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Unit 428, POB 301402, Houston, TX 77230 USA.	hkantarj@mdanderson.org	manley, paul william/GVT-9482-2022; Ottmann, Oliver G/D-5007-2016	Ottmann, Oliver G/0000-0001-9559-1330; Bhalla, Kapil/0000-0001-5209-5126; Cortes, Jorge/0000-0002-8636-1071; Hochhaus, Andreas/0000-0003-0626-0834				BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Cohen MH, 2005, CLIN CANCER RES, V11, P12; Cortes J, 2005, CLIN CANCER RES, V11, P3425, DOI 10.1158/1078-0432.CCR-04-2139; Cortes JE, 2003, BLOOD, V101, P3794, DOI 10.1182/blood-2002-09-2790; Deininger MWN, 2003, J CLIN ONCOL, V21, P1637, DOI 10.1200/JCO.2003.11.143; Faderl S, 1999, ANN INTERN MED, V131, P207, DOI 10.7326/0003-4819-131-3-199908030-00008; Golemovic M, 2005, CLIN CANCER RES, V11, P4941, DOI 10.1158/1078-0432.CCR-04-2601; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2004, BLOOD, V103, P2873, DOI 10.1182/blood-2003-11-3800; Kantarjian HM, 2002, BLOOD, V99, P3547, DOI 10.1182/blood.V99.10.3547; KANTARJIAN HM, 1988, CANCER, V61, P1441, DOI 10.1002/1097-0142(19880401)61:7<1441::AID-CNCR2820610727>3.0.CO;2-C; KANTARJIAN HM, 1987, AM J MED, V83, P445, DOI 10.1016/0002-9343(87)90754-6; Manley P, 2005, 96 ANN M AM ASS CANC; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; O'Quigley J, 1999, J Biopharm Stat, V9, P17, DOI 10.1081/BIP-100100998; Ottmann OG, 2003, BLOOD, V102, p226A; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; Silver RT, 2004, BLOOD, V104, p11A; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Thomas DA, 2004, BLOOD, V103, P4396, DOI 10.1182/blood-2003-08-2958; Towatari M, 2004, BLOOD, V104, P3507, DOI 10.1182/blood-2004-04-1389; Verstovsek S, 2005, CANCER-AM CANCER SOC, V104, P1230, DOI 10.1002/cncr.21299; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2005, CANCER CELL, V7, P399, DOI 10.1016/j.ccr.2005.03.026	25	1002	1048	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2542	2551		10.1056/NEJMoa055104	http://dx.doi.org/10.1056/NEJMoa055104			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775235	Bronze			2022-12-28	WOS:000238233400004
J	Ghabrial, AS; Krasnow, MA				Ghabrial, Amin S.; Krasnow, Mark A.			Social interactions among epithelial cells during tracheal branching morphogenesis	NATURE			English	Article							MIDLINE GLIAL-CELLS; DROSOPHILA TRACHEA; FGF; GENE; ACTIVATION; ENCODES; NOTCH; FATE; TUBULOGENESIS; BREATHLESS	Many organs are composed of tubular networks that arise by branching morphogenesis in which cells bud from an epithelium and organize into a tube(1-3). Fibroblast growth factors ( FGFs) and other signalling molecules have been shown to guide branch budding and outgrowth(4-7), but it is not known how epithelial cells coordinate their movements and morphogenesis. Here we use genetic mosaic analysis in Drosophila melanogaster to show that there are two functionally distinct classes of cells in budding tracheal branches: cells at the tip that respond directly to Branchless FGF and lead branch outgrowth, and trailing cells that receive a secondary signal to follow the lead cells and form a tube. These roles are not pre-specified; rather, there is competition between cells such that those with the highest FGF receptor activity take the lead positions, whereas those with less FGF receptor activity assume subsidiary positions and form the branch stalk. Competition appears to involve Notch-mediated lateral inhibition that prevents extra cells from assuming the lead. There may also be cooperation between budding cells, because in a mosaic epithelium, cells that cannot respond to the chemoattractant, or respond only poorly, allow other cells in the epithelium to move ahead of them.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA.	krasnow@cmgm.stanford.edu	Ghabrial, Amin S/J-4586-2013; Ghabrial, Amin/ABB-1364-2020	Ghabrial, Amin S/0000-0002-6160-3003; 	NIGMS NIH HHS [F32 GM020723-03, F32 GM020723] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020723] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chihara T, 2000, DEVELOPMENT, V127, P4433; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Ikeya T, 1999, DEVELOPMENT, V126, P4455; Imam F, 1999, GENETICS, V152, P307; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; KLAMBT C, 1993, DEVELOPMENT, V117, P163; Llimargas M, 2000, DEVELOPMENT, V127, P4407; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Ohshiro T, 2002, MECH DEVELOP, V114, P3, DOI 10.1016/S0925-4773(02)00042-4; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Weaver M, 2000, DEVELOPMENT, V127, P2695	30	171	176	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					746	749		10.1038/nature04829	http://dx.doi.org/10.1038/nature04829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760977	Green Published			2022-12-28	WOS:000238095100053
J	Theos, A; Korf, BR				Theos, Amy; Korf, Bruce R.			Pathophysiology of neurofibromatosis type 1	ANNALS OF INTERNAL MEDICINE			English	Review							NERVE SHEATH TUMORS; CONSENSUS STATEMENT; SCHWANN-CELLS; NF1; GENE; MUTATIONS; MOSAICISM; CHILDREN; DELETION; ENCODES		Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Korf, BR (corresponding author), Univ Alabama Birmingham, Dept Genet, 1530 3rd Ave S, Birmingham, AL 35294 USA.	bkorf@uab.edu	Korf, Bruce R/H-4882-2012					[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Bajenaru ML, 2003, CANCER RES, V63, P8573; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Carey J C, 1979, Birth Defects Orig Artic Ser, V15, P271; DASTON MM, 1992, NEURON, V8, P415, DOI 10.1016/0896-6273(92)90270-N; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; EASTON DF, 1993, AM J HUM GENET, V53, P305; Eisenbarth I, 1997, BIOCHEM BIOPH RES CO, V237, P138, DOI 10.1006/bbrc.1997.7097; Emanuel Peter D, 2004, Curr Hematol Rep, V3, P203; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2000, J NEUROL NEUROSUR PS, V68, P353, DOI 10.1136/jnnp.68.3.353; Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002; Head Julia E, 2003, Expert Opin Emerg Drugs, V8, P163, DOI 10.1517/eoed.8.1.163.21041; HEIM RA, 1994, NAT GENET, V8, P218, DOI 10.1038/ng1194-218; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; Korf B R, 2000, Oncologist, V5, P477, DOI 10.1634/theoncologist.5-6-477; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; KORF BR, 1999, NEUROFIBROMATOSIS PH, P142; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; LEGIUS E, 1994, GENE CHROMOSOME CANC, V10, P250, DOI 10.1002/gcc.2870100405; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Listernick R, 1997, ANN NEUROL, V41, P143, DOI 10.1002/ana.410410204; McClatchey AI, 2001, BBA-REV CANCER, V1471, pM73, DOI 10.1016/S0304-419X(00)00026-3; Messiaen L, 2003, J MED GENET, V40, P122, DOI 10.1136/jmg.40.2.122; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; MOLLOY PT, 1995, NEUROLOGY, V45, P1897, DOI 10.1212/WNL.45.10.1897; North KN, 1997, NEUROLOGY, V48, P1121, DOI 10.1212/WNL.48.4.1121; Poussaint TY, 2003, AM J ROENTGENOL, V180, P419, DOI 10.2214/ajr.180.2.1800419; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Ruggieri M, 2000, J NEUROSURG, V93, P530; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; SHANNON KM, 1992, BLOOD, V79, P1311; Silva AJ, 1998, PATHOL BIOL, V46, P697; Tinschert S, 2000, EUR J HUM GENET, V8, P455, DOI 10.1038/sj.ejhg.5200493; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Wu BL, 1997, HUM GENET, V99, P209, DOI 10.1007/s004390050341; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zoller M, 1997, ACTA NEUROL SCAND, V95, P225; Zoller MET, 1999, J PSYCHIATR RES, V33, P63, DOI 10.1016/S0022-3956(98)00052-1	46	96	102	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					842	849		10.7326/0003-4819-144-11-200606060-00010	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZN	16754926				2022-12-28	WOS:000238057000007
J	Nordt, C; Stohler, R				Nordt, C; Stohler, R			Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis	LANCET			English	Article							HARM REDUCTION; DRUG-TREATMENT; PREVALENCE; TRENDS; PROJECTION; NUMBER; SCENE	Background Switzerland has been criticised for its liberal drug policy, which could attract new users and lengthen periods of heroin addiction. We sought to estimate incidence trends and prevalence of problem heroin use in Switzerland. Methods We obtained information about first year of regular heroin use from the case register of substitution treatments in the canton of Zurich for 7256 patients (76% of those treated between 1991 and March, 2005). We estimated the proportion of heroin users not yet in substitution treatment programmes using the conditional lag-time distribution. Cessation rate was the proportion of individuals leaving substitution treatment programmes and not re-entering within the subsequent 10 years. Overall prevalence of problematic heroin use was modelled as a function of incidence and cessation rate. Findings Every second person began their first substitution treatment within 2 years of starting to use heroin regularly. Incidence of heroin use rose steeply, starting with about 80 people in 1975, culminating in 1990 with 850 new users, and declining substantially to about 150 users in 2002. Two-thirds of those who had left substitution treatment programmes re-entered within the next 10 years. The population of problematic heroin users declined by 4% a year. The cessation rate in Switzerland was low, and therefore, the prevalence rate declined slowly. Our prevalence model accords with data generated by different approaches. Interpretation The harm reduction policy of Switzerland and its emphasis on the medicalisation of the heroin problem seems to have contributed to the image of heroin as unattractive for young people. Our model could enable the study of incidence trends across different countries and thus urgently needed assessments of the effect of different drug policies.	Psychiat Univ Hosp, Zurich, Switzerland		Nordt, C (corresponding author), Psychiat Univ Hosp, Militar Str, Zurich, Switzerland.	cnordt@bli.unizh.ch	Nordt, Carlos/H-1033-2017	Nordt, Carlos/0000-0002-1156-152X				[Anonymous], 1973, AM DIS ORIGINS NARCO; De Angelis D, 2004, AM J EPIDEMIOL, V160, P994, DOI 10.1093/aje/kwh306; De Preux E, 2004, SWISS MED WKLY, V134, P313; Ditton J, 2001, SUBST USE MISUSE, V36, P151, DOI 10.1081/JA-100000233; Estermann J, 1998, SOZ PRAVENTIV MED, V43, P173, DOI 10.1007/BF01359726; Falcato L, 2001, ADDICTION, V96, P623, DOI 10.1046/j.1360-0443.2001.96462310.x; *FED OFF POL, 2004, BETAUBUNGSMITTELSTAT; Hickman M, 2001, AM J EPIDEMIOL, V153, P632, DOI 10.1093/aje/153.7.632; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hunt G., 1998, DRUG TREATMENT SYSTE, P94; International Narcotics Control Board, 2003, REP INT NARC CONTR B; Klingemann H, 1999, EUR ADDICT RES, V5, P109, DOI 10.1159/000018978; Klingemann HKH, 1996, ADDICTION, V91, P723, DOI 10.1046/j.1360-0443.1996.9157238.x; Law MG, 2001, ADDICTION, V96, P433, DOI 10.1046/j.1360-0443.2001.9634337.x; Maag V, 2003, EUR ADDICT RES, V9, P176, DOI 10.1159/000070984; Millar T, 2001, J EPIDEMIOL COMMUN H, V55, P930, DOI 10.1136/jech.55.12.930; MUSTO DF, 1999, AM DIS ORIGINS NAROC; Negrete JC, 2001, ADDICTION, V96, P543, DOI 10.1046/j.1360-0443.2001.9645432.x; RAVA L, 2001, UN B NARCOTICS, V53, P135; ROHRIG S, 1990, SCHWEIZ MED WSCHR, V120, P621; Stohler R, 2004, SOZ PRAVENTIV MED, V49, P276, DOI 10.1007/s00038-004-3046-6; *SWISS FED OFF PUB, 2005, NAT SUBST STAT METH	22	90	93	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1830	1834		10.1016/S0140-6736(06)68804-1	http://dx.doi.org/10.1016/S0140-6736(06)68804-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753485				2022-12-28	WOS:000238194200028
J	Dusek, U; Frank, GP; Hildebrandt, L; Curtius, J; Schneider, J; Walter, S; Chand, D; Drewnick, F; Hings, S; Jung, D; Borrmann, S; Andreae, MO				Dusek, U.; Frank, G. P.; Hildebrandt, L.; Curtius, J.; Schneider, J.; Walter, S.; Chand, D.; Drewnick, F.; Hings, S.; Jung, D.; Borrmann, S.; Andreae, M. O.			Size matters more than chemistry for cloud-nucleating ability of aerosol particles	SCIENCE			English	Article							CONDENSATION NUCLEI; CCN ACTIVATION; SOLUBLE ORGANICS; CARBON; URBAN; SALT	Size-resolved cloud condensation nuclei (CCN) spectra measured for various aerosol types at a non-urban site in Germany showed that CCN concentrations are mainly determined by the aerosol number size distribution. Distinct variations of CCN activation with particle chemical composition were observed but played a secondary role. When the temporal variation of chemical effects on CCN activation is neglected, variation in the size distribution alone explains 84 to 96% of the variation in CCN concentrations. Understanding that particles' ability to act as CCN is largely controlled by aerosol size rather than composition greatly facilitates the treatment of aerosol effects on cloud physics in regional and global models.	Max Planck Inst Chem, Dept Biogeochem, D-55128 Mainz, Germany; Max Planck Inst Chem, Dept Particle Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Atmospher Phys, D-55128 Mainz, Germany; CALTECH, Pasadena, CA 91125 USA	Max Planck Society; Max Planck Society; Johannes Gutenberg University of Mainz; California Institute of Technology	Dusek, U (corresponding author), Max Planck Inst Chem, Dept Biogeochem, D-55128 Mainz, Germany.		Drewnick, Frank/D-3978-2018; Curtius, Joachim/A-2681-2011; Andreae, Meinrat O./B-1068-2008; Schneider, Johannes/A-2674-2010; Borrmann, Stephan/E-3868-2010; Ruiz, Lea Hildebrandt/A-4236-2010	Curtius, Joachim/0000-0003-3153-4630; Andreae, Meinrat O./0000-0003-1968-7925; Schneider, Johannes/0000-0001-7169-3973; Borrmann, Stephan/0000-0002-4774-9380; Dusek, Ulrike/0000-0002-7793-312X; Frank, Goran/0000-0003-4207-7391				Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Bilde M, 2004, TELLUS B, V56, P128, DOI 10.1111/j.1600-0889.2004.00090.x; Broekhuizen K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018203; Charlson RJ, 2001, SCIENCE, V292, P2025, DOI 10.1126/science.1060096; Chuang PY, 2000, TELLUS B, V52, P843, DOI 10.1034/j.1600-0889.2000.00018.x; Covert DS, 1996, J GEOPHYS RES-ATMOS, V101, P6919, DOI 10.1029/95JD03068; Dusek U, 2006, ENVIRON SCI TECHNOL, V40, P1223, DOI 10.1021/es0503478; Dusek U, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022473; Ervens B, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005634; Facchini MC, 1999, NATURE, V401, P257, DOI 10.1038/45758; Feingold G, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017967; FITZGERALD JW, 1982, J ATMOS SCI, V39, P1838, DOI 10.1175/1520-0469(1982)039<1838:TSASCO>2.0.CO;2; FRANK GP, 2006, ATMOS CHEM PHYS DISC, V6, P2151; FRANK GP, IN PRESS ATMOS PHYS; Giebl H, 2002, J AEROSOL SCI, V33, P1623, DOI 10.1016/S0021-8502(02)00115-5; Hudson JG, 1996, J GEOPHYS RES-ATMOS, V101, P4435, DOI 10.1029/95JD00192; Jayne JT, 2000, AEROSOL SCI TECH, V33, P49, DOI 10.1080/027868200410840; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Levin Z, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005810; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; Lohmann U, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018999; MCFIGGANS G, 2005, ATMOS CHEM PHYS DISC, V5, P8507; Putaud JP, 2004, ATMOS ENVIRON, V38, P2579, DOI 10.1016/j.atmosenv.2004.01.041; Raymond TM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002159; Roberts MC, 2001, GEOPHYS RES LETT, V28, P2807, DOI 10.1029/2000GL012585; Shulman ML, 1996, GEOPHYS RES LETT, V23, P277, DOI 10.1029/95GL03810; Snider JR, 2000, TELLUS B, V52, P828, DOI 10.1034/j.1600-0889.2000.00044.x; SWIETLICKI E, COMMUNICATION; VanReken TM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003582	29	651	674	5	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1375	1378		10.1126/science.1125261	http://dx.doi.org/10.1126/science.1125261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741120				2022-12-28	WOS:000237961600054
J	He, W; Dorn, DC; Erdjument-Bromage, H; Tempst, P; Moore, MAS; Massague, J				He, Wei; Dorn, David C.; Erdjument-Bromage, Hediye; Tempst, Paul; Moore, Malcolm A. S.; Massague, Joan			Hematopoiesis controlled by distinct TIF1 gamma and Smad4 branches of the TGF beta pathway	CELL			English	Article							NUCLEAR RECEPTORS; PROGENITOR CELLS; STRUCTURAL BASIS; SWI/SNF COMPLEX; GROWTH; TRANSCRIPTION; FAMILY; DOMAIN; PROTEIN; KINASE	Tissue homeostasis in mammals relies on powerful cytostatic and differentiation signals delivered by the cytolkine TGF beta and relayed within the cell via the activation of Smad transcription factors. Formation of transcription regulatory complexes by the association of Smad4 with receptor-phosphorylated Smads 2 and 3 is a central event in the canonical TGF beta pathway. Here we provide evidence for a branching of this pathway. The ubiquitious nuclear protein Transcriptional Intermediary Factor 1 gamma(TIF1 gamma) selectively binds receptor-phosphorylated Smad2/3 in competition with Smad4. Rapid and robust binding of TIF1 gamma to Smad2/3 occurs in hematopoietic, mesenchymal, and epithelial cell types in response to TGF beta. In human hematopoietic stem/progenitor cells, where TGF beta inhibits proliferation and stimulates erythroid differentiation, TIF1 gamma mediates the differentiation response while Smad4 mediates the anti proliferative response with Smad2/3 participating in both responses. Thus, Smad2/3-TIF1 gamma and Smad2/3-Smad4 function as complementary effector arms in the control of hematopoietic cell fate by the TGF beta/Smad pathway.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA.	j-massague@ski.mskcc.org		Erdjument-Bromage, Hediye/0000-0003-0224-3594; Massague, Joan/0000-0001-9324-8408; Tempst, Paul/0000-0002-6680-3987	NATIONAL CANCER INSTITUTE [P30CA008748, P01CA059350, R01CA034610] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061401] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA59350, P30 CA08748, R01 CA34610] Funding Source: Medline; NHLBI NIH HHS [R01 HL61401] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beckstead R, 2001, MOL CELL, V7, P753, DOI 10.1016/S1097-2765(01)00220-9; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Cohen Y, 2004, BLOOD REV, V18, P167, DOI 10.1016/S0268-960X(03)00064-X; Davidson AJ, 2000, CURR TOP DEV BIOL, V50, P45, DOI 10.1016/S0070-2153(00)50003-9; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Epperly MW, 2005, EXP HEMATOL, V33, P353, DOI 10.1016/j.exphem.2004.11.010; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; JOHANSSON M, 1994, INT J CANCER, V57, P463, DOI 10.1002/ijc.2910570404; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng KC, 1999, J PEDIAT HEMATOL ONC, V21, P428, DOI 10.1097/00043426-199909000-00017; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Sawyer JR, 2002, CANCER GENET CYTOGEN, V138, P102, DOI 10.1016/S0165-4608(02)00598-8; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Subramanian G, 2004, CANCER RES, V64, P5200, DOI 10.1158/0008-5472.CAN-04-0018; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X	44	285	304	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 2	2006	125	5					929	941		10.1016/j.cell.2006.03.045	http://dx.doi.org/10.1016/j.cell.2006.03.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751102	Bronze			2022-12-28	WOS:000238116400019
J	Bredemeyer, AL; Sharma, GG; Huang, CY; Helmink, BA; Walker, LM; Khor, KC; Nuskey, B; Sullivan, KE; Pandita, TK; Bassing, CH; Sleckman, BP				Bredemeyer, Andrea L.; Sharma, Girdhar G.; Huang, Ching-Yu; Helmink, Beth A.; Walker, Laura M.; Khor, Katrina C.; Nuskey, Beth; Sullivan, Kathleen E.; Pandita, Tej K.; Bassing, Craig H.; Sleckman, Barry P.			ATM stabilizes DNA double-strand-break complexes during V(D)J recombination	NATURE			English	Article							T-CELL DEVELOPMENT; ATAXIA-TELANGIECTASIA; RAG PROTEINS; B-CELL; ENDS; TUMORIGENESIS; REARRANGEMENT; INHIBITOR; DEFICIENT; LYMPHOMA	The ATM (ataxia-telangiectasia mutated) protein kinase mediates early cellular responses to DNA double-strand breaks (DSBs) generated during metabolic processes or by DNA-damaging agents(1-4). ATM deficiency leads to ataxia-telangiectasia, a disease marked by lymphopenia, genomic instability and an increased predisposition to lymphoid malignancies with chromosomal translocations involving lymphocyte antigen receptor loci(5,6). ATM activates cell-cycle checkpoints and can induce apoptosis in response to DNA DSBs(1-4). However, defects in these pathways of the DNA damage response cannot fully account for the phenotypes of ATM deficiency. Here, we show that ATM also functions directly in the repair of chromosomal DNA DSBs by maintaining DNA ends in repair complexes generated during lymphocyte antigen receptor gene assembly. When coupled with the cell-cycle checkpoint and pro-apoptotic activities of ATM, these findings provide a molecular explanation for the increase in lymphoid tumours with translocations involving antigen receptor loci associated with ataxia-telangiectasia.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Allergy & Immunol, Philadelphia, PA 19104 USA; Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Sleckman@immunology.wustl.edu	Huang, Ching-Yu/E-3981-2010; Pandita, Tej K/AAM-9188-2020	Bredemeyer, Andrea/0000-0003-2970-5998; Huang, Ching-yu/0000-0002-5758-281X; Helmink, Beth/0000-0002-8206-0351; Sullivan, Kathleen/0000-0003-4018-1646				Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEWIS SM, 1988, CELL, V55, P1099, DOI 10.1016/0092-8674(88)90254-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liao MJ, 1999, GENE DEV, V13, P1246, DOI 10.1101/gad.13.10.1246; Matei IR, 2006, IMMUNOL REV, V209, P142, DOI 10.1111/j.0105-2896.2006.00361.x; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MORZYCKAWROBLEWSKA E, 1988, SCIENCE, V242, P261, DOI 10.1126/science.3140378; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1; Pandita Tej K, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006318; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Petiniot LK, 2000, P NATL ACAD SCI USA, V97, P6664, DOI 10.1073/pnas.97.12.6664; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Sekiguchi J, 2001, MOL CELL, V8, P1383, DOI 10.1016/S1097-2765(01)00423-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0	29	302	316	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					466	470		10.1038/nature04866	http://dx.doi.org/10.1038/nature04866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16799570				2022-12-28	WOS:000239278900046
J	Gagneux, S; Long, CD; Small, PM; Van, T; Schoolnik, GK; Bohannan, BJM				Gagneux, Sebastien; Long, Clara Davis; Small, Peter M.; Van, Tran; Schoolnik, Gary K.; Bohannan, Brendan J. M.			The competitive cost of antibiotic resistance in Mycobacterium tuberculosis	SCIENCE			English	Article							RIFAMPIN RESISTANCE; BIOLOGICAL COST; EVOLUTION; FITNESS; ADAPTATION; MUTATIONS	Mathematical models predict that the future of the multidrug-resistant tuberculosis epidemic will depend on the fitness cost of drug resistance. We show that in laboratory-derived mutants of Mycobacterium tuberculosis, rifampin resistance is universally associated with a competitive fitness cost and that this cost is determined by the specific resistance mutation and strain genetic background. In contrast, we demonstrate that prolonged patient treatment can result in multidrug-resistant strains with no fitness defect and that strains with low- or no-cost resistance mutations are also the most frequent among clinical isolates.	Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Inst Syst Biol, Seattle, WA 98103 USA; Bill & Melinda Gates Fdn, Seattle, WA 98102 USA	Stanford University; Stanford University; Stanford University; Institute for Systems Biology (ISB); Bill & Melinda Gates Foundation	Gagneux, S (corresponding author), Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.	sgagneux@systemsbiology.org	Bohannan, Brendan J. M./R-1582-2017; Gagneux, Sebastien/ABE-7909-2020	Bohannan, Brendan J. M./0000-0003-2907-1016; Gagneux, Sebastien/0000-0001-7783-9048	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Bottger EC, 1998, NAT MED, V4, P1343, DOI 10.1038/3906; COHAN FM, 1994, EVOLUTION, V48, P81, DOI 10.1111/j.1558-5646.1994.tb01296.x; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; File TM, 1999, CHEST, V115, p3S, DOI 10.1378/chest.115.suppl_1.3S; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; O'Sullivan DM, 2005, J ANTIMICROB CHEMOTH, V55, P674, DOI 10.1093/jac/dki069; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Post FA, 2004, J INFECT DIS, V190, P99, DOI 10.1086/421501; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reynolds MG, 2000, GENETICS, V156, P1471; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; *WHO, 2004, 3 WHO GTC PROGR; Wichelhaus TA, 2002, ANTIMICROB AGENTS CH, V46, P3381, DOI 10.1128/AAC.46.11.3381-3385.2002	28	455	470	6	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1944	1946		10.1126/science.1124410	http://dx.doi.org/10.1126/science.1124410			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809538				2022-12-28	WOS:000238848100057
J	Zaatreh, M; Alabulkarim, W				Zaatreh, M; Alabulkarim, W			Disseminated central nervous system nocardiosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Zaatreh, M (corresponding author), Univ N Carolina, Chapel Hill, NC 27514 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2802	2802		10.1056/NEJMicm990952	http://dx.doi.org/10.1056/NEJMicm990952			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807417				2022-12-28	WOS:000238584700008
J	Morrison, SJ; Kimble, J				Morrison, Sean J.; Kimble, Judith			Asymmetric and symmetric stem-cell divisions in development and cancer	NATURE			English	Article							COLONY-STIMULATING FACTOR; KINASE-C-IOTA; HEMATOPOIETIC STEM; SELF-RENEWAL; NEURONAL DIFFERENTIATION; TUMOR-SUPPRESSOR; MITOTIC REGION; MAMMALIAN NUMB; PIE-1 PROTEIN; BONE-MARROW	Much has been made of the idea that asymmetric cell division is a defining characteristic of stem cells that enables them to simultaneously perpetuate themselves (self-renew) and generate differentiated progeny. Yet many stem cells can divide symmetrically, particularly when they are expanding in number during development or after injury. Thus, asymmetric division is not necessary for stem-cell identity but rather is a tool that stem cells can use to maintain appropriate numbers of progeny. The facultative use of symmetric or asymmetric divisions by stem cells may be a key adaptation that is crucial for adult regenerative capacity.	Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Mol Biol Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Genet, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu; jekimble@wisc.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329				Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bodine DM, 1996, BLOOD, V88, P89; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GONCZY P, 2005, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.30.1; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kimble Judith, 2005, WormBook, P1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kostic I, 2003, DEV BIOL, V263, P242, DOI 10.1016/S0012-1606(03)00452-4; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Lam N, 2006, CURR BIOL, V16, P287, DOI 10.1016/j.cub.2005.12.015; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Reid CB, 1997, DEVELOPMENT, V124, P2441; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Shen Q, 2002, DEVELOPMENT, V129, P4843; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	88	930	982	2	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1068	1074		10.1038/nature04956	http://dx.doi.org/10.1038/nature04956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810241	Green Published			2022-12-28	WOS:000238615500033
J	Rothstein, MA; Talbott, MK				Rothstein, MA; Talbott, MK			Compelled disclosure of health information - Protecting against the greatest potential threat to privacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Louisville, Sch Med, Inst Bioeth Hlth Policy & Law, Louisville, KY 40202 USA	University of Louisville	Rothstein, MA (corresponding author), Univ Louisville, Sch Med, Inst Bioeth Hlth Policy & Law, 501 E Broadway,310, Louisville, KY 40202 USA.	mark.rothstein@louisville.edu						[Anonymous], 2004, FED REG, V69, P24059; BISHOP L, 2005, FORESTER RES INC NAT; BRAILER D, 2005, COMMUNICATION   0118; *CA HLTH CAR FDN, 1999, MED PRIV CONF SUMM O; California Health Care Foundation, 2005, NAT CONS HLTH PRIV S; Gorlin R., 1999, CODES PROFESSIONAL R; PRITTS JOY, 2002, STATE HLTH PRIVACY S; *PRIV RIGHTS CLEAR, 8 PRIV RIGHTS CLEAR	8	30	30	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2882	2885		10.1001/jama.295.24.2882	http://dx.doi.org/10.1001/jama.295.24.2882			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057DY	16804155				2022-12-28	WOS:000238577700026
J	Lindenauer, PK; Pekow, P; Gao, S; Crawford, AS; Gutierrez, B; Benjamin, EM				Lindenauer, Peter K.; Pekow, Penelope; Gao, Shan; Crawford, Allison S.; Gutierrez, Benjamin; Benjamin, Evan M.			Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Article							ELDERLY-PATIENTS; MANAGEMENT; OUTCOMES; DISPARITIES; APPRAISAL; PNEUMONIA	Background: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is 1 of the 10 leading causes of hospitalization among adults in the United States. Objective: To evaluate the quality of care provided to patients hospitalized for acute exacerbations of COPD and to determine whether hospital or patient characteristics influence treatment. Design: Retrospective cohort study. Setting: 360 hospitals throughout the United States. Patients: 69 820 patients hospitalized for acute exacerbations of COPD. Measurements: Adherence to diagnosis and treatment recommendations contained in guidelines produced by the American College of Physicians and the American College of Chest Physicians; analyses of associations between hospital and patient characteristics and composite measures of performance. Results: Of the 69 820 patients, 66 276 (95%) underwent chest radiography, 63 715 (91%) received supplemental oxygen, 67 515 (97%) received bronchodilators, 59 240 (85%) received systemic steroids, and 59 053 (85%) were given antibiotics. In total, 45 800 (66%) received this entire set of recommended care processes. Numerous participants received tests or treatments that were not beneficial: 16 607 (24%) were treated with methylxanthine bronchodilators, 10 051 (14%) had sputum testing, 8354 (12%) underwent acute spirometry, 4299 (6%) had chest physiotherapy, and 1409 (2%) were treated with mucolytic medications. Overall, 31 519 patients (45%) received at least 1 of these non-recommended care elements, and 22 929 (33%) received ideal care, defined as all of the recommended care processes and none of the non-recommended ones. Individual hospital performance varied widely; whereas older patients and women were more likely to receive ideal care than their counterparts, a higher annual volume of admissions for COPD was not associated with improved hospital performance. Limitations: The study used administrative data, not chart review, and was limited to the inpatient management of COPD. Conclusions: The quality of care for patients hospitalized for acute exacerbations of COPD may be improved by increasing the use of systemic corticosteroid and antibiotic therapy, decreasing the use of unnecessary and potentially harmful treatments, and reducing variation in practice across hospitals.	Baystate Med Ctr, Div Healthcare Qual, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA; Univ Massachusetts, Amherst, MA 01003 USA; Premier Healthcare Informat, Charlotte, NC USA	Baystate Medical Center; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Div Healthcare Qual, 759 Chestnut St,P-5928, Springfield, MA 01199 USA.	Peter.Lindenauer@bhs.org						Agency for Healthcare Research and Quality, HCUPNET HEALTHC COST; *AM THOR SOC EUR R, 2005, STAND DIAGN MAN PAT; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; [Anonymous], AHRQ PUBL; Bach PB, 2001, ANN INTERN MED, V134, P600, DOI 10.7326/0003-4819-134-7-200104030-00016; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Bratzler Dale W, 2004, J Okla State Med Assoc, V97, P227; *CTR MED SERV, MED PAY PERF DEM SHO; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fine JM, 2002, ARCH INTERN MED, V162, P827, DOI 10.1001/archinte.162.7.827; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gibson P G, 1998, J Qual Clin Pract, V18, P125; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Hoyert DL, 2005, NATL VITAL STAT REPO, V53; *I HEALTHC IMP R, BUNDL SAF; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; *JOINT COMM ACCR H, 2005, SPEC MAN NAT HOSP QU; McCrory DC, 2001, CHEST, V119, P1190, DOI 10.1378/chest.119.4.1190; Meehan TP, 2000, CHEST, V117, P1378, DOI 10.1378/chest.117.5.1378; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; Moody A, 2004, THORAX, V59, P1; O'Donnell Denis E, 2003, Can Respir J, V10 Suppl A, p11A; Snow V, 2001, ANN INTERN MED, V134, P595, DOI 10.7326/0003-4819-134-7-200104030-00015; *US DEP HHS, HOSP COMP QUAL TOOOL	27	152	160	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					894	903		10.7326/0003-4819-144-12-200606200-00006	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785478				2022-12-28	WOS:000238555500004
J	Koes, BW; van Tulder, MW; Thomas, S				Koes, B. W.; van Tulder, M. W.; Thomas, S.			Diagnosis and treatment of low back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; LUMBAR SPINE; CLINICAL GUIDELINES; GENERAL-PRACTICE; MANAGEMENT; SURGERY; FUSION		Erasmus MC, Univ Med Ctr Rotterdam, Dept Gen Practice, NL-3000 DR Rotterdam, Netherlands; Vrije Univ Amsterdam Med Ctr, EMGO Inst, NL-1081 BT Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Koes, BW (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Gen Practice, POB 1738, NL-3000 DR Rotterdam, Netherlands.	b.koes@erasmusmc.nl	van Tulder, Maurits/AAB-9785-2022; Koes, Bart w/K-4614-2016	van Tulder, Maurits/0000-0002-7589-8471; Koes, Bart w/0000-0002-0450-9969				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Andersson Gunnar B. J., 1997, P93; Bekkering GE, 2005, PHYS THER, V85, P544, DOI 10.1093/ptj/85.6.544; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Brox JI, 2003, SPINE, V28, P1913; CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; CHERKIN DC, 1995, SPINE, V20, P1, DOI 10.1097/00007632-199501000-00001; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Croft P, 1997, HLTH CARE NEEDS ASSE, P129; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Engers AJ, 2005, SPINE, V30, P595; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jellema P, 2005, BMJ-BRIT MED J, V331, P84, DOI 10.1136/bmj.38495.686736.E0; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Koes BW, 2005, BMJ-BRIT MED J, V330, P1220, DOI 10.1136/bmj.330.7502.1220; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Linton SJ, 1998, CLIN J PAIN, V14, P209, DOI 10.1097/00002508-199809000-00007; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; PICAVET HSJ, 1996, PREVALANCES CONSEQUE; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; ROLAND M, 1998, LANCET, V352, P348; van den Hoogen HJM, 1998, ANN RHEUM DIS, V57, P13, DOI 10.1136/ard.57.1.13; van Tulder M, 2002, BEST PRACT RES CL RH, V16, P761, DOI 10.1053/berh.2002.0267; van Tulder MW, 2006, EUR SPINE J, V15, pS82, DOI 10.1007/s00586-005-1049-5; vandenHoogen H, 1997, SPINE, V22, P1515, DOI 10.1097/00007632-199707010-00019; vanTulder MW, 1997, SPINE, V22, P427, DOI 10.1097/00007632-199702150-00015; VANTULDER MW, 2006, CLIN EVIDENCE; Waddell G., 1998, BACK PAIN REVOLUTION	34	600	629	2	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1430	1434A		10.1136/bmj.332.7555.1430	http://dx.doi.org/10.1136/bmj.332.7555.1430			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16777886	Green Published			2022-12-28	WOS:000238550800033
J	Seguin, B; Singer, PA; Daar, AS				Seguin, Beatrice; Singer, Peter A.; Daar, Abdallah S.			Scientific diasporas	SCIENCE			English	Editorial Material									Univ Toronto, Canadian Program Genom & Global Hlth, Toronto, ON M5G 1L4, Canada; Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; Univ Hlth Network, Toronto, ON M5G 2C4, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5T 3M7, Canada; McLaughlin Ctr Mol Med, Toronto, ON M5G 1L4, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Daar, AS (corresponding author), Univ Toronto, Canadian Program Genom & Global Hlth, 88 Coll St, Toronto, ON M5G 1L4, Canada.	beatrice.seguin@utoronto.ca; a.daar@utoronto.ca						Barr? R., 2003, SCI DIASPORAS CAN DE; Berle A, 1940, NEW DIRECTIONS NEW W; Juma C., 2005, INNOVATION APPL KNOW; Khandkar S. H., 1998, BASICS QUAL RES, P101, DOI 10.4135/9781412957397.n342; Lowell B. L., 2004, DIASPORAS EC DEV STA; RAVENHILL L, 2005, S AFRICAN NETWORK SK; Salamanca-Buentello F, 2005, PLOS MED, V2, P383, DOI 10.1371/journal.pmed.0020097; Seguin Beatrice, 2006, International Journal of Biotechnology, V8, P78; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC3, DOI 10.1038/nbt1204supp-DC3; 2006, CONSERVATIVE PARTY C, P38	10	28	28	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1602	1603		10.1126/science.1126325	http://dx.doi.org/10.1126/science.1126325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778041				2022-12-28	WOS:000238288600028
J	Graham, TE; Yang, Q; Bluher, M; Hammarstedt, A; Ciaraldi, TP; Henry, RR; Wason, CJ; Oberbach, A; Jansson, P; Smith, U; Kahn, BB				Graham, Timothy E.; Yang, Qin; Blueher, Matthias; Hammarstedt, Ann; Ciaraldi, Theodore P.; Henry, Robert R.; Wason, Christopher J.; Oberbach, Andreas; Jansson, Per-Anders; Smith, Ulf; Kahn, Barbara B.			Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RETINOL-BINDING-PROTEIN; CORONARY-HEART-DISEASE; PLASMA-CONCENTRATIONS; METABOLIC DEFECTS; FAT DISTRIBUTION; GLUCOSE; HYPERINSULINEMIA; DYSLIPIDEMIA; ADIPOSITY; NIDDM	BACKGROUND: Insulin resistance has a causal role in type 2 diabetes. Serum levels of retinol-binding protein 4 (RBP4), a protein secreted by adipocytes, are increased in insulin-resistant states. Experiments in mice suggest that elevated RBP4 levels cause insulin resistance. We sought to determine whether serum RBP4 levels correlate with insulin resistance and change after an intervention that improves insulin sensitivity. We also determined whether elevated serum RBP4 levels are associated with reduced expression of glucose transporter 4 (GLUT4) in adipocytes, an early pathological feature of insulin resistance. METHODS: We measured serum RBP4, insulin resistance, and components of the metabolic syndrome in three groups of subjects. Measurements were repeated after exercise training in one group. GLUT4 protein was measured in isolated adipocytes. RESULTS: Serum RBP4 levels correlated with the magnitude of insulin resistance in subjects with obesity, impaired glucose tolerance, or type 2 diabetes and in nonobese, nondiabetic subjects with a strong family history of type 2 diabetes. Elevated serum RBP4 was associated with components of the metabolic syndrome, including increased body-mass index, waist-to-hip ratio, serum triglyceride levels, and systolic blood pressure and decreased high-density lipoprotein cholesterol levels. Exercise training was associated with a reduction in serum RBP4 levels only in subjects in whom insulin resistance improved. Adipocyte GLUT4 protein and serum RBP4 levels were inversely correlated. CONCLUSIONS: RBP4 is an adipocyte-secreted molecule that is elevated in the serum before the development of frank diabetes and appears to identify insulin resistance and associated cardiovascular risk factors in subjects with varied clinical presentations. These findings provide a rationale for antidiabetic therapies aimed at lowering serum RBP4 levels.	Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Leipzig, Med Ctr, Dept Med, D-7010 Leipzig, Germany; Sahlgrens Univ Hosp, Dept Internal Med, Lundberg Lab Diabet Res, Gothenburg, Sweden; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Leipzig University; Sahlgrenska University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, 99 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043051, K08DK069624, R01DK058291] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00827] Funding Source: Medline; NIDDK NIH HHS [K08 DK-69624, R01 DK-43051, R01 DK-58291, R01 DK043051] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abahusain MA, 1999, EUR J CLIN NUTR, V53, P630, DOI 10.1038/sj.ejcn.1600825; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Basu TK, 1997, NUTRITION, V13, P804, DOI 10.1016/S0899-9007(97)00192-5; Basualdo CG, 1997, J AM COLL NUTR, V16, P39, DOI 10.1080/07315724.1997.10718647; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DIMITROV NV, 1990, AM J CLIN NUTR, V51, P1082, DOI 10.1093/ajcn/51.6.1082; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; Gavin JR, 2000, DIABETES CARE, V23, pS4; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Johanson EH, 2003, J CLIN ENDOCR METAB, V88, P4232, DOI 10.1210/jc.2002-021961; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kahn CR, 1996, ANNU REV MED, V47, P509; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; Organization WH, 1998, WELLB MEAS PRIM HLTH; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; REAVEN GM, 1991, DIABETES METAB, V17, P78; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; Tamori Y, 2006, NAT MED, V12, P30, DOI 10.1038/nm0106-30; THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	34	1005	1086	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2552	2563		10.1056/NEJMoa054862	http://dx.doi.org/10.1056/NEJMoa054862			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775236				2022-12-28	WOS:000238233400005
J	Robinson, J				Robinson, Jane			The patient's journey: systemic lupus erythematosus	BMJ-BRITISH MEDICAL JOURNAL			English	Article											Robinson, J (corresponding author), 38 Percival St, Peterborough PE3 6AU, Cambs, England.	cambslupus@ntlworld.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2006	332	7554					1374	1376		10.1136/bmj.332.7554.1374	http://dx.doi.org/10.1136/bmj.332.7554.1374			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763250	Green Published			2022-12-28	WOS:000238587000023
J	Carey, LA; Perou, CM; Livasy, CA; Dressler, LG; Cowan, D; Conway, K; Karaca, G; Troester, MA; Tse, CK; Edmiston, S; Deming, SL; Geradts, J; Cheang, MCU; Nielsen, TO; Moorman, PG; Earp, HS; Millikan, RC				Carey, Lisa A.; Perou, Charles M.; Livasy, Chad A.; Dressler, Lynn G.; Cowan, David; Conway, Kathleen; Karaca, Gamze; Troester, Melissa A.; Tse, Chiu Kit; Edmiston, Sharon; Deming, Sandra L.; Geradts, Joseph; Cheang, Maggie C. U.; Nielsen, Torsten O.; Moorman, Patricia G.; Earp, H. Shelton; Millikan, Robert C.			Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	40th Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 05-08, 2004	New Orleans, LA	Amer Soc Clin Oncol			GENE-EXPRESSION PROFILES; RACIAL-DIFFERENCES; AFRICAN-AMERICAN; BRCA1 MUTATIONS; HER-2/NEU GENE; CELL-CYCLE; TUMORS; CARCINOMAS; PHENOTYPE; WOMEN	Context Gene expression analysis has identified several breast cancer subtypes, including basal-like, human epidermal growth factor receptor-2 positive/estrogen receptor negative (HER2+/ER-), luminal A, and luminal B. Objectives To determine population-based distributions and clinical associations for breast cancer subtypes. Design, Setting, and Participants Immunohistochemical surrogates for each subtype were applied to 496 incident cases of invasive breast cancer from the Carolina Breast Cancer Study ( ascertained between May 1993 and December 1996), a population-based, case-control study that oversampled premenopausal and African American women. Subtype definitions were as follows: luminal A ( ER + and/or progesterone receptor positive [PR+], HER2-), luminal B ( ER + and/or PR +, HER2+), basal-like (ER-, PR-, HER2-, cytokeratin 5/6 positive, and/or HER1+), HER2+/ ER- ( ER-, PR-, and HER2+), and unclassified ( negative for all 5 markers). Main Outcome Measures We examined the prevalence of breast cancer subtypes within racial and menopausal subsets and determined their associations with tumor size, axillary nodal status, mitotic index, nuclear pleomorphism, combined grade, p53 mutation status, and breast cancer - specific survival. Results The basal-like breast cancer subtype was more prevalent among premenopausal African American women (39%) compared with postmenopausal African American women (14%) and non - African American women (16%) of any age ( P <. 001), whereas the luminal A subtype was less prevalent (36% vs 59% and 54%, respectively). The HER2+/ER-subtype did not vary with race or menopausal status (6%-9%). Compared with luminal A, basal-like tumors had more TP53 mutations (44% vs 15%, P <. 001), higher mitotic index ( odds ratio [ OR], 11.0; 95% confidence interval [CI], 5.6-21.7), more marked nuclear pleomorphism ( OR, 9.7; 95% CI, 5.3-18.0), and higher combined grade ( OR, 8.3; 95% CI, 4.4-15.6). Breast cancer - specific survival differed by subtype ( P <. 001), with shortest survival among HER2+/ER- and basal-like subtypes. Conclusions Basal-like breast tumors occurred at a higher prevalence among premenopausal African American patients compared with postmenopausal African American and non - African American patients in this population-based study. A higher prevalence of basal-like breast tumors and a lower prevalence of luminal A tumors could contribute to the poor prognosis of young African American women with breast cancer.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; Univ British Columbia, Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 1M9, Canada; Roswell Pk Canc Inst, Buffalo, NY 14263 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of British Columbia; Roswell Park Cancer Institute	Carey, LA (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol Oncol, CB 7305,3009 Old Clin Bldg, Chapel Hill, NC 27599 USA.	Lisa_Carey@med.unc.edu	Perou, Charles M/H-9934-2014; , Pathology Services Core/CEZ-2246-2022	Perou, Charles M/0000-0001-9827-2247; Cheang, Maggie Chon U/0000-0001-5718-2501	NATIONAL CANCER INSTITUTE [R01CA101227, P50CA058223] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NCI NIH HHS [P50-CA58223, R01-CA-101227-01] Funding Source: Medline; NCRR NIH HHS [M01RR00046] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ademuyiwa FO, 2003, CANCER METAST REV, V22, P47, DOI 10.1023/A:1022259901319; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Conway K, 2002, CANCER RES, V62, P1987; Cox D. R., 1984, ANAL SURVIVAL DATA; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; del Carmen MG, 2003, CANCER-AM CANCER SOC, V98, P590, DOI 10.1002/cncr.11517; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Foulkes WD, 1997, CLIN CANCER RES, V3, P2465; Furberg H, 2001, BREAST CANCER RES TR, V68, P33, DOI 10.1023/A:1017994726207; Genestie C, 1998, ANTICANCER RES, V18, P571; Grushko TA, 2002, CANCER RES, V62, P1481; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; HOSMER DW, 1989, APPL LOGISTIC REGRES; Huang WY, 2000, AM J EPIDEMIOL, V151, P703, DOI 10.1093/oxfordjournals.aje.a010265; Joslyn SA, 2002, CANCER, V95, P1759, DOI 10.1002/cncr.10827; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Millikan R, 2003, BREAST CANCER RES TR, V79, P355, DOI 10.1023/A:1024068525763; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Moorman PG, 1999, ANN EPIDEMIOL, V9, P188, DOI 10.1016/S1047-2797(98)00057-X; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; *NAT CANC I DC CPS, 2004, SURV EP END RES PROG; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; NEWMAN B, 1995, BREAST CANCER RES TR, V35, P51, DOI 10.1007/BF00694745; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Olopade OI, 2001, NEW ENGL J MED, V344, P2028; OLOPADE OI, 2004, AM SOC CLIN ONC ANN; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porter PL, 2004, CANCER-AM CANCER SOC, V100, P2533, DOI 10.1002/cncr.20279; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stoppa-Lyonnet D, 2000, J CLIN ONCOL, V18, P4053, DOI 10.1200/JCO.2000.18.24.4053; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu K, 2004, CLIN CANCER RES, V10, P5508, DOI 10.1158/1078-0432.CCR-04-0085	48	2716	2874	9	184	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2492	2502		10.1001/jama.295.21.2492	http://dx.doi.org/10.1001/jama.295.21.2492			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	049ZQ	16757721	Green Submitted, Bronze			2022-12-28	WOS:000238057300024
J	Roth, AF; Wan, JM; Bailey, AO; Sun, BM; Kuchar, JA; Green, WN; Phinney, BS; Yates, JR; Davis, NG				Roth, Amy F.; Wan, Junmei; Bailey, Aaron O.; Sun, Beimeng; Kuchar, Jason A.; Green, William N.; Phinney, Brett S.; Yates, John R., III; Davis, Nicholas G.			Global analysis of protein palmitoylation in yeast	CELL			English	Article							SNARE YKT6; CRYSTAL-STRUCTURE; EARLY-STAGE; MEMBRANE; LOCALIZATION; IDENTIFICATION; ACYLATION; KINASE; RAS; ACYLTRANSFERASE	Protein palmitoylation is a reversible lipid modification that regulates membrane tethering for key proteins in cell signaling, cancer, neuronal transmission, and membrane trafficking. Palmitoylation has proven to be a difficult study: Specifying consensuses for predicting palmitoylation remain unavailable, and first-example palmitoylation enzymes-i.e., protein acyltransferases (PATs)-were identified only recently. Here, we use a new proteomic methodology that purifies and identifies palmitoylated proteins to characterize the palmitoyl proteome of the yeast Saccharomyces cerevisiae. Thirty-five new palmitoyl proteins are identified, including many SNARE proteins and amino acid permeases as well as many other participants in cellular signaling and membrane trafficking. Analysis of mutant yeast strains defective for members of the DHHC protein family, a putative PAT family, allows a matching of substrate palmitoyl proteins to modifying PATs and reveals the DHHC family to be a family of diverse PAT specificities responsible for most of the palmitoylation within the cell.	Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Wayne State University; Scripps Research Institute; Michigan State University; University of Chicago	Davis, NG (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	ndavis@med.wayne.edu	Phinney, Brett/S-6404-2016; Bailey, Aaron/ABB-8522-2021	Phinney, Brett/0000-0003-3870-3302; Bailey, Aaron/0000-0001-8063-3032	NCRR NIH HHS [P41 RR011823, RR11823] Funding Source: Medline; NIGMS NIH HHS [GM65525, R01 GM065525] Funding Source: Medline; NINDS NIH HHS [R01 NS043782, R01 NS043782-01A2, R01 NS043782-05, R01 NS043782-02, R01 NS043782-04, R01 NS043782-03] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043782] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AEL DE, 2002, CELL, V108, P849; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; COUVE A, 1995, P NATL ACAD SCI USA, V92, P5987, DOI 10.1073/pnas.92.13.5987; Dietrich LEP, 2005, EMBO REP, V6, P245, DOI 10.1038/sj.embor.7400350; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jones TLZ, 1997, BIOCHEMISTRY-US, V36, P7185, DOI 10.1021/bi9628376; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; Leventis R, 1997, BIOCHEMISTRY-US, V36, P5546, DOI 10.1021/bi963029h; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Moffett S, 2001, J NEUROCHEM, V76, P269, DOI 10.1046/j.1471-4159.2001.00005.x; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Veit M, 2000, BIOCHEM J, V345, P145, DOI 10.1042/0264-6021:3450145; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	410	428	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					1003	1013		10.1016/j.cell.2006.03.042	http://dx.doi.org/10.1016/j.cell.2006.03.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751107	Green Accepted, Bronze			2022-12-28	WOS:000238116400024
J	Landi, MT; Bauer, J; Pfeiffer, RM; Elder, DE; Hulley, B; Minghetti, P; Calista, D; Kanetsky, PA; Pinkel, D; Bastian, BC				Landi, Maria Teresa; Bauer, Juergen; Pfeiffer, Ruth M.; Elder, David E.; Hulley, Benjamin; Minghetti, Paola; Calista, Donato; Kanetsky, Peter A.; Pinkel, Daniel; Bastian, Boris C.			MC1R germline variants confer risk for BRAF-mutant melanoma	SCIENCE			English	Article							MELANOCORTIN-1 RECEPTOR MC1R; CUTANEOUS MELANOMA; PIGMENTATION; MELANOCYTES; POPULATION; RADIATION; COLOR	Germline variants in MC1R, the gene encoding the melanocortin-1 receptor, and sun exposure increase risk for melanoma in Caucasians. The majority of melanomas that occur on skin with little evidence of chronic sun-induced damage (non-CSD melanoma) have mutations in the BRAF oncogene, whereas in melanomas on skin with marked CSD ( CSD melanoma) these mutations are less frequent. In two independent Caucasian populations, we show that MC1R variants are strongly associated with BRAF mutations in non-CSD melanomas. In this tumor subtype, the risk for melanoma associated with MC1R is due to an increase in risk of developing melanomas with BRAF mutations.	NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Osped Gen Provinciale M Bufalini, Dept Dermatol, I-47023 Cesena, Italy; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Pennsylvania; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine	Landi, MT (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	landim@mail.nih.gov	Calista, Donato/AAM-1567-2020; Pfeiffer, Ruth M/F-4748-2011; Bauer, Jurgen/B-4656-2008	Bauer, Jurgen/0000-0001-8789-1536; Bastian, Boris/0000-0003-1836-6062	NCI NIH HHS [R33 CA95300, K07 CA80700, P01 CA025874-25-A1, R01 CA5558, R01 CA94963] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA025874, R01CA094963, R33CA095300, K07CA080700] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brenner AV, 2002, AM J EPIDEMIOL, V156, P353, DOI 10.1093/aje/kwf045; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Landi MT, 2001, BRIT J CANCER, V85, P1304, DOI 10.1054/bjoc.2001.2029; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; Scott MC, 2002, J CELL SCI, V115, P2349; Siskind V, 2005, CANCER CAUSE CONTROL, V16, P193, DOI 10.1007/s10552-004-4325-5; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Wakamatsu K, 2006, PIGM CELL RES, V19, P154, DOI 10.1111/j.1600-0749.2006.00293.x; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806	16	246	250	3	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					521	522		10.1126/science.1127515	http://dx.doi.org/10.1126/science.1127515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16809487				2022-12-28	WOS:000239308600062
J	Bartlett, JG				Bartlett, John G.			Planning for avian influenza	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE-RESPIRATORY-SYNDROME; PANDEMIC INFLUENZA; RESISTANCE; VIRUS; WORK; TIME; SARS; CARE	Avian influenza, or influenza A (H5N1), has 3 of the 4 properties necessary to cause a serious pandemic: It can infect people, nearly all people are immunologically naive, and it is highly lethal. The Achilles heel of the virus is the lack of sustained human-human transmission. Fortunately, among the 124 cases reported through 30 May 2006, nearly all were acquired by direct contact with poultry. Unfortunately, the capability for efficient human-human transmission requires only a single mutation by a virus that is notoriously genetically unstable, hence the need for a new vaccine each year for seasonal influenza. Influenza A (H5N1) is being compared to another avian strain, the agent of the "Spanish flu" of 1918-1919, which traversed the world in 3 months and caused an estimated 50 million deaths. The question is, are we ready for this type of pandemic? The answer is probably no. The main problems are the lack of an effective vaccine, very poor surge capacity, a health care system that could not accommodate even a modest pandemic, and erratic regional planning. It's time to get ready, and in the process be ready for bioterrorism, natural disasters, and epidemics of other infectious diseases.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Bartlett, JG (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Room 439, Baltimore, MD 21205 USA.	jb@jhmi.edu						*AM COLL PHYS, 2006, ANN INTERN MED, V145, P135; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Blank S, 2003, EMERG INFECT DIS, V9, P615; Bournes DA, 2005, NURS SCI QUART, V18, P324, DOI 10.1177/0894318405280353; Clark CC, 2005, J MED PHILOS, V30, P65, DOI 10.1080/03605310590907066; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Hayden F, 2005, ANTIVIR THER, V10, P873; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Homeland Security Council, 2006, NAT STRAT PAND INFL; INGLESBY T, 2006, SENATE SUBCOMMITTEE; Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc; MARGHELLA PD, 2005, HOMELAND DEFENSE J, P2; Masur H, 2003, JAMA-J AM MED ASSOC, V289, P2861, DOI 10.1001/jama.289.21.JED30036; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Starr I, 2006, ANN INTERN MED, V145, P138, DOI 10.7326/0003-4819-145-2-200607180-00132; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; TONER E, 2006, BIOSECUR BIOTERROR, V4, P1; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024	24	42	55	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					141	144		10.7326/0003-4819-145-2-200607180-00133	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00133			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16801627				2022-12-28	WOS:000239051400009
J	Carstensen, LL				Carstensen, Laura L.			The influence of a sense of time on human development	SCIENCE			English	Editorial Material							OLD; MEMORY; AGE; PREFERENCES	The subjective sense of future time plays an essential rote in human motivation. Gradually, time left becomes a better predictor than chronological age for a range of cognitive, emotional, and motivational variables. Socioemotionat selectivity theory maintains that constraints on time horizons shift motivational priorities in such a way that the regulation of emotional states becomes more important than other types of goats. This motivational shift occurs with age but also appears in other contexts (for example, geographical relocations, illnesses, and war) that limit subjective future time.	Stanford Univ, Stanford, CA 94305 USA	Stanford University	Carstensen, LL (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	ttc@psych.stanford.edu		carstensen, laura/0000-0002-5011-3789	NATIONAL INSTITUTE ON AGING [R37AG008816] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG008816-17, R37 AG008816] Funding Source: Medline; PHS HHS [R018816] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baltes P.B., 2001, BERLIN AGING STUDY A; BALTES PB, 1987, DEV PSYCHOL, V23, P611, DOI 10.1037/0012-1649.23.5.611; Burke DM, 2004, CURR DIR PSYCHOL SCI, V13, P21, DOI 10.1111/j.0963-7214.2004.01301006.x; Carstensen LL, 1998, HEALTH PSYCHOL, V17, P494, DOI 10.1037/0278-6133.17.6.494; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; FREDRICKSON BL, 1990, PSYCHOL AGING, V5, P335, DOI 10.1037/0882-7974.5.3.335; Fung HH, 2006, SOC COGNITION, V24, P248, DOI 10.1521/soco.2006.24.3.248; Fung HH, 2003, J PERS SOC PSYCHOL, V85, P163, DOI 10.1037/0022-3514.85.1.163; Fung HH, 1999, PSYCHOL AGING, V14, P595, DOI 10.1037/0882-7974.14.4.595; House JS, 2002, J HEALTH SOC BEHAV, V43, P125, DOI 10.2307/3090192; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Kunzmann U, 2002, J GERONTOL B-PSYCHOL, V57, pP484, DOI 10.1093/geronb/57.6.P484; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2004, PSYCHOL SCI, V15, P259, DOI 10.1111/j.0956-7976.2004.00662.x; Mikels JA, 2005, PSYCHOL AGING, V20, P542, DOI 10.1037/0882-7974.20.4.542; Salthouse TA, 2006, DEV REV, V26, P31, DOI 10.1016/j.dr.2005.09.001; Schlagman S, 2006, MEMORY, V14, P161, DOI 10.1080/09658210544000024	19	1350	1380	18	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1913	1915		10.1126/science.1127488	http://dx.doi.org/10.1126/science.1127488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061CF	16809530	Green Accepted			2022-12-28	WOS:000238848100048
J	Long, SP; Ainsworth, EA; Leakey, ADB; Nosberger, J; Ort, DR				Long, Stephen P.; Ainsworth, Elizabeth A.; Leakey, Andrew D. B.; Noesberger, Josef; Ort, Donald R.			Food for thought: Lower-than-expected crop yield stimulation with rising CO2 concentrations	SCIENCE			English	Article							CLIMATE-CHANGE IMPACTS; ATMOSPHERIC CARBON-DIOXIDE; UNITED-STATES; INTEGRATED ASSESSMENT; ENRICHMENT FACE; PHOTOSYNTHESIS; PRODUCTIVITY; RESPONSES; GROWTH; WHEAT	Model projections suggest that although increased temperature and decreased soil moisture will act to reduce global crop yields by 2050, the direct fertilization effect of rising carbon dioxide concentration ([CO2]) will offset these tosses. The CO2 fertilization factors used in models to project future yields were derived from, enclosure studies conducted approximately 20 years ago. Free-air concentration enrichment (FACE) technology has now facilitated large-scale trials of the major grain crops at elevated [CO2] under fully open-air field conditions. In those trials, elevated [CO2] enhanced yield by similar to 50% less than in enclosure studies. This casts serious doubt on projections that rising [CO2] will fully offset losses due to climate change.	Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; Univ Illinois, Inst Geom Biol, Urbana, IL 61801 USA; ARS, Photonsynth Res Unit, USDA, Urbana, IL 61801 USA; Swiss Fed Inst Technol, Inst Plant Sci, CH-8902 Zurich, Switzerland	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Long, SP (corresponding author), Univ Illinois, Dept Plant Biol, 1201 W Gregory Dr, Urbana, IL 61801 USA.	stevel@life.uiuc.edu	Long, Stephen/AAA-1741-2019; Leakey, Andrew DB/Q-9889-2016; Long, Stephen P/A-2488-2008	Long, Stephen/0000-0002-8501-7164; Leakey, Andrew DB/0000-0001-6251-024X; Long, Stephen P/0000-0002-8501-7164				ADAMS RM, 1990, NATURE, V345, P219, DOI 10.1038/345219a0; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; Allen LH, 1987, GLOBAL BIOGEOCHEM CY, V1, P1, DOI 10.1029/GB001i001p00001; Amthor JS, 2001, FIELD CROP RES, V73, P1, DOI 10.1016/S0378-4290(01)00179-4; Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; ASHMORE MR, 2002, AIR POLLUTION PLANT, P89; Black B, 2004, ABSTR PAP AM CHEM S, V228, pU84; Brown RA, 1999, CLIMATIC CHANGE, V41, P73, DOI 10.1023/A:1005449132633; CURE JD, 1986, AGR FOREST METEOROL, V38, P127, DOI 10.1016/0168-1923(86)90054-7; Gitay H., 2001, CLIMATE CHANGE 2001, P237, DOI DOI 10.1387/IJDB.113386MM; HOOGENBOOM G, 1995, ASA SPEC P, P51; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Izaurralde RC, 2003, AGR FOREST METEOROL, V117, P97, DOI 10.1016/S0168-1923(03)00024-8; KIMBALL BA, 1983, AGRON J, V75, P779, DOI 10.2134/agronj1983.00021962007500050014x; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Leakey ADB, 2004, GLOBAL CHANGE BIOL, V10, P951, DOI 10.1111/j.1529-8817.2003.00767.x; LIPFERT FW, 1992, CRIT REV PLANT SCI, V11, P143, DOI 10.1080/713608034; Long SP, 2005, PHILOS T R SOC B, V360, P2011, DOI 10.1098/rstb.2005.1749; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; McLeod AR, 1999, ADV ECOL RES, V28, P1, DOI 10.1016/S0065-2504(08)60028-8; Miglietta F, 1997, GLOB CHANGE BIOL, V3, P417, DOI 10.1046/j.1365-2486.1997.00076.x; Morgan PB, 2006, NEW PHYTOL, V170, P333, DOI 10.1111/j.1469-8137.2006.01679.x; NOSBERGER J, 2006, ECOLOGICAL STUDIES, V187; Ottman MJ, 2001, NEW PHYTOL, V150, P261, DOI 10.1046/j.1469-8137.2001.00110.x; Parry M, 2005, PHILOS T R SOC B, V360, P2125, DOI 10.1098/rstb.2005.1751; Parry M, 1999, GLOBAL ENVIRON CHANG, V9, pS51, DOI 10.1016/S0959-3780(99)00018-7; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; PEART RM, 1989, POTENTIAL EFFECTS GL, P2; Rosenweig C, 1998, SYST APPR S, V7, P267; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; STOCKLE CO, 1992, AGR SYST, V38, P225, DOI 10.1016/0308-521X(92)90067-X; Thomson AM, 2005, CLIMATIC CHANGE, V69, P43, DOI 10.1007/s10584-005-3612-9; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; Wall GW, 2001, NEW PHYTOL, V152, P231, DOI 10.1046/j.0028-646X.2001.00260.x; Whitmore G A, 1995, Lifetime Data Anal, V1, P307, DOI 10.1007/BF00985762	36	993	1097	18	646	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1918	1921		10.1126/science.1114722	http://dx.doi.org/10.1126/science.1114722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809532	Green Submitted			2022-12-28	WOS:000238848100050
J	Bradley, RS; Vuille, M; Diaz, HF; Vergara, W				Bradley, Raymond S.; Vuille, Mathias; Diaz, Henry F.; Vergara, Walter			Threats to water supplies in the tropical Andes	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; GLACIER; BOLIVIA; 20TH-CENTURY; CHACALTAYA		Univ Massachusetts, Climate Syst Res Ctr, Dept Geosci, Amherst, MA 01003 USA; NOAA, Earth Syst Res Lab, Boulder, CO 80303 USA; World Bank, Latin Amer Environm Dept, Washington, DC 20433 USA	University of Massachusetts System; University of Massachusetts Amherst; National Oceanic Atmospheric Admin (NOAA) - USA; The World Bank	Bradley, RS (corresponding author), Univ Massachusetts, Climate Syst Res Ctr, Dept Geosci, Amherst, MA 01003 USA.	rbradley@geo.umass.edu	Bradley, Raymond S/P-9358-2015; Vuille, Mathias/S-3906-2019; Vuille, Mathias/O-8128-2019	Bradley, Raymond S/0000-0002-4032-9519; Vuille, Mathias/0000-0002-9736-4518				Bradley RS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020229; Carrasco JF, 2005, HYDROLOG SCI J, V50, P933, DOI 10.1623/hysj.2005.50.6.933; Coudrain A, 2005, HYDROLOG SCI J, V50, P925, DOI 10.1623/hysj.2005.50.6.925; Diaz HF, 1996, NATURE, V383, P152, DOI 10.1038/383152a0; Francou B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004484; Francou B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002959; Kaser G, 2005, ADV GLOB CHANGE RES, P185, DOI 10.1007/1-4020-3508-X_19; Mark BG, 2005, HYDROLOG SCI J, V50, P975, DOI 10.1623/hysj.2005.50.6.975; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Ramirez E, 2001, J GLACIOL, V47, P187, DOI 10.3189/172756501781832214; Seidel DJ, 2003, CLIMATIC CHANGE, V59, P53, DOI 10.1023/A:1024459610680; Vergara W, 2005, 25 WORLD BANK; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Wagnon P, 2001, J GLACIOL, V47, P21, DOI 10.3189/172756501781832593	14	448	472	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1755	1756		10.1126/science.1128087	http://dx.doi.org/10.1126/science.1128087			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055LS	16794068	Green Submitted			2022-12-28	WOS:000238452800042
J	Chang, MM; Zhang, JY; Miao, DD				Chang, Mee-mann; Zhang, Jiangyong; Miao, Desui			A lamprey from the Cretaceous Jehol biota of China	NATURE			English	Article							PETROMYZON-MARINUS; SEA LAMPREY; BEAR-GULCH; MONTANA; LARVAE; USA	Widespread nowadays in freshwater and coastal seas of the cold and temporal zones, lampreys are a jawless vertebrate group that has been in existence for more than 300 million years but left a meagre fossil record. Only two fossil lamprey species, namely Mayomyzon pieckoensis(1,2) and Hardistiella montanensis(3-5), have been recognized with certainty from North American Carboniferous marine deposits(6). Here we report a freshwater lamprey from the Early Cretaceous epoch ( about 125 million years ago) of Inner Mongolia, China. The new taxon, Mesomyzon mengae, has a long snout, a well-developed sucking oral disk, a relatively long branchial apparatus showing branchial basket, seven gill pouches, gill arches and impressions of gill filaments, about 80 myomeres and several other characters that are previously unknown or ambiguous. Our finding not only indicates Mesomyzon's closer relationship to extant lampreys but also reveals the group's invasion into a freshwater environment no later than the Early Cretaceous. The new material furthers our understanding of ancient lampreys, bridges the gap between the Carboniferous ones and their recent relatives, and adds to our knowledge of the evolutionary history of lampreys.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Kansas; University of Kansas	Chang, MM (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhangmiman@ivpp.ac.cn						BARDACK D, 1977, Fieldiana Geology, V33, P489; BARDACK D, 1968, SCIENCE, V162, P1265, DOI 10.1126/science.162.3859.1265; Bardack D., 1971, BIOL LAMPREYS, V1, P67; Barker LA, 1998, COPEIA, P1070; BRIGGS DEG, 1994, LETHAIA, V26, P275, DOI DOI 10.1111/J.1502-3931.1993.TB01532.X); Chang M., 2003, JEHOL BIOTA; Grogan Eileen D., 2002, Geodiversitas, V24, P295; HARDISTY MW, 1974, BIOL LAMPREYS; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 2004, J VERTEBR PALEONTOL, V24, P742, DOI 10.1671/0272-4634(2004)024[0742:FCOTEK]2.0.CO;2; JANVIER P, 1983, Journal of Vertebrate Paleontology, V2, P407; Janvier P., 1996, EARLY VERTEBRATES; LUND R, 1986, GEOBIOS-LYON, V19, P647, DOI 10.1016/S0016-6995(86)80061-4; POTTER IC, 1987, J ZOOL, V212, P713, DOI 10.1111/j.1469-7998.1987.tb05966.x; Wang H., 1985, ATLAS PALAEOGEOGRAPH; Wicks BJ, 1998, J GREAT LAKES RES, V24, P962, DOI 10.1016/S0380-1330(98)70876-7; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhu Y. D., 2001, FAUNA SINICA CYCLOST	18	46	49	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					972	974		10.1038/nature04730	http://dx.doi.org/10.1038/nature04730			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791193				2022-12-28	WOS:000238422300040
J	Fujisawa, T; Hayashi, T; Tomita, R; Hirayama, Y				Fujisawa, T; Hayashi, T; Tomita, R; Hirayama, Y			Bidirectional counting of single electrons	SCIENCE			English	Article							DOUBLE-QUANTUM DOTS; COULOMB BLOCKADE; NOISE; STATISTICS	A bidirectional single-electron counting device is demonstrated. Individual electrons flowing in forward and reverse directions through a double quantum dot are detected with a quantum point contact acting as a charge sensor. A comprehensive statistical analysis in the frequency and time domains and of higher order moments of noise reveals antibunching correlation in single-electron transport through the device itself. The device can also be used to investigate current flow in the attoampere range, which cannot be measured by existing current meters.	NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; Tokyo Inst Technol, Meguro Ku, Tokyo 1528551, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaguchi 3310012, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Nippon Telegraph & Telephone Corporation; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tohoku University	Fujisawa, T (corresponding author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	fujisawa@nttbrl.jp	Fujisawa, Toshimasa/M-2428-2013; Hirayama, Yoshiro/AAE-1598-2019	Fujisawa, Toshimasa/0000-0002-0451-6579; Hirayama, Yoshiro/0000-0003-2638-9133				Aguado R, 2000, PHYS REV LETT, V84, P1986, DOI 10.1103/PhysRevLett.84.1986; Beenakker CWJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.176802; BIRK H, 1995, PHYS REV LETT, V75, P1610, DOI 10.1103/PhysRevLett.75.1610; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; BORNZE Y, 2005, PHYS REV LETT, V95, P6601; Bylander J, 2005, NATURE, V434, P361, DOI 10.1038/nature03375; COBDEN DH, 1995, PHYS REV LETT, V75, P4274, DOI 10.1103/PhysRevLett.75.4274; Cobden DH, 1998, PHYS REV LETT, V81, P681, DOI 10.1103/PhysRevLett.81.681; dePicciotto R, 1997, NATURE, V389, P162, DOI 10.1038/38241; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Fujisawa T, 2004, APPL PHYS LETT, V84, P2343, DOI 10.1063/1.1691491; Fujisawa T, 1998, SCIENCE, V282, P932, DOI 10.1126/science.282.5390.932; GRABERT H, 1991, SINGLE CHARGE TUNNEL, pCH3; Gustavsson S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076605; HERSHFIELD S, 1993, PHYS REV B, V47, P1967, DOI 10.1103/PhysRevB.47.1967; Levitov LS, 1996, J MATH PHYS, V37, P4845, DOI 10.1063/1.531672; Levitov LS, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115305; Loudon R., 2000, QUANTUM THEORY LIGHT; Nazarov Yu. V., 2003, NATO SCI 2, V97; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Reulet B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.196601; Saminadayar L, 1997, PHYS REV LETT, V79, P2526, DOI 10.1103/PhysRevLett.79.2526; Samuelsson P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026805; UEDA M, 1989, PHYS REV A, V40, P1096, DOI 10.1103/PhysRevA.40.1096; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1; Van Kampen NG, 1992, STOCHASTIC PROCESSES	28	305	307	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1634	1636		10.1126/science.1126788	http://dx.doi.org/10.1126/science.1126788			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778051				2022-12-28	WOS:000238288600040
J	Haugen, SP; Berkmen, MB; Ross, W; Gaal, T; Ward, C; Gourse, RL				Haugen, Shanil P.; Berkmen, Melanie B.; Ross, Wilma; Gaal, Tamas; Ward, Christopher; Gourse, Richard L.			rRNA promoter regulation by nonoptimal binding of a region 1.2: An additional recognition element for RNA polymerase	CELL			English	Article							RATE-DEPENDENT CONTROL; TRANSCRIPTION INITIATION; STRINGENT CONTROL; DNA-BINDING; STRUCTURAL ORGANIZATION; COMPLEX-FORMATION; PPGPP; SEQUENCE; HOLOENZYME; SIGMA(70)	Regulation of transcription initiation is generally attributable to activator/repressor proteins that bind to specific DNA sequences. However, regulators can also achieve specificity by binding directly to RNA polymerase (RNAP) and exploiting the kinetic variation intrinsic to different RNAP-promoter complexes. We report here a previously unknown interaction with Escherichia coli RNAP that defines an additional recognition element in bacterial promoters. The strength of this sequence-specific interaction varies at different promoters and affects the lifetime of the complex with RNAP. Selection of rRNA promoter mutants forming long-lived complexes, kinetic analyses of duplex and bubble templates, dimethylsulfate footprinting, and zero-Angstrom crosslinking demonstrated that sigma subunit region 1.2 directly contacts the nontemplate strand base two positions downstream of the -10 element (within the "discriminator" region). By making a nonoptimal sigma 1.2-discriminator interaction, rRNA promoters create the short-lived complex required for specific responses to the RNAP binding factors ppGpp and DksA, ultimately accounting for regulation of ribosome synthesis.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Haugen, SP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	rgourse@bact.wisc.edu	Ward, Christopher S/H-6889-2019	Ward, Christopher S/0000-0002-3445-6327; Berkmen, Melanie/0000-0003-0365-6040; Haugen, Shanil/0000-0001-7386-094X	NIGMS NIH HHS [R37 GM037048, GM37048] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037048, R01GM037048] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Baldwin NE, 2001, MOL MICROBIOL, V42, P427, DOI 10.1046/j.1365-2958.2001.02642.x; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Becker G, 2001, MOL MICROBIOL, V39, P1153, DOI 10.1046/j.1365-2958.2001.02313.x; Brodolin K, 2005, J MOL BIOL, V350, P930, DOI 10.1016/j.jmb.2005.05.048; DUVALVALENTIN G, 1986, NUCLEIC ACIDS RES, V14, P1967, DOI 10.1093/nar/14.5.1967; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Geszvain Kati, 2005, P283; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; JOSAITIS CA, 1995, P NATL ACAD SCI USA, V92, P1117, DOI 10.1073/pnas.92.4.1117; Jung YH, 1997, BIOCHEM BIOPH RES CO, V230, P582, DOI 10.1006/bbrc.1996.6005; KEENER J, 1996, REGULATION RIBOSOME, P1417; LAMOND AI, 1985, CELL, V41, P6, DOI 10.1016/0092-8674(85)90050-9; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NEWLANDS JT, 1991, J MOL BIOL, V220, P569, DOI 10.1016/0022-2836(91)90101-B; NIKIFOROV TT, 1992, NUCLEIC ACIDS RES, V20, P1209, DOI 10.1093/nar/20.6.1209; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pemberton IK, 2000, J MOL BIOL, V299, P859, DOI 10.1006/jmbi.2000.3780; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; Ross W, 2005, P NATL ACAD SCI USA, V102, P291, DOI 10.1073/pnas.0405814102; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; TRAVERS AA, 1980, J BACTERIOL, V141, P973, DOI 10.1128/JB.141.2.973-976.1980; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Villemain J, 1998, J MOL BIOL, V281, P793, DOI 10.1006/jmbi.1998.1989; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; WILSON BA, 1997, J REHABILITATION OUT, V1, P60	41	162	165	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1069	1082		10.1016/j.cell.2006.04.034	http://dx.doi.org/10.1016/j.cell.2006.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777598	Bronze			2022-12-28	WOS:000238602700013
J	Qi, H; Egen, JG; Huang, AYC; Germain, RN				Qi, Hai; Egen, Jackson G.; Huang, Alex Y. C.; Germain, Ronald N.			Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells	SCIENCE			English	Article							ANTIBODY-RESPONSES; IN-VIVO; LYMPHOCYTES; FOLLICLES; TRANSPORT; MEMBRANE; INTERACT; MOTILITY; PROTEIN; CORTEX	In contrast to naive T cells that recognize short antigen-derived peptides displayed by specialized antigen-presenting cells, immunoglobulin receptors of B lymphocytes primarily recognize intact proteins. How and where within a lymph node such unprocessed antigens become available for naive B cell recognition is not clear. We used two-photon intravital imaging to show that, after exiting high-endothelial venules and before entry into lymph node follicles, B cells survey locally concentrated dendritic cells. Engagement of the B cell receptor by the dendritic cell (DC)-associated antigen leads to lymphocyte calcium signaling, migration arrest, antigen acquisition, and extrafollicular accumulation. These findings suggest a possible role for antigen-specific B-DC interactions in promoting T cell - dependent antibody responses in vivo.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	rgermain@nih.gov	Huang, Alex Y./ABG-8182-2021; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; Qi, Hai/A-3955-2009	Huang, Alex Y./0000-0002-5701-4521; Qi, Hai/0000-0001-5475-3989; Egen, Jackson/0000-0003-2053-0837	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000545, ZIAAI000545] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ANDERSON AO, 1975, AM J PATHOL, V80, P387; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; DRINEKR C, 1935, ANAT REC, V56, P261; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Ludewig B, 2000, EUR J IMMUNOL, V30, P185, DOI 10.1002/1521-4141(200001)30:1<185::AID-IMMU185>3.3.CO;2-C; Lutz MB, 1997, J IMMUNOL, V159, P3707; MacLennan ICM, 1997, IMMUNOL REV, V156, P53, DOI 10.1111/j.1600-065X.1997.tb00958.x; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Wang H, 2000, P NATL ACAD SCI USA, V97, P847, DOI 10.1073/pnas.97.2.847; Wykes M, 1998, J IMMUNOL, V161, P1313	29	390	418	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1672	1676		10.1126/science.1125703	http://dx.doi.org/10.1126/science.1125703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778060				2022-12-28	WOS:000238288600052
J	von Hippel, PH				von Hippel, Peter H.			Transcriptional pausing caught in the act	CELL			English	Editorial Material							RNA-POLYMERASE; ELONGATION	Single-molecule techniques now permit the tracking of a transcription complex along a DNA template in real time and to 1 bp resolution. As reported in this issue of Cell, Herbert et al. (2006) exploit this approach to study a central component of transcription regulation, the sequence-dependent pausing of RNA polymerase during transcript elongation.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	von Hippel, PH (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	petevh@moibio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097				Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Pasman Z, 2002, J MOL BIOL, V322, P505, DOI 10.1016/S0022-2836(02)00814-8; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Tolic-Norrelykke SF, 2004, J BIOL CHEM, V279, P3292, DOI 10.1074/jbc.M310290200	7	3	3	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1027	1029		10.1016/j.cell.2006.06.006	http://dx.doi.org/10.1016/j.cell.2006.06.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777591	Bronze			2022-12-28	WOS:000238602700006
J	Hutchinson, RA; Lindsay, SW				Hutchinson, Robert A.; Lindsay, Steven W.			Malaria and deaths in the English marshes	LANCET			English	Article							MATERNAL MORTALITY; PLASMODIUM-VIVAX; ENGLAND; HISTORY; AGUE		Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Lindsay, SW (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	S.W.Lindsay@durham.ac.uk		Lindsay, Steve/0000-0002-3461-9050				[Anonymous], 1949, MALARIOLOGY COMPREHE; BRUCECHWATT LJ, 1976, J TROP MED HYG, V79, P168; Camargo EP, 1999, LANCET, V353, P1415, DOI 10.1016/S0140-6736(99)00941-1; Chandramohan D, 2001, TROP MED INT HEALTH, V6, P505, DOI 10.1046/j.1365-3156.2001.00739.x; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Chin T, 2004, POSTGRAD MED J, V80, P663, DOI 10.1136/pgmj.2004.021857; CHRISOTPHERS SR, 1911, MALARIA PUNJAB; CREIGHTON C, 1891, HIST EPIDEMICS BRIT; DEFOE D, 1742, PENGUIN CLASSICS; DOBSON M, 1980, J HIST GEOGR, V6, P357, DOI 10.1016/0305-7488(80)90145-0; Dobson M J, 1994, Parassitologia, V36, P35; Dobson M.J., 1997, CONTOURS DEATH DIS E; DOBSON MJ, 1989, J ROY SOC MED, V82, P3; Donaldson GC, 1997, BRIT MED J, V315, P1055, DOI 10.1136/bmj.315.7115.1055; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Farr W., 1852, REPORT MORTALITY CHO; GENERAL R, 1921, ANN REPORT REGISTRAR; Granja AC, 1998, ANN TROP MED PARASIT, V92, P257, DOI 10.1080/00034989859816; Granja ACL, 2001, J ADOLESCENT HEALTH, V28, P303, DOI 10.1016/S1054-139X(00)00205-6; Hasted Edward, 1797, HIST TOPOGRAPHICAL S; *HLTH PROT AG, 2004, WINT TAL COM TERMS W; *HLTH PROT AG, 2001, COMM DIS LOND; *HMSO, 1864, 6 HMSO MED OFF PRIV; HUNTER M, 1988, ASTROLOGICAL DIARY 1; James S P, 1929, Proc R Soc Med, V23, P71; James SP, 1920, MALARIA HOME ABROAD; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kochar Dhanpat, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P259; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Kuhn KG, 2003, P NATL ACAD SCI USA, V100, P9997, DOI 10.1073/pnas.1233687100; KUHN KG, 2002, ENV DETERMINANTS MAL; Lindsay S.W., 2001, GLOB CHANGE HUM HLTH, V2, P80, DOI DOI 10.1023/A:1011995115713; LINDSAY SW, 2001, GLOB CHANGE HUM HLTH, V2, P184; Marchant P, 1998, PARASITOL TODAY, V14, P344, DOI 10.1016/S0169-4758(98)01274-5; Nicholls A, 2000, MED HIST, V44, P513, DOI 10.1017/S0025727300067107; Nuttall G H, 1901, J Hyg (Lond), V1, P4; OSLER W, 1998, PRINCIPLES PRACTISE; Pal Pramod K., 1997, Journal of the Neurological Sciences, V150, pS131, DOI 10.1016/S0022-510X(97)85501-3; Pelling Margaret, 1978, CHOLERA FEVER ENGLIS; Pinto C., 1939, Memorias do Instituto Oswaldo Cruz, V34, P293, DOI 10.1590/S0074-02761939000300001; POWER H, 1899, NEW SYDENHAM SOC LEX; RAMSDALE C D, 1975, Parassitologia (Rome), V17, P39; Reiter P, 2000, EMERG INFECT DIS, V6, P1; Shute P. G., 1940, Journal of Tropical Medicine London, V43, P175; SMITH TS, 1930, TREATISE FEVER; Snow J., 1855, MODE COMMUNICATION C; Snow Keith, 2000, Biologist (London), V47, P176; Snow Keith, 1999, European Mosquito Bulletin, V4, P17; Soper FL, 1943, ANOPHELES GAMBIAE BR; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; Swellengrebel NH, 1938, MALARIA NETHERLANDS; SYDENHAM T, 1848, WORKS T SYDENHAM CLA; TALBOR R, 1672, PYRETOLOGIA RATIONAL; TYLER L, 1994, HIST SHEPPEY; WATTANAGOON Y, 1994, T ROY SOC TROP MED H, V88, P426, DOI 10.1016/0035-9203(94)90415-4; Williams TN, 1997, QJM-INT J MED, V90, P751; Worboys M., 1994, Parassitologia (Rome), V36, P61; Wrigley EA, 1981, POPULATION HIST ENGL	58	18	18	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1947	1951		10.1016/S0140-6736(06)68850-8	http://dx.doi.org/10.1016/S0140-6736(06)68850-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XG	16765764				2022-12-28	WOS:000238194400034
J	Zwi, AB; Grove, NJ; Kelly, P; Gayer, M; Ramos-Jimenez, P; Sommerfeld, J				Zwi, Anthony B.; Grove, Natalie J.; Kelly, Paul; Gayer, Michelle; Ramos-Jimenez, Pilar; Sommerfeld, Johannes			Child health in armed conflict: time to rethink	LANCET			English	Editorial Material							COMPLEX EMERGENCIES		Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; Australian Natl Univ, Natl Ctr Epidemiol & Publ Hlth, Canberra, ACT, Australia; WHO, Dis Control Humanitarian Emergencies, Communicable Dis Cluster CDS NTD, CH-1211 Geneva, Switzerland; De La Salle Univ, Social Dev Res Ctr, Manila, Philippines; De La Salle Univ, Dept Behav Sci, Manila, Philippines; WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	University of New South Wales Sydney; Australian National University; World Health Organization; De La Salle University; De La Salle University; World Health Organization	Zwi, AB (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.	a.zwi@unsw.edu.au	Zwi, Anthony/AAP-7026-2021; Zwi, Anthony/AAP-8731-2020; Sommerfeld, Johannes/AAI-5816-2020	Zwi, Anthony/0000-0001-6902-6602; 				Amnesty International, 2005, NEP CHILDR CAUGHT CO; [Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P1; Boyden J., 2004, CHILDREN YOUTH FRONT; Christensen P., 2000, RES CHILDREN PERSPEC; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Gbesso S, 2006, LANCET, V367, P1221, DOI 10.1016/S0140-6736(06)68518-8; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; Lansdown G, 2006, LANCET, V367, P690, DOI 10.1016/S0140-6736(06)68268-8; Moss WJ, 2006, B WORLD HEALTH ORGAN, V84, P58, DOI 10.2471/BLT.04.019570; Moss WJ, 2006, CHILD HLTH COMPLEX E; Rutta E, 2005, DISASTERS, V29, P291, DOI 10.1111/j.0361-3666.2005.00293.x; *SCH PUBL HLTH COM, 2006, INT S MAN JAN 9 13; Singh S, 2005, PLOS MED, V2, P705, DOI 10.1371/journal.pmed.0020216; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; Women's Commission for Refugee Women and Children, 2004, NO SAF PLAC CALL HOM	15	10	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 10	2006	367	9526					1886	1888		10.1016/S0140-6736(06)68823-5	http://dx.doi.org/10.1016/S0140-6736(06)68823-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XG	16765745				2022-12-28	WOS:000238194400009
J	Lord, SJ; Irwig, L; Simes, RJ				Lord, Sarah J.; Irwig, Les; Simes, R. John			When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP VENOUS THROMBOSIS; METAANALYSIS; CANCER	The clinical value of using a new diagnostic test depends on whether it improves patient outcomes beyond the outcomes achieved using an old diagnostic test. When can studies of diagnostic test accuracy provide sufficient information to infer clinical value, and when do clinicians need to wait for results from randomized trials? The authors argue that accuracy studies suffice if a new diagnostic test is safer or more specific than, but of similar sensitivity to, an old test. However, if a new test is more sensitive than an old test, it leads to the detection of extra cases of disease. Results from treatment trials that enrolled only patients detected by the old test may not apply to these extra cases. Clinicians need to wait for results from randomized trials assessing treatment efficacy in cases detected by the new diagnostic test, unless they can be satisfied that the new test detects the same spectrum and subtype of disease as the old test or that treatment response is similar across the spectrum of disease.	Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Lord, SJ (corresponding author), Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, 88 Mallett St, Camperdown, NSW 2050, Australia.	sally.lord@ctc.usyd.edu.au	Lord, Sally/GZM-7796-2022; Simes, Robert John/P-1497-2014	Lord, Sally/0000-0003-2763-5949; 				[Anonymous], 1998, LANCET, V351, P1451; BAILEY KR, 1994, CONTROL CLIN TRIALS, V15, P15, DOI 10.1016/0197-2456(94)90024-8; Barratt A, 1999, JAMA-J AM MED ASSOC, V281, P2029, DOI 10.1001/jama.281.21.2029; BIESHEUVEL CJ, 2006, DISTRACTION RANDOMIZ; Bossuyt PMM, 2000, LANCET, V356, P1844, DOI 10.1016/S0140-6736(00)03246-3; Busse R, 2002, INT J TECHNOL ASSESS, V18, P361, DOI 10.1017/S0266462302000284; Dauzat M, 1997, J CLIN ULTRASOUND, V25, P343, DOI 10.1002/(SICI)1097-0096(199709)25:7<343::AID-JCU1>3.0.CO;2-A; Fletcher JG, 2000, RADIOLOGY, V216, P704, DOI 10.1148/radiology.216.3.r00au41704; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Irwig L, 2006, BMJ-BRIT MED J, V332, P678, DOI 10.1136/bmj.332.7543.678; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; OTVOS JD, MEASUREMENT ISSUES R; Ouyang DL, 2005, AM J GASTROENTEROL, V100, P1393, DOI 10.1111/j.1572-0241.2005.41427.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	18	178	183	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					850	855		10.7326/0003-4819-144-11-200606060-00011	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZN	16754927				2022-12-28	WOS:000238057000008
J	Roux, AVD; Ranjit, N; Powell, L; Jackson, S; Lewis, TT; Shea, S; Wu, C				Roux, Ana V. Diez; Ranjit, Nalini; Powell, Lynda; Jackson, Sharon; Lewis, Tene T.; Shea, Steven; Wu, Colin			Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; HEART-RATE-VARIABILITY; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; YOUNG-ADULTS; CAROTID ATHEROSCLEROSIS; PSYCHOLOGICAL-FACTORS; PLATELET REACTIVITY; TRAIT ANXIETY	Background: Psychosocial factors have been linked to coronary events, but the mechanisms underlying these associations have not been established. Evidence is mixed regarding associations of psychosocial factors with subclinical coronary atherosclerosis. Objective: To examine associations of 4 psychosocial factors (depressive symptoms, anger, anxiety, and chronic stress) with the presence of subclinical coronary atherosclerosis. Design: Cross-sectional study. Setting: The Multiethnic Study of Atherosclerosis, a population-based study of subclinical atherosclerosis. Patients: A multiethnic sample of 6789 adults, 45 to 84 years of age, with no history of clinical cardiovascular disease. Measurements: Coronary calcium was assessed by using chest computed tomography, and psychosocial factors were assessed by using questionnaires with validated scales. Results: There was no evidence that higher levels of the psychosocial measures were associated with greater prevalence of calcification or with greater amounts of calcium among persons with calcium. Age- and risk factor-adjusted relative prevalences of coronary calcification in men for the top fourth category versus the bottom fourth category of anger, anxiety, and depressive symptoms were 0.94 (95% Cl, 0.88 to 1.01), 0.97 (Cl, 0.90 to 1.04), and 0.97 (Cl, 0.90 to 1.05), respectively; these values for women were 1.01 (Cl, 0.90 to 1.15), 0.93 (Cl, 0.83 to 1.05), and 0.92 (Cl, 0.82 to 1.04), respectively. Relative prevalences for the top versus the bottom category of chronic stress burden were 1.02 (Cl, 0.94 to 1.11) for men and 0.88 (Cl, 0.79 to 0.99) for women. Limitations: Current measures of psychosocial factors may be a poor proxy for cumulative exposure during development of atherosclerosis. Conclusion: Depressive symptoms, anger, anxiety, and chronic stress burden were not associated with coronary calcification in a multiethnic sample of asymptomatic adults.	Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48103 USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Columbia Univ, New York, NY USA; NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Rush University; Wake Forest University; Columbia University; National Institutes of Health (NIH) - USA	Roux, AVD (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 1214 S Univ,2nd Floor, Ann Arbor, MI 48103 USA.	adiezrou@umich.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095161, N01HC095163, N01HC095164, N01HC095160, N01HC095165, N01HC095162, N01HC095159, N01HC095169] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-95163, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95165, N01-HC-95164, N01-HC-95169, N01-HC-95159, R01 HL0768] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agatisa PIK, 2005, ARCH INTERN MED, V165, P1229, DOI 10.1001/archinte.165.11.1229; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANGELL M, 1985, NEW ENGL J MED, V312, P1570, DOI 10.1056/NEJM198506133122411; [Anonymous], 1980, PRELIMINARY MANUAL S; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; BAREFOOT JC, 1994, AM J CARDIOL, V74, P439, DOI 10.1016/0002-9149(94)90899-0; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Black HR, 1997, ARCH INTERN MED, V157, P2413; BREEN JF, 1992, RADIOLOGY, V185, P435, DOI 10.1148/radiology.185.2.1410350; Bromberger JT, 1996, PSYCHOL AGING, V11, P207, DOI 10.1037/0882-7974.11.2.207; Canalis E, 2001, J CLIN ENDOCR METAB, V86, P5681, DOI 10.1210/jc.86.12.5681; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; COSTA PT, 1993, DIAGNOSIS TREATMENT, P155; deLeon CFM, 1996, AM J CARDIOL, V77, P252, DOI 10.1016/S0002-9149(97)89388-5; Dennison E, 1999, J CLIN ENDOCR METAB, V84, P3058, DOI 10.1210/jc.84.9.3058; Denollet J, 1998, CIRCULATION, V97, P167, DOI 10.1161/01.CIR.97.2.167; Detrano RC, 2000, CURR PROB CARDIOLOGY, V25, P374, DOI 10.1067/mcd.2000.104848; Di Somma C, 2002, CLIN ENDOCRINOL, V56, P153, DOI 10.1046/j.0300-0664.2001.01454.doc.x; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Everson SA, 1996, PSYCHOSOM MED, V58, P113, DOI 10.1097/00006842-199603000-00003; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Finney ML, 2002, PSYCHOPHYSIOLOGY, V39, P340, DOI 10.1017/S0048577201393101; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frimerman A, 1997, AM J CARDIOL, V79, P72, DOI 10.1016/S0002-9149(96)00680-7; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Guyll M, 1998, HEALTH PSYCHOL, V17, P30, DOI 10.1037/0278-6133.17.1.30; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; JULKUNEN J, 1994, PSYCHOSOM MED, V56, P519, DOI 10.1097/00006842-199411000-00007; Kawachi I, 1996, CIRCULATION, V94, P2090, DOI 10.1161/01.CIR.94.9.2090; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; KAWACHI I, 1995, AM J CARDIOL, V75, P882, DOI 10.1016/S0002-9149(99)80680-8; Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0; Krantz DS, 2002, ANNU REV PSYCHOL, V53, P341, DOI 10.1146/annurev.psych.53.100901.135208; Low KG, 1998, ANN BEHAV MED, V20, P221, DOI 10.1007/BF02884964; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Markovitz JH, 1998, PSYCHOSOM MED, V60, P586, DOI 10.1097/00006842-199809000-00013; Matthews KA, 1998, PSYCHOSOM MED, V60, P633, DOI 10.1097/00006842-199809000-00021; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; O'Malley PG, 2000, NEW ENGL J MED, V343, P1298, DOI 10.1056/NEJM200011023431803; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rajagopalan S, 2001, AM J CARDIOL, V88, P196, DOI 10.1016/S0002-9149(01)01623-X; Reilly MP, 2004, ATHEROSCLEROSIS, V173, P69, DOI 10.1016/j.atherosclerosis.2003.10.010; REINSCH CH, 1967, NUMER MATH, V10, P177, DOI 10.1007/BF02162161; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sas Institute inc, 2004, SAS STAT VERS 9 1 US; Scheidt S, 2000, J PSYCHOSOM RES, V48, P317, DOI 10.1016/S0022-3999(00)00091-X; Shimbo D, 2002, AM J CARDIOL, V89, P331, DOI 10.1016/S0002-9149(01)02236-6; Skantze HB, 1998, ATHEROSCLEROSIS, V136, P153, DOI 10.1016/S0021-9150(97)00202-5; Stein PK, 2000, J PSYCHOSOM RES, V48, P493, DOI 10.1016/S0022-3999(99)00085-9; Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Tiemeier H, 2004, ARCH GEN PSYCHIAT, V61, P369, DOI 10.1001/archpsyc.61.4.369; USALA PD, 1991, J PERS SOC PSYCHOL, V60, P471, DOI 10.1037/0022-3514.60.3.471; Williams JE, 2002, STROKE, V33, P13, DOI 10.1161/hs0102.101625; WILLIAMS RB, 1988, PSYCHOSOM MED, V50, P139, DOI 10.1097/00006842-198803000-00004; WILLIAMS RB, 1980, PSYCHOSOM MED, V42, P539, DOI 10.1097/00006842-198011000-00002; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Yaghoubi S, 1995, Am J Card Imaging, V9, P231; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	73	64	64	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					822	831		10.7326/0003-4819-144-11-200606060-00008	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049ZN	16754924	Green Published			2022-12-28	WOS:000238057000005
J	Fitzgerald, KA; Chen, ZJJ				Fitzgerald, KA; Chen, ZJJ			Sorting out toll signals	CELL			English	Editorial Material							NF-KAPPA-B; PATHWAY; TRAM; TRIF; CD14		Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu; zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012; Fitzgerald, Katherine/ABE-6317-2020	Chen, Zhijian/0000-0002-8475-8251; Fitzgerald, Kate/0000-0003-3175-609X				Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flo TH, 2000, INFECT IMMUN, V68, P6770, DOI 10.1128/IAI.68.12.6770-6776.2000; KAGAN JC, 2006, CELL; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	8	73	85	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 2	2006	125	5					834	836		10.1016/j.cell.2006.05.014	http://dx.doi.org/10.1016/j.cell.2006.05.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751092	Bronze			2022-12-28	WOS:000238116400009
J	Tang, YC; Chang, HC; Roeben, A; Wischnewski, D; Wischnewski, N; Kerner, MJ; Hartl, FU; Hayer-Hartl, M				Tang, Yun-Chi; Chang, Hung-Chun; Roeben, Annette; Wischnewski, Dirk; Wischnewski, Nadine; Kerner, Michael J.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Structural features of the GroEL-GroES nano-cage required for rapid folding of encapsulated protein	CELL			English	Article							MALTOSE-BINDING PROTEIN; CHAPERONIN GROEL; IN-VIVO; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CENTRAL CAVITY; POLYPEPTIDE; EVOLUTION; INTERMEDIATE; CONFINEMENT	GroEL and GroES form a chaperonin nano-cage for proteins up to similar to 60 kDa to fold in isolation. Here we explored the structural features of the chaperonin cage critical for rapid folding of encapsulated substrates. Modulating the volume of the GroEL central cavity affected folding speed in accordance with confinement theory. Small proteins (similar to 30 kDa) folded more rapidly as the size of the cage was gradually reduced to a point where restriction in space slowed folding dramatically. For larger proteins (similar to 40-50 kDa), either expanding or reducing cage volume decelerated folding. Additionally, interactions with the C-terminal, mildly hydrophobic Gly-Gly-Met repeat sequences of GroEL protruding into the cavity, and repulsion effects from the negatively charged cavity wall were required for rapid folding of some proteins. We suggest that by combining these features, the chaperonin cage provides a physical environment optimized to catalyze the structural annealing of proteins with kinetically complex folding pathways.	Tech Univ Denmark, BioCent, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Technical University of Denmark; Max Planck Society	Hartl, FU (corresponding author), Tech Univ Denmark, BioCent, Ctr Biol Sequence Anal, Kemitorvet 208, DK-2800 Lyngby, Denmark.	uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Tang, Yun-Chi/GRE-8205-2022; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; tang, yun qi/0000-0001-9385-2787; zhang, hong jun/0000-0003-0030-8323				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Bakkes PJ, 2005, P NATL ACAD SCI USA, V102, P8144, DOI 10.1073/pnas.0500048102; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Brocchieri L, 2000, PROTEIN SCI, V9, P476; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; CHUN SY, 1993, J BIOL CHEM, V268, P20855; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Ganesh C, 2001, PROTEIN SCI, V10, P1635, DOI 10.1110/ps.8101; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Jewett AI, 2004, P NATL ACAD SCI USA, V101, P13192, DOI 10.1073/pnas.0400720101; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Marvin JS, 1997, P NATL ACAD SCI USA, V94, P4366, DOI 10.1073/pnas.94.9.4366; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Stan G, 2003, BIOPHYS CHEM, V100, P453, DOI 10.1016/S0301-4622(02)00298-3; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Vendruscolo M, 2003, P NATL ACAD SCI USA, V100, P14817, DOI 10.1073/pnas.2036516100; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhou HX, 2004, J MOL RECOGNIT, V17, P368, DOI 10.1002/jmr.711	43	227	231	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					903	914		10.1016/j.cell.2006.04.027	http://dx.doi.org/10.1016/j.cell.2006.04.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751100	hybrid, Green Submitted			2022-12-28	WOS:000238116400017
J	Wyllie, DH; Crook, DW; Peto, TEA				Wyllie, David H.; Crook, Derrick W.; Peto, Tim E. A.			Mortality after Staphylococcus aureus bacteraemia in two acute hospitals in Oxfordshire, 1997-2003: cohort study	BRITISH MEDICAL JOURNAL			English	Article							METHICILLIN-RESISTANT; NOSOCOMIAL INFECTION; DEFINITIONS	Objective To determine the incidence of methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA and MSSA) bacteraemia in inpatients and associated mortality within 30 days after diagnosis. Design Anonymised record linkage study of data from hospital information systems and microbiology databases. Setting Teaching hospital and district general hospital in Oxfordshire. Participants Inpatients aged 18 or over admitted to a teaching hospital between 1 April 1997 and 31 March 2004 and to a district general hospital between 1 April 1999 and 31 March 2004. The main part of the study comprised 216 644 inpatients; patients admitted to haematology, nephrology, or oncology services were not included because most were managed as outpatients. Outcome measures Nosocomial MSSA and MRSA bacteraemia; death in hospital within 30 days after bacteraemia. Results Rates of S aureus bacteraemia rose between 1997 and 2003, and MRSA was responsible for this increase. Overall mortality 30 days after bacteraemia was 29%. The crude odds ratio for death after MRSA bacteraemia compared with MSSA bacteraemia was 1.49 (95% confidence interval 0.99 to 2.26). Conclusion The spread of MRSA has greatly increased the overall number of cases of S aureus bacteraemia and has contributed to short term mortality after S aureus bacteraemia.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; Univ Oxford, Nuffield Dept Med, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Wyllie, DH (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	david.wyllie@ndcls.ox.ac.uk		peto, tim/0000-0003-3477-8307				Ayliffe GAJ, 1998, J HOSP INFECT, V39, P253, DOI 10.1016/S0195-6701(98)90293-6; BATES DW, 1995, ARCH INTERN MED, V155, P593, DOI 10.1001/archinte.155.6.593; Blot SI, 2002, ARCH INTERN MED, V162, P2229, DOI 10.1001/archinte.162.19.2229; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Crowcroft NS, 2002, BRIT MED J, V325, P1390, DOI 10.1136/bmj.325.7377.1390; Department of Health website, MRSA SURV SYST RES; Fatkenheuer G, 2004, EUR J CLIN MICROBIOL, V23, P157, DOI 10.1007/s10096-003-1083-3; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GRIFFITHS C, 2004, HLTH STAT Q, V21, P15; Griffiths Clare, 2004, Health Stat Q, P15; Hanon FX, 2002, SCAND J INFECT DIS, V34, P520, DOI 10.1080/00365540110080827; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Keogh B, 2004, BMJ-BRIT MED J, V329, P450, DOI 10.1136/bmj.329.7463.450; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Mermel L A, 2001, J Intraven Nurs, V24, P180; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; REID J, BLOODBORNE MRSA INFE; *REID J, BLOODBORNE MRSA INFE; STAMM AM, 1993, AM J INFECT CONTROL, V21, P70, DOI 10.1016/0196-6553(93)90227-U; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE; Wyllie DH, 2005, BMJ-BRIT MED J, V331, P992, DOI 10.1136/bmj.38558.453310.8F	23	153	154	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 5	2006	333	7562					281	284		10.1136/bmj.38834.421713.2F	http://dx.doi.org/10.1136/bmj.38834.421713.2F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073MV	16798756	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000239748200015
J	Ebrahim, S; Sung, JH; Song, YM; Ferrer, R; Lawlor, DA; Smith, GD				Ebrahim, Shah; Sung, Joohon; Song, Yun-Mi; Ferrer, Robert; Lawlor, Debbie A.; Smith, George Davey			Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; ALCOHOL-CONSUMPTION; MORTALITY; MEN; TRENDS; METAANALYSIS; POPULATION; PREVENTION; LEVEL	Objective To investigate risk factors, such as heavy alcohol consumption, that might explain any increased risk of haemorrhagic stroke associated with low blood cholesterol. Design Prospective cohort study. Setting Korea. Participants 787 442 civil servants (661700 men, 125 742 women) aged 30-64. Main outcome measures Cardiovascular risk factors were assessed at biennial health check. Data on morbidity and mortality were ascertained from 1990 to 2001 using hospital admissions and mortality surveillance systems. Results 6328 cases of ischaemic stroke (6021 men, 307 women), 3947 cases of haemorrhagic stroke (3748 men, 199 women), 3170 cases of undefined stroke (2902 men, 268 women), and 4417 cases of myocardial infarction (4305 men, 112 women) occurred. Ischaemic stroke and myocardial infarction were strongly and positively associated With blood cholesterol (hazard ratio per 1 mmol/l cholesterol 1.20 (95% confidence interval 1.16 to 1.24) and 1.48 (1.43 to 1.53), respectively). Haemorrhagic stroke showed an inverse association in fully adjusted models (0.91, 0.87 to 0.95). This inverse association was confined to participants with hypertension. When stratified by concentration of gamma glutamyl transferase (GGT), an indicator of alcohol consumption, the association was not seen in participants with low concentrations of GGT, and it was independent of hypertension in those With high concentrations of GGT (> 80 U/l). Conclusions High alcohol consumption may underlie the association between low blood cholesterol and increased risk of haemorrhagic stroke.	Kangwon Natl Univ, Coll Med, Dept Prevent Med, Chunchon, Kangwon Do, South Korea; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; Univ Texas, Hlth Sci Ctr, Dept Family & Community Med, San Antonio, TX 78229 USA	Kangwon National University; University of Bristol; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Texas System; University of Texas Health San Antonio	Sung, JH (corresponding author), Kangwon Natl Univ, Coll Med, Dept Prevent Med, Hyoja 2 Dong, Chunchon, Kangwon Do, South Korea.	sungjohn@kangwon.ac.kr	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063749] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bots ML, 2002, J EPIDEMIOL COMMUN H, V56, pI19, DOI 10.1136/jech.56.suppl_1.i19; CHEN ZM, 1993, BMJ-BRIT MED J, V306, P890, DOI 10.1136/bmj.306.6882.890; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHUNG WS, 1991, J CLIN PATHOL QUAL C, V13, P1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Corvol JC, 2003, ARCH INTERN MED, V163, P669, DOI 10.1001/archinte.163.6.669; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; Hart CL, 1999, STROKE, V30, P1999, DOI 10.1161/01.STR.30.10.1999; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; IRIBARREN C, 1995, JAMA-J AM MED ASSOC, V273, P1926, DOI 10.1001/jama.273.24.1926; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; *KOR NAT STAT OFF, 2002, ANN REP CAUS DEATH S; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lawlor DA, 2002, LANCET, V360, P1818, DOI 10.1016/S0140-6736(02)11769-7; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; Park JK, 2000, KOREAN J PREV MED, V33, P76, DOI DOI 10.1161/01.STR.0000078562.82918.F6; Qizilbash N, 1995, LANCET, V346, P1647; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; SHIMAMOTO T, 1989, CIRCULATION, V79, P503, DOI 10.1161/01.CIR.79.3.503; Song YM, 2000, AM J EPIDEMIOL, V151, P739, DOI 10.1093/oxfordjournals.aje.a010272; Suh I, 2001, LANCET, V357, P922, DOI 10.1016/S0140-6736(00)04213-6; SUH SI, 1997, KOREAN J HOSP MANAGE, V3, P121; TUOMILEHTO J, 1991, STROKE, V22, P7, DOI 10.1161/01.STR.22.1.7; VARTIAINEN E, 1995, BMJ-BRIT MED J, V310, P901, DOI 10.1136/bmj.310.6984.901; Wannamethee SG, 2000, STROKE, V31, P1882, DOI 10.1161/01.STR.31.8.1882; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	31	127	135	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2006	333	7557					22	25		10.1136/bmj.38855.610324.80	http://dx.doi.org/10.1136/bmj.38855.610324.80			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16757495	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000238922900022
J	Rao, M; Clarke, A; Sanderson, C; Hammersley, R				Rao, Mala; Clarke, Aileen; Sanderson, Colin; Hammersley, Richard			Patients' own assessments of quality of primary care compared with objective records based measures of technical quality of care: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; UNITED-KINGDOM; HEALTH-CARE; PERFORMANCE; TESTS	Objective To investigate the relation between older patients' assessments of the quality of their primary care and measures of good clinical practice on the basis of data from administrative and clinical records. Design Cross sectional population based study using the general practice assessment survey. Setting 18 general practices hi the Basildon primary care trust area, south cast England. Participants 3487 people aged 65 or more. Main outcome measures Correlations between mean practice scores on the general practice assessment survey and three evidence based measures on survey of case records (monitoring for, and control of, hypertension, and vaccination against influenza). Results 76% of people (3487/4563) responded to the general practice assessment surveys Correlations between patient assessed survey scores for technical quality and the objective records based measures of good clinical practice were 0.22 (95% confidence interval - 0.28 to 0.62) for hypertension monitored, 0.30 (- 0.19 to 0.67) for hypertension controlled, and - 0.05 (- 0.50 to 0.43) for influenza vaccination. Conclusions Older patients' assessments are not a sufficient basis for assessing die technical quality of their primary care. For an overall assessment it both patient based and records based measures are required.	Queen Mary Univ London, Publ Hlth & Policy Res Unit, London E1 2AT, England; Univ Essex, Dept Hlth & Human Sci, Colchester CO4 3SQ, Essex, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Glasgow Caledonian Univ, Ctr Behav Aspects Hlth & Dis, Glasgow G4 OBA, Lanark, Scotland	University of London; Queen Mary University London; University of Essex; University of London; London School of Hygiene & Tropical Medicine; Glasgow Caledonian University	Clarke, A (corresponding author), Queen Mary Univ London, Publ Hlth & Policy Res Unit, London E1 2AT, England.	aileen.clarke@nhs.net	Clarke, Aileen/I-5679-2012; Hammersley, Richard/I-9347-2012; Sanderson, Colin F/O-9877-2014	Clarke, Aileen/0000-0001-8299-3146; Sanderson, Colin/0000-0002-4838-6112				Alazri MH, 2003, DIABETIC MED, V20, P486, DOI 10.1046/j.1464-5491.2003.00957.x; Bland M., 2000, INTRO MED STAT, V3rd; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; CAMPBELL JI, 2004, QUAL HEALTH CARE, V10, P90; Chapple A, 2002, SOC SCI MED, V54, P1215, DOI 10.1016/S0277-9536(01)00091-0; *DEP HLTH ENGL WAL, 1998, INFL INN EXTENSION C; *DEP HLTH ENGL WAL, 1998, INFL IMM EXT CURR PO; Department of Health, 2003, DEL INV GEN PRACT IM; Department of Health, 2003, CHOIC RESP EQ NHS; Donabedian A., 1980, EXPLORATION QUALITY; ERENS B, 1999, HLTH SURVEY ENGLAND; Heaney DJ, 2002, FAM PRACT, V19, P77, DOI 10.1093/fampra/19.1.77; MAXWELL RJ, 1984, BRIT MED J, V288, P1470, DOI 10.1136/bmj.288.6428.1470; McColl A, 2000, QUAL HEALTH CARE, V9, P90, DOI 10.1136/qhc.9.2.90; Ramsay J, 2000, FAM PRACT, V17, P372, DOI 10.1093/fampra/17.5.372; RELMAN AS, 1988, NEW ENGL J MED, V319, P1220, DOI 10.1056/NEJM198811033191810; Rhodes Penny, 1998, Health Expect, V1, P73; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Schneider EC, 2001, MED CARE, V39, P1313, DOI 10.1097/00005650-200112000-00007; SEVER P, 1993, BMJ-BRIT MED J, V306, P983, DOI 10.1136/bmj.306.6883.983; Shickle D, 1997, BIOETHICS, V11, P277, DOI 10.1111/1467-8519.00067; TOON P, 1999, 78 ROYAL COLL GEN PR	23	102	102	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2006	333	7557					19	22		10.1136/bmj.38874.499167.7C	http://dx.doi.org/10.1136/bmj.38874.499167.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16793783	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000238922900021
J	Das, S; Incarvito, CD; Crabtree, RH; Brudvig, GW				Das, Siddhartha; Incarvito, Christopher D.; Crabtree, Robert H.; Brudvig, Gary W.			Molecular recognition in the selective oxygenation of saturated C-H bonds by a dimanganese catalyst	SCIENCE			English	Article							HYDROXYLATION; FUNCTIONALIZATION; DESATURATION; COMPLEX; MODELS; ACIDS	Although enzymes often incorporate molecular recognition elements to orient substrates selectively, such strategies are rarely achieved by synthetic catalysts. We combined molecular recognition through hydrogen bonding with C-H activation to obtain high-turnover catalytic regioselective functionalization of sp(3) C-H bonds remote from the -CCOH recognition group. The catalyst contains a Mn(mu-O)(2)Mn reactive center and a ligand based on Kemp's triacid that directs a -COOH group to anchor the carboxylic acid group of the substrate and thus modify the usual selectivity for oxidation. Control experiments supported the rote of hydrogen bonding in orienting the substrate to achieve high selectivity.	Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Crabtree, RH (corresponding author), Yale Univ, Dept Chem, 225 Prospect St,POB 208107, New Haven, CT 06520 USA.	robert.crabtree@yale.edu; gary.brudvig@yale.edu	Das, Siddhartha/E-5604-2011		NIGMS NIH HHS [GM32715] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032715] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behrouzian B, 2003, PROSTAG LEUKOTR ESS, V68, P107, DOI 10.1016/S0952-3278(02)00260-0; Behrouzian B, 2002, J AM CHEM SOC, V124, P3277, DOI 10.1021/ja012252l; Breslow R, 1997, P NATL ACAD SCI USA, V94, P11156, DOI 10.1073/pnas.94.21.11156; Breslow R, 1997, J AM CHEM SOC, V119, P4535, DOI 10.1021/ja9704951; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; CASTELLINO AJ, 1988, J AM CHEM SOC, V110, P158, DOI 10.1021/ja00209a025; Caviglioli G, 2002, J PHARMACEUT BIOMED, V30, P499, DOI 10.1016/S0731-7085(02)00400-4; Chen HY, 2005, INORG CHEM, V44, P7661, DOI 10.1021/ic0509940; Dangel BD, 2001, J AM CHEM SOC, V123, P8149, DOI 10.1021/ja016280f; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; GOODMAN MS, 1995, J AM CHEM SOC, V117, P11610, DOI 10.1021/ja00151a039; GOODMAN MS, 1995, J AM CHEM SOC, V117, P8447, DOI 10.1021/ja00137a021; KAUFMAN MD, 1993, J AM CHEM SOC, V115, P11648, DOI 10.1021/ja00077a094; KOMURO M, 1992, TETRAHEDRON LETT, V33, P4949, DOI 10.1016/S0040-4039(00)61242-X; Limburg J, 2001, J AM CHEM SOC, V123, P423, DOI 10.1021/ja001090a; Limburg J, 1999, SCIENCE, V283, P1524, DOI 10.1126/science.283.5407.1524; Meunier B., 2000, BIOMIMETIC OXIDATION; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; Moreira RF, 2000, ANGEW CHEM INT EDIT, V39, P1618, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1618::AID-ANIE1618>3.0.CO;2-M; Rauk A, 1996, J AM CHEM SOC, V118, P3761, DOI 10.1021/ja9531900; VANBEILEN JB, 1994, ENZYME MICROBIOL TEC, V106, P7928; Wessel J, 1996, J MOL CATAL A-CHEM, V113, P13, DOI 10.1016/S1381-1169(96)00029-5; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u; Yang J, 2000, ANGEW CHEM INT EDIT, V39, P2692, DOI 10.1002/1521-3773(20000804)39:15<2692::AID-ANIE2692>3.0.CO;2-3	26	376	377	3	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1941	1943		10.1126/science.1127899	http://dx.doi.org/10.1126/science.1127899			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	061CF	16809537				2022-12-28	WOS:000238848100056
J	Rhee, SG				Rhee, Sue Goo			H2O2, a necessary evil for cell signaling	SCIENCE			English	Editorial Material							REACTIVE OXYGEN; GROWTH		Ewha Womans Univ, Inst Mol Life Sci & Technol, Seoul 120750, South Korea	Ewha Womans University	Rhee, SG (corresponding author), Ewha Womans Univ, Inst Mol Life Sci & Technol, Seoul 120750, South Korea.	rheesg@ewha.ac.kr	Franzeck, Fabian C/B-5055-2011					BIENERT GB, IN PRESS BIOCH BIOPH; *CATH U, 2006, RED SIGN HUM DIS AG; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; *U NEW ENGL, 2006, THIOL BAS RED REG SI; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004	13	1640	1697	10	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1882	1883		10.1126/science.1130481	http://dx.doi.org/10.1126/science.1130481			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809515				2022-12-28	WOS:000238848100033
J	Willingham, AT; Gingeras, TR				Willingham, Aarron T.; Gingeras, Thomas R.			TUF love for "junk" DNA	CELL			English	Editorial Material							HIGH-RESOLUTION MAP; NONCODING RNAS; HUMAN GENOME; BINDING SITES; TRANSCRIPTION; GENE	The widespread occurrence of noncoding (nc) RNAs-unannotated eukaryotic transcripts with reduced protein coding potential-suggests that they are functionally important. Study of ncRNAs is increasing our understanding of the organization and regulation of genomes.	Affymetrix Inc, Santa Clara, CA 95051 USA	Affymetrix	Willingham, AT (corresponding author), Affymetrix Inc, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com		Gingeras, Thomas/0000-0001-9106-3573				Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; ARAVIN A, 2006, NATURE; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GIRARD A, 2006, NATURE; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Samanta MP, 2006, P NATL ACAD SCI USA, V103, P4192, DOI 10.1073/pnas.0507669103; Semon M, 2004, TRENDS GENET, V20, P229, DOI 10.1016/j.tig.2004.03.001; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wong GKS, 2001, GENOME RES, V11, P1975, DOI 10.1101/gr.202401; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	28	127	137	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1215	1220		10.1016/j.cell.2006.06.009	http://dx.doi.org/10.1016/j.cell.2006.06.009			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814704	Bronze			2022-12-28	WOS:000239104500001
J	Wong, CK; Gao, WZ; Raffel, OC; French, JK; Stewart, RA; White, HD				Wong, Cheuk-Kit; Gao, Wanzhen; Raffel, O. Christopher; French, John K.; Stewart, Ralph A.; White, Harvey D.		HERO-2 Investigators	Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2	LANCET			English	Article							PLASMINOGEN-ACTIVATOR; PRESENTING ELECTROCARDIOGRAM; PREHOSPITAL FIBRINOLYSIS; THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; CORONARY-OCCLUSION; REPERFUSION; TRIAL; TIME; ANGINA	Background The presence of pathological Q waves in the infarct leads on the surface electrocardiogram in an ST-elevation acute myocardial infarction indicates myocardial necrosis. Clinically it might be difficult to ascertain the onset of acute myocardial infarction. Our aim was to assess whether the presence or absence of Q waves at presentation could be used as an indicator of the duration of acute myocardial infarction and predict mortality. Methods 15 222 patients with ST-elevation acute myocardial infarction and normal intraventricular conduction were randomly assigned streptokinase and aspirin plus bivalirudin or unfractionated heparin in the HERO-2 trial; randomisation did not alter 30-day mortality. 10244 patients (67%) had Q waves in the infarct territory at the time of randomisation, and 4978 (33%) did not. The primary endpoint was 30-day mortality. Findings There were more deaths at 30 days in patients with initial Q waves than in those without (1044 [10%] VS 344 [7%], p<0.0001). These findings were similar in patients with a first acute myocardial infarction and when stratified by time to randomisation (0-2, >2-4, >4 h) and by acute myocardial infarction location (anterior or inferior). Both the presence of initial Q waves and time to randomisation were positive univariate predictors, but only the presence of initial Q waves independently predicted 30-day mortality on multivariate analysis (adjusted OR 1.44, 95% CI 1.25-1.65 with clinical indices, and 1.31, 1.12-1-54 with clinical plus ST indices included as predictors). Interpretation The presence of Q waves in the infarct leads at presentation of ST-elevation acute myocardial infarction independently predicts higher 30-day mortality in patients treated with fibrinolytic therapy. Therefore, a more aggressive approach to reperfusion might be warranted in these patients.	Auckland City Hosp, Cardiovasc Res Unit, Auckland 1001, New Zealand; Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	Auckland City Hospital; University of Otago	White, HD (corresponding author), Auckland City Hosp, Coronary Care & Green Lane Cardiovasc Res Unit, Green Lane Cardiovasc Serv, Auckland 1001, New Zealand.	HarveyW@adhb.govt.nz	Raffel, Owen C/Q-1158-2016	Raffel, Owen C/0000-0001-5470-7050				Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Andreotti F, 1996, NEW ENGL J MED, V334, P7, DOI 10.1056/NEJM199601043340102; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; French JK, 2002, AM HEART J, V143, P265, DOI 10.1067/mhj.2002.120147; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Giugliano RP, 2003, CIRCULATION, V108, P2828, DOI 10.1161/01.CIR.0000106684.71725.98; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; HACKETT D, 1987, NEW ENGL J MED, V317, P1055, DOI 10.1056/NEJM198710223171704; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; KLONER RA, 1995, CIRCULATION, V91, P37, DOI 10.1161/01.CIR.91.1.37; KUNITADA S, 1992, BLOOD, V79, P1420; McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C; OTTANI F, 1995, CIRCULATION, V91, P291, DOI 10.1161/01.CIR.91.2.291; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; REIMER KA, 1985, CIRC RES, V56, P651, DOI 10.1161/01.RES.56.5.651; Roe MT, 2001, J AM COLL CARDIOL, V37, P9, DOI 10.1016/S0735-1097(00)01101-3; SCHRODER R, 1995, J AM COLL CARDIOL, V26, P1657, DOI 10.1016/0735-1097(95)00372-X; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Steg PG, 1998, J AM COLL CARDIOL, V31, P776, DOI 10.1016/S0735-1097(98)00018-7; White HD, 2001, LANCET, V358, P1855; Wong CK, 1999, AM J CARDIOL, V83, P164, DOI 10.1016/S0002-9149(98)00818-2; Wong CK, 2002, EUR HEART J, V23, P1449, DOI 10.1053/euhj.2002.3263; Wong CK, 2002, EUR HEART J, V23, P399, DOI 10.1053/euhj.2001.2795; Wong CK, 2001, AM J CARDIOL, V88, P558, DOI 10.1016/S0002-9149(01)01740-4	28	56	55	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2061	2067		10.1016/S0140-6736(06)68929-0	http://dx.doi.org/10.1016/S0140-6736(06)68929-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798389				2022-12-28	WOS:000238657400031
J	Lotze, HK; Lenihan, HS; Bourque, BJ; Bradbury, RH; Cooke, RG; Kay, MC; Kidwell, SM; Kirby, MX; Peterson, CH; Jackson, JBC				Lotze, Heike K.; Lenihan, Hunter S.; Bourque, Bruce J.; Bradbury, Roger H.; Cooke, Richard G.; Kay, Matthew C.; Kidwell, Susan M.; Kirby, Michael X.; Peterson, Charles H.; Jackson, Jeremy B. C.			Depletion, degradation, and recovery potential of estuaries and coastal seas	SCIENCE			English	Article							MARINE; IMPACTS; EXTINCTIONS; RESILIENCE; ECOSYSTEM; COLLAPSE	Estuarine and coastal transformation is as old as civilization yet has dramatically accelerated over the past 150 to 300 years. Reconstructed time lines, causes, and consequences of change in 12 once diverse and productive estuaries and coastal seas worldwide show similar patterns: Human impacts have depleted >90% of formerly important species, destroyed >65% of seagrass and wetland habitat, degraded water quality, and accelerated species invasions. Twentieth-century conservation efforts achieved partial recovery of upper trophic levels but have so far failed to restore former ecosystem structure and function. Our results provide detailed historical baselines and quantitative targets for ecosystem-based management and marine conservation.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; Bates Coll, Dept Anthropol, Lewiston, ME 04240 USA; Australian Natl Univ, Res Sch Pacific & Asian Studie, Resources Management Asia Pacific Program, Canberra, ACT 0200, Australia; Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archeol, Unit 0948, APO, AA 34002 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA	Dalhousie University; University of California System; University of California Santa Barbara; Australian National University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Chicago; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; Scripps Institution of Oceanography	Lotze, HK (corresponding author), Dalhousie Univ, Dept Biol, 1355 Oxford St, Halifax, NS B3H 4J1, Canada.	hlotze@dal.ca		Bradbury, Roger/0000-0002-0940-3493; Lotze, Heike/0000-0001-6258-1304				Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Broughton JM, 2002, WORLD ARCHAEOL, V34, P60, DOI 10.1080/00438240220134269; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Carlton JT, 1999, ANNU REV ECOL SYST, V30, P515, DOI 10.1146/annurev.ecolsys.30.1.515; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Griffiths CL, 2004, OCEANOGR MAR BIOL, V42, P303; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; Lotze HK, 2005, HELGOLAND MAR RES, V59, P71, DOI 10.1007/s10152-004-0208-0; Lotze HK, 2005, HELGOLAND MAR RES, V59, P84, DOI 10.1007/s10152-004-0209-z; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Pahlow M, 2000, SCIENCE, V287, P831, DOI 10.1126/science.287.5454.831; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; PETERSEN KS, 1992, NATURE, V359, P679, DOI 10.1038/359679a0; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Ruiz GM, 1997, AM ZOOL, V37, P621; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stokstad E, 2005, SCIENCE, V310, P1264, DOI 10.1126/science.310.5752.1264; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	27	2116	2186	42	1216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1806	1809		10.1126/science.1128035	http://dx.doi.org/10.1126/science.1128035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794081				2022-12-28	WOS:000238452800061
J	Strunk, RC; Bloomberg, GR				Strunk, RC; Bloomberg, GR			Omalizumab for asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-IGE ANTIBODY; HUMANIZED MONOCLONAL-ANTIBODY; SEVERE PERSISTENT ASTHMA; SEVERE ALLERGIC-ASTHMA; EPSILON-RI EXPRESSION; CHILDHOOD ASTHMA; DOWN-REGULATION; IN-VIVO; THERAPY; EXACERBATIONS		Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Strunk, RC (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.							Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Berger W, 2003, ANN ALLERG ASTHMA IM, V91, P182, DOI 10.1016/S1081-1206(10)62175-8; Bousquet J, 2005, ALLERGY, V60, P302, DOI 10.1111/j.1398-9995.2004.00770.x; Bousquet J, 2004, CHEST, V125, P1378, DOI 10.1378/chest.125.4.1378; Broide DH, 2001, J ALLERGY CLIN IMMUN, V108, pS65, DOI 10.1067/mai.2001.116436; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Casale TB, 1997, J ALLERGY CLIN IMMUN, V100, P110, DOI 10.1016/S0091-6749(97)70202-1; Castro M, 2001, J ASTHMA, V38, P625, DOI 10.1081/JAS-100107540; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; DACUS JJ, 2003, PEC UPDATE, V3, P4; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; *FOOD DRUG ADM, 2002, 1039760 BLA STN FOOD; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; *GEN, XOL OM; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Hamilton RG, 2006, J ALLERGY CLIN IMMUN, V117, P759, DOI 10.1016/j.jaci.2006.01.012; Hamilton RG, 2005, J IMMUNOL METHODS, V303, P81, DOI 10.1016/j.jim.2005.06.008; Hochhaus G, 2003, CURR MED RES OPIN, V19, P491, DOI 10.1185/030079903125002171; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Infuhr D, 2005, ALLERGY, V60, P977, DOI 10.1111/j.1398-9995.2005.00832.x; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Maurer D, 1998, J IMMUNOL, V161, P2731; Milgrom H, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e36; *NAT HEART LUNG BL, 1997, NIH PUBL; National Heart Lung and Blood Institute, 2003, NIH PUBL, V02-5074; Oettgen HC, 2001, J ALLERGY CLIN IMMUN, V107, P429, DOI 10.1067/mai.2001.113759; Oettgen HC, 2001, J ALLERGY CLIN IMMUN, V107, P591; Ong YE, 2005, J ALLERGY CLIN IMMUN, V116, P558, DOI 10.1016/j.jaci.2005.05.035; Owen CE, 2002, PULM PHARMACOL THER, V15, P417, DOI 10.1006/pupt.2002.0372; PRESTA LG, 1993, J IMMUNOL, V151, P2623; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Saini SS, 1999, J IMMUNOL, V162, P5624; Schulman ES, 2001, AM J RESP CRIT CARE, V164, pS6, DOI 10.1164/ajrccm.164.supplement_1.2103025; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Soler M, 2001, EUR RESPIR J, V18, P739; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262	39	159	170	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2689	2695		10.1056/NEJMct055184	http://dx.doi.org/10.1056/NEJMct055184			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790701				2022-12-28	WOS:000238416900007
J	Kremer, JM; Genant, HK; Moreland, LW; Russell, AS; Emery, P; Abud-Mendoza, C; Szechinski, J; Li, T; Ge, ZY; Becker, JC; Westhovens, R				Kremer, Joel M.; Genant, Harry K.; Moreland, Larry W.; Russell, Anthony S.; Emery, Paul; Abud-Mendoza, Carlos; Szechinski, Jacek; Li, Tracy; Ge, Zhiyu; Becker, Jean-Claude; Westhovens, Rene			Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH ASSESSMENT QUESTIONNAIRE; CLINICAL-TRIALS; DOUBLE-BLIND; DISEASE; COSTIMULATION; CRITERIA; INHIBITION; BLOCKADE; DAS28	Background: The selective co-stimulation modulator abatacept demonstrated efficacy for treating rheumatoid arthritis in early clinical studies. Objective: To evaluate the effects of abatacept in patients with persistent, active rheumatoid arthritis despite methotrexate treatment. Design: One-year, multicenter, randomized, double-blind, placebo-controlled trial (November 2002 to October 2004). Setting: 116 centers worldwide. Patients: 652 patients with active rheumatoid arthritis despite methotrexate treatment. Intervention: Once-monthly infusion of a fixed dose of abatacept, approximately 10 mg/kg of body weight, or placebo. Measurements: Co-primary end points were a 20% improvement in American College of Rheumatology (ACR) response criteria (ACR 20) at 6 months, clinically meaningful improvements in physical function, and change from baseline in joint erosion score at 1 year. Results: Four hundred thirty-three and 219 patients were randomly assigned to abatacept or placebo, respectively, and 385 (89%) and 162 (74%), respectively, completed 1 year of treatment. In a modified intention-to-treat analysis, 6-month ACR 20, ACR 50, and ACR 70 responses were 67.9% for abatacept versus 39.7% for placebo (difference, 28.2 percentage points (95% CI, 19.8 to 36.7 percentage points]), 39.9% for abatacept versus 16.8% for placebo (difference, 23.0 percentage points [CI, 15.0 to 31.1 percentage points]), and 19.8% for abatacept versus 6.5% for placebo (difference, 13.3 percentage points [CI, 7.0 to 19.5 percentage points]), respectively. At 1 year, the responses increased to 73.1% for abatacept versus 39.7% for placebo (difference, 33.4 percentage points [CI, 25.1 to 41.7 percentage points]), 48.3% for abatacept versus 18.2% for placebo (difference, 30.1 percentage points [CI, 21.8 to 38.5 percentage points]), and 28.8% for abatacept versus 6.1% for placebo (difference, 22.7 percentage points [CI, 15.6 to 29.8 percentage points]), respectively (P < 0.001 for all). Physical function significantly improved in 63.7% versus 39.3% of patients (P < 0.001). At 1 year, abatacept statistically significantly slowed the progression of structural joint damage compared with placebo. Abatacept-treated patients had a similar incidence of adverse events (87.3% vs. 84.0%; difference, 3.3 percentage points [CI, -2.5 to 9.1 percentage points]) and a higher incidence of prespecified serious infections (2.5% vs. 0.9%; difference, 1.6 percentage points [CI, -0.3 to 3.6 percentage points]) and infusion reactions (acute, 8.8% vs. 4.1%; difference, 4.7 percentage points [CI, 0.9 to 8.4 percentage points]; peri-infusional, 24.5% vs. 16.9%; difference, 7.6 percentage points [CI, 1.2 to 14.0 percentage points]) compared with placebo recipients. Limitations: The study involved only 1 group of patients over 1 year. Conclusions: Abatacept statistically significantly reduced disease activity in patients with rheumatoid arthritis and an inadequate response to methotrexate. Longer treatment in different patient populations is needed to establish its appropriate role in rheumatoid arthritis.	Ctr Rheumatol, Albany, NY 12206 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Synarc Inc, San Francisco, CA USA; Univ Alabama Birmingham, Med Sch Birmingham, Birmingham, AL USA; Univ Alberta, Edmonton, AB, Canada; Leeds Gen Infirm, Leeds, W Yorkshire, England; Cent Hosp, San Luis Potosi, Mexico; Univ Med Sci, Wroclaw, Poland; Bristol Myers Squibb Co, Princeton, NJ 08543 USA; Univ Hosp Leuven, Louvain, Belgium	University of California System; University of California San Francisco; Synarc; University of Alabama System; University of Alabama Birmingham; University of Alberta; Leeds General Infirmary; University of Leeds; Wroclaw Medical University; Bristol-Myers Squibb; KU Leuven; University Hospital Leuven	Kremer, JM (corresponding author), Ctr Rheumatol, 1367 Washington Ave,Suite 1, Albany, NY 12206 USA.	jkremer@joint-docs.com	emery, paul/B-3560-2013	Abud-Mendoza, Carlos/0000-0002-3749-5831; Moreland, Larry/0000-0003-4483-0359				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bruce B, 2003, J RHEUMATOL, V30, P167; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Diggle PJ, 1994, ANAL LONGITUDINAL DA; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; FRIES JF, 1982, J RHEUMATOL, V9, P789; Genant HK, 1998, ARTHRITIS RHEUM, V41, P1583, DOI 10.1002/1529-0131(199809)41:9<1583::AID-ART8>3.0.CO;2-H; GENANT HK, 1983, AM J MED, V75, P35, DOI 10.1016/0002-9343(83)90473-4; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Goronzy JJ, 2004, CURR OPIN RHEUMATOL, V16, P212, DOI 10.1097/00002281-200405000-00008; Hoffman RW, 2001, FRONT BIOSCI-LANDMRK, V6, pD1369, DOI 10.2741/Hoffman; Khanna D, 2004, DRUG SAFETY, V27, P307, DOI 10.2165/00002018-200427050-00003; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Little R, 1996, BIOMETRICS, V52, P1324, DOI 10.2307/2532847; Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Silver PB, 2000, J IMMUNOL, V165, P5041, DOI 10.4049/jimmunol.165.9.5041; Vrijhoef HJM, 2003, ANN RHEUM DIS, V62, P419, DOI 10.1136/ard.62.5.419; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLS GA, 1993, J RHEUMATOL, V20, P557	28	563	609	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					865	876		10.7326/0003-4819-144-12-200606200-00003	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785475				2022-12-28	WOS:000238555500001
J	Lexchin, J; Light, DW				Lexchin, Joel; Light, Donald W.			Commercial bias in medical journals - Commercial influence and the content of medical journals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada; Univ Med & Dent New Jersey, Stratford, NJ USA	York University - Canada; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lexchin, J (corresponding author), 121 Walmer Rd, Toronto, ON M5R 2X8, Canada.	jlexchin@yorku.ca						ALTMAN LK, 1999, NY TIMES D      0824, P7; [Anonymous], 2002, MED LETT DRUGS THER, V44, P83; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Dyer O, 2004, BRIT MED J, V328, P244, DOI 10.1136/bmj.328.7434.244-b; Fletcher RH, 2003, LANCET, V361, P10, DOI 10.1016/S0140-6736(03)12185-X; Glassman PA, 1999, WESTERN J MED, V171, P234; GOOZNER U, 2004, UNREVEALED NONDISCLO; Haivas I, 2004, CAN MED ASSOC J, V171, P475, DOI 10.1503/cmaj.1031982; Hoey J, 1999, CAN MED ASSOC J, V160, P507; Hussain A, 2001, BRIT MED J, V323, P263, DOI 10.1136/bmj.323.7307.263; Kassirer JP, 2006, CAN MED ASSOC J, V174, P945, DOI 10.1503/cmaj.060290; Landefeld C. S., 1995, JGIM, V10, P111; Ray JG, 2002, QJM-INT J MED, V95, P769, DOI 10.1093/qjmed/95.12.769; SCHROTER S, 2004, COPE REPORT 2003 ANN, P24; Smith R, 2003, BRIT MED J, V326, P1202, DOI 10.1136/bmj.326.7400.1202; SMITH R, 2005, PLSO MED, V2, pC138; VANMCCRARY S, 2000, NEW ENGL J MED, V343, P1621; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912; WILKES MS, 1995, J GEN INTERN MED, V10, P443, DOI 10.1007/BF02599916	20	65	71	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1444	1447		10.1136/bmj.332.7555.1444	http://dx.doi.org/10.1136/bmj.332.7555.1444			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056UO	16777891	Green Published			2022-12-28	WOS:000238550800037
J	Srinivasan, S; Loff, B				Srinivasan, S; Loff, B			Medical research in India	LANCET			English	Editorial Material									Indian Journal Med Eth, Bombay, Maharashtra, India; Alfred Hosp, Monash Med Sch, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Srinivasan, S (corresponding author), Indian Journal Med Eth, Bombay, Maharashtra, India.	sandhya_srinivasan@vsnl.com	Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503				BEECHAM B, 2005, IND J MED ETH 1 NAT; Bhatnagar N, 2002, ADV CONSUM RES, V29, P259; Bhattacharya N., 2001, Clinical and Experimental Obstetrics and Gynecology, V28, P233; Bhattacharya N., 2001, Clinical and Experimental Obstetrics and Gynecology, V28, P47; Bhattacharya N, 2001, EUR J GYNAECOL ONCOL, V22, P273; ICMR, 2000, ETH GUID BIOM RES HU; Jayaraman KS, 2005, NATURE, V434, P259, DOI 10.1038/434259a; KASHYAP SD, 2005, TIMES NEWS NETW 0315; KRISHNAKUMAR F, 2005, FRONTLINE, V22; KRISHNAKUMAR R, 2001, FRONTLINE, V18; KRISHNAKUMAR R, 2005, FRONTLINE, V22; *MIN HLTH FAM WELF, 2005, DRUGS COSM; Mudur G, 2005, BRIT MED J, V331, P1044, DOI 10.1136/bmj.331.7524.1044-b; Mudur Ganapati, 2005, BMJ, V330, P60, DOI 10.1136/bmj.330.7482.60-d; PADMA TV, 2005, INDIA STRUGGLES REGU; PANDYA SK, 2002, ISSUES MED ETHICS, V10	16	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2006	367	9527					1962	1964		10.1016/S0140-6736(06)68861-2	http://dx.doi.org/10.1016/S0140-6736(06)68861-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782469				2022-12-28	WOS:000238488900008
J	Schindler, M; Munch, J; Kutsch, O; Li, H; Santiago, ML; Bibollet-Ruche, F; Muller-Trutwin, MC; Novembre, FJ; Peeters, M; Courgnaud, V; Bailes, E; Roques, P; Sodora, DL; Silvestri, G; Sharp, PM; Hahn, BH; Kirchhoff, F				Schindler, Michael; Muench, Jan; Kutsch, Olaf; Li, Hui; Santiago, Mario L.; Bibollet-Ruche, Frederic; Muller-Trutwin, Michaela C.; Novembre, Francis J.; Peeters, Martine; Courgnaud, Valerie; Bailes, Elizabeth; Roques, Pierre; Sodora, Donald L.; Silvestri, Guido; Sharp, Paul M.; Hahn, Beatrice H.; Kirchhoff, Frank			Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1	CELL			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; SURFACE EXPRESSION; IN-VIVO; GASTROINTESTINAL-TRACT; LYMPHOCYTE-ACTIVATION; IMMUNE ACTIVATION; DOWN-MODULATION; SOOTY MANGABEYS; RHESUS MACAQUES; HUMAN RECEPTORS	High-level immune activation and T cell apoptosis represent a hallmark of HIV-1 infection that is absent from nonpathogenic SIV infections in natural primate hosts. The mechanisms causing these varying levels of immune activation are not understood. Here, we report that nef alleles from the great majority of primate lentiviruses, including HIV-2, downmodulate TCR-CD3 from infected T cells, thereby blocking their responsiveness to activation. In contrast, nef alleles from HIV-1 and a subset of closely related SIVs fail to downregulate TCR-CD3 and to inhibit cell death. Thus, Nef-mediated suppression of T cell activation is a fundamental property of primate lentiviruses; that likely evolved to maintain viral persistence in the context of an intact host immune system. This function was lost during viral evolution in a lineage that gave rise to HIV-1 and may have predisposed the simian precursor of HIV-1 for greater pathogenicity in humans.	Univ Ulm, Dept Virol, D-89081 Ulm, Germany; Univ Alabama, Dept Med & Microbiol, Birmingham, AL 35294 USA; Inst Pasteur, Unite Biol Retrovirus, F-75015 Paris, France; Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Univ Montpellier, Retrovirus Lab, UMR145, Inst Rech Dev, F-34032 Montpellier, France; Univ Montpellier, Dept Int Hlth, F-34032 Montpellier, France; Univ Nottingham, Queens Med Ctr, Genet Inst, Nottingham NG7 2UH, England; CIRMF, Dept Virol, Franceville, Gabon; Univ Texas, SW Med Ctr, Dept Internal Med, Div Infect Dis, Dallas, TX 75390 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Ulm University; University of Alabama System; University of Alabama Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Emory University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Nottingham; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Schindler, M (corresponding author), Univ Ulm, Dept Virol, D-89081 Ulm, Germany.	frank.kirchhoff@medizin.uni-ulm.de	Roques, Pierre/M-2212-2013; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010; Sharp, Paul/Y-3787-2019; Schindler, Michael/C-1647-2015; Kirchhoff, Frank/O-8367-2018	Roques, Pierre/0000-0003-1825-1054; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Schindler, Michael/0000-0001-8989-5813; Kirchhoff, Frank/0000-0002-7052-2360; Hahn, Beatrice/0000-0002-9400-9887; Muller-Trutwin, Michaela/0000-0002-3854-2396; Santiago, Mario L./0000-0001-7792-2706; Jan, Munch/0000-0001-7316-7141	NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050529, N01AI085338, R21AI055380, U01AI067854, P30AI027767] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA 13148] Funding Source: Medline; NCRR NIH HHS [P51 RR-00165] Funding Source: Medline; NIAID NIH HHS [N01 AI 85338, P30 AI 27767, U01 AI-067854, R21 AI 55380, R01 AI-06998, R01 AI-052775, R01 AI 058718, R01 AI 50529] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aghokeng AF, 2006, VIROLOGY, V345, P174, DOI 10.1016/j.virol.2005.09.046; Alexander L, 1999, J VIROL, V73, P5814, DOI 10.1128/JVI.73.7.5814-5825.1999; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bell I, 1998, J GEN VIROL, V79, P2717, DOI 10.1099/0022-1317-79-11-2717; Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DU ZJ, 1995, CELL, V82, P665, DOI 10.1016/0092-8674(95)90038-1; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Fortin JF, 2004, J BIOL CHEM, V279, P39520, DOI 10.1074/jbc.M407477200; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hirsch VM, 2004, AIDS REV, V6, P40; Howe AYM, 1998, J VIROL, V72, P9827, DOI 10.1128/JVI.72.12.9827-9834.1998; Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; KEELE BF, 2006, SCIENCE; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2004, J VIROL, V78, P6864, DOI 10.1128/JVI.78.13.6864-6874.2004; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LEITNER T, 2005, HIV SEQUENCE COMPEND; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MARLINK RG, 1988, AIDS RES HUM RETROV, V4, P137, DOI 10.1089/aid.1988.4.137; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Michel P, 2000, J INFECT DIS, V181, P64, DOI 10.1086/315170; Munch J, 2005, J VIROL, V79, P10547, DOI 10.1128/JVI.79.16.10547-10560.2005; Munch J, 2002, J VIROL, V76, P12360, DOI 10.1128/JVI.76.23.12360-12364.2002; PEPIN J, 1991, AIDS, V5, P1165, DOI 10.1097/00002030-199110000-00002; RAMBAUT A, 2003, TRACER V1 2; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Silvestri G, 2005, J MED PRIMATOL, V34, P243, DOI 10.1111/j.1600-0684.2005.00122.x; Skowronski J, 1999, COLD SPRING HARB SYM, V64, P453, DOI 10.1101/sqb.1999.64.453; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Wei BL, 2003, CURR HIV RES, V1, P41, DOI 10.2174/1570162033352057	50	312	321	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1055	1067		10.1016/j.cell.2006.04.033	http://dx.doi.org/10.1016/j.cell.2006.04.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777597	Bronze			2022-12-28	WOS:000238602700012
J	Weiss, E; Kislev, ME; Hartmann, A				Weiss, E; Kislev, ME; Hartmann, A			Autonomous cultivation before domestication	SCIENCE			English	Editorial Material							ORIGIN		Bar Ilan Univ, Dept Land Israel Studies & Archaeol, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Weiss, E (corresponding author), Bar Ilan Univ, Dept Land Israel Studies & Archaeol, IL-52900 Ramat Gan, Israel.	eweiss@mail.biu.ac.il	Weiss, Ehud/AAJ-3619-2020; Weiss, Ehud/F-2588-2016	Weiss, Ehud/0000-0002-9730-4726; Weiss, Ehud/0000-0002-9730-4726				Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Behre KE., 1992, VEG HIST ARCHAEOBOT, V1, P141; COLLEDGE S, 1998, ORIGINS AGR CROP DOM; GARFINKEL Y, 1988, ISRAEL J BOT, V37, P49; Hartmann A., UNPUB; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; Hillman G., 1978, ANATOL STUD, V28, P157, DOI [DOI 10.2307/3642748, 10.2307/3642748]; Kislev M.E., EARLY NEOLITHIC VILL, V43, P209; Kislev ME, 2006, SCIENCE, V312, P1372, DOI 10.1126/science.1125910; Kislev ME, 2002, ISRAEL J PLANT SCI, V50, pS85, DOI 10.1560/QV07-WYET-WPQ5-QRDC; LADIZINSKY G, 1987, ECON BOT, V41, P60, DOI 10.1007/BF02859349; Ladizinsky G, 1999, GENET RESOUR CROP EV, V46, P115, DOI 10.1023/A:1008626128871; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Smith B. D., 2006, RIVERS CHANGE; van ZEIST W., 1984, PALAEOHISTORIA, V26, P151; Willcox G, 2002, VEG HIST ARCHAEOBOT, V11, P55, DOI 10.1007/s003340200006; YELLIN J, 1997, EARLY NEOLITHIC VI 1, P193; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	18	195	201	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1608	1610		10.1126/science.1127235	http://dx.doi.org/10.1126/science.1127235			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778044				2022-12-28	WOS:000238288600032
J	Mougous, JD; Cuff, ME; Raunser, S; Shen, A; Zhou, M; Gifford, CA; Goodman, AL; Joachimiak, G; Ordonez, CL; Lory, S; Walz, T; Joachimiak, A; Mekalanos, JJ				Mougous, Joseph D.; Cuff, Marianne E.; Raunser, Stefan; Shen, Aimee; Zhou, Min; Gifford, Casey A.; Goodman, Andrew L.; Joachimiak, Grazyna; Ordonez, Claudia L.; Lory, Stephen; Walz, Thomas; Joachimiak, Andrzej; Mekalanos, John J.			A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus	SCIENCE			English	Article							ACUTE INFECTION; GENES; TRANSLOCATION; SYSTEM; CLPB; ICMF	Bacterial pathogens frequently use protein secretion to mediate interactions with their hosts. Here we found that a virulence locus (HSI-I) of Pseudomonas aeruginosa encodes a protein secretion apparatus. The apparatus assembled in discrete subcellular locations and exported Hcp1, a hexameric protein that forms rings with a 40 angstrom internal diameter. Regulatory patterns of HSI-I suggested that the apparatus functions during chronic infections. We detected Hcp1 in pulmonary secretions of cystic fibrosis (CF) patients and Hcp1-specific antibodies in their sera. Thus, HSI-I likely contributes to the pathogenesis of P. aeruginosa in CF patients. HSI-I-related loci are widely distributed among bacterial pathogens and may play a general role in mediating host interactions.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Argonne Natl Lab, Midw Ctr Struct Genom & Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Resp Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Cyst Fibrosis Ctr, Boston, MA 02115 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Chicago	Joachimiak, A (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	andrzejj@anl.gov; John_Mekalanos@hms.harvard.edu	Raunser, Stefan/AHE-1573-2022	Shen, Aimee/0000-0002-9786-5742; Raunser, Stefan/0000-0001-9373-3016; Gifford, Casey/0000-0002-7757-573X; Walz, Thomas/0000-0003-2606-2835	NIAID NIH HHS [R37 AI021451, AI26289, R01 AI026289, AI21451, R01 AI021451] Funding Source: Medline; NIGMS NIH HHS [U54 GM074942, GM074942, GM62414, P50 GM062414, P50 GM062414-02, U54 GM074942-04S2] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021451, R01AI021451, R01AI026289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, P50GM062414] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Das Soumita, 2003, In Silico Biology, V3, P287; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; VanRheenen SM, 2004, INFECT IMMUN, V72, P5972, DOI 10.1128/IAI.72.10.5972-5982.2004; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Williams SG, 1996, INFECT IMMUN, V64, P283, DOI 10.1128/IAI.64.1.283-289.1996; Yahr TL, 2004, MOL CELL, V16, P497, DOI 10.1016/j.molcel.2004.11.009; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004	17	761	815	9	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1526	1530		10.1126/science.1128393	http://dx.doi.org/10.1126/science.1128393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763151	Green Accepted			2022-12-28	WOS:000238124100049
J	Wadman, M				Wadman, M			Biochemist strikes gold	NATURE			English	News Item							MACULAR DEGENERATION; VISUAL CYCLE; RPE65; BINDING											Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Maiti P, 2005, BIOCHEMISTRY-US, V44, P14463, DOI 10.1021/bi0510779; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016	5	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					689	689		10.1038/441689a	http://dx.doi.org/10.1038/441689a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760950				2022-12-28	WOS:000238095100024
J	Buhl, J; Sumpter, DJT; Couzin, ID; Hale, JJ; Despland, E; Miller, ER; Simpson, SJ				Buhl, J; Sumpter, DJT; Couzin, ID; Hale, JJ; Despland, E; Miller, ER; Simpson, SJ			From disorder to order in marching locusts	SCIENCE			English	Article							SELF-PROPELLED PARTICLES; DESERT LOCUST; VEGETATION PATTERNS; PHASE-TRANSITION; DECISION-MAKING; ANIMAL GROUPS; GREGARIZATION; ENVIRONMENT; BEHAVIOR; MOTION	Recent models from theoretical physics have predicted that mass-migrating animal groups may share group-level properties, irrespective of the type of animals in the group. One key prediction is that as the density of animals in the group increases, a rapid transition occurs from disordered movement of individuals within the group to highly aligned collective motion. Understanding such a transition is crucial to the control of mobile swarming insect pests such as the desert locust. We confirmed the prediction of a rapid transition from disordered to ordered movement and identified a critical density for the onset of coordinated marching in locust nymphs. We also demonstrated a dynamic instability in motion at densities typical of locusts in the field, in which groups can switch direction without external perturbation, potentially facilitating the rapid transfer of directional information.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Oxford; University of Sydney; Princeton University	Buhl, J (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	jbuhl@usyd.edu.au	Despland, Emma/ABI-5924-2020; Buhl, Jerome/AAE-1687-2020; Couzin, Iain D./Q-6862-2018; BUHL, Jerome/B-6755-2008	Buhl, Jerome/0000-0002-7506-6835; Couzin, Iain D./0000-0001-8556-4558; Simpson, Stephen J./0000-0003-0256-7687				Collett M, 1998, P NATL ACAD SCI USA, V95, P13052, DOI 10.1073/pnas.95.22.13052; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Czirok A, 1997, J PHYS A-MATH GEN, V30, P1375, DOI 10.1088/0305-4470/30/5/009; Czirok A, 1999, PHYS REV LETT, V82, P209, DOI 10.1103/PhysRevLett.82.209; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Despland E, 2000, OIKOS, V88, P652, DOI 10.1034/j.1600-0706.2000.880322.x; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; Despland E, 2000, PHYSIOL ENTOMOL, V25, P74, DOI 10.1046/j.1365-3032.2000.00166.x; Ellis P.E., 1951, ANTILOCUST B, V7, P1; ELLIS PE, 1961, BEHAVIOUR, V20, P282; Enserink M, 2004, SCIENCE, V306, P1880, DOI 10.1126/science.306.5703.1880; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Huepe C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.168701; Kennedy J. S., 1945, TRANS ROY ENT SOC LONDON, V95, P247; Lorch PD, 2005, ECOL ENTOMOL, V30, P548, DOI 10.1111/j.0307-6946.2005.00725.x; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Reynolds C.W., 1987, ACM SIGGRAPH COMPUTE, V21, P25, DOI DOI 10.1145/37402.37406; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; SIMPSON SJ, IN PRESS J ORTHOPTER; Symmons P.M., 2001, DESERT LOCUST GUIDEL; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; UVAROV BP, 1977, GRASSHOPPER LOCUST H, V2; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	32	711	724	8	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1402	1406		10.1126/science.1125142	http://dx.doi.org/10.1126/science.1125142			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741126				2022-12-28	WOS:000237961600062
J	Sharon, E; Galun, M; Sharon, D; Basri, R; Brandt, A				Sharon, Eitan; Galun, Meirav; Sharon, Dahlia; Basri, Ronen; Brandt, Achi			Hierarchy and adaptivity in segmenting visual scenes	NATURE			English	Article								Finding salient, coherent regions in images is the basis for many visual tasks, and is especially important for object recognition. Human observers perform this task with ease, relying on a system in which hierarchical processing seems to have a critical role(1). Despite many attempts, computerized algorithms(2-5) have so far not demonstrated robust segmentation capabilities under general viewing conditions. Here we describe a new, highly efficient approach that determines all salient regions of an image and builds them into a hierarchical structure. Our algorithm, segmentation by weighted aggregation, is derived from algebraic multigrid solvers for physical systems(6), and consists of fine-to-coarse pixel aggregation. Aggregates of various sizes, which may or may not overlap, are revealed as salient, without predetermining their number or scale. Results using this algorithm are markedly more accurate and significantly faster ( linear in data size) than previous approaches.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Weizmann Inst Sci, Moross Lab Vis & Motor Control, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Harvard University; Massachusetts General Hospital; Weizmann Institute of Science	Sharon, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eitan.sharon@weizmann.ac.il						BRANDT A, 1986, APPL MATH COMPUT, V19, P23, DOI 10.1016/0096-3003(86)90095-0; Brandt A., 1984, SPARSITY ITS APPL, P257; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; GALUN M, 2003, P INT C COMPUT VISIO, V1, P469; Golub G. H., 1989, MATRIX COMPUTATIONS; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Malik J, 2001, INT J COMPUT VISION, V43, P7, DOI 10.1023/A:1011174803800; PIETIKAINEN M, 1982, PATTERN RECOGN, V15, P287, DOI 10.1016/0031-3203(82)90031-0; Sharon E, 2001, PROC CVPR IEEE, P469; Sharon E, 2000, PROC CVPR IEEE, P70, DOI 10.1109/CVPR.2000.855801; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; VOORHEES H, 1988, NATURE, V333, P364, DOI 10.1038/333364a0	17	161	184	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2006	442	7104					810	813		10.1038/nature04977	http://dx.doi.org/10.1038/nature04977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16810176				2022-12-28	WOS:000239792700045
J	du Toit, J; Hamilton, W; Barraclough, K				du Toit, Jennifer; Hamilton, William; Barraclough, Kevin			Risk in primary care of colorectal cancer from new onset rectal bleeding: 10 year prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE	Objective To measure the risk of colorectal cancer and adenoma with new onset rectal bleeding reported to primary care. Design Cohort study. Setting A rural general practice in the United Kingdom. Participants Patients aged 45 or more with new onset rectal bleeding, irrespective of other symptoms. Main outcome measures Percentage of participants in whom colorectal cancer or colonic adenoma was identified after investigation of the bowel. Results During a 10 year period, 265 patients reported new rectal bleeding. Of these, 15 (5.7%,95% confidence interval 3.2% to 9.2%) had colorectal cancer, and 13 (4.9%,2.6% to 8.4%) had colonic adenoma. Only two of the patients with cancer had had diarrhoea. Conclusions One in 10 patients aged 45 or more with new onset rectal bleeding had colonic neoplasia, so investigation of the bowel should be offered to all such patients, whether or not they have other symptoms.	Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1AU, Avon, England	University of Bristol	du Toit, J (corresponding author), Hoyland House, Painswick GL6 6RD, Glos, England.	kbarraclough@ehotspot.co.uk	Hamilton, Willie/G-8612-2014	Hamilton, William/0000-0003-1611-1373				*DEP HLTH, 2000, REF GUID SUSP CANC; Ellis BG, 2005, BRIT J GEN PRACT, V55, P949; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; *NICE, 2005, REF GUID SUSP CANC; Wauters H, 2000, BRIT MED J, V321, P998, DOI 10.1136/bmj.321.7267.998; 2003, UPDATE CANC TRENDS E	7	33	33	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2006	333	7558					69	70		10.1136/bmj.38846.684850.2F	http://dx.doi.org/10.1136/bmj.38846.684850.2F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16790459	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000239133200014
J	Gold, W; Ewing, K; Banks, J; Groom, M; Hinckley, T; Secord, D; Shebitz, D				Gold, Warren; Ewing, Kern; Banks, John; Groom, Martha; Hinckley, Tom; Secord, David; Shebitz, Daniela			Collaborative ecological restoration	SCIENCE			English	Editorial Material								Faculty and students at the University of Washington forge interdisciplinary partnerships with the regional community to restore damaged habitats.	Univ Washington, Interdisciplinary Arts & Sci Program, Bothell, WA 98011 USA; Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; Univ Washington, Program Environm, Seattle, WA 98195 USA; Univ Washington, Sch Marine Affairs, Seattle, WA 98195 USA; Univ Washington, Interdisciplinary Arts & Sci Program, Tacoma, WA 98402 USA	University of Washington; University of Washington Bothell; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Tacoma	Gold, W (corresponding author), Univ Washington, Interdisciplinary Arts & Sci Program, Bothell, WA 98011 USA.	wgoid@u.washington.edu	Banks, John E./AAN-2300-2020; Banks, John/D-4194-2012; Hinckley, Thomas M/F-9249-2010; Groom, Martha/AAF-4483-2021	Banks, John E./0000-0001-6793-7613; Hinckley, Thomas M/0000-0002-2821-6044; 				Bradshaw A.D., 1980, RESTORATION LAND; Hall M., 2005, EARTH REPAIR TRANSAT; Higgs E, 2005, RESTOR ECOL, V13, P159, DOI 10.1111/j.1526-100X.2005.00020.x; LEVENDED B, 1999, ECOL RESTOR, V17, P120; McManus P, 2006, AUST GEOGR, V37, P57, DOI 10.1080/00049180500511970; National Research Council, 2005, FAC INT RES; Society for Ecological Restoration, 2002, SER PRIM EC REST	7	19	23	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1880	1881		10.1126/science.1128088	http://dx.doi.org/10.1126/science.1128088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809514				2022-12-28	WOS:000238848100032
J	Markel, H				Markel, Howard			Dr Osler's relapsing fever	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Sch Med, Ctr Hist Med, Observ Simpson Mem Inst 102, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, Observ Simpson Mem Inst 102, Ann Arbor, MI 48109 USA.	howard@umich.edu						BILLINGS JS, 1990, DESCRIPTION J HOPKIN; BLISS M, 1999, W OSLER LIFE MED, P208; CHESNEY AM, 1943, J HOPKINS HOSP J HOP, V1; CUSHING H, 1925, LIFE W OSLER, V1, P378; ESTES JW, 1991, MED HIST, V35, P189, DOI 10.1017/S0025727300053485; *INT ASS MED MUS, 1926, B INT ASS MED MUS J, V9, P250; Markel Howard, 2004, GERMS TRAVEL 6 MAJOR; McGehee Harvey A, 1989, MODEL ITS KIND CENTE; Osler W., 1896, JAMA-J AM MED ASSOC, V26, P999, DOI 10.1001/jama.1896.02430730001001; PRATT JH, 1949, YEAR OSLER 1896 1897, V4, P199; SIGERIST H, 1971, GREAT DOCTORS, P329; Winslow, 1943, CONQUEST EPIDEMIC DI; Wunderlich C.A, 1870, VERHALTEN EIGENWARME; Zinsser Hans., 1935, RATS LICE HIST	14	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2886	2887		10.1001/jama.295.24.2886	http://dx.doi.org/10.1001/jama.295.24.2886			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057DY	16804156				2022-12-28	WOS:000238577700027
J	Collinge, J; Whitfield, J; McKintosh, E; Beck, J; Mead, S; Thomas, DJ; Alpers, MP				Collinge, John; Whitfield, Jerome; McKintosh, Edward; Beck, John; Mead, Simon; Thomas, Dafydd J.; Alpers, Michael P.			Kuru in the 21st century - an acquired human prion disease with very long incubation periods	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; PROTEIN GENE PRND; VARIANT; LOCI; MICE; SUSCEPTIBILITY; POLYMORPHISMS; IDENTIFICATION; TRANSMISSION	Background Kuru provides the principal experience of epidemic human prion disease. Its incidence has steadily fallen after the abrupt cessation of its route of transmission (endocannibalism) in Papua New Guinea in the 1950s. The onset of variant Creutzfeldt-Jakob disease (vCJD), and the unknown prevalence of infection after the extensive dietary exposure to bovine spongiform encephalopathy (BSE) prions in the UK, has led to renewed interest in kuru. We investigated possible incubation periods, pathogenesis, and genetic susceptibility factors in kuru patients in Papua New Guinea. Methods We strengthened active kuru surveillance in 1996 with an expanded field team to investigate all suspected patients. Detailed histories of residence and exposure to mortuary feasts were obtained together with serial neurological examination, if possible. Findings We identified 11 patients with kuru from July, 1996, to June, 2004, all living in the South Fore. All patients were born before the cessation of cannibalism in the late 1950s. The minimum estimated incubation periods ranged from 34 to 41 years. However, likely incubation periods in men ranged from 39 to 56 years and could have been up to 7 years longer. PRNP analysis showed that most patients with kuru were heterozygous at polymorphic codon 129, a genotype associated with extended incubation periods and resistance to prion disease. Interpretation Incubation periods of infection with human prions can exceed 50 years. In human infection with BSE prions, species-barrier effects, which are characteristic of cross-species transmission, would be expected to further increase the mean and range of incubation periods, compared with recycling of prions within species. These data should inform attempts to model variant CJD epidemiology.	UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Papua New Guinea Inst Med Res, Goroka, EHP, Papua N Guinea; Curtin Univ Technol, Ctr Int Hlth, Perth, WA 6001, Australia	University of London; University College London; University of London; University College London; PNG Institute Of Medical Research; Curtin University	Collinge, J (corresponding author), UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Mead, Simon/E-9414-2011	Mead, Simon/0000-0002-4326-1468	Medical Research Council [MC_U123160651, MC_U123192748, MC_U123160657] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U123160657, MC_U123160651] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALPERS M, 1987, P451; ALPERS MP, 1968, CENTRAL NERVOUS SYST, P234; Alpers MP., 1965, NINDB MONOGRAPH, V2, P65; AMOUYEL P, 1994, LANCET, V344, P1315, DOI 10.1016/S0140-6736(94)90691-2; BARLOW RM, 1990, VET REC, V126, P111; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Chapman J, 1998, NEUROLOGY, V51, P548, DOI 10.1212/WNL.51.2.548; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; d'Aignaux JNH, 2001, SCIENCE, V294, P1729, DOI 10.1126/science.1064748; Donnelly CA, 2002, P ROY SOC B-BIOL SCI, V269, P2179, DOI 10.1098/rspb.2002.2156; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Ghani AC, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-4; GLASSE R, 1967, T NEW YORK ACAD SCI, V29, P748, DOI 10.1111/j.2164-0947.1967.tb02298.x; HADLOW WJ, 1959, LANCET, V2, P289; Jackson GS, 2001, NATURE, V414, P269, DOI 10.1038/35104694; KLITZMAN R L, 1984, Neuroepidemiology, V3, P3, DOI 10.1159/000110837; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Lindenbaum S., 1979, KURU SORCERY DIS DAN; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Mead S, 2000, NEUROSCI LETT, V290, P117, DOI 10.1016/S0304-3940(00)01319-7; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2001, AM J HUM GENET, V69, P1225, DOI 10.1086/324710; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Peoc'h K, 2000, NEUROSCI LETT, V286, P144, DOI 10.1016/S0304-3940(00)01100-9; Pepys MB, 2003, LANCET, V361, P487, DOI 10.1016/S0140-6736(03)12455-5; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schroder B, 2001, HUM GENET, V109, P319, DOI 10.1007/s004390100591; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103	36	254	262	0	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2068	2074		10.1016/S0140-6736(06)68930-7	http://dx.doi.org/10.1016/S0140-6736(06)68930-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798390				2022-12-28	WOS:000238657400032
J	Mitchell, AJ				Mitchell, AJ			Depressed patients and treatment adherence	LANCET			English	Editorial Material							ANTIDEPRESSANT ADHERENCE; PHYSICIAN COMMUNICATION; PRIMARY-CARE; MEDICATION; ATTITUDES; PREDICTORS; DISORDERS; SYMPTOMS; BELIEFS		Leicester Gen Hosp, Dept Liaison Psychiat, Brandon Unit, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital	Mitchell, AJ (corresponding author), Leicester Gen Hosp, Dept Liaison Psychiat, Brandon Unit, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	alex.mitchell@leicspart.nhs.uk	Mitchell, Alex J/A-3090-2009; Mitchell, Alex J/P-5671-2015; Mitchell, Alex/Z-1920-2019	Mitchell, Alex J/0000-0001-6014-598X; Mitchell, Alex J/0000-0001-6014-598X; Mitchell, Alex/0000-0001-6014-598X				Aikens JE, 2005, GEN HOSP PSYCHIAT, V27, P229, DOI 10.1016/j.genhosppsych.2005.04.001; Aikens JE, 2005, ANN FAM MED, V3, P23, DOI 10.1370/afm.238; Althaus D, 2002, NERVENARZT, V73, P659, DOI 10.1007/s00115-002-1321-4; Ashton AK, 2005, CURR THER RES CLIN E, V66, P96, DOI 10.1016/j.curtheres.2005.04.006; Bambauer KZ, 2006, ARCH INTERN MED, V166, P498, DOI 10.1001/archinte.166.5.498; Beck CA, 2004, COMPR PSYCHIAT, V45, P268, DOI 10.1016/j.comppsych.2004.03.003; Brambilla P, 2005, PHARMACOPSYCHIATRY, V38, P69, DOI 10.1055/s-2005-837806; Bull SA, 2002, ANN PHARMACOTHER, V36, P578, DOI 10.1345/aph.1A254; Bull SA, 2002, JAMA-J AM MED ASSOC, V288, P1403, DOI 10.1001/jama.288.11.1403; Bultman DC, 2000, PATIENT EDUC COUNS, V40, P173, DOI 10.1016/S0738-3991(99)00083-X; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694; MADDOX JC, 1994, J PSYCHOPHARMACOL, V8, P48, DOI 10.1177/026988119400800108; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Olfson M, 2006, AM J PSYCHIAT, V163, P101, DOI 10.1176/appi.ajp.163.1.101; Paykel ES, 1998, BRIT J PSYCHIAT, V173, P519, DOI 10.1192/bjp.173.6.519; Pyne JM, 2005, PSYCHOL MED, V35, P839, DOI 10.1017/S0033291704003332; Sirey JA, 2001, PSYCHIAT SERV, V52, P1615, DOI 10.1176/appi.ps.52.12.1615; Sleath B, 2003, COMPR PSYCHIAT, V44, P198, DOI 10.1016/S0010-440X(03)00007-5; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097	20	27	28	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2041	2043		10.1016/S0140-6736(06)68902-2	http://dx.doi.org/10.1016/S0140-6736(06)68902-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	058HZ	16798371				2022-12-28	WOS:000238657400008
J	Cuvelier, A; Muir, JF				Cuvelier, A; Muir, JF			Venous air embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rouen Univ Hosp, F-76031 Rouen, France	CHU de Rouen	Cuvelier, A (corresponding author), Rouen Univ Hosp, F-76031 Rouen, France.		CUVELIER, Antoine/F-5965-2014	CUVELIER, Antoine/0000-0003-0263-1845					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					E26	E26		10.1056/NEJMicm050577	http://dx.doi.org/10.1056/NEJMicm050577			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790694				2022-12-28	WOS:000238416900009
J	Uno, K; Katagiri, H; Yamada, T; Ishigaki, Y; Ogihara, T; Imai, J; Hasegawa, Y; Gao, JH; Kaneko, K; Iwasaki, H; Ishihara, H; Sasano, H; Inukai, K; Mizuguchi, H; Asano, T; Shiota, M; Nakazato, M; Oka, Y				Uno, Kenji; Katagiri, Hideki; Yamada, Tetsuya; Ishigaki, Yasushi; Ogihara, Takehide; Imai, Junta; Hasegawa, Yutaka; Gao, Junhong; Kaneko, Keizo; Iwasaki, Hiroko; Ishihara, Hisamitsu; Sasano, Hironobu; Inukai, Kouichi; Mizuguchi, Hiroyuki; Asano, Tomoichiro; Shiota, Masakazu; Nakazato, Masamitsu; Oka, Yoshitomo			Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity	SCIENCE			English	Article							PPAR-GAMMA; GLUCOSE-HOMEOSTASIS; ADIPOSE-TISSUE; EXPRESSION; LEPTIN; MUSCLE; FAT; RESISTANCE; AGONIST; OBESITY	Coordinated control of energy metabolism and glucose homeostasis requires communication between organs and tissues. We identified a neuronal pathway that participates in the cross talk between the liver and adipose tissue. By studying a mouse model, we showed that adenovirus-mediated expression of peroxisome proliferator - activated receptor ( PPAR) - gamma 2 in the liver induces acute hepatic steatosis while markedly decreasing peripheral adiposity. These changes were accompanied by increased energy expenditure and improved systemic insulin sensitivity. Hepatic vagotomy and selective afferent blockage of the hepatic vagus revealed that the effects on peripheral tissues involve the afferent vagal nerve. Furthermore, an antidiabetic thiazolidinedione, a PPAR gamma agonist, enhanced this pathway. This neuronal pathway from the liver may function to protect against metabolic perturbation induced by excessive energy storage.	Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; Saitama Med Sch, Dept Internal Med 4, Moroyama, Saitama 3500495, Japan; Natl Inst Biomed Innovat, Lab Gene Transfer & Regulat, Osaka 5670085, Japan; Univ Tokyo, Dept Physiol Chem & Metab, Tokyo 1138655, Japan; Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan	Tohoku University; Tohoku University; Tohoku University; Saitama Medical University; National Institute of Health Sciences - Japan; University of Tokyo; Vanderbilt University; University of Miyazaki	Katagiri, H (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan.	katagiri@mail.tains.tohoku.ac.jp		Mizuguchi, Hiroyuki/0000-0003-0594-8178				An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bocher V, 2002, ANN NY ACAD SCI, V967, P7; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; Hatakeyama Y, 2004, AM J PHYSIOL-REG I, V287, pR336, DOI 10.1152/ajpregu.00131.2004; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hosono T, 2005, GENE, V348, P157, DOI 10.1016/j.gene.2005.01.005; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; WELLSTEIN A, 1986, J CARDIOVASC PHARM, V8, pS36; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001	25	185	200	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1656	1659		10.1126/science.1126010	http://dx.doi.org/10.1126/science.1126010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778057				2022-12-28	WOS:000238288600047
J	Nestle, M				Nestle, M			Food marketing and childhood obesity - A matter of policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY 10012 USA	New York University	Nestle, M (corresponding author), NYU, 550 1st Ave, New York, NY 10012 USA.							California Pan-Ethnic Health Network and Consumers Union, 2005, OUT BAL MARK SOD CAN; *CTR SCI PUBL INT, 2003, PEST PAR FOOD CO MAR; Koplan J., 2005, PREVENTING CHILDHOOD; McGinnis J.M., 2006, FOOD MARKETING CHILD	4	116	121	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2527	2529		10.1056/NEJMp068014	http://dx.doi.org/10.1056/NEJMp068014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052KU	16775233				2022-12-28	WOS:000238233400002
J	Triggs, WJ; Harris, NL; Menkes, DL; Cros, DP; Brown, RH				Triggs, WJ; Harris, NL; Menkes, DL; Cros, DP; Brown, RH			Case 18-2006: A 57-year-old woman with numbness and weakness of the feet and legs - Charcot-Marie-Tooth disease type 2, with Adie's pupil and a mutation in the MPZ gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEIN ZERO GENE; SENSORY NEUROPATHY; HEREDITARY MOTOR; PERIPHERAL NEUROPATHY; AXONAL NEUROPATHY; THR124MET; PHENOTYPE; PATHOLOGY; FEATURES; P0		Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Gainesville, FL USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Tennessee System; University of Tennessee Health Science Center	Triggs, WJ (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32611 USA.							BENOTHMANE K, 1993, GENOMICS, V17, P370; Boerkoel CF, 2002, ANN NEUROL, V51, P190, DOI 10.1002/ana.10089; Chapon F, 1999, J NEUROL NEUROSUR PS, V66, P779, DOI 10.1136/jnnp.66.6.779; CORNBLATH DR, 1990, ANN NEUROL, V27, pS17, DOI 10.1002/ana.410270706; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; DYCK PJ, 1994, ANN NEUROL, V35, P608, DOI 10.1002/ana.410350515; Elliott JL, 1997, NEUROLOGY, V48, P23, DOI 10.1212/WNL.48.1.23; England JD, 2004, LANCET, V363, P2151, DOI 10.1016/S0140-6736(04)16508-2; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HARRIMAN DG, 1968, BRAIN, V91, P401, DOI 10.1093/brain/91.3.401; Hattori N, 2003, BRAIN, V126, P134, DOI 10.1093/brain/awg012; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Kimura J, 2001, ELECTRODIAGNOSIS DIS; Klein CJ, 2004, J NEUROL SCI, V220, P141, DOI 10.1016/j.jns.2004.03.017; KWON JM, 1995, AM J HUM GENET, V57, P853; Leal A, 2003, NEUROGENETICS, V4, P191, DOI 10.1007/s10048-003-0153-0; LINDENBAUM J, 1990, AM J HEMATOL, V34, P99, DOI 10.1002/ajh.2830340205; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Marrosu MG, 1998, NEUROLOGY, V50, P1397, DOI 10.1212/WNL.50.5.1397; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Maurer M, 2002, J ANAT, V200, P405, DOI 10.1046/j.1469-7580.2002.00045.x; MILLER NR, 1982, WALSH HOYTS CLIN NEU, P492; Misu K, 2000, J NEUROL NEUROSUR PS, V69, P806, DOI 10.1136/jnnp.69.6.806; MIYASAKI JM, 1988, NEUROLOGY, V38, P262, DOI 10.1212/WNL.38.2.262; Novella SP, 2001, MUSCLE NERVE, V24, P1229, DOI 10.1002/mus.1137; Pareyson D, 2004, NEUROL SCI, V25, P72, DOI 10.1007/s10072-004-0233-4; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Runker AE, 2004, J CELL BIOL, V165, P565, DOI 10.1083/jcb.200402087; Senderek J, 2000, BRAIN PATHOL, V10, P235, DOI 10.1111/j.1750-3639.2000.tb00257.x; Shy ME, 2004, BRAIN, V127, P371, DOI 10.1093/brain/awh048; Teunissen LL, 1997, BRAIN, V120, P955, DOI 10.1093/brain/120.6.955; Thomas PK, 2005, PERIPHERAL NEUROPATH, V2, P1623; TIMMERMAN V, 1992, NAT GENET, V2, P84, DOI 10.1038/ng0992-84b; Watanabe M, 2002, NEUROLOGY, V59, P767, DOI 10.1212/WNL.59.5.767	36	6	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2584	2592		10.1056/NEJMcpc069009	http://dx.doi.org/10.1056/NEJMcpc069009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775239				2022-12-28	WOS:000238233400010
J	Brouwer, IA; Zock, PL; Camm, AJ; Bocker, D; Hauer, RNW; Wever, EFD; Dullemeijer, C; Ronden, JE; Katan, MB; Lubinski, A; Buschler, H; Schouten, EG				Brouwer, IA; Zock, PL; Camm, AJ; Bocker, D; Hauer, RNW; Wever, EFD; Dullemeijer, C; Ronden, JE; Katan, MB; Lubinski, A; Buschler, H; Schouten, EG		SOFA Study Grp	Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators - The Study on Omega-3 Fatty acids and ventricular Arrhythmia (SOFA) randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; SUDDEN CARDIAC DEATH; SERUM CHOLESTERYL ESTERS; CORONARY HEART-DISEASE; DIETARY-INTAKE; N-3; PREVENTION; RISK; FIBRILLATION; SUPPLEMENTATION	Context Very-long-chain n-3 polyunsaturated fatty acids (omega-3 PUFAs) from fish are thought to reduce risk of sudden death, possibly by reducing susceptibility to cardiac arrhythmia. Objective To study the effect of supplemental fish oil vs placebo on ventricular tachyarrhythmia or death. Design, Setting, and Patients The Study on Omega-3 Fatty acids and ventricular Arrhythmia ( SOFA) was a randomized, parallel, placebo-controlled, double-blind trial conducted at 26 cardiology clinics across Europe. A total of 546 patients with implantable cardioverter-defibrillators ( ICDs) and prior documented malignant ventricular tachycardia ( VT) or ventricular fibrillation ( VF) were enrolled between October 2001 and August 2004. Patients were randomly assigned to receive 2 g/d of fish oil ( n= 273) or placebo ( n= 273) for a median period of 356 days ( range, 14-379 days). Main Outcome Measure Appropriate ICD intervention for VT or VF, or all-cause death. Results The primary end point occurred in 81 ( 30%) patients taking fish oil vs 90 ( 33%) patients taking placebo ( hazard ratio [ HR], 0.86;95% confidence interval [ CI], 0.64-1.16; P=. 33). In prespecified subgroup analyses, the HR was 0.91 ( 95% CI, 0.661.26) for fish oil vs placebo in the 411 patients who had experienced VT in the year before the study, and 0.76 ( 95% CI, 0.52-1.11) for 332 patients with prior myocardial infarctions. Conclusion Our findings do not indicate evidence of a strong protective effect of intake of omega-3 PUFAs from fish oil against ventricular arrhythmia in patients with ICDs.	Wageningen Ctr Food Sci, NL-6703 HD Wageningen, Netherlands; Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; St Georges Hosp & Med Sch, Dept Cardiol Sci, London, England; Univ Klinikum Munster, Dept Cardiol, Munster, Germany; Heart Lung Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; Cardialysis BV, Rotterdam, Netherlands; Med Univ Gdansk, Dept Cardiovasc Dis, Gdansk, Poland; Herz & Diabeteszenturm Bad Oeynhausen, Dept Cardiol, Bad Oeynhausen, Germany	Wageningen University & Research; Wageningen University & Research; St Georges University London; University of Munster; Utrecht University; Utrecht University Medical Center; Cardialysis; Fahrenheit Universities; Medical University Gdansk	Brouwer, IA (corresponding author), Wageningen Ctr Food Sci, Bomenweg 2, NL-6703 HD Wageningen, Netherlands.	ingeborg.brouwer@wur.nl	Katan, Martijn/ABB-6613-2021	Brouwer, Ingeborg/0000-0002-8762-382X; Zock, Peter/0000-0002-0322-0565				Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; Billman GE, 1997, LIPIDS, V32, P1161, DOI 10.1007/s11745-997-0149-2; BILLMAN GE, 1994, P NATL ACAD SCI USA, V91, P4427, DOI 10.1073/pnas.91.10.4427; Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; Brouwer IA, 2003, EUR J CLIN NUTR, V57, P1323, DOI 10.1038/sj.ejcn.1601695; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Katan MB, 1997, J LIPID RES, V38, P2012; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Leaf A, 1996, J INTERN MED, V240, P5, DOI 10.1046/j.1365-2796.1996.449803000.x; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; LEAF A, 1993, AM J CLIN NUTR, V34, pS187; MCLENNAN PL, 1993, AM J CLIN NUTR, V58, P666, DOI 10.1093/ajcn/58.5.666; MCLENNAN PL, 1993, AM J CLIN NUTR, V57, P207, DOI 10.1093/ajcn/57.2.207; MCLENNAN PL, 1988, AM HEART J, V116, P709, DOI 10.1016/0002-8703(88)90328-6; McLennan PL, 2001, LIPIDS, V36, pS111, DOI 10.1007/s11745-001-0692-x; Pacifico A, 1999, NEW ENGL J MED, V340, P1855, DOI 10.1056/NEJM199906173402402; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Schrepf R, 2004, LANCET, V363, P1441, DOI 10.1016/S0140-6736(04)16105-9; Siscovick DS, 2000, AM J CLIN NUTR, V71, p208S, DOI 10.1093/ajcn/71.1.208S; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zock PL, 1997, AM J EPIDEMIOL, V145, P1114, DOI 10.1093/oxfordjournals.aje.a009074	29	223	292	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2613	2619		10.1001/jama.295.22.2613	http://dx.doi.org/10.1001/jama.295.22.2613			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772624	Bronze			2022-12-28	WOS:000238224000023
J	Eaton, L				Eaton, Lynn			Commentary: Green buildings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											No Org, London SE22 9AL, England.	lynn@lynneaton.co.uk						Stott R, 2006, BRIT MED J, V332, P1385, DOI 10.1136/bmj.332.7554.1385	1	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2006	332	7554					1389	1390		10.1136/bmj.332.7554.1389	http://dx.doi.org/10.1136/bmj.332.7554.1389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763257	Green Published			2022-12-28	WOS:000238587000028
J	Bondevik, S; Mangerud, J; Birks, HH; Gulliksen, S; Reimer, P				Bondevik, S; Mangerud, J; Birks, HH; Gulliksen, S; Reimer, P			Changes in North Atlantic radiocarbon reservoir ages during the Allerod and Younger Dryas	SCIENCE			English	Article							CAL KYR BP; LAST DEGLACIATION; MARINE SAMPLES; NORWEGIAN SEA; ICE CORES; C-14 AGES; VEDDE ASH; CALIBRATION; NORWAY; COAST	Estimates of the radiocarbon age of seawater are required in correlations between marine and terrestrial records of the late Quaternary climate. We radiocarbon-dated marine shells and terrestrial plant remains deposited in two bays on Norway's west coast between 11,000 and 14,000 years ago, a time of large and abrupt climatic changes that included the Younger Dryas (YD) cold episode. The radiocarbon age difference between the shells and the plants showed that sea surface reservoir ages increased from 400 to 600 years in the early YD, stabilized for 900 years, and dropped by 300 years within a century across the YD-Holocene transition.	Univ Tromso, Dept Geol, N-9037 Tromso, Norway; Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Univ Bergen, Dept Biol, N-5007 Bergen, Norway; Radiol Dating Lab, N-7034 Trondheim, Norway; Queens Univ Belfast, Sch Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland	UiT The Arctic University of Tromso; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; University of Bergen; Queens University Belfast	Bondevik, S (corresponding author), Univ Tromso, Dept Geol, N-9037 Tromso, Norway.	stein.bondevik@ig.uit.no	Reimer, Paula/I-5915-2015; Birks, Hilary H/C-1859-2008					Aure J., 1993, FISKEN HAV, V6, P1; AUSTIN WEN, 1995, RADIOCARBON, V37, P53, DOI 10.1017/S0033822200014788; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bjorck S, 2003, QUATERNARY SCI REV, V22, P429, DOI 10.1016/S0277-3791(03)00002-7; Bondevik S, 1999, QUATERNARY RES, V52, P104, DOI 10.1006/qres.1999.2048; Bondevik S, 2001, J QUATERNARY SCI, V16, P3, DOI 10.1002/1099-1417(200101)16:1<3::AID-JQS592>3.0.CO;2-G; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Deo JN, 2004, AM ANTIQUITY, V69, P771, DOI 10.2307/4128449; Forman SL, 1997, GEOPHYS RES LETT, V24, P885, DOI 10.1029/97GL00761; Friedrich M, 2004, RADIOCARBON, V46, P1111, DOI 10.1017/S003382220003304X; Gulliksen S, 1998, HOLOCENE, V8, P249, DOI 10.1191/095968398672301347; HAFLIDASON H, 1995, GEOLOGY, V23, P1059, DOI 10.1130/0091-7613(1995)023<1059:CROTLG>2.3.CO;2; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Klitgaard-Kristensen D, 2001, PALEOCEANOGRAPHY, V16, P455, DOI 10.1029/1999PA000495; Kromer B, 2004, RADIOCARBON, V46, P1203, DOI 10.1017/S0033822200033099; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; MANGERUD J, 1972, Boreas (Oslo), V1, P143; MANGERUD J, IN PRESS QUAT SCI RE; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rochon A, 1998, QUATERNARY RES, V49, P197, DOI 10.1006/qres.1997.1956; Siani G, 2001, SCIENCE, V294, P1917, DOI 10.1126/science.1063649; Southon J, 2004, RADIOCARBON, V46, P1239, DOI 10.1017/S0033822200033129; Stocker TF, 1996, PALEOCEANOGRAPHY, V11, P773, DOI 10.1029/96PA02640; STUIVER M, 1993, RADIOCARBON, V35, P137; STUIVER M, 1986, RADIOCARBON, V28, P980, DOI 10.1017/S0033822200060264; Waelbroeck C, 2001, NATURE, V412, P724, DOI 10.1038/35089060	27	143	146	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1514	1517		10.1126/science.1123300	http://dx.doi.org/10.1126/science.1123300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763147				2022-12-28	WOS:000238124100045
J	Crinion, J; Turner, R; Grogan, A; Hanakawa, T; Noppeney, U; Devlin, JT; Aso, T; Urayama, S; Fukuyama, H; Stockton, K; Usui, K; Green, DW; Price, CJ				Crinion, J.; Turner, R.; Grogan, A.; Hanakawa, T.; Noppeney, U.; Devlin, J. T.; Aso, T.; Urayama, S.; Fukuyama, H.; Stockton, K.; Usui, K.; Green, D. W.; Price, C. J.			Language control in the bilingual brain	SCIENCE			English	Article							PARKINSONS-DISEASE; CORTICAL-LESIONS; BASAL GANGLIA; SIGNAL CHANGE; FMRI; SENTENCES; WORDS; INDIVIDUALS; PROFICIENCY; APHASIA	How does the bilingual brain distinguish and control which language is in use? Previous functional imaging experiments have not been able to answer this question because proficient bilinguals activate the same brain regions irrespective of the language being tested. Here, we reveal that neuronal responses within the left caudate are sensitive to changes in the language or the meaning of words. By demonstrating this effect in populations of German-English and Japanese-English bilinguals, we suggest that the left caudate plays a universal role in monitoring and controlling the language in use.	UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Natl Ctr Neurol & Psychiat, Dept Cort Funct Disorders, Tokyo 1878502, Japan; Kyoto Univ, Human Brain Res Ctr, Kyoto 6068507, Japan; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Oxford, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; UCL, Dept Psychol, London WC1E 6BT, England	University of London; University College London; National Center for Neurology & Psychiatry - Japan; Kyoto University; Max Planck Society; University of Oxford; University of London; University College London	Price, CJ (corresponding author), UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England.	c.price@fil.ion.ucl.ac.uk	Devlin, Joseph T/C-1525-2008; Hanakawa, Takashi/A-6536-2011; Crinion, Jennifer/A-1992-2019	Crinion, Jennifer/0000-0001-8080-6562; Devlin, Joseph/0000-0001-9737-3070; Green, David/0000-0001-7152-1485; Noppeney, Uta/0000-0002-7697-2290; Price, Catherine/0000-0001-7448-4835	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abutalebi J, 2000, NEUROCASE, V6, P51, DOI 10.1093/neucas/6.1.51; BROWN RG, 1988, NEUROSCIENCE, V25, P363, DOI 10.1016/0306-4522(88)90246-1; Chee MWL, 2003, NEUROIMAGE, V18, P468, DOI 10.1016/S1053-8119(02)00019-8; Chee MWL, 2003, J COGNITIVE NEUROSCI, V15, P85, DOI 10.1162/089892903321107846; Chee MWL, 1999, NEURON, V23, P127, DOI 10.1016/S0896-6273(00)80759-X; Chee MWL, 2001, NEUROIMAGE, V13, P1155, DOI 10.1006/nimg.2001.0781; Chee MWL, 2000, NEUROIMAGE, V12, P392, DOI 10.1006/nimg.2000.0631; Copland D, 2003, J INT NEUROPSYCH SOC, V9, P1041, DOI 10.1017/S1355617703970081; Copland DA, 2000, CORTEX, V36, P601, DOI 10.1016/S0010-9452(08)70541-0; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hasegawa M, 2002, NEUROIMAGE, V15, P647, DOI 10.1006/nimg.2001.1001; Hernandez AE, 2001, NEUROIMAGE, V14, P510, DOI 10.1006/nimg.2001.0810; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Lucas TH, 2004, J NEUROSURG, V101, P449, DOI 10.3171/jns.2004.101.3.0449; Meschyan G, 2006, NEUROIMAGE, V29, P1135, DOI 10.1016/j.neuroimage.2005.08.055; Moretti R, 2001, PERCEPT MOTOR SKILL, V92, P803, DOI 10.2466/PMS.92.3.803-814; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; Mummery CJ, 1999, NEUROIMAGE, V9, P516, DOI 10.1006/nimg.1999.0434; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; Neely J. H., 1991, BASIC PROCESSES READ, P264; Perani D, 2005, CURR OPIN NEUROBIOL, V15, P202, DOI 10.1016/j.conb.2005.03.007; Price CJ, 1999, BRAIN, V122, P2221, DOI 10.1093/brain/122.12.2221; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Robles SG, 2005, J NEUROL NEUROSUR PS, V76, P940, DOI 10.1136/jnnp.2004.045948; Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559; Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Roux FE, 2004, BRAIN, V127, P1796, DOI 10.1093/brain/awh204; Vingerhoets G, 2003, NEUROIMAGE, V20, P2181, DOI 10.1016/j.neuroimage.2003.07.029; Wallesch, 1992, NEUROPSYCHOLOGICAL D, P7; Wallesch C-W., 1988, APHASIA, P256; Yeterian EH, 1998, J COMP NEUROL, V399, P384; Yokoyama S, 2006, NEUROIMAGE, V30, P570, DOI 10.1016/j.neuroimage.2005.09.066	37	366	371	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1537	1540		10.1126/science.1127761	http://dx.doi.org/10.1126/science.1127761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	050XT	16763154				2022-12-28	WOS:000238124100052
J	Katz, N; Ansmann, M; Bialczak, RC; Lucero, E; McDermott, R; Neeley, M; Steffen, M; Weig, EM; Cleland, AN; Martinis, JM; Korotkov, AN				Katz, N.; Ansmann, M.; Bialczak, Radoslaw C.; Lucero, Erik; McDermott, R.; Neeley, Matthew; Steffen, Matthias; Weig, E. M.; Cleland, A. N.; Martinis, John M.; Korotkov, A. N.			Coherent state evolution in a superconducting qubit from partial-collapse measurement	SCIENCE			English	Article							FLUX QUBIT; QUANTUM; DYNAMICS; CIRCUIT	Measurement is one of the fundamental building blocks of quantum-information processing systems. Partial measurement, where full wavefunction collapse is not the only outcome, provides a detailed test of the measurement process. We introduce quantum-state tomography in a superconducting qubit that exhibits high-fidelity single-shot measurement. For the two probabilistic outcomes of partial measurement, we find either a full collapse or a coherent yet nonunitary evolution of the state. This latter behavior explicitly confirms modern quantum-measurement theory and may prove important for error-correction algorithms in quantum computation.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Nanosyst Inst, Santa Barbara, CA 93106 USA; Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Riverside	Martinis, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	martinis@physics.ucsb.edu	Weig, Eva M/E-9973-2010; Cleland, Andrew/AAG-7581-2019	Weig, Eva M/0000-0003-4294-8601; Katz, Nadav/0000-0002-9264-078X				Ahn C, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052310; Bertet P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257002; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Cooper KB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180401; D'Ariano GM, 2003, ADV IMAG ELECT PHYS, V128, P205, DOI 10.1016/S1076-5670(03)80065-4; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Geremia JM, 2004, SCIENCE, V304, P270, DOI 10.1126/science.1095374; Korotkov AN, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115403; Lupascu A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127003; Martinis JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210503; MARTINIS JM, 1985, PHYS REV LETT, V55, P1543, DOI 10.1103/PhysRevLett.55.1543; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Oliver WD, 2005, SCIENCE, V310, P1653, DOI 10.1126/science.1119678; Schlosshauer M, 2004, REV MOD PHYS, V76, P1267, DOI 10.1103/RevModPhys.76.1267; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; STEFFEN M, IN PRESS COND MAT; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; You JQ, 2005, PHYS TODAY, V58, P42, DOI 10.1063/1.2155757	25	137	138	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1498	1500		10.1126/science.1126475	http://dx.doi.org/10.1126/science.1126475			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763142	Green Submitted			2022-12-28	WOS:000238124100040
J	Patten, C				Patten, C			Europe pays the price for spending less	NATURE			English	Editorial Material									Univ Oxford, Oxford OX1 2JD, England; Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Oxford; Newcastle University - UK	Patten, C (corresponding author), Univ Oxford, Oxford OX1 2JD, England.								0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					691	693		10.1038/441691a	http://dx.doi.org/10.1038/441691a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760956				2022-12-28	WOS:000238095100031
J	van de Lavoir, MC; Diamond, JH; Leighton, PA; Mather-Love, C; Heyer, BS; Bradshaw, R; Kerchner, A; Hooi, LT; Gessaro, TM; Swanberg, SE; Delany, ME; Etches, RJ				van de lavoir, Marie-Cecile; Diamond, Jennifer H.; Leighton, Philip A.; Mather-Love, Christine; Heyer, Babette S.; Bradshaw, Renee; Kerchner, Allyn; Hooi, Lisa T.; Gessaro, Terri M.; Swanberg, Susan E.; Delany, Mary E.; Etches, Robert J.			Germline transmission of genetically modified primordial germ cells	NATURE			English	Article							CHIMERIC CHICKENS; DOMESTIC-FOWL; EMBRYO; BLOOD	Primordial germ cells ( PGCs) are the precursors of sperm and eggs(1). In most animals, segregation of the germ line from the somatic lineages is one of the earliest events in development(2); in avian embryos, PGCs are first identified in an extra-embryonic region, the germinal crescent, after approximately 18 h of incubation. After 50-55 h of development, PGCs migrate to the gonad and subsequently produce functional sperm and oocytes(3,4). So far, cultures of PGCs that remain restricted to the germ line have not been reported in any species(5,6). Here we show that chicken PGCs can be isolated, cultured and genetically modified while maintaining their commitment to the germline. Furthermore, we show that chicken PGCs can be induced in vitro to differentiate into embryonic germ cells that contribute to somatic tissues. Retention of the commitment of PGCs to the germ line after extended periods in culture and after genetic modification combined with their capacity to acquire somatic competence in vitro provides a new model for developmental biology. The utility of the model is enhanced by the accessibility of the avian embryo, which facilitates access to the earliest stages of development and supplies a facile route for the reintroduction of PGCs into the embryonic vasculature. In addition, these attributes create new opportunities to manipulate the genome of chickens for agricultural and pharmaceutical applications.	Origen Therapeut, Burlingame, CA 94010 USA; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Etches, RJ (corresponding author), Origen Therapeut, 1450 Rollins Rd, Burlingame, CA 94010 USA.	retches@origentherapeutics.com		Swanberg, Susan/0000-0001-7487-7065				BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; FUJIMOTO T, 1976, DEV BIOL, V49, P278, DOI 10.1016/0012-1606(76)90273-6; Halfter W, 1996, DEVELOPMENT, V122, P915; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KODAMA H, 1987, CHROMOSOMA, V96, P18, DOI 10.1007/BF00285878; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; MCLAREN A, 1992, NATURE, V359, P482, DOI 10.1038/359482a0; Naito M, 1999, J REPROD FERTIL, V117, P291, DOI 10.1530/jrf.0.1170291; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Petitte J.N., 2004, HDB STEM CELLS, P471; ROWLETT K, 1987, BRIT POULTRY SCI, V28, P91, DOI 10.1080/00071668708416940; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Sutasurya L. A., 1979, PRIMORDIAL GERM CELL; Swift CH, 1914, AM J ANAT, V15, P483, DOI DOI 10.1002/AJA.1000150404; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; van de Lavoir MC, 2006, MECH DEVELOP, V123, P31, DOI 10.1016/j.mod.2005.10.002; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	22	302	339	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					766	769		10.1038/nature04831	http://dx.doi.org/10.1038/nature04831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760981				2022-12-28	WOS:000238095100058
J	Victora, CG; Barros, FC				Victora, CG; Barros, FC			Beware: unnecessary caesarean sections may be hazardous	LANCET			English	Editorial Material							MORTALITY; DELIVERY; BRAZIL; TRIAL; RATES		Univ Fed Pelotas, BR-96001970 Pelotas, Brazil; WHO, Latin Amer Ctr Perinatol Women & Reprod Hlth, PAHO, Montevideo, Uruguay	Universidade Federal de Pelotas; World Health Organization	Victora, CG (corresponding author), Univ Fed Pelotas, BR-96001970 Pelotas, Brazil.	cvictora@terra.com.br	Barros, Fernando C/D-4857-2013; Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180				Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4; BARROS FC, 1991, LANCET, V338, P167, DOI 10.1016/0140-6736(91)90149-J; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Hall MH, 1999, LANCET, V354, P776, DOI 10.1016/S0140-6736(05)76016-5; HEMMINKI E, 1991, J EPIDEMIOL COMMUN H, V45, P24, DOI 10.1136/jech.45.1.24; Henderson J, 2001, BRIT J OBSTET GYNAEC, V108, P149; Lavender T, 2005, BMJ-BRIT MED J, V331, P490, DOI 10.1136/bmj.38560.572639.3A; MILLER JM, 1988, OBSTET GYN CLIN N AM, V15, P629; *ROYAL COLL OBST G, 2001, WHY MOTH DIE 1997 19; Royal College of Obstetricians and Gynaecologists, 2004, WHY MOTH DIE 2000 20; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Walker R, 2002, BIRTH-ISS PERINAT C, V29, P28, DOI 10.1046/j.1523-536X.2002.00153.x; *WHO, 2005, WHO HLTH REP 2005 MA	14	36	37	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1796	1797		10.1016/S0140-6736(06)68780-1	http://dx.doi.org/10.1016/S0140-6736(06)68780-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753467				2022-12-28	WOS:000238194200005
J	Barnetson, RA; Tenesa, A; Farrington, SM; Nicholl, ID; Cetnarskyj, R; Porteous, ME; Campbell, H; Dunlop, MG				Barnetson, Rebecca A.; Tenesa, Albert; Farrington, Susan M.; Nicholl, Iain D.; Cetnarskyj, Roseanne; Porteous, Mary E.; Campbell, Harry; Dunlop, Malcolm G.			Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; TUMOR MICROSATELLITE-INSTABILITY; MSH6 GERMLINE MUTATIONS; FAMILY-HISTORY; LYNCH-SYNDROME; YOUNG-PATIENTS; HMLH1; HMSH2; RISK; SUSCEPTIBILITY	BACKGROUND: The identification of mutations in germ-line DNA mismatch-repair genes at the time of diagnosis of colorectal cancer is important in the management of the disease. METHODS: Without preselection and regardless of family history, we recruited 870 patients under the age of 55 years soon after they received a diagnosis of colorectal cancer. We studied these patients for germ-line mutations in the DNA mismatch-repair genes MLH1, MSH2, and MSH6 and developed a two-stage model by multivariate logistic regression for the prediction of the presence of mutations in these genes. Stage 1 of the model incorporated only clinical variables; stage 2 comprised analysis of the tumor by immunohistochemical staining and tests for microsatellite instability. The model was validated in an independent population of patients. We analyzed 2938 patient-years of follow-up to determine whether genotype influenced survival. RESULTS: There were 38 mutations among the 870 participants (4 percent): 15 mutations in MLH1, 16 in MSH2, and 7 in MSH6. Carrier frequencies in men (6 percent) and women (3 percent) differed significantly (P<0.04). The addition of immunohistochemical analysis in stage 2 of the model had a sensitivity of 62 percent and a positive predictive value of 80 percent. There were 35 mutations in the validation series of 155 patients (23 percent): 19 mutations in MLH1, 13 in MSH2, and 3 in MSH6. The performance of the model was robust among a wide range of cutoff probabilities and was superior to that of the Bethesda and Amsterdam criteria for hereditary nonpolyposis colorectal cancer. Survival among carriers was not significantly different from that among noncarriers. CONCLUSIONS: We devised and validated a method of identifying patients with colorectal cancer who are carriers of mutations in DNA repair genes. Survival was similar among carriers and noncarriers.	Univ Edinburgh, Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Sch Mol & Clin Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; Western Gen Hosp, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; Wolverhampton Univ, Sch Appl Sci, Res Inst Healthcare Sci, Wolverhampton, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Wolverhampton	Dunlop, MG (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	malcolm.dunlop@hgu.mrc.ac.uk	Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/Q-2710-2019; Campbell, Harry/E-2959-2010; Farrington, Susan M/C-7319-2013	Dunlop, Malcolm G/0000-0002-3033-5851; Farrington, Susan M/0000-0001-5955-7389; Campbell, Harry/0000-0002-6169-6262; Tenesa, Albert/0000-0003-4884-4475	MRC [MC_U127527198] Funding Source: UKRI; Medical Research Council [MC_U127527198] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Aarnio M, 1998, ANN MED, V30, P75, DOI 10.3109/07853899808999387; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Bertario L, 1999, INT J CANCER, V80, P183, DOI 10.1002/(SICI)1097-0215(19990118)80:2<183::AID-IJC4>3.0.CO;2-W; Boland CR, 1998, CANCER RES, V58, P5248; Bubb VJ, 1996, ONCOGENE, V12, P2641; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; *COL CANC GEN GROU, 2006, PRED DNA MISM REP GE; Croitoru ME, 2004, JNCI-J NATL CANCER I, V96, P1631, DOI 10.1093/jnci/djh288; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Dunlop MG, 2000, BRIT J CANCER, V83, P1643, DOI 10.1054/bjoc.2000.1520; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; KEE F, 1991, GUT, V32, P513, DOI 10.1136/gut.32.5.513; Kim JC, 2001, CANCER DETECT PREV, V25, P503; Kolodner RD, 1999, CANCER RES, V59, P5068; Lin KM, 1998, DIS COLON RECTUM, V41, P428, DOI 10.1007/BF02235755; Lipkin SM, 2004, NAT GENET, V36, P694, DOI 10.1038/ng1374; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; LOTHE RA, 1993, CANCER RES, V53, P5849; Lynch HT, 2005, NEW ENGL J MED, V352, P1920, DOI 10.1056/NEJMe058058; Millar AL, 1999, HUM MOL GENET, V8, P823, DOI 10.1093/hmg/8.5.823; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Sankila R, 1996, GASTROENTEROLOGY, V110, P682, DOI 10.1053/gast.1996.v110.pm8608876; SLATTERY ML, 1995, INT J EPIDEMIOL, V24, P888, DOI 10.1093/ije/24.5.888; Southey MC, 2005, J CLIN ONCOL, V23, P6524, DOI 10.1200/JCO.2005.04.671; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Watson P, 1998, CANCER, V83, P259, DOI 10.1002/(SICI)1097-0142(19980715)83:2<259::AID-CNCR9>3.0.CO;2-L; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	40	330	342	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2751	2763		10.1056/NEJMoa053493	http://dx.doi.org/10.1056/NEJMoa053493			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807412				2022-12-28	WOS:000238584700003
J	Baroni, SS; Santillo, M; Bevilacqua, F; Luchetti, M; Spadoni, T; Mancini, M; Fraticelli, P; Sambo, P; Funaro, A; Kazlauskas, A; Avvedimento, EV; Gabrielli, A				Baroni, Silvia Svegliati; Santillo, Mariarosaria; Bevilacqua, Federica; Luchetti, Michele; Spadoni, Tatiana; Mancini, Matteo; Fraticelli, Paolo; Sambo, Paola; Funaro, Ada; Kazlauskas, Andrius; Avvedimento, Enrico V.; Gabrielli, Armando			Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR; FIBROBLAST PHENOTYPE; REVISED CRITERIA; SCLERODERMA; CLASSIFICATION; GENERATION; OXIDATION	Background: Systemic sclerosis (scleroderma) is characterized by immunologic abnormalities, injury of endothelial cells, and tissue fibrosis. Abnormal oxidative stress has been documented in scleroderma and linked to fibroblast activation. Since platelet-derived growth factor (PDGF) stimulates the production of reactive oxygen species (ROS) and since IgG from patients with scleroderma reacts with human fibroblasts, we tested the hypothesis that patients with scleroderma have serum autoantibodies that stimulate the PDGF receptor (PDGFR), activating collagen-gene expression. Methods: We analyzed serum from 46 patients with scleroderma and 75 controls, including patients with other autoimmune diseases, for stimulatory autoantibodies to PDGFR by measuring the production of ROS produced by the incubation of purified IgG with mouse-embryo fibroblasts carrying inactive copies of PDGFR (alpha) or (beta) chains or the same cells expressing PDGFR (alpha) or (beta). Generation of ROS was assayed with and without specific PDGFR inhibitors. Antibodies were characterized by immunoprecipitation, immunoblotting, and absorption experiments. Results: Stimulatory antibodies to the PDGFR were found in all the patients with scleroderma. The antibodies recognized native PDGFR, inducing tyrosine phosphorylation and ROS accumulation. Autoantibody activity was abolished by preincubation with cells expressing the PDGFR (alpha) chain or with recombinant PDGFR or by PDGFR tyrosine kinase inhibitors. Stimulatory PDGFR antibodies selectively induced the Ha-Ras-ERK1/2 and ROS cascades and stimulated type I collagen-gene expression and myofibroblast phenotype conversion in normal human primary fibroblasts. Conclusions: Stimulatory autoantibodies against PDGFR appear to be a specific hallmark of scleroderma. Their biologic activity on fibroblasts strongly suggests that they have a causal role in the pathogenesis of the disease.	Univ Politecn Marche, Dipartimento Sci Med & Chirurg, Sez Clin Med, I-60020 Ancona, Italy; Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA; Univ Turin, Dipartimento Genet Biol & Biochim, Turin, Italy; Univ Turin, Res Ctr Expt Med, Turin, Italy; Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare, CNR, Ctr Endocrinol & Oncol Sperimentale, Naples, Italy; Univ Naples Federico II, Sez Fisiol, Naples, Italy	Marche Polytechnic University; Harvard University; Harvard Medical School; Schepens Eye Research Institute; University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Naples Federico II	Gabrielli, A (corresponding author), Univ Politecn Marche, Dipartimento Sci Med & Chirurg, Sez Clin Med, Polo Didattico,Via Tronto 10, I-60020 Ancona, Italy.	avvedim@unina.it; a.gabrielli@univpm.it	Svegliati, Silvia/L-2614-2016; Gabrielli, Armando/AAC-3173-2019; Funaro, Ada/AAC-3203-2019; Luchetti, Michele Maria/J-6955-2019; fraticelli, paolo/AAN-1803-2020	Svegliati, Silvia/0000-0001-6863-2600; Luchetti, Michele Maria/0000-0001-9132-7401; Fraticelli, Paolo/0000-0001-8220-9593; Funaro, Ada/0000-0001-6341-1817	NATIONAL EYE INSTITUTE [R01EY012509] Funding Source: NIH RePORTER; NEI NIH HHS [EY012509] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Black CM, 1993, OXFORD TXB RHEUMATOL, P771; BRUCKDORFER KR, 1995, ARTHRITIS RHEUM-US, V38, P1060, DOI 10.1002/art.1780380807; CasciolaRosen L, 1997, J EXP MED, V185, P71, DOI 10.1084/jem.185.1.71; Chizzolini C, 2002, ARTHRITIS RHEUM-US, V46, P1602, DOI 10.1002/art.10361; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; LEROY EC, 1988, J RHEUMATOL, V15, P202; LEROY EC, 1992, CLIN EXP RHEUMATOL, V10, P485; POLLARD TD, 2004, CELL BIOL, P394; Sambo P, 2001, ARTHRITIS RHEUM-US, V44, P2653, DOI 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1; Sambo P, 1999, J INVEST DERMATOL, V112, P78, DOI 10.1046/j.1523-1747.1999.00476.x; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; Stein CM, 1996, ARTHRITIS RHEUM-US, V39, P1146, DOI 10.1002/art.1780390711; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200	19	439	457	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2667	2676						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790699				2022-12-28	WOS:000238416900005
J	Winer, RL; Hughes, JP; Feng, QH; O'Reilly, S; Kiviat, NB; Holmes, KK; Koutsky, LA				Winer, Rachel L.; Hughes, James P.; Feng, Qinghua; O'Reilly, Sandra; Kiviat, Nancy B.; Holmes, King K.; Koutsky, Laura A.			Condom use and the risk of genital human papillomavirus infection in young women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	16th Biennial Meeting of the International-Society-for-Sexually-Transmitted-Diseases-Research	JUL 10-13, 2005	Amsterdam, NETHERLANDS	Int Soc Sexually Transmitted Dis Res			NATURAL-HISTORY; CERVICAL-CANCER; PREVALENCE; CLASSIFICATION; NEOPLASIA; BEHAVIOR; SEX	Background: To evaluate whether the use of male condoms reduces the risk of male-to-female transmission of human papillomavirus (HPV) infection, longitudinal studies explicitly designed to evaluate the temporal relationship between condom use and HPV infection are needed. Methods: We followed 82 female university students who reported their first intercourse with a male partner either during the study period or within two weeks before enrollment. Cervical and vulvovaginal samples for HPV DNA testing and Papanicolaou testing were collected at gynecologic examinations every four months. Every two weeks, women used electronic diaries to record information about their daily sexual behavior. Cox proportional-hazards models were used to evaluate risk factors for HPV infection. Results: The incidence of genital HPV infection was 37.8 per 100 patient-years at risk among women whose partners used condoms for all instances of intercourse during the eight months before testing, as compared with 89.3 per 100 patient-years at risk in women whose partners used condoms less than 5 percent of the time (adjusted hazard ratio, 0.3; 95 percent confidence interval, 0.1 to 0.6, adjusted for the number of new partners and the number of previous partners of the male partner). Similar associations were observed when the analysis was restricted to high-risk and low-risk types of HPV and HPV types 6, 11, 16, and 18. In women reporting 100 percent condom use by their partners, no cervical squamous intraepithelial lesions were detected in 32 patient-years at risk, whereas 14 incident lesions were detected during 97 patient-years at risk among women whose partners did not use condoms or used them less consistently. Conclusions: Among newly sexually active women, consistent condom use by their partners appears to reduce the risk of cervical and vulvovaginal HPV infection.	Univ Washington, HPV Res Grp, Dept Epidemiol, Seattle, WA 98103 USA; Univ Washington, Dept Biostat, Seattle, WA 98103 USA; Univ Washington, Dept Pathol, Seattle, WA 98103 USA; Univ Washington, Ctr AIDS & STD, Seattle, WA 98103 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Winer, RL (corresponding author), Univ Washington, HPV Res Grp, Dept Epidemiol, Lake Union Pl,Suite 300,1914 N 34th St, Seattle, WA 98103 USA.	rlw@u.washington.edu	, Holmes/K-6215-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140] Funding Source: NIH RePORTER; NIAID NIH HHS [T32-AI007140-24] Funding Source: Medline; PHS HHS [R01-A138383] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baer A, 2002, EPIDEMIOLOGY, V13, P640, DOI 10.1097/00001648-200211000-00007; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Christopher A, 2004, J NATL CANCER I, V96, P985, DOI 10.1093/jnci/96.13.985; DAVIDSON M, 1994, J INFECT DIS, V169, P792, DOI 10.1093/infdis/169.4.792; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DOVER R, 1993, DERMATOLOGY GEN MED, V1, P165; GREER CE, 1995, J CLIN MICROBIOL, V33, P2058, DOI 10.1128/JCM.33.8.2058-2063.1995; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Ho GYF, 1998, INT J CANCER, V78, P281, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt;281::AID-IJC3&gt;3.0.CO;2-R; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; JAMISON JH, 1995, SEX TRANSM DIS, V22, P236, DOI 10.1097/00007435-199507000-00007; Kjaer SK, 2000, SEX TRANSM DIS, V27, P438, DOI 10.1097/00007435-200009000-00003; KJAER SK, 1991, INT J CANCER, V48, P39; Kjaer SK, 1997, CANCER EPIDEM BIOMAR, V6, P799; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; KURMAN RJ, 1994, JAMA-J AM MED ASSOC, V271, P1866, DOI 10.1001/jama.271.23.1866; LOCKE SE, 1992, JAMA-J AM MED ASSOC, V268, P1301, DOI 10.1001/jama.268.10.1301; Marrazzo JM, 1998, J INFECT DIS, V178, P1604, DOI 10.1086/314494; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Paz-Bailey G, 2005, ARCH PEDIAT ADOL MED, V159, P536, DOI 10.1001/archpedi.159.6.536; Peterman TA, 2000, SEX TRANSM DIS, V27, P446, DOI 10.1097/00007435-200009000-00004; SHAFII T, IN PRESS AM J PUBLIC; SPARROW MJ, 1994, CONTRACEPTION, V50, P117, DOI 10.1016/0010-7824(94)90048-5; Thomas DB, 1996, AM J EPIDEMIOL, V143, P779, DOI 10.1093/oxfordjournals.aje.a008815; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Wang PD, 1996, GYNECOL ONCOL, V62, P10, DOI 10.1006/gyno.1996.0183; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Winer RL, 2003, AM J EPIDEMIOL, V157, P859; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Young TK, 1997, SEX TRANSM DIS, V24, P293, DOI 10.1097/00007435-199705000-00011; ZENILMAN JM, 1995, SEX TRANSM DIS, V22, P15, DOI 10.1097/00007435-199501000-00003	37	417	453	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2645	2654		10.1056/NEJMoa053284	http://dx.doi.org/10.1056/NEJMoa053284			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	054ZJ	16790697				2022-12-28	WOS:000238416900003
J	Deeks, SG				Deeks, Steven G.			The risk of treatment versus the risk of HIV replication	LANCET			English	Editorial Material							TREATMENT INTERRUPTION; ADULTS; TRIAL		San Francisco Gen Hosp, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center	Deeks, SG (corresponding author), San Francisco Gen Hosp, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu						ANANWORANICH J, 2006, 13 C RETR OPP INF DE, P102; [Anonymous], 13 C RETR OPP INF DE; Cardiello PG, 2005, CLIN INFECT DIS, V40, P594, DOI 10.1086/427695; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Levy AR, 2006, LANCET INFECT DIS, V6, P171, DOI 10.1016/S1473-3099(06)70413-3; Maggiolo F, 2004, AIDS, V18, P439, DOI 10.1097/00002030-200402200-00010; Panel on Clinical Practices for the Treatment of HIV Infection and DHHS Guidelines, 2006, GUID US ANT AG HIV I	8	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					1955	1956		10.1016/S0140-6736(06)68857-0	http://dx.doi.org/10.1016/S0140-6736(06)68857-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782465				2022-12-28	WOS:000238488900004
J	Deplancke, B; Mukhopadhyay, A; Ao, WY; Elewa, AM; Grove, CA; Martinez, NJ; Sequerra, R; Doucette-Stamm, L; Reece-Hoyes, JS; Hope, IA; Tissenbaum, HA; Mango, SE; Walhout, AJM				Deplancke, Bart; Mukhopadhyay, Arnab; Ao, Wanyuan; Elewa, Ahmed M.; Grove, Christian A.; Martinez, Natalia J.; Sequerra, Reynaldo; Doucette-Stamm, Lynn; Reece-Hoyes, John S.; Hope, Ian A.; Tissenbaum, Heidi A.; Mango, Susan E.; Walhout, Albertha J. M.			A gene-centered C. elegans protein-DNA interaction network	CELL			English	Article							CAENORHABDITIS-ELEGANS; TRANSCRIPTIONAL REGULATION; BINDING SPECIFICITIES; REGULATORY NETWORKS; GENOMIC ANALYSIS; LIFE-SPAN; EXPRESSION; RESOURCE; COMPLEX; TARGETS	Transcription regulatory networks consist of physical and functional interactions between transcription factors (TFs) and their target genes. The systematic mapping of TF-target gene interactions has been pioneered in unicellular systems, using "TF-centered" methods (e.g., chromatin immunoprecipitation). However, metazoan systems are less amenable to such methods. Here, we used "gene-centered" high-throughput yeast one-hybrid (Y1 H) assays to identify 283 interactions between 72 C. elegans digestive tract gene promoters and 117 proteins. The resulting protein-DNA interaction (PDI) network is highly connected and enriched for TFs that are expressed in the digestive tract. We provide functional annotations for similar to 10% of all worm TFs, many of which were previously uncharacterized, and find ten novel putative TFs, illustrating the power of a gene-centered approach. We provide additional in vivo evidence for multiple PDIs and illustrate how the PDI network provides insights into metazoan differential gene expression at a systems level.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Univ Leeds, Sch Biol, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Leeds	Deplancke, B (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu	Deplancke, Bart/B-3250-2008; Hope, Ian/M-4186-2018; Reece-Hoyes, John/B-2321-2008; Mukhopadhyay, Arnab/N-6005-2016; Rosa, Bruce/F-6393-2010	Hope, Ian/0000-0002-8990-3163; Mukhopadhyay, Arnab/0000-0002-5266-7849; Elewa, Ahmed/0000-0002-1988-7970; Mango, Susan/0000-0002-2146-3237; Reece-Hoyes, John/0000-0001-5251-5813; Deplancke, Bart/0000-0001-9935-843X; Grove, Christian/0000-0001-9076-6015; Walhout, Marian/0000-0001-5587-3608	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025891] Funding Source: NIH RePORTER; NIA NIH HHS [AG025891] Funding Source: Medline; NIDDK NIH HHS [DK068429] Funding Source: Medline; NIGMS NIH HHS [R01 GM056264-08, R01 GM056264-10, R01 GM056264, R01 GM056264-09, GM056246, R01 GM056264-08S1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Davidson E, 2005, P NATL ACAD SCI USA, V102, P4935, DOI 10.1073/pnas.0502024102; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Gaudet J, 2004, PLOS BIOL, V2, P1828, DOI 10.1371/journal.pbio.0020352; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Labouesse M, 1999, TRENDS GENET, V15, P307, DOI 10.1016/S0168-9525(99)01750-3; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maduro MF, 2002, DEV BIOL, V246, P68, DOI 10.1006/dbio.2002.0655; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2003, CURR BIOL, V13, pR279, DOI 10.1016/S0960-9822(03)00201-X; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Thatcher JD, 1999, DEVELOPMENT, V126, P97; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008	48	168	194	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1193	1205		10.1016/j.cell.2006.04.038	http://dx.doi.org/10.1016/j.cell.2006.04.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777607	Bronze			2022-12-28	WOS:000238602700022
J	Graham, RK; Deng, Y; Slow, EJ; Haigh, B; Bissada, N; Lu, G; Pearson, J; Shehadeh, J; Bertram, L; Murphy, Z; Warby, SC; Doty, CN; Roy, S; Wellinpton, CL; Leavitt, BR; Raymond, LA; Nicholson, DW; Hayden, MR				Graham, Rona K.; Deng, Yu; Slow, Elizabeth J.; Haigh, Brendan; Bissada, Nagat; Lu, Ge; Pearson, Jacqueline; Shehadeh, Jacqueline; Bertram, Lisa; Murphy, Zoe; Warby, Simon C.; Doty, Crystal N.; Roy, Sophie; Wellinpton, Cheryl L.; Leavitt, Blair R.; Raymond, Lynn A.; Nicholson, Donald W.; Hayden, Michael R.			Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin	CELL			English	Article							YAC128 MOUSE MODEL; WILD-TYPE HUNTINGTIN; INTRANUCLEAR INCLUSIONS; NUCLEAR-LOCALIZATION; 3-NITROPROPIONIC ACID; REDUCES TOXICITY; IN-VIVO; DISEASE; MICE; NEURODEGENERATION	Cleavage of huntingtin (htt) has been characterized in vitro, and accumulation of caspase cleavage fragments represents an early pathological change in brains of Huntington's disease (HD) patients. However, the relationship between htt proteolysis and the pathogenesis of HD is unknown. To determine whether caspase cleavage of htt is a key event in the neuronal dysfunction and selective neurodegeneration in HID, we generated YAC mice expressing caspase-3- and caspase-6- resistant mutant htt. Mice expressing mutant htt, resistant to cleavage by caspase-6 but not caspase-3, maintain normal neuronal function and do not develop striatal neurodegeneration. Furthermore, caspase-6-resistant mutant htt mice are protected against neurotoxicity induced by multiple stressors including NMDA, quinolinic acid (QA), and staurosporine. These results are consistent with proteolysis of htt at the caspase-6 cleavage site being an important event in mediating neuronal dysfunction and neurodegeneration and highlight the significant role of htt proteolysis; and excitotoxicity in HID.	Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; Merck Res Labs, Whitehouse Stn, NJ 08889 USA	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; Merck & Company	Graham, RK (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Graham, Rona K/R-7358-2018; Hayden, Michael R/D-8581-2011; Raymond, Lynn A./R-6707-2016; Leavitt, Blair R/G-1934-2012; Raymond, Lynn A/A-6664-2010	Graham, Rona K/0000-0003-3722-6241; Hayden, Michael R/0000-0001-5159-1419; Raymond, Lynn A./0000-0002-8610-1042; Raymond, Lynn A/0000-0002-8610-1042; leavitt, Blair/0000-0002-4532-766X				ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bizat N, 2005, NEUROPHARMACOLOGY, V49, P695, DOI 10.1016/j.neuropharm.2005.04.030; Bizat N, 2003, J BIOL CHEM, V278, P43245, DOI 10.1074/jbc.M305057200; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jarabek BR, 2004, BRAIN, V127, P505, DOI 10.1093/brain/awh058; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zeron MM, 2001, MOL CELL NEUROSCI, V17, P41, DOI 10.1006/mcne.2000.0909; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x	39	489	509	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1179	1191		10.1016/j.cell.2006.04.026	http://dx.doi.org/10.1016/j.cell.2006.04.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777606	Bronze			2022-12-28	WOS:000238602700021
J	Schmidt, MW; Connolly, JAD; Gunther, D; Bogaerts, M				Schmidt, M. W.; Connolly, J. A. D.; Gunther, D.; Bogaerts, M.			Element partitioning: The role of melt structure and composition	SCIENCE			English	Article							SYSTEM K2O-FEO-AL2O3-SIO2; TRACE-ELEMENTS; SILICATE MELTS; LIQUID IMMISCIBILITY; COEFFICIENTS; FRACTIONATION; CLINOPYROXENE; CARBONATE; EXAMPLE; RUTILE	We segregated coexisting gabbroic and granitic melts by centrifuging them at high pressures and temperatures and measured the trace element compositions of the melts by laser ablation inductively coupled plasma mass spectrometry. Our results demonstrate that the effect of melt structure contributes about one order of magnitude to crystal/melt partition coefficients. Partitioning of alkali and alkaline earth elements strongly depends on field strength: Amphoteric and lone pair electron elements partition into the polymerized granitic melt; and rare earth, transition, and high field strength elements coordinated by nonbridging oxygens partition remarkably similar into the gabbroic melt. A regular solution model predicts these effects.	ETH, Dept Earth Sci, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland; ETH, Dept Chem, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schmidt, MW (corresponding author), ETH, Dept Earth Sci, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland.	max.schmidt@erdw.ethz.ch	Schmidt, Max/A-1676-2008; connolly, james a d/A-7931-2013	connolly, james a d/0000-0001-5060-4281; Schmidt, Max W./0000-0002-3870-5781				BANNO S, 1973, CHEM GEOL, V11, P1, DOI 10.1016/0009-2541(73)90073-9; BLUNDY J, 1994, NATURE, V372, P452, DOI 10.1038/372452a0; Blundy J, 2000, CONTRIB MINERAL PETR, V139, P356, DOI 10.1007/s004100000139; BRICE JC, 1975, J CRYST GROWTH, V28, P249, DOI 10.1016/0022-0248(75)90241-9; Brooker RA, 2003, NATURE, V423, P738, DOI 10.1038/nature01708; DRAKE MJ, 1975, GEOCHIM COSMOCHIM AC, V39, P689, DOI 10.1016/0016-7037(75)90011-3; ELLISON AJG, 1989, GEOCHIM COSMOCHIM AC, V53, P1965, DOI 10.1016/0016-7037(89)90317-7; Galoisy L, 2000, MINERAL MAG, V64, P409, DOI 10.1180/002646100549472; Klemme S, 2005, GEOCHIM COSMOCHIM AC, V69, P2361, DOI 10.1016/j.gca.2004.11.015; LANGE RL, 1990, REV MINERAL, V24, P25; Lide R. David, 2005, HDB CHEM PHYS; Linnen RL, 2002, GEOCHIM COSMOCHIM AC, V66, P3293, DOI 10.1016/S0016-7037(02)00924-9; MYSEN BO, 1980, GEOCHIM COSMOCHIM AC, V44, P1917, DOI 10.1016/0016-7037(80)90191-X; Mysen BO, 2004, GEOCHIM COSMOCHIM AC, V68, P1617, DOI 10.1016/j.gca.2003.09.010; MYSEN BO, 1988, DEV GEOCHEMISTRY, V4; ONUMA N, 1968, EARTH PLANET SC LETT, V5, P47, DOI 10.1016/S0012-821X(68)80010-X; RAMSAY WRH, 1984, CONTRIB MINERAL PETR, V88, P386, DOI 10.1007/BF00376763; ROEDDER E, 1978, GEOCHIM COSMOCHIM AC, V42, P1597, DOI 10.1016/0016-7037(78)90250-8; RYERSON FJ, 1980, GEOCHIM COSMOCHIM AC, V44, P611, DOI 10.1016/0016-7037(80)90253-7; RYERSON FJ, 1978, GEOCHIM COSMOCHIM AC, V42, P921, DOI 10.1016/0016-7037(78)90103-5; Schmidt MW, 2004, EARTH PLANET SC LETT, V226, P415, DOI 10.1016/j.epsl.2004.08.010; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SORENSON H, 1974, ALKALINE ROCKS, P117; Veksler IV, 1998, J PETROL, V39, P2095, DOI 10.1093/petrology/39.11.2095; VISSER W, 1979, AM J SCI, V279, P970, DOI 10.2475/ajs.279.8.970; VISSER W, 1979, AM J SCI, V279, P70, DOI 10.2475/ajs.279.1.70; WATSON EB, 1976, CONTRIB MINERAL PETR, V56, P119, DOI 10.1007/BF00375424; Wood BJ, 1997, CONTRIB MINERAL PETR, V129, P166, DOI 10.1007/s004100050330; Wood BJ, 2002, GEOCHIM COSMOCHIM AC, V66, P3647, DOI 10.1016/S0016-7037(02)00935-3	29	98	100	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1646	1650		10.1126/science.1126690	http://dx.doi.org/10.1126/science.1126690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778055				2022-12-28	WOS:000238288600044
J	Ostrinsky, Y; Cohen, Z				Ostrinsky, Y; Cohen, Z			Images in clinical medicine - Tooth aspiration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Ostrinsky, Y (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07101 USA.								0	9	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					E25	E25		10.1056/NEJMicm050561	http://dx.doi.org/10.1056/NEJMicm050561			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775231				2022-12-28	WOS:000238233400009
J	Steinbrook, R				Steinbrook, Robert			New technology, old dilemma - Monitoring EEG activity during executions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						[Anonymous], 2006, ANESTHESIOLOGY, V104, P847; Gawande A, 2006, NEW ENGL J MED, V354, P1221, DOI 10.1056/NEJMp068042; Koniaris LG, 2005, LANCET, V365, P1412, DOI 10.1016/S0140-6736(05)66377-5; Mendoza Moises, 2006, LOS ANGELES TIM 0428, pB1; Zimmerman Rachel, 2005, Wall St J (East Ed), pB5	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2525	2527		10.1056/NEJMp068117	http://dx.doi.org/10.1056/NEJMp068117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775232				2022-12-28	WOS:000238233400001
J	Schaefer, JM; Denton, GH; Barrell, DJA; Ivy-Ochs, S; Kubik, PW; Andersen, BG; Phillips, FM; Lowell, TV; Schluchter, C				Schaefer, JM; Denton, GH; Barrell, DJA; Ivy-Ochs, S; Kubik, PW; Andersen, BG; Phillips, FM; Lowell, TV; Schluchter, C			Near-synchronous interhemispheric termination of the last glacial maximum in mid-latitudes	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; LATE PLEISTOCENE; ICE CORE; ATLANTIC; EVENTS; PERIOD; DEGLACIATION; ANTARCTICA; CHRONOLOGY; AUSTRALIA	Isotopic records from polar ice cores imply globally asynchronous warming at the end of the last glaciation. However, Be-10 exposure dates show that large-scale retreat of mid-latitude Last Glacial Maximum glaciers commenced at about the same time in both hemispheres. The timing of retreat is consistent with the onset of temperature and atmospheric CO2 increases in Antarctic ice cores. We suggest that a global trend of rising summer temperatures at the end of the Last Glacial Maximum was obscured in North Atlantic regions by hypercold winters associated with unusually extensive winter sea ice.	Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA; Univ Maine, Dept Earth Sci, Orono, ME 04469 USA; Univ Maine, Climate Change Inst, Orono, ME 04469 USA; GNS Sci, Dunedin, New Zealand; ETH Honggerberg, Inst Particle Phys, Paul Scherrer Inst, NL-8093 Zurich, Switzerland; Univ Zurich Irchel, Inst Geog, CH-8057 Zurich, Switzerland; Univ Oslo, N-0316 Oslo, Norway; New Mexico Inst Min & Technol, Socorro, NM 87801 USA; Univ Cincinnati, Cincinnati, OH 45221 USA; Univ Bern, Inst Geol, CH-3012 Bern, Switzerland	Columbia University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; GNS Science - New Zealand; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; University of Oslo; New Mexico Institute of Mining Technology; University System of Ohio; University of Cincinnati; University of Bern	Schaefer, JM (corresponding author), Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA.	schaefer@ldeo.columbia.edu		Lowell, Thomas/0000-0001-7826-0636				Alley RB, 2002, QUATERNARY SCI REV, V21, P431, DOI 10.1016/S0277-3791(01)00072-5; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Barrows TT, 2002, QUATERNARY SCI REV, V21, P159, DOI 10.1016/S0277-3791(01)00109-3; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; CLAPPERTON CM, 1990, QUATERNARY SCI REV, V9, P299, DOI 10.1016/0277-3791(90)90024-5; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Denton GH, 1999, GEOGR ANN A, V81A, P105; Denton GH, 1999, GEOGR ANN A, V81A, P107, DOI 10.1111/j.0435-3676.1999.00055.x; GOSSE JC, 1995, SCIENCE, V268, P1329, DOI 10.1126/science.268.5215.1329; Ivy-Ochs S, 2004, ECLOGAE GEOL HELV, V97, P47, DOI 10.1007/s00015-004-1110-0; Jouzel J, 2001, GEOPHYS RES LETT, V28, P3199, DOI 10.1029/2000GL012243; Kaplan MR, 2004, GEOL SOC AM BULL, V116, P308, DOI 10.1130/B25178.1; Licciardi JM, 2004, GEOLOGY, V32, P81, DOI 10.1130/G19868.1; Licciardi JM, 2001, GEOLOGY, V29, P1095, DOI 10.1130/0091-7613(2001)029<1095:CHABCO>2.0.CO;2; LICCIARDI JM, 2005, GEOL SOC AM ABSTR, V37, P41; LISTER G, 1988, J QUATERNARY SCI, V7, P187; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Oerlemans J., 2001, GLACIERS CLIMATE CHA, P148; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Phillips FM, 1996, SCIENCE, V274, P749, DOI 10.1126/science.274.5288.749; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; SHACKLETON NJ, 1988, NATURE, V335, P708, DOI 10.1038/335708a0; Smith JA, 2005, SCIENCE, V308, P678, DOI 10.1126/science.1107075; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Walker MJC, 1999, QUATERNARY SCI REV, V18, P1143, DOI 10.1016/S0277-3791(99)00023-2	31	217	223	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1510	1513		10.1126/science.1122872	http://dx.doi.org/10.1126/science.1122872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763146				2022-12-28	WOS:000238124100044
J	Lake, RA; van der Most, RG				Lake, RA; van der Most, RG			A better way for a cancer cell to die	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHEMOTHERAPY		Univ Western Australia, Perth, WA 6009, Australia	University of Western Australia	Lake, RA (corresponding author), Univ Western Australia, Perth, WA 6009, Australia.							Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; van Ruth S, 2003, ANN SURG ONCOL, V10, P176, DOI 10.1245/ASO.2003.03.022	4	49	55	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2503	2504		10.1056/NEJMcibr061443	http://dx.doi.org/10.1056/NEJMcibr061443			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760453				2022-12-28	WOS:000238100800016
J	Sander, PM; Mateus, O; Laven, T; Knotschke, N				Sander, PM; Mateus, O; Laven, T; Knotschke, N			Bone histology indicates insular dwarfism in a new Late Jurassic sauropod dinosaur	NATURE			English	Article							GROWTH	Sauropod dinosaurs were the largest animals ever to inhabit the land, with truly gigantic forms in at least three lineages(1-3). Small species with an adult body mass less than five tonnes are very rare(4,5), and small sauropod bones generally represent juveniles. Here we describe a new diminutive species of basal macronarian sauropod, Europasaurus holgeri gen. et sp. nov., and on the basis of bone histology we show it to have been a dwarf species. The fossils, including excellent skull material, come from Kimmeridgian marine beds of northern Germany(6,7), and record more than 11 individuals of sauropods 1.7 to 6.2 m in total body length. Morphological overlap between partial skeletons and isolated bones links all material to the same new taxon. Cortical histology of femora and tibiae indicates that size differences within the specimens are due to different ontogenetic stages, from juveniles to fully grown individuals. The little dinosaurs must have lived on one of the large islands around the Lower Saxony basin(8). Comparison with the long-bone histology of large-bodied sauropods suggests that the island dwarf species evolved through a decrease in growth rate from its larger ancestor.	Univ Bonn, Inst Paleontol, D-53115 Bonn, Germany; Univ Nova Lisboa, Ctr Estud Geol, P-2530157 Lourinha, Portugal; Museu Lourinha, P-2530157 Lourinha, Portugal; Dinosaurier Freilichtmuseum Munchehagen, D-31547 Rehburg, Germany	University of Bonn; Universidade Nova de Lisboa	Sander, PM (corresponding author), Univ Bonn, Inst Paleontol, Nussallee 8, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de; omateus@museulourinha.org	Mateus, Octávio/F-2910-2010	Mateus, Octávio/0000-0003-1253-3616				Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Dalla Vecchia Fabio M., 2001, Bollettino della Societa Paleontologica Italiana, V40, P25; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Jianu CM, 1999, GEOL MIJNBOUW, V78, P335, DOI 10.1023/A:1003855416962; Le Loeuff Jean, 2005, Historical Biology, V17, P15, DOI 10.1080/08912960500376210; LOTZE F, 1968, NEUES JB GEOL PAL, P730; Nopcsa F., 1914, VERHANDLUNGEN ZOOLOG, V54, P12; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Pape H, 1970, MITTEILUNGEN GEOLOGI, V9, P41; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Sander P.M., 2003, PALAEONTOL Z, V77, P161, DOI DOI 10.1007/BF03004566; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; WEISHAMPEL DB, 1991, RES EXPLOR, V7, P196; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C	25	165	171	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					739	741		10.1038/nature04633	http://dx.doi.org/10.1038/nature04633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760975				2022-12-28	WOS:000238095100051
J	Montenegro, RA; Stephens, C				Montenegro, Raul A.; Stephens, Carolyn			Indigenous health 2 - Indigenous health in Latin America and the Caribbean	LANCET			English	Review							CARDIOVASCULAR RISK; ECUADOR; INDIANS; DEPOPULATION; COMMUNITIES; POPULATIONS; PATTERNS; CHILDREN; SYSTEM; PLANTS	This review is the second in a series on Indigenous health, covering different regions and issues. We look briefly at the current state of Indigenous health in Latin America and the Caribbean, a region with over 400 different indigenous groups and a total population of 45 to 48 million people. We describe the complex history and current reality of Indigenous peoples' situation within the American continent. We discuss the importance of Indigenous health systems and medicines, and look at changing political environments in the region. The paper concludes with a discussion of the changing political and legislative environment in Latin American countries.	Univ Nacl Cordoba, Fac Psicol, RA-5000 Cordoba, Argentina; London Sch Hyg & Trop Med, London WC1, England	National University of Cordoba; University of London; London School of Hygiene & Tropical Medicine	Montenegro, RA (corresponding author), FUNAM, Casilla Correo 83, RA-5000 Cordoba, Argentina.	montenegro@funam.org.ar	Lohmann, Gui/E-8037-2010					*AG DYN, 2005, DIAR VOZ INT, P17; ALIAGAPERU C, 2003, WORLD LIB INF C 69 I, P1; Anguiano M E, 1993, Demos, P16; [Anonymous], 1997, Rev Panam Salud Publica, V2, P357; [Anonymous], 2004, WORKSH DAT COLL DIS; Araujo Zaida, 2003, Acta Cientifica Venezolana, V54, P247; *AS IND SAL MAK PE, 2000, SAL MAK PEL; ASIS R, 2005, MUNDIALIZACION REALI, P71; ATHAIS R, 2004, IND PEOPL RIGHTS HLT, P44; AZANHA G, 2004, WORLD RAINFOREST MOV, V87, P6; AZEVEDO M, 2006, MANY WERE THEY MANY; BARROSO A, 2004, INDIGENAS PRESERVAN; Baruzzi R G, 2001, Cad Saude Publica, V17, P407, DOI 10.1590/S0102-311X2001000200015; Beltrame A., 2002, Parassitologia (Rome), V44, P137; BENNETT BC, 1992, BRITTONIA, V44, P483, DOI 10.2307/2807199; Botto C., 2005, Parassitologia (Rome), V47, P145; Bou L C, 2000, Dev Pract, V10, P71, DOI 10.1080/09614520052510; BRISTOW F, 2003, UTZ WACHIL HLTH WELL; *CAB AID PROJ, 2001, UPDATE, P1; CABRERA AD, 2003, THESIS CHACO; Cardoso A M, 2001, Cad Saude Publica, V17, P345, DOI 10.1590/S0102-311X2001000200009; Cardoso Andrey Moreira, 2005, Cad. Saúde Pública, V21, P1602, DOI 10.1590/S0102-311X2005000500035; Carneiro O, 1993, Arq Bras Cardiol, V61, P279; Casas JA, 2001, HLTH DISPARITIES LAT; CHAGNON NA, 1970, ACTA CIENT VENEZ, V21, P186; Chapin M, 1992, Grassroots Dev, V16, P2; Chaunu P., 1969, CONQUETE EXPLOITATIO; *COICA, 1997, ORG IMH SUR COORD OR; Coimbra Carlos E. A. Jr., 2001, Ethnicity and Disease, V11, P232; CONEJO M, 1998, POBLACION INDIGENA R, P37; *CONF NAC IND EC, 1997, PROYECT POL CONAIE; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Denevan WM, 1976, NATIVE POPULATION AM; Deruyttere A., 2001, PUEBLOS INDIGENAS GL; Dietz V, 2004, B WORLD HEALTH ORGAN, V82, P852; Dorea JG, 2005, ENVIRON RES, V97, P209, DOI 10.1016/j.envres.2004.04.007; Escobar A L, 2001, Cad Saude Publica, V17, P285, DOI 10.1590/S0102-311X2001000200004; Etkin NL, 2005, J ETHNOPHARMACOL, V100, P23, DOI 10.1016/j.jep.2005.05.025; Farmer A, 2000, Reprod Freedom News, V9, P4; FEATHER C, 2004, WORLD RAINFOREST MOV, V87, P14; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Finger C, 2003, LANCET, V362, pS38, DOI 10.1016/S0140-6736(03)15070-2; Flowers N, 1994, South Am Indian Stud, P18; FORTE M, 2005, ISSUES CARIBBEAN AM, V4; Garnelo L, 2005, REV SAUDE PUBL, V39, P634, DOI 10.1590/S0034-89102005000400018; GLAUSER B, 2004, WORLD RAINFOREST MOV, V87, P13; GONZALEZ G, 2005, INTER PRESS SER 0606; GONZALEZ ML, 1994, MANY INDIGENOUS PEOP, P21; GOTTLIEB OR, 1993, CIENCIA HOJE, V15, P51; Gracia D, 1996, J MED PHILOS, V21, P593; Healy K, 1992, Grassroots Dev, V16, P22; Hern W M, 1991, Cad Saude Publica, V7, P451, DOI 10.1590/S0102-311X1991000400002; Hinojosa Servando, 2004, Med Anthropol, V23, P263, DOI 10.1080/01459740490506934; Hinrichsen D., 2006, WORKING JAMBI HUASI; Hollenberg NK, 1997, HYPERTENSION, V29, P171, DOI 10.1161/01.HYP.29.1.171; Hughes J., 2004, GENDER EQUITY INDIGE; *I SOC AMB, 2006, MAN DIFF EST IND PEO; *I SOC AMB, 2006, COM VIV POV IND BRAS; *INDEC, 2005, PRIM RES ENC COMPL P; *INT LAB OFF, 1999, IND PEOPL LAT AM; JORALEMON D, 1982, J ANTHROPOL RES, V38, P108, DOI 10.1086/jar.38.1.3629951; JORDANPANDO R, 1990, POBLACIONES INDIGENA; Junge B, 1994, Sante Salud, P10; KAPLAN JE, 1980, AM J TROP MED HYG, V29, P298, DOI 10.4269/ajtmh.1980.29.298; Kestler Edgar E., 1995, World Health Statistics Quarterly, V48, P28; Kroeger A, 1982, Bull Pan Am Health Organ, V16, P242; Livi-Bacci M, 2004, J INTERDISCIPL HIST, V35, P185, DOI 10.1162/0022195041742201; MAHAR DJ, 1989, GOVT POLICIES DEFORE; MAHECHARUBIO D, 2004, WORLD RAINFOREST MOV, V87, P8; Mancilha-Carvalho J J, 1992, Arq Bras Cardiol, V59, P275; Martinez-Cruzado JC, 2005, AM J PHYS ANTHROPOL, V128, P131, DOI 10.1002/ajpa.20108; Martinez-Cruzado JC, 2001, HUM BIOL, V73, P491, DOI 10.1353/hub.2001.0056; Mckenna N, 1993, WorldAIDS, P5; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; MELATTI J, 2004, SERIE ANTROPOLOGIA B, P39; MELIA B, 1993, BIBLIOTECA PARAGUAYA, V5, P1; Miller KE, 1996, CHILD DEV, V67, P89, DOI 10.1111/j.1467-8624.1996.tb01721.x; *MIN SAL, 2006, 2005 AN LOGR SAL IND; MONTENEGRO R, 2005, REV LETRA VIVA, V5, P9; MONTENEGRO R, 2004, DETERMINACION TERRIT; MONTENEGRO R, 2006, SILENCIOSO GENOCIDIO; MONTENEGRO R, 1999, INTRO ECOLOGIA URBAN; NAPOLITANO D, 2003, SALUD PUEBLOS INDIGE; Newson Linda A., 1987, CIVILIZATION AM INDI, V175; Oyhenart EE, 2003, HOMO, V54, P170, DOI 10.1078/0018-442X-00069; *PAHO, 2006, COUNTR HLTH PROF EC; *PAHO, 1997, HLTH IND PEOPL; Patrinos HA, 1994, INDIGENOUS PEOPLES P; PEDERSEN D, 1989, SOC SCI MED, V29, P487, DOI 10.1016/0277-9536(89)90194-9; PEDERSEN D, 1983, SOC SCI MED, V17, P1249, DOI 10.1016/0277-9536(83)90017-5; Perry GE, 2006, POVERTY REDUCTION AND GROWTH: VIRTUOUS AND VICIOUS CIRCLES, P1, DOI 10.1596/978-0-8213-6511-3; Peyser A, 1994, Notas Poblacion, V22, P93; Pineros-Petersen M, 1998, SALUD PUBLICA MEXICO, V40, P324, DOI 10.1590/S0036-36341998000400004; PLANT R, 1998, IND105 INT DEV BANK; *POP REF BUR, 1994, WORLD POP DAT SHEET; Price D, 1994, South Am Indian Stud, P63; RAMENOFSKY A, 1993, CAMBRIDGE WORLD HIST; Raunig Lesley, 2002, Midwifery Today Int Midwife, P51; REATEGUI J, 2003, PROGRAMA SALUD INDIG; RIBEIRO D, 1957, EDUCACAO CIENCIAS SO, V2, P5; RIVAL L, 2004, WORLD RAINFOREST MOV, V87, P10; Rodrigues E, 2005, PHYTOTHER RES, V19, P129, DOI 10.1002/ptr.1636; San Sebastian M, 2004, REV PANAM SALUD PUBL, V16, P328, DOI 10.1590/S1020-49892004001100006; SANCHEZ G, 2004, IND PEOPL RIGHT HLTH, P16; Santos R V, 1993, Cad Saude Publica, V9 Suppl 1, P46; SCHMAL J, 2004, HISPANIC EXPERIENCE; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P211, DOI 10.2307/2137904; SCHWIMLER D, 2006, BBC NEWS ONLINE 0122; Seale JP, 2002, ALCOHOL ALCOHOLISM, V37, P603, DOI 10.1093/alcalc/37.6.603; SMITH CT, 1970, CURR ANTHROPOL, V11, P453, DOI 10.1086/201146; SOUZA AB, 2003, J ETHNOPHARMACOL, V39, P53; Souza L G, 2001, Cad Saude Publica, V17, P355, DOI 10.1590/S0102-311X2001000200010; Spindel R, 2001, TROP DOCT, V31, P142, DOI 10.1177/004947550103100308; *SUMM I LING, 1996, ETHN LANG FAM IND; Tavares EF, 2003, HUM BIOL, V75, P31, DOI 10.1353/hub.2003.0028; Terborgh A, 1995, INT FAM PLAN PERSPEC, V21, P143, DOI 10.2307/2133321; TOUSIGNANT M, 1981, ACTA PSIQUIAT PSICOL, V27, P194; TUDELA F, 1990, DESARROLLO MEDIO AMB; *UN EC SOC COUNC, 2004, REP WORKSH DAT COLL; VINDING D, 2003, INDIGENOUS WORLD 200, P70; VINUESA S, 2003, THESIS U NACL CORDOB; Whitmore T M, 1996, Int J Popul Geogr, V2, P291, DOI 10.1002/(SICI)1099-1220(199612)2:4<291::AID-IJPG39>3.0.CO;2-W; Witzig R, 1999, Health Hum Rights, V4, P60, DOI 10.2307/4065168; WRONG D, 1965, POPULATION SOC; ZAMUDIO T, 2003, CALIDAD LEGISLATIVA, P17; 1996, AIDS WKLY PLUS, P9	126	279	295	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2006	367	9525					1859	1869		10.1016/S0140-6736(06)68808-9	http://dx.doi.org/10.1016/S0140-6736(06)68808-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753489				2022-12-28	WOS:000238194200032
J	Ellies, DL; Krumlauf, R				Ellies, Debra L.; Krumlauf, Robb			Bone formation: The nuclear matrix reloaded	CELL			English	Editorial Material							NEURAL CREST CELLS; GENES; SATB1		Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Krumlauf, R (corresponding author), Stowers Inst Med Res, 1000 50th St, Kansas City, MO 64110 USA.	rek@stowers-institute.org	Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927				Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; DOBREVA G, 2006, CELL; Drubin DA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-19; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Maconochie M, 1999, DEVELOPMENT, V126, P1483; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	10	30	34	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					840	842		10.1016/j.cell.2006.05.022	http://dx.doi.org/10.1016/j.cell.2006.05.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751095	Bronze			2022-12-28	WOS:000238116400012
J	Sheppard, SS; Trujillo, CA				Sheppard, Scott S.; Trujillo, Chadwick A.			A thick cloud of Neptune Trojans and their colors	SCIENCE			English	Article							KUIPER-BELT OBJECTS; ESO LARGE PROGRAM; PHOTOMETRIC SURVEY; SIZE DISTRIBUTION; GIANT PLANETS; CENTAURS; CAPTURE; ORIGIN; MIGRATION; ACCRETION	The dynamical and physical properties of asteroids offer one of the few constraints on the formation, evolution, and migration of the giant planets. Trojan asteroids share a planet's semimajor axis but lead or follow it by about 60 degrees near the two triangular Lagrangian points of gravitational equilibrium. Here we report the discovery of a high-inclination Neptune Trojan, 2005 TN53. This discovery demonstrates that the Neptune Trojan population occupies a thick disk, which is indicative of "freeze-in'' capture instead of in situ or collisional formation. The Neptune Trojans appear to have a population that is several times larger than the Jupiter Trojans. Our color measurements show that Neptune Trojans have statistically indistinguishable slightly red colors, which suggests that they had a common formation and evolutionary history and are distinct from the classical Kuiper Belt objects.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Gemini Observ, Hilo, HI 96720 USA	Carnegie Institution for Science	Sheppard, SS (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	sheppard@dtm.ciw.edu		Trujillo, Chadwick/0000-0001-9859-0894				Barucci MA, 2005, ASTRON J, V130, P1291, DOI 10.1086/431957; Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Chiang EI, 2005, ASTROPHYS J, V628, P520, DOI 10.1086/430825; Chiang EI, 2003, ASTRON J, V126, P430, DOI 10.1086/375207; Cruikshank DP, 2003, EARTH MOON PLANETS, V92, P315, DOI 10.1023/B:MOON.0000031948.39136.7d; Doressoundiram A, 2003, ASTRON J, V125, P2721, DOI 10.1086/374632; Fleming HJ, 2000, ICARUS, V148, P479, DOI 10.1006/icar.2000.6523; Fornasier S, 2004, ICARUS, V172, P221, DOI 10.1016/j.icarus.2004.06.015; Gomes RS, 2003, ICARUS, V161, P404, DOI 10.1016/S0019-1035(02)00056-8; Gomes RS, 1998, ASTRON J, V116, P2590, DOI 10.1086/300582; Grav T, 2003, ICARUS, V166, P33, DOI 10.1016/j.icarus.2003.07.005; Hahn JM, 2005, ASTRON J, V130, P2392, DOI 10.1086/452638; Horner J, 2006, MON NOT R ASTRON SOC, V367, pL20, DOI 10.1111/j.1745-3933.2006.00131.x; Jewitt DC, 2000, ASTRON J, V120, P1140, DOI 10.1086/301453; Jewitt DC, 2002, ASTRON J, V123, P1039, DOI 10.1086/338692; Kortenkamp SJ, 2004, ICARUS, V167, P347, DOI 10.1016/j.icarus.2003.09.021; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Marzari F, 1998, ICARUS, V131, P41, DOI 10.1006/icar.1997.5841; Marzari F, 2000, ICARUS, V146, P232, DOI 10.1006/icar.2000.6376; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Nesvorny D, 2002, ICARUS, V160, P271, DOI 10.1006/icar.2002.6961; PEALE SJ, 1993, ICARUS, V106, P308, DOI 10.1006/icar.1993.1173; Peixinho N, 2004, ICARUS, V170, P153, DOI 10.1016/j.icarus.2004.03.004; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; SHOEMAKER EM, 1989, ASTEROIDS, V2, P487; Smith JA, 2002, ASTRON J, V123, P2121, DOI 10.1086/339311; Tegler SC, 2000, NATURE, V407, P979, DOI 10.1038/35039572; Trujillo CA, 2002, ASTROPHYS J, V566, pL125, DOI 10.1086/339437; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539	30	83	88	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					511	514		10.1126/science.1127173	http://dx.doi.org/10.1126/science.1127173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16778021				2022-12-28	WOS:000239308600059
J	Wilkinson, J				Wilkinson, J			Commentary: What's all the fuss about?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		*NHS, CAR REC GUAR	1	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 1	2006	333	7557					42	43		10.1136/bmj.333.7557.42	http://dx.doi.org/10.1136/bmj.333.7557.42			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16809715	Green Published			2022-12-28	WOS:000238922900031
J	Tashkin, DP; Elashoff, R; Clements, PJ; Goldin, J; Roth, MD; Furst, DE; Arriola, E; Silver, R; Strange, C; Bolster, M; Seibold, JR; Riley, DJ; Hsu, VM; Varga, J; Schraufnagel, DE; Theodore, A; Simms, R; Wise, R; Wigley, F; White, B; Steen, V; Read, C; Mayes, M; Parsley, E; Mubarak, K; Connolly, MK; Golden, J; Olman, M; Fessler, B; Rothfield, N; Metersky, M				Tashkin, Donald P.; Elashoff, Robert; Clements, Philip J.; Goldin, Jonathan; Roth, Michael D.; Furst, Daniel E.; Arriola, Edgar; Silver, Richard; Strange, Charlie; Bolster, Marcy; Seibold, James R.; Riley, David J.; Hsu, Vivien M.; Varga, John; Schraufnagel, Dean E.; Theodore, Arthur; Simms, Robert; Wise, Robert; Wigley, Fredrick; White, Barbara; Steen, Virginia; Read, Charles; Mayes, Maureen; Parsley, Ed; Mubarak, Kamal; Connolly, M. Kari; Golden, Jeffrey; Olman, Mitchell; Fessler, Barri; Rothfield, Naomi; Metersky, Mark		Scleroderma Lung Study Res Grp	Cyclophosphamide versus placebo in scleroderma lung disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-ASSESSMENT QUESTIONNAIRE; SYSTEMIC-SCLEROSIS; INTRAVENOUS CYCLOPHOSPHAMIDE; RHEUMATOID-ARTHRITIS; PULMONARY-FUNCTION; NORMAL VALUES; ALVEOLITIS; MANAGEMENT; SURVIVAL; THERAPY	Background: We conducted a double-blind, randomized, placebo-controlled trial to determine the effects of oral cyclophosphamide on lung function and health-related symptoms in patients with evidence of active alveolitis and scleroderma-related interstitial lung disease. Methods: At 13 clinical centers throughout the United States, we enrolled 158 patients with scleroderma, restrictive lung physiology, dyspnea, and evidence of inflammatory interstitial lung disease on examination of bronchoalveolar-lavage fluid, thoracic high-resolution computed tomography, or both. Patients received oral cyclophosphamide (lessthan/equal 2 mg per kilogram of body weight per day) or matching placebo for one year and were followed for an additional year. Pulmonary function was assessed every three months during the first year, and the primary end point was the forced vital capacity (FVC, expressed as a percentage of the predicted value) at 12 months, after adjustment for the baseline FVC. Results: Of 158 patients, 145 completed at least six months of treatment and were included in the analysis. The mean absolute difference in adjusted 12-month FVC percent predicted between the cyclophosphamide and placebo groups was 2.53 percent (95 percent confidence interval, 0.28 to 4.79 percent), favoring cyclophosphamide (P < 0.03). There were also treatment-related differences in physiological and symptom outcomes, and the difference in FVC was maintained at 24 months. There was a greater frequency of adverse events in the cyclophosphamide group, but the difference between the two groups in the number of serious adverse events was not significant. Conclusions: One year of oral cyclophosphamide in patients with symptomatic scleroderma-related interstitial lung disease had a significant but modest beneficial effect on lung function, dyspnea, thickening of the skin, and the health-related quality of life. The effects on lung function were maintained through the 24 months of the study.	Univ Connecticut, Ctr Hlth, Farmington, CT USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Wayne State Univ, Detroit, MI USA; Univ Texas, Sch Med, Houston, TX USA; Georgetown Univ, Washington, DC USA; Johns Hopkins Sch Med, Baltimore, MD USA; Boston Univ, Boston, MA 02215 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Calif Los Angeles, Los Angeles, CA USA	University of Connecticut; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; Wayne State University; University of Texas System; Georgetown University; Johns Hopkins University; Johns Hopkins Medicine; Boston University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Medical University of South Carolina; University of California System; University of California Los Angeles	Tashkin, DP (corresponding author), David Geffen Sch Med, Div Pulm & Crit Care Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	dtashkin@mednet.ucla.edu	Bolster, Marcy/AAJ-9063-2020; Varga, John/AAK-6472-2021	Strange, Charlie/0000-0002-8109-8067; Bolster, Marcy/0000-0002-5413-9345; Simms, Robert/0000-0002-0101-1807; Schraufnagel, Dean/0000-0003-0063-7223; Wise, Robert/0000-0002-8353-2349; Theodore, Arthur/0000-0003-0740-4481; Goldin, Jonathan/0000-0003-3007-9947	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL060839, U01HL060597, U01HL060587, U01HL060794, U01HL060823, U01HL060606, U01HL060895, U01HL060750, U01HL060682, U01HL060748] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01 RR 00865] Funding Source: Medline; NHLBI NIH HHS [UO1 HL 60587, UO1 HL 60597, UO1 HL 60606, UO1 HL 60682, UO1 HL 60748, UO1 HL 60750, UO1 HL 60794, UO1 HL 60823, UO1 HL 60895, UO1 HL 60838, UO1 HL 60839, UO1 HL 50550] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKESSON A, 1994, ARTHRITIS RHEUM, V37, P729, DOI 10.1002/art.1780370518; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1994, Respir Care, V39, P1184; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; [Anonymous], 1994, Respir Med, V88, P165; BALTUS JAM, 1983, ANN RHEUM DIS, V42, P368, DOI 10.1136/ard.42.4.368; Behr J, 1996, AM J RESP CRIT CARE, V154, P400, DOI 10.1164/ajrccm.154.2.8756813; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Clements PJ, 2001, ARTHRITIS RHEUM-US, V44, P653, DOI 10.1002/1529-0131(200103)44:3<653::AID-ANR114>3.3.CO;2-H; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Davas EM, 1999, CLIN RHEUMATOL, V18, P455, DOI 10.1007/s100670050138; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Furst, 2004, SYSTEMIC SCLEROSIS, P17; Giacomelli R, 2002, J RHEUMATOL, V29, P731; HUBER PJ, 1973, ANN STAT, V1, P799, DOI 10.1214/aos/1176342503; Latsi PI, 2003, CURR OPIN RHEUMATOL, V15, P748, DOI 10.1097/00002281-200311000-00011; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; Pakas I, 2002, J RHEUMATOL, V29, P298; PETTY TL, 1990, CHEST, V97, P75, DOI 10.1378/chest.97.1.75; RADIS CD, 1995, ARTHRITIS RHEUM, V38, P1120, DOI 10.1002/art.1780380815; SILVER RM, 1993, J RHEUMATOL, V20, P838; STEEN VD, 1994, ARTHRITIS RHEUM-US, V37, P1290, DOI 10.1002/art.1780370904; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1984, DOI 10.1002/art.1780401110; TalarWilliams C, 1996, ANN INTERN MED, V124, P477, DOI 10.7326/0003-4819-124-5-199603010-00003; The BAL Cooperative Group Steering Committee, 1990, AM REV RESPIR DIS, V141, pS169; Varai G, 1998, J RHEUMATOL, V25, P1325; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; Witek TJ, 2003, EUR RESPIR J, V21, P267, DOI 10.1183/09031936.03.00068503a	34	1097	1156	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2655	2666		10.1056/NEJMoa055120	http://dx.doi.org/10.1056/NEJMoa055120			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790698				2022-12-28	WOS:000238416900004
J	Messerli, FH; Mancia, G; Conti, CR; Hewkin, AC; Kupfer, S; Champion, A; Kolloch, R; Benetos, A; Pepine, CJ				Messerli, Franz H.; Mancia, Giuseppe; Conti, C. Richard; Hewkin, Ann C.; Kupfer, Stuart; Champion, Annette; Kolloch, Rainer; Benetos, Athanase; Pepine, Carl J.			Dogma disputed: Can aggressively hypertensive patients with coronary artery lowering blood pressure in disease be dangerous?	ANNALS OF INTERNAL MEDICINE			English	Article							J-CURVE; MYOCARDIAL-INFARCTION; CALCIUM-ANTAGONISTS; PULSE PRESSURE; FOLLOW-UP; MORTALITY; REDUCTION; VERAPAMIL; TRIAL; OLDER	Background: Because coronary perfusion occurs mainly during diastole, patients with coronary artery disease (CAD) could be at increased risk for coronary events if diastolic pressure falls below critical levels. Objective: To determine whether low blood pressure could be associated with excess mortality and morbidity in this population. Design: A secondary analysis of data from the International Verapamil-Trandolapril Study (INVEST), which was conducted from September 1997 to February 2003. Setting: 862 sites in 14 countries. Patients: 22 576 patients with hypertension and CAD Interventions: Patients from INVEST were randomly assigned to a verapamil sustained-release- or atenolol-based strategy; blood pressure control and outcomes were equivalent. Measurements: An unadjusted quadratic proportional hazards model was used to evaluate the relationship between average on-treatment blood pressure and risk for the primary outcome (all-cause death, nonfatal stroke, and nonfatal myocardial infarction [MI]), all-cause death, total MI, and total stroke. A second model adjusted for differences in baseline covariates. Results: The relationship between blood pressure and the primary outcome, all-cause death, and total MI was J-shaped, particularly for diastolic pressure, with a nadir at 119/84 mm Hg. After adjustment, the J-shaped relationship persisted between diastolic pressure and primary outcome. The MI-stroke ratio remained constant over a wide blood pressure range, but at a lower diastolic blood pressure, there were substantially more MIs than strokes. An interaction between decreased diastolic pressure and history of revascularization was observed; low diastolic pressure was associated with a relatively lower risk for the primary outcome in patients with revascularization than in those without revascularization. Limitations: This is a post hoc analysis of hypertensive patients with CAD. Conclusions: The risk for the primary outcome, all-cause death, and MI, but not stroke, progressively increased with low diastolic blood pressure. Excessive reduction in diastolic pressure should be avoided in patients with CAD who are being treated for hypertension.	St Lukes Roosevelt Hosp, Div Cardiol, New York, NY 10019 USA; Univ Milan, I-20122 Milan, Italy; Univ Florida, Gainesville, FL USA; Abbott, Abbott Pk, IL USA; Med Klin, Bielefeld, Germany; Univ Nancy, Hop Brabois, Nancy, France	Mount Sinai St. Luke's; Mount Sinai West; University of Milan; State University System of Florida; University of Florida; Abbott Laboratories; Abbott Vascular; CHU de Nancy; Universite de Lorraine	Messerli, FH (corresponding author), St Lukes Roosevelt Hosp, Div Cardiol, 1000 10th Ave, New York, NY 10019 USA.	Fmesserli@aol.com	Messerli, Franz/AAR-4783-2021					[Anonymous], 1985, J Hypertens, V3, P379; BARRETTCONNOR E, 1994, BRIT MED J, V308, P446, DOI 10.1136/bmj.308.6926.446; Benetos A, 2002, ARCH INTERN MED, V162, P577, DOI 10.1001/archinte.162.5.577; Benetos A, 1998, HYPERTENSION, V32, P560, DOI 10.1161/01.HYP.32.3.560; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Boshuizen HC, 1998, BMJ-BRIT MED J, V316, P1780, DOI 10.1136/bmj.316.7147.1780; Bots ML, 1996, ARCH INTERN MED, V156, P843, DOI 10.1001/archinte.156.8.843; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; CRUICKSHANK JM, 1987, LANCET, V1, P581; CRUICKSHANK JM, 1992, LANCET, V339, P187, DOI 10.1016/0140-6736(92)90259-6; FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489; FLETCHER A, 1988, J HUM HYPERTENS, V2, P219; FLORAS JS, 1988, LANCET, V2, P994, DOI 10.1016/S0140-6736(88)90745-3; Gibson RS, 2000, AM J CARDIOL, V86, P275, DOI 10.1016/S0002-9149(00)00913-9; Glynn RJ, 2000, ARCH INTERN MED, V160, P2765, DOI 10.1001/archinte.160.18.2765; Greenberg JA, 2003, J HYPERTENS, V21, P49, DOI 10.1097/00004872-200301000-00013; Grossman E, 1998, J HUM HYPERTENS, V12, P729, DOI 10.1038/sj.jhh.1000730; Hakala SM, 1997, EUR HEART J, V18, P1019; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Kannel WB, 2004, AM J CARDIOL, V94, P380, DOI 10.1016/j.amjcard.2004.04.043; Kaplan N, 1998, LANCET, V351, P1748, DOI 10.1016/S0140-6736(98)22024-1; Messerli FH, 2001, J HYPERTENS, V19, P977, DOI 10.1097/00004872-200105000-00019; MESSERLI FH, INCREASED PULSE PRES; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Owens P, 1999, HEART, V82, P477, DOI 10.1136/hrt.82.4.477; Pastor-Barriuso R, 2003, ANN INTERN MED, V139, P731, DOI 10.7326/0003-4819-139-9-200311040-00007; Pepine CJ, 1998, J AM COLL CARDIOL, V31, P118; Pepine CJ, 1998, CLIN CARDIOL, V21, P633, DOI 10.1002/clc.4960210906; Pepine CJ, 2004, JAMA-J AM MED ASSOC, V292, P2271, DOI 10.1001/jama.292.18.2271; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; SAMUELSSON O, 1987, JAMA-J AM MED ASSOC, V258, P1768; Staessen JA, 1996, LANCET, V348, P696, DOI 10.1016/S0140-6736(05)65599-7; Staessen JA, 2003, J HYPERTENS, V21, P1055, DOI 10.1097/00004872-200306000-00002; STEWART IMG, 1979, LANCET, V1, P861; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tuomilehto J, 1998, J HYPERTENS, V16, P1235, DOI 10.1097/00004872-199816090-00002; van den Hoogen PCW, 1999, J HYPERTENS, V17, P1373, DOI 10.1097/00004872-199917100-00003; VATTEN LJ, 1995, EPIDEMIOLOGY, V6, P70, DOI 10.1097/00001648-199501000-00014; WALLER PC, 1988, J HUM HYPERTENS, V2, P7; WALLER PC, 1988, BRIT MED J, V297, P1606; WEINBERGER MH, 1992, ARCH INTERN MED, V152, P473, DOI 10.1001/archinte.152.3.473; WITTEMAN JCM, 1994, LANCET, V343, P504, DOI 10.1016/S0140-6736(94)91459-1; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; YUSUF S, 1991, AM J CARDIOL, V67, P1295, DOI 10.1016/0002-9149(91)90944-G; Zanchetti A, 2003, J HYPERTENS, V21, P797, DOI 10.1097/00004872-200304000-00024; 1997, ARCH INTERN MED, V157, P2413	47	598	624	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					884	893		10.7326/0003-4819-144-12-200606200-00005	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785477				2022-12-28	WOS:000238555500003
J	Thomas, RE; Croal, BL; Ramsay, C; Eccles, M; Grimshaw, J				Thomas, Ruth E.; Croal, Bernard Lewis; Ramsay, Craig; Eccles, Martin; Grimshaw, Jeremy			Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care: a cluster randomised trial	LANCET			English	Article							DIAGNOSTIC-TESTS; PHYSICIANS; PERFORMANCE; CONTRACT; BEHAVIOR; TIME	Background Laboratory services play an important part in screening, diagnosis, and management of patients within primary care. However, unnecessary use of laboratory tests is increasing. Our aim was to assess the effect of two interventions on the number of laboratory tests requested by primary-care physicians. Methods We did a duster randomised controlled trial using a 2x2 factorial design, involving 85 primary-care practices (370 family practitioners) that request all laboratory tests from one regional Centre. The interventions were quarterly feedback of practice requesting rates for nine laboratory tests, enhanced with educational messages, and brief educational reminder messages added to the test result reports for nine laboratory tests. The primary outcome was the number of targeted tests requested by primary-care practices during the 12 months of the intervention. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTNO6490422. Findings Practices that received either or both the enhanced feedback and the reminder messages were significantly less likely than the control group to request the targeted tests in total (enhanced feedback odds ratio 0.87, 95% CI 0.81-0.94; reminder messages 0.89, 0.83-0.93). The effect of the interventions varied across the targeted tests individually, although the number of tests requested for both interventions was generally reduced. Neither intervention was consistently better than the other. Interpretation Enhanced feedback of requesting rates and brief educational reminder messages, alone and in combination, are effective strategies for reducing test requesting in primary care. Both strategies are feasible within most laboratory settings.	NHS Grampian, Dept Clin Biochem, Aberdeen, Scotland; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; Univ Newcastle Upon Tyne, Sch Populat & Hlth Sci, Ctr Hlth Serv Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Ottawa Hlth Res Inst, Clin Epidemiol Programme, Ottawa, ON, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Aberdeen; University of Aberdeen; Newcastle University - UK; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Croal, BL (corresponding author), NHS Grampian, Dept Clin Biochem, Polwarth Bldg, Aberdeen, Scotland.	bernie.croal@nhs.net	Eccles, Martin P/AAD-4029-2020; Grimshaw, Jeremy/D-8726-2013; Ramsay, Craig/AAD-8249-2021	Ramsay, Craig/0000-0003-4043-7349; Grimshaw, Jeremy/0000-0001-8015-8243	Wellcome Trust Funding Source: Medline; Chief Scientist Office [HSRU2] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); Chief Scientist Office		[Anonymous], 1979, QUASIEXPERIMENTATION; AXTADAM P, 1993, MED CARE, V31, P784, DOI 10.1097/00005650-199309000-00003; Beastall G, 2004, B R COLL PATHOL, V128, P24; BUNTINX F, 1993, FAM PRACT, V10, P219, DOI 10.1093/fampra/10.2.219; BURGER HG, 1994, EUR J ENDOCRINOL, V130, P38, DOI 10.1530/eje.0.1300038; CASSCELLS W, 1978, NEW ENGL J MED, V299, P999, DOI 10.1056/NEJM197811022991808; DURANDZALESKI I, 1993, LANCET, V342, P150, DOI 10.1016/0140-6736(93)91349-Q; Eccles M, 2001, LANCET, V357, P1406, DOI 10.1016/S0140-6736(00)04564-5; Fleisher M, 2002, TUMOR MARKERS PHYSL, P33; Gama R, 2001, Clin Lab, V47, P57; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GRINER PF, 1982, NEW ENGL J MED, V307, P1336, DOI 10.1056/NEJM198211183072109; *INF STAT DIV, 2000, LAB STAT; Jamtvedt G, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858; LEESE B, 1991, 79 U YORK; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Montgomery Alan A, 2003, BMC Med Res Methodol, V3, P26, DOI 10.1186/1471-2288-3-26; *NHS CTR REV DISS, 1999, EFF HLTH CAR GETT EV, V5; O'Reilly DS, 2000, BRIT MED J, V320, P1332, DOI 10.1136/bmj.320.7245.1332; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Smellie WSA, 2005, ANN CLIN BIOCHEM, V42, P4, DOI 10.1258/0004563053026781; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020; Sorum PC, 2004, MED DECIS MAKING, V24, P149, DOI 10.1177/0272989X04263163; TIERNEY WM, 1990, NEW ENGL J MED, V322, P1499, DOI 10.1056/NEJM199005243222105; Twomey PJ, 2004, J CLIN PATHOL, V57, P1022, DOI 10.1136/jcp.2003.015016; van der Weijden T, 2003, MED DECIS MAKING, V23, P226, DOI 10.1177/0272989X03023003004; van der Weijden T, 2002, BRIT J GEN PRACT, V52, P974; van Walraven C, 1998, JAMA-J AM MED ASSOC, V280, P2028, DOI 10.1001/jama.280.23.2028; VANDERWEIJDEN T, 1996, COCHRANE DB SYST REV, V2, P461; Verstappen WHJM, 2003, JAMA-J AM MED ASSOC, V289, P2407, DOI 10.1001/jama.289.18.2407; Winkens R, 2002, BRIT MED J, V324, P783, DOI 10.1136/bmj.324.7340.783; Winkens RAG, 1996, BRIT MED J, V312, P490, DOI 10.1136/bmj.312.7029.490	32	74	74	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					1990	1996		10.1016/S0140-6736(06)68888-0	http://dx.doi.org/10.1016/S0140-6736(06)68888-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16782489				2022-12-28	WOS:000238488900033
J	Holmberg, J; Genander, M; Halford, MM; Anneren, C; Sondell, M; Chumley, MJ; Silvany, RE; Henkemeyer, M; Frisen, J				Holmberg, Johan; Genander, Maria; Halford, Michael M.; Anneren, Cecilia; Sondell, Mariann; Chumley, Michael J.; Silvany, Robert E.; Henkemeyer, Mark; Frisen, Jonas			EphB receptors coordinate migrationand proliferation in the intestinal stem cell niche	CELL			English	Article							COLORECTAL-CANCER; PROGENITOR CELLS; COMMISSURAL AXONS; BETA-CATENIN; PANETH CELLS; MOUSE; EPHRINS; EXPRESSION; HEDGEHOG; DIFFERENTIATION	More than 10(10) cells are generated every day in the human intestine. Wnt proteins are key regulators of proliferation and are known endogenous mitogens for intestinal progenitor cells. The positioning of cells within the stem cell niche in the intestinal epithelium is controlled by B subclass ephrins through their interaction with EphB receptors. We report that EphB receptors, in addition to directing cell migration, regulate proliferation in the intestine. EphB signaling promotes cell-cycle reentry of progenitor cells and accounts for approximately 50% of the mitogenic activity in the adult mouse small intestine and colon. These data establish EphB receptors as key coordinators of migration and proliferation in the intestinal stem cell niche.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA	Karolinska Institutet; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Holmberg, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se		Anneren, Cecilia/0000-0003-3600-6650; Genander, Maria/0000-0002-2428-8040; Henkemeyer, Mark/0000-0002-7525-1061	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006225] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC006225] Funding Source: Medline; NIDDK NIH HHS [R01 DK059164] Funding Source: Medline; NIMH NIH HHS [R01 MH66332, R01 MH066332] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ayabe T, 2004, TRENDS MICROBIOL, V12, P394, DOI 10.1016/j.tim.2004.06.007; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Holmberg J, 2002, TRENDS NEUROSCI, V25, P239, DOI 10.1016/S0166-2236(02)02149-5; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; SCHMAHL W, 1983, ANAT EMBRYOL, V167, P355, DOI 10.1007/BF00315673; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2	50	225	238	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1151	1163		10.1016/j.cell.2006.04.030	http://dx.doi.org/10.1016/j.cell.2006.04.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777604	Bronze			2022-12-28	WOS:000238602700019
J	Hallstrom, A; Rea, TD; Sayre, MR; Christenson, J; Anton, AR; Mosesso, VN; Van Ottingham, L; Olsufka, M; Pennington, S; White, LJ; Yahn, S; Husar, J; Morris, MF; Cobb, LA				Hallstrom, Al; Rea, Thomas D.; Sayre, Michael R.; Christenson, James; Anton, Andy R.; Mosesso, Vince N., Jr.; Van Ottingham, Lois; Olsufka, Michele; Pennington, Sarah; White, Lynn J.; Yahn, Stephen; Husar, James; Morris, Mary F.; Cobb, Leonard A.			Manual chest compression vs use of an automated chest compression device during resuscitation following out-of-hospital cardiac arrest - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; PORCINE MODEL; QUALITY; DEFIBRILLATION; SURVIVORS; SIZE; TIME	Context High-quality cardiopulmonary resuscitation ( CPR) may improve both cardiac and brain resuscitation following cardiac arrest. Compared with manual chest compression, an automated load-distributing band ( LDB) chest compression device produces greater blood flow to vital organs and may improve resuscitation outcomes. Objective To compare resuscitation outcomes following out-of-hospital cardiac arrest when an automated LDB-CPR device was added to standard emergency medical services ( EMS) care with manual CPR. Design, Setting, and Patients Multicenter, randomized trial of patients experiencing out-of-hospital cardiac arrest in the United States and Canada. The a priori primary population was patients with cardiac arrest that was presumed to be of cardiac origin and that had occurred prior to the arrival of EMS personnel. Initial study enrollment varied by site, ranging from late July to mid November 2004; all sites halted study enrollment on March 31, 2005. Intervention Standard EMS care for cardiac arrest with an LDB-CPR device ( n= 554) or manual CPR ( n= 517). Main Outcome Measures The primary end point was survival to 4 hours after the 911 call. Secondary end points were survival to hospital discharge and neurological status among survivors. Results Following the first planned interim monitoring conducted by an independent data and safety monitoring board, study enrollment was terminated. No difference existed in the primary end point of survival to 4 hours between the manual CPR group and the LDB-CPR group overall ( N= 1071; 29.5% vs 28.5%; P=. 74) or among the primary study population ( n= 767; 24.7% vs 26.4%, respectively; P=. 62). However, among the primary population, survival to hospital discharge was 9.9% in the manual CPR group and 5.8% in the LDB-CPR group ( P=. 06, adjusted for covariates and clustering). A cerebral performance category of 1 or 2 at hospital discharge was recorded in 7.5% of patients in the manual CPR group and in 3.1% of the LDB-CPR group ( P=. 006). Conclusions Use of an automated LDB-CPR device as implemented in this study was associated with worse neurological outcomes and a trend toward worse survival than manual CPR. Device design or implementation strategies require further evaluation.	Univ Washington, Dept Biostat, Seattle, WA 98105 USA; Univ Washington, Dept Med, Seattle, WA USA; Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; British Columbia Ambulance Serv, Vancouver, BC, Canada; Calgary Emergency Med Serv, Calgary, AB, Canada; Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St. Paul's Hospital; University of Saskatchewan	Hallstrom, A (corresponding author), Univ Washington, Dept Biostat, 1107 NE 45th St,Suite 505, Seattle, WA 98105 USA.	aph@u.washington.edu	Sayre, Michael R/E-8383-2017; White, Lynn/C-9399-2009	Sayre, Michael R/0000-0003-0322-3181; White, Lynn/0000-0003-2464-0304				Anderson Travis, 2003, Curr Opin Crit Care, V9, P194, DOI 10.1097/00075198-200306000-00004; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Casner Michael, 2005, Prehosp Emerg Care, V9, P61, DOI 10.1080/10903120590891714; Chen YHJ, 2004, STAT MED, V23, P1023, DOI 10.1002/sim.1688; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Connelly LB, 2003, CONTROL CLIN TRIALS, V24, P544, DOI 10.1016/S0197-2456(03)00093-X; *CYT SOFTW CO, 2003, E VERS 3 0 SOFTW DES; Ewy GA, 2005, CIRCULATION, V111, P2134, DOI 10.1161/01.CIR.0000162503.57657.FA; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Hallstrom AP, 2005, RESUSCITATION, V65, P65, DOI 10.1016/j.resuscitation.2004.10.008; Halperin HR, 2002, CIRCULATION, V106, P538; Hart AP, 2005, J FORENSIC SCI, V50, P164; HERLITZ J, 1995, ANN EMERG MED, V25, P58, DOI 10.1016/S0196-0644(95)70356-X; HIGHTOWER D, 1995, ANN EMERG MED, V26, P300, DOI 10.1016/S0196-0644(95)70076-5; Huseyin TS, 2002, RESUSCITATION, V54, P57, DOI 10.1016/S0300-9572(02)00040-0; Ikeno F, 2006, RESUSCITATION, V68, P109, DOI 10.1016/j.resuscitation.2005.05.024; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; Lairet JR, 2005, ANN EMERG MED, V46, pS114; NIEMANN JT, 1992, NEW ENGL J MED, V327, P1075; ORNATO J, 2005, AM HEART ASS RES SCI; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Rogers WH., 1993, STATA TECHNICAL B RE, V13, P19; Steen S, 2003, RESUSCITATION, V58, P249, DOI 10.1016/S0300-9572(03)00265-X; Stiell I, 2003, CIRCULATION, V108, P1939, DOI 10.1161/01.CIR.0000095028.95929.B0; Timmerman S, 2003, PREHOSP EMERG CARE, V7, P162; Venables WN., 2002, MODERN APPL STAT S; VUKMIR RB, SURVIVAL OUTCOME PRE; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E	37	274	290	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2620	2628		10.1001/jama.295.22.2620	http://dx.doi.org/10.1001/jama.295.22.2620			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772625	Bronze			2022-12-28	WOS:000238224000024
J	Levine, OS; O'Brien, KL; Knoll, M; Adegbola, RA; Black, S; Cherian, T; Dagan, R; Goldblatt, D; Grange, A; Greenwood, B; Hennessy, T; Klugman, KP; Madhi, SA; Mulholland, K; Nohynek, H; Santosham, M; Saha, SK; Scott, JA; Sow, S; Whitney, CG; Cutts, F				Levine, Orin S.; O'Brien, Katherine L.; Knoll, Maria; Adegbola, Richard A.; Black, Steven; Cherian, Thomas; Dagan, Ron; Goldblatt, David; Grange, Adenike; Greenwood, Brian; Hennessy, Tom; Klugman, Keith P.; Madhi, Shabir A.; Mulholland, Kim; Nohynek, Hanna; Santosham, Mathuram; Saha, Samir K.; Scott, J. Anthony; Sow, Samba; Whitney, Cynthia G.; Cutts, Felicity			Pneumococcal vaccination in developing countries	LANCET			English	Editorial Material							CONJUGATE VACCINE; CHILDREN; DISEASE; PNEUMONIA; FORMULATION; INFECTIONS; SEROGROUPS; IMPACT; TRIAL		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; MRC Labs, Fajara, Gambia; Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; WHO, CH-1211 Geneva, Switzerland; Soroka Univ, Med Ctr, Paediat Infect Dis Unit, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; UCL, Inst Child Hlth, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Int Paediat Assoc, Lagos, Nigeria; London Sch Hyg & Trop Med, London WC1, England; Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, Anchorage, AK USA; Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; Natl Publ Hlth Inst, Helsinki, Finland; Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh; Wellcome Trust Kenya Med Res Inst, Ctr Geog Med Res Coast, Kilifi, Kenya; Ctr Dev Vaccins Mali, Bamako, Mali	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; MRC Laboratory Molecular Biology; Kaiser Permanente; World Health Organization; Ben Gurion University; Soroka Medical Center; Ben Gurion University; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; University of Witwatersrand; Finland National Institute for Health & Welfare; Kenya Medical Research Institute	Levine, OS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	olevine@jhsph.edu	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242; Deloria Knoll, Maria/0000-0001-9041-2671; O'Brien, Katherine/0000-0002-0164-4030	Wellcome Trust [061089, 081835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; OBRIEN KL, 2006, 5 INT S PNEUM PNEUM, P189; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO, 2003, WKLY EPIDEMIOL REC, V14, P110; *WHO, 1999, MEN PNEUM DIS VACC; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; *WYETH, 2006, WYETH ANN M STOCKH D	16	119	134	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 10	2006	367	9526					1880	1882		10.1016/S0140-6736(06)68703-5	http://dx.doi.org/10.1016/S0140-6736(06)68703-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765742				2022-12-28	WOS:000238194400006
J	Maheshwari, V; Saraf, RF				Maheshwari, Vivek; Saraf, Ravi F.			High-resolution thin-film device to sense texture by touch	SCIENCE			English	Article							TACTILE SENSOR; CONTACT FORCE; PERCEPTION; SHAPE	Touch ( or tactile) sensors are gaining renewed interest as the level of sophistication in the application of minimum invasive surgery and humanoid robots increases. The spatial resolution of current large-area ( greater than 1 cm(2)) tactile sensor lags by more than an order of magnitude compared with the human finger. By using metal and semiconducting nanoparticles, a similar to 100-nm- thick, large-area thin-film device is self-assembled such that the change in current density through the film and the electroluminescent light intensity are linearly proportional to the local stress. A stress image is obtained by pressing a copper grid and a United States 1-cent coin on the device and focusing the resulting electroluminescent light directly on the charge-coupled device. Both the lateral and height resolution of texture are comparable to the human finger at similar stress levels of similar to 10 kilopascals.	Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA; Edward Via Virginia Coll Osteopath Med, Blacksburg, VA 24060 USA	University of Nebraska System; University of Nebraska Lincoln	Saraf, RF (corresponding author), Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA.	rsaraf@unlnotes.unl.edu						Brett PN, 1997, P I MECH ENG H, V211, P309, DOI 10.1243/0954411971534430; Cassagneau T, 1998, J AM CHEM SOC, V120, P7848, DOI 10.1021/ja9806027; Dario P, 2001, J ROBOTIC SYST, V18, P673, DOI 10.1002/rob.8106; De Rossi D, 2005, ADV COLLOID INTERFAC, V116, P165, DOI 10.1016/j.cis.2005.05.002; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; DeLongchamp DM, 2003, CHEM MATER, V15, P1165, DOI 10.1021/cm020945a; DOMENICI C, 1992, SENSOR ACTUAT A-PHYS, V31, P97, DOI 10.1016/0924-4247(92)80086-I; Durstock MF, 2001, LANGMUIR, V17, P7865, DOI 10.1021/la010954i; Engel J, 2003, J MICROMECH MICROENG, V13, P359, DOI 10.1088/0960-1317/13/3/302; Ferrier NJ, 2000, INT J ROBOT RES, V19, P795, DOI 10.1177/02783640022067184; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; Gray BL, 1996, IEEE INT CONF ROBOT, P1, DOI 10.1109/ROBOT.1996.503564; HOWE RD, 1993, IEEE T ROBOTIC AUTOM, V9, P140, DOI 10.1109/70.238278; Jia YB, 2005, IEEE T ROBOT, V21, P726, DOI 10.1109/TRO.2005.844675; Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212; JOHANSSON RS, 1983, SOMATOSENS RES, V1, P21, DOI 10.3109/07367228309144538; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; KANEKO M, 1994, IEEE T ROBOTIC AUTOM, V10, P355, DOI 10.1109/70.294210; KASAP SO, 2000, PRINCIPLES ELECT ENG, P284; Kelley TW, 2004, CHEM MATER, V16, P4413, DOI 10.1021/cm049614j; Lacour SP, 2004, IEEE ELECTR DEVICE L, V25, P792, DOI 10.1109/LED.2004.839227; Mascaro SA, 2001, IEEE T ROBOTIC AUTOM, V17, P698, DOI 10.1109/70.964669; Matsumoto S, 1997, SURG ENDOSC-ULTRAS, V11, P939, DOI 10.1007/s004649900492; MORLEY JW, 1983, EXP BRAIN RES, V49, P291; Okamura AM, 2001, INT J ROBOT RES, V20, P925, DOI 10.1177/02783640122068191; Okumura Y, 2004, ADV ROBOTICS, V18, P699, DOI 10.1163/1568553041719447; Ouyang JY, 2004, NAT MATER, V3, P918, DOI 10.1038/nmat1269; Plinkert PK, 1997, LARYNGO RHINO OTOL, V76, P543, DOI 10.1055/s-2007-997476; Robles-De-La-Torre G, 2001, NATURE, V412, P445, DOI 10.1038/35086588; Sakai N, 2000, GASTROINTEST ENDOSC, V51, P69, DOI 10.1016/S0016-5107(00)70390-7; Seeger A, 2001, J VAC SCI TECHNOL B, V19, P2717, DOI 10.1116/1.1412890; Shikida M, 2003, SENSOR ACTUAT A-PHYS, V103, P213, DOI 10.1016/S0924-4247(02)00336-9; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Tajima R, 2002, ADV ROBOTICS, V16, P381, DOI 10.1163/15685530260174548; Tohyama O, 1999, IEEE J SEL TOP QUANT, V5, P115, DOI 10.1109/2944.748114	35	219	235	12	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1501	1504		10.1126/science.1126216	http://dx.doi.org/10.1126/science.1126216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763143	Green Submitted			2022-12-28	WOS:000238124100041
J	Elachi, C; Wall, S; Janssen, M; Stofan, E; Lopes, R; Kirk, R; Lorenz, R; Lunine, J; Paganelli, F; Soderblom, L; Wood, C; Wye, L; Zebker, H; Anderson, Y; Ostro, S; Allison, M; Boehmer, R; Callahan, P; Encrenaz, P; Flamini, E; Francescetti, G; Gim, Y; Hamilton, G; Hensley, S; Johnson, W; Kelleher, K; Muhleman, D; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Stiles, B; Vetrella, S; West, R				Elachi, C.; Wall, S.; Janssen, M.; Stofan, E.; Lopes, R.; Kirk, R.; Lorenz, R.; Lunine, J.; Paganelli, F.; Soderblom, L.; Wood, C.; Wye, L.; Zebker, H.; Anderson, Y.; Ostro, S.; Allison, M.; Boehmer, R.; Callahan, P.; Encrenaz, P.; Flamini, E.; Francescetti, G.; Gim, Y.; Hamilton, G.; Hensley, S.; Johnson, W.; Kelleher, K.; Muhleman, D.; Picardi, G.; Posa, F.; Roth, L.; Seu, R.; Shaffer, S.; Stiles, B.; Vetrella, S.; West, R.			Titan Radar Mapper observations from Cassini's T3 fly-by	NATURE			English	Article							WINDS	Cassini's Titan Radar Mapper imaged the surface of Saturn's moon Titan on its February 2005 fly-by ( denoted T-3), collecting high-resolution synthetic-aperture radar and larger-scale radiometry and scatterometry data. These data provide the first definitive identification of impact craters on the surface of Titan, networks of fluvial channels and surficial dark streaks that may be longitudinal dunes. Here we describe this great diversity of landforms. We conclude that much of the surface thus far imaged by radar of the haze-shrouded Titan is very young, with persistent geologic activity.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Proxemy Res, Bowie, MD 20715 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; IFSI INAF, I-00133 Rome, Italy; Planetary Sci Inst, Tucson, AZ 85719 USA; Stanford Univ, Stanford, CA 94305 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Observ Paris, F-92195 Meudon, France; Alenia Aerosp, I-00131 Rome, Italy; Fac Ingn, I-80125 Naples, Italy; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Roma La Sapienza, I-00184 Rome, Italy; Politecn Bari, INFM, I-70126 Bari, Italy; Politecn Bari, Dipartimento Interateneo Fis, I-70126 Bari, Italy	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; University of Arizona; Istituto Nazionale Astrofisica (INAF); Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Leonardo; California Institute of Technology; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Politecnico di Bari; Politecnico di Bari	Wall, S (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	steve.wall@jpl.nasa.gov	Lorenz, Ralph D/B-8759-2016; Lopes, Rosaly M.C./D-1608-2016	Lorenz, Ralph D/0000-0001-8528-4644; Lopes, Rosaly M.C./0000-0002-7928-3167; Lunine, Jonathan/0000-0003-2279-4131; zebker, howard/0000-0001-9931-5237				BLOM R, 1981, J GEOPHYS RES, V86, P3061, DOI 10.1029/JB086iB04p03061; Elachi C, 2004, SPACE SCI REV, V115, P71, DOI 10.1007/s11214-004-1438-9; ELACHI C, 1991, P IEEE, V79, P867, DOI 10.1109/5.90164; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Fahnestock MA, 2000, GEOPHYS RES LETT, V27, P3719, DOI 10.1029/1999GL011248; KARGEL JS, 1991, ICARUS, V89, P93, DOI 10.1016/0019-1035(91)90090-G; KIRK R, 2005, P 36 ANN LUN PLAN SC, V36; Lorenz RD, 1995, J GEOPHYS RES-PLANET, V100, P26377, DOI 10.1029/95JE02708; Lorenz RD, 1997, PLANET SPACE SCI, V45, P1009, DOI 10.1016/S0032-0633(97)00085-8; Melosh H. J., 1989, IMPACT CRATERING GEO, P87; MITRI G, UNPUB ICARUS; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; SCHENK PM, 1993, J GEOPHYS RES-PLANET, V98, P7475, DOI 10.1029/93JE00176; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; WOOD C, 2005, P 36 ANN LUN PLAN SC, V36	17	84	84	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					709	713		10.1038/nature04786	http://dx.doi.org/10.1038/nature04786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760968				2022-12-28	WOS:000238095100044
J	Felzer, KR; Brodsky, EE				Felzer, K. R.; Brodsky, E. E.			Decay of aftershock density with distance indicates triggering by dynamic stress	NATURE			English	Article							SOUTHERN-CALIFORNIA; EARTHQUAKE; SEQUENCE; MODELS	The majority of earthquakes are aftershocks(1), yet aftershock physics is not well understood. Many studies suggest that static stress changes(2,3) trigger aftershocks, but recent work suggests that shaking ( dynamic stresses) may also play a role(4,5). Here we measure the decay of aftershocks as a function of distance from magnitude 2-6 mainshocks in order to clarify the aftershock triggering process. We find that for short times after the main-shock, when low background seismicity rates allow for good aftershock detection, the decay is well fitted by a single inverse power law over distances of 0.2-50 km. The consistency of the trend indicates that the same triggering mechanism is working over the entire range. As static stress changes at the more distant aftershocks are negligible, this suggests that dynamic stresses may be triggering all of these aftershocks. We infer that the observed aftershock density is consistent with the probability of triggering aftershocks being nearly proportional to seismic wave amplitude. The data are not fitted well by models that combine static stress change with the evolution of frictionally locked faults(3).	US Geol Survey, Pasadena, CA 91106 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95060 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Cruz	Felzer, KR (corresponding author), US Geol Survey, 525 S Wilson, Pasadena, CA 91106 USA.	kfelzer@gps.caltech.edu	Brodsky, Emily/B-9139-2014	Brodsky, Emily/0000-0002-6855-6860				Bak P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.178501; CAMPBELL KW, 2003, STRONG MOTION ATTENU; Davidsen J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048501; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; DODGE DA, 1995, J GEOPHYS RES-SOL EA, V100, P9865, DOI 10.1029/95JB00871; Felzer KR, 2004, B SEISMOL SOC AM, V94, P88, DOI 10.1785/0120030069; GARDNER JK, 1974, B SEISMOL SOC AM, V64, P1363; Gomberg J, 2003, B SEISMOL SOC AM, V93, P118, DOI 10.1785/0120020075; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Helmstetter A, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003286; Huc M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001645; ICHINOSE GA, 1997, EOS, V78; Johnson PA, 2005, NATURE, V437, P871, DOI 10.1038/nature04015; Kagan YY, 2004, B SEISMOL SOC AM, V94, P1207, DOI 10.1785/012003098; KAGAN YY, 1980, GEOPHYS J ROY ASTR S, V62, P303, DOI 10.1111/j.1365-246X.1980.tb04857.x; KANAMORI H, 1993, B SEISMOL SOC AM, V83, P330; Main IG, 1999, GEOPHYS RES LETT, V26, P2801, DOI 10.1029/1999GL005372; Michael AJ, 1998, B SEISMOL SOC AM, V88, P117; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Omori F, 1894, J COLL SCI IMP U TOK, V7, P111; Richter C. F., 1935, B SEISMOL SOC AM, V25, P1; Rubin AM, 1999, NATURE, V400, P635, DOI 10.1038/23196; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shearer P, 2005, B SEISMOL SOC AM, V95, P904, DOI 10.1785/0120040168; Silverman B., 1986, DENSITY ESTIMATION S, V175; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Vidale JE, 1998, J GEOPHYS RES-SOL EA, V103, P24567, DOI 10.1029/98JB00594; WELLS D, 1995, SEISMOLOGY SOC AM B, V84, P974	28	265	271	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					735	738		10.1038/nature04799	http://dx.doi.org/10.1038/nature04799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760974	Green Published			2022-12-28	WOS:000238095100050
J	Harries, AD; Schouten, EJ; Libamba, E				Harries, AD; Schouten, EJ; Libamba, E			Scaling up antiretroviral treatment in resource-poor settings	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; THERAPY; MALAWI; TUBERCULOSIS; HIV		Malawi Country Off, Lilongwe 3, Malawi; Minist Hlth, Lilongwe, Malawi; London Sch Hyg & Trop Med, London WC1, England; Management Sci Hlth, Lilongwe, Malawi	University of London; London School of Hygiene & Tropical Medicine	Harries, AD (corresponding author), Malawi Country Off, POB 30455, Lilongwe 3, Malawi.	adharries@malawi.net						Bates I, 2006, CLIN INFECT DIS, V42, P383, DOI 10.1086/499368; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Gebrekristos HT, 2005, BMJ-BRIT MED J, V331, P772, DOI 10.1136/bmj.331.7519.772; Harries AD, 2004, BMJ-BRIT MED J, V329, P1163, DOI 10.1136/bmj.329.7475.1163; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; *MIN HLTH REP MAL, 2004, HUM RES HLTH SECT SO; *NAT AIDS COMM, 2003, NAT EST HIV AIDS MAL; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2003, SCAL ANT THER RES LT	13	103	105	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1870	1872		10.1016/S0140-6736(06)68809-0	http://dx.doi.org/10.1016/S0140-6736(06)68809-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753490				2022-12-28	WOS:000238194200033
J	Millay, OJ; Connell, TG; Bryant, PA; Curtis, N				Millay, Olivia J.; Connell, Tom G.; Bryant, Penelope A.; Curtis, Nigel			Skin ulceration: what lies beneath	LANCET			English	Editorial Material									Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Royal Childrens Hosp Melbourne, Paediat Infect Dis Unit, Dept Gen Med, Parkville, Vic 3052, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Curtis, N (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	nigel.curtis@rch.org.au	Curtis, Nigel/B-3491-2012	Curtis, Nigel/0000-0003-3446-4594				George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; Ross BC, 1997, J CLIN MICROBIOL, V35, P1696, DOI 10.1128/JCM.35.7.1696-1700.1997; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; WHO, 2004, PROV GUID ROL SPEC A	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2006	367	9525					1874	1874		10.1016/S0140-6736(06)68811-9	http://dx.doi.org/10.1016/S0140-6736(06)68811-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753492				2022-12-28	WOS:000238194200035
J	Giles, J				Giles, J			Mystery and myth behind the plesiosaur	NATURE			English	News Item																		McHenry CR, 2005, SCIENCE, V310, P75, DOI 10.1126/science.1117241	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					390	390		10.1038/441390b	http://dx.doi.org/10.1038/441390b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16789076				2022-12-28	WOS:000237778900007
J	Sadqi, M; Fushman, D; Munoz, V				Sadqi, Mourad; Fushman, David; Munoz, Victor			Atom-by-atom analysis of global downhill protein folding	NATURE			English	Article							CHEMICAL-SHIFTS; SPEED LIMIT; 2-STATE; MODEL; STABILITY; DOMAIN	Protein folding is an inherently complex process involving coordination of the intricate networks of weak interactions that stabilize native three-dimensional structures. In the conventional paradigm, simple protein structures are assumed to fold in an all-or-none process(1) that is inaccessible to experiment. Existing experimental methods therefore probe folding mechanisms indirectly. A widely used approach interprets changes in protein stability(2) and/or folding kinetics(3,4), induced by engineered mutations, in terms of the structure of the native protein. In addition to limitations in connecting energetics with structure(5), mutational methods have significant experimental uncertainties(6) and are unable to map complex networks of interactions. In contrast, analytical theory predicts small barriers to folding and the possibility of downhill folding(7,8). These theoretical predictions have been confirmed experimentally in recent years(9-11), including the observation of global downhill folding(12). However, a key remaining question is whether downhill folding can indeed lead to the high-resolution analysis of protein folding processes(13). Here we show, with the use of nuclear magnetic resonance (NMR), that the downhill protein BBL from Escherichia coli unfolds atom by atom starting from a defined three-dimensional structure. Thermal unfolding data on 158 backbone and side-chain protons out of a total of 204 provide a detailed view of the structural events during folding. This view confirms the statistical nature of folding, and exposes the interplay between hydrogen bonding, hydrophobic forces, backbone conformation and side-chain entropy. From the data we also obtain a map of the interaction network in this protein, which reveals the source of folding cooperativity. Our approach can be extended to other proteins with marginal barriers ( less than 3RT), providing a new tool for the study of protein folding.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Munoz, V (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	vmunoz@umd.edu	Sadqi, Mourad/J-3180-2018	Sadqi, Mourad/0000-0003-3553-3408				Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; Arai M, 1996, FOLD DES, V1, P275, DOI 10.1016/S1359-0278(96)00041-7; BRYNGELSON JD, 1995, PROTEINS STRUCT DESI, V1, P167; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; Goldenberg David P., 1992, P353; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Holtzer ME, 1997, BIOPHYS J, V73, P1031, DOI 10.1016/S0006-3495(97)78136-0; HONIG B, 1995, ADV PROTEIN CHEM, V46, P27, DOI 10.1016/S0065-3233(08)60331-9; Klimov DK, 2002, J COMPUT CHEM, V23, P161, DOI 10.1002/jcc.10005; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; MATTHEWS BW, 1993, CURR OPIN STRUC BIOL, V3, P589, DOI 10.1016/0959-440X(93)90088-3; Munoz V, 2004, P NATL ACAD SCI USA, V101, P17646, DOI 10.1073/pnas.0405829101; Munoz V, 2002, INT J QUANTUM CHEM, V90, P1522, DOI 10.1002/qua.10384; Naganathan AN, 2005, BIOCHEMISTRY-US, V44, P7435, DOI 10.1021/bi050118y; Naganathan AN, 2005, J AM CHEM SOC, V127, P480, DOI 10.1021/ja044449u; Oliva FY, 2004, J AM CHEM SOC, V126, P8596, DOI 10.1021/ja048309w; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Plotkin SS, 1997, J CHEM PHYS, V106, P2932, DOI 10.1063/1.473355; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Shimizu S, 2002, PROTEINS, V48, P15, DOI 10.1002/prot.10108; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	29	212	212	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					317	321		10.1038/nature04859	http://dx.doi.org/10.1038/nature04859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16799571				2022-12-28	WOS:000239122100042
J	Condit, R; Ashton, P; Bunyavejchewin, S; Dattaraja, HS; Davies, S; Esufali, S; Ewango, C; Foster, R; Gunatilleke, IAUN; Gunatilleke, CVS; Hall, P; Harms, KE; Hart, T; Hernandez, C; Hubbell, S; Itoh, A; Kiratiprayoon, S; LaFrankie, J; de Lao, SL; Makana, JR; Noor, MNS; Kassim, AR; Russo, S; Sukumar, R; Samper, C; Suresh, HS; Tan, S; Thomas, S; Valencia, R; Vallejo, M; Villa, G; Zillio, T				Condit, Richard; Ashton, Peter; Bunyavejchewin, Sarayudh; Dattaraja, H. S.; Davies, Stuart; Esufali, Shameema; Ewango, Corneille; Foster, Robin; Gunatilleke, I. A. U. N.; Gunatilleke, C. V. S.; Hall, Pamela; Harms, Kyle E.; Hart, Terese; Hernandez, Consuelo; Hubbell, Stephen; Itoh, Akira; Kiratiprayoon, Somboon; LaFrankie, James; de Lao, Suzanne Loo; Makana, Jean-Remy; Noor, Md. Nur Supardi; Kassim, Abdul Rahman; Russo, Sabrina; Sukumar, Raman; Samper, Cristian; Suresh, Hebbalalu S.; Tan, Sylvester; Thomas, Sean; Valencia, Renato; Vallejo, Martha; Villa, Gorky; Zillio, Tommaso			The importance of demographic niches to tree diversity	SCIENCE			English	Article							PLANT COMMUNITIES; SPECIES-RICHNESS; TROPICAL FOREST; LONG-TERM; DYNAMICS; RATES; DISTRIBUTIONS; COEXISTENCE; COMPETITION	Most ecological hypotheses about species coexistence hinge on species differences, but quantifying trait differences across species in diverse communities is often unfeasible. We examined the variation of demographic traits using a global tropical forest data set covering 4500 species in 10 large-scale tree inventories. With a hierarchical Bayesian approach, we quantified the distribution of mortality and growth rates of all tree species at each site. This allowed us to test the prediction that demographic differences facilitate species richness, as suggested by the theory that a tradeoff between high growth and high survival allows species to coexist. Contrary to the prediction, the most diverse forests had the least demographic variation. Although demographic differences may foster coexistence, they do not explain any of the 16-fold variation in tree species richness observed across the tropics.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Unit 0948, APO, AA 34002 USA; Harvard Univ Herbaria, Ctr Trop Forest Sci, Asia Program, Arnold Arboretum Asia Program, Cambridge, MA 02138 USA; Thai Natl Pk Wildlife & Plant Conservat Dept, Res Off, Bangkok 10900, Thailand; Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; Univ Peradeniya, Fac Sci, Dept Bot, Peradeniya 20400, Sri Lanka; Univ Missouri, St Louis, MO 63121 USA; Field Museum, Dept Bot, Chicago, IL 60605 USA; Florida State Univ, Dept Biol, Tallahassee, FL 32309 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Wildlife Conservat Soc, Kinshasa 1, DEM REP CONGO; Pontificia Univ Catolica Ecuador, Quito, Ecuador; Univ Georgia, Dept Plant Sci, Athens, GA 30602 USA; Osaka City Univ, Fac Sci, Plant Ecol Lab, Sumiyoshi Ku, Osaka 558, Japan; Thammasat Univ Rangsit, Fac Sci & Technol, Pathum Thani 12121, Thailand; Nanyang Technol Univ, Ctr Trop Forest Sci, Asia Program, Natl Inst Educ, Singapore 637616, Singapore; Forest Res Inst, Forest Environm Div, Kuala Lumpur 52109, Malaysia; Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; Sarawak forest Dept, Forest Res Ctr, Kuching 93250, Sarawak, Malaysia; Univ Toronto, Toronto, ON M5S 3B3, Canada; Inst Alexander von Humboldt, Bogota, Colombia	National Center for Ecological Analysis & Synthesis; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Indian Institute of Science (IISC) - Bangalore; University of Peradeniya; University of Missouri System; University of Missouri Saint Louis; Field Museum of Natural History (Chicago); State University System of Florida; Florida State University; Louisiana State University System; Louisiana State University; Pontificia Universidad Catolica del Ecuador; University System of Georgia; University of Georgia; Osaka Metropolitan University; Thammasat University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; Institute Penyelidikan Perhutanan Malaysia; Smithsonian Institution; Smithsonian National Museum of Natural History; Jabatan Hutan Sarawak; Pusat Penyelidikan Hutan; University of Toronto	Condit, R (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	condit@ctfs.si.edu	Bunyavejchewin, Sarayudh/P-1529-2017; Raman, Sukumar/C-9809-2013; THOMAS, Sean C./B-6089-2008	Bunyavejchewin, Sarayudh/0000-0002-1976-5041; THOMAS, Sean C./0000-0002-0686-2483; Makana, Jean-Remy/0000-0002-6006-2938; Esufali, Shameema/0000-0002-6522-0050; Valencia, Renato/0000-0001-9770-6568				Bolker BM, 2003, AM NAT, V162, P135, DOI 10.1086/376575; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Gelman Andrew, 1995, BAYESIAN DATA ANAL; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; HUBBELL SP, IN PRESS ECOLOGY; Liermann M, 1997, CAN J FISH AQUAT SCI, V54, P1976, DOI 10.1139/cjfas-54-9-1976; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Sukumar R, 1998, MAN BIOSPH, V20, P495; SWAINE MD, 1987, J TROP ECOL, V3, P359, DOI 10.1017/S0266467400002339; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TILMAN D, 1988; Vanclay J. K., 1991, Journal of Tropical Forest Science, V4, P15; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	24	189	233	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					98	101		10.1126/science.1124712	http://dx.doi.org/10.1126/science.1124712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16763113	Green Published			2022-12-28	WOS:000238850200040
J	McMahon, JA; Green, TJ; Skeaff, CM; Knight, RG; Mann, JI; Williams, SM				McMahon, Jennifer A.; Green, Timothy J.; Skeaff, C. Murray; Knight, Robert G.; Mann, Jim I.; Williams, Sheila M.			A controlled trial of homocysteine lowering and cognitive performance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMA TOTAL HOMOCYSTEINE; VITAMIN-B STATUS; ELDERLY POPULATION; ALZHEIMERS-DISEASE; FOLATE-DEFICIENCY; FOLIC-ACID; SERUM; DECLINE; DEMENTIA; RISK	BACKGROUND: The results of observational studies suggest that plasma homocysteine concentrations are inversely related to cognitive function in older people. Our objective was to test the hypothesis that lowering the plasma homocysteine concentration improves cognitive function in healthy older people. METHODS: We conducted a two-year, double-blind, placebo-controlled, randomized clinical trial involving 276 healthy participants, 65 years of age or older, with plasma homocysteine concentrations of at least 13 micromol per liter. Homocysteine-lowering treatment was a daily supplement containing folate (1000 microg) and vitamins B(sub 12) (500 microg) and B(sub 6) (10 mg). Tests of cognition were conducted at baseline and after one and two years of treatment. Treatment effects were adjusted for baseline values, sex, and education. RESULTS: On average, during the course of the study, the plasma homocysteine concentration was 4.36 micromol per liter (95 percent confidence interval, 3.81 to 4.91 micromol per liter) lower in the vitamin group than in the placebo group (P<0.001). Overall, there were no significant differences between the vitamin and placebo groups in the scores on tests of cognition. CONCLUSIONS: The results of this trial do not support the hypothesis that homocysteine lowering with B vitamins improves cognitive performance.	Univ Otago, Dept Human Nutr, Dunedin, New Zealand; Univ Otago, Dept Psychol, Dunedin, New Zealand; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Skeaff, CM (corresponding author), Univ Otago, Dept Human Nutr, POB 56, Dunedin, New Zealand.	murray.skeaff@stonebow.otago.ac.nz	Green, Tim J/E-5043-2010; Skeaff, Clark/C-2713-2009; Williams, Sheila/L-4028-2019; Green, Tim/AAA-8601-2019	Green, Tim/0000-0002-0667-4300				Benton AL., 1983, MULTILINGUAL APHASIA; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Budge M, 2000, ANN NY ACAD SCI, V903, P407, DOI 10.1111/j.1749-6632.2000.tb06392.x; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Clarke R, 2003, J INTERN MED, V254, P67, DOI 10.1046/j.1365-2796.2003.01154.x; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; Duthie SJ, 2002, AM J CLIN NUTR, V75, P908, DOI 10.1093/ajcn/75.5.908; Duthie SJ, 2003, AM J CLIN NUTR, V77, P523; Elias MF, 2005, AM J EPIDEMIOL, V162, P644, DOI 10.1093/aje/kwi259; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOODWIN JS, 1983, JAMA-J AM MED ASSOC, V249, P2917, DOI 10.1001/jama.249.21.2917; HERBERT V, 1962, T ASSOC AM PHYSICIAN, V75, P307; Joosten E, 1997, J GERONTOL A-BIOL, V52, pM76, DOI 10.1093/gerona/52A.2.M76; Kado DM, 2005, AM J MED, V118, P161, DOI 10.1016/j.amjmed.2004.08.019; Lewerin C, 2005, AM J CLIN NUTR, V81, P1155; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lindeman RD, 2000, J AM COLL NUTR, V19, P68, DOI 10.1080/07315724.2000.10718916; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; McCaddon A, 2001, DEMENT GERIATR COGN, V12, P309, DOI 10.1159/000051275; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; Mitrushina MN, 1999, HDB NORMATIVE DATA N, DOI DOI 10.1016/S1474-4422(06)70630-5; Mooijaart SP, 2005, AM J CLIN NUTR, V82, P866, DOI 10.1093/ajcn/82.4.866; Morris MS, 2005, BONE, V37, P234, DOI 10.1016/j.bone.2005.04.017; Morris MS, 2001, AM J CLIN NUTR, V73, P927; Nelson H., 1991, NATL ADULT READING T; Nurk E, 2005, ANN NEUROL, V58, P847, DOI 10.1002/ana.20645; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Ravaglia G, 2003, AM J CLIN NUTR, V77, P668, DOI 10.1093/ajcn/77.3.668; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Riggs KM, 1996, AM J CLIN NUTR, V63, P306, DOI 10.1093/ajcn/63.3.306; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Selhub J, 2000, AM J CLIN NUTR, V71, p614S; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird	35	295	299	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2764	2772		10.1056/NEJMoa054025	http://dx.doi.org/10.1056/NEJMoa054025			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807413				2022-12-28	WOS:000238584700004
J	Garb, JE; DiMauro, T; Vo, V; Hayashi, CY				Garb, Jessica E.; DiMauro, Teresa; Vo, Victoria; Hayashi, Cheryl Y.			Silk genes support the single origin of orb webs	SCIENCE			English	Article							SPIDER SILK		Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Garb, JE (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	jessica.garb@ucr.edu	Garb, Jessica E/J-4566-2015					Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1; Platnick N. I., 1991, AM MUS NOVIT, V3016, P1; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; Shear W. A., 1986, SPIDERS WEBS BEHAV E; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	6	74	77	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1762	1762		10.1126/science.1127946	http://dx.doi.org/10.1126/science.1127946			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794073	Green Submitted			2022-12-28	WOS:000238452800047
J	Pearce, EN				Pearce, Elizabeth N.			Diagnosis and management of thyrotoxicosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTITHYROID DRUGS; RADIOIODINE THERAPY; THYROID-FUNCTION; GRAVES-DISEASE; PROPYLTHIOURACIL; METHIMAZOLE; MOTHERS; INFANTS; AGE		Boston Univ, Med Ctr, Boston, MA 02118 USA	Boston University	Pearce, EN (corresponding author), Boston Univ, Med Ctr, 88 E Newton St,Evans 201, Boston, MA 02118 USA.	elizabeth.pearce@bmc.org		Pearce, Elizabeth/0000-0003-3799-0354				Abraham P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003420.pub3; Azizi F, 2000, J CLIN ENDOCR METAB, V85, P3233, DOI 10.1210/jc.85.9.3233; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; Bonnema SJ, 2002, EUR J ENDOCRINOL, V147, P1, DOI 10.1530/eje.0.1470001; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; COOPER DS, 1983, ANN INTERN MED, V98, P26, DOI 10.7326/0003-4819-98-1-26; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Diav-Citrin O, 2002, TERATOLOGY, V65, P38, DOI 10.1002/tera.1095.abs; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; He CT, 2004, CLIN ENDOCRINOL, V60, P676, DOI 10.1111/j.1365-2265.2004.02032.x; HOLM LE, 1981, ACTA RADIOL ONCOL, V20, P161, DOI 10.3109/02841868109130191; Momotani N, 1997, J CLIN ENDOCR METAB, V82, P3633, DOI 10.1210/jc.82.11.3633; Momotani N, 2000, CLIN ENDOCRINOL, V53, P177, DOI 10.1046/j.1365-2265.2000.01078.x; Mortimer RH, 1997, J CLIN ENDOCR METAB, V82, P3099, DOI 10.1210/jc.82.9.3099; Muller AF, 2001, ENDOCR REV, V22, P605, DOI 10.1210/er.22.5.605; Noh JY, 2001, CLIN ENDOCRINOL, V54, P651, DOI 10.1046/j.1365-2265.2001.01282.x; Nygaard B, 1999, ARCH INTERN MED, V159, P1364, DOI 10.1001/archinte.159.12.1364; Palit TK, 2000, J SURG RES, V90, P161, DOI 10.1006/jsre.2000.5875; Papi G, 2005, AM J MED, V118, P349, DOI 10.1016/j.amjmed.2005.01.004; Pearce EN, 2003, NEW ENGL J MED, V348, P2646, DOI 10.1056/NEJMra021194; Streetman DD, 2003, ANN PHARMACOTHER, V37, P1100, DOI 10.1345/aph.1C299; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Toft AD, 2001, NEW ENGL J MED, V345, P512, DOI 10.1056/NEJMcp010145; WEETMAN AP, 1984, CLIN ENDOCRINOL, V21, P163, DOI 10.1111/j.1365-2265.1984.tb03456.x; Woeber Kenneth A, 2002, Endocr Pract, V8, P222	25	52	58	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2006	332	7554					1369	1373		10.1136/bmj.332.7554.1369	http://dx.doi.org/10.1136/bmj.332.7554.1369			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763249	Green Published			2022-12-28	WOS:000238587000022
J	Long, JA; Ohno, C; Smith, ZR; Meyerowitz, EM				Long, JA; Ohno, C; Smith, ZR; Meyerowitz, EM			TOPLESS regulates apical embryonic fate in Arabidopsis	SCIENCE			English	Article							HISTONE ACETYLTRANSFERASE; THALIANA; MERISTEM; GENE; EMBRYOGENESIS; SHOOT; COREPRESSOR; EXPRESSION; DYNAMICS; ENCODES	The embryos of seed plants develop with an apical shoot pole and a basal root pole. In Arabidopsis, the topless-1 (tpl-1) mutation transforms the shoot pole into a second root pole. Here, we show that TPL resembles known transcriptional corepressors and that tpl-1 acts as a dominant negative mutation for multiple TPL-related proteins. Mutations in the putative coactivator HISTONE ACETYLTRANSFERASE GNAT SUPERFAMILY1 suppress the tpl-1 phenotype. Mutations in HISTONE DEACETYLASE19, a putative corepressor, increase the penetrance of tpl-1 and display similar apical defects. These data point to a transcriptional repression mechanism that prevents root formation in the shoot pole during Arabidopsis embryogenesis.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Salk Institute; California Institute of Technology	Long, JA (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	long@salk.edu	Meyerowitz, Elliot M/A-7118-2009		NIGMS NIH HHS [GM45697, R01 GM072764, GM072764] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aida M, 1999, DEVELOPMENT, V126, P1563; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BARTON MK, 1993, DEVELOPMENT, V119, P823; Bertrand C, 2003, J BIOL CHEM, V278, P28246, DOI 10.1074/jbc.M302787200; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; GOODNER B, 1993, PLANT CELL, V5, P1471; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Laux T, 1996, DEVELOPMENT, V122, P87; Long JA, 2002, DEVELOPMENT, V129, P2797; Long JA, 1998, DEVELOPMENT, V125, P3027; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; OHNO C, COMMUNICATION; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998; Vlachonasios KE, 2003, PLANT CELL, V15, P626, DOI 10.1105/tpc.007922; Wu KQ, 2000, PLANT J, V22, P19, DOI 10.1046/j.1365-313x.2000.00711.x; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	27	361	393	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1520	1523		10.1126/science.1123841	http://dx.doi.org/10.1126/science.1123841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763149				2022-12-28	WOS:000238124100047
J	Cabal, GG; Genovesio, A; Rodriguez-Navarro, S; Zimmer, C; Gadal, O; Lesne, A; Buc, H; Feuerbach-Fournier, F; Olivo-Marin, JC; Hurt, EC; Nehrbass, U				Cabal, Ghislain G.; Genovesio, Auguste; Rodriguez-Navarro, Susana; Zimmer, Christophe; Gadal, Olivier; Lesne, Annick; Buc, Henri; Feuerbach-Fournier, Frank; Olivo-Marin, Jean-Christophe; Hurt, Eduard C.; Nehrbass, Ulf			SAGA interacting factors confine sub-diffusion of transcribed genes to the nuclear envelope	NATURE			English	Article							RNA EXPORT MACHINERY; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; DISORDERED MEDIA; IN-VIVO; ORGANIZATION; COMPLEX; LOCALIZATION; RECRUITMENT; PROTEINS	Changes in the transcriptional state of genes have been correlated with their repositioning within the nuclear space(1). Tethering reporter genes to the nuclear envelope alone can impose repression(2) and recent reports have shown that, after activation, certain genes can also be found closer to the nuclear periphery(3-6). The molecular mechanisms underlying these phenomena have remained elusive. Here, with the use of dynamic three-dimensional tracking of a single locus in live yeast ( Saccharomyces cerevisiae) cells, we show that the activation of GAL genes ( GAL7, GAL10 and GAL1) leads to a confinement in dynamic motility. We demonstrate that the GAL locus is subject to sub-diffusive movement, which after activation can become constrained to a two-dimensional sliding motion along the nuclear envelope. RNA-fluorescence in situ hybridization analysis after activation reveals a higher transcriptional activity for the peripherally constrained GAL genes than for loci remaining intranuclear. This confinement was mediated by Sus1 and Ada2, members of the SAGA histone acetyltransferase complex, and Sac3, a messenger RNA export factor, physically linking the activated GAL genes to the nuclear-pore-complex component Nup1. Deleting ADA2 or NUP1 abrogates perinuclear GAL confinement without affecting GAL1 transcription. Accordingly, transcriptional activation is necessary but not sufficient for the confinement of GAL genes at the nuclear periphery. The observed real-time dynamic mooring of active GAL genes to the inner side of the nuclear pore complex is in accordance with the 'gene gating' hypothesis(7).	Inst Pasteur Korea, Seoul 136791, South Korea; Inst Pasteur, Unite Biol Cellulaire Noyau, F-75724 Paris 15, France; Inst Pasteur, Unite Anal Images Quantitat, F-75724 Paris 15, France; Inst Pasteur, Dept Biol Cellulaire & Infect, F-75724 Paris 15, France; Univ Heidelberg BZH, Zentrum Biochem, D-69120 Heidelberg, Germany; Lab Phys Theor Mat Condensee, F-75252 Paris 05, France	Institut Pasteur Korea; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ruprecht Karls University Heidelberg	Nehrbass, U (corresponding author), Inst Pasteur Korea, 39-1 Hawolgok Dong, Seoul 136791, South Korea.	jcolivo@pasteur.fr; cg5@ix.urz.uni-heidelberg.de; nehrbass@pasteur.fr	GENOVESIO, Auguste/I-1656-2017; Ed Hurt, Dr./AAE-8874-2019; Rodríguez-Navarro, Susana/B-5182-2014; Gadal, Olivier/A-4731-2008; Olivo-Marin, Jean-Christophe/K-4428-2015; Lesne, Annick/W-9444-2018	Ed Hurt, Dr./0000-0002-4535-8255; Rodríguez-Navarro, Susana/0000-0001-7472-3111; Gadal, Olivier/0000-0001-9421-0831; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; feuerbach, frank/0000-0002-8631-5120; Lesne, Annick/0000-0002-6647-612X; Nehrbass, Ulf/0000-0002-7028-8076; Genovesio, Auguste/0000-0003-1877-5595; Cabal, Ghislain/0000-0002-9728-506X				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Havlin S, 2002, ADV PHYS, V51, P187, DOI 10.1080/00018730110116353; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6	20	354	365	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					770	773		10.1038/nature04752	http://dx.doi.org/10.1038/nature04752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760982				2022-12-28	WOS:000238095100059
J	Joiner, WJ; Crocker, A; White, BH; Sehgal, A				Joiner, William J.; Crocker, Amanda; White, Benjamin H.; Sehgal, Amita			Sleep in Drosophila is regulated by adult mushroom bodies	NATURE			English	Article							SHORT-TERM-MEMORY; LOCOMOTOR-ACTIVITY; REST; EXPRESSION; ABLATION	Sleep is one of the few major whole-organ phenomena for which no function and no underlying mechanism have been conclusively demonstrated. Sleep could result from global changes in the brain during wakefulness or it could be regulated by specific loci that recruit the rest of the brain into the electrical and metabolic states characteristic of sleep. Here we address this issue by exploiting the genetic tractability of the fruitfly, Drosophila melanogaster, which exhibits the hallmarks of vertebrate sleep(1-4). We show that large changes in sleep are achieved by spatial and temporal enhancement of cyclic-AMP-dependent protein kinase ( PKA) activity specifically in the adult mushroom bodies of Drosophila. Other manipulations of the mushroom bodies, such as electrical silencing, increasing excitation or ablation, also alter sleep. These results link sleep regulation to an anatomical locus known to be involved in learning and memory.	Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; NIMH, Mol Biol Lab, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Sehgal, A (corresponding author), Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [R01 NS072431] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong JD, 1998, LEARN MEMORY, V5, P102; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Joiner MLA, 1999, LEARN MEMORY, V6, P177; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Martin JR, 1998, LEARN MEMORY, V5, P179; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	30	318	322	0	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					757	760		10.1038/nature04811	http://dx.doi.org/10.1038/nature04811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760980				2022-12-28	WOS:000238095100056
J	Philip, P; Taillard, J; Moore, N; Delord, S; Valtat, C; Sagaspe, P; Bioulac, B				Philip, Pierre; Taillard, Jacques; Moore, Nicholas; Delord, Sandrine; Valtat, Cedric; Sagaspe, Patricia; Bioulac, Bernard			The effects of coffee and napping on nighttime highway driving - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							AUTOMOBILE DRIVERS; SLEEP-DEPRIVATION; VEHICLE ACCIDENTS; TRUCK DRIVERS; FATIGUE; PERFORMANCE; WORK; CAFFEINE; CRASHES; RISK	Background: Sleep-related accidents often involve healthy young persons who are driving at night. Coffee and napping restore alertness, but no study has compared their effects on real nighttime driving performances. Objective: To test the effects of 125 mL of coffee (half a cup) containing 200 mg of caffeine, placebo (decaffeinated coffee containing 15 mg of caffeine), or a 30-minute nap (at 1:00 a.m.) in a car on nighttime driving performance. Design: Double-blind, randomized, crossover study. Setting: Sleep laboratory and open highway. Participants: 12 young men (mean age, 21.3 years [SD, 1.8]). Measurements: Self-rated fatigue and sleepiness, inappropriate line crossings from video recordings during highway driving, and polysomnographic recordings during the nap and subsequent sleep. Intervention: Participants drove 200 km (125 miles) between 6:00 p.m. and 7:30 p.m. (daytime reference condition) or between 2:00 a.m. and 3:30 a.m. (coffee, decaffeinated coffee, or nap condition). After intervention, participants returned to the laboratory to sleep. Results: Nighttime driving performance was similar to daytime performance (0 to 1 line crossing) for 75% of participants after coffee (0 or 1 line crossing), for 66% after the nap (P = 0.66 vs. coffee), and for only 13% after placebo (P = 0.041 vs. nap; P = 0.014 vs. coffee). The incidence rate ratios for having a line crossing after placebo were 3.7 (95% Cl, 1.2 to 11.0; P = 0.001) compared with coffee and 2.9 (Cl, 1.7 to 5.1; P = 0.021) compared with nap. A statistically significant interindividual variability was observed in response to sleep deprivation and countermeasures. Sleep latencies and efficiency during sleep after nighttime driving were similar in the 3 conditions. Limitations: Only 1 dose of coffee and 1 nap duration were tested. Effects may differ in other patient or age groups. Conclusions: Drinking coffee or napping at night statistically significantly reduces driving impairment without altering subsequent sleep.	CHU Bordeaux, Bordeaux, France; Univ Victor Segalen, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Philip, P (corresponding author), CHU Pellegrin, Clim Sommeil, UMR 5543, CNRS, Pl Arnelie Raba Leon, F-33076 Bordeaux, France.	pierrephilip@compuserve.com	Moore, Nicholas/B-2368-2013; Taillard, Jacques/H-5063-2018	Moore, Nicholas/0000-0003-1212-2817; Taillard, Jacques/0000-0001-9067-8189; SAGASPE, Patricia/0000-0003-2845-1199; PHILIP, Pierre/0000-0003-3267-634X				Arnold PK, 1997, ACCIDENT ANAL PREV, V29, P471, DOI 10.1016/S0001-4575(97)00026-2; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; D'amicis A., 1993, CAFFEINE COFFEE HLTH, P1; Delafosse JY, 2000, REV NEUROL, V156, P641; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; HARRISON JE, 1993, ACCIDENT ANAL PREV, V25, P443, DOI 10.1016/0001-4575(93)90073-6; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Horne JA, 2001, AMINO ACIDS, V20, P83, DOI 10.1007/s007260170068; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lamberg L, 2002, JAMA-J AM MED ASSOC, V287, P303, DOI 10.1001/jama.287.3.303; Leproult R, 2003, AM J PHYSIOL-REG I, V284, pR280, DOI 10.1152/ajpregu.00197.2002; Menzin J, 2001, PHARMACOECONOMICS, V19, P69, DOI 10.2165/00019053-200119010-00005; Mitler MM, 1997, NEW ENGL J MED, V337, P755, DOI 10.1056/NEJM199709113371106; OHANLON JF, 1995, NEUROPSYCHOBIOLOGY, V31, P81, DOI 10.1159/000119177; OHANLON JF, 1986, ACTA PSYCHIAT SCAND, V74, P95, DOI 10.1111/j.1600-0447.1986.tb08985.x; Pack AI, 1995, ACCIDENT ANAL PREV, V27, P769, DOI 10.1016/0001-4575(95)00034-8; PARTINEN M, 1995, J SLEEP RES, V4, P150, DOI 10.1111/j.1365-2869.1995.tb00205.x; Personick M, 1997, Stat Bull Metrop Insur Co, V78, P19; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 1999, J SLEEP RES, V8, P9, DOI 10.1046/j.1365-2869.1999.00127.x; Philip P, 1996, J PSYCHOSOM RES, V41, P279, DOI 10.1016/0022-3999(96)00127-4; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; RAMAEKERS JG, 1992, EUR J CLIN PHARMACOL, V42, P363; RAMAEKERS JG, 1994, EUR J CLIN PHARMACOL, V47, P261, DOI 10.1007/BF02570506; Reyner LA, 2000, PSYCHOPHYSIOLOGY, V37, P251, DOI 10.1017/S0048577200000949; Reyner LA, 1997, PSYCHOPHYSIOLOGY, V34, P721, DOI 10.1111/j.1469-8986.1997.tb02148.x; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Van Dongen HPA, 2004, SLEEP, V27, P423; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116	37	119	125	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					785	791		10.7326/0003-4819-144-11-200606060-00004	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049ZN	16754920				2022-12-28	WOS:000238057000001
J	Meynert, A; Birney, E				Meynert, Alison; Birney, Ewan			Picking pyknons out of the human genome	CELL			English	Editorial Material							DISCOVERY; MOTIFS		European Bioinformat Inst, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL)	Birney, E (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	birney@ebi.ac.uk		Birney, Ewan/0000-0001-8314-8497				Ettwiller L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r104; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Smit A, 1996, REPEATMASKER OPEN 30; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	8	7	7	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					836	838		10.1016/j.cell.2006.05.019	http://dx.doi.org/10.1016/j.cell.2006.05.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751093	Bronze			2022-12-28	WOS:000238116400010
J	Truman, JW; Hiruma, K; Allee, JP; MacWhinnie, SGB; Champlin, DT; Riddiford, LM				Truman, JW; Hiruma, K; Allee, JP; MacWhinnie, SGB; Champlin, DT; Riddiford, LM			Juvenile hormone is required to couple imaginal disc formation with nutrition in insects	SCIENCE			English	Article							MANDUCA-SEXTA L; TOBACCO HORNWORM; BROAD-COMPLEX; METAMORPHOSIS; DROSOPHILA; GROWTH; SIZE; EPIDERMIS; EXPRESSION; WEIGHT	In starved larvae of the tobacco hornworm moth Manduca sexta, larval and imaginal tissues stop growing, the former because they lack nutrient-dependent signals but the latter because of suppression by juvenile hormone. Without juvenile hormone, imaginal discs form and grow despite severe starvation. This hormone inhibits the intrinsic signaling needed for disc morphogenesis and does so independently of ecdysteroid action. Starvation and juvenile hormone treatments allowed the separation of intrinsic and nutrient-dependent aspects of disc growth and showed that both aspects must occur during the early phases of disc morphogenesis to ensure normal growth leading to typical-sized adults.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA	University of Washington; University of Washington Seattle; Hirosaki University; University of Maine System; University of Southern Maine	Truman, JW (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jwt@u.washington.edu		Riddiford, Lynn/0000-0002-3026-7430				ALLEE JP, IN PRESS J INSECT PH; Biggers WJ, 1996, ARCH INSECT BIOCHEM, V32, P475, DOI 10.1002/(SICI)1520-6327(1996)32:3/4<475::AID-ARCH19>3.0.CO;2-9; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Champlin DT, 1998, DEVELOPMENT, V125, P2009; Cohen Stephen M., 1993, P747; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; CYMBOROWSKI B, 1982, J INSECT PHYSIOL, V28, P129, DOI 10.1016/0022-1910(82)90120-2; Day SJ, 2000, DEVELOPMENT, V127, P2977; Erezyilmaz DF, 2004, DEV GENES EVOL, V214, P313, DOI 10.1007/s00427-004-0408-2; Fristrom Dianne, 1993, P843; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; HATAKOSHI M, 1988, J INSECT PHYSIOL, V34, P373, DOI 10.1016/0022-1910(88)90106-0; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; MacWhinnie SGB, 2005, DEV BIOL, V285, P285, DOI 10.1016/j.ydbio.2005.06.021; MILES CI, 1993, DEV BIOL, V155, P147, DOI 10.1006/dbio.1993.1014; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; NARDI JB, 1985, TISSUE CELL, V17, P473, DOI 10.1016/0040-8166(85)90026-6; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; RIDDIFORD LM, 1994, ADV INSECT PHYSL, V24, P211; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sawaya AL, 2004, NUTR REV, V62, pS127, DOI 10.1111/j.1753-4887.2004.tb00082.x; SVACHA P, 1992, DEV BIOL, V154, P101, DOI 10.1016/0012-1606(92)90052-I; Tanaka K, 2005, DEV GENES EVOL, V215, P78, DOI 10.1007/s00427-004-0458-5; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; WILLIAMS CM, 1961, BIOL BULL-US, V121, P572, DOI 10.2307/1539456; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143	31	115	123	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1385	1388		10.1126/science.1123652	http://dx.doi.org/10.1126/science.1123652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741122				2022-12-28	WOS:000237961600057
J	Pregueiro, AM; Liu, QY; Baker, CL; Dunlap, JC; Loros, JJ				Pregueiro, Antonio M.; Liu, Qiuyun; Baker, Christopher L.; Dunlap, Jay C.; Loros, Jennifer J.			The Neurospora checkpoint kinase 2: A regulatory link between the circadian and cell cycles	SCIENCE			English	Article							TUMOR SUPPRESSION; PERIOD LENGTH; CLOCK; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION; EXPRESSION; FREQUENCY; GENES; PLAYS	The clock gene period-4 (prd-4) in Neurospora was identified by a single allele displaying shortened circadian period and altered temperature compensation. Positional cloning followed by functional tests show that PRD-4 is an ortholog of mammalian checkpoint kinase 2 (Chk2). Expression of prd-4 is regulated by the circadian clock and, reciprocally, PRD-4 physically interacts with the clock component FRQ, promoting its phosphorylation. DNA-damaging agents can reset the clock in a manner that depends on time of day, and this resetting is dependent on PRD-4. Thus, prd-4, the Neurospora Chk2, identifies a molecular link that feeds back conditionally from circadian output to input and the cell cycle.	Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Zhongshan Univ, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Peoples R China; Zhongshan Univ, Biotechnol Res Ctr, Guangzhou 510275, Peoples R China	Dartmouth College; Dartmouth College; Sun Yat Sen University; Sun Yat Sen University	Dunlap, JC (corresponding author), Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA.	jay.c.dunlap@dartmouth.edu; jennifer.loros@dartmouth.edu	Dunlap, Jay/L-6232-2013; Loros, Jennifer/B-6293-2014	Dunlap, Jay/0000-0003-1577-0457; Liu, Qiuyun/0000-0001-5533-0128	NIGMS NIH HHS [R01 GM034985, P01 GM068087, R37GM34985] Funding Source: Medline; NIMH NIH HHS [MH44651] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034985, R01GM034985, P01GM068087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Anderson LE, 2000, CANCER LETT, V148, P121, DOI 10.1016/S0304-3835(99)00320-1; ARONSON BD, 1992, CHRONOBIOL INT, V9, P231, DOI 10.3109/07420529209064532; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bjarnason GA, 2000, PROG CELL CYC RES, V4, P193; Cardone L, 2003, NAT CELL BIOL, V5, P859, DOI 10.1038/ncb1003-859; Chehab NH, 2000, GENE DEV, V14, P278; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; DUNLAP JC, 2004, CHRONOBIOLOGY BIOL T, P210; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; GARDNER GF, 1981, PLANT PHYSIOL, V68, P1244, DOI 10.1104/pp.68.6.1244; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hrushesky WJM, 2001, J CONTROL RELEASE, V74, P27, DOI 10.1016/S0168-3659(01)00307-8; Krucher NA, 1997, CELL MOL NEUROBIOL, V17, P495, DOI 10.1023/A:1026358821640; Lee CC, 2005, METHOD ENZYMOL, V393, P852, DOI 10.1016/S0076-6879(05)93045-0; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; LIU Q, 1991, THESIS DARTMOUTH; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2001, CANCER RES, V61, P5362; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Suda M, 1979, BIOL RHYTHMS THEIR C, P57; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	37	110	113	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					644	649		10.1126/science.1121716	http://dx.doi.org/10.1126/science.1121716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16809488				2022-12-28	WOS:000239667500036
J	Tanaka, M; Collins, SR; Toyama, BH; Weissman, JS				Tanaka, Motomasa; Collins, Sean R.; Toyama, Brandon H.; Weissman, Jonathan S.			The physical basis of how prion conformations determine strain phenotypes	NATURE			English	Article							YEAST PSI+ PRION; GUANIDINE-HYDROCHLORIDE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-BASIS; IN-VITRO; PROTEIN; GENERATION; HSP104; TRANSMISSION; REPLICATION	A principle that has emerged from studies of protein aggregation is that proteins typically can misfold into a range of different aggregated forms. Moreover, the phenotypic and pathological consequences of protein aggregation depend critically on the specific misfolded form(1,2). A striking example of this is the prion strain phenomenon, in which prion particles composed of the same protein cause distinct heritable states(3). Accumulating evidence from yeast prions such as [PSI+] and mammalian prions argues that differences in the prion conformation underlie prion strain variants(3-7). Nonetheless, it remains poorly understood why changes in the conformation of misfolded proteins alter their physiological effects. Here we present and experimentally validate an analytical model describing how [PSI+] strain phenotypes arise from the dynamic interaction among the effects of prion dilution, competition for a limited pool of soluble protein, and conformation-dependent differences in prion growth and division rates. Analysis of three distinct prion conformations of yeast Sup35 ( the [PSI+] protein determinant) and their in vivo phenotypes reveals that the Sup35 amyloid causing the strongest phenotype surprisingly shows the slowest growth. This slow growth, however, is more than compensated for by an increased brittleness that promotes prion division. The propensity of aggregates to undergo breakage, thereby generating new seeds, probably represents a key determinant of their physiological impact for both infectious ( prion) and non-infectious amyloids.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Japan Science & Technology Agency (JST)	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	Tanaka, Motomasa/N-5064-2015	Tanaka, Motomasa/0000-0002-2994-7703; Weissman, Jonathan/0000-0003-2445-670X; Collins, Sean/0000-0002-4276-5840; Toyama, Brandon/0000-0002-8355-9138				Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cox B, 2003, GENETICS, V165, P23; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Derkatch IL, 1996, GENETICS, V144, P1375; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tuite MF, 2004, MOL CELL, V14, P541, DOI 10.1016/j.molcel.2004.05.012; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	30	478	481	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					585	589		10.1038/nature04922	http://dx.doi.org/10.1038/nature04922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16810177				2022-12-28	WOS:000239455900048
J	Raymo, ME; Lisiecki, LE; Nisancioglu, KH				Raymo, M. E.; Lisiecki, L. E.; Nisancioglu, Kerim H.			Plio-pleistocene ice volume, Antarctic climate, and the global delta O-18 record	SCIENCE			English	Article							SEA-LEVEL; MIDDLE PLIOCENE; HISTORY; CYCLES; SHEET; VARIABILITY; GLACIATION; TRANSITION; INSOLATION; GREENLAND	We propose that from similar to 3 to 1 million years ago, ice volume changes occurred in both the Northern and Southern Hemispheres, each controlled by local summer insolation. Because Earth's orbital precession is out of phase between hemispheres, 23,000-year changes in ice volume in each hemisphere cancel out in globally integrated proxies such as ocean delta O-18 or sea level, leaving the in-phase obliquity ( 41,000 years) component of insolation to dominate those records. Only a modest ice mass change in Antarctica is required to effectively cancel out a much larger northern ice volume signal. At the mid-Pleistocene transition, we propose that marine-based ice sheet margins replaced terrestrial ice margins around the perimeter of East Antarctica, resulting in a shift to in-phase behavior of northern and southern ice sheets as well as the strengthening of 23,000-year cyclicity in the marine delta O-18 record.	Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; Bjerknes Ctr Climate Res, N-5007 Bergen, Norway	Boston University; Bjerknes Centre for Climate Research	Raymo, ME (corresponding author), Boston Univ, Dept Earth Sci, 685 Commnwealth Ave, Boston, MA 02215 USA.	raymo@bu.ecu	Nisancioglu, Kerim/AAW-9315-2021; Raymo, Maureen E/A-1270-2012; Nisancioglu, Kerim H/E-3360-2010; Lisiecki, Lorraine/C-4066-2008	Nisancioglu, Kerim/0000-0002-5737-5765; Nisancioglu, Kerim H/0000-0002-5737-5765; 				Alley RB, 2002, QUATERNARY SCI REV, V21, P431, DOI 10.1016/S0277-3791(01)00072-5; Bassett SE, 2005, SCIENCE, V309, P925, DOI 10.1126/science.1111575; Benn D.I., 1998, GLACIERS GLACIATION; Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; COOPER AK, 2004, P OCEAN DRILL PROG S, V188, pCH1; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; DOWSETT H, 1994, GLOBAL PLANET CHANGE, V9, P169, DOI 10.1016/0921-8181(94)90015-9; DOWSETT HJ, 1990, GEOLOGY, V18, P435, DOI 10.1130/0091-7613(1990)018<0435:HESLDT>2.3.CO;2; Hodgson DA, 2006, QUATERNARY SCI REV, V25, P179, DOI 10.1016/j.quascirev.2005.03.004; HUYBERS P, IN PRESS QUAT SCI RE; Huybrechts P, 2000, ANN GLACIOL-SER, V30, P52, DOI 10.3189/172756400781820778; HUYBRECHTS P, 2001, CLIMATE 21 CENTURY C, P221; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; JOYCE JE, 1993, GEOLOGY, V21, P483, DOI 10.1130/0091-7613(1993)021<0483:NAGMHF>2.3.CO;2; JUNTTILA J, 2005, EOS T AGU S, V86; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Latimer JC, 2001, PALEOCEANOGRAPHY, V16, P627, DOI 10.1029/2000PA000586; Lee SY, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001161; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; LOURENS LJ, 1992, MAR MICROPALEONTOL, V19, P49, DOI 10.1016/0377-8398(92)90021-B; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Murphy L, 2002, PALAEOGEOGR PALAEOCL, V182, P183, DOI 10.1016/S0031-0182(01)00495-3; NISANCIOGLU K, 2004, THESIS MIT CAMBRIDGE; Paillard D, 2001, REV GEOPHYS, V39, P325, DOI 10.1029/2000RG000091; QUILTY PG, 2005, EOS T AGU S, V86; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Raymo ME, 1990, PALEOCEANOGRAPHY, V5, P367, DOI 10.1029/PA005i003p00367; Raymo ME, 1989, PALEOCEANOGRAPHY, V4, P413, DOI 10.1029/PA004i004p00413; Raymo ME, 1998, NATURE, V392, P699, DOI 10.1038/33658; RAYMO ME, 1994, ANNU REV EARTH PL SC, V22, P353, DOI 10.1146/annurev.ea.22.050194.002033; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Retallack GJ, 2001, J GEOL SOC LONDON, V158, P925, DOI 10.1144/0016-764901-030; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; Ruddiman WF, 2003, QUATERNARY SCI REV, V22, P1597, DOI 10.1016/S0277-3791(03)00087-8; RUDDIMAN WF, 1984, GEOL SOC AM BULL, V95, P381, DOI 10.1130/0016-7606(1984)95<381:ITRACR>2.0.CO;2; SCHERER RP, 2005, EOS T AGU S, V86; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Sun YB, 2006, QUATERNARY SCI REV, V25, P33, DOI 10.1016/j.quascirev.2005.07.005; THOMPSON WG, IN PRESS QUAT SCI RE; TZIPERMAN E, IN PRESS PALEOCEANOG; Venz KA, 1999, PALEOCEANOGRAPHY, V14, P42, DOI 10.1029/1998PA900013; WARDLAW BR, 1991, QUATERNARY SCI REV, V10, P247, DOI 10.1016/0277-3791(91)90023-N; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	53	279	291	6	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					492	495		10.1126/science.1123296	http://dx.doi.org/10.1126/science.1123296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16794038				2022-12-28	WOS:000239308600053
J	Schimel, D				Schimel, D			Climate change and crop yields: Beyond Cassandra	SCIENCE			English	Editorial Material									Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Schimel, D (corresponding author), Natl Ctr Atmospher Res, Climate & Global Dynam Div, POB 3000, Boulder, CO 80307 USA.	schimel@ucar.edu						Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Reilly JM, 1999, CLIMATIC CHANGE, V43, P745, DOI 10.1023/A:1005553518621	3	23	26	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2006	312	5782					1889	1890		10.1126/science.1129913	http://dx.doi.org/10.1126/science.1129913			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809520				2022-12-28	WOS:000238848100038
J	Rando, TA				Rando, Thomas A.			Stem cells, ageing and the quest for immortality	NATURE			English	Article							MURINE HEMATOPOIETIC STEM; LIFE-SPAN EXTENSION; AGE-RELATED-CHANGES; CAENORHABDITIS-ELEGANS; REPOPULATING ABILITY; DIETARY RESTRICTION; SATELLITE CELLS; DNA-REPAIR; MUSCLE; YOUNG	Adult stem cells reside in most mammalian tissues, but the extent to which they contribute to normal homeostasis and repair varies widely. There is an overall decline in tissue regenerative potential with age, and the question arises as to whether this is due to the intrinsic ageing of stem cells or, rather, to the impairment of stem-cell function in the aged tissue environment. Unravelling these distinct contributions to the aged phenotype will be critical to the success of any therapeutic application of stem cells in the emerging field of regenerative medicine with respect to tissue injury, degenerative diseases or normal functional declines that accompany ageing.	VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Rando, TA (corresponding author), VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564				Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Bortoli S, 2003, GENE, V321, P145, DOI 10.1016/j.gene.2003.08.025; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Carmel R, 2001, BLOOD REV, V15, P9, DOI 10.1054/blre.2001.0146; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; de Grey Aubrey, 2005, Stud Health Technol Inform, V118, P209; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; HARRISON DE, 1977, J IMMUNOL, V118, P1223; HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Hayflick L., 1994, WHY WE AGE; Holstein TW, 2003, DEV DYNAM, V226, P257, DOI 10.1002/dvdy.10227; Hornsby PJ, 2002, J GERONTOL A-BIOL, V57, pB251, DOI 10.1093/gerona/57.7.B251; HOTTA T, 1980, EXP HEMATOL, V8, P933; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Medawar P., 1952, UNSOLVED PROBLEM BIO; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010; Oh SH, 2002, SEMIN CELL DEV BIOL, V13, P405, DOI 10.1016/S1084952102001271; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; PHELAN JP, 1989, GROWTH DEVELOP AGING, V53, P4; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139; Snyder EY, 2005, J AM GERIATR SOC, V53, pS287, DOI 10.1111/j.1532-5415.2005.53491.x; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thorndyke MC, 2001, MICROSC RES TECHNIQ, V55, P474, DOI 10.1002/jemt.1192; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; VANZANT G, 1992, EXP HEMATOL, V20, P470; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328	68	516	540	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1080	1086		10.1038/nature04958	http://dx.doi.org/10.1038/nature04958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057SM	16810243				2022-12-28	WOS:000238615500035
J	Ruskin, R				Ruskin, R			The autopsy room	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ronaldruskinmd@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2827	2828		10.1001/jama.295.24.2827	http://dx.doi.org/10.1001/jama.295.24.2827			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057DY	16804138				2022-12-28	WOS:000238577700001
J	Cooper, H; Panza, JA				Cooper, Howard; Panza, Julio A.			Q waves to guide treatment of myocardial infarction	LANCET			English	Editorial Material							NATIONAL REGISTRY; PRIMARY ANGIOPLASTY; UNITED-STATES; THERAPY; ELEVATION; OUTCOMES		Washington Hosp Ctr, Coronary Care Unit, Washington, DC 20010 USA	MedStar Washington Hospital Center	Cooper, H (corresponding author), Washington Hosp Ctr, Coronary Care Unit, Washington, DC 20010 USA.	howard.a.cooper@medstar.net						Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Dalby M, 2003, CIRCULATION, V108, P1809, DOI 10.1161/01.CIR.0000091088.63921.8C; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Nallamothu BK, 2006, CIRCULATION, V113, P1189, DOI 10.1161/CIRCULATIONAHA.105.596346; REIMER KA, 1985, CIRC RES, V56, P651, DOI 10.1161/01.RES.56.5.651; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; White HD, 2001, LANCET, V358, P1855; Wong CK, 2006, LANCET, V367, P2061, DOI 10.1016/S0140-6736(06)68929-0; Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3	14	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2035	2037		10.1016/S0140-6736(06)68899-5	http://dx.doi.org/10.1016/S0140-6736(06)68899-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798367				2022-12-28	WOS:000238657400004
J	Steer, AC; Kado, J; Colquhoun, S; Noonan, S; Babitu, T				Steer, AC; Kado, J; Colquhoun, S; Noonan, S; Babitu, T			Awareness of rheumatic heart disease	LANCET			English	Editorial Material							FEVER		Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Melbourne, Vic 3052, Australia; Colonial War Mem Hosp, Fiji Minist Hlth, Childrens Ward, Suva, Fiji	Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Steer, AC (corresponding author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia.		Kado, Joseph Hiroshi Hisanasuke/CAA-1530-2022; Steer, Andrew C/C-2840-2013; Kado, Joseph Hiroshi Hisanasuke/CAE-9501-2022	Kado, Joseph Hiroshi Hisanasuke/0000-0003-3121-4397; Kado, Joseph Hiroshi Hisanasuke/0000-0003-3121-4397; Colquhoun, Samantha/0000-0002-6750-1147				Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1999, AUST NZ J PUBL HEAL, V23, P159, DOI 10.1111/j.1467-842X.1999.tb01227.x; PADMAVATI S, 1978, B WORLD HEALTH ORGAN, V56, P543; TOMPKINS DG, 1972, CIRCULATION, V45, P543, DOI 10.1161/01.CIR.45.3.543; World Health Organisation, 2004, WHO TECHN REP SER	5	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2118	2118		10.1016/S0140-6736(06)68934-4	http://dx.doi.org/10.1016/S0140-6736(06)68934-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798395				2022-12-28	WOS:000238657400037
J	Haince, JF; Rouleau, M; Poirier, GG				Haince, Jean-Francois; Rouleau, Michele; Poirier, Guy G.			Gene expression needs a break to unwind before carrying on	SCIENCE			English	Editorial Material							CHROMATIN-STRUCTURE; PARP-1; POLY(ADP-RIBOSYL)ATION; TRANSCRIPTION; MODULATION; PATHWAY		Univ Laval, Hlth & Environm Unit, Fac Med, Res Ctr, Quebec City, PQ G1V 4G2, Canada	Laval University	Haince, JF (corresponding author), Univ Laval, Hlth & Environm Unit, Fac Med, Res Ctr, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	guy.poirier@crchul.ulaval.ca		Poirier, Guy/0000-0002-4869-1424				D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239	11	22	23	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1752	1753		10.1126/science.1129808	http://dx.doi.org/10.1126/science.1129808			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794066				2022-12-28	WOS:000238452800040
J	Bhattacharyya, SN; Habermacher, R; Martine, U; Closs, EI; Filipowicz, W				Bhattacharyya, Suvendra N.; Habermacher, Regula; Martine, Ursula; Closs, Ellen I.; Filipowicz, Witold			Relief of microRNA-mediated translational repression in human cells subjected to stress	CELL			English	Article							PROTEIN-SYNTHESIS; MESSENGER-RNAS; HUR; INITIATION; ARGONAUTE2; TRANSPORT	In metazoans, most microRNAs imperfectly base-pair with the 3' untranslated region (3'UTR) of target mRNAs and prevent protein accumulation by either repressing translation or inducing mRNA degradation. Examples of specific mRNAs undergoing microRNA-mediated repression are numerous, but whether the repression is a reversible process remains largely unknown. Here we show that cationic amino acid transporter 1 (CAT-1) mRNA and reporters bearing its 3'UTR can be relieved from the microRNA miR-122-induced inhibition in human hepatocarcinoma cells subjected to different stress conditions. The derepression of CAT-1 mRNA is accompanied by its release from cytoplasmic processing bodies and its recruitment to polysomes. The derepression requires binding of HuR, an AU-rich-element binding protein, to the TUTR of CAT-1 mRNA. We propose that proteins interacting with the 3'UTR will generally act as modifiers altering the potential of miRNAs to repress gene expression.	Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; Johannes Gutenberg Univ Mainz, Dept Pharmacol, D-55101 Mainz, Germany	Friedrich Miescher Institute for Biomedical Research; Johannes Gutenberg University of Mainz	Bhattacharyya, SN (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	Filipowi@fmi.ch	Closs, Ellen/ABD-5217-2020	Closs, Ellen/0000-0002-9505-2289				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson P, 2002, J CELL SCI, V115, P3227; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Graf P, 2001, BRIT J PHARMACOL, V132, P1193, DOI 10.1038/sj.bjp.0703921; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; WU JY, 1994, J VIROL, V68, P1615, DOI 10.1128/JVI.68.3.1615-1623.1994; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200	32	1010	1055	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1111	1124		10.1016/j.cell.2006.04.031	http://dx.doi.org/10.1016/j.cell.2006.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777601	Bronze			2022-12-28	WOS:000238602700016
J	Bruno, I; Wilkinson, MF				Bruno, Ivone; Wilkinson, Miles F.			P-bodies react to stress and nonsense	CELL			English	Editorial Material							MICRORNA	P-bodies are specialized cytoplasmic compartments where translational repression and mRNA turnover may occur. Findings in this issue of Cell provide evidence that P-bodies are sites of "mRNA purgatory." Bhattacharyya et al. (2006) reveal that normal mRNA can be released from P-bodies and translated into protein in response to stress. Meanwhile, Sheth and Parker (2006) report that aberrant mRNAs are targeted to P-bodies to undergo rapid decay.	Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bruno, I (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	mwilkins@mdanderson.org						Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; CHANG J, 2006, RNA BIOL, V1, P106; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3	8	30	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1036	1038		10.1016/j.cell.2006.06.003	http://dx.doi.org/10.1016/j.cell.2006.06.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777595	Bronze			2022-12-28	WOS:000238602700010
J	Farkas, IJ; Beg, QK; Oltvai, ZN				Farkas, Illes J.; Beg, Qasim K.; Oltvai, Zoltan N.			Exploring transcriptional regulatory networks in the worm	CELL			English	Editorial Material							FACTOR-BINDING-SITES; GENOME; SYSTEM; MAP	Using a yeast one-hybrid assay, Deplancke et al. (2006) report in this issue a protein-DNA interaction network for 72 gene promoters and 117 regulatory proteins expressed in cells of the nematode digestive tract. This study is a first step toward mapping transcriptional regulatory networks in distinct metazoan cell lineages and organs using a "gene-centered" approach.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; Eotvos Lorand Univ, HAS Grp, H-1117 Budapest, Hungary	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Eotvos Lorand University; Eotvos Lorand University	Farkas, IJ (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA.	oltvai@pitt.edu	Beg, Qasim/E-4212-2010					Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088	9	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1032	1034		10.1016/j.cell.2006.06.002	http://dx.doi.org/10.1016/j.cell.2006.06.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777593	Bronze			2022-12-28	WOS:000238602700008
J	Winkler, K; Thalhammer, G; Lang, F; Grimm, R; Denschlag, JH; Daley, AJ; Kantian, A; Buchler, HP; Zoller, P				Winkler, K.; Thalhammer, G.; Lang, F.; Grimm, R.; Denschlag, J. Hecker; Daley, A. J.; Kantian, A.; Buechler, H. P.; Zoller, P.			Repulsively bound atom pairs in an optical lattice	NATURE			English	Article							TONKS-GIRARDEAU GAS; ULTRACOLD ATOMS; TRANSITION; SUPERFLUID; INSULATOR; MOLECULES	Throughout physics, stable composite objects are usually formed by way of attractive forces, which allow the constituents to lower their energy by binding together. Repulsive forces separate particles in free space. However, in a structured environment such as a periodic potential and in the absence of dissipation, stable composite objects can exist even for repulsive interactions. Here we report the observation of such an exotic bound state, which comprises a pair of ultracold rubidium atoms in an optical lattice. Consistent with our theoretical analysis, these repulsively bound pairs exhibit long lifetimes, even under conditions when they collide with one another. Signatures of the pairs are also recognized in the characteristic momentum distribution and through spectroscopic measurements. There is no analogue in traditional condensed matter systems of such repulsively bound pairs, owing to the presence of strong decay channels. Our results exemplify the strong correspondence between the optical lattice physics of ultracold bosonic atoms and the Bose-Hubbard model(1,2)-a link that is vital for future applications of these systems to the study of strongly correlated condensed matter and to quantum information.	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; Austrian Academy of Sciences	Denschlag, JH (corresponding author), Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria.	Johannes.Denschlag@uibk.ac.at	Kantian, Adrian/L-6464-2013; Grimm, Rudolf/D-2864-2009; Zoller, Peter/O-1639-2014; Büchler, Hans Peter/M-6543-2018; Denschlag, Johannes P Hecker/B-6047-2008; Daley, Andrew J/F-5366-2014; Thalhammer-Thurner, Gregor/K-8825-2015	Grimm, Rudolf/0000-0003-1085-5558; Zoller, Peter/0000-0003-4014-1505; Büchler, Hans Peter/0000-0002-7233-6828; Denschlag, Johannes P Hecker/0000-0003-1984-4994; Daley, Andrew J/0000-0001-9005-7761; Thalhammer-Thurner, Gregor/0000-0002-3948-8045; Kantian, Adrian/0000-0002-8439-3539				Berman P., 1994, CAVITY QUANTUM ELECT; Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; Cubizolles J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.240401; Daley AJ, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/04/P04005; Donley EA, 2002, NATURE, V417, P529, DOI 10.1038/417529a; Durr S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.020406; FALLANI L, 2006, ONSET BOSE GLASS ULT; Fedichev PO, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080401; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; HECKERDENSCHLAG J, 2002, J PHYS B ATOM MOL PH, V35, P3095; Herbig J, 2003, SCIENCE, V301, P1510, DOI 10.1126/science.1088876; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; KOEHLER T, 2006, PRODUCTION COLD MOL; Lewenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.050401; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; REINER M, 2001, PHYS REV LETT, V87; Ryu C., 2005, RAMAN INDUCED OSCILL; Stoferle T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030401; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Thalhammer G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.050402; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Vidal G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147902; Volz T, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.010702; White SR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.076401; Xu K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.210402	30	435	440	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2006	441	7095					853	856		10.1038/nature04918	http://dx.doi.org/10.1038/nature04918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778884	Green Submitted			2022-12-28	WOS:000238254100037
J	Crowther, CA; Haslam, RR; Hiller, JE; Doyle, LW; Robinson, JS				Crowther, Caroline A.; Haslam, Ross R.; Hiller, Janet E.; Doyle, Lex W.; Robinson, Jeffrey S.		ACTORDS Study Grp	Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial	LANCET			English	Article							WEEKLY COURSES; SINGLE COURSE; BIRTH; GLUCOCORTICOIDS; GROWTH	Background The efficacy and safety of repeat doses of prenatal corticosteroids remains uncertain. Our aim was to establish whether repeat prenatal corticosteroids given to women at risk of preterm. birth can reduce neonatal morbidity without harm. Methods In this hospital-based study, 982 women who remained at risk of preterm birth at less than 32 weeks' gestation, 7 or more days after receiving a first course of prenatal corticosteroids, were randomly assigned to receive a repeat intramuscular dose of either 11.4 mg betamethasone (as Celestone Chronodose), or saline placebo. This was repeated every week the woman remained undelivered, at less than 32 weeks' gestation, and at risk of preterm birth. Primary outcomes were occurrence and severity of neonatal respiratory distress syndrome, use and duration of oxygen and mechanical ventilation, and weight, length, and head circumference at birth and hospital discharge. Statistical analyses were on an intention to treat basis. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN48656428. Findings Fewer babies exposed to repeat corticosteroids had respiratory distress syndrome (33% vs 41%; relative risk 0.82,95% CI 0.71-0.95, p=0.01) and fewer had severe lung disease (12% vs 20%; relative risk 0.60,95% CI 0.46-0.79, P=0.0003) than those in the placebo group. in keeping with these benefits, babies exposed to repeat corticosteroids needed less oxygen therapy (p=0.03), and shorter duration of mechanical ventilation (p=0.01). Mean weight, length, and head circumference at birth and hospital discharge did not differ between treatment groups. Z-scores for weight (p=0.04) and head circumference (p=0.03) at birth were lower in the babies who received repeat corticosteroids although at the time of hospital discharge Z-scores did not differ between treatment groups (p=0.29 for weight, p=0.48 for head circumference). Interpretation Exposure to repeat doses of antenatal corticosteroids reduces neonatal morbidity. Pending long-term outcome results, the short-term benefits for the babies in our study support the use of repeat doses of corticosteroids in women who remain at risk of very preterm birth 7 or more days after an initial course.	Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA 5006, Australia; Univ Adelaide, Dept Publ Hlth, Adelaide, SA 5006, Australia; Womens & Childrens Hosp, Dept Neonatal Med, Adelaide, SA, Australia; Univ Melbourne, Royal Hosp Women, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; Univ Melbourne, Royal Hosp Women, Dept Paediat, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; Womens & Childrens Hospital Australia; University of Melbourne; University of Melbourne	Crowther, CA (corresponding author), Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA 5006, Australia.	caroline.crowther@adelaide.edu.au	Pritchard, Margo A/G-5188-2010; Lawrence, Annemarie/I-4180-2013; Dodd, Jodie/Y-6849-2019; Hiller, Janet E./A-5633-2008; Flenady, Vicki Jane/O-9609-2014; Doyle, Lex/AAJ-5205-2021	Pritchard, Margo A/0000-0002-1058-9117; Lawrence, Annemarie/0000-0002-8736-4741; Dodd, Jodie/0000-0002-6363-4874; Hiller, Janet E./0000-0002-8532-4033; Flenady, Vicki Jane/0000-0001-8114-7677; Doyle, Lex/0000-0002-7667-7312				Aghajafari Fariba, 2002, J Obstet Gynaecol Can, V24, P321; Beeby PJ, 1996, J PAEDIATR CHILD H, V32, P512, DOI 10.1111/j.1440-1754.1996.tb00965.x; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Brocklehurst P, 1999, BRIT J OBSTET GYNAEC, V106, P977, DOI 10.1111/j.1471-0528.1999.tb08440.x; Crowley P, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000065; CROWTHER CA, 1995, LANCET, V345, P877; CROWTHER CA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003935; Dalziel SR, 2005, LANCET, V365, P1856, DOI 10.1016/S0140-6736(05)66617-2; Dunlop S A, 1997, J Matern Fetal Med, V6, P309; ESPLIN M, 2000, AM J OBSTET GYNECOL, V182; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Guinn DA, 2001, JAMA-J AM MED ASSOC, V286, P1581, DOI 10.1001/jama.286.13.1581; GUINN DA, 2000, AM J OBSTET GYNECOL, V182; Hasbargen U, 2001, EUR J PEDIATR, V160, P552, DOI 10.1007/s004310100804; Ikegami M, 1997, AM J RESP CRIT CARE, V156, P178, DOI 10.1164/ajrccm.156.1.9612036; Laws P, 2004, PERINATAL STAT SERIE; LIGGINS GC, 1972, PEDIATRICS, V50, P515; *MAT INF REPR HLTH, MULT COURS ANT CORT; McCullagh P, 1989, GEN LINEAR MODELS; McEvoy C, 2002, PEDIATRICS, V110, P280, DOI 10.1542/peds.110.2.280; McLaughlin KJ, 2003, AUST NZ J OBSTET GYN, V43, P101, DOI 10.1046/j.0004-8666.2003.00052.x; McLaughlin KJ, 2002, AUST NZ J OBSTET GYN, V42, P353, DOI 10.1111/j.0004-8666.2002.00353.x; PELTONIEMI OM, 2005, ESPR ABSTR; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Smith GN, 2000, LANCET, V355, P251, DOI 10.1016/S0140-6736(99)00448-1; Thorp JA, 2001, AM J OBSTET GYNECOL, V185, pS87, DOI 10.1016/S0002-9378(01)80077-6; TSCHANZ SA, 1995, BIOL NEONATE, V68, P229; Wapner RJ, 2003, AM J OBSTET GYNECOL, V189, pS56, DOI 10.1016/j.ajog.2003.10.003; 2000, OBSTET GYNECOL, V98, P144, DOI DOI 10.1016/S0029-7844(01)01410-7	30	215	228	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1913	1919		10.1016/S0140-6736(06)68846-6	http://dx.doi.org/10.1016/S0140-6736(06)68846-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765760				2022-12-28	WOS:000238194400030
J	Wu, ZY; Sun, XH; Sullivan, SG; Detels, R				Wu, Zunyou; Sun, Xinhua; Sullivan, Sheena G.; Detels, Roger			Public health - HIV testing in China	SCIENCE			English	Editorial Material							SEXUAL-BEHAVIOR		Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China; Minist Hlth, Dept Dis Prevent & Control, Div AIDS, Beijing 100044, Peoples R China; Edith Cowan Univ, Ctr Human Genet, Perth, WA 6207, Australia	University of California System; University of California Los Angeles; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Edith Cowan University	Detels, R (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA.	detels@ucla.edu		Sullivan, Sheena G./0000-0002-0856-0294				Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Amaro H, 2005, J HEALTH PSYCHOL, V10, P287, DOI 10.1177/1359105305048780; Bayer R, 1996, NEW ENGL J MED, V334, P1540, DOI 10.1056/NEJM199606063342312; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; *CHIN MIN HLTH, 2005, 3 C HIV AIDS INT COO; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; ERIKSON A, 2006, CORRESPONDENT, V15, P24; FOX R, 1987, AIDS, V1, P241; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Inciardi JA, 2005, AIDS CARE, V17, pS88, DOI 10.1080/09540120500121011; Leveton Lauren B., 1995, HIV BLOOD SUPPLY ANA, P49; *MIN HLTH CHIN, 2006, UPD HIV AIDS EP RESP; *MIN HLTH EXP CONS, 2005, REP HIV SCREEN KEY P; Robles R R, 1996, Drugs Soc (New York), V9, P173, DOI 10.1300/J023v09n01_10; Rotheram-Borus MJ, 2000, J ACQ IMMUN DEF SYND, V25, pS105, DOI 10.1097/00126334-200012152-00004; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; Watts J, 2003, LANCET, V362, P1983, DOI 10.1016/S0140-6736(03)15085-4	17	119	135	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1475	1476		10.1126/science.1120682	http://dx.doi.org/10.1126/science.1120682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050XT	16763133				2022-12-28	WOS:000238124100029
J	Cooper, WO; Hernandez-Diaz, S; Arbogast, PG; Dudley, JA; Dyer, S; Gideon, PS; Hall, K; Ray, WA				Cooper, William O.; Hernandez-Diaz, Sonia; Arbogast, Patrick G.; Dudley, Judith A.; Dyer, Shannon; Gideon, Patricia S.; Hall, Kathi; Ray, Wayne A.			Major congenital malformations after first-trimester exposure to ACE inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITORS; OVINE FETAL; ANGIOTENSIN; PREGNANCY; PRESCRIPTION; OUTCOMES	Background: Use of angiotensin-converting-enzyme (ACE) inhibitors during the second and third trimesters of pregnancy is contraindicated because of their association with an increased risk of fetopathy. In contrast, first-trimester use of ACE inhibitors has not been linked to adverse fetal outcomes. We conducted a study to assess the association between exposure to ACE inhibitors during the first trimester of pregnancy only and the risk of congenital malformations. Methods: We studied a cohort of 29,507 infants enrolled in Tennessee Medicaid and born between 1985 and 2000 for whom there was no evidence of maternal diabetes. We identified 209 infants with exposure to ACE inhibitors in the first trimester alone, 202 infants with exposure to other antihypertensive medications in the first trimester alone, and 29,096 infants with no exposure to antihypertensive drugs at any time during gestation. Major congenital malformations were identified from linked vital records and hospitalization claims during the first year of life and confirmed by review of medical records. Results: Infants with only first-trimester exposure to ACE inhibitors had an increased risk of major congenital malformations (risk ratio, 2.71; 95 percent confidence interval, 1.72 to 4.27) as compared with infants who had no exposure to antihypertensive medications. In contrast, fetal exposure to other antihypertensive medications during only the first trimester did not confer an increased risk (risk ratio, 0.66; 95 percent confidence interval, 0.25 to 1.75). Infants exposed to ACE inhibitors were at increased risk for malformations of the cardiovascular system (risk ratio, 3.72; 95 percent confidence interval, 1.89 to 7.30) and the central nervous system (risk ratio, 4.39; 95 percent confidence interval, 1.37 to 14.02). Conclusions: Exposure to ACE inhibitors during the first trimester cannot be considered safe and should be avoided.	Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Boston University	Cooper, WO (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, AA-0216 MCN, Nashville, TN 37232 USA.	william.cooper@vanderbilt.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BHATTMEHTA V, 1993, PHARMACOTHERAPY, V13, P515; Briggs GG, 2002, CLIN OBSTET GYNECOL, V45, P6, DOI 10.1097/00003081-200203000-00004; Burrell JH, 2001, EXP PHYSIOL, V86, P71, DOI 10.1113/eph8602075; Centers for Disease Control and Prevention, METR ATL CONG DEF PR; Chisholm CA, 1997, AM J PERINAT, V14, P511, DOI 10.1055/s-2007-994324; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper WO, 2002, OBSTET GYNECOL, V100, P101, DOI 10.1016/S0029-7844(02)02001-X; Correa-Villasenor A, 2003, BIRTH DEFECTS RES A, V67, P617, DOI 10.1002/bdra.10111; Eriksson UJ, 2003, REV ENDOCR METAB DIS, V4, P79, DOI 10.1023/A:1021879504372; Feldkamp M, 1997, JAMA-J AM MED ASSOC, V277, P1193; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hu F, 2004, DEV BRAIN RES, V150, P51, DOI 10.1016/j.devbrainres.2004.02.007; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lip GYH, 1997, LANCET, V350, P1446, DOI 10.1016/S0140-6736(05)64207-9; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; MARTIN RA, 1992, TERATOLOGY, V46, P317, DOI 10.1002/tera.1420460402; Moore KL, 1993, DEV HUMAN CLIN ORIEN DEV HUMAN CLIN ORIEN, V7th; *NAT CTR HLTH STAT, NAT HLTH CAR SURV; PIPER JM, 1990, AM J EPIDEMIOL, V132, P561, DOI 10.1093/oxfordjournals.aje.a115692; PIPER JM, 1993, AM J EPIDEMIOL, V137, P758, DOI 10.1093/oxfordjournals.aje.a116736; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; Saji H, 2001, LANCET, V357, P363, DOI 10.1016/S0140-6736(00)03648-5; Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1; Steffensen FH, 1998, LANCET, V351, P596, DOI 10.1016/S0140-6736(05)78584-6; Tabacova S, 2003, PHARMACOEPIDEM DR S, V12, P633, DOI 10.1002/pds.796; Tsuchida S, 1998, J CLIN INVEST, V101, P755, DOI 10.1172/JCI1899; *US BUR CENS, 2004, US CENS BUR POP EST; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Yip SK, 1998, ACTA OBSTET GYN SCAN, V77, P570, DOI 10.1034/j.1600-0412.1998.770517.x; ZEGER SL, 1989, BIOMETRICS, V45, P347; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	36	681	712	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2443	2451		10.1056/NEJMoa055202	http://dx.doi.org/10.1056/NEJMoa055202			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760444				2022-12-28	WOS:000238100800006
J	Dobreva, G; Chahrour, M; Dautzenberg, M; Chirivella, L; Kanzler, B; Farinas, I; Karsenty, G; Grosschedl, R				Dobreva, Gergana; Chahrour, Maria; Dautzenberg, Marcel; Chirivella, Laura; Kanzler, Benoit; Farinas, Isabel; Karsenty, Gerard; Grosschedl, Rudolf			SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation	CELL			English	Article							CRANIAL NEURAL CREST; MAR-BINDING PROTEIN; GENE-EXPRESSION; CLEFT-PALATE; HOMEOTIC TRANSFORMATION; TRANSCRIPTION; ELEMENTS; REGIONS; HOXA-2; MICE	Vertebrate skeletogenesis involves two processes, skeletal patterning and osteoblast differentiation. Here, we show that Satb2, encoding a nuclear matrix protein, is expressed in branchial arches and in cells of the osteoblast lineage. Satb2(-/-) mice exhibit both craniofacial abnormalities that resemble those observed in humans carrying a translocation in SATB2 and defects in osteoblast differentiation and function. Multiple osteoblast-specific genes were identified as targets positively regulated by SATB2. In addition, SATB2 was found to repress the expression of several Hox genes including Hoxa2, an inhibitor of bone formation and regulator of branchial arch patterning. Molecular analysis revealed that SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation. This synergy was genetically confirmed by bone formation defects in Satb2/Runx2 and Satb2/Atf4 double heterozygous mice. Thus, SATB2 acts as a molecular node in a transcriptional network regulating skeletal development and osteoblast differentiation.	Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Valencia, Dept Biol Celular, Unidad Mixta CIPF, UVEG, E-46100 Burjassot, Spain	Max Planck Society; Baylor College of Medicine; Prince Felipe Research Center; University of Valencia	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany.	grosschedl@immunbio.mpg.de	Chirivella, Laura/L-5932-2017; Farinas, Isabel/L-7118-2014	Chirivella, Laura/0000-0002-3637-5168; Dobreva, Gergana/0000-0002-4814-9416; Chahrour, Maria/0000-0002-3174-1480; Farinas, Isabel/0000-0003-2903-4960				Alvarez JD, 2000, GENE DEV, V14, P521; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; BIDWELL JP, 1993, P NATL ACAD SCI USA, V90, P3162, DOI 10.1073/pnas.90.8.3162; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Bronner-Fraser Marianne, 1993, Trends in Cell Biology, V3, P392, DOI 10.1016/0962-8924(93)90089-J; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; Creuzet S, 2002, DEVELOPMENT, V129, P4301; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; DUCY P, 1995, MOL CELL BIOL, V15, P1858; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; FRASCH M, 1995, DEVELOPMENT, V121, P957; GASSER SM, 1986, CELL, V46, P521, DOI 10.1016/0092-8674(86)90877-9; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kanzler B, 1998, DEVELOPMENT, V125, P2587; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; Kontges G, 1996, DEVELOPMENT, V122, P3229; Lampe X, 2004, BIOCHEM BIOPH RES CO, V316, P898, DOI 10.1016/j.bbrc.2004.02.138; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Namciu SJ, 2004, MAMM GENOME, V15, P162, DOI 10.1007/s00335-003-2311-y; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; Tumpel S, 2002, DEV BIOL, V246, P45, DOI 10.1006/dbio.2002.0665; VALENTIN D, 2003, J BONE MINER RES J B, V18, P1622; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002	43	387	415	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					971	986		10.1016/j.cell.2006.05.012	http://dx.doi.org/10.1016/j.cell.2006.05.012			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751105	Bronze			2022-12-28	WOS:000238116400022
J	Schilling, SH; Datto, MB; Wang, XF				Schilling, Stephen H.; Datto, Michael B.; Wang, Xiao-Fan			A phosphatase controls the fate of receptor-regulated Smads	CELL			English	Editorial Material							BETA; NUCLEUS; PATHWAY; CELLS		Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	wang0011@mc.duke.edu						Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; LIN X, 2006, CELL; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Wu JY, 2005, J IMMUNOL, V174, P6122, DOI 10.4049/jimmunol.174.10.6122; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200	11	12	15	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					838	840		10.1016/j.cell.2006.05.015	http://dx.doi.org/10.1016/j.cell.2006.05.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751094	Bronze			2022-12-28	WOS:000238116400011
J	Scadden, DT				Scadden, DT			The stem-cell niche as an entity of action	NATURE			English	Article							HEMATOPOIETIC STEM; BONE-MARROW; SELF-RENEWAL; DROSOPHILA OVARY; PROGENITOR CELLS; PERIPHERAL-BLOOD; VASCULAR NICHE; BETA-CATENIN; TENASCIN-C; GERM-CELLS	Stem-cell populations are established in 'niches'-specific anatomic locations that regulate how they participate in tissue generation, maintenance and repair. The niche saves stem cells from depletion, while protecting the host from over-exuberant stem-cell proliferation. It constitutes a basic unit of tissue physiology, integrating signals that mediate the balanced response of stem cells to the needs of organisms. Yet the niche may also induce pathologies by imposing aberrant function on stem cells or other targets. The interplay between stem cells and their niche creates the dynamic system necessary for sustaining tissues, and for the ultimate design of stem-cell therapeutics.	Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Stem Cell Inst, 185 Cambridge St,CPZN-4265A, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu						Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohta M, 1998, BLOOD, V91, P4074; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Paladini RD, 2005, J INVEST DERMATOL, V125, P638, DOI 10.1111/j.0022-202X.2005.23867.x; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rieger K, 2005, EXP HEMATOL, V33, P605, DOI 10.1016/j.exphem.2005.02.004; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	55	1339	1415	1	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2006	441	7097					1075	1079		10.1038/nature04957	http://dx.doi.org/10.1038/nature04957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810242				2022-12-28	WOS:000238615500034
J	Sivertsen, B; Omvik, S; Pallesen, S; Bjorvatn, B; Havik, OE; Kvale, G; Nielsen, GH; Nordhus, IH				Sivertsen, Borge; Omvik, Siri; Pallesen, Stale; Bjorvatn, Bjorn; Havik, Odd E.; Kvale, Gerd; Nielsen, Geir Hostmark; Nordhus, Inger Hilde			Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPHARMACOLOGICAL INTERVENTIONS; COMPARATIVE METAANALYSIS; UNITED-STATES; PREVALENCE; PHARMACOTHERAPY; RESTRICTION; DISORDERS; EFFICACY; PEOPLE; RISKS	Context Insomnia is a common condition in older adults and is associated with a number of adverse medical, social, and psychological consequences. Previous research has suggested beneficial outcomes of both psychological and pharmacological treatments, but blinded placebo-controlled trials comparing the effects of these treatments are lacking. Objective To examine short- and long-term clinical efficacy of cognitive behavioral therapy (CBT) and pharmacological treatment in older adults experiencing chronic primary insomnia. Design, Setting, and Participants A randomized, double-blinded, placebo-controlled trial of 46 adults ( mean age, 60.8 y; 22 women) with chronic primary insomnia conducted between January 2004 and December 2005 in a single Norwegian university-based outpatient clinic for adults and elderly patients. Intervention CBT ( sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relaxation; n=18), sleep medication (7.5-mg zopiclone each night; n=16), or placebo medication (n=12). All treatment duration was 6 weeks, and the 2 active treatments were followed up at 6 months. Main Outcome Measures Ambulant clinical polysomnographic data and sleep diaries were used to determine total wake time, total sleep time, sleep efficiency, and slow-wave sleep ( only assessed using polysomnography) on all 3 assessment points. Results CBT resulted in improved short- and long-term outcomes compared with zopiclone on 3 out of 4 outcome measures. For most outcomes, zopiclone did not differ from placebo. Participants receiving CBT improved their sleep efficiency from 81.4% at pretreatment to 90.1% at 6-month follow-up compared with a decrease from 82.3% to 81.9% in the zopiclone group. Participants in the CBT group spent much more time in slow-wave sleep ( stages 3 and 4) compared with those in other groups, and spent less time awake during the night. Total sleep time was similar in all 3 groups; at 6 months, patients receiving CBT had better sleep efficiency using polysomnography than those taking zopiclone. Conclusion These results suggest that interventions based on CBT are superior to zopiclone treatment both in short- and long-term management of insomnia in older adults.	Univ Bergen, Dept Clin Psychol, N-5015 Bergen, Norway; Univ Bergen, Dept Psychosocial Sci, N-5015 Bergen, Norway; Univ Bergen, Norwegian Competence Ctr Sleep Disorders, N-5015 Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5015 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen	Sivertsen, B (corresponding author), Univ Bergen, Dept Clin Psychol, Christiesgt 12, N-5015 Bergen, Norway.	borge.sivertsen@psykp.uib.no	Sivertsen, Børge/F-3553-2010; Kvale, Gerd/AAJ-4170-2020	Sivertsen, Borge/0000-0003-4654-9296				[Anonymous], 2005, SLEEP, V28, P1049; Avidan Alon Y, 2003, Clin Cornerstone, V5, P51, DOI 10.1016/S1098-3597(03)90035-4; Bastien CH, 2004, J CONSULT CLIN PSYCH, V72, P653, DOI 10.1037/0022-006X.72.4.653; BECK A T, 1976, P356; Bootzin RR., 1978, PROGR BEHAV MODIFICA, P1, DOI DOI 10.1016/B978-0-12-535606-0.50007-9; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; EDINGER JD, 1995, SLEEP, V18, P232, DOI 10.1093/sleep/18.4.232; Edinger JD, 2005, CLIN PSYCHOL REV, V25, P539, DOI 10.1016/J.CPR.2005.04.003; First M. B., 1995, STRUCTURAL CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Hajak G, 1999, DRUG SAFETY, V21, P457, DOI 10.2165/00002018-199921060-00003; HOHAGEN F, 1994, ACTA PSYCHIAT SCAND, V90, P102, DOI 10.1111/j.1600-0447.1994.tb01563.x; Holbrook A, 2001, J Am Geriatr Soc, V49, P824, DOI 10.1046/j.1532-5415.2001.49161.x; Irwin MR, 2006, HEALTH PSYCHOL, V25, P3, DOI 10.1037/0278-6133.25.1.3; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; JACOBSEN E, 1938, YOU CAN SLEEP WELL; LICHSTEIN KL, 1994, BEHAV THER, V25, P659, DOI 10.1016/S0005-7894(05)80203-5; Lorenzo JL, 2002, PSYCHOPHYSIOLOGY, V39, P409, DOI 10.1017/S0048577202394010; MELLINGER GD, 1985, ARCH GEN PSYCHIAT, V42, P225, DOI 10.1001/archpsyc.1985.01790260019002; Moldofsky Harvey, 2001, Sleep Med Rev, V5, P385, DOI 10.1053/smrv.2001.0179; Montgomery P, 2004, SLEEP MED REV, V8, P47, DOI 10.1016/S1087-0792(03)00026-1; Montgomery P, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003161, 10.1002/14651858.CD003161]; Morgan K, 2003, J PSYCHOSOM RES, V54, P21, DOI 10.1016/S0022-3999(02)00569-X; Morin CM, 2005, SLEEP, V28, P1319, DOI 10.1093/sleep/28.10.1319; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 1996, CLIN PSYCHOL REV, V16, P521, DOI 10.1016/0272-7358(96)00027-X; Morin CM., 1993, INSOMNIA PSYCHOL ASS; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; Noble S, 1998, DRUGS, V55, P277, DOI 10.2165/00003495-199855020-00015; *NORW I PUBL HLTH, 2004, DRUG CONS NORW; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 1997, J PSYCHIATR RES, V31, P333, DOI 10.1016/S0022-3956(97)00002-2; Pallesen S, 1998, PSYCHOTHERAPY, V35, P472, DOI 10.1037/h0087829; Pallesen S, 2001, SLEEP, V24, P771; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Riedel BW, 2001, BEHAV RES THER, V39, P201, DOI 10.1016/S0005-7967(00)00002-4; Roth T, 1999, SLEEP, V22, pS354; Roth Thomas, 2003, Clin Cornerstone, V5, P5, DOI 10.1016/S1098-3597(03)90031-7; Sateia MJ, 2000, SLEEP, V23, P243; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5; SPIELMAN AJ, 1987, SLEEP, V10, P45; Strom L, 2004, J CONSULT CLIN PSYCH, V72, P113, DOI 10.1037/0022-006X.72.1.113; STUEVER H, 2006, WASHINGTON POST 0506; Walsh JK, 1999, SLEEP, V22, pS386; Zammit GK, 1999, SLEEP, V22, pS379	50	356	364	5	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2851	2858		10.1001/jama.295.24.2851	http://dx.doi.org/10.1001/jama.295.24.2851			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	057DY	16804151				2022-12-28	WOS:000238577700022
J	Steiner, MJ; Cates, W				Steiner, MJ; Cates, W			Condoms and sexually-transmitted infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK		Family Hlth Int, Inst Family Hlth, Res Triangle Pk, NC 27709 USA		Steiner, MJ (corresponding author), Family Hlth Int, Inst Family Hlth, POB 13950, Res Triangle Pk, NC 27709 USA.							Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; National Institute of Allergy and Infectious Diseases, 2001, WORKSH SUMM SCI EV C; Smoak ND, 2006, JAIDS-J ACQ IMM DEF, V41, P374, DOI 10.1097/01.qai.0000185575.36591.fc; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd	5	35	38	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2642	2643		10.1056/NEJMp068111	http://dx.doi.org/10.1056/NEJMp068111			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	054ZJ	16790696				2022-12-28	WOS:000238416900002
J	Pannu, N; Wiebe, N; Tonelli, M				Pannu, Neesh; Wiebe, Natasha; Tonelli, Marcello		Alberta Kidney Dis Network	Prophylaxis strategies for contrast-induced nephropathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; RADIOCONTRAST-INDUCED NEPHROPATHY; PERCUTANEOUS CORONARY INTERVENTION; CHRONIC RENAL-INSUFFICIENCY; HIGH-RISK PATIENTS; ADENOSINE ANTAGONIST THEOPHYLLINE; AGENT-ASSOCIATED NEPHROTOXICITY; INTRAVENOUS N-ACETYLCYSTEINE; MEDIA-INDUCED NEPHROTOXICITY; ACUTE MYOCARDIAL-INFARCTION	Context Contrast-induced nephropathy is associated with significant economic and clinical consequences, including prolonged hospitalization, the requirement for dialysis, and an increased risk of death. Objectives To summarize the current state of evidence for prophylaxis of contrast-induced nephropathy, provide evidence-based recommendations regarding management of high-risk patients undergoing angiographic procedures, and identify new avenues for research. Data Sources Systematic searches of peer-reviewed publications were performed in MEDLINE, EMBASE, and the Cochrane database from 1966 to January 2006. Search terms included radio contrast nephropathy, contrast media, acetylcysteine, theophylline, sodium bicarbonate, HMG Co-A reductase inhibitors, ascorbic acid, kidney diseases, renal insufficiency, kidney failure, nephropathy, fenoldopam, diuretics, and saline or half saline. Study Selection Observational studies of risk factors and randomized controlled trials of prophylaxis strategies for contrast-induced nephropathy that specified a definition of contrast-induced nephropathy or postprocedure creatinine level as an outcome measure. Evidence Synthesis Important patient-related risk factors for contrast-induced nephropathy include chronic kidney disease, diabetes mellitus, heart failure, older age, anemia, and left ventricular systolic dysfunction. Non - patient-related risk factors include high-osmolar contrast, ionic contrast, contrast viscosity, and contrast volume. Practice guidelines recommend obtaining preprocedural serum creatinine levels among patients with renal disease, diabetes, proteinuria, hypertension, gout, or congestive heart failure. Available evidence, largely based on small- to medium-sized trials, supports the use of hydration, bicarbonate, and low volumes of iso- or low-osmolar contrast in patients at risk. N-acetylcysteine or ascorbic acid may be of value in very high-risk patients. Conclusions While several risk factors for contrast-induced nephropathy have been identified, the development of an effective prophylaxis strategy for contrast-induced nephropathy has been limited by our poor understanding of the pathophysiology and the clinical significance of this condition. Future research should focus on correctly identifying higher-risk patients and testing therapies in the setting of large well-powered clinical trials.	Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB T6G 2M7, Canada; Univ Alberta, Div Crit Care, Edmonton, AB T6G 2M7, Canada; Univ Alberta, Inst Hlth Econ, Edmonton, AB T6G 2M7, Canada	University of Alberta; University of Alberta; University of Alberta	Pannu, N (corresponding author), 11-107 Clin Sci Bldg,8440-112 St, Edmonton, AB T6G 2G3, Canada.	lauerm@ccf.org	Wiebe, Natasha/V-7803-2019; Tonelli, Marcello/B-3028-2009	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187				Abizaid AS, 1999, AM J CARDIOL, V83, P260, DOI 10.1016/S0002-9149(98)00833-9; ALBERT SG, 1994, INVEST RADIOL, V29, P618, DOI 10.1097/00004424-199406000-00004; Allaqaband S, 2002, CATHETER CARDIO INTE, V57, P279, DOI 10.1002/ccd.10323; Alonso A, 2004, AM J KIDNEY DIS, V43, P1, DOI 10.1053/j.ajkd.2003.09.009; Arici Mustafa, 2003, International Urology and Nephrology, V35, P255; ARSTALL MA, 1995, CIRCULATION, V92, P2855, DOI 10.1161/01.CIR.92.10.2855; Ashby DT, 2003, AM J CARDIOL, V91, P979, DOI 10.1016/S0002-9149(03)00118-8; Asif A, 2004, J CLIN PHARMACOL, V44, P1342, DOI 10.1177/0091270004269842; Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Azmus Alexandre D, 2005, J Invasive Cardiol, V17, P80; Bader BD, 2004, CLIN NEPHROL, V62, P1, DOI 10.5414/cnp62001; Bagshaw SM, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-38; Bagshaw SM, 2005, ARCH INTERN MED, V165, P1087, DOI 10.1001/archinte.165.10.1087; Baker CSR, 2003, J AM COLL CARDIOL, V41, P2114, DOI 10.1016/S0735-1097(03)00487-X; BARRETT BJ, 1992, RADIOLOGY, V183, P105, DOI 10.1148/radiology.183.1.1549654; BARRETT BJ, 1992, KIDNEY INT, V41, P1274, DOI 10.1038/ki.1992.189; BARRETT BJ, 1993, RADIOLOGY, V188, P171, DOI 10.1148/radiology.188.1.8511292; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X; Briguori C, 2004, J AM COLL CARDIOL, V44, P762, DOI 10.1016/j.jacc.2004.04.052; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; BRUNET J, 1995, FREE RADICAL BIO MED, V19, P627, DOI 10.1016/0891-5849(95)00077-B; Carraro M, 1996, NEPHROL DIAL TRANSPL, V11, P444; COCHRAN ST, 1983, AM J ROENTGENOL, V141, P1027, DOI 10.2214/ajr.141.5.1027; DAVIDSON CJ, 1989, ANN INTERN MED, V110, P119, DOI 10.7326/0003-4819-110-2-119; Diaz-Sandoval LJ, 2002, AM J CARDIOL, V89, P356, DOI 10.1016/S0002-9149(01)02243-3; Drager LF, 2004, NEPHROL DIAL TRANSPL, V19, P1803, DOI 10.1093/ndt/gfh261; Duong MH, 2005, CATHETER CARDIO INTE, V64, P471, DOI 10.1002/ccd.20342; Durham JD, 2002, KIDNEY INT, V62, P2202, DOI 10.1046/j.1523-1755.2002.00673.x; Efrati S, 2003, KIDNEY INT, V64, P2182, DOI 10.1046/j.1523-1755.2003.00322.x; Erley CM, 1999, NEPHROL DIAL TRANSPL, V14, P1146, DOI 10.1093/ndt/14.5.1146; ERLEY CM, 1994, KIDNEY INT, V45, P1425, DOI 10.1038/ki.1994.186; Frank H, 2003, CLIN NEPHROL, V60, P176; Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6; Fung JWH, 2004, AM J KIDNEY DIS, V43, P801, DOI 10.1053/j.ajkd.2004.01.010; Furukawa T, 1996, ACTA RADIOL, V37, P966; GANDHI MR, 1992, BRIT J RADIOL, V65, P838, DOI 10.1259/0007-1285-65-777-838; Gare M, 1999, J AM COLL CARDIOL, V34, P1682, DOI 10.1016/S0735-1097(99)00422-2; Gill NK, 2004, CLIN CARDIOL, V27, P554, DOI 10.1002/clc.4960271006; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673, DOI 10.2214/ajr.183.6.01831673; Goldenberg I, 2004, EUR HEART J, V25, P212, DOI 10.1016/j.ehj.2003.11.011; Gomes VO, 2005, HEART, V91, P774, DOI 10.1136/hrt.2004.039636; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Gruberg L, 2001, CATHETER CARDIO INTE, V52, P409, DOI 10.1002/ccd.1093; Gulel O, 2005, J CARDIOVASC PHARM, V46, P464, DOI 10.1097/01.fjc.0000176730.59443.dd; Gupta R K, 1999, Indian Heart J, V51, P521; Guru V, 2004, CLIN NEPHROL, V62, P77; Hans SS, 1998, AM SURGEON, V64, P432; HARRIS KG, 1991, RADIOLOGY, V179, P849, DOI 10.1148/radiology.179.3.2028004; Huber W, 2003, AM J CARDIOL, V91, P1157, DOI 10.1016/S0002-9149(03)00259-5; Huber W, 2002, RADIOLOGY, V223, P772, DOI 10.1148/radiol.2233010609; Iakovou Ioannis, 2003, J Invasive Cardiol, V15, P18; Isenbarger DW, 2003, AM J CARDIOL, V92, P1454, DOI 10.1016/j.amjcard.2003.08.059; Kapoor A, 2002, NEPHROL DIAL TRANSPL, V17, P1936, DOI 10.1093/ndt/17.11.1936; KATHOLI RE, 1995, RADIOLOGY, V195, P17, DOI 10.1148/radiology.195.1.7892462; KATZBERG RW, 1983, RADIOLOGY, V147, P331, DOI 10.1148/radiology.147.2.6836113; Kay J, 2003, JAMA-J AM MED ASSOC, V289, P553, DOI 10.1001/jama.289.5.553; KHOURY Z, 1995, PHARMACOTHERAPY, V15, P59; Klarenbach SW, 2006, CRIT CARE MED, V34, P1044, DOI 10.1097/01.CCM.0000206287.22318.C3; Koch JA, 2000, NEPHROL DIAL TRANSPL, V15, P43, DOI 10.1093/ndt/15.1.43; Kolonko A, 1998, J NEPHROL, V11, P151; Kotlyar Eugene, 2005, Heart Lung Circ, V14, P245, DOI 10.1016/j.hlc.2005.06.007; Krasuski Richard A, 2003, J Invasive Cardiol, V15, P699; Kshirsagar AV, 2004, J AM SOC NEPHROL, V15, P761, DOI 10.1097/01.ASN.0000116241.47678.49; Kurnik BRC, 1998, AM J KIDNEY DIS, V31, P674, DOI 10.1053/ajkd.1998.v31.pm9531185; Lasser EC, 1997, RADIOLOGY, V203, P605, DOI 10.1148/radiology.203.3.9169676; Lehnert T, 1998, NEPHROL DIAL TRANSPL, V13, P358, DOI 10.1093/oxfordjournals.ndt.a027830; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Liss P, 2005, J VASC INTERV RADIOL, V16, P57, DOI 10.1097/01.RVI.0000144807.81633.79; Liu R, 2005, J GEN INTERN MED, V20, P193, DOI 10.1111/j.1525-1497.2005.30323.x; MacNeill BD, 2003, CATHETER CARDIO INTE, V60, P458, DOI 10.1002/ccd.10684; Maeder M, 2004, J AM COLL CARDIOL, V44, P1763, DOI 10.1016/j.jacc.2004.06.075; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; Marenzi G, 2006, AM J MED, V119, P155, DOI 10.1016/j.amjmed.2005.08.002; Marenzi G, 2005, NAT CLIN PRACT CARD, V2, P80, DOI 10.1038/ncpcardio0098; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; Marenzi G, 2003, NEW ENGL J MED, V349, P1333, DOI 10.1056/NEJMoa023204; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough Peter A, 2003, Rev Cardiovasc Med, V4 Suppl 5, pS3; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; Miller HI, 2003, AM J NEPHROL, V23, P91, DOI 10.1159/000068036; Miner SES, 2004, AM HEART J, V148, P690, DOI 10.1016/j.ahj.2004.05.015; Misra D, 2004, CLIN CARDIOL, V27, P607, DOI 10.1002/clc.4960271106; MOORE RD, 1992, RADIOLOGY, V182, P649, DOI 10.1148/radiology.182.3.1535876; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Mueller C, 2004, CAN J CARDIOL, V20, P505; Nallamothu BK, 2004, AM J MED, V117, P938, DOI 10.1016/j.amjmed.2004.06.046; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Ng TMH, 2006, INT J CARDIOL, V109, P322, DOI 10.1016/j.ijcard.2005.06.038; Nikolsky E, 2005, KIDNEY INT, V67, P706, DOI 10.1111/j.1523-1755.2005.67131.x; Nikolsky Eugenia, 2003, Rev Cardiovasc Med, V4 Suppl 1, pS7; Ochoa Anthony, 2004, J Interv Cardiol, V17, P159, DOI 10.1111/j.1540-8183.2004.09880.x; Oldemeyer JB, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00511-8; Pannu N, 2004, KIDNEY INT, V65, P1366, DOI 10.1111/j.1523-1755.2004.00516.x; Parfrey P, 2005, CARDIOVASC INTER RAD, V28, pS3, DOI 10.1007/s00270-005-0196-8; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Rashid ST, 2004, J VASC SURG, V40, P1136, DOI 10.1016/j.jvs.2004.09.026; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; RUDNICK MR, 1994, AM J KIDNEY DIS, V24, P713, DOI 10.1016/S0272-6386(12)80235-6; RUDNICK MR, 1995, KIDNEY INT, V47, P254, DOI 10.1038/ki.1995.32; RUSSO D, 1995, J AM SOC NEPHROL, V6, P1451; Safirstein R, 2000, NEW ENGL J MED, V343, P210, DOI 10.1056/NEJM200007203430311; SCHWAB SJ, 1989, NEW ENGL J MED, V320, P149, DOI 10.1056/NEJM198901193200304; Sharma SK, 2005, CATHETER CARDIO INTE, V65, P386, DOI 10.1002/ccd.20404; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shyu KG, 2002, J AM COLL CARDIOL, V40, P1383, DOI 10.1016/S0735-1097(02)02308-2; Solomon R, 2005, KIDNEY INT, V68, P2256, DOI 10.1111/j.1523-1755.2005.00684.x; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73; Sterner G, 2000, SCAND J UROL NEPHROL, V34, P323, DOI 10.1080/003655900750048350; Stevens NA, 1999, J AM COLL CARDIOL, V33, P403; Stone GW, 2003, JAMA-J AM MED ASSOC, V290, P2284, DOI 10.1001/jama.290.17.2284; TALIERCIO CP, 1986, ANN INTERN MED, V104, P501, DOI 10.7326/0003-4819-104-4-501; Taylor AJ, 1998, CHEST, V114, P1570, DOI 10.1378/chest.114.6.1570; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Thomsen HS, 2005, NEPHROL DIAL TRANSPL, V20, pI18, DOI 10.1093/ndt/gfh1070; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; Tumlin JA, 2002, AM HEART J, V143, P894, DOI 10.1067/mhj.2002.122118; Ueda J, 1996, EUR J RADIOL, V23, P197, DOI 10.1016/S0720-048X(96)01100-X; Vlietstra RE, 1996, AM HEART J, V132, P1049, DOI 10.1016/S0002-8703(96)90021-6; Vogt B, 2001, AM J MED, V111, P692, DOI 10.1016/S0002-9343(01)00983-4; WAALER A, 1990, NEPHRON, V56, P81, DOI 10.1159/000186105; Wang A, 2000, KIDNEY INT, V57, P1675, DOI 10.1046/j.1523-1755.2000.00012.x; Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041; WEINSTEIN JM, 1992, NEPHRON, V62, P413, DOI 10.1159/000187090; WEISBERG LS, 1994, KIDNEY INT, V45, P259, DOI 10.1038/ki.1994.32; Zagler A, 2006, AM HEART J, V151, P140, DOI 10.1016/j.ahj.2005.01.055	130	279	309	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2765	2779		10.1001/jama.295.23.2765	http://dx.doi.org/10.1001/jama.295.23.2765			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16788132	Bronze			2022-12-28	WOS:000238389700032
J	Stephens, C; Porter, J; Nettleton, C; Willis, R				Stephens, Carolyn; Porter, John; Nettleton, Clive; Willis, Ruth			Indigenous health 4 - Disappearing, displaced, and undervalued: a call to action for Indigenous health worldwide	LANCET			English	Review							INTELLECTUAL PROPERTY-RIGHTS; ABORIGINAL PEOPLES; WESTERN-AUSTRALIA; INFANT-MORTALITY; 1ST NATIONS; CHILDREN; COMMUNITY; CONTAMINANTS; ETHNOBOTANY; POPULATIONS	"What sets worlds in motion is the interplay of differences, their attractions and repulsions. Life is plurality; death is uniformity. By suppressing differences and peculiarities, by eliminating different civilisations and cultures, progress weakens life and favours death. The ideal of a single civilisation for everyone implicit in the cult of progress and technique, impoverishes and mutilates us. Every view of the world that becomes extinct, every culture that disappears, diminishes a possibility of life!("1).	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Hlth Unltd, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Stephens, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	carolyn.stephens@lshtm.ac.uk		Willis, Ruth/0000-0001-9570-7436				African Commission on Human and Peoples' Rights & International Work Group for Indigenous Affairs, 2005, REP AFR COMM WORK GR; Alessandri LM, 1999, ARCH DIS CHILD, V80, P15, DOI 10.1136/adc.80.1.15; Alessandri LM, 2001, MED J AUSTRALIA, V175, P185, DOI 10.5694/j.1326-5377.2001.tb143092.x; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Andrade-Neto VF, 2003, J ETHNOPHARMACOL, V87, P253, DOI 10.1016/S0378-8741(03)00141-7; *AUSTR BUR STAT, 2002, YB AUSTR 2002 POP SP; BARTON JH, 1994, CIBA F SYMP, V185, P214; BASU S, 1993, NAT WORKSH STAT TRIB; Basu S K, 1994, Health Millions, V2, P12; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bramley Dale, 2004, N Z Med J, V117, pU1215; BRISTOW F, 2003, HLTH WELLBEING INDIG; *CAB AID PROJ, 2001, UPDATE, P1; CABRERA AD, 2003, THESIS RESISTENCIA C; Calle R, 1996, J ETHNOPHARMACOL, V51, P127, DOI 10.1016/0378-8741(95)01355-5; CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F; Chang H K, 2001, Pac Health Dialog, V8, P260; Chiu A, 2004, J ENVIRON SCI HEAL C, V22, P13, DOI 10.1081/GNC-120038004; Cook B P, 2001, Pac Health Dialog, V8, P368; Crengle S, 2000, Pac Health Dialog, V7, P48; Cunningham J, 2002, AUST NZ J PUBL HEAL, V26, P497, DOI 10.1111/j.1467-842X.2002.tb00355.x; Duarte MCT, 2005, J ETHNOPHARMACOL, V97, P305, DOI 10.1016/j.jep.2004.11.016; Escobar A L, 2001, Cad Saude Publica, V17, P285, DOI 10.1590/S0102-311X2001000200004; Etkin NL, 2005, J ETHNOPHARMACOL, V100, P23, DOI 10.1016/j.jep.2005.05.025; Fink S, 2002, AM J PUBLIC HEALTH, V92, P1734, DOI 10.2105/AJPH.92.11.1734; *GOV IND, 1949, CONST IND; Gupta R, 1991, Indian J Matern Child Health, V2, P72; Hickman M S, 2001, Hawaii Med J, V60, P95; *HLTH CAN, 2005, STAT PROF HLTH 1 NAT; Hsu H J, 1990, Pneumologie, V44 Suppl 1, P453; Hunter Ernest, 2002, Emerg Med (Fremantle), V14, P14, DOI 10.1046/j.1442-2026.2002.00281.x; *INT WORK GROUP IN, 2000, IND WORLD 2000 2001; *INT WORK GROUP IN, IND ISS; Jackson R H, 1996, Cah Que Demogr, V25, P69; Janes CR, 1999, SOC SCI MED, V48, P1803, DOI 10.1016/S0277-9536(99)00082-9; KING D, 1996, HUMAN GENOME DIVERSI; King SR, 1996, J ETHNOPHARMACOL, V51, P45, DOI 10.1016/0378-8741(95)01349-0; KING SR, 1994, CIBA F SYMP, V185, P197; Kirmayer LJ, 2000, CAN J PSYCHIAT, V45, P607, DOI 10.1177/070674370004500702; Kong JM, 2003, ACTA PHARMACOL SIN, V24, P7; Kuhnlein HV, 2000, ANNU REV NUTR, V20, P595, DOI 10.1146/annurev.nutr.20.1.595; Kuper A, 2005, LANCET, V366, P983, DOI 10.1016/S0140-6736(05)67374-6; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee JW, 2003, LANCET, V362, P262, DOI 10.1016/S0140-6736(03)14006-8; *LOND SCH HYG TROP, 2004, HLTH UNL IND PEOPL R; Louw CAM, 2002, J ETHNOPHARMACOL, V82, P147, DOI 10.1016/S0378-8741(02)00184-8; LUM MKW, 1986, PUBLIC HEALTH REP, V101, P309; Luo ZC, 2004, INT J EPIDEMIOL, V33, P1252, DOI 10.1093/ije/dyh290; Luo ZC, 2004, PAEDIATR PERINAT EP, V18, P40, DOI 10.1111/j.1365-3016.2003.00529.x; Macaulay AC, 1999, BRIT MED J, V319, P774, DOI 10.1136/bmj.319.7212.774; MACDONALD D, 1999, ALCOHOL PELASURE HLT, P1; Maciel MAM, 2000, J ETHNOPHARMACOL, V70, P41, DOI 10.1016/S0378-8741(99)00159-2; MAIL PD, 1989, PATIENT EDUC COUNS, V13, P91, DOI 10.1016/0738-3991(89)90053-0; Merson J, 2000, OSIRIS, V15, P282, DOI 10.1086/649331; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; NAPOLITANO D, 2003, SALUD PUEBLOS INDIGE; NO O, 2006, LANCET, V367, P1937; Pal DK, 2002, EPILEPSIA, V43, P904, DOI 10.1046/j.1528-1157.2002.47601.x; Palafox N A, 2001, Pac Health Dialog, V8, P388; Paz O., 1985, LABYRINTH SOLITUDE; Pennington R, 2001, BIOSOCIAL S, V13, P170; Perazzo FF, 2005, J ETHNOPHARMACOL, V99, P215, DOI 10.1016/j.jep.2005.02.023; PETERS JF, 1980, SOC BIOL, V27, P272, DOI 10.1080/19485565.1980.9988430; Pineros-Petersen M, 1998, SALUD PUBLICA MEXICO, V40, P324, DOI 10.1590/S0036-36341998000400004; Puertas B, 2001, J COMMUN HEALTH, V26, P133, DOI 10.1023/A:1005281314274; Raden Sanusi H., 1985, MALAYS J REPROD HLTH, V3, pS82; Raunig Lesley, 2002, Midwifery Today Int Midwife, P51; Reading J, 2002, AM J PUBLIC HEALTH, V92, P1396, DOI 10.2105/AJPH.92.9.1396; Reading J, 2003, CAN J PUBLIC HEALTH, V94, P185, DOI 10.1007/BF03405063; REATEGUI J, 2003, PROGRAMA SALUD INDIG; RHOADES ER, 1988, PUBLIC HEALTH REP, V103, P621; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; SCHWEIMLER D, 2006, BBC NEWS ONLINE; Shephard MDS, 2005, ANN CLIN BIOCHEM, V42, P208, DOI 10.1258/0004563053857806; *SIL INT, 2005, ETHN LANG WORLD; Simmons D, 2003, HEALTH PROMOT INT, V18, P41, DOI 10.1093/heapro/18.1.41; Smeja C, 2000, INT J TUBERC LUNG D, V4, P925; SOUZA AB, 2003, J ETHNOPHARMACOL, V39, P53; Souza L G, 2001, Cad Saude Publica, V17, P355, DOI 10.1590/S0102-311X2001000200010; Suzman J., 2001, REGIONAL ASSESSMENT; Sylvain R, 2002, AM ANTHROPOL, V104, P1074, DOI 10.1525/aa.2002.104.4.1074; SYLVAIN R, 2002, INDIGENOUS WOMEN, V1, P8; TAULICORPUZ V, 1994, 2 SESS UN CSD BEH CO; Trotti JL, 2001, FOOD DRUG LAW J, V56, P367; *UN, 2005, ADV UN DRAFT PROGR A; *UN, 2004, PFII2004WS13 DEP EC; *UN DEV PROGR, 2004, HUM DEV REP CULT LIB; *UN GEN ASS, 2005, DRAFT PROGR ACT 2 IN, P7; *UN MILL IND, 2005, INF MORT RAT 0 1 YEA; *UN PERM FOR IND I, 2006, EC19200322 UN PERM F; *UNESCO, 2005, BEST PRACT IND KNOWL; *UNICEF, 2004, ENS RIGHTS IND CHILD; United Nations General Assembly, 2000, UN MILL DECL; Van Oostdam J, 1999, SCI TOTAL ENVIRON, V230, P1, DOI 10.1016/S0048-9697(99)00036-4; Venis S, 2003, LANCET, V361, P2172, DOI 10.1016/S0140-6736(03)13787-7; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Wilkinson D, 2001, J PUBLIC HEALTH MED, V23, P74, DOI 10.1093/pubmed/23.1.74; Witzig R, 1999, Health Hum Rights, V4, P60, DOI 10.2307/4065168; *WORLD BANK, 1993, 8 WORLD BANK; 2005, UN PERM FOR IND ISS	101	188	191	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					2019	2028		10.1016/S0140-6736(06)68892-2	http://dx.doi.org/10.1016/S0140-6736(06)68892-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782493				2022-12-28	WOS:000238488900037
J	Bruno, RM; Sakmann, B				Bruno, Randy M.; Sakmann, Bert			Cortex is driven by weak but synchronously active thalamocortical synapses	SCIENCE			English	Article							RAT BARREL CORTEX; CAT VISUAL-CORTEX; INFORMATION-PROCESSING STATES; SHORT-TERM DEPRESSION; SPINY STELLATE CELLS; SOMATOSENSORY CORTEX; IN-VIVO; MONOSYNAPTIC CONNECTIONS; SYNAPTIC CONNECTIONS; THALAMIC BARRELOIDS	Sensory stimuli reach the brain via the thalamocortical projection, a group of axons thought to be among the most powerful in the neocortex. Surprisingly, these axons account for only similar to 15% of synapses onto cortical neurons. The thalamocortical pathway might thus achieve its effectiveness via high-efficacy thalamocortical synapses or via amplification within cortical layer 4. In rat somatosensory cortex, we measured in vivo the excitatory postsynaptic potential evoked by a single synaptic connection and found that thalamocortical synapses have low efficacy. Convergent inputs, however, are both numerous and synchronous, and intracortical amplification is not required. Our results suggest a mechanism of cortical activation by which thalamic input alone can drive cortex.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Max Planck Society	Bruno, RM (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	bruno@mpimf-heidelberg.mpg.de	Bruno, Randy M./ABC-2117-2021	Bruno, Randy M./0000-0002-5122-4632				Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arnold PB, 2001, EXP BRAIN RES, V136, P152, DOI 10.1007/s002210000570; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2002, J NEUROSCI, V22, P10966; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Matsumura M, 1996, J NEUROSCI, V16, P7757; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SUAREZ H, 1995, J NEUROSCI, V15, P6700; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; Varga C, 2002, J NEUROSCI, V22, P6186; Waters J, 2004, J NEUROSCI, V24, P11127, DOI 10.1523/JNEUROSCI.2933-04.2004; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005	40	502	505	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1622	1627		10.1126/science.1124593	http://dx.doi.org/10.1126/science.1124593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778049				2022-12-28	WOS:000238288600037
J	Zimov, SA; Schuur, EAG; Chapin, FS				Zimov, Sergey A.; Schuur, Edward A. G.; Chapin, F. Stuart, III			Permafrost and the global carbon budget	SCIENCE			English	Editorial Material							LAST GLACIAL MAXIMUM; METHANE SOURCE; CLIMATE; BIOLOGY; STORAGE		Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Cherskii 678830, Republic Sakha, Russia; Univ Florida, Dept Bot, Gainesville, FL 32611 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks	Zimov, SA (corresponding author), Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Cherskii 678830, Republic Sakha, Russia.	sazi-mov@cher.sakha.ru	Chapin, F Stuart/AAZ-3931-2020; Zimov, Sergey/K-3009-2018	Chapin, F Stuart/0000-0002-2558-9910; Zimov, Sergey/0000-0002-0053-6599				ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; Arctic Climate Impact Assessment, 2005, IMP WARM ARCT; BIRD MI, 1994, NATURE, V371, P566, DOI 10.1038/371566a0; Brovkin V, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000270; FRIEDLINGSTEIN P, 1995, J GEOPHYS RES-ATMOS, V100, P7203, DOI 10.1029/94JD02948; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Lawrence DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL025080; ROMANOVSKY VE, 2001, TOHOKU GEOPHYS J, V36, P224; Sher AV, 2005, QUATERNARY SCI REV, V24, P533, DOI 10.1016/j.quascirev.2004.09.007; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Velichko AA, 1973, PRIRODNYI PROCESS PL; Washburn A. L., 1979, GEOCRYOLOGY SURVEY P; Zeng N, 2003, ADV ATMOS SCI, V20, P677, DOI 10.1007/BF02915395; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800	16	688	741	35	457	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1612	1613		10.1126/science.1128908	http://dx.doi.org/10.1126/science.1128908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053EO	16778046				2022-12-28	WOS:000238288600034
J	Jop, P; Forterre, Y; Pouliquen, O				Jop, Pierre; Forterre, Yoel; Pouliquen, Olivier			A constitutive law for dense granular flows	NATURE			English	Article							MODEL	A continuum description of granular flows would be of considerable help in predicting natural geophysical hazards or in designing industrial processes. However, the constitutive equations for dry granular flows, which govern how the material moves under shear, are still a matter of debate(1-10). One difficulty is that grains can behave(11) like a solid ( in a sand pile), a liquid ( when poured from a silo) or a gas ( when strongly agitated). For the two extreme regimes, constitutive equations have been proposed based on kinetic theory for collisional rapid flows(12), and soil mechanics for slow plastic flows(13). However, the intermediate dense regime, where the granular material flows like a liquid, still lacks a unified view and has motivated many studies over the past decade(14). The main characteristics of granular liquids are: a yield criterion ( a critical shear stress below which flow is not possible) and a complex dependence on shear rate when flowing. In this sense, granular matter shares similarities with classical visco-plastic fluids such as Bingham fluids. Here we propose a new constitutive relation for dense granular flows, inspired by this analogy and recent numerical(15,16) and experimental work(17-19). We then test our three-dimensional ( 3D) model through experiments on granular flows on a pile between rough sidewalls, in which a complex 3D flow pattern develops. We show that, without any fitting parameter, the model gives quantitative predictions for the flow shape and velocity profiles. Our results support the idea that a simple visco-plastic approach can quantitatively capture granular flow properties, and could serve as a basic tool for modelling more complex flows in geophysical or industrial applications.	Univ Aix Marseille 1, CNRS, IUSTI, UMR 6595, F-13453 Marseille 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Jop, P (corresponding author), Univ Aix Marseille 1, CNRS, IUSTI, UMR 6595, 5 Rue Enrico Fermi, F-13453 Marseille 13, France.	Pierre.Jop@polytech.univ-mrs.fr	Pouliquen, Olivier/AAU-8149-2021; Jop, Pierre/F-1940-2011	Pouliquen, Olivier/0000-0002-2246-1137; Jop, Pierre/0000-0003-3527-2922				Ancey C, 1999, J RHEOL, V43, P1673, DOI 10.1122/1.551067; Aranson IS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.020301; Bocquet L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.011307; Borzsonyi T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208001; da Cruz F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021309; Daerr A, 1999, NATURE, V399, P241, DOI 10.1038/20392; DRUCKER DC, 1952, Q APPL MATH, V10, P157, DOI 10.1090/qam/48291; Ertas D, 2002, EUROPHYS LETT, V60, P931, DOI 10.1209/epl/i2002-00307-8; Fenistein D, 2003, NATURE, V425, P256, DOI 10.1038/425256a; Forterre Y, 2003, J FLUID MECH, V486, P21, DOI 10.1017/S0022112003004555; Goldhirsch I, 2003, ANNU REV FLUID MECH, V35, P267, DOI 10.1146/annurev.fluid.35.101101.161114; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; Iordanoff I, 2004, J TRIBOL-T ASME, V126, P137, DOI 10.1115/1.1633575; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Jop P, 2005, J FLUID MECH, V541, P167, DOI 10.1017/S0022112005005987; Josserand C, 2004, EUR PHYS J E, V14, P127, DOI 10.1140/epje/i2OO3-10141-4; Kumaran V, 2004, J FLUID MECH, V506, P1, DOI 10.1017/S0022112003007602; Lemaitre A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.064303; MiDi GDR, 2004, EUR PHYS J E, V14, P341, DOI [10.1140/epje/i2004-10022-4, 10.1140/epje/i2003-10153-0]; Mills P, 1999, EUROPHYS LETT, V45, P733, DOI 10.1209/epl/i1999-00229-y; Mohan LS, 2002, J FLUID MECH, V457, P377, DOI 10.1017/S0022112002007796; Mueth DM, 2000, NATURE, V406, P385, DOI 10.1038/35019032; Nedderman R.M., 1992, STATIC KINEMATICS GR; Pouliquen O, 1999, PHYS FLUIDS, V11, P542, DOI 10.1063/1.869928; Pouliquen O, 2002, J FLUID MECH, V453, P133, DOI 10.1017/S0022112001006796; POULIQUEN O, 2001, ADV COMPLEX SYST, V4, P441; SAVAGE SB, 1984, ADV APPL MECH, V24, P289, DOI 10.1016/S0065-2156(08)70047-4; Savage SB, 1998, J FLUID MECH, V377, P1, DOI 10.1017/S0022112098002936; Silbert LE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051302; Tanner RI, 1985, ENG RHEOLOGY	30	1120	1148	21	400	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					727	730		10.1038/nature04801	http://dx.doi.org/10.1038/nature04801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760972	Green Submitted			2022-12-28	WOS:000238095100048
J	Merson, MH				Merson, MH			The HIV-AIDS pandemic at 25 - The global response	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Sch Publ Hlth, New Haven, CT 06520 USA; Yales Ctr Interdisciplinary Res AIDS, New Haven, CT USA	Yale University; Yale University	Merson, MH (corresponding author), Yale Sch Publ Hlth, New Haven, CT 06520 USA.							*DECL COMM HIV AID, 2001, GLOB CRIS GLOB ACT; *GLEN COMM AFR, 2005, CLIM CHANG EN SUST D; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; UNAIDS, 2006, REP GLOB AIDS EP; 1981, MMWR MORB MORTAL WKL, V30, P250	5	68	73	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2414	2417		10.1056/NEJMp068074	http://dx.doi.org/10.1056/NEJMp068074			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	050PQ	16760441	Bronze			2022-12-28	WOS:000238100800003
J	Wilson, BD; Ii, M; Park, KW; Suli, A; Sorensen, LK; Larrieu-Lahargue, F; Urness, LD; Suh, W; Asai, J; Kock, GAH; Thorne, T; Silver, M; Thomas, KR; Chien, CB; Losordo, DW; Li, DY				Wilson, Brent D.; Ii, Masaaki; Park, Kye Won; Suli, Arminda; Sorensen, Lise K.; Larrieu-Lahargue, Frederic; Urness, Lisa D.; Suh, Wonhee; Asai, Jun; Kock, Gerhardus A. H.; Thorne, Tina; Silver, Marcy; Thomas, Kirk R.; Chien, Chi-Bin; Losordo, Douglas W.; Li, Dean Y.			Netrins promote developmental and therapeutic angiogenesis	SCIENCE			English	Article							AXON OUTGROWTH; GENE-TRANSFER; GUIDANCE; EXPRESSION; RECEPTORS; FAMILY; IDENTIFICATION; REGENERATION; NERVE; DCC	Axonal guidance and vascular patterning share several guidance cues, including proteins in the netrin family. We demonstrate that netrins stimulate proliferation, migration, and tube formation of human endothelial cells in vitro and that this stimulation is independent of known netrin receptors. Suppression of netrin1a messenger RNA in zebrafish inhibits vascular sprouting, implying a proangiogenic rote for netrins during vertebrate development. We also show that netrins accelerate neovascularization in an in vivo model of ischemia and that they reverse neuropathy and vasculopathy in a diabetic murine model. We propose that the attractive vascular and neural guidance functions of netrins offer a unique therapeutic potential.	Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Div Cardiol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Div Hematol, Salt Lake City, UT 84112 USA; Univ Utah, Inst Brain, Salt Lake City, UT 84112 USA; Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Div Cardiovasc Res, Brighton, MA 02135 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; St. Elizabeth's Medical Center; Tufts University	Chien, CB (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	chi-bin.chien@neuro.utah.edu; douglas.losordo@tufts.edu; dean.li@hmbg.utah.edu	Asai, Jun/AAD-4796-2020; Losordo, Douglas W/F-9782-2011	Asai, Jun/0000-0002-7610-0820; Suli, Arminda/0000-0003-2690-8407; Losordo, Douglas/0000-0002-6857-7506; Park, Kye Won/0000-0003-2771-249X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077671, R01HL068873] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL068873, R01 HL077671-03, R01 HL077671] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, ANN INTERN MED, V122, P561, DOI 10.7326/0003-4819-122-8-199504150-00001; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Ii M, 2005, CIRCULATION, V112, P93, DOI 10.1161/CIRCULATIONAHA.104.511964; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Kawamoto A, 2004, CIRCULATION, V110, P1398, DOI 10.1161/01.CIR.0000141563.71410.64; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Madison RD, 2000, EXP NEUROL, V161, P563, DOI 10.1006/exnr.1999.7292; Mehlen P, 2005, CELL MOL LIFE SCI, V62, P2599, DOI 10.1007/s00018-005-5191-3; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Reilly John P, 2005, J Interv Cardiol, V18, P27, DOI 10.1111/j.1540-8183.2005.04026.x; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Walter DH, 2004, CIRCULATION, V110, P36, DOI 10.1161/01.CIR.0000133324.38115.0A; Weinstein BM, 2005, CELL, V120, P299, DOI 10.1016/j.cell.2005.01.010; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yin Y, 2000, MECH DEVELOP, V96, P115, DOI 10.1016/S0925-4773(00)00369-5; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36	32	264	291	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					640	644		10.1126/science.1124704	http://dx.doi.org/10.1126/science.1124704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16809490	Green Accepted			2022-12-28	WOS:000239667500035
J	Ivanova, N; Dobrin, R; Lu, R; Kotenko, I; Levorse, J; DeCoste, C; Schafer, X; Lun, Y; Lemischka, IR				Ivanova, Natalia; Dobrin, Radu; Lu, Rong; Kotenko, Iulia; Levorse, John; DeCoste, Christina; Schafer, Xenia; Lun, Yi; Lemischka, Ihor R.			Dissecting self-renewal in stem cells with RNA interference	NATURE			English	Article							MOUSE EMBRYOS; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; NANOG; MAINTENANCE; ACTIVATION; INDUCTION; EPIBLAST; LACKING	We present an integrated approach to identify genetic mechanisms that control self-renewal in mouse embryonic stem cells. We use short hairpin RNA (shRNA) loss-of-function techniques to downregulate a set of gene products whose expression patterns suggest self-renewal regulatory functions. We focus on transcriptional regulators and identify seven genes for which shRNA-mediated depletion negatively affects self-renewal, including four genes with previously unrecognized roles in self-renewal. Perturbations of these gene products are combined with dynamic, global analyses of gene expression. Our studies suggest specific biological roles for these molecules and reveal the complexity of cell fate regulation in embryonic stem cells.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Ivanova, N (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	nivanova@molbio.princeton.edu; ilemischka@molbio.princeton.edu		Dobrin, Radu/0000-0002-3336-0091				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tighe AP, 2004, J CELL PHYSIOL, V198, P223, DOI 10.1002/jcp.10424; Ting DT, 2004, METH MOLEC MED, V105, P23; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565	37	748	799	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					533	538		10.1038/nature04915	http://dx.doi.org/10.1038/nature04915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16767105				2022-12-28	WOS:000239455900036
J	Walker, L; Williams, J; Jamrozik, K				Walker, Lesley; Williams, Jonathan; Jamrozik, Konrad			Unsafe driving behaviour and four wheel drive vehicles: observational study	BRITISH MEDICAL JOURNAL			English	Article							TRAFFIC ACCIDENTS; CELLULAR PHONES; COLLISIONS	Objective To assess the level of compliance with the new law in the United Kingdom mandating penalties for rising a hand held mobile phone while driving, to compare compliance with this law with the one on the use of seat belts, and to compare compliance with these laws between drivers of four wheel drive vehicles and drivers of normal cars. Design Observational study with two phases-one within the "grace" period, the other starting one week after penalties were imposed on drivers using such telephones. Setting Three busy sites in London. Participants Drivers of 38 182 normal cars and 2944 four wheel drive vehicles. Main outcome measures Proportions of drivers seen to be using hand held mobile phones and not using seat belts. Results Drivers of four wheel drive vehicles were more likely than drivers of other cars to be seen using hand held mobile phones (8.2% v 2.0%) and not complying with the law on seat belts (19.5% v 15.0%). Levels of non-compliance with both laws were slightly higher in the penalty phase of observation, and breaking one law was associated with increased likelihood of breaking the other. Conclusions The level of non-compliance with the law on the use of hand held mobile phones by drivers in London is high, as is non-compliance with the law on seat belts. Drivers of four wheel drive vehicles were four times more likely than drivers of other cars to be seen using hand held mobile phones and slightly more likely not to comply with the law on seat belts.	Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia; Univ London Imperial Coll Sci & Technol, Dept Primary Care & Social Med, London, England	University of Queensland; Imperial College London	Jamrozik, K (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.	k.jamrozik@sph.uq.edu.au						Adams J., 2000, RISK; Broyles RW, 2003, ACCIDENT ANAL PREV, V35, P677, DOI 10.1016/S0001-4575(02)00046-5; Eby DW, 2003, ACCIDENT ANAL PREV, V35, P893, DOI 10.1016/S0001-4575(02)00096-9; HARVEY AC, 1986, J ROY STAT SOC A STA, V149, P187, DOI 10.2307/2981553; Johal S, 2005, J PUBLIC HEALTH-UK, V27, P112, DOI 10.1093/pubmed/fdh213; Lamble D, 1999, ACCIDENT ANAL PREV, V31, P617, DOI 10.1016/S0001-4575(99)00018-4; McCartt AT, 2003, PREV MED, V36, P629, DOI 10.1016/S0091-7435(03)00021-5; MCKNIGHT AJ, 1993, ACCIDENT ANAL PREV, V25, P259, DOI 10.1016/0001-4575(93)90020-W; PELTZMAN S, 1975, J POLIT ECON, V83, P677, DOI 10.1086/260352; Rajalin Sirpa, 2005, Traffic Inj Prev, V6, P225, DOI 10.1080/15389580590969166; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; *ROSPA, RISK US MOB PHON WHI; STEWART W, 2000, MOBILE PHONES HLTH R; Taylor DM, 2003, MED J AUSTRALIA, V179, P140, DOI 10.5694/j.1326-5377.2003.tb05472.x; Toy EL, 2003, RISK ANAL, V23, P641, DOI 10.1111/1539-6924.00343; Violanti JM, 1997, PUBLIC HEALTH, V111, P423, DOI 10.1016/S0033-3506(97)00094-2; Violanti JM, 1996, ACCIDENT ANAL PREV, V28, P265, DOI 10.1016/0001-4575(95)00070-4	17	22	22	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2006	333	7558					71	73		10.1136/bmj.38848.627731.2F	http://dx.doi.org/10.1136/bmj.38848.627731.2F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065BA	16798755	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000239133200015
J	Yoshida, S; Kono, K; Lowery, DM; Bartolini, S; Yaffe, MB; Ohya, Y; Pellman, D				Yoshida, Satoshi; Kono, Keiko; Lowery, Drew M.; Bartolini, Sara; Yaffe, Michael B.; Ohya, Yoshikazu; Pellman, David			Polo-like kinase Cdc5 controls the local activation of Rho1 to promote cytokinesis	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CELL-WALL; BUDDING YEAST; PHOSPHORYLATION; PLK1; IDENTIFICATION; ACTOMYOSIN; SUBSTRATE; DIVISION	The links between the cell cycle machinery and the cytoskeletal proteins controlling cytokinesis are poorly understood. The small guanine nucleotide triphosphate (GTP)-binding protein RhoA stimulates type II myosin contractility and formin-dependent assembly of the cytokinetic actin contractile ring. We found that budding yeast Polo-like kinase Cdc5 controls the targeting and activation of Rho1 ( RhoA) at the division site via Rho1 guanine nucleotide exchange factors. This role of Cdc5 (Polo-like kinase) in regulating Rho1 is likely to be relevant to cytokinesis and asymmetric cell division in other organisms.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Tokyo; Massachusetts Institute of Technology (MIT)	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	Ohya, Yoshikazu/AAW-2200-2021; Yoshida, Satoshi/C-5016-2011	Ohya, Yoshikazu/0000-0003-0837-1239; Kono, Keiko/0000-0003-4057-8790				Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Lippincott J, 2001, J CELL SCI, V114, P1379; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Morrell-Falvey JL, 2005, J CELL SCI, V118, P5563, DOI 10.1242/jcs.02664; Mutoh T, 2005, GENES CELLS, V10, P1189, DOI 10.1111/j.1365-2443.2005.00908.x; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Park CJ, 2003, GENETICS, V163, P21; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Schmidt M, 2002, J CELL SCI, V115, P293; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Tajadura V, 2004, J CELL SCI, V117, P6163, DOI 10.1242/jcs.01530; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617	28	123	124	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					108	111		10.1126/science.1126747	http://dx.doi.org/10.1126/science.1126747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16763112				2022-12-28	WOS:000238850200043
J	Nakamura, A; Yao, M; Chimnaronk, S; Sakai, N; Tanaka, I				Nakamura, Akiyoshi; Yao, Min; Chimnaronk, Sarin; Sakai, Naoki; Tanaka, Isao			Ammonia channel couples glutaminase with transamidase reactions in GatCAB	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; GLU-TRNA(GLN) AMIDOTRANSFERASE; PROTEIN; GLN-TRNA(GLN); TRANSLATION; SOFTWARE; REVEALS	The formation of glutaminyl. transfer RNA (Gln-tRNA(Gln)) differs among the three domains of life. Most bacteria employ an indirect pathway to produce Gln-tRNA(Gln) by a heterotrimeric glutamine amidotransferase CAB (GatCAB) that acts on the misacylated Glu-tRNA(Gln). Here, we describe a series of crystal structures of intact GatCAB from Staphylococcus aureus in the apo form and in the complexes with glutamine, asparagine, Mn2+, and adenosine triphosphate analog. Two identified catalytic centers for the glutaminase and transamidase reactions are markedly distant but connected by a hydrophilic ammonia channel 30 angstrom in length. Further, we show that the first U-A base pair in the acceptor stem and the D loop of tRNA(Gln) serve as identity elements essential for discrimination by GatCAB and propose a complete model for the overall concerted reactions to synthesize Gin-tRNA(Gln).	Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; Mahidol Univ, Inst Mol Biol & Genet, Nakhon Pathom 73170, Thailand	Hokkaido University; Mahidol University	Tanaka, I (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.	tanaka@castor.sci.hokudai.ac.jp	Sakai, Naoki/E-1120-2017; Nakamura, Akiyoshi/L-4928-2016; yao, min/F-5287-2011	Sakai, Naoki/0000-0001-8544-1187; Nakamura, Akiyoshi/0000-0003-2828-3033; yao, min/0000-0003-1687-5904				Becker HD, 2000, FEBS LETT, V476, P140, DOI 10.1016/S0014-5793(00)01697-5; Bera AK, 2000, J BIOL CHEM, V275, P7975, DOI 10.1074/jbc.275.11.7975; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Curnow AW, 1996, NATURE, V382, P589, DOI 10.1038/382589b0; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Douangamath A, 2002, STRUCTURE, V10, P185, DOI 10.1016/S0969-2126(02)00702-5; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; Horiuchi KY, 2001, BIOCHEMISTRY-US, V40, P6450, DOI 10.1021/bi002599l; HUNT JB, 1972, BIOCHEMISTRY-US, V11, P3723, DOI 10.1021/bi00770a010; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Ibba M, 2000, TRENDS BIOCHEM SCI, V25, P311, DOI 10.1016/S0968-0004(00)01600-5; JAHN D, 1990, J BIOL CHEM, V265, P8059; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; PETREK OM, CAVER PROGRAM; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Schmitt E, 2005, STRUCTURE, V13, P1421, DOI 10.1016/j.str.2005.06.016; SCHON A, 1988, BIOCHIMIE, V70, P391, DOI 10.1016/0300-9084(88)90212-X; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Stadtman E R, 1980, Mol Biol Biochem Biophys, V32, P144; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; WEDLER FC, 1972, J BIOL CHEM, V247, P993; WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	28	109	111	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1954	1958		10.1126/science.1127156	http://dx.doi.org/10.1126/science.1127156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809541	Green Submitted			2022-12-28	WOS:000238848100060
J	Marenzi, G; Assanelli, E; Marana, I; Lauri, G; Campodonico, J; Grazi, M; De Metrio, M; Galli, S; Fabbiocchi, F; Montorsi, P; Veglia, F; Bartorelli, AL				Marenzi, Giancarlo; Assanelli, Emilio; Marana, Ivana; Lauri, Gianfranco; Campodonico, Jeness; Grazi, Marco; De Metrio, Monica; Galli, Stefano; Fabbiocchi, Franco; Montorsi, Piero; Veglia, Fabrizio; Bartorelli, Antonio L.			N-acetylcysteine and contrast-induced nephropathy in primary angioplasty	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; ACUTE-RENAL-FAILURE; PERCUTANEOUS CORONARY INTERVENTIONS; AGENT-ASSOCIATED NEPHROTOXICITY; OXIDATIVE STRESS; PREVENTION; METAANALYSIS; ANGIOGRAPHY; INSUFFICIENCY	BACKGROUND: Patients with acute myocardial infarction undergoing primary angioplasty are at high risk for contrast-medium-induced nephropathy because of hemodynamic instability, the need for a high volume of contrast medium, and the lack of effective prophylaxis. We investigated the antioxidant N-acetylcysteine for the prevention of contrast-medium-induced nephropathy in patients undergoing primary angioplasty. METHODS: We randomly assigned 354 consecutive patients undergoing primary angioplasty to one of three groups: 116 patients were assigned to a standard dose of N-acetylcysteine (a 600-mg intravenous bolus before primary angioplasty and 600 mg orally twice daily for the 48 hours after angioplasty), 119 patients to a double dose of N-acetylcysteine (a 1200-mg intravenous bolus and 1200 mg orally twice daily for the 48 hours after intervention), and 119 patients to placebo. RESULTS: The serum creatinine concentration increased 25 percent or more from baseline after primary angioplasty in 39 of the control patients (33 percent), 17 of the patients receiving standard-dose N-acetylcysteine (15 percent), and 10 patients receiving high-dose N-acetylcysteine (8 percent, P<0.001). Overall in-hospital mortality was higher in patients with contrast-medium-induced nephropathy than in those without such nephropathy (26 percent vs. 1 percent, P<0.001). Thirteen patients (11 percent) in the control group died, as did five (4 percent) in the standard-dose N-acetylcysteine group and three (3 percent) in the high-dose N-acetylcysteine group (P=0.02). The rate for the composite end point of death, acute renal failure requiring temporary renal-replacement therapy, or the need for mechanical ventilation was 21 (18 percent), 8 (7 percent), and 6 (5 percent) in the three groups, respectively (P=0.002). CONCLUSIONS: Intravenous and oral N-acetylcysteine may prevent contrast-medium-induced nephropathy with a dose-dependent effect in patients treated with primary angioplasty and may improve hospital outcome.	Univ Milan, Inst Cardiol, Ist Ric & Cura Carattere Sci, Ctr Cardiol Monzino, I-20138 Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan	Marenzi, G (corresponding author), Univ Milan, Inst Cardiol, Ist Ric & Cura Carattere Sci, Ctr Cardiol Monzino, Via Parea 4, I-20138 Milan, Italy.	giancarlo.marenzi@ccfm.it	Grazi, Marco/ABH-5946-2020; Bartorelli, Antonio/K-3955-2018; Assanelli, Emilio/ABH-4902-2020; Veglia, Fabrizio/K-1958-2016; De Metrio, Monica/ABH-6561-2020; campodonico, jeness/AAC-2284-2022; Montorsi, Piero/ABG-9579-2020; Bartorelli, Antonio Luca/ABG-9593-2020	Grazi, Marco/0000-0003-1518-3199; Veglia, Fabrizio/0000-0002-9378-8874; Marenzi, Giancarlo/0000-0003-4410-4461; De Metrio, Monica/0000-0002-1955-747X				Alonso A, 2004, AM J KIDNEY DIS, V43, P1, DOI 10.1053/j.ajkd.2003.09.009; Anfossi G, 2001, EUR J CLIN INVEST, V31, P452, DOI 10.1046/j.1365-2362.2001.00815.x; ARSTALL MA, 1995, CIRCULATION, V92, P2855, DOI 10.1161/01.CIR.92.10.2855; Baker CSR, 2003, J AM COLL CARDIOL, V41, P2114, DOI 10.1016/S0735-1097(03)00487-X; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; Carrabba N, 2004, AM J CARDIOL, V94, P1118, DOI 10.1016/j.amjcard.2004.07.076; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dhalla NS, 1999, CAN J CARDIOL, V15, P587; Diaz-Sandoval LJ, 2002, AM J CARDIOL, V89, P356, DOI 10.1016/S0002-9149(01)02243-3; Drager LF, 2004, NEPHROL DIAL TRANSPL, V19, P1803, DOI 10.1093/ndt/gfh261; Durham JD, 2002, KIDNEY INT, V62, P2202, DOI 10.1046/j.1523-1755.2002.00673.x; Goldenberg I, 2004, EUR HEART J, V25, P212, DOI 10.1016/j.ehj.2003.11.011; Grech ED, 1996, AM J CARDIOL, V77, P122, DOI 10.1016/S0002-9149(96)90580-9; Gruberg L, 2001, CATHETER CARDIO INTE, V52, P409, DOI 10.1002/ccd.1093; Heyman SN, 2003, KIDNEY INT, V63, P634, DOI 10.1046/j.1523-1755.2003.00783.x; Isenbarger DW, 2003, AM J CARDIOL, V92, P1454, DOI 10.1016/j.amjcard.2003.08.059; Kay J, 2003, JAMA-J AM MED ASSOC, V289, P553, DOI 10.1001/jama.289.5.553; Kshirsagar AV, 2004, J AM SOC NEPHROL, V15, P761, DOI 10.1097/01.ASN.0000116241.47678.49; Landray MJ, 1998, LANCET, V352, P960, DOI 10.1016/S0140-6736(05)61514-0; Lopez BL, 1998, ANN EMERG MED, V32, P405, DOI 10.1016/S0196-0644(98)70167-2; Marenzi G, 2006, AM J MED, V119, P155, DOI 10.1016/j.amjmed.2005.08.002; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; Marenzi G, 2003, NEW ENGL J MED, V349, P1333, DOI 10.1056/NEJMoa023204; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Miner SES, 2004, AM HEART J, V148, P690, DOI 10.1016/j.ahj.2004.05.015; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Nallamothu BK, 2004, AM J MED, V117, P938, DOI 10.1016/j.amjmed.2004.06.046; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21; Sochman J, 1996, CLIN CARDIOL, V19, P94, DOI 10.1002/clc.4960190205; SOCHMAN J, 1990, INT J CARDIOL, V28, P191, DOI 10.1016/0167-5273(90)90060-I; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041; WEINRAUCH LA, 1977, ANN INTERN MED, V86, P56, DOI 10.7326/0003-4819-86-1-56; Zahn R, 2005, HEART, V91, P1041, DOI 10.1136/hrt.2004.045336	40	458	496	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2773	2782		10.1056/NEJMoa054209	http://dx.doi.org/10.1056/NEJMoa054209			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807414				2022-12-28	WOS:000238584700005
J	Eisenstein, M				Eisenstein, M			Cell sorting: Divide and conquer	NATURE			English	Article																			0	67	68	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2006	441	7097					1179	+		10.1038/4411179a	http://dx.doi.org/10.1038/4411179a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810261	Bronze			2022-12-28	WOS:000238615500057
J	Collin, J; MacKenzie, R				Collin, J; MacKenzie, R			The World Cup, sport sponsorship, and health	LANCET			English	Editorial Material									Univ Edinburgh, Sch Hlth Social Sci, Ctr Int Publ Hlth Policy, Edinburgh EH8 9AG, Midlothian, Scotland; London Sch Hyg & Trop Med, Ctr Global Change & Hlth, London WC1, England	University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Collin, J (corresponding author), Univ Edinburgh, Sch Hlth Social Sci, Ctr Int Publ Hlth Policy, Edinburgh EH8 9AG, Midlothian, Scotland.	jeff.collin@ed.ac.uk	MacKenzie, Ross/M-2511-2016	MacKenzie, Ross/0000-0002-9862-2101	NCI NIH HHS [R01 CA091021-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA091021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Carlyle J, 2004, BRIT MED J, V329, P104, DOI 10.1136/bmj.329.7457.104; *FED INT FOOTB ASS, 2006, OFF PARTN 2006 FIFA; *FOOTB ASS, 2003, FA PARTN; Hamlyn PJ, 2005, BRIT J SPORT MED, V39, P882, DOI 10.1136/bjsm.2005.021006; *LOND 2012, 2006, LAST LEG FUT GEN; MACINNIS L, 2006, FIFA URGED RESTOR SM; Madrigal R., 2005, Global sport sponsorship, P179; *MCD UK, 2005, 3 GEN BRIT SPORT BES; MCGREGOR R, 2003, FINANCIAL TIMES 0801; NESTLE M, 2002, FOOD POLITICS, P197; *RJ REYN TOB INT, 1982, WORLD CUP MEANS GLOB; SALTER G, 1989, 555 FOOTBALL SPECIAL	12	20	21	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2006	367	9527					1964	1966		10.1016/S0140-6736(06)68862-4	http://dx.doi.org/10.1016/S0140-6736(06)68862-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782470				2022-12-28	WOS:000238488900009
J	Harris, R; Tobias, M; Jeffreys, M; Waldegrave, K; Karlsen, S; Nazroo, J				Harris, Ricci; Tobias, Martin; Jeffreys, Mona; Waldegrave, Kiri; Karlsen, Saffron; Nazroo, James			Effects of self-reported racial discrimination and deprivation on Maori health and inequalities in New Zealand: cross-sectional study	LANCET			English	Article							ETHNIC-MINORITY GROUPS; UNITED-STATES; SOCIAL-CLASS; QUESTIONS; RACE	Background Inequalities in health between different ethnic groups in New Zealand are most pronounced between Maori and Europeans. Our aim was to assess the effect of self-reported racial discrimination and deprivation on health inequalities in these two ethnic groups. Methods We used data from the 2002/03 New Zealand Health Survey to assess prevalence of experiences of self-reported racial discrimination in Maori (n=4108) and Europeans (n=6269) by analysing the responses to five questions about: verbal attacks, physical attacks, and unfair treatment by a health professional, at work, or when buying or renting housing. We did logistic regression analyses to assess the effect of adjustment for experience of racial discrimination and deprivation on ethnic inequalities for various health outcomes. Findings Maori were more likely to report experiences of self-reported racial discrimination in all instances assessed, and were almost ten times more likely to experience discrimination in three or more settings than were Europeans (4.5% [95% CI 3.2-5.8] vs 0.5% [0.3-0.7]). After adjustment for discrimination and deprivation, odds ratios (95% CI) comparing Maori and European ethnic groups were reduced from 1.67 (1.35-2.08) to 1.18 (0.92-1.50) for poor or fair self-rated health, 1.70 (1.42-2.02) to 1.21 (1.00-1.47) for low physical functioning, 1.30 (1.11-1.54) to 1.02 (0.85-1.22) for low mental health, and 1.46 (1.12-1.91)to 1.11 (0.82-1.51) for cardiovascular disease. Interpretation Racism, both interpersonal and institutional, contributes to Maori health losses and leads to inequalities in health between Maori and Europeans in New Zealand. Interventions and policies to improve Maori health and address these inequalities should take into account the health effects of racism.	Minist Hlth, Maori Hlth Directorate, Wellington, New Zealand; Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; UCL, Dept Epidemiol & Publ Hlth, Int Inst Soc & Hlth, London, England	Massey University; University of London; University College London	Tobias, M (corresponding author), Minist Hlth, Maori Hlth Directorate, POB 5013, Wellington, New Zealand.	Martin_Tobias@moh.govt.nz	Jeffreys, Mona/W-3425-2019	Jeffreys, Mona/0000-0002-2617-0361				AJWANI S, 2003, DECADES DISPARITY ET; Bhopal R, 1998, BMJ-BRIT MED J, V316, P1970, DOI 10.1136/bmj.316.7149.1970; Bramley D, 2005, AM J PUBLIC HEALTH, V95, P844, DOI 10.2105/AJPH.2004.040907; Centers for Disease Control and Prevention, 2002, BEH RISK FACT SURV S; Chahal K, 1999, WE CANT ALL BE WHITE; Crampton P., 2004, DEGREES DEPRIVATION; HARRIS R, IN PRESS SOC SCI MED; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HOUSE JS, 2001, PROMOTING HLTH INTER; Howden-Chapman P., 2000, SOCIAL INEQUALITIES; *HUM RIGHTS COMM, 2004, HUM RIGHTS NZ TOD; Jones CP, 2001, AM J EPIDEMIOL, V154, P299, DOI 10.1093/aje/154.4.299; Karlsen S, 2005, PSYCHOL MED, V35, P1795, DOI 10.1017/S0033291705005830; Karlsen S, 2004, J EPIDEMIOL COMMUN H, V58, P1017, DOI 10.1136/jech.2004.020479; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; KOTT PS, 1998, USING DELTE GROUP JA; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P194, DOI 10.2105/AJPH.93.2.194; Krieger N., 2000, Discrimination and Health Social Epidemiology, P36, DOI DOI 10.1093/EPIREV/MXP001; Ministry of Health, 2004, PORTR HLTH KEY RES 2; Ministry of Health, 2004, IND NZ HLTH 2004; Ministry of Social Development, 2004, SOC REP 2004; Modood T., 1997, ETHNIC MINORITIES BR; Nazroo JY, 2003, AM J PUBLIC HEALTH, V93, P277, DOI 10.2105/AJPH.93.2.277; Nazroo JY, 1998, SOCIOL HEALTH ILL, V20, P710, DOI 10.1111/1467-9566.00126; Reid P, 2000, Pac Health Dialog, V7, P38; ROTHMAN RJ, 1998, MODERN EPIDEMIOLOGY; Salmond C, 2002, NZDEP2001 INDEX DEPR; Sporle A, 2002, NEW ZEAL MED J, V115, P127; *STAT NZ, 2001, 2001 CENS POP DWELL; *STAT NZ, 2004, NZ LIF TABL 2000 200; Statistics New Zealand, 2002, 2001 CENS POP DWELL; *UN HIGH COMM HUM, DRAFT UN DECL RIGHTS; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whitbeck LB, 2002, J HEALTH SOC BEHAV, V43, P400, DOI 10.2307/3090234; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Williams DR, 1997, ANN EPIDEMIOL, V7, P322, DOI 10.1016/S1047-2797(97)00051-3; Williams DR, 2000, ETHNIC HEALTH, V5, P243, DOI 10.1080/713667453	38	267	270	1	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 17	2006	367	9527					2005	2009		10.1016/S0140-6736(06)68890-9	http://dx.doi.org/10.1016/S0140-6736(06)68890-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782491				2022-12-28	WOS:000238488900035
J	Sechi, LA; Novello, M; Lapenna, R; Baroselli, S; Nadalini, E; Colussi, GL; Catena, C				Sechi, LA; Novello, M; Lapenna, R; Baroselli, S; Nadalini, E; Colussi, GL; Catena, C			Long-term renal outcomes in patients with primary aldosteronism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIABETIC-NEPHROPATHY; PRIMARY HYPERALDOSTERONISM; ORGAN DAMAGE; HYPERTENSION; PROTEINURIA; EPLERENONE; FAILURE; RENIN; VASOCONSTRICTION; SPIRONOLACTONE	Context Experimental animal studies indicate that exposure to increased aldosterone levels might result in renal damage, but the clinical evidence supporting this role of aldosterone is preliminary. Objective To determine the long-term outcome of renal function in patients with primary aldosteronism after surgical or medical treatment. Design, Setting, and Participants Prospective study conducted at an Italian university medical center among a consecutive sample of 50 patients who were diagnosed as having primary aldosteronism between January 1994 and December 2001 and who were followed up for a mean of 6.4 years after treatment with adrenalectomy or spironolactone. Patients with primary aldosteronism were compared with 100 patients with essential hypertension, matched for severity and duration of hypertension. All patients were treated with antihypertensive drugs to reach a target blood pressure of less than 140/90 mm Hg. Main Outcome Measures Primary outcome measures were rates of change of glomerular filtration rate and albuminuria during follow-up. Detection of new-onset microalbuminuria and restoration of normal albumin excretion during follow-up were considered as secondary outcomes. Results At baseline, glomerular filtration rate and albuminuria were higher in patients with primary aldosteronism than those with essential hypertension. The mean blood pressure during the study was 136/81 mm Hg in the primary aldosteronism group and 137/81 mm Hg in the essential hypertension group. Glomerular filtration rate and albuminuria declined during the initial 6-month period in both groups, with a change that was significantly greater ( P <. 001 for both variables) in patients with primary aldosteronism. Subsequent rate of decline of glomerular filtration was comparable in the 2 groups, whereas albuminuria did not progress in the remainder of the follow-up. Restoration of normal albumin excretion from microalbuminuria was significantly more frequent in primary aldosteronism than in essential hypertension ( P=. 02). Conclusion In the majority of patients in this study, primary aldosteronism was characterized by partially reversible renal dysfunction in which elevated albuminuria is a marker of a dynamic rather than structural renal defect.	Univ Udine, Med Clin, Dept Expt & Clin Pathol & Med, Div Internal Med,Hypertens Unit, I-33100 Udine, Italy	University of Udine	Sechi, LA (corresponding author), Univ Udine, Med Clin, Dept Expt & Clin Pathol & Med, Div Internal Med,Hypertens Unit, Piazzale S Maria della Misericordia 1, I-33100 Udine, Italy.	sechi@uniud.it	Sechi, Leonardo Antonio/Y-3109-2018; Colussi, GianLuca/I-2061-2012	Colussi, GianLuca/0000-0003-1673-540X; Catena, Cristiana/0000-0001-5039-435X; novello, marileda/0000-0003-1573-1845				Arima S, 2004, HYPERTENSION, V43, P352, DOI 10.1161/01.HYP.0000111138.78714.1a; BEEVERS DG, 1976, Q J MED, V45, P401; BERL T, 1978, KIDNEY INT, V14, P228, DOI 10.1038/ki.1978.114; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; CONN JW, 1964, AM J SURG, V107, P159, DOI 10.1016/0002-9610(64)90252-1; Epstein M, 2003, NEPHROL DIAL TRANSPL, V18, P1984, DOI 10.1093/ndt/gfg339; Epstein M, 2005, AM J KIDNEY DIS, V45, P2, DOI 10.1053/j.ajkd.2004.08.040; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Epstein M, 2002, J AM COLL CARDIOL, V39, p249A, DOI 10.1016/S0735-1097(02)81115-9; Ferrari P, 2004, J HYPERTENS, V22, P377, DOI 10.1097/00004872-200402000-00023; Gordon RD, 2004, J HYPERTENS, V22, P251, DOI 10.1097/00004872-200402000-00006; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; HENE RJ, 1982, KIDNEY INT, V21, P98, DOI 10.1038/ki.1982.14; Hofmann W, 1989, LAB MED, V13, P470; Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x; Hostetter TH, 2001, SEMIN NEPHROL, V21, P573, DOI 10.1053/snep.2001.26797; KIMURA G, 1987, HYPERTENSION, V10, P11, DOI 10.1161/01.HYP.10.1.11; LARAGH JH, 1973, AM J MED, V55, P261, DOI 10.1016/0002-9343(73)90128-9; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Nishimura M, 1999, AM J KIDNEY DIS, V33, P261, DOI 10.1016/S0272-6386(99)70298-2; Oelkers W, 2000, J CLIN ENDOCR METAB, V85, P3266, DOI 10.1210/jc.85.9.3266; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Plouin PF, 2004, NEPHROL DIAL TRANSPL, V19, P774, DOI 10.1093/ndt/gfh112; Ribstein J, 2005, J AM SOC NEPHROL, V16, P1320, DOI 10.1681/ASN.2004100878; Rocha R, 2002, ANN NY ACAD SCI, V970, P89, DOI 10.1111/j.1749-6632.2002.tb04415.x; Rossi GP, 2005, TRENDS ENDOCRIN MET, V16, P104, DOI 10.1016/j.tem.2005.02.010; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; Sato A, 2003, HYPERTENSION, V41, P64, DOI 10.1161/01.HYP.0000044937.95080.E9; Sawka AM, 2001, ANN INTERN MED, V135, P258, DOI 10.7326/0003-4819-135-4-200108210-00010; Schjoedt KJ, 2005, KIDNEY INT, V68, P2829, DOI 10.1111/j.1523-1755.2005.00756.x; Sechi LA, 1999, KIDNEY INT, V56, P1049, DOI 10.1046/j.1523-1755.1999.00621.x; Sechi LA, 2000, HYPERTENSION, V36, P978, DOI 10.1161/01.HYP.36.6.978; Sechi LA, 1997, JAMA-J AM MED ASSOC, V277, P1689, DOI 10.1001/jama.277.21.1689; SEELIG HP, 1969, Z KLIN CHEM KLIN BIO, V7, P581; Uhrenholt TR, 2003, CIRC RES, V93, P1258, DOI 10.1161/01.RES.0000106135.02935.E1	39	273	289	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2638	2645		10.1001/jama.295.22.2638	http://dx.doi.org/10.1001/jama.295.22.2638			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772627	Green Published, Bronze			2022-12-28	WOS:000238224000026
J	Bradshaw, WE; Holzapfel, CM				Bradshaw, William E.; Holzapfel, Christina M.			Climate change - Evolutionary response to rapid climate change	SCIENCE			English	Editorial Material							DROSOPHILA; SELECTION; SHIFT		Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Bradshaw, WE (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	mosquito@uoregon.edu						Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bradshaw WE, 2004, EVOLUTION, V58, P1748, DOI 10.1111/j.0014-3820.2004.tb00458.x; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kolbert Elizabeth, 2006, FIELD NOTES CATASTRO; Levitan M, 2003, EVOL ECOL RES, V5, P597; LYNCH M, 1996, CONSERV GENET, pCH15; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Reale D, 2003, EVOLUTION, V57, P2416; Rodriguez-Trelles F, 1998, EVOL ECOL, V12, P829, DOI 10.1023/A:1006546616462; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; VANVLIET A, 2006, AVOIDING DANGEROUS C, pCH12; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARREN R, 2006, AVOIDING DANGEROUS C, pCH11	23	530	553	15	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1477	1478		10.1126/science.1127000	http://dx.doi.org/10.1126/science.1127000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050XT	16763134				2022-12-28	WOS:000238124100030
J	Nesvorny, D; Vokrouhlicky, D; Bottke, WF				Nesvorny, David; Vokrouhlicky, David; Bottke, William F.			The breakup of a main-belt asteroid 450 thousand years ago	SCIENCE			English	Article									SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA		Nesvorny, D (corresponding author), SW Res Inst, Dept Space Studies, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	davidn@boulder.swri.edu	Vokrouhlický, David/Q-4359-2017	Vokrouhlický, David/0000-0002-6034-5452				Bottke W. F., 2002, ASTEROIDS, P395; BOWELL E, 1994, IAU SYMP, P477; Nesvorny D, 2003, ASTROPHYS J, V591, P486, DOI 10.1086/374807; Nesvorny D, 2002, NATURE, V417, P720, DOI 10.1038/nature00789; SYKES MV, 1988, ASTROPHYS J, V334, pL55, DOI 10.1086/185311; ZAPPALA V, 1990, ASTRON J, V100, P2030, DOI 10.1086/115658	6	68	68	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1490	1490		10.1126/science.1126175	http://dx.doi.org/10.1126/science.1126175			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763141	Green Submitted			2022-12-28	WOS:000238124100037
J	Arora, V; Dunphy, C; Chang, VY; Ahmad, F; Humphrey, HJ; Meltzer, D				Arora, Vineet; Dunphy, Carrie; Chang, Vivian Y.; Ahmad, Fawaz; Humphrey, Holly J.; Meltzer, David			The effects of on-duty napping on intern sleep time and fatigue	ANNALS OF INTERNAL MEDICINE			English	Article							WORK HOURS; BELL COMMISSION; NIGHT-SHIFT; CALL; RESIDENTS; MEDICINE; RISK; PERFORMANCE; ACTIGRAPHY; HOUSESTAFF	Background: Naps during extended work shifts are effective in reducing fatigue in other industries, but the use of a nap as a countermeasure to prevent fatigue in residents is uncertain. Objective: To assess the effects of a call-night nap on resident sleep and fatigue. Design: 1-year, within-participant, paired trial with crossover at midmonth. Setting: Academic teaching hospital. Participants: 38 of 40 internal medicine interns. Measurements: Sleep was measured by using wristwatch actigraphy. By using the experience sampling method on a personal digital assistant, random alerts prompted interns to rate fatigue on the 7-point Stanford Sleepiness Scale (7 is most tired). Hospital paging logs and structured interviews provided information on use of coverage. Intervention: For 2 weeks of every month, interns were assigned to the nap schedule, which provided coverage to on-duty interns from midnight to 7:00 a.m. so that they could finish their work and take a nap. The other 2 weeks of the month constituted a standard schedule. Results: Interns received 41 more minutes of sleep while on call with the nap schedule (185 minutes vs. 144 minutes; P < 0.001). When interns with the nap schedule used coverage, they received 68 more minutes of sleep (210 minutes vs. 142 minutes; P < 0.001). Despite these small increases in sleep, interns reported less overall fatigue while on the nap schedule than while on the standard schedule (1.74 vs. 2.26; P = 0.017). Postcall fatigue with the nap schedule was lower by nearly 1 point (2.23 vs 3.16; P = 0.036), which is almost equivalent to the difference between oncall and postcall fatigue with the standard schedule (2.06 vs. 3.16). However, use of coverage by interns on the nap schedule was impaired by their desire to care for their patients and concerns about discontinuity of care. Limitations: This was a single-institution study that did not have the power to examine outcomes related to intern or patient wellbeing. Conclusions: Coverage to allow a nap during an extended duty-hour shift can increase sleep and decrease fatigue for residents.	Univ Chicago, Chicago, IL 60637 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA	University of Chicago; University of Arkansas System; University of Arkansas Medical Sciences	Arora, V (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 2007,AMB W216, Chicago, IL 60637 USA.	varora@medicine.bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393; Arora, Vineet/0000-0002-4745-7599	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075292] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 T35DK062719-16] Funding Source: Medline; NIGMS NIH HHS [1 R01 GM075292-01] Funding Source: Medline; PHS HHS [R01 10597] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*ACCR COUNC GRAD M, RES DUT HOURS COMM P; [Anonymous], AHRQ PUBLICATION, V12-EHC039-EF; Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BERKOFF K, 1991, J DEV BEHAV PEDIATR, V12, P6; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Cherr Gregory S, 2002, Bull Am Coll Surg, V87, P23; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Dimarino AJ, 2005, ALIMENT PHARM THER, V22, P325, DOI 10.1111/j.1365-2036.2005.02573.x; FINS JJ, 1991, B NEW YORK ACAD MED, V67, P359; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; GRUNEBAUM A, 1987, AM J OBSTET GYNECOL, V157, P79, DOI 10.1016/S0002-9378(87)80350-2; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Holzman IR, 2000, MT SINAI J MED, V67, P136; Institute of Medicine, 2001, CROSSING QUALITY CHA; JAIN RK, 2003, AM MED NEWS     0407; KLEBANOFF MA, 1990, NEW ENGL J MED, V323, P1040, DOI 10.1056/NEJM199010113231506; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; LURIE N, 1989, NEW ENGL J MED, V320, P1673, DOI 10.1056/NEJM198906223202507; Marcus CL, 1996, SLEEP, V19, P763, DOI 10.1093/sleep/19.10.763; MATSUMOTO K, 1994, ERGONOMICS, V37, P899, DOI 10.1080/00140139408963699; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Purnell MT, 2002, J SLEEP RES, V11, P219, DOI 10.1046/j.1365-2869.2002.00309.x; Rosenbaum JR, 2004, AM J MED, V117, P846, DOI 10.1016/j.amjmed.2004.09.001; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Sallinen M, 1998, J SLEEP RES, V7, P240, DOI 10.1046/j.1365-2869.1998.00121.x; Steele MT, 1999, ACAD EMERG MED, V6, P1050, DOI 10.1111/j.1553-2712.1999.tb01191.x; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; TORSVALL L, 1988, SLEEP, V11, P35, DOI 10.1093/sleep/11.1.35; VANCAUTER E, 1997, SLEEP QUALITY ENDOCR; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116; 2003, SLEEP ALERTNESS FATI	37	105	107	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					792	798		10.7326/0003-4819-144-11-200606060-00005	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049ZN	16754921				2022-12-28	WOS:000238057000002
J	Sharp, D				Sharp, D			Some like it hottest	LANCET			English	Editorial Material							CAPSAICIN; GROWTH; CELLS		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							DAVIDSON A, 1999, OXFORD COMPANION FOO, P171; DEBRUXELLES S, 2006, TIMES LONDON    0401; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; 2005, W SCOVILLE PEPPER CH	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1804	1804		10.1016/S0140-6736(06)68785-0	http://dx.doi.org/10.1016/S0140-6736(06)68785-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753472				2022-12-28	WOS:000238194200010
J	Sluijs, A; Schouten, S; Pagani, M; Woltering, M; Brinkhuis, H; Damste, JSS; Dickens, GR; Huber, M; Reichart, GJ; Stein, R; Matthiessen, J; Lourens, LJ; Pedentchouk, N; Backman, J; Moran, K				Sluijs, Appy; Schouten, Stefan; Pagani, Mark; Woltering, Martijn; Brinkhuis, Henk; Damste, Jaap S. Sinninghe; Dickens, Gerald R.; Huber, Matthew; Reichart, Gert-Jan; Stein, Ruediger; Matthiessen, Jens; Lourens, Lucas J.; Pedentchouk, Nikolai; Backman, Jan; Moran, Kathryn		Expedition 302 Scientists	Subtropical arctic ocean temperatures during the Palaeocene/Eocene thermal maximum	NATURE			English	Article							PALEOCENE; ISOTOPE; EOCENE; INDICATORS; GREENHOUSE; PALEOGENE; BOUNDARY; MARINE; LIPIDS; END	The Palaeocene/Eocene thermal maximum, similar to 55 million years ago, was a brief period of widespread, extreme climatic warming(1-3), that was associated with massive atmospheric greenhouse gas input(4). Although aspects of the resulting environmental changes are well documented at low latitudes, no data were available to quantify simultaneous changes in the Arctic region. Here we identify the Palaeocene/Eocene thermal maximum in a marine sedimentary sequence obtained during the Arctic Coring Expedition(5). We show that sea surface temperatures near the North Pole increased from similar to 18 degrees C to over 23 degrees C during this event. Such warm values imply the absence of ice and thus exclude the influence of ice-albedo feedbacks on this Arctic warming. At the same time, sea level rose while anoxic and euxinic conditions developed in the ocean's bottom waters and photic zone, respectively. Increasing temperature and sea level match expectations based on palaeoclimate model simulations(6), but the absolute polar temperatures that we derive before, during and after the event are more than 10 degrees C warmer than those model-predicted. This suggests that higher-than-modern greenhouse gas concentrations must have operated in conjunction with other feedback mechanisms - perhaps polar stratospheric clouds(7) or hurricane-induced ocean mixing(8) - to amplify early Palaeogene polar temperatures.	Univ Utrecht, Palaeobot & Palynol Lab, Inst Environm Biol, NL-3584 CD Utrecht, Netherlands; Royal Netherlands Inst Sea Res NIOZ, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Texel, Netherlands; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Utrecht, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47906 USA; Purdue Univ, Purdue Climate Change Res Ctr, W Lafayette, IN 47906 USA; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; Stockholm Univ, Dept Geol & Geochem, SE-10691 Stockholm, Sweden; Univ Rhode Isl, Narragansett, RI 02882 USA	Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Yale University; Utrecht University; Rice University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Stockholm University; University of Rhode Island	Sluijs, A (corresponding author), Univ Utrecht, Palaeobot & Palynol Lab, Inst Environm Biol, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	a.sluijs@bio.uu.nl; schouten@nioz.nl	Gattacceca, Jerome/AAG-5651-2019; Brinkhuis, Henk/B-4223-2009; Huber, Matthew/A-7677-2008; Woltering, Martijn/U-4621-2017; O'Regan, Matt/P-6277-2019; Palike, Heiko/A-6560-2008; Pedentchouk, Nikolai/C-9935-2011; Pagani, Mark/B-3233-2008; Reichart, Gert-Jan/N-6308-2018; Damste, Jaap S Sinninghe/F-6128-2011; Sluijs, Appy/B-3726-2009; Jakobsson, Martin/F-6214-2010; Dickens, Gerald R/G-1222-2011; O'Regan, Matt/B-2157-2010	Gattacceca, Jerome/0000-0002-1639-7140; Huber, Matthew/0000-0002-2771-9977; O'Regan, Matt/0000-0002-6046-1488; Palike, Heiko/0000-0003-3386-0923; Pedentchouk, Nikolai/0000-0002-2923-966X; Reichart, Gert-Jan/0000-0002-7256-2243; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Sluijs, Appy/0000-0003-2382-0215; Jordan, Richard/0000-0002-8997-7349; Kaminski, Michael A/0000-0002-7344-5874; Matthiessen, Jens/0000-0002-6952-2494; Rea, Brice/0000-0002-9928-145X; Dickens, Gerald/0000-0003-2869-4860; Eynaud, Frederique/0000-0003-1283-7425; Stein, Ruediger/0000-0002-4453-9564; Jakobsson, Martin/0000-0002-9033-3559; Onodera, Jonaotaro/0000-0001-6942-2285; Takahashi, Kozo/0000-0001-8660-4371; Brinkhuis, Henk/0000-0003-0253-6610				Backman J., 2006, P ODP, DOI [10.2204/iodp.proc.302.2006, DOI 10.2204/IODP.PROC.302.2006]; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bujak JP, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P277; Caballero R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021581; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; DAMSTE JSS, 1993, NATURE, V362, P827, DOI 10.1038/362827a0; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Emanuel K, 2004, J ATMOS SCI, V61, P843, DOI 10.1175/1520-0469(2004)061<0843:ECOTCI>2.0.CO;2; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; HUBER M, 2003, GEOL SOC AM SPEC PAP, V369, P25, DOI DOI 10.1130/0-8137-2369-8.25; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; PAGANI M, UNPUB NATURE; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Shellito CJ, 2003, PALAEOGEOGR PALAEOCL, V193, P113, DOI 10.1016/S0031-0182(02)00718-6; Sloan LC, 1998, GEOPHYS RES LETT, V25, P3517, DOI 10.1029/98GL02492; Sluijs A, 2005, EARTH-SCI REV, V68, P281, DOI 10.1016/j.earscirev.2004.06.001; Speijer RP, 2002, GEOLOGY, V30, P23, DOI 10.1130/0091-7613(2002)030<0023:OTASLC>2.0.CO;2; Steurbaut E., 2003, Geological Society of America Special Paper, V369, P291; Thomas E., 1996, Geological Society Special Publication, V101, P401, DOI 10.1144/GSL.SP.1996.101.01.20; Tripati A, 2005, SCIENCE, V308, P1894, DOI 10.1126/science.1109202; Tripati A, 2001, PALAEOGEOGR PALAEOCL, V170, P101, DOI 10.1016/S0031-0182(01)00230-9; Wing SL, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P380; Wuchter C, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001041; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	29	493	517	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					610	613		10.1038/nature04668	http://dx.doi.org/10.1038/nature04668			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16752441	Green Published			2022-12-28	WOS:000237920800041
J	Yang, FJ; Vought, BW; Satterlee, JS; Walker, AK; Sun, ZYJ; Watts, JL; DeBeaumont, R; Saito, RM; Hyberts, SG; Yang, S; Macol, C; Iyer, L; Tjian, R; van den Heuvel, S; Hart, AC; Wagner, G; Naar, AM				Yang, Fajun; Vought, Bryan W.; Satterlee, John S.; Walker, Amy K.; Sun, Z. -Y. Jim; Watts, Jennifer L.; DeBeaumont, Rosalie; Saito, R. Mako; Hyberts, Sven G.; Yang, Shaosong; Macol, Christine; Iyer, Lakshmanan; Tjian, Robert; van den Heuvel, Sander; Hart, Anne C.; Wagner, Gerhard; Naar, Anders M.			An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CAENORHABDITIS-ELEGANS; KIX DOMAIN; TRANSACTIVATION DOMAIN; SECONDARY STRUCTURE; PROTEIN CBP; C-ELEGANS; COACTIVATOR; ACTIVATION; CREB	The sterol regulatory element binding protein ( SREBP) family of transcription activators are critical regulators of cholesterol and fatty acid homeostasis(1,2). We previously demonstrated that human SREBPs bind the CREB- binding protein ( CBP)/ p300 acetyltransferase KIX domain and recruit activator- recruited co- factor ( ARC)/ Mediator co- activator complexes through unknown mechanisms(3-5). Here we show that SREBPs use the evolutionarily conserved ARC105 ( also called MED15) subunit to activate target genes. Structural analysis of the SREBP- binding domain in ARC105 by NMR revealed a three- helix bundle with marked similarity to the CBP/ p300 KIX domain. In contrast to SREBPs, the CREB and c- Myb activators do not bind the ARC105 KIX domain, although they interact with the CBP KIX domain, revealing a surprising specificity among structurally related activator- binding domains. The Caenorhabditis elegans SREBP homologue SBP- 1 promotes fatty acid homeostasis by regulating the expression of lipogenic enzymes(6,7). We found that, like SBP- 1, the C. elegans ARC105 homologue MDT- 15 is required for fatty acid homeostasis, and show that both SBP- 1 and MDT- 15 control transcription of genes governing desaturation of stearic acid to oleic acid. Notably, dietary addition of oleic acid significantly rescued various defects of nematodes targeted with RNA interference against sbp- 1 and mdt- 15, including impaired intestinal fat storage, infertility, decreased size and slow locomotion, suggesting that regulation of oleic acid levels represents a physiologically critical function of SBP- 1 and MDT- 15. Taken together, our findings demonstrate that ARC105 is a key effector of SREBP-dependent gene regulation and control of lipid homeostasis in metazoans.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington State University; Harvard University; University of California System; University of California Berkeley	Naar, AM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu	van den Heuvel, Sander J.L./B-8892-2011; Watts, Jennifer/AAC-7425-2020	van den Heuvel, Sander J.L./0000-0001-9015-7463; Watts, Jennifer/0000-0003-4349-0639; Iyer, Lakshmanan/0000-0001-9167-6396	NCI NIH HHS [R01 CA127990] Funding Source: Medline; NIDDK NIH HHS [R01 DK074114, R01 DK074114-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Novatchkova M, 2004, CURR BIOL, V14, pR54, DOI 10.1016/j.cub.2003.12.042; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	30	277	320	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					700	704		10.1038/nature04942	http://dx.doi.org/10.1038/nature04942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799563				2022-12-28	WOS:000239630200049
J	Macintosh, MCM; Fleming, KM; Bailey, JA; Doyle, P; Modder, J; Acolet, D; Golightly, S; Miller, A				Macintosh, Mary C. M.; Fleming, Kate M.; Bailey, Jaron A.; Doyle, Pat; Modder, Jo; Acolet, Dominique; Golightly, Shona; Miller, Alison			Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; PREGNANCY; OUTCOMES; MELLITUS; MALFORMATIONS; PREVALENCE; NATIONWIDE; DIAGNOSIS; RISK	Objective To Provide perinatal mortality and congenital anomaly rates for babies born to women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland. Design National Population based pregnancy cohort. Setting 231 maternity units in England, Wales, and Northern Ireland. Participants 2359 pregnancies to women with type 1 or type 2 diabetes who delivered between 1 March 2002 and 28 February 2003. Main outcome measures Stillbirth rates; perinatal and neonatal mortality; prevalence of congenital anomalies. Results Of 2359 women with diabetes, 652 had type 2 diabetes and 1707 had type 1 diabetes. Women with type 2 diabetes were more likely to come front a black, Asian, or other ethnic minority group (type 2, 48.8%; type 1, 9.1%) and from a deprived area (type 2, 46.3% in most deprived fifth; type 1, 22.8%). Perinatal mortality in babies of women with diabetes was 31.8/1000 births. Perinatal mortality was comparable in babies of women with type 1 (31.7/1000 births) and type 2 diabetes (32.3; 1000) and was nearly four times higher than that in the general maternity Population. 141 major congenital anomalies were confirmed in 109 offspring. The Prevalence of major congenital anomaly was 46/1000 births in women with diabetes (48/1000 births for type 1 diabetes; 43/1000 for type 2 diabetes), more than double that expected. This increase was driven by anomalies of the nervous system, notably neural tube defects (4.2-fold), and congenital heart disease (3.4-fold). Anomalies in 71/109 (65%) offspring were diagnosed antenatally. Congenital heart disease was diagnosed antenatally in 23/42 (54.8%) offspring; anomalies other than congenital heart disease were diagnosed antenatally in 48/67 (71.6%) offspring. Conclusion Perinatal mortality and prevalence of congenital anomalies are high in the babies of women with type 1 or type 2 diabetes. The rates do not seem to differ between the two types of diabetes.	Confidential Enquiry Maternal & Child Hlth, London NW1 5SD, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Macintosh, MCM (corresponding author), Confidential Enquiry Maternal & Child Hlth, London NW1 5SD, England.	mary.macintosh@hpa.org.uk	Fleming, Kate M/A-6475-2010	Fleming, Kate M/0000-0002-6572-5016				Boulot P, 2003, DIABETES CARE, V26, P2990; Brydon P, 2000, INT J CLIN PRACT, V54, P418; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Carvalho JS, 2002, HEART, V88, P387, DOI 10.1136/heart.88.4.387; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Clausen TD, 2005, DIABETES CARE, V28, P323, DOI 10.2337/diacare.28.2.323; COETZEE E J, 1985, Diabetes Research and Clinical Practice, V1, P281, DOI 10.1016/S0168-8227(86)80036-5; *CONF ENQ MAT CHIL, 2005, STILLB NEON POSTN MO; *CONF ENQ MAT CHIL, 2004, MAT SERV 2002 WOM TY; Confidential Enquiry into Maternal and Child Health, 2005, PREGN WOM TYP 1 TYP; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; DAMM P, 1989, AM J OBSTET GYNECOL, V161, P1161; Department of Health, 2001, NAT SERV FRAM DIAB S; Diabet Control Complications Trial Res Grp, 1996, AM J OBSTET GYNECOL, V174, P1343; Dunne F, 2005, SEMIN FETAL NEONAT M, V10, P333, DOI 10.1016/j.siny.2005.04.007; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9; FUHRMANN K, 1984, EXP CLIN ENDOCRINOL, V83, P173, DOI 10.1055/s-0029-1210327; HAWTHORNE G, 1994, BRIT MED J, V315, P279; Hotu S, 2004, J PAEDIATR CHILD H, V40, P201, DOI 10.1111/j.1440-1754.2004.00337.x; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Khoshnood B, 2005, PEDIATRICS, V115, P95, DOI 10.1542/peds.2004-0516; *OFF DEP PRIM MIN, IND MULT DEPR 2004; Penney GC, 2003, BJOG-INT J OBSTET GY, V110, P315, DOI 10.1016/S1470-0328(03)02967-7; Platt MJ, 2002, DIABETIC MED, V19, P216, DOI 10.1046/j.1464-5491.2002.00665.x; Sacks DA, 1997, AM J OBSTET GYNECOL, V177, P1113, DOI 10.1016/S0002-9378(97)70025-5; Scottish Intercollegiate Guidelines Network, 2001, SIGN PUBL; Suhonen L, 2000, DIABETOLOGIA, V43, P79, DOI 10.1007/s001250050010; TOWNER D, 1995, DIABETES CARE, V18, P1446, DOI 10.2337/diacare.18.11.1446; Zhu L, 1997, J Obstet Gynaecol Res, V23, P555; 1990, DIABET MED, V7, P360	32	399	409	1	21	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					177	180		10.1136/bmj.38856.692986.AE	http://dx.doi.org/10.1136/bmj.38856.692986.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16782722	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-28	WOS:000239352100021
J	Alderman, H; Konde-Lule, J; Sebuliba, I; Bundy, D; Hall, A				Alderman, Harold; Konde-Lule, Joseph; Sebuliba, Isaac; Bundy, Donald; Hall, Andrew			Effect on weight gain of routinely giving albendazole to preschool children during child health days in Uganda: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							EDUCATION; SCHOOLS; GROWTH	Objective To estimate the effectiveness of delivering an anthelmintic through a community child health programme on the weight gain of preschool children in Uganda. Design Cluster randomised controlled trial. Setting Eastern Uganda. Participants 48 parishes participating in a new programme for child health: 24 offered children an additional service of anthelmintic treatment. The outcome is based on measurements from 27 995 children. Intervention Treatment of children aged between I and 7 years with 400 mg albendazole added to standard services offered during child health days over a three year period. Main outcome measure Weight gain. Results The provision of periodic anthelmintic treatment as a part of child health services in Uganda resulted in an increase in weight gain of about 10% (166 g per child per year, 95% confidence interval 16 to 316) above expected weight gain when treatments were given twice a year, and an increase of 5% when the treatment was given annually. Conclusion Deworming of preschool children in Uganda as part of regularly scheduled health services seems practical and associated with increased weight gain.	World Bank, Washington, DC 20433 USA; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Univ Westminster, Sch Integrated Hlth, Ctr Publ Hlth Nutr, London W1W 6UW, England	The World Bank; Makerere University; University of Westminster	Alderman, H (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	halderman@worldbank.org						[Anonymous], 1995, PHYS STAT US INT ANT; Awasthi S, 2003, BMJ-BRIT MED J, V327, P431, DOI 10.1136/bmj.327.7412.431; BUNDY DAP, 1990, T ROY SOC TROP MED H, V84, P115, DOI 10.1016/0035-9203(90)90399-Y; Bundy DAP, 1996, PARASITOL TODAY, V12, P1, DOI 10.1016/0169-4758(96)30011-2; BUNDY DAP, 2005, DIS CONTROL PRIORITI, pCH61; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Goodman T, 2000, B WORLD HEALTH ORGAN, V78, P305; HOTEZ P, 2005, DIS CONTROL PRIORITI, pCH24; Jalal F, 1998, AM J CLIN NUTR, V68, P623, DOI 10.1093/ajcn/68.3.623; Kabatereine N B, 2001, East Afr Med J, V78, P283; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; STEPHENSON LS, 1993, J NUTR, V123, P656, DOI 10.1093/jn/123.4.656; Stoltzfus RJ, 2004, J NUTR, V134, P348, DOI 10.1093/jn/134.2.348; World Health Organization, 2002, WHO TECHN REP SER	14	51	52	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 15	2006	333	7559					122	124		10.1136/bmj.38877.393530.7C	http://dx.doi.org/10.1136/bmj.38877.393530.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16790460	Green Published, Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000239155900016
J	Navarre, WW; Porwollik, S; Wang, YP; McClelland, M; Rosen, H; Libby, SJ; Fang, FC				Navarre, William Wiley; Porwollik, Steffen; Wang, Yipeng; McClelland, Michael; Rosen, Henry; Libby, Stephen J.; Fang, Ferric C.			Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella	SCIENCE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SHIGELLA-FLEXNERI; VIBRIO-CHOLERAE; VIRULENCE; REPRESSOR; ANTIREPRESSION; ORGANIZATION; TEMPERATURE	Horizontal gene transfer plays a major role in microbial evolution. However, newly acquired sequences can decrease fitness unless integrated into preexisting regulatory networks. We found that the histone-like nucleoid structuring protein (H-NS) selectively silences horizontally acquired genes by targeting sequences with GC content lower than the resident genome. Mutations in hns are lethal in Salmonella unless accompanied by compensatory mutations in other regulatory loci. Thus, H-NS provides a previously unrecognized mechanism of bacterial defense against foreign DNA, enabling the acquisition of DNA from exogenous sources while avoiding detrimental consequences from unregulated expression of newly acquired genes. Characteristic GC/AT ratios of bacterial genomes may facilitate discrimination between a cell's own DNA and foreign DNA.	Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fang, FC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	fcfang@u.washington.edu	McClelland, Michael/A-8583-2011	Fang, Ferric/0000-0002-3243-110X; McClelland, Michael/0000-0003-1788-9347; Navarre, William/0000-0002-9293-9220	NIAID NIH HHS [AI049417, AI052237, AI034829, AI057733, AI48622, AI39557] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034829, R21AI057733, R01AI049417, R21AI039557, R01AI039557, R01AI048622, R21AI048622, R01AI052237] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Beloin C, 2003, MOL MICROBIOL, V47, P825, DOI 10.1046/j.1365-2958.2003.03347.x; Beltrametti F, 1999, J BACTERIOL, V181, P3409, DOI 10.1128/JB.181.11.3409-3418.1999; Bertin P, 1999, MOL MICROBIOL, V31, P319, DOI 10.1046/j.1365-2958.1999.01176.x; Brunetti R, 2001, BIOCHIMIE, V83, P873, DOI 10.1016/S0300-9084(01)01331-1; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Coker C, 2000, J BACTERIOL, V182, P2649, DOI 10.1128/JB.182.9.2649-2653.2000; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorman CJ, 2001, INT J MED MICROBIOL, V291, P89, DOI 10.1078/1438-4221-00105; Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003; FORSMAN K, 1992, P NATL ACAD SCI USA, V89, P9880, DOI 10.1073/pnas.89.20.9880; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Haack KR, 2003, INFECT IMMUN, V71, P384, DOI 10.1128/IAI.71.1.384-392.2003; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; HROMOCKYJ AE, 1992, MOL MICROBIOL, V6, P2113, DOI 10.1111/j.1365-2958.1992.tb01385.x; Krishnan HH, 2004, INFECT IMMUN, V72, P3961, DOI 10.1128/IAI.72.7.3961-3967.2004; Lee Shang-Jung, 2004, Appl Bioinformatics, V3, P219, DOI 10.2165/00822942-200403040-00003; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Nasser W, 2002, MOL MICROBIOL, V43, P733, DOI 10.1046/j.1365-2958.2002.02782.x; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004; Yang J, 2005, MICROBIOL-SGM, V151, P1199, DOI 10.1099/mic.0.27734-0; Yu RR, 2002, MOL MICROBIOL, V43, P119, DOI 10.1046/j.1365-2958.2002.02721.x; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249; Zimmerman SB, 2006, J STRUCT BIOL, V153, P160, DOI 10.1016/j.jsb.2005.10.011	29	543	559	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					236	238		10.1126/science.1128794	http://dx.doi.org/10.1126/science.1128794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16763111				2022-12-28	WOS:000239008000048
J	Simpson, SH; Eurich, DT; Majumdar, SR; Padwal, RS; Tsuyuki, RT; Varney, J; Johnson, JA				Simpson, Scot H.; Eurich, Dean T.; Majumdar, Sumit R.; Padwal, Rajdeep S.; Tsuyuki, Ross T.; Varney, Janice; Johnson, Jeffrey A.			A meta-analysis of the association between adherence to drug therapy and mortality	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; PATIENT ADHERENCE; OUTCOMES; IMPACT; RECOMMENDATIONS; NONCOMPLIANCE; PROPHYLAXIS; MEDICATIONS; PREVENTION	Objective To evaluate the relation between adherence to drug therapy, including placebo, and mortality. Design Meta-analysis of observational Studies. Data sources Electronic databases, contact with investigators, and textbooks and reviews on adherence. Review methods Predefined criteria were used to select studies reporting mortality among participants with good and poor adherence to drug therapy. Data were extracted for disease, drug therapy groups, methods for measurement of adherence rate, definition for good adherence, and mortality. Results Data were available from 21 studies (46 847 participants), including eight studies with placebo arms (19 633 participants). Compared with poor adherence, good adherence was associated with lower mortality (odds ratio 0,56, 95% confidence interval 0.50 to 0.63). Good adherence to placebo was associated with lower mortality (0.56, 0.43 to 0.74), as was good adherence to beneficial drug therapy (0.55, 0.49 to 0.62). Good adherence to harmful drug therapy was associated with increased mortality (2.90,1.04 to 8.11). Conclusion Good adherence to drug therapy is associated with positive health Outcomes. Moreover, the observed association between good adherence to placebo and mortality supports the existence of die "healthy adherer" effect, whereby adherence to drug therapy may be a Surrogate marker for overall health), behaviour.	Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; Inst Hlth Econ, Edmonton, AB, Canada; Univ Alberta, Fac Med & Dent, Dept Med, Div Internal Med, Edmonton, AB T6G 2M7, Canada; Univ Alberta, Fac Med & Dent, Dept Med, Div Cardiol, Edmonton, AB T6G 2M7, Canada; Univ Alberta, Fac Med & Dent, Dept Publ Hlth Sci, Edmonton, AB T6G 2M7, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Simpson, SH (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.	ssimpson@pharmacy.ualberta.ca	Tsuyuki, Ross T/E-2462-2016; Padwal, Raj/G-6903-2016	Tsuyuki, Ross T/0000-0002-3724-598X; Padwal, Raj/0000-0003-3541-2817; Johnson, Jeffrey/0000-0001-8290-2857; Simpson, Scot/0000-0002-9880-2129				Boudes P, 1998, CONTROL CLIN TRIALS, V19, P257, DOI 10.1016/S0197-2456(98)00005-1; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohn SE, 2002, CLIN INFECT DIS, V34, P1129, DOI 10.1086/339542; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; CORNFEIL.J, 1971, J AMER MED ASSOC, V217, P1676, DOI 10.1001/jama.217.12.1676; Cotter G, 2004, AM HEART J, V147, P293, DOI 10.1016/j.ahj.2003.07.011; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; CZAJKOWSKI SM, 1990, HDB HLTH BEHAV CHANG, P515; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dobbels F, 2004, J HEART LUNG TRANSPL, V23, P1245, DOI 10.1016/j.healun.2003.09.016; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; EFRON B, 1991, J AM STAT ASSOC, V86, P9, DOI 10.2307/2289707; Ellis S, 2000, CONTROL CLIN TRIALS, V21, p218S, DOI 10.1016/S0197-2456(00)00082-9; Fogarty L, 2002, PATIENT EDUC COUNS, V46, P93, DOI 10.1016/S0738-3991(01)00219-1; GALLAGHER EJ, 1993, JAMA-J AM MED ASSOC, V270, P742, DOI 10.1001/jama.270.6.742; GLYNN RJ, 1994, ARCH INTERN MED, V154, P2649, DOI 10.1001/archinte.1994.00420230032005; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; HAYNES RB, 1987, CONTROL CLIN TRIALS, V8, P12, DOI 10.1016/0197-2456(87)90021-3; HAYS RD, 1994, J BEHAV MED, V17, P347, DOI 10.1007/BF01858007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Howell N., 2004, PHARM J, V272, P23; Irvine J, 1999, PSYCHOSOM MED, V61, P566, DOI 10.1097/00006842-199907000-00023; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; McDermott MM, 1997, ARCH INTERN MED, V157, P1921, DOI 10.1001/archinte.157.17.1921; MEINERT CL, 1970, DIABETES, V19, P789; Miller NH, 1997, CIRCULATION, V95, P1085; Miura T, 2001, EUR J CLIN PHARMACOL, V57, P77, DOI 10.1007/s002280100272; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; MORRIS LS, 1992, J CLIN PHARM THER, V17, P283, DOI 10.1111/j.1365-2710.1992.tb01306.x; Myers LB, 1998, ADHERENCE TREATMENT; ObiasManno D, 1996, ANN EPIDEMIOL, V6, P93, DOI 10.1016/1047-2797(95)00134-4; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; REBOLLO FJS, 2004, AN MED INTERN, V21, P523; RUDD P, 1979, ARCH INTERN MED, V139, P627, DOI 10.1001/archinte.139.6.627; Shepherd J, 1997, EUR HEART J, V18, P1718; SHUMAKER SA, 1990, HDB HLTH BEHAV CHANG; Simoni Jane M, 2003, Top HIV Med, V11, P185; Spilker B., 1991, PATIENT COMPLIANCE M; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Wei L, 2002, HEART, V88, P229, DOI 10.1136/heart.88.3.229; Wei L, 2004, PHARMACOEPIDEM DR S, V13, P761, DOI 10.1002/pds.963; WEINTRAUB M, 1981, CONTEMP PHARM PRACT, V4, P8; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	53	844	869	3	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2006	333	7557					15	18		10.1136/bmj.38875.675486.55	http://dx.doi.org/10.1136/bmj.38875.675486.55			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062CT	16790458	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000238922900019
J	Kress, TL; Guthrie, C				Kress, Tracy L.; Guthrie, Christine			Accurate RNA siting and splicing gets help from a DEK-hand	SCIENCE			English	Editorial Material							FACTOR U2AF(35); SITE AG; PROTEIN; CHROMATIN; FIDELITY		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kress, TL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	guthrie@biochem.ucsf.edu						BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Guth S, 2001, MOL CELL BIOL, V21, P7673, DOI 10.1128/MCB.21.22.7673-7681.2001; Kappes F, 2004, MOL CELL BIOL, V24, P6011, DOI 10.1128/MCB.24.13.6011-6020.2004; Konarska MM, 2005, GENE DEV, V19, P2255, DOI 10.1101/gad.1363105; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	16	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1886	1887		10.1126/science.1130324	http://dx.doi.org/10.1126/science.1130324			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809518				2022-12-28	WOS:000238848100036
J	Crichton, J; Nyamu-Musembi, C; John-Langba, J; Theobald, S				Crichton, J; Nyamu-Musembi, C; John-Langba, J; Theobald, S			Sexual and reproductive health rights in Africa	LANCET			English	Editorial Material									African Populat & Hlth Res Ctr, Nairobi, Kenya; Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	African Population & Health Research Centre; University of Sussex; Liverpool School of Tropical Medicine; University of Liverpool	Crichton, J (corresponding author), African Populat & Hlth Res Ctr, Shelter Afrigue Bldg, Nairobi, Kenya.	jo.crichton@gmail.com	John-Langba, Johannes/AAC-3252-2019	Theobald, Sally/0000-0002-9053-211X; John-Langba, Johannes/0000-0002-3057-6831				Cornwall A, 2002, REALIZING RIGHTS TRA; *CRLP, 2000, BEIJ 5 ASS REPR RIGH; International Women's Health Coalition, 1995, CAIR CONS RIGHT AG R; Isfahan Merali, 2000, Development in Practice, V10, P609, DOI 10.1080/09614520020008797; Misra G, 2005, SEXUALITY GENDER RIG; Nyamu-Musembi C, 2002, ACTOR ORIENTED PERSP; *REAL RIGHTS, 2005, IMPR SEX REPR HLTH P; SILBERSCHMIDT M, 2005, SEXUAL AFRICA MAGAZI, P2; *UNFRPA, 1998, ENS REPR RIGHTS IMPL; *WHO, 2005, GEND REPR RIGHTS	10	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2043	2045		10.1016/S0140-6736(06)68903-4	http://dx.doi.org/10.1016/S0140-6736(06)68903-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	058HZ	16798372				2022-12-28	WOS:000238657400009
J	Boyle, EA				Boyle, EA			A direct proxy for oceanic phosphorus?	SCIENCE			English	Editorial Material							FORAMINIFERA; SEDIMENTS; CO2		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Boyle, EA (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	eaboyle@mit.edu						Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Alley RB, 1997, J GEOPHYS RES-OCEANS, V102, P26367, DOI 10.1029/96JC03837; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Erez J, 2003, REV MINERAL GEOCHEM, V54, P115, DOI 10.2113/0540115; Feely RA, 1998, GEOPHYS RES LETT, V25, P2253, DOI 10.1029/98GL01546; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Montagna P, 2006, SCIENCE, V312, P1788, DOI 10.1126/science.1125781; PALMER MR, 1985, EARTH PLANET SC LETT, V73, P285, DOI 10.1016/0012-821X(85)90077-9; Schaller T, 2000, GEOCHIM COSMOCHIM AC, V64, P2243, DOI 10.1016/S0016-7037(99)00443-3; SHERWOOD BA, 1987, GEOCHIM COSMOCHIM AC, V51, P1861, DOI 10.1016/0016-7037(87)90176-1	11	3	3	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1758	1759		10.1126/science.1129723	http://dx.doi.org/10.1126/science.1129723			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794070				2022-12-28	WOS:000238452800044
J	Tung, R; Kaul, S; Diamond, GA; Shah, PK				Tung, Roderick; Kaul, Sanjay; Diamond, George A.; Shah, Prediman K.			Narrative review: Drug-eluting stents for the management of restenosis: A critical appraisal of the evidence	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; IIB/IIIA INTEGRIN BLOCKADE; CORONARY-ARTERY-DISEASE; BARE-METAL STENT; COST-EFFECTIVENESS; CLINICAL-OUTCOMES; SIRIUS TRIAL; REAL-WORLD; FOLLOW-UP	Interventional cardiologists have quickly replaced bare metal stents with intravascular drug-eluting stents for treating and preventing restenosis, largely on the basis of empirical evidence that shows profound reduction in angiographic and clinical restenosis. A critical reassessment of the published evidence, however, suggests that the putative superiority of intravascular drug-eluting stents is founded on questionable premises, including 1) overestimation of restenosis benefit, 2) underestimation of the risk for stent thrombosis, 3) overreliance on "soft" rather than "hard" outcomes (need for repeated revascularization vs. death or myocardial infarction), and 4) the attendant overestimation of cost-effectiveness. Because the long-term incremental risks, benefits, and costs of drug-eluting stents have not yet been optimally evaluated in a broad spectrum of patient and lesion cohorts, the rational role of these devices in clinical management warrants reappraisal.	Cedars Sinai Med Ctr, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Kaul, S (corresponding author), Cedars Sinai Med Ctr, David Geffen Sch Med, Div Cardiol, Room 5536,S Tower,8700 Beverly Blvd, Los Angeles, CA 90048 USA.			Tung, Roderick/0000-0002-8513-1303				Bagust A, 2006, HEART, V92, P68, DOI 10.1136/hrt.2004.053850; Brophy JM, 2005, INT J TECHNOL ASSESS, V21, P326, DOI 10.1017/S0266462305050439; Cohen DJ, 2004, CIRCULATION, V110, P508, DOI 10.1161/01.CIR.0000136821.99814.43; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; Ellis SG, 2005, J AM COLL CARDIOL, V45, P1193, DOI 10.1016/j.jacc.2004.11.063; Ge L, 2005, J AM COLL CARDIOL, V46, P613, DOI 10.1016/j.jacc.2005.05.032; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Hodgson JM, 2004, CATHETER CARDIO INTE, V62, P1, DOI 10.1002/ccd.20025; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kandzari DE, 2005, AM J CARDIOL, V96, P750, DOI 10.1016/j.amjcard.2005.05.015; Lansky AJ, 2004, CIRCULATION, V109, P1948, DOI 10.1161/01.CIR.0000127129.94129.6F; Laskey WK, 2001, AM J CARDIOL, V87, P964, DOI 10.1016/S0002-9149(01)01430-8; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Leon MB, 2005, J AM COLL CARDIOL, V45, p49A; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; Mattos L A, 2001, Arq Bras Cardiol, V77, P549; Mauri L, 2005, CIRCULATION, V111, P3435, DOI 10.1161/CIRCULATIONAHA.104.513952; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nordmann AJ, 2004, AM J MED, V116, P253, DOI 10.1016/j.amjmed.2003.08.035; O'Shea JC, 2002, JAMA-J AM MED ASSOC, V287, P618, DOI 10.1001/jama.287.5.618; O'Shea JC, 2001, JAMA-J AM MED ASSOC, V285, P2468, DOI 10.1001/jama.285.19.2468; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Pache J, 2003, J AM COLL CARDIOL, V41, P1283, DOI 10.1016/S0735-1097(03)00119-0; POCOCK SJ, 1987, BIOMETRICS, V43, P487, DOI 10.2307/2531989; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4	33	99	106	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					913	919		10.7326/0003-4819-144-12-200606200-00009	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785479				2022-12-28	WOS:000238555500006
J	Fuyuno, I; Cyranoski, D				Fuyuno, I; Cyranoski, D			Cash for papers: putting a premium on publication	NATURE			English	News Item																			0	50	50	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2006	441	7095					792	792		10.1038/441792b	http://dx.doi.org/10.1038/441792b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778850	Bronze			2022-12-28	WOS:000238254100006
J	Paul, J				Paul, John			Commentary: What is the optimal duration of antibiotic therapy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Sussex Cty Hosp, Dept Microbiol, Brighton BN2 5BE, E Sussex, England	University of Brighton	Paul, J (corresponding author), Royal Sussex Cty Hosp, Dept Microbiol, Brighton BN2 5BE, E Sussex, England.	tetrix@pavilion.co.uk						Casey JR, 2005, PEDIATR INFECT DIS J, V24, P909, DOI 10.1097/01.inf.0000180573.21718.36; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1	4	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2006	332	7554					1358	1358		10.1136/bmj.332.7554.1358	http://dx.doi.org/10.1136/bmj.332.7554.1358			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763248	Green Published, Bronze			2022-12-28	WOS:000238587000015
J	Meinecke, M; Wagner, R; Kovermann, P; Guiard, B; Mick, DU; Hutu, DP; Voos, W; Truscott, KN; Chacinska, A; Pfanner, N; Rehling, P				Meinecke, Michael; Wagner, Richard; Kovermann, Peter; Guiard, Bernard; Mick, David U.; Hutu, Dana P.; Voos, Wolfgang; Truscott, Kaye N.; Chacinska, Agnieszka; Pfanner, Nikolaus; Rehling, Peter			Tim50 maintains the permeability barrier of the mitochondrial inner membrane	SCIENCE			English	Article							TRANSLOCATION CONTACT SITES; TWIN-PORE TRANSLOCASE; PROTEIN IMPORT; PRESEQUENCE TRANSLOCASE; PREPROTEIN TRANSLOCASE; TIM23; COMPONENT; CHANNEL; COMPLEX; MOTOR	Transport of metabolites across the mitochondrial inner membrane is highly selective, thereby maintaining the electrochemical proton gradient that functions as the main driving force for cellular adenosine triphosphate synthesis. Mitochondria import many preproteins via the presequence translocase of the inner membrane. However, the reconstituted Tim23 protein constitutes a pore remaining mainly in its open form, a state that would be deleterious in organello. We found that the intermembrane space domain of Tim50 induced the Tim23 channel to close. Presequences overcame this effect and activated the channel for translocation. Thus, the hydrophilic cis domain of Tim50 maintains the permeability barrier of mitochondria by closing the translocation pore in a presequence-regulated manner.	Univ Osnabruck, FB Biol Chem, D-49034 Osnabruck, Germany; CNRS, Ctr Genet Mol, Lab Propre, F-91190 Gif Sur Yvette, France; Univ Freiburg, Inst Biochem & Molekularbiol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia	University Osnabruck; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; University of Freiburg; La Trobe University	Wagner, R (corresponding author), Univ Osnabruck, FB Biol Chem, D-49034 Osnabruck, Germany.	wagner@biologie.uni-osnabrueck.de; nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Kovermann, Peter/AAF-4411-2020; Truscott, Kaye/D-3362-2012; Mick, David/AAW-3726-2021; Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; Kovermann, Peter/0000-0001-5296-4918; Mick, David/0000-0003-1427-9412; Truscott, Kaye/0000-0002-5352-9835; Chacinska, Agnieszka/0000-0002-2832-2568				Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Oka T, 2005, MOL CELL, V18, P145, DOI 10.1016/j.molcel.2005.03.022; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; RASSOW J, 1989, J CELL BIOL, V109, P1421, DOI 10.1083/jcb.109.4.1421; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Voos W, 1996, EMBO J, V15, P2668, DOI 10.1002/j.1460-2075.1996.tb00627.x; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	29	147	149	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1523	1526		10.1126/science.1127628	http://dx.doi.org/10.1126/science.1127628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763150				2022-12-28	WOS:000238124100048
J	Horikawa, K; Ishimatsu, K; Yoshimoto, E; Kondo, S; Takeda, H				Horikawa, Kazuki; Ishimatsu, Kana; Yoshimoto, Eiichi; Kondo, Shigeru; Takeda, Hiroyuki			Noise-resistant and synchronized oscillation of the segmentation clock	NATURE			English	Article							SOMITE SEGMENTATION; GENE-EXPRESSION; ZEBRAFISH SOMITOGENESIS; LUNATIC-FRINGE; VERTEBRATE SEGMENTATION; INDIVIDUAL FIBROBLASTS; MECHANISM; NETWORK; CELLS; HER1	Periodic somite segmentation in vertebrate embryos is controlled by the 'segmentation clock', which consists of numerous cellular oscillators. Although the properties of a single oscillator, driven by a hairy negative-feedback loop, have been investigated, the system-level properties of the segmentation clock remain largely unknown. To explore these characteristics, we have examined the response of a normally oscillating clock in zebrafish to experimental stimuli using in vivo mosaic experiments and mathematical simulation. We demonstrate that the segmentation clock behaves as a coupled oscillator, by showing that Notch-dependent intercellular communication, the activity of which is regulated by the internal hairy oscillator, couples neighbouring cells to facilitate synchronized oscillation. Furthermore, the oscillation phase of individual oscillators fluctuates due to developmental noise such as stochastic gene expression and active cell proliferation. The intercellular coupling was found to have a crucial role in minimizing the effects of this noise to maintain coherent oscillation.	Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan	University of Tokyo; Nagoya University	Horikawa, K (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Hongo 7-3-1, Tokyo 1130033, Japan.	kazu@biol.s.u-tokyo.ac.jp; htakeda@biol.s.u-tokyo.ac.jp	TAKEDA, HIROYUKI/G-4950-2014	Kondo, Shigeru/0000-0003-0192-5526; Horikawa, Kazuki/0000-0002-9285-4171				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Cooke J, 1998, TRENDS GENET, V14, P85, DOI 10.1016/S0168-9525(98)01396-1; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; COOKE J, 1975, NATURE, V254, P196, DOI 10.1038/254196a0; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Hall B. K., 2003, KEYWORDS CONCEPTS EV; Henry CA, 2002, DEVELOPMENT, V129, P3693; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Ingolia NT, 2004, PLOS BIOL, V2, P805, DOI 10.1371/journal.pbio.0020123; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Ueda HR, 2002, J THEOR BIOL, V216, P501, DOI 10.1006/jtbi.2002.3000; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Winfree A.T., 2000, GEOMETRY BIOL TIME; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	44	205	211	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					719	723		10.1038/nature04861	http://dx.doi.org/10.1038/nature04861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760970				2022-12-28	WOS:000238095100046
J	Pitman, JL; McGill, JJ; Keegan, KP; Allada, R				Pitman, Jena L.; McGill, Jermaine J.; Keegan, Kevin P.; Allada, Ravi			A dynamic role for the mushroom bodies in promoting sleep in Drosophila	NATURE			English	Article							LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; TERM-MEMORY; REST; SHIBIRE; LOCALIZATION; DEPRIVATION; BEHAVIOR; MUTANT; WAKING	The fruitfly, Drosophila melanogaster, exhibits many of the cardinal features of sleep, yet little is known about the neural circuits governing its sleep(1). Here we have performed a screen of GAL4 lines expressing a temperature-sensitive synaptic blocker shibire(ts1) ( ref. 2) in a range of discrete neural circuits, and assayed the amount of sleep at different temperatures. We identified three short-sleep lines at the restrictive temperature with shared expression in the mushroom bodies, a neural locus central to learning and memory(3). Chemical ablation of the mushroom bodies also resulted in reduced sleep. These studies highlight a central role for the mushroom bodies in sleep regulation.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu						ARMSTRONG JD, 1996, FLYTRAP LINES; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; Hendricks JC, 2004, SLEEP, V27, P334, DOI 10.1093/sleep/27.2.334; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, SLEEP, V26, P139, DOI 10.1093/sleep/26.2.139; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Martin JR, 1998, LEARN MEMORY, V5, P179; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; SAPP RJ, 1991, J NEUROCYTOL, V20, P597, DOI 10.1007/BF01215267; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	241	242	1	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					753	756		10.1038/nature04739	http://dx.doi.org/10.1038/nature04739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760979				2022-12-28	WOS:000238095100055
J	Han, JJ; Lee, Y; Yeom, KH; Nam, JW; Heo, I; Rhee, JK; Sohn, SY; Cho, YJ; Zhang, BT; Kim, VN				Han, Jinju; Lee, Yoontae; Yeom, Kyu-Hyeon; Nam, Jin-Wu; Heo, Inha; Rhee, Je-Keun; Sohn, Sun Young; Cho, Yunje; Zhang, Byoung-Tak; Kim, V. Narry			Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex	CELL			English	Article							RNA-INTERFERENCE; NUCLEAR EXPORT; STRUCTURAL BASIS; HUMAN DICER; BIOGENESIS; PRECURSORS; EXPRESSION; CLEAVAGE; TRANSCRIPTS; MATURATION	The Drosha-DGCR8 complex initiates microRNA maturation by precise cleavage of the stem loops that are embedded in primary transcripts (pri-miRNAs). Here we propose a model for this process that is based upon evidence from both computational and biochemical analyses. A typical metazoan pri-miRNA consists of a stem of similar to 33 bp, with a terminal loop and flanking segments. The terminal loop is unessential, whereas the flanking ssRNA segments are critical for processing. The cleavage site is determined mainly by the distance (similar to 11 bp) from the stem-ssRNA junction. Purified DGCR8, but not Drosha, interacts with pri-miRNAs both directly and specifically, and the flanking ssRNA segments are vital for this binding to occur. Thus, DGCR8 may function as the molecular anchor that measures the distance from the dsRNA-ssRNA junction. Our current study thus facilitates the prediction of novel microRNAs and will assist in the rational design of small hairpin RNAs for RNA interference.	Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; Seoul Natl Univ, Res Ctr Funct Cellulom, Seoul, South Korea; Seoul Natl Univ, Sch Comp Sci & Engn, Seoul, South Korea; Pohang Univ Sci & Technol, Natl Creat Res Ctr Sruct Biol, Pohang, Kyungbook, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Kyungbook, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	narrykim@snu.ac.kr	Nam, Jin-Wu/F-7370-2017; Han, Jinju/D-9091-2017	Rhee, Je-Keun/0000-0003-4811-8895; HAN, Jinju/0000-0003-1844-2301				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	1100	1227	3	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					887	901		10.1016/j.cell.2006.03.043	http://dx.doi.org/10.1016/j.cell.2006.03.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751099	Bronze			2022-12-28	WOS:000238116400016
J	Zohn, IE; Li, YQ; Skolnik, EY; Anderson, KV; Han, JH; Niswander, L				Zohn, Irene E.; Li, Yingqiu; Skolnik, Edward Y.; Anderson, Kathryn V.; Han, Jiahuai; Niswander, Lee			p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; MAP KINASE; NEURAL-TUBE; PREIMPLANTATION DEVELOPMENT; MESODERM DIFFERENTIATION; STE20-RELATED KINASE; PRIMITIVE STREAK; EXPRESSION; GENE	During vertebrate gastrulation, an epithelial to mesenchymal transition (EMT) is necessary for migration of mesoderm from the primitive streak. We demonstrate that p38 MAP kinase and a p38-interacting protein (p38IP) are critically required for downregulation of E-cadherin during gastrulation. In an ENU-mutagenesis screen we identified the droopy eye (drey) mutation, which affects splicing of p38IP. p38IP(drey) mutant embryos display incompletely penetrant defects in neural tube closure, eye development, and gastrulation. A stronger allele, (p381P(RRK)) exhibits gastrulation defects in which mesoderm migration is defective due to deficiency in E-cadherin protein downregulation in the primitive streak. We show that p38IP binds directly to p38 and is required for p38 activation in vivo. Moreover, both p38 and p38IP are required for E-cadherin downregulation during gastrulation. Finally, p38 regulates E-cadherin protein expression downstream from NCK-interacting kinase (NIK) and independently of the regulation of transcription by Fibroblast Growth Factor (Fgf) signaling and Snail.	Univ Colorado, Sect Dev Biol, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA; Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; NYU, Med Ctr, Skirball Inst Biomol Med, Dept Pharmacol, New York, NY 10016 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Memorial Sloan Kettering Cancer Center; Scripps Research Institute; New York University	Niswander, L (corresponding author), Univ Colorado, Sect Dev Biol, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA.	lee.niswander@uchsc.edu	Han, J/G-4671-2010; Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594; Zohn, Irene/0000-0001-7688-682X; Anderson, Kathryn/0000-0003-1657-2161	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008605, U01HD043478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI041637] Funding Source: Medline; NICHD NIH HHS [U01-HD43478, F32-HD08605, R01-HD035455] Funding Source: Medline; NIGMS NIH HHS [R01-GM37696] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gomes I, 2002, BLOOD, V100, P107, DOI 10.1182/blood.V100.1.107; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Maekawa M, 2005, DEVELOPMENT, V132, P1773, DOI 10.1242/dev.01729; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Natale DR, 2004, DEV BIOL, V268, P76, DOI 10.1016/j.ydbio.2003.12.011; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Paricio N, 1999, EMBO J, V18, P4669, DOI 10.1093/emboj/18.17.4669; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schmidt U, 2005, CANCER LETT, V225, P253, DOI 10.1016/j.canlet.2004.10.037; Schmidt U, 2001, PROSTATE, V47, P91, DOI 10.1002/pros.1051; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Timmer JR, 2002, DEVELOPMENT, V129, P2459; Xue YZ, 2001, DEVELOPMENT, V128, P1559; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Zohn IE, 2005, BIRTH DEFECTS RES A, V73, P583, DOI 10.1002/bdra.20164	42	193	209	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					957	969		10.1016/j.cell.2006.03.048	http://dx.doi.org/10.1016/j.cell.2006.03.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751104	Bronze			2022-12-28	WOS:000238116400021
J	Winkley, K; Landau, S; Eisler, I; Ismail, K				Winkley, Kirsty; Landau, Sabine; Eisler, Ivan; Ismail, Khalida			Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HYPOGLYCEMIA; DEPRESSION; QUALITY; BIAS	Objective To determine whether psychological interventions have an), effect on glycaemic control in people with type I diabetes. Design Systematic review and meta-analysis of psychological therapies to assess their effectiveness in improving glycaemic control in type I diabetes. Data sources Medline, PsycINFO, Embase, and Cochrane central register of controlled trials searched to September 2004. Review methods All included studies were randomised controlled trials in children (including adolescents) or adults with type I diabetes that evaluated the effect of a psychological therapy (counselling cognitive behaviour therapy, family systems therapy, and psychodynamic therapy) on control of diabetes. Data were extracted on sample size, acre.. duration of diabetes, type of psychological therapy, its mode of delivery, and type of intervention group. in control group. Main outcome measures Glycaemic control measured by percentage of glycated haemoglobin and psychological distress. Pooled standardised effect sizes were calculated. Results 29 trials were eligible for the systematic review and 21 trials for the meta-analysis. In the 10 studies of children and adolescents included in the meta-analysis, the mean percentage of glycated haemoglobin was significantly reduced in those who had received a psychological intervention compared with those in die control group (pooled standardised mean difference - 0.35 (95% confidence interval - 0.66 to - 0.04), equivalent to a 0.48% (0.05% to 0.91%) absolute reduction in glycated haemoglobin. In die I I studies in adults the pooled standardised mean difference was 0.17 ( - 0.45 to 0.10), equivalent to 0.22% -0.13% to 0.56%) absolute reduction in glycated haemoglobin. Psychological distress was significantly lower in the intervention groups in children and adolescents (pooled standardised effect size - 0.46, - 0.83 to - 0.10) but not in adults (- 0.25, - 0.51 to 0.01). Conclusion Psychological treatments can slightly improve glycaemic control in children and adolescents with diabetes but have no effect in adults.	Kings Coll London, Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England; Kings Coll London, Inst Psychiat, Dept Biostat, London SE5 9RJ, England; Kings Coll London, Inst Psychiat, Dept Psychol, London SE5 9RJ, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Ismail, K (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England.	khalida.ismail@iop.kcl.ac.uk	Landau, Sabine/B-9354-2011; Winkley, Kirsty/AAH-9458-2020; Eisler, Ivan/C-8386-2009	Winkley, Kirsty/0000-0002-1725-6040; Eisler, Ivan/0000-0002-8211-7514; Landau, Sabine/0000-0002-3615-8075				Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; BECK A T, 1976, P356; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BRADBURN M, 1998, STATA TECH B, V440, P4; Churchill R, 2001, HEALTH TECHNOL ASSES, V5, P1, DOI DOI 10.3310/HTA5350; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fleiss JL., 2003, STAT METHODS RATES P; Gold AE, 1997, DIABETIC MED, V14, P111, DOI 10.1002/(SICI)1096-9136(199702)14:2<111::AID-DIA309>3.3.CO;2-J; GRIFFIN S, 1998, ED PSYCHOSOCIAL INTE; Hampson S E, 2001, Health Technol Assess, V5, P1; Harris R., 2001, ECON BULL, V5, P1; HODES M, 1993, PSYCHOL TREATMENT DI; JACOBSON AM, 1994, PSYCHOSOM MED, V56, P401, DOI 10.1097/00006842-199409000-00004; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Malan D. H., 1963, STUDY BRIEF PSYCHOTH, DOI [10.1007/978-1-4613-4395-0, DOI 10.1007/978-1-4613-4395-0]; Miller W.R., 1991, PREPARING PEOPLE CHA; MILLER WR, 1988, BEHAV PSYCHOTHER, V16, P251, DOI 10.1017/S0141347300014129; MINUCHIN S, 1991, FAMILIES FAMILY THER; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; MOOREY S, 1997, ESSENTIALS POSTGRADU; *NAT I CLIN EXC, 2004, TYP 1 DIAB DIAGN MAN; Orwin R.G., 1994, HDB RES SYNTHESIS; Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Snoek FJ, 2002, DIABETIC MED, V19, P265, DOI 10.1046/j.1464-5491.2002.00678.x; Whitney J, 2005, BRIT J PSYCHIAT, V187, P444, DOI 10.1192/bjp.187.5.444	30	207	210	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2006	333	7558					65	68A		10.1136/bmj.38874.652569.55	http://dx.doi.org/10.1136/bmj.38874.652569.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16803942	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000239133200013
J	Ellison, CRW; Chapman, MR; Hall, IR				Ellison, Christopher R. W.; Chapman, Mark R.; Hall, Ian R.			Surface and deep ocean interactions during the cold climate event 8200 years ago	SCIENCE			English	Article							HOLOCENE CLIMATE; NORTH-ATLANTIC; THERMOHALINE CIRCULATION; WATER; VARIABILITY; EUROPE; RECORD; GISP2; CYCLE	Evidence from a North Atlantic deep-sea sediment core reveals that the largest climatic perturbation in our present interglacial, the 8200-year event, is marked by two distinct cooling events in the subpolar North Atlantic at 8490 and 8290 years ago. An associated reduction in deep flow Speed provides evidence of a significant change to a major downwelting limb of the Atlantic meridional overturning circulation. The existence of a distinct surface freshening signal during these events strongly suggests that the sequenced surface and deep ocean changes were forced by pulsed meltwater outbursts from a multistep final drainage of the proglacial takes associated with the decaying Laurentide Ice Sheet margin.	Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, Wales; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Cardiff University; University of East Anglia	Chapman, MR (corresponding author), Cardiff Univ, Sch Earth Ocean & Planetary Sci, Main Bldg,Pk Pl, Cardiff CF10 3YE, Wales.	Mark.Chapman@uea.ac.uk; Hatt@cardiff.ac.uk	Mark, Chapman/H-4850-2011; Hall, Ian R/C-2755-2009	Hall, Ian R/0000-0001-6960-1419	Natural Environment Research Council [NE/C509107/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Alley RB, 2005, QUATERNARY SCI REV, V24, P1123, DOI 10.1016/j.quascirev.2004.12.004; Andersson C, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000654; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Bauer E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001030; Bianchi GG, 1999, NATURE, V397, P515, DOI 10.1038/17362; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hall IR, 2004, QUATERNARY SCI REV, V23, P1529, DOI 10.1016/j.quascirev.2004.04.004; Hall IR, 1998, EARTH PLANET SC LETT, V164, P15, DOI 10.1016/S0012-821X(98)00209-X; Klitgaard-Kristensen D, 1998, J QUATERNARY SCI, V13, P165, DOI 10.1002/(SICI)1099-1417(199803/04)13:2<165::AID-JQS365>3.0.CO;2-#; MASLIN MA, 1995, PALEOCEANOGRAPHY, V10, P527, DOI 10.1029/94PA03040; MCCAVE IN, 1995, PALEOCEANOGRAPHY, V10, P593, DOI 10.1029/94PA03039; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MEESE DA, 1994, SCIENCE, V266, P1680, DOI 10.1126/science.266.5191.1680; Moros M, 2004, QUATERNARY SCI REV, V23, P2113, DOI 10.1016/j.quascirev.2004.08.003; Muscheler R, 2004, QUATERNARY SCI REV, V23, P2101, DOI 10.1016/j.quascirev.2004.08.007; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; Oppo DW, 2003, NATURE, V422, P277, DOI 10.1038/422277b; PRICE JF, 1994, PROG OCEANOGR, V33, P161, DOI 10.1016/0079-6611(94)90027-2; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Renssen H, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000649; Rohling EJ, 2005, NATURE, V434, P975, DOI 10.1038/nature03421; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Teller JT, 2002, QUATERNARY SCI REV, V21, P879, DOI 10.1016/S0277-3791(01)00145-7; von Grafenstein U, 1999, SCIENCE, V284, P1654, DOI 10.1126/science.284.5420.1654; Wood RA, 2003, PHILOS T ROY SOC A, V361, P1961, DOI 10.1098/rsta.2003.1245	30	227	231	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1929	1932		10.1126/science.1127213	http://dx.doi.org/10.1126/science.1127213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809535				2022-12-28	WOS:000238848100053
J	Langford, DJ; Crager, SE; Shehzad, Z; Smith, SB; Sotocinal, SG; Levenstadt, JS; Chanda, ML; Levitin, DJ; Mogil, JS				Langford, Dale J.; Crager, Sara E.; Shehzad, Zarrar; Smith, Shad B.; Sotocinal, Susana G.; Levenstadt, Jeremy S.; Chanda, Mona Lisa; Levitin, Daniel J.; Mogil, Jeffrey S.			Social modulation of pain as evidence for empathy in mice	SCIENCE			English	Article							MOUSE STRAINS; BEHAVIOR; NOCICEPTION; RAT; ALTRUISM; OTHERS	Empathy is thought to be unique to higher primates, possibly to humans alone. We report the modulation of pain sensitivity in mice produced solely by exposure to their cagemates, but not to strangers, in pain. Mice tested in dyads and given an identical noxious stimulus displayed increased pain behaviors with statistically greater co-occurrence, effects dependent on visual observation. When familiar mice were given noxious stimuli of different intensities, their pain behavior was influenced by their neighbor's status bidirectionally. Finally, observation of a cagemate in pain altered pain sensitivity of an entirely different modality, suggesting that nociceptive mechanisms in general are sensitized.	McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Ctr Res Pain, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Mogil, JS (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.	jeffrey.mogil@mcgill.ca	Smith, Shad/AAO-8760-2020; Mogil, Jeffrey/AAA-9611-2019	Mogil, Jeffrey/0000-0003-1359-5720; Chanda, Mona Lisa/0000-0002-7265-6215				Adams B, 2002, BEHAV BRAIN RES, V133, P351, DOI 10.1016/S0166-4328(02)00020-7; Agren G, 1997, NEUROREPORT, V8, P3073, DOI 10.1097/00001756-199709290-00013; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; CLAYTON DA, 1978, Q REV BIOL, V53, P373, DOI 10.1086/410789; CRAIG KD, 1971, J PERS SOC PSYCHOL, V19, P53, DOI 10.1037/h0031097; DAMATO FR, 1993, BEHAV NEURAL BIOL, V60, P79, DOI 10.1016/0163-1047(93)90768-D; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; FANSELOW MS, 1985, BEHAV NEUROSCI, V99, P589, DOI 10.1037/0735-7044.99.3.589; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; KAPLAN HB, 1960, J NERV MENT DIS, V131, P128, DOI 10.1097/00005053-196008000-00006; LAVERY JJ, 1963, SCIENCE, V140, P172, DOI 10.1126/science.140.3563.172; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V63, P234, DOI 10.1037/0022-3514.63.2.234; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Raber P, 2002, PAIN, V97, P139, DOI 10.1016/S0304-3959(02)00013-1; RICE GE, 1962, J COMP PHYSIOL PSYCH, V55, P123, DOI 10.1037/h0042276; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; Wilson SG, 2002, PAIN, V96, P385, DOI 10.1016/S0304-3959(01)00489-4	23	540	560	7	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1967	1970		10.1126/science.1128322	http://dx.doi.org/10.1126/science.1128322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809545	Green Submitted			2022-12-28	WOS:000238848100064
J	Oshikane, H; Sheppard, K; Fukai, S; Nakamura, Y; Ishitani, R; Numata, T; Sherrer, RL; Feng, L; Schmitt, E; Panvert, M; Blanquet, S; Mechulam, Y; Soll, D; Nureki, O				Oshikane, Hiroyuki; Sheppard, Kelly; Fukai, Shuya; Nakamura, Yuko; Ishitani, Ryuichiro; Numata, Tomoyuki; Sherrer, R. Lynn; Feng, Liang; Schmitt, Emmanuelle; Panvert, Michel; Blanquet, Sylvain; Mechulam, Yves; Soell, Dieter; Nureki, Osamu			Structural basis of RNA-dependent recruitment of glutamine to the genetic code	SCIENCE			English	Article							AMINOACYL-TRANSFER-RNAS; CCA-ADDING ENZYME; ESCHERICHIA-COLI; AMIDOTRANSFERASE; BIOSYNTHESIS; SYNTHETASES; RECOGNITION; TEMPLATE; BINDING; TU	Glutaminyl-transfer RNA (Gln-tRNA(Gln)) in archaea is synthesized in a pretranslational amidation of misacylated Glu-tRNA(Gln) by the heterodimeric Glu-tRNA(Gln) amidotransferase GatDE. Here we report the crystal structure of the Methanothermobacter thermautotrophicus GatDE complexed to tRNA(Gln) at 3.15 angstroms resolution. Biochemical analysis of GatDE and of tRNAGln mutants characterized the catalytic centers for the enzyme's three reactions (glutaminase, kinase, and amidotransferase activity). A 40 angstrom-long channel for ammonia transport connects the active sites in GatD and GatE. tRNA(Gln) recognition by indirect readout based on shape complementarity of the D loop suggests an early anticodon-independent RNA-based mechanism for adding glutamine to the genetic code.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Ecole Polytech, CNRS, UMR 7654, Biochim Lab, F-91128 Palaiseau, France	Yale University; Tokyo Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Nureki, O (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; onureki@bio.titech.ac.jp	Mechulam, Yves/F-3313-2019; Fukai, Shuya/X-4838-2018; Emmanuelle, SCHMITT/ABF-8658-2020; SCHMITT, Emmanuelle/F-2605-2019; NUREKI, OSAMU/G-4960-2014	Mechulam, Yves/0000-0003-3586-3554; Fukai, Shuya/0000-0002-1241-1443; Emmanuelle, SCHMITT/0000-0001-7532-338X; SCHMITT, Emmanuelle/0000-0001-7532-338X; Sherrer, Lynn/0000-0001-9771-9035				Asahara H, 2002, P NATL ACAD SCI USA, V99, P3499, DOI 10.1073/pnas.052028599; Ataide SF, 2005, EMBO REP, V6, P742, DOI 10.1038/sj.embor.7400474; BOCK A, 2004, AMINOACYL TRNA SYNTH; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Di Giulio M, 2002, J MOL EVOL, V55, P616, DOI 10.1007/s00239-002-2357-6; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Ibba M, 2000, TRENDS BIOCHEM SCI, V25, P311, DOI 10.1016/S0968-0004(00)01600-5; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; LAMOUR V, 1994, P NATL ACAD SCI USA, V91, P8670, DOI 10.1073/pnas.91.18.8670; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Mouilleron S, 2006, J BIOL CHEM, V281, P4404, DOI 10.1074/jbc.M511689200; MULERO JJ, 1994, CURR GENET, V25, P299, DOI 10.1007/BF00351481; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; Polycarpo C, 2003, MOL CELL, V12, P287, DOI 10.1016/S1097-2765(03)00280-6; Raczniak G, 2001, J BIOL CHEM, V276, P45862, DOI 10.1074/jbc.M109494200; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schmitt E, 2005, STRUCTURE, V13, P1421, DOI 10.1016/j.str.2005.06.016; SCHON A, 1988, NATURE, V331, P187, DOI 10.1038/331187a0; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; TANAKA I, COMMUNICATION; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	36	72	73	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1950	1954		10.1126/science.1128470	http://dx.doi.org/10.1126/science.1128470			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809540				2022-12-28	WOS:000238848100059
J	Rhee, H; Polak, L; Fuchs, E				Rhee, Horace; Polak, Lisa; Fuchs, Elaine			Lhx2 maintains stem cell character in hair follicles	SCIENCE			English	Article							SONIC-HEDGEHOG; DIFFERENTIATION; MORPHOGENESIS; EPIDERMIS; SKIN; TRANSCRIPTION; POPULATIONS; MECHANISMS; INDUCTION; GENE	During embryogenesis, stem cells are set aside to fuel the postnatal hair cycle and repair the epidermis after injury. To define how hair follicle stem cells are specified and maintained in an undifferentiated state, we developed a strategy to isolate and transcriptionally profile embryonic hair progenitors in mice. We identified Lhx2 as a transcription factor positioned downstream of signals necessary to specify hair follicle stem cells, but upstream from signals required to drive activated stem cells to terminally differentiate. Using gain- and loss-of-function studies, we uncovered a rote for Lhx2 in maintaining the growth and undifferentiated properties of hair follicle progenitors.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR050452, R01 AR050452-04, R01 AR031737, R01 AR031737-24, R01-AR050452] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; DasGupta R, 1999, DEVELOPMENT, V126, P4557; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Porter FD, 1997, DEVELOPMENT, V124, P2935; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Yue ZC, 2005, NATURE, V438, P1026, DOI 10.1038/nature04222	31	248	263	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1946	1949		10.1126/science.1128004	http://dx.doi.org/10.1126/science.1128004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809539	Green Accepted			2022-12-28	WOS:000238848100058
J	Stone, JH				Stone, JH			Incidentalomas - Clinical correlation and translational science required	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVALENCE		Johns Hopkins Univ, Sch Med, Baltimore, MD 21204 USA	Johns Hopkins University	Stone, JH (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21204 USA.							HEDELAND H, 1968, ACTA MED SCAND, V184, P211; Hellmann David B, 2003, Pharos Alpha Omega Alpha Honor Med Soc, V66, P24; RAVINE D, 1993, AM J KIDNEY DIS, V22, P803, DOI 10.1016/S0272-6386(12)70338-4; WUDKA J, WHAT IS OCKHAMS RAZO	4	44	45	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2748	2749		10.1056/NEJMp058264	http://dx.doi.org/10.1056/NEJMp058264			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807411				2022-12-28	WOS:000238584700002
J	Neels, JG; Olefsky, JM				Neels, Jaap G.; Olefsky, Jerrold M.			A new way to burn fat	SCIENCE			English	Editorial Material							INSULIN-RESISTANCE; COA; CARBOXYLASE-2; LIVER; TRB3		Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Neels, JG (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Neels, Jaap G/F-5534-2010	Neels, Jaap G/0000-0002-5900-8395				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Corcoran CA, 2005, CANCER BIOL THER, V4, P1063, DOI 10.4161/cbt.4.10.2205; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Saltiel AR, 2003, NEW ENGL J MED, V349, P2560, DOI 10.1056/NEJMcibr031668; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300	11	18	19	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1756	1758		10.1126/science.1130476	http://dx.doi.org/10.1126/science.1130476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794069				2022-12-28	WOS:000238452800043
J	Rossi, SW; Jenkinson, WE; Anderson, G; Jenkinson, EJ				Rossi, Simona W.; Jenkinson, William E.; Anderson, Graham; Jenkinson, Eric J.			Clonal analysis reveals a common progenitor for thymic cortical and medullary epithelium	NATURE			English	Article							CELLS; DIFFERENTIATION; FATE	The thymus provides an essential environment for the development of T cells from haemopoietic progenitors. This environment is separated into cortical and medullary regions, each containing functionally distinct epithelial populations that are important at successive stages of T-cell development and selection(1,2). However, the developmental origin and lineage relationships between cortical and medullary epithelial cell types remain controversial(3). Here we describe a clonal assay to investigate the developmental potential of single, individually selected, thymic epithelial progenitors ( marked with enhanced yellow fluorescent protein) developing within the normal architecture of the thymus. Using this approach, we show that cortical and medullary epithelial cells share a common origin in bipotent precursors, providing definitive evidence that they have a single rather than dual germ layer origin during embryogenesis. Our findings resolve a long-standing issue in thymus development, and are important in relation to the development of cell-based strategies for thymus disorders and the possibility of restoring function of the atrophied adult thymus.	Univ Birmingham, Sch Med, Inst Biomed Res, Div Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Anderson, G (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Div Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	g.anderson@bham.ac.uk		anderson, graham/0000-0002-2917-4085; Jenkinson, William/0000-0003-3422-8372; Rossi, Simona W/0000-0002-8212-0502	MRC [G0401620] Funding Source: UKRI; Medical Research Council [G0401620] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson G, 1997, EUR J IMMUNOL, V27, P1838, DOI 10.1002/eji.1830270803; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Jenkinson WE, 2005, MECH DEVELOP, V122, P1294, DOI 10.1016/j.mod.2005.08.003; Jenkinson WE, 2003, J EXP MED, V198, P325, DOI 10.1084/jem.20022135; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Smalley MJ, 2005, CYTOTHERAPY, V7, P497, DOI 10.1080/14653240500361145; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wils EJ, 2005, BLOOD REV, V19, P89, DOI 10.1016/j.blre.2004.04.001; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2	23	239	241	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					988	991		10.1038/nature04813	http://dx.doi.org/10.1038/nature04813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791197				2022-12-28	WOS:000238422300044
J	Alkalaeva, EZ; Pisarev, AV; Frolova, LY; Kisselev, LL; Pestova, TV				Alkalaeva, Elena Z.; Pisarev, Andrey V.; Frolova, Lyudmila Y.; Kisselev, Lev L.; Pestova, Tatyana V.			In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3	CELL			English	Article							TERMINATION FACTOR ERF1; INTERNAL RIBOSOMAL ENTRY; TRANSFER-RNA HYDROLYSIS; STOP CODON RECOGNITION; INITIATION-FACTORS; AMINO-ACIDS; GGQ MOTIF; MESSENGER-RNA; FISSION YEAST; ELONGATION	Eukaryotic translation termination is triggered by peptide release factors eRF1 and eRF3. Whereas eRF1 recognizes all three termination codons and induces hydrolysis of peptidyl tRNA, eRF3's function remains obscure. Here, we reconstituted all steps of eukaryotic translation in vitro using purified ribosomal subunits; initiation, elongation, and termination factors; and aminoacyl tRNAs. This allowed us to investigate termination using pretermination complexes assembled on mRNA encoding a tetrapeptide and to propose a model for translation termination that accounts for the cooperative action of eRF1 and eRF3 in ensuring fast release of nascent polypeptide. In this model, binding of eRF1, eRF3, and GTP to pretermination complexes first induces a structural rearrangement that is manifested as a :2 nucleotide forward shift of the toeprint attributed to pretermination complexes that leads to GTP hydrolysis followed by rapid hydrolysis of pepticlyl tRNA. Cooperativity between eRF1 and eRF3 required the eRF3 binding C-terminal domain of eRF1.	Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University	Alkalaeva, EZ (corresponding author), Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA.	kissel@eimb.relarn.ru; tatyana.pestova@downstate.edu	Alkalaeva, Elena/ABC-3888-2021	Alkalaeva, Elena/0000-0003-2078-7261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063940] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM63940] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caskey C T, 1974, Methods Enzymol, V30, P293; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; Ebihara K, 1999, RNA, V5, P739, DOI 10.1017/S135583829998216X; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; FROLOVA L, 1996, RNA, V2, P34; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Frolova LY, 2000, RNA, V6, P381, DOI 10.1017/S135583820099143X; Frolova LY, 1998, EUR J BIOCHEM, V256, P36, DOI 10.1046/j.1432-1327.1998.2560036.x; Ito K, 2002, P NATL ACAD SCI USA, V99, P8494, DOI 10.1073/pnas.142690099; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Kervestin S, 2001, EMBO REP, V2, P680, DOI 10.1093/embo-reports/kve156; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Kobayashi T, 2004, J BIOL CHEM, V279, P45693, DOI 10.1074/jbc.M405163200; Kolosov P, 2005, NUCLEIC ACIDS RES, V33, P6418, DOI 10.1093/nar/gki927; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Nakamura Y, 2003, TRENDS BIOCHEM SCI, V28, P99, DOI 10.1016/S0968-0004(03)00006-9; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Seit-Nebi A, 2002, EMBO REP, V3, P881, DOI 10.1093/embo-reports/kvf178; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	35	211	221	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1125	1136		10.1016/j.cell.2006.04.035	http://dx.doi.org/10.1016/j.cell.2006.04.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777602	Bronze			2022-12-28	WOS:000238602700017
J	Hillman, M				Hillman, M			Commentary: Personal carbon allowances	BRITISH MEDICAL JOURNAL			English	Editorial Material									Policy Studies Inst, London W1W 6UP, England		Hillman, M (corresponding author), Policy Studies Inst, London W1W 6UP, England.	mayer.hillman@blueyonder.co.uk						Carley M., 1991, Policy Studies, V12, P36, DOI 10.1080/01442879108423585; Hillman M, 2004, WE CAN SAVE PLANET; Meyer A., 2000, CONTRACTION CONVERGE; STARKEY R, 39 TYND CTR; Stott R, 2006, BRIT MED J, V332, P1385, DOI 10.1136/bmj.332.7554.1385	5	2	2	2	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 10	2006	332	7554					1387	1388		10.1136/bmj.332.7554.1387	http://dx.doi.org/10.1136/bmj.332.7554.1387			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763256	Green Published			2022-12-28	WOS:000238587000027
J	Hickman, M; Macleod, J; De Angelis, D				Hickman, M; Macleod, J; De Angelis, D			Harm-reduction interventions in injection drug use	LANCET			English	Editorial Material							UNITED-STATES; HEROIN USE; COHORT		Univ Bristol, Bristol, Avon, England; Univ Birmingham, Dept Primary Care & Gen Practice, Sch Med, Birmingham, W Midlands, England; Inst Publ Hlth, MRC Biostat Unit, Cambridge, England	University of Bristol; University of Birmingham; MRC Biostatistics Unit; University of Cambridge	Hickman, M (corresponding author), Univ Bristol, Canynge Hall, Bristol, Avon, England.	Matthew.Hickman@bristol.ac.uk	Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; De Angelis, Daniela/0000-0001-6619-6112; Macleod, John/0000-0001-8202-1144	Medical Research Council [MC_U105260556] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ades AE, 2006, J R STAT SOC A STAT, V169, P5, DOI 10.1111/j.1467-985X.2005.00377.x; Ben-Shlomo Y, 2005, INT J EPIDEMIOL, V34, P1181, DOI 10.1093/ije/dyi242; Bishop YM., 2007, DISCRETE MULTIVARIAT; De Angelis D, 2004, AM J EPIDEMIOL, V160, P994, DOI 10.1093/aje/kwh306; Galai N, 2003, AM J EPIDEMIOL, V158, P695, DOI 10.1093/aje/kwg209; GFROERER J, 1992, BRIT J ADDICT, V87, P1345; Hickman M, 2001, AM J EPIDEMIOL, V153, P632, DOI 10.1093/aje/153.7.632; HICKMAN M, 2002, UN B NARCOTICS, V1, P15; HUNT LG, 1974, AM J PUBLIC HEALTH, V64, P16, DOI 10.2105/AJPH.64.12_Suppl.16; *I MED, 1996, PATHW ADD OPP DRUG A; KAPLAN EH, 1989, REV INFECT DIS, V11, P289; Negrete JC, 2001, ADDICTION, V96, P543, DOI 10.1046/j.1360-0443.2001.9645432.x; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; Termorshuizen F, 2005, AM J EPIDEMIOL, V161, P271, DOI 10.1093/aje/kwi035; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310	15	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1797	1798		10.1016/S0140-6736(06)68781-3	http://dx.doi.org/10.1016/S0140-6736(06)68781-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753468				2022-12-28	WOS:000238194200006
J	Valery, PC; Coory, M; Stirling, J; Green, AC				Valery, PC; Coory, M; Stirling, J; Green, AC			Cancer diagnosis, treatment,, and survival in Indigenous and non-indigenous Australians: a matched cohort study	LANCET			English	Article							NORTHERN-TERRITORY; BREAST-CANCER; DISPARITIES; QUEENSLAND; MORTALITY; STAGE	Background Indigenous Australians do not have the high standard of health that Australians in general have, and have worse outcomes for several diseases such as cancer. However, few comparative data exist to prove this disparity. We assessed differences in disease stage at cancer diagnosis, treatment, and survival between these two populations in Queensland. Methods Indigenous people diagnosed with cancer between 1997 and 2002 were identified through the cancer registry and compared with randomly selected non-Indigenous patients who were frequency-matched for age, sex, place of residence, cancer site, and year of diagnosis. We obtained details of treatment from hospital medical records. We restricted analyses to patients treated in the public sector, since less than 5% of Indigenous cases were treated privately. We used multivariate models, mainly Cox regression analyses, to assess differences. Findings We studied 815 Indigenous and 810 non-Indigenous cancer patients. Stage at diagnosis differed significantly (p=0.007): 47% of indigenous versus 53% of non-Indigenous patients had localised cancer, 22% versus 21% had distant metastases, and 12% versus 7% had no information on stage in the medical chart examined. Comorbidities such as diabetes mellitus or chronic renal disease were more common in Indigenous patients. These individuals were less likely to have had treatment for cancer (surgery, chemotherapy, radiotherapy), and waited longer for surgery (hazard ratio=0.84, 95% CI 0.72-0.97) than non-Indigenous patients. After adjustment for stage at diagnosis, treatment, and comorbidities, non-Indigenous patients had better survival than Indigenous ones (hazard ratio=1.3, 95% CI 1.1-1.5). Interpretation Non-Indigenous cancer patients survive longer than Indigenous ones, even after adjustment for stage at diagnosis, cancer treatment, and greater comorbidity in Indigenous cases. We believe that better understanding of cultural differences in attitudes to cancer and its treatment could translate into meaningful public-health and clinical interventions to improve cancer survival in Indigenous Australians.	Royal Brisbane Hosp, Epidemiol & Populat Hlth Div, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Valery, PC (corresponding author), Royal Brisbane Hosp, Epidemiol & Populat Hlth Div, Queensland Inst Med Res, PO, Brisbane, Qld 4029, Australia.	Patricia.Valery@qimr.edu.au	Green, Adele C/B-5324-2011; Green, Adele C/P-2736-2014; Valery, Patricia/AAV-5448-2020; VALERY, Patricia/G-6230-2013	Green, Adele C/0000-0002-2753-4841; Valery, Patricia/0000-0002-8823-3006; VALERY, Patricia/0000-0002-8823-3006				Adams J, 2004, BRIT MED J, V329, P142, DOI 10.1136/bmj.38114.679387.AE; *AUSTR BUR STAT, 2004, CENS POP HOUS SOC IN; *AUSTR BUR STAT, 2005, HLTH WELF AB TORR ST; *AUSTR BUR STAT, 2003, CAUS DEATH 2002; Baquet C R, 1999, J Assoc Acad Minor Phys, V10, P51; Bramley D, 2005, AM J PUBLIC HEALTH, V95, P844, DOI 10.2105/AJPH.2004.040907; CONDON J, 2004, THESIS C DARWIN U; Condon JR, 2005, MED J AUSTRALIA, V182, P277, DOI 10.5694/j.1326-5377.2005.tb06700.x; Condon JR, 2005, AUST NZ J PUBL HEAL, V29, P123, DOI 10.1111/j.1467-842X.2005.tb00061.x; Condon JR, 2003, CANCER CAUSE CONTROL, V14, P109, DOI 10.1023/A:1023064400004; Coory M, 2000, MED J AUSTRALIA, V173, P301, DOI 10.5694/j.1326-5377.2000.tb125661.x; Department of Health and Aged Care, 2000, MEAS REM ACC REM IND; Eckerman A, 1992, BINANG GOONJ BRIDGIN; Freeman HP, 2004, CA-CANCER J CLIN, V54, P72, DOI 10.3322/canjclin.54.2.72; GLOVER J, 1999, SOCIAL HLTH ATLAS AU; Hall SE, 2004, MED J AUSTRALIA, V181, P191, DOI 10.5694/j.1326-5377.2004.tb06234.x; Hall Sonja E, 2004, Aust Health Rev, V27, P68; HARRIS E, 1999, PERSPECTIVES HLTH IN; HOSMER DW, 1999, MODEL DEV, P158; Jong KE, 2004, MED J AUSTRALIA, V180, P618, DOI 10.5694/j.1326-5377.2004.tb06123.x; O'Brien ED, 2000, INT J EPIDEMIOL, V29, P813, DOI 10.1093/ije/29.5.813; Paradies Y, 2002, AUST NZ J PUBL HEAL, V26, P11, DOI 10.1111/j.1467-842X.2002.tb00264.x; PRIOR D, 2005, THESIS U QUEENSLAND; Robertson H, 1995, Aust Coll Midwives Inc J, V8, P26, DOI 10.1016/S1031-170X(05)80021-2; *SEER, 2001, SUMM STAG MAN 2000 C; Shaw IM, 2003, ANZ J SURG, V73, P758, DOI 10.1046/j.1445-2197.2003.02751.x; South Australian Cancer Registry, 1997, CANC INC MORT CASE S, P13; Threlfall TJ, 2002, CANC INCIDENCE MORTA; *US BUR CENS, 1999, POV 1999 CENS 2000 B; Young M, 2001, ASSESSING QUALITY ID; Zhao YJ, 2004, MED J AUSTRALIA, V180, P498, DOI 10.5694/j.1326-5377.2004.tb06051.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	149	149	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1842	1848		10.1016/S0140-6736(06)68806-5	http://dx.doi.org/10.1016/S0140-6736(06)68806-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753487				2022-12-28	WOS:000238194200030
J	Kerssemakers, JWJ; Munteanu, EL; Laan, L; Noetzel, TL; Janson, ME; Dogterom, M				Kerssemakers, Jacob W. J.; Munteanu, E. Laura; Laan, Liedewij; Noetzel, Tim L.; Janson, Marcel E.; Dogterom, Marileen			Assembly dynamics of microtubules at molecular resolution	NATURE			English	Article							END-TRACKING PROTEINS; PLUS-END; TRANSITION FREQUENCIES; XENOPUS EGGS; TUBULIN; XMAP215; INSTABILITY; MICROSCOPY; MECHANICS; CLIP-170	Microtubules are highly dynamic protein polymers(1) that form a crucial part of the cytoskeleton in all eukaryotic cells. Although microtubules are known to self- assemble from tubulin dimers, information on the assembly dynamics of microtubules has been limited, both in vitro(2,3) and in vivo(4,5), to measurements of average growth and shrinkage rates over several thousands of tubulin subunits. As a result there is a lack of information on the sequence of molecular events that leads to the growth and shrinkage of microtubule ends. Here we use optical tweezers to observe the assembly dynamics of individual microtubules at molecular resolution. We find that microtubules can increase their overall length almost instantaneously by amounts exceeding the size of individual dimers ( 8 nm). When the microtubule- associated protein XMAP215 ( ref. 6) is added, this effect is markedly enhanced and fast increases in length of about 40 - 60 nm are observed. These observations suggest that small tubulin oligomers are able to add directly to growing microtubules and that XMAP215 speeds up microtubule growth by facilitating the addition of long oligomers. The achievement of molecular resolution on the microtubule assembly process opens the way to direct studies of the molecular mechanism by which the many recently discovered microtubule end-binding proteins regulate microtubule dynamics in living cells(7-9).	FOM, Inst Atom & Mol Phys, AMOLF, Fdn Fundamental Res Matter, NL-1098 SJ Amsterdam, Netherlands; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	AMOLF; Max Planck Society; University of Pennsylvania	Dogterom, M (corresponding author), FOM, Inst Atom & Mol Phys, AMOLF, Fdn Fundamental Res Matter, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	dogterom@amolf.nl		Laan, Liedewij/0000-0002-7138-9004; Kerssemakers, Jacob Willem Jozef/0000-0002-6184-7913				Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Cassimeris L, 2001, J CELL SCI, V114, P3025; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Janson ME, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.248101; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kerssemakers JWJ, 2003, APPL PHYS LETT, V83, P4441, DOI 10.1063/1.1629796; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Komarova YA, 2002, J CELL SCI, V115, P3527; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Pierce DW, 1998, METHOD ENZYMOL, V298, P154, DOI 10.1016/S0076-6879(98)98016-8; Schek HT, 2005, BIOMED MICRODEVICES, V7, P41, DOI 10.1007/s10544-005-6170-z; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606	30	429	435	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					709	712		10.1038/nature04928	http://dx.doi.org/10.1038/nature04928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799566				2022-12-28	WOS:000239630200051
J	Seehusen, DA; Johnson, DR; Earwood, JS; Sethuraman, SN; Cornali, J; Gillespie, K; Doria, M; Farnell, E; Lanham, J				Seehusen, Dean A.; Johnson, Dawn R.; Earwood, J. Scott; Sethuraman, Sankar N.; Cornali, Jamie; Gillespie, Kelly; Doria, Maria; Farnell, Edwin; Lanham, Jason			Improving women's experience during speculum examinations at routine gynaecological visits: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PAIN	Objectives To determine if a standardised method of leg positioning without stirrups reduces the physical discomfort and sense of vulnerability and increases the sense of control among women undergoing speculum examination as part of a routine gynaecological examination. Design Randomised clinical trial. Setting Family medicine outpatient clinic. Patients 197 adult women undergoing routine gynaecological examination and cervical smear. Intervention Examination with or without stirrups. Main outcome measures Women's perceived levels of physical discomfort, sense of vulnerability, and sense of control during the examination, measured on 100 turn visual analogue scales. Results Women undergoing examination without stirrups had a reduction in mean sense of vulnerability from 23.6 to 13.1 (95% confidence interval of the difference - 16.6 to - 4.4). Mean physical discomfort was reduced front 30.4 to 17.2 (- 19.7 to - 6.8). There was no significant reduction in sense of loss of control. Conclusion Women should be able to have gynaecological examinations without using stirrups to reduce the stress associated with speculum examinations.	Eisenhower Army Med Ctr, Dept Family & Community Med, Ft Gordon, GA 30905 USA; Augusta State Univ, Dept Math & Comp Sci, Augusta, GA 30904 USA	United States Department of Defense; United States Army; University System of Georgia; Augusta University	Seehusen, DA (corresponding author), Eisenhower Army Med Ctr, Dept Family & Community Med, Ft Gordon, GA 30905 USA.	dseehusen@msn.con		Seehusen, Dean/0000-0002-2139-6484				CURTIS P, 1991, J FAM PRACTICE, V33, P345; Doig A, 2002, CAN FAM PHYSICIAN, V48, P876; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; Greiver M, 2001, CAN FAM PHYSICIAN, V47, P1979; Hoyo C, 2005, PREV MED, V41, P439, DOI 10.1016/j.ypmed.2004.11.021; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM; Kahn JA, 2003, OBSTET GYNECOL, V101, P490, DOI 10.1016/S0029-7844(02)02592-9; Klassen D, 2002, CAN FAM PHYSICIAN, V48, P457; Larsen M, 1997, FAM PRACT, V14, P148, DOI 10.1093/fampra/14.2.148; Moettus A, 1999, AM J EMERG MED, V17, P635, DOI 10.1016/S0735-6757(99)90148-1; *NCI, PAP TEST QUEST ANSW; Olson B K, 1981, JOGN Nurs, V10, P104, DOI 10.1111/j.1552-6909.1981.tb00842.x; Sellathurai M, 2000, MULTIACCESS, MOBILITY AND TELETRAFFIC IN WIRELESS COMMUNICATIONS: VOLUME 5, P13; SEYMORE C, 1986, J PEDIATR-US, V108, P312, DOI 10.1016/S0022-3476(86)81011-3; Thomas A, 2001, AUST NZ J OBSTET GYN, V41, P379, DOI 10.1111/j.1479-828X.2001.tb01313.x; WILLIAMS JG, 1992, WOMEN HEALTH, V18, P41, DOI 10.1300/J013v18n02_03; Wright D, 2005, J CLIN NURS, V14, P1098, DOI 10.1111/j.1365-2702.2005.01205.x	17	44	46	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2006	333	7560					171	173		10.1136/bmj.38888.588519.55	http://dx.doi.org/10.1136/bmj.38888.588519.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16803941	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000239352100018
J	Teng, WP; Shan, ZY; Teng, XC; Guan, HX; Li, YH; Teng, D; Jin, Y; Yu, XH; Fan, CL; Chong, W; Yang, F; Dai, H; Yu, Y; Li, J; Chen, YY; Zhao, D; Shi, XG; Hu, FN; Mao, JY; Gu, XL; Yang, R; Tong, YJ; Wang, WB; Gao, TS; Li, CY				Teng, Weiping; Shan, Zhongyan; Teng, Xiaochun; Guan, Haixia; Li, Yushu; Teng, Di; Jin, Ying; Yu, Xiaohui; Fan, Chenling; Chong, Wei; Yang, Fan; Dai, Hong; Yu, Yang; Li, Jia; Chen, Yanyan; Zhao, Dong; Shi, Xiaoguang; Hu, Fengnan; Mao, Jinyuan; Gu, Xiaolan; Yang, Rong; Tong, Yajie; Wang, Weibo; Gao, Tianshu; Li, Chenyang			Effect of iodine intake on thyroid diseases in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYROTROPIN REFERENCE RANGE; DISORDERS; HYPERTHYROIDISM; THYROTOXICOSIS	BACKGROUND: Iodine is an essential component of thyroid hormones; either low or high intake may lead to thyroid disease. We observed an increase in the prevalence of overt hypothyroidism, subclinical hypothyroidism, and autoimmune thyroiditis with increasing iodine intake in China in cohorts from three regions with different levels of iodine intake: mildly deficient (median urinary iodine excretion, 84 microg per liter), more than adequate (median, 243 microg per liter), and excessive (median, 651 microg per liter). Participants enrolled in a baseline study in 1999, and during the five-year follow-up through 2004, we examined the effect of regional differences in iodine intake on the incidence of thyroid disease. METHODS: Of the 3761 unselected subjects who were enrolled at baseline, 3018 (80.2 percent) participated in this follow-up study. Levels of thyroid hormones and thyroid autoantibodies in serum, and iodine in urine, were measured and B-mode ultrasonography of the thyroid was performed at baseline and follow-up. RESULTS: Among subjects with mildly deficient iodine intake, those with more than adequate intake, and those with excessive intake, the cumulative incidence of overt hypothyroidism was 0.2 percent, 0.5 percent, and 0.3 percent, respectively; that of subclinical hypothyroidism, 0.2 percent, 2.6 percent, and 2.9 percent, respectively; and that of autoimmune thyroiditis, 0.2 percent, 1.0 percent, and 1.3 percent, respectively. Among subjects with euthyroidism and antithyroid antibodies at baseline, the five-year incidence of elevated serum thyrotropin levels was greater among those with more than adequate or excessive iodine intake than among those with mildly deficient iodine intake. A baseline serum thyrotropin level of 1.0 to 1.9 mIU per liter was associated with the lowest subsequent incidence of abnormal thyroid function. CONCLUSIONS: More than adequate or excessive iodine intake may lead to hypothyroidism and autoimmune thyroiditis.	China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Peoples R China; China Med Univ, Affiliated Hosp 1, Inst Endocrinol, Shenyang, Peoples R China	China Medical University; China Medical University	Teng, WP (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, 155 Nanjing Bei St, Shenyang, Peoples R China.	twpendocrine@yahoo.com.cn						ALLEN EM, 1986, ENDOCRINOLOGY, V118, P1977, DOI 10.1210/endo-118-5-1977; [Anonymous], 2001, CHIN J ENDOCRINOL; Bourdoux PP, 1996, LANCET, V347, P552, DOI 10.1016/S0140-6736(96)91188-5; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; Chen Z, 2001, CHIN J CONTROL ENDEM, V16, P185; Dunn JT., 1993, METHODS MEASURING IO; Guan H, 2001, Zhonghua Nei Ke Za Zhi, V40, P597; Guan H, 2001, Zhonghua Yi Xue Za Zhi, V81, P457; [胡凤楠 Hu Fengnan], 2002, [中国地方病学杂志, Chinese Journal of Endemiology], V21, P464; Laurberg P, 1998, J CLIN ENDOCR METAB, V83, P765, DOI 10.1210/jc.83.3.765; Li Chen-yang, 2003, Zhonghua Nei Ke Za Zhi, V42, P316; [李玉姝 Li Yushu], 2002, [上海免疫学杂志, Shanghai Journal of Immunology], V22, P91; MA T, 1982, CHINESE MED J-PEKING, V95, P692; MA T, 1993, IODINE DEFICIENCY DI; Rasooly L, 1996, CLIN IMMUNOL IMMUNOP, V81, P287, DOI 10.1006/clin.1996.0191; Stanbury JB, 1998, THYROID, V8, P83, DOI 10.1089/thy.1998.8.83; Surks MI, 2005, J CLIN ENDOCR METAB, V90, P5489, DOI 10.1210/jc.2005-0170; Szabolcs I, 1997, CLIN ENDOCRINOL, V47, P87, DOI 10.1046/j.1365-2265.1997.2271040.x; Teng Xiaochun, 2002, Zhonghua Yufang Yixue Zazhi, V36, P176; TODD CH, 1995, LANCET, V346, P1563, DOI 10.1016/S0140-6736(95)92095-1; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wartofsky L, 2005, J CLIN ENDOCR METAB, V90, P5483, DOI 10.1210/jc.2005-0455; WHO, 2001, ASS IOD DEF DIS MON; Yang F, 2002, EUR J ENDOCRINOL, V146, P613, DOI 10.1530/eje.0.1460613	24	522	668	6	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2783	2793		10.1056/NEJMoa054022	http://dx.doi.org/10.1056/NEJMoa054022			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807415				2022-12-28	WOS:000238584700006
J	Bordignon, C				Bordignon, Claudio			Stem-cell therapies for blood diseases	NATURE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; GENE-THERAPY; BONE-MARROW; TRANSPLANTATION; LYMPHOCYTES	For decades, transplantation of haematopoietic stem cells-either unmodified, or genetically modified to correct genetic disorders-has been used to treat disorders of the blood and immune systems. The present challenge is to reduce the risk of such transplants and increase the number of patients who can safely access this treatment. In developing countries, such 'one-shot' treatments are highly desirable because chronic treatments are difficult to sustain. To make these therapies more accessible and effective it will be important to improve clinical protocols and gene-delivery vectors, and to gain a deeper understanding of stem cells.	Univ Vita Salute, Ist Sci San Raffaele, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bordignon, C (corresponding author), Univ Vita Salute, Ist Sci San Raffaele, Via Olgettina 58, I-20132 Milan, Italy.	bordignon.claudio@hsr.it						Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Boulad F, 2000, BRIT J HAEMATOL, V111, P1153, DOI 10.1046/j.1365-2141.2000.02443.x; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Corti P, 2005, BRIT J HAEMATOL, V130, P249, DOI 10.1111/j.1365-2141.2005.05585.x; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fischer A, 2004, NEW ENGL J MED, V350, P2526; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; GATTI RA, 1968, LANCET, V2, P1366; Gregori S, 2005, CURR OPIN HEMATOL, V12, P451, DOI 10.1097/01.moh.0000177826.41262.0a; Grompe Markus, 2005, V265, P20; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Lucarelli G, 2002, BLOOD REV, V16, P81, DOI 10.1054/blre.2002.0192; Nadal-Ginard Bernardo, 2005, V265, P142; O'Reilly R J, 1989, Immunodefic Rev, V1, P273; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; REISNER Y, 1983, BLOOD, V61, P341; Sadelain M, 2005, ANN NY ACAD SCI, V1054, P78, DOI 10.1196/annals.1345.010; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; THOMAS ED, 1959, J CLIN INVEST, V38, P1709, DOI 10.1172/JCI103949; THOMAS ED, 1990, NOBEL LECT	26	50	57	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1100	1102		10.1038/nature04962	http://dx.doi.org/10.1038/nature04962			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810247				2022-12-28	WOS:000238615500039
J	Srivastava, D; Ivey, KN				Srivastava, D; Ivey, KN			Potential of stem-cell-based therapies for heart disease	NATURE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MYOCARDIAL REGENERATION; INFARCTED MYOCARDIUM; DIFFERENTIATION; EXPRESSION; SURVIVAL; FUSION; MIGRATION; MESODERM; REPAIR	The use of stem cells to generate replacement cells for damaged heart muscle, valves, vessels and conduction cells holds great potential. Recent identification of multipotent progenitor cells in the heart and improved understanding of developmental processes relevant to pluripotent embryonic stem cells may facilitate the generation of specific types of cell that can be used to treat human heart disease. Secreted factors from circulating progenitor cells that localize to sites of damage may also be useful for tissue protection or neovascularization. The exciting discoveries in basic science will require rigorous testing in animal models to determine those most worthy of future clinical trials.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@Gladstone.ucsf.edu						*AM HEART ASS, 2004, HEART DIS STROK STAT, P11; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Sachinidis A, 2003, CARDIOVASC RES, V58, P278, DOI 10.1016/S0008-6363(03)00248-7; Shim WSN, 2004, BIOCHEM BIOPH RES CO, V324, P481, DOI 10.1016/j.bbrc.2004.09.087; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	35	109	122	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2006	441	7097					1097	1099		10.1038/nature04961	http://dx.doi.org/10.1038/nature04961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810246				2022-12-28	WOS:000238615500038
J	Ju, BG; Lunyak, VV; Perissi, V; Garcia-Bassets, I; Rose, DW; Glass, CK; Rosenfeld, MG				Ju, BG; Lunyak, VV; Perissi, V; Garcia-Bassets, I; Rose, DW; Glass, CK; Rosenfeld, MG			A topoisomerase II beta-mediated dsDNA break required for regulated transcription	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; ESTROGEN-RECEPTOR-ALPHA; RNA-POLYMERASE-II; POLY(ADP-RIBOSE) POLYMERASE; KAPPA-B; CHROMATIN-STRUCTURE; NUCLEAR RECEPTORS; ADP-RIBOSYLATION; BINDING PROTEIN; COACTIVATOR	Multiple enzymatic activities are required for transcriptional initiation. The enzyme DNA topoisomerase II associates with gene promoter regions and can generate breaks in double-stranded DNA (dsDNA). Therefore, it is of interest to know whether this enzyme is critical for regulated gene activation. We report that the signal-dependent activation of gene transcription by nuclear receptors and other classes of DNA binding transcription factors, including activating protein 1, requires DNA topoisomerase II beta-dependent, transient, site-specific dsDNA break formation. Subsequent to the break, poly( adenosine diphosphate-ribose) polymerase-1 enzymatic activity is induced, which is required for a nucleosome-specific histone H1-high-mobility group B exchange event and for local changes of chromatin architecture. Our data mechanistically link DNA topoisomerase IIb-dependent dsDNA breaks and the components of the DNA damage and repair machinery in regulated gene transcription.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021; Garcia-Bassets, Ivan/F-5075-2010; lunyak, victoria/R-3765-2017	Glass, Christopher/0000-0003-4344-3592; Garcia-Bassets, Ivan/0000-0002-6941-9585; lunyak, victoria/0000-0001-9093-2714; Perissi, Valentina/0000-0002-3716-0003				ALTHAUS FR, 1994, MOL CELL BIOCHEM, V138, P53, DOI 10.1007/BF00928443; Barkhem T, 2002, MOL PHARMACOL, V61, P1273, DOI 10.1124/mol.61.6.1273; Binaschi M, 2000, CANCER RES, V60, P3770; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Chibazakura T, 1997, EUR J BIOCHEM, V247, P1166, DOI 10.1111/j.1432-1033.1997.01166.x; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Glass CK, 2000, GENE DEV, V14, P121; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P1401, DOI 10.1093/nar/15.4.1401; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Le Page C, 1998, BIOCHEM BIOPH RES CO, V243, P451; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Leontiou C, 2006, MOL PHARMACOL, V69, P130, DOI 10.1124/mol.105.015933; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Ruh MF, 2004, MOL CELL ENDOCRINOL, V214, P71, DOI 10.1016/j.mce.2003.11.023; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	34	638	655	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1798	1802		10.1126/science.1127196	http://dx.doi.org/10.1126/science.1127196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794079				2022-12-28	WOS:000238452800059
J	Lorette, G; Maruani, A				Lorette, G; Maruani, A			Acquired hypertrichosis lanuginosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CHU Tours, Hop Trousseau, F-37044 Tours, France	CHU Tours	Lorette, G (corresponding author), CHU Tours, Hop Trousseau, F-37044 Tours, France.			Maruani, Annabel/0000-0003-3734-810X					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2696	2696		10.1056/NEJMicm050344	http://dx.doi.org/10.1056/NEJMicm050344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790702				2022-12-28	WOS:000238416900008
J	George, A; Tokars, JI; Clutterbuck, EJ; Bamford, KB; Pusey, C; Holmes, AH				George, Abraham; Tokars, Jerome I.; Clutterbuck, Elaine J.; Bamford, Kathleen B.; Pusey, Charles; Holmes, Alison H.			Quality improvement report - Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEMODIALYSIS; INFECTIONS; MORTALITY	Problem Bacteraemia in dialysis units accounts for major morbidity, mortality and antibiotic usage. Risk is much greater when lines rather than fistulas are used for haemodialysis. Surveillance is critical for infection control, but no standardised surveillance scheme exists in die United Kingdom. Design Prospective study in a London dialysis unit of the implementation and applicability of a dialysis associated bacteraemia surveillance scheme developed in the United States and its effect on bacteraemia, antibiotic usage, and admission. Setting Hammersmith Hospital dialysis unit, London, where 112 outpatients receive dialysis three times weekly. Between June 2002 and December 2004, 3418 patient months of data were collected. Key measures for improvement Successful adoption of the scheme and reductions in bacteraemia rates, antibiotic usage, and admission to hospital. Strategy for improvement Embedding the surveillance scheme in the unit's clinical activity. Effects of change Raised awareness of bacteraemia prevention, prudent antibiotic prescribing, and the need for improved provision of vascular access. The scheme required two hours a month of consultant time. Significant downward trends were seen in bacteraemia rates and antibiotic usage: mean rate ratios from quarter to quarter 0.90 (95% confidence interval 0.85 to 0.94) and 0.91 (0.87 to 0.96), respectively The rate of admission to hospital also showed a significant downward trend, with admissions directly connected to access related infection declining more rapidly: mean rate ratio Of Successive quarters 0.90 (0.84 to 0.96).The overall proportion of patients dialysed through catheters was significantly higher than in US outpatient centres (62.3% v 29.4%, P < 0.01). Study data were successfully, used in a business case to improve access provision. Lessons learnt Dialysis specific surveillance of bacteraemia is critical to infection control in dialysis units and improving quality of care. Such a scheme could be adopted across the United Kingdom.	Imperial Coll London, Dept Infect Dis, London W12 0NN, England; Hammersmith Hosp NHS Trust, Renal Unit, London, England; Ctr Dis Control & Prevent, Atlanta, GA USA	Imperial College London; Imperial College London; Centers for Disease Control & Prevention - USA	Holmes, AH (corresponding author), Imperial Coll London, Dept Infect Dis, London W12 0NN, England.	alison.holmes@imperial.ac.uk						[Anonymous], 2000, KDOQI CLIN PRACT GUI; [Anonymous], 2002, MMWR-MORBID MORTAL W, V51, P565; BLOEMBERGEN WE, 1995, J AM SOC NEPHROL, V6, P184; Briggs JD, 1997, NEPHROL DIAL TRANSPL, V12, P2251, DOI 10.1093/ndt/12.11.2251; CHURCHILL DN, 1992, AM J KIDNEY DIS, V19, P214, DOI 10.1016/S0272-6386(13)80002-9; Dhingra RK, 2001, KIDNEY INT, V60, P1443, DOI 10.1046/j.1523-1755.2001.00947.x; Duckworth G, 2005, BRIT MED J, V331, P976, DOI 10.1136/bmj.331.7523.976; DUCKWORTH G, 2005, BRIT MED J, V351, P976; GREENWOOD RN, 2002, KIDNEY INT, V61, P305; Hugonnet S, 2004, CURR OPIN INFECT DIS, V17, P329, DOI 10.1097/01.qco.0000136931.83167.d2; *NAT AUD OFF, 2004, IMPR PAT RAR RED RIS; *NIH, 2003, USRDS2003 DAT REP AT, P161; *NIT, 2003, USRDS2003 ANN DAT RE, P161; RADY AR, 1997, TRANSPLANT P, V29, P8724; Rayner HC, 2004, NEPHROL DIAL TRANSPL, V19, P108, DOI 10.1093/ndt/gfg483; *REN ASS, 2002, TREATM AD CHILDR REN; RODERICK PJ, 1994, BMJ-BRIT MED J, V300, P1111; SCHWAB SJ, 1988, AM J KIDNEY DIS, V11, P166, DOI 10.1016/S0272-6386(88)80206-3; Taylor G, 2002, INFECT CONT HOSP EP, V23, P716, DOI 10.1086/501999; Tokars JI, 2002, AM J INFECT CONTROL, V30, P288, DOI 10.1067/mic.2002.120904; *UK DEP HLTH, 2004, NAT SERV FRAM REN 1; *UK NAT AUD OFF, 2003, IMPR PAT CAR RED RIS; UNLEY AH, 1989, EPIDEMIOL INFECT, V103, P173; UTTLEY AHC, 1989, EPIDEMIOL INFECT, V103, P173, DOI 10.1017/S0950268800030478	24	35	38	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1435	1437		10.1136/bmj.332.7555.1435	http://dx.doi.org/10.1136/bmj.332.7555.1435			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16777887	Green Published			2022-12-28	WOS:000238550800034
J	Sambrook, P; Cooper, C				Sambrook, Philip; Cooper, Cyrus			Osteoporosis	LANCET			English	Review							BONE-MINERAL DENSITY; VITAMIN-D SUPPLEMENTATION; VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; RANDOMIZED-TRIAL; NONVERTEBRAL FRACTURES; CALCIUM SUPPLEMENTATION; BIOCHEMICAL MARKERS; GENE POLYMORPHISMS	Osteoporosis is a serious public health issue. The past 10 years have seen great advances in our understanding of its epidemiology, pathophysiology, and treatment, and further advances are rapidly being made. Clinical assessment win probably evolve from decisions mainly being made on the basis of bone densitometry, to use of algorithms of absolute fracture risk. Biochemical markers of bone turnover are also likely to become more widely used. Bisphosphonates will probably remain the mainstay of therapy, but improved understanding of the optimum amount of remodelling suppression and duration of therapy will be important. At the same time, other diagnostic and therapeutic approaches, including biological agents, are likely to become more widespread.	Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2065, Australia; Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton, Hants, England	University of Sydney; University of Southampton	Sambrook, P (corresponding author), Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2065, Australia.	sambrook@med.usyd.edu.au		Cooper, Cyrus/0000-0003-3510-0709				Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bollerslev J, 2005, BONE, V36, P599, DOI 10.1016/j.bone.2005.01.006; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Bonjour JP, 2001, LANCET, V358, P1208, DOI 10.1016/S0140-6736(01)06342-5; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown JP, 2002, CALCIFIED TISSUE INT, V71, P103, DOI 10.1007/s00223-002-2011-8; Caro JJ, 2004, OSTEOPOROSIS INT, V15, P1003, DOI 10.1007/s00198-004-1652-z; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chavassieux PM, 1997, J CLIN INVEST, V100, P1475, DOI 10.1172/JCI119668; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; COOPER C, 2005, PREVENTION TREATMENT, P27; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Cranney A, 2002, ENDOCR REV, V23, P524, DOI 10.1210/er.2001-4002; Cummings SR, 2000, AM J MED, V109, P330, DOI 10.1016/S0002-9343(00)00539-8; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Currey JD, 2003, OSTEOPOROSIS INT, V14, pS29, DOI 10.1007/s00198-003-1470-8; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Department of Health and Human Services, 2004, BON HLTH OST REP SUR; Eastell R, 2003, J BONE MINER RES, V18, P1051, DOI 10.1359/jbmr.2003.18.6.1051; Efstathiadou Z, 2001, J BONE MINER RES, V16, P1586, DOI 10.1359/jbmr.2001.16.9.1586; Ensrud KE, 1999, J BONE MINER RES, V14, P1637, DOI 10.1359/jbmr.1999.14.10.1637; Ensrud KE, 2004, J BONE MINER RES, V19, P1259, DOI 10.1359/JBMR.040326; Ettinger B, 2004, J BONE MINER RES, V19, P745, DOI 10.1359/JBMR.040117; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Garnero P, 2000, J BONE MINER RES, V15, P1526, DOI 10.1359/jbmr.2000.15.8.1526; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Greenwald AS, 2005, J ARTHROPLASTY, V20, P1, DOI 10.1016/j.arth.2005.03.010; HARRIS ST, 1993, AM J MED, V95, P557, DOI 10.1016/0002-9343(93)90350-X; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Heaney RP, 2003, OSTEOPOROSIS INT, V14, pS12, DOI 10.1007/s00198-003-1466-4; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Johnell O, 2002, J CLIN ENDOCR METAB, V87, P985, DOI 10.1210/jc.87.3.985; Johnell O, 2002, OSTEOPOROSIS INT, V13, P523, DOI 10.1007/s001980200068; Johnell O, 1997, AM J MED, V103, p20S, DOI DOI 10.1016/S0002-9343(97)90023-1; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P443, DOI 10.1007/s001980200052; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Koay MA, 2004, J BONE MINER RES, V19, P1619, DOI 10.1359/JBMR.040704; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; MARHSALL D, 1996, BMJ-BRIT MED J, V312, P1254; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Melton LJ, 1999, OSTEOPOROSIS INT, V10, P214, DOI 10.1007/s001980050218; Melton LJ, 2001, OSTEOPOROSIS, P557, DOI [10.1016/B978-012470862-4/50022-2, DOI 10.1016/B978-012470862-4/50022-2]; MEUNIER PJ, 2004, NEW ENGL J MED, V350, P259; Miller PD, 2005, J BONE MINER RES, V20, P1315, DOI 10.1359/JBMR.050313; Naganathan V, 2002, J BONE MINER RES, V17, P725, DOI 10.1359/jbmr.2002.17.4.725; Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Parker MJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub3; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; REID IR, 1995, AM J MED, V98, P331, DOI 10.1016/S0002-9343(99)80310-6; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11; Rosen CJ, 2005, J BONE MINER RES, V20, P141, DOI 10.1359/jbmr.2005.20.1.141; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Salpeter SR, 2004, J GEN INTERN MED, V19, P791, DOI 10.1111/j.1525-1497.2004.30281.x; Sambrook PN, 2004, J INTERN MED, V255, P503, DOI 10.1111/j.1365-2796.2004.01317.x; Schnitzer T, 2000, AGING CLIN EXP RES, V12, P1; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Sorensen OH, 2003, BONE, V32, P120, DOI 10.1016/S8756-3282(02)00946-8; STORM T, 1990, NEW ENGL J MED, V322, P1265, DOI 10.1056/NEJM199005033221803; Tosteson ANA, 2003, AM J MED, V115, P209, DOI 10.1016/S0002-9343(03)00362-0; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458	98	914	963	4	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					2010	2018		10.1016/S0140-6736(06)68891-0	http://dx.doi.org/10.1016/S0140-6736(06)68891-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16782492				2022-12-28	WOS:000238488900036
J	Berdichevsky, A; Viswanathan, M; Horvitz, HR; Guarente, L				Berdichevsky, Ala; Viswanathan, Mohan; Horvitz, H. Robert; Guarente, Leonard			C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span	CELL			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROMOTES CELL-SURVIVAL; CAENORHABDITIS-ELEGANS; SIRT1 DEACETYLASE; CALORIE RESTRICTION; SIGNALING PATHWAY; DNA-BINDING; FACTOR FKHR; STRESS; LONGEVITY	The longevity of Caenorhabditis elegans is promoted by extra copies of the sir-2.1 gene in a manner dependent on the forkhead transcription factor DAF-16. We identify two C. elegans 14-3-3 proteins as SIR-2.1 binding partners and show that 14-3-3 genes are required for the life-span extension conferred by extra copies of sir-2.1. 14-3-3 proteins are also required for SIR-2.1-induced transcriptional activation of DAF-16 and stress resistance. Following heat stress, SIR-2.1 can bind DAF-16 in a 14-3-3-dependent manner. Ely contrast, low insulin-like signaling does not promote SIR-2.1/DAF-16 interaction, and sir-2.1 and the 14-3-3 genes are not required for the regulation of life span by the insulin-like signaling pathway. We propose the existence of a stress-dependent pathway in which SIR-2.1 and 14-3-3 act in parallel to the insulin-like pathway to activate DAF16 and extend life span.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Berdichevsky, A (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	58	286	317	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1165	1177		10.1016/j.cell.2006.04.036	http://dx.doi.org/10.1016/j.cell.2006.04.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777605	Bronze			2022-12-28	WOS:000238602700020
J	Chen, JY; Bottjer, DJ; Davidson, EH; Dornbos, SQ; Gao, X; Yang, YH; Li, CW; Li, G; Wang, XQ; Xian, DC; Wu, HJ; Hwu, YK; Tafforeau, P				Chen, Jun-Yuan; Bottjer, David J.; Davidson, Eric H.; Dornbos, Stephen Q.; Gao, Xiang; Yang, Yong-Hua; Li, Chia-Wei; Li, Gang; Wang, Xiu-Qiang; Xian, Ding-Chang; Wu, Hung-Jen; Hwu, Yeu-Kuang; Tafforeau, Paul			Phosphatized polar lobe-forming embryos from the Precambrian of Southwest China	SCIENCE			English	Article							NEOPROTEROZOIC DOUSHANTUO FORMATION; ANIMAL EMBRYOS; FOSSILS	In developing embryos of some extant spiralian animals, polar lobe formation is one of the symmetry-breaking mechanisms for segregation of maternal cytoplasmic substances to certain blastomeres and not others. Polar lobe formation leads to unique early cleavage morphologies that include trilobed, J-shaped, and five-lobed structures. Fossil embryos similar to modern lobe-forming embryos are recognized from the Precambrian Doushantuo Formation phosphates, Weng'an, Guizhou Province, China. These embryos are abundant and form a developmental sequence comparable to different developing stages observed in lobe-forming embryos of extant spiralians. These data imply that lobe formation is an evolutionarily ancient process of embryonic specification.	Nanjing Univ, Inst Evodev Biol, Nanjing Inst Geol & Paleontol, Nanjing 210093, Peoples R China; Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Wisconsin, Dept Geosci, Milwaukee, WI 53201 USA; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan; Inst High Energy Phys, Beijing 100049, Peoples R China; Acad Sinica, Inst Phys, Taipei, Taiwan; European Synchrotron Radiat Facil, F-38043 Grenoble, France; CNRS, UMR 6046, Lab Geobiol Biochronol & Paleontol Humaine, F-86022 Poitiers, France	Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Nanjing University; Nanjing University; University of Southern California; California Institute of Technology; University of Wisconsin System; University of Wisconsin Milwaukee; National Tsing Hua University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Academia Sinica - Taiwan; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Chen, JY (corresponding author), Nanjing Univ, Inst Evodev Biol, Nanjing Inst Geol & Paleontol, Nanjing 210093, Peoples R China.	chenjy@nju.edu.cn	Hwu, Yeukuang/AAH-9947-2020; Hwu, Yeukuang/ABH-5311-2020	Tafforeau, Paul/0000-0002-5962-1683				Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Bengtson S, 2004, SCIENCE, V306; BOYER BC, 1988, INT J INVER REP DEV, V13, P157, DOI 10.1080/01688170.1988.10510352; BOYER BC, 1986, INT J INVER REP DEV, V9, P243, DOI 10.1080/01688170.1986.10510199; Browder LW, 1991, DEV BIOL; CHEN J. Y., 2004, DAWN ANIMAL WORLD; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JY, 2004, SCIENCE, V306; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; CONN DB, 2000, ALTAS INVERTEBRATE R; CONRAD GW, 1973, J CELL BIOL, V59, P228, DOI 10.1083/jcb.59.1.228; Davidson E. H., 1986, GENE ACTIVITY EARLY; Davidson E. H., 2001, DEV EVOLUTION; Giese A. C., 1977, REPROD MARINE INVERT; GIESE AC, 1979, REPROD MARINE INVERT; GILBERT SF, 1997, EMBRYOLOGY CONSTRUCI; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; MacBride E.W., 1914, TXB EMBRYOLOGY; TOMPA AS, 1984, MOLLUSCA REPROD; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yuan X., 2002, DOUSHANTUO FOSSILS L	25	72	97	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1644	1646		10.1126/science.1125964	http://dx.doi.org/10.1126/science.1125964			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778054				2022-12-28	WOS:000238288600043
J	Estarriol, MH; Goday, MR				Estarriol, MH; Goday, MR			Images in clinical medicine - Cutaneous metastases of small-cell lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Univ Girona Doctor Josep Trueta, Girona 17007, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Estarriol, MH (corresponding author), Hosp Univ Girona Doctor Josep Trueta, Girona 17007, Spain.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2583	2583		10.1056/NEJMicm031071	http://dx.doi.org/10.1056/NEJMicm031071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775238				2022-12-28	WOS:000238233400008
J	Wood, BJ; Walter, MJ; Wade, J				Wood, Bernard J.; Walter, Michael J.; Wade, Jonathan			Accretion of the Earth and segregation of its core	NATURE			English	Review							SILICATE PARTITION-COEFFICIENTS; HF-W CHRONOMETRY; OXIDATION-STATE; OXYGEN FUGACITY; HIGH-PRESSURE; PHASE-TRANSFORMATIONS; SIDEROPHILE ELEMENTS; TERRESTRIAL PLANETS; CHEMICAL EVOLUTION; LIGHT-ELEMENTS	The Earth took 30-40 million years to accrete from smaller 'planetesimals'. Many of these planetesimals had metallic iron cores and during growth of the Earth this metal re-equilibrated with the Earth's silicate mantle, extracting siderophile ('iron-loving') elements into the Earth's iron-rich core. The current composition of the mantle indicates that much of the re-equilibration took place in a deep (>400 km) molten silicate layer, or 'magma ocean', and that conditions became more oxidizing with time as the Earth grew. The high-pressure nature of the core-forming process led to the Earth's core being richer in low-atomic-number elements, notably silicon and possibly oxygen, than the cores of the smaller planetesimal building blocks.	Macquarie Univ, Dept Earth & Planetary Sci, N Ryde, NSW 2109, Australia; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	Macquarie University; University of Bristol	Wood, BJ (corresponding author), Macquarie Univ, Dept Earth & Planetary Sci, N Ryde, NSW 2109, Australia.	bwood@els.mq.edu.au	Wood, Bernard J/E-8173-2010; Badham, Richard/ABE-2076-2020; Wade, Jon/H-7012-2012	Wood, Bernard J/0000-0003-1038-7301; Badham, Richard/0000-0003-4755-4775; Wade, Jon/0000-0002-6998-236X				Abe Y, 1997, PHYS EARTH PLANET IN, V100, P27, DOI 10.1016/S0031-9201(96)03229-3; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; Anderson OL, 2002, PHYS EARTH PLANET IN, V131, P19, DOI 10.1016/S0031-9201(02)00017-1; ARCULUS RJ, 1981, GEOCHIM COSMOCHIM AC, V45, P1331, DOI 10.1016/0016-7037(81)90226-X; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; BIRCH F, 1952, J GEOPHYS RES, V57, P227, DOI 10.1029/JZ057i002p00227; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Chabot NL, 2005, GEOCHIM COSMOCHIM AC, V69, P2141, DOI 10.1016/j.gca.2004.10.019; Chabot NL, 2003, GEOCHIM COSMOCHIM AC, V67, P2077, DOI [10.1016/S0016-7037(02)01272-3, 10.1016/S0016-7037(02)012723]; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; COTTRELL E, IN PRESS GEOCHIM COS; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Dreibus G, 1996, GEOCHIM COSMOCHIM AC, V60, P1125, DOI 10.1016/0016-7037(96)00028-2; FRANCIS RD, 1990, CHEM GEOL, V85, P199, DOI 10.1016/0009-2541(90)90001-N; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Gessmann CK, 1998, GEOCHIM COSMOCHIM AC, V62, P867, DOI 10.1016/S0016-7037(98)00023-4; Gessmann CK, 2001, EARTH PLANET SC LETT, V184, P367, DOI 10.1016/S0012-821X(00)00325-3; Ghosh A, 1998, ICARUS, V134, P187, DOI 10.1006/icar.1998.5956; Harper CL, 1996, GEOCHIM COSMOCHIM AC, V60, P1131, DOI 10.1016/0016-7037(96)00027-0; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; HUNTEN DM, 1993, SCIENCE, V259, P915, DOI 10.1126/science.259.5097.915; JONES JH, 1986, NATURE, V322, P221, DOI 10.1038/322221a0; JONES JH, 1993, GEOCHIM COSMOCHIM AC, V57, P453, DOI 10.1016/0016-7037(93)90443-Z; Karato S, 1997, PHYS EARTH PLANET IN, V100, P61, DOI 10.1016/S0031-9201(96)03232-3; Kilburn MR, 1997, EARTH PLANET SC LETT, V152, P139, DOI 10.1016/S0012-821X(97)00125-8; KILINC A, 1983, CONTRIB MINERAL PETR, V83, P136, DOI 10.1007/BF00373086; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Kunihiro T, 2004, GEOCHIM COSMOCHIM AC, V68, P2947, DOI 10.1016/j.gca.2004.02.006; Leinhardt ZM, 2000, ICARUS, V146, P133, DOI 10.1006/icar.2000.6370; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Li J, 2001, GEOCHIM COSMOCHIM AC, V65, P1821, DOI 10.1016/S0016-7037(00)00613-X; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Newsom H. E, 1990, ORIGIN EARTH, P273; Newsom H. E., 1995, GLOBAL EARTH PHYS HD, V1, P159, DOI DOI 10.1029/RF001P0159; O'Neill H.S.C., 1998, EARTHS MANTLE COMPOS, P3; O'Neill HS, 1998, J GEOPHYS RES-SOL EA, V103, P12239, DOI 10.1029/97JB02601; Ohtani E, 1997, PHYS EARTH PLANET IN, V100, P97, DOI 10.1016/S0031-9201(96)03234-7; OHTANI E, 1984, EARTH PLANET SC LETT, V71, P94, DOI 10.1016/0012-821X(84)90055-4; OHTANI E, 1984, EARTH PLANET SC LETT, V71, P85, DOI 10.1016/0012-821X(84)90054-2; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Poppe T, 2000, ASTROPHYS J, V533, P454, DOI 10.1086/308626; Righter K, 2000, GEOCHIM COSMOCHIM AC, V64, P3581, DOI 10.1016/S0016-7037(00)00466-X; Righter K, 1997, PHYS EARTH PLANET IN, V100, P115, DOI 10.1016/S0031-9201(96)03235-9; Righter K, 1997, EARTH PLANET SC LETT, V146, P541, DOI 10.1016/S0012-821X(96)00243-9; Righter K, 1999, EARTH PLANET SC LETT, V171, P383, DOI 10.1016/S0012-821X(99)00156-9; RINGWOOD AE, 1966, GEOCHIM COSMOCHIM AC, V30, P41, DOI 10.1016/0016-7037(66)90090-1; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Rubie DC, 2003, EARTH PLANET SC LETT, V205, P239, DOI 10.1016/S0012-821X(02)01044-0; SHUKOLYUKOV A, 1993, SCIENCE, V259, P1138, DOI 10.1126/science.259.5098.1138; Solomatov V.S., 2000, ORIGIN EARTH MOON, P323; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; Stevenson DJ., 1990, ORIGIN EARTH, P231; Takafuji N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022773; TAYLOR SR, 1990, ORIGIN EARTH, P00029; THIBAULT Y, 1995, GEOCHIM COSMOCHIM AC, V59, P991, DOI 10.1016/00167-0379(50)00178-; Tronnes RG, 2002, EARTH PLANET SC LETT, V197, P117, DOI 10.1016/S0012-821X(02)00466-1; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; WANKE H, 1981, PHILOS T R SOC A, V303, P287, DOI 10.1098/rsta.1981.0203; Wasson J. T., 1985, METEORITES THEIR REC; Weidenschilling SJ, 1997, ICARUS, V128, P429, DOI 10.1006/icar.1997.5747; Wood BJ, 2005, NATURE, V437, P1345, DOI 10.1038/nature04129; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3; Wood BJ, 1996, SCIENCE, V273, P1522, DOI 10.1126/science.273.5281.1522; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995; Yoshino T, 2003, NATURE, V422, P154, DOI 10.1038/nature01459; Youdin AN, 2002, ASTROPHYS J, V580, P494, DOI 10.1086/343109	78	314	329	8	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					825	833		10.1038/nature04763	http://dx.doi.org/10.1038/nature04763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778882				2022-12-28	WOS:000238254100033
J	Commerford, P; Mayosi, B				Commerford, Patrick; Mayosi, Bongani			An appropriate research agenda for heart disease in Africa	LANCET			English	Editorial Material							RISK-FACTORS; GLOBAL BURDEN; CARDIOVASCULAR-DISEASES; MYOCARDIAL-INFARCTION; RHEUMATIC-FEVER; SOUTH-AFRICA; INTERHEART		Univ Cape Town, Dept Med, Cardiac Clin, Cape Town, Western Cape, South Africa; Groote Schuur Hosp, Cape Town, Western Cape, South Africa	University of Cape Town; University of Cape Town	Commerford, P (corresponding author), Univ Cape Town, Dept Med, Cardiac Clin, Cape Town, Western Cape, South Africa.	pjcomfrd@uctgsh1.uct.ac.za		Mayosi, Bongani/0000-0001-6641-8950				[Anonymous], 1996, GLOBAL BURDEN DIS CO; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Commerford PJ, 2005, SAMJ S AFR MED J, V95, P568; Hakim J. G., 1995, Central African Journal of Medicine, V41, P303; Mayosi B, 2006, SAMJ S AFR MED J, V96, P246; Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066; Robertson KA, 2006, SAMJ S AFR MED J, V96, P241; SEFTEL HC, 1978, S AFR MED J, V54, P99; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; STEYN K, 1991, S AFR MED J, V79, P480; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	15	24	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1884	1886		10.1016/S0140-6736(06)68822-3	http://dx.doi.org/10.1016/S0140-6736(06)68822-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XG	16765744				2022-12-28	WOS:000238194400008
J	Kolber, ZS				Kolber, Zbigniew S.			Ecology - Getting a better picture of the ocean's nitrogen budget	SCIENCE			English	Editorial Material							TRICHODESMIUM; FIXATION; N-2; CYANOBACTERIUM; ABUNDANCE		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Kolber, ZS (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	zkolber@mbari.org						Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Chang J, 2000, J EXP MAR BIOL ECOL, V245, P215, DOI 10.1016/S0022-0981(99)00163-X; Coles VJ, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001754; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Orcutt KM, 2001, DEEP-SEA RES PT II, V48, P1583, DOI 10.1016/S0967-0645(00)00157-0; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	11	10	11	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1479	1480		10.1126/science.1129129	http://dx.doi.org/10.1126/science.1129129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763136				2022-12-28	WOS:000238124100032
J	Loeb, M; Carusone, SC; Goeree, R; Walter, SD; Brazil, K; Krueger, P; Simor, A; Moss, L; Marrie, T				Loeb, Mark; Carusone, Soo Chan; Goeree, Ron; Walter, Stephen D.; Brazil, Kevin; Krueger, Paul; Simor, Andrew; Moss, Lorraine; Marrie, Thomas			Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TERM-CARE FACILITIES; RISK-FACTORS; INFECTIONS; OUTCOMES; SURVEILLANCE; DEFINITIONS; SURVIVAL; CLUSTER	Context Nursing home residents with pneumonia are frequently hospitalized. Such transfers may be associated with multiple hazards of hospitalization as well as economic costs. Objective To assess whether using a clinical pathway for on-site treatment of pneumonia and other lower respiratory tract infections in nursing homes could reduce hospital admissions, related complications, and costs. Design, Setting, and Participants A cluster randomized controlled trial of 680 residents aged 65 years or older in 22 nursing homes in Hamilton, Ontario, Canada. Nursing homes began enrollment between January 2, 2001, and April 18, 2002, with the last resident follow-up occurring July 4, 2005. Residents were eligible if they met a standardized definition of lower respiratory tract infection. Interventions Treatment in nursing homes according to a clinical pathway, which included use of oral antimicrobials, portable chest radiographs, oxygen saturation monitoring, rehydration, and close monitoring by a research nurse, or usual care. Main Outcome Measures Hospital admissions, length of hospital stay, mortality, health-related quality of life, functional status, and cost. Results Thirty-four (10%) of 327 residents in the clinical pathway group were hospitalized compared with 76 (22%) of 353 residents in the usual care group. Adjusting for clustering of residents in nursing homes, the weighted mean reduction in hospitalizations was 12% (95% confidence interval [CI], 5%-18%; P=.001). The mean number of hospital days per resident was 0.79 in the clinical pathway group vs 1.74 in the usual care group, with a weighted mean difference of 0.95 days per resident ( 95% CI, 0.34-1.55 days; P=.004). The mortality rate was 8% ( 24 deaths) in the clinical pathway group vs 9% ( 32 deaths) in the usual care group, with a weighted mean difference of 2.9% ( 95% CI, - 2.0% to 7.9%; P=.23). There were no significant differences between the groups in health-related quality of life or functional status. The clinical pathway resulted in an overall cost savings of US $1016 per resident ( 95% CI, $207$ 1824) treated. Conclusion Treating residents of nursing homes with pneumonia and other lower respiratory tract infections with a clinical pathway can result in comparable clinical outcomes, while reducing hospitalizations and health care costs.	McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Microbiol, Toronto, ON, Canada; Univ Alberta, Dept Med, Edmonton, AB, Canada	McMaster University; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Alberta	Loeb, M (corresponding author), McMaster Univ, Dept Pathol, 1200 Main St W,MDCL 3200, Hamilton, ON L8N 3Z5, Canada.	loebm@mcmaster.ca	Walter, Stephen/AAB-5548-2022	Walter, Stephen/0000-0003-4157-8928; Chan Carusone, Soo/0000-0003-3977-0523				Allard JP, 2004, J AM GERIATR SOC, V52, P59, DOI 10.1111/j.1532-5415.2004.52011.x; BERGMAN H, 1991, J AM GERIATR SOC, V39, P1164, DOI 10.1111/j.1532-5415.1991.tb03568.x; Boockvar KS, 2005, J AM GERIATR SOC, V53, P590, DOI 10.1111/j.1532-5415.2005.53205.x; Centers for Medicare & Medicaid Services, PHYS FEE SCHED; Collin C, 1988, Int Disabil Stud, V10, P61; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Dasgupta M, 2000, J AM GERIATR SOC, V48, P795, DOI 10.1111/j.1532-5415.2000.tb04755.x; DEMPSEY CL, 1995, PHARMACOTHERAPY, V15, pS33; Ellis SE, 2003, J AM GERIATR SOC, V51, P761, DOI 10.1046/j.1365-2389.2003.51254.x; Fried TR, 1997, J AM GERIATR SOC, V45, P302, DOI 10.1111/j.1532-5415.1997.tb00944.x; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; HSIEH FY, 1988, STAT MED, V7, P1195, DOI 10.1002/sim.4780071113; JACKSON MM, 1992, AM J EPIDEMIOL, V135, P685, DOI 10.1093/oxfordjournals.aje.a116348; JONES A, 2002, VITAL HLTH STAT, V152, P1; KAYSERJONES JS, 1989, GERONTOLOGIST, V29, P502, DOI 10.1093/geront/29.4.502; KERR HD, 1991, J AM GERIATR SOC, V39, P132, DOI 10.1111/j.1532-5415.1991.tb01614.x; Kerry SM, 2001, STAT MED, V20, P377, DOI 10.1002/1097-0258(20010215)20:3<377::AID-SIM799>3.0.CO;2-N; Kruse RL, 2004, MED CARE, V42, P860, DOI 10.1097/01.mlr.0000135828.95415.b1; Loeb M, 1999, ARCH INTERN MED, V159, P2058, DOI 10.1001/archinte.159.17.2058; Loeb M, 2001, J GEN INTERN MED, V16, P376, DOI 10.1046/j.1525-1497.2001.016006376.x; Mandell L A, 2000, Can Respir J, V7, P371; Marrie TJ, 2002, INFECT CONT HOSP EP, V23, P159, DOI 10.1086/502030; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; MCGEER A, 1991, AM J INFECT CONTROL, V19, P1, DOI 10.1016/0196-6553(91)90154-5; Muder RR, 1998, AM J MED, V105, P319, DOI 10.1016/S0002-9343(98)00262-9; Muder RR, 1996, ARCH INTERN MED, V156, P2365, DOI 10.1001/archinte.156.20.2365; Naughton BJ, 2000, J AM GERIATR SOC, V48, P1292, DOI 10.1111/j.1532-5415.2000.tb02604.x; *OCCI, ONT CAS COST IN WEB; Samsa GP, 2005, CHEST, V128, P3246, DOI 10.1378/chest.128.5.3246; Scanlan A, 1996, MED CARE, V34, P837, DOI 10.1097/00005650-199608000-00010; *STAT CAN, RES CAR FAC SURV; TERESI JA, 1991, GERONTOLOGIST, V31, P795, DOI 10.1093/geront/31.6.795; Thompson R S, 1997, J Am Board Fam Pract, V10, P82; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517; Wodchis WP, 2003, INT J TECHNOL ASSESS, V19, P490; WUNDERLICH GS, 2000, IMPROVING QUALITY LO	38	188	192	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2503	2510		10.1001/jama.295.21.2503	http://dx.doi.org/10.1001/jama.295.21.2503			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZQ	16757722	Bronze			2022-12-28	WOS:000238057300025
J	Eke, N; Nkanginieme, KEO				Eke, N.; Nkanginieme, K. E. O.			Female genital mutilation and obstetric outcome	LANCET			English	Editorial Material									Univ Port Harcourt, Dept Surg, Port Harcourt, Nigeria; Univ Port Harcourt, Dept Paediat, Port Harcourt, Nigeria	University of Port Harcourt; University of Port Harcourt	Eke, N (corresponding author), Univ Port Harcourt, Dept Surg, Port Harcourt, Nigeria.	ndubuisi_eke@hotmail.com						Almroth Lars, 2005, Afr J Reprod Health, V9, P118; [Anonymous], 2005, CHANG HARMF SOC CONV; Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; Bitong L, 2005, B WORLD HEALTH ORGAN, V83, P806; Eke N, 2000, LANCET, V356, pS57, DOI 10.1016/S0140-6736(00)92043-9; El-Gibaly O, 2002, SOC SCI MED, V54, P205, DOI 10.1016/S0277-9536(01)00020-X; Reyners M M, 1989, Ned Tijdschr Geneeskd, V133, P2557; TABA AH, 1979, WHO EMRO TECHNICAL P, V2; *UNICEF, 2005, WOM STAT WORLDS CHIL; *WOM INT, 1997, FEM GEN MUT; World Health Organization, 1998, FEMALE GENITAL MUTIL	11	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2006	367	9525					1799	1800		10.1016/S0140-6736(06)68782-5	http://dx.doi.org/10.1016/S0140-6736(06)68782-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753469				2022-12-28	WOS:000238194200007
J	Ramu, Y; Xu, YP; Lu, Z				Ramu, Yajamana; Xu, Yanping; Lu, Zhe			Enzymatic activation of voltage-gated potassium channels	NATURE			English	Article							PHOSPHOLIPID SURFACE-CHARGE; LOXOSCELES-RECLUSA; SPHINGOMYELINASES-D; CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; ION CONDUCTION; SPIDER VENOM; K+ CHANNELS; MECHANISM; TARANTULA; CURRENTS	Voltage- gated ion channels in excitable nerve, muscle, and endocrine cells generate electric signals in the form of action potentials(1). However, they are also present in non- excitable eukaryotic cells and prokaryotes, which raises the question of whether voltage- gated channels might be activated by means other than changing the voltage difference between the solutions separated by the plasma membrane. The search for so- called voltage- gated channel activators is motivated in part by the growing importance of such agents in clinical pharmacology. Here we report the apparent activation of voltage- gated K+ ( Kv) channels by a sphingomyelinase.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	zhelu@mail.med.upenn.edu						Aggarwal S.K., 1996, THESIS HARVARD U; BARKSDALE L, 1981, J CLIN MICROBIOL, V13, P335, DOI 10.1128/JCM.13.2.335-343.1981; BELL JE, 1984, BIOPHYS J, V45, P279, DOI 10.1016/S0006-3495(84)84154-5; BERNHEIMER AW, 1985, SCIENCE, V228, P590, DOI 10.1126/science.3983643; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; de Andrade SA, 2006, TOXICON, V47, P380, DOI 10.1016/j.toxicon.2005.12.005; de Andrade SA, 2005, BIOCHEM BIOPH RES CO, V327, P117, DOI 10.1016/j.bbrc.2004.11.146; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; REES RS, 1984, J INVEST DERMATOL, V83, P270, DOI 10.1111/1523-1747.ep12340340; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; SOUCEK A, 1971, BIOCHIM BIOPHYS ACTA, V227, P116, DOI 10.1016/0005-2744(71)90173-2; Stith BJ, 2000, J LIPID RES, V41, P1448; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200	30	126	127	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					696	699		10.1038/nature04880	http://dx.doi.org/10.1038/nature04880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799569				2022-12-28	WOS:000239630200048
J	Ando, K				Ando, Koji			Seeking room-temperature ferromagnetic semiconductors	SCIENCE			English	Editorial Material							MAGNETISM; ZNO; GAN; MN		Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058568, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Ando, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Umezono 1-1-1,Cent 2, Tsukuba, Ibaraki 3058568, Japan.	ando-koji@aist.go.jp	Ando, Koji/AAN-7314-2020					Abraham DW, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146057; Ando K, 2004, J PHYS-CONDENS MAT, V16, pS5541, DOI 10.1088/0953-8984/16/48/009; Ando K, 2004, J MAGN MAGN MATER, V272, P2004, DOI 10.1016/j.jmmm.2003.12.791; Ando K, 2003, APPL PHYS LETT, V82, P100, DOI 10.1063/1.1534618; Ando K, 2000, SPRINGER SERIES SOLI, V128, P211; Ando K, 1998, J APPL PHYS, V83, P6548, DOI 10.1063/1.367780; Bergqvist L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195210; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Jungwirth T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.165204; Kundaliya DC, 2004, NAT MATER, V3, P709, DOI 10.1038/nmat1221; Liu C, 2005, J MATER SCI-MATER EL, V16, P555, DOI 10.1007/s10854-005-3232-1; Matsumoto Y, 2001, SCIENCE, V291, P854, DOI 10.1126/science.1056186; Ohno H, 2003, J CRYST GROWTH, V251, P285, DOI 10.1016/S0022-0248(02)02290-X; Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Saito H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207202; Sato K, 2000, PHYS REV B, V70; Shinde SR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166601; Sonoda S, 2002, J CRYST GROWTH, V237, P1358, DOI 10.1016/S0022-0248(01)02183-2; Toyosaki H, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1922569; Ueda K, 2001, APPL PHYS LETT, V79, P988, DOI 10.1063/1.1384478; Venkatesan M, 2004, NATURE, V430, P630, DOI 10.1038/430630a	22	237	242	3	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1883	1885		10.1126/science.1125461	http://dx.doi.org/10.1126/science.1125461			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809516				2022-12-28	WOS:000238848100034
J	Sim, F; Mackie, P				Sim, Fiona; Mackie, Phil			Climate change and health	LANCET			English	Editorial Material									Royal Inst Publ Hlth, London W1B 1DE, England		Sim, F (corresponding author), Royal Inst Publ Hlth, London W1B 1DE, England.	public.health@riph.org.uk		Mackie, Phil/0000-0002-0130-049X				Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; HAINES A, 2006, PUBLIC HLTH; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Porritt J, 2005, PUBLIC HEALTH, V119, P952, DOI 10.1016/j.puhe.2005.08.004; Sim F, 2005, PUBLIC HEALTH, V119, P947, DOI 10.1016/j.puhe.2005.08.014	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2039	2039		10.1016/S0140-6736(06)68901-0	http://dx.doi.org/10.1016/S0140-6736(06)68901-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	058HZ	16798369				2022-12-28	WOS:000238657400006
J	Baer, B; Armitage, SAO; Boomsma, JJ				Baer, Boris; Armitage, Sophie A. O.; Boomsma, Jacobus J.			Sperm storage induces an immunity cost in ants	NATURE			English	Article							ATTA-COLOMBICA; FIRE ANT; HYMENOPTERA; BUMBLEBEE; QUEENS; FITNESS; TRAITS; SIZE	Ant queens are among the most long-lived insects known(1,2). They mate early in adult life and maintain millions of viable sperm in their sperm storage organ until they die many years later(3,4). Because they never re-mate, the reproductive success of queens is ultimately sperm-limited, but it is not known what selective forces determine the upper limit to sperm storage. Here we show that sperm storage carries a significant cost of reduced immunity during colony founding. Newly mated queens of the leaf-cutting ant Atta colombica upregulate their immune response shortly after completing their nest burrow, probably as an adaptive response to a greater exposure to pathogens in the absence of grooming workers. However, the immune response nine days after colony founding is negatively correlated with the amount of sperm in the sperm storage organ, indicating that short-term survival is traded off against long-term reproductive success. The immune response was lower when more males contributed to the stored sperm, indicating that there might be an additional cost of mating or storing genetically different ejaculates.	Inst Biol, Dept Populat Biol, DK-2100 Copenhagen, Denmark		Baer, B (corresponding author), Univ Western Australia, Sch Anim Biol MO92, Zool Bldg, Nedlands, WA 6009, Australia.	bcbaer@bi.ku.dk	Boomsma, Jacobus J/M-2785-2014; Baer, Boris/F-5301-2011; Armitage, Sophie AO/A-6961-2012	Boomsma, Jacobus J/0000-0002-3598-1609; Baer, Boris/0000-0002-1136-5967; Armitage, Sophie AO/0000-0002-5561-9543				Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Baer B, 2003, OIKOS, V101, P563, DOI 10.1034/j.1600-0706.2003.12395.x; Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x; Baer B, 2000, INSECT SOC, V47, P183, DOI 10.1007/PL00001699; Baer B, 2005, P ROY SOC B-BIOL SCI, V272, P319, DOI 10.1098/rspb.2004.2958; Baer B, 2004, BEHAV ECOL, V15, P426, DOI 10.1093/beheco/arh025; Birkhead TR, 1998, SPERM COMPETITION SE; Boomsma J.J., 2005, P139, DOI 10.1079/9780851998121.0139; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Breque C, 2003, MOL REPROD DEV, V66, P314, DOI 10.1002/mrd.10347; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Fjerdingstad EJ, 1998, HEREDITY, V80, P118, DOI 10.1038/sj.hdy.6882470; Fjerdingstad EJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P257, DOI 10.1007/s002650050437; Fjerdingstad EJ, 1997, INSECT SOC, V44, P209, DOI 10.1007/s000400050042; Fowler H.G., 1986, P123; Holldobler B., 1990, pi; HOLLDOBLER B, 1985, EXPT BEHAV ECOLOGY S, P237; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; PAMILO P, 1991, INSECT SOC, V38, P111, DOI 10.1007/BF01240961; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Simmons L. W., 2001, MG BEH ECOL; Tian HS, 2004, INSECT BIOCHEM MOLEC, V34, P937, DOI 10.1016/j.ibmb.2004.06.004; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P777, DOI 10.1093/aesa/81.5.777; Weber N. A., 1972, GARDENING ANTS ATTIN; WHEELER DE, 1994, ZOOMORPHOLOGY, V114, P203, DOI 10.1007/BF00416859	26	164	165	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					872	875		10.1038/nature04698	http://dx.doi.org/10.1038/nature04698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778889				2022-12-28	WOS:000238254100042
J	Chbeir, E; Casas, L; Toubia, N; Tawk, M; Brown, B				Chbeir, E; Casas, L; Toubia, N; Tawk, M; Brown, B			Adult cystic fibrosis presenting with recurrent non-tuberculous mycobacterial infections	LANCET			English	Editorial Material							EPIDEMIOLOGY		Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Div Endocrinol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Div Pulm & Crit Care, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Chbeir, E (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, 1100 N Lindsay, Oklahoma City, OK 73104 USA.	eliechbeir@yahoo.com						GRUFT H, 1981, REV INFECT DIS, V3, P990; HORSBURGH CR, 1989, AM REV RESPIR DIS, V139, P4, DOI 10.1164/ajrccm/139.1.4; Oliver Antonio, 2001, Clinical Infectious Diseases, V32, P1298, DOI 10.1086/319987; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S	4	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 10	2006	367	9526					1952	1952		10.1016/S0140-6736(06)68851-X	http://dx.doi.org/10.1016/S0140-6736(06)68851-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765765				2022-12-28	WOS:000238194400035
J	Feng, XD; Sayle, DC; Wang, ZL; Paras, MS; Santora, B; Sutorik, AC; Sayle, TXT; Yang, Y; Ding, Y; Wang, XD; Her, YS				Feng, Xiangdong; Sayle, Dean C.; Wang, Zhong Lin; Paras, M. Sharon; Santora, Brian; Sutorik, Anthony C.; Sayle, Thi X. T.; Yang, Yi; Ding, Yong; Wang, Xudong; Her, Yie-Shein			Converting ceria polyhedral nanoparticles into single-crystal nanospheres	SCIENCE			English	Article							FLAME SPRAY-PYROLYSIS; OXIDE NANOPARTICLES; SOLID-SOLUTIONS; POWDERS; NANOPOWDERS; SHAPE; SIZE	Ceria nanoparticles are one of the key abrasive materials for chemical-mechanical planarization of advanced integrated circuits. However, ceria nanoparticles synthesized by existing techniques are irregularly faceted, and they scratch the silicon wafers and increase defect concentrations. We developed an approach for large-scale synthesis of single-crystal ceria nanospheres that can reduce the polishing defects by 80% and increase the silica removal rate by 50%, facilitating precise and reliable mass-manufacturing of chips for nanoelectronics. We doped the ceria system with titanium, using flame temperatures that facilitate crystallization of the ceria yet retain the titania in a molten state. In conjunction with molecular dynamics simulation, we show that under these conditions, the inner ceria core evolves in a single-crystal spherical shape without faceting, because throughout the crystallization it is completely encapsulated by a molten 1- to 2-nanometer shell of titania that, in liquid state, minimizes the surface energy. The principle demonstrated here could be applied to other oxide systems.	Cranfield Univ, Def Acad United Kingdom, Swindon SN6 8LA, Wilts, England; Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; Peking Univ, Dept Adv Mat & Nanotechnol, Coll Engn, Beijing 100871, Peoples R China; Natl Ctr Nanosci & Technol, Beijing 100080, Peoples R China; Nanocerox Inc, Ann Arbor, MI 48108 USA; Ferro Corp, Independence, OH 44131 USA	Cranfield University; University System of Georgia; Georgia Institute of Technology; Peking University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Feng, XD (corresponding author), James Harding Bldg Prod, 10901 Elm Ave, Fontana, CA 92337 USA.	shawn.feng@jhresearchusa.com; zhong.wang@mse.gatech.edu	wang, jie/GRS-0942-2022; Ding, Yong/F-3705-2017; Sayle, Dean/D-8555-2013; Wang, Zhong Lin/E-2176-2011; Wang, Xudong/A-7067-2009	Ding, Yong/0000-0001-5805-347X; Sayle, Dean/0000-0001-7227-9010; Wang, Zhong Lin/0000-0002-5530-0380; 	Engineering and Physical Sciences Research Council [GR/S48431/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		America WG, 2004, ELECTROCHEM SOLID ST, V7, pG327, DOI 10.1149/1.1817870; Bickmore CR, 1996, J AM CERAM SOC, V79, P1419, DOI 10.1111/j.1151-2916.1996.tb08608.x; Bondioli F, 2005, J MATER CHEM, V15, P1061, DOI 10.1039/b415628c; Bumajdad A, 2004, LANGMUIR, V20, P11223, DOI 10.1021/la040079b; Chen HI, 2005, CERAM INT, V31, P795, DOI 10.1016/j.ceramint.2004.09.006; Hartridge A, 2002, J PHYS CHEM SOLIDS, V63, P441, DOI 10.1016/S0022-3697(01)00158-5; Hirano M, 2000, J AM CERAM SOC, V83, P1287; KODAS T, 1999, AEROSOL PROCESSING M; Lopez-Navarrete E, 2002, J MATER RES, V17, P797, DOI 10.1557/JMR.2002.0117; SAYLE DC, 1995, J PHYS CHEM SOLIDS, V56, P799, DOI 10.1016/0022-3697(94)00270-3; Sayle TXT, 2004, CHEM COMMUN, P2438, DOI 10.1039/b408752f; SAYLE TXT, 1994, SURF SCI, V316, P329, DOI 10.1016/0039-6028(94)91225-4; Shuk P, 1999, SOLID STATE IONICS, V116, P217, DOI 10.1016/S0167-2738(98)00345-2; Singh RK, 2002, MRS BULL, V27, P743, DOI 10.1557/mrs2002.244; Sutorik AC, 2002, MATER SCI FORUM, V386-3, P371, DOI 10.4028/www.scientific.net/MSF.386-388.371; Tsuzuki T., 2002, Journal of the Australasian Ceramic Society, V38, P15; Wang YR, 2002, J AM CERAM SOC, V85, P3105, DOI 10.1111/j.1151-2916.2002.tb00591.x; Wang ZL, 2003, J PHYS CHEM B, V107, P13563, DOI 10.1021/jp036815m; YABE S, 1999, KIDORUI, V34, P124; Zhang F, 2004, J APPL PHYS, V95, P4319, DOI 10.1063/1.1667251; Zhang F, 2002, APPL PHYS LETT, V80, P127, DOI 10.1063/1.1430502	21	536	592	13	419	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1504	1508		10.1126/science.1125767	http://dx.doi.org/10.1126/science.1125767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763144				2022-12-28	WOS:000238124100042
J	Ge, WP; Yang, XJ; Zhang, ZJ; Wang, HK; Shen, WH; Deng, QD; Duan, SM				Ge, Woo-Ping; Yang, Xiu-Juan; Zhang, Zhijun; Wang, Hui-Kun; Shen, Wanhua; Deng, Qiu-Dong; Duan, Shumin			Long-term potentiation of neuron-glia synapses mediated by Ca2+-permeable AMPA receptors	SCIENCE			English	Article							CALCIUM-PERMEABLE AMPA; OLIGODENDROCYTE PRECURSOR CELLS; PROGENITOR CELLS; ASTROCYTES; HIPPOCAMPUS; INTERNEURONS; ACTIVATION; SPERMINE; MATTER; WHITE	Interactions between neurons and glial cells in the brain may serve important functions in the development, maintenance, and plasticity of neural circuits. Fast neuron-glia synaptic transmission has been found between hippocampal neurons and NG2 cells, a distinct population of macroglia-like cells widely distributed in the brain. We report that these neuron-glia synapses undergo activity-dependent modifications analogous to long-term potentiation (LTP) at excitatory synapses, a hallmark of neuronal plasticity. However, unlike the induction of LTP at many neuron-neuron synapses, both induction and expression of LTP at neuron-NG2 synapses involve Ca2+-permeable AMPA receptors on NG2 cells.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn	Shen, Wanhua/B-5554-2011; Deng, Qiudong/D-2446-2010; Wang, Huikun/V-3677-2017	Shen, Wanhua/0000-0002-5178-9561; Wang, Huikun/0000-0001-8556-3504				Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; LEVINE JM, 1987, J NEUROSCI, V7, P2711; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Wan JJ, 1999, SCIENCE, V285, P1725, DOI 10.1126/science.285.5434.1725; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	29	168	188	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1533	1537		10.1126/science.1124669	http://dx.doi.org/10.1126/science.1124669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763153				2022-12-28	WOS:000238124100051
J	Lehtinen, MK; Yuan, ZQ; Boag, PR; Yang, Y; Villen, J; Becker, EBE; DiBacco, S; de la Iglesia, N; Gygi, S; Blackwell, TK; Bonni, A				Lehtinen, Maria K.; Yuan, Zengqiang; Boag, Peter R.; Yang, Yue; Villen, Judit; Becker, Esther B. E.; DiBacco, Sara; de la Iglesia, Nuria; Gygi, Steven; Blackwell, T. Keith; Bonni, Azad			A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span	CELL			English	Article							CELL-CYCLE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; PROTEIN-KINASE; HISTONE H2B; APOPTOSIS; PHOSPHORYLATION; DAF-16; DROSOPHILA; GENE	Oxidative stress influences cell survival and homeostasis, but the mechanisms underlying the biological effects of oxidative stress remain to be elucidated. Here, we demonstrate that the protein kinase MST1 mediates oxidative-stress-induced cell death in primary mammalian neurons by directly activating the FOXO transcription factors. MST1 phosphorylates FOXO proteins at a conserved site within the forkhead domain that disrupts their interaction with 14-3-3 proteins, promotes FOXO nuclear translocation, and thereby induces cell death in neurons. We also extend the MST-FOXO signaling link to nematodes. Knockdown of the C. elegans MST1 ortholog CST-1 shortens life span and accelerates tissue aging, while overexpression of cst-1 promotes life span and delays aging. The cst-1-induced life-span extension occurs in a daf-16-dependent manner. The identification of the FOXO transcription factors as major and evolutionarily conserved targets of MST1 suggests that MST kinases play important roles in diverse biological processes including cellular responses to oxidative stress and longevity.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biomed & Biol Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	de la Iglesia, Nuria/E-1420-2015; Yuan, Zengqiang/G-5245-2017	de la Iglesia, Nuria/0000-0002-1083-7715; Villen, Judit/0000-0002-1005-1739; Yang, Yue/0000-0002-6201-8818; Boag, Peter/0000-0002-0889-0859; Becker, Esther B E/0000-0002-5238-4902; Yuan, Zengqiang/0000-0001-5739-2867	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062891, GM62891] Funding Source: Medline; NINDS NIH HHS [NS41021] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gems D, 1998, GENETICS, V150, P129; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X	45	637	674	5	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					987	1001		10.1016/j.cell.2006.03.046	http://dx.doi.org/10.1016/j.cell.2006.03.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751106	Bronze			2022-12-28	WOS:000238116400023
J	Olsen, A; Vantipalli, MC; Lithgow, GJ				Olsen, Anders; Vantipalli, Maithili C.; Lithgow, Gordon J.			Checkpoint proteins control survival of the postmitotic cells in Caenorhabditis elegans	SCIENCE			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; S-M CHECKPOINT; LIFE-SPAN; C-ELEGANS; MESSENGER-RNA; DNA-DAMAGE; DAF-16; LONGEVITY; SIGNALS; GENE	Checkpoints are evolutionarily conserved signaling mechanisms that arrest cell division and alter cellular stress resistance in response to DNA damage or stalled replication forks. To study the consequences of loss of checkpoint functions in whole animals, checkpoint genes were inactivated in the nematode C. elegans. We show that checkpoint proteins are not only essential for normal development but also determine adult somatic maintenance. Checkpoint proteins play a role in the survival of postmitotic adult cells.	Buck Inst, Novato, CA 94945 USA	Buck Institute for Research on Aging	Lithgow, GJ (corresponding author), Buck Inst, 8001 Redwood Blvd, Novato, CA 94945 USA.	glithgow@buckinstitute.org	Olsen, Anders/T-7301-2018; Olsen, Anders/N-8284-2019	Olsen, Anders/0000-0002-9613-9722; Olsen, Anders/0000-0002-9613-9722	NIA NIH HHS [AG22868, R01 AG022868, AG21069, R01 AG021069, R01 AG021069-04, R01 AG022868-04] Funding Source: Medline; NINDS NIH HHS [NS050789-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS050789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022868, R01AG021069] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ashcroft N, 2002, GENESIS, V33, P1, DOI 10.1002/gene.10083; Ashcroft NR, 1999, DEV BIOL, V206, P15, DOI 10.1006/dbio.1998.9135; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Clucas C, 2002, EMBO J, V21, P665, DOI 10.1093/emboj/21.4.665; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kalogeropoulos N, 2004, CELL CYCLE, V3, P1196; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wodarz D, 2004, ONCOGENE, V23, P7799, DOI 10.1038/sj.onc.1207833; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5	28	50	62	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1381	1385		10.1126/science.1124981	http://dx.doi.org/10.1126/science.1124981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741121	Green Accepted			2022-12-28	WOS:000237961600056
J	Seitz, H; Zamore, PD				Seitz, Herve; Zamore, Phillip D.			Rethinking the microprocessor	CELL			English	Editorial Material							MICRORNA; COMPLEX		Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Northborough, MA 01532 USA	University of Massachusetts System	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Northborough, MA 01532 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Seitz, Hervé/AAE-6487-2019	Seitz, Hervé/0000-0001-8172-5393; Zamore, Phillip/0000-0002-4505-9618				Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; HAN J, 2006, CELL, V125; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200	11	51	54	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					827	829		10.1016/j.cell.2006.05.018	http://dx.doi.org/10.1016/j.cell.2006.05.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751089	Bronze			2022-12-28	WOS:000238116400006
J	Giraudo, CG; Eng, WS; Melia, TJ; Rothman, JE				Giraudo, Claudio G.; Eng, William S.; Melia, Thomas J.; Rothman, James E.			A clamping mechanism involved in SNARE-dependent exocytosis	SCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I; MEMBRANE-FUSION; VESICLE EXOCYTOSIS; CA2+ SENSOR; COMPLEX; BINDING; DETERMINANTS; NEUROTOXINS; SPECIFICITY	During neurotransmitter release at the synapse, influx of calcium ions stimulates the release of neurotransmitter. However, the mechanism by which synaptic vesicle fusion is coupled to calcium has been unclear, despite the identification of both the core fusion machinery [soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)] and the principal calcium sensor (synaptotagmin). Here, we describe what may represent a basic principle of the coupling mechanism: a reversible clamping protein (complexin) that can freeze the SNAREpin, an assembled fusion-competent intermediate en route to fusion. When calcium binds to the calcium sensor synaptotagmin, the clamp would then be released. SNARE proteins, and key regulators like synaptotagmin and complexin, can be ectopically expressed on the cell surface. Celts expressing such "flipped" synaptic SNARES fuse constitutively, but when we coexpressed complexin, fusion was blocked. Adding back calcium triggered fusion from this intermediate in the presence of synaptotagmin.	Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Rothman, JE (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jr2269@columbia.edu						Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BELTZER JP, 1991, J BIOL CHEM, V266, P973; BHALLA A, 2006, NAT STRUCT MOL BIOL; BRACHER A, 2002, J BIOL CHEM; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	36	264	275	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					676	680		10.1126/science.1129450	http://dx.doi.org/10.1126/science.1129450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16794037				2022-12-28	WOS:000239667500046
J	Huybers, P				Huybers, Peter			Early Pleistocene glacial cycles and the integrated summer insolation forcing	SCIENCE			English	Article							CLIMATE; ORIGIN; FLUX	Long-term variations in Northern Hemisphere summer insolation are generally thought to control glaciation. But the intensity of summer insolation is primarily controlled by 20,000-year cycles in the precession of the equinoxes, whereas early Pleistocene glacial cycles occur at 40,000-year intervals, matching the period of changes in Earth's obliquity. The resolution of this 40,000-year problem is that glaciers are sensitive to insolation integrated over the duration of the summer. The integrated summer insolation is primarily controlled by obliquity and not precession because, by Kepler's second law, the duration of the summer is inversely proportional to Earth's distance from the Sun.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Huybers, P (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.	phuybers@fas.harvard.edu		Huybers, Peter/0000-0002-3734-8145				ADHEMAR JA, 1842, REVOLUTIONS MER DELU; Bard E, 2004, CR GEOSCI, V336, P603, DOI 10.1016/j.crte.2004.02.005; Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; BERGER A, 1992, EARTH PLANET SC LETT, V111, P369, DOI 10.1016/0012-821X(92)90190-7; Braithwaite RJ, 2000, J GLACIOL, V46, P7, DOI 10.3189/172756500781833511; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; CROLL J., 1864, PHILOS MAG, V28, P121; DeConto RM, 2003, PALAEOGEOGR PALAEOCL, V198, P39, DOI 10.1016/S0031-0182(03)00393-6; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Houghton J. T., 2001, CLIMATE CHANGE 2001; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Milankovitch M., 1941, KANON ERDBESTRAHLUNG; NISANCIOGLU KH, 2004, THESIS MIT; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; Paterson W.S.B., 1994, PHYS GLACIERS, Vthird; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; RAYMO ME, 1994, ANNU REV EARTH PL SC, V22, P353, DOI 10.1146/annurev.ea.22.050194.002033; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Tziperman E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000627; Wunsch C, 2005, J CLIMATE, V18, P4374, DOI 10.1175/JCLI3539.1; Wunsch C, 2003, CLIM DYNAM, V20, P353, DOI 10.1007/s00382-002-0279-z; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	29	267	281	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					508	511		10.1126/science.1125249	http://dx.doi.org/10.1126/science.1125249			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16794041	Green Published			2022-12-28	WOS:000239308600058
J	Sugerman, BEK; Ercolano, B; Barlow, MJ; Tielens, AGGM; Clayton, GC; Zijlstra, AA; Meixner, M; Speck, A; Gledhill, TM; Panagia, N; Cohen, M; Gordon, KD; Meyer, M; Fabbri, J; Bowey, JE; Welch, DL; Regan, MW; Kennicutt, RC				Sugerman, Ben E. K.; Ercolano, Barbara; Barlow, M. J.; Tielens, A. G. G. M.; Clayton, Geoffrey C.; Zijlstra, Albert A.; Meixner, Margaret; Speck, Angela; Gledhill, Tim M.; Panagia, Nino; Cohen, Martin; Gordon, Karl D.; Meyer, Martin; Fabbri, Joanna; Bowey, Janet. E.; Welch, Douglas L.; Regan, Michael W.; Kennicutt, Robert C., Jr.			Massive-star supernovae as major dust factories	SCIENCE			English	Article							EVOLUTION; HYDRODYNAMICS; PROGENITOR; CASSIOPEIA; EMISSION; SN-1987A; 2003GD	We present late-time optical and mid-infrared observations of the Type II supernova 2003gd in the galaxy NGC 628. Mid-infrared excesses consistent with cooling dust in the ejecta are observed 499 to 678 days after outburst and are accompanied by increasing optical extinction and growing asymmetries in the emission-line profiles. Radiative-transfer models show that up to 0.02 solar masses of dust has formed within the ejecta, beginning as early as 250 days after outburst. These observations show that dust formation in supernova ejecta can be efficient and that massive-star supernovae could have been major dust producers throughout the history of the universe.	Space Telescope Sci Inst, Baltimore, MD 21218 USA; UCL, Dept Phys & Astron, London WC1E 6BT, England; Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; Univ Manchester, Sch Phys & Astron, Manchester M60 1QD, Lancs, England; Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; Univ Hertfordshire, Dept Phys Astron & Maths, Hatfield AL10 9AB, Herts, England; Monterey Inst Res Astron, Marina, CA 93933 USA; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	Space Telescope Science Institute; University of London; University College London; University of Groningen; Louisiana State University System; Louisiana State University; University of Manchester; University of Missouri System; University of Missouri Columbia; University of Hertfordshire; University of Arizona; McMaster University; University of Cambridge	Sugerman, BEK (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	sugerman@stsci.edu	Barlow, Michael J/A-5638-2009; Bowey, Janet/AAL-5809-2021	Barlow, Michael J/0000-0002-3875-1171; Bowey, Janet/0000-0003-3738-8857; Zijlstra, Albert/0000-0002-3171-5469; Regan, Michael/0000-0001-9367-0705; Gledhill, Tim/0000-0002-2859-4600; Clayton, Geoffrey/0000-0002-0141-7436; Welch, Doug/0000-0002-2350-0898; Gordon, Karl/0000-0001-5340-6774; Meyer, Martin/0000-0002-2838-3010				BENETTI S, 1994, ASTRON ASTROPHYS, V285, P147; Bertoldi F, 2003, ASTRON ASTROPHYS, V406, pL55, DOI 10.1051/0004-6361:20030710; CERNUSCHI F, 1965, ANN ASTROPHYS, V28, P860; CHEVALIER RA, 1978, ASTROPHYS J, V219, P994, DOI 10.1086/155864; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; Clayton DD, 1997, ASTROPHYS SPACE SCI, V251, P355, DOI 10.1023/A:1000799831553; DOTY SD, 1994, ASTROPHYS J, V424, P729, DOI 10.1086/173926; Douvion T, 1999, ASTRON ASTROPHYS, V352, pL111; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; DWEK E, 1988, ASTROPHYS J, V329, P814, DOI 10.1086/166425; DWEK E, 1983, ASTROPHYS J, V274, P175, DOI 10.1086/161435; Dwek E, 1998, ASTROPHYS J, V501, P643, DOI 10.1086/305829; Elmhamdi A, 2003, MON NOT R ASTRON SOC, V338, P939, DOI 10.1046/j.1365-8711.2003.06150.x; Ercolano B, 2005, MON NOT R ASTRON SOC, V362, P1038, DOI 10.1111/j.1365-2966.2005.09381.x; Fesen RA, 1999, ASTRON J, V117, P725, DOI 10.1086/300751; Hanner M., 1988, NASA C PUB, V3004, P22; Hendry MA, 2005, MON NOT R ASTRON SOC, V359, P906, DOI 10.1111/j.1365-2966.2005.08928.x; HERANT M, 1994, ASTROPHYS J, V425, P814, DOI 10.1086/174026; Hines DC, 2004, ASTROPHYS J SUPPL S, V154, P290, DOI 10.1086/422583; Kennicutt RC, 2003, PUBL ASTRON SOC PAC, V115, P928, DOI 10.1086/376941; KOZASA T, 1989, ASTROPHYS J, V344, P325, DOI 10.1086/167801; Krause O, 2004, NATURE, V432, P596, DOI 10.1038/nature03110; LUCY LB, 1991, SUPERNOVAE //, P82; MATHIS JS, 1977, ASTROPHYS J, V217, P425, DOI 10.1086/155591; Morgan HL, 2003, MON NOT R ASTRON SOC, V343, P427, DOI 10.1046/j.1365-8711.2003.06681.x; Pozzo M, 2004, MON NOT R ASTRON SOC, V352, P457, DOI 10.1111/j.1365-2966.2004.07951.x; Smartt SJ, 2004, SCIENCE, V303, P499, DOI 10.1126/science.1092967; Sugerman BEK, 2005, ASTROPHYS J, V632, pL17, DOI 10.1086/497578; SUNTZEFF NB, 1990, ASTRON J, V99, P650, DOI 10.1086/115358; Tielens AGGM, 1998, ASTROPHYS J, V499, P267, DOI 10.1086/305640; Todini P, 2001, MON NOT R ASTRON SOC, V325, P726, DOI 10.1046/j.1365-8711.2001.04486.x; Van Dyk SD, 2003, PUBL ASTRON SOC PAC, V115, P1289, DOI 10.1086/378308; Varosi F, 1999, ASTROPHYS J, V523, P265, DOI 10.1086/307729; WOODEN DH, 1993, ASTROPHYS J SUPPL S, V88, P477, DOI 10.1086/191830; WOOSLEY SE, 1989, ASTROPHYS J, V346, P395, DOI 10.1086/168019; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237	37	165	167	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					196	200		10.1126/science.1128131	http://dx.doi.org/10.1126/science.1128131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16763110	Bronze, Green Submitted			2022-12-28	WOS:000239008000036
J	Roman-Leshkov, Y; Chheda, JN; Dumesic, JA				Roman-Leshkov, Yuriy; Chheda, Juben N.; Dumesic, James A.			Phase modifiers promote efficient production of hydroxymethylfurfural from fructose	SCIENCE			English	Article							DEHYDRATION; 5-HYDROXYMETHYL-2-FURALDEHYDE; CONVERSION; CATALYSTS; WATER	Furan derivatives obtained from renewable biomass resources have the potential to serve as substitutes for the petroleum-based building blocks that are currently used in the production of plastics and fine chemicals. We developed a process for the selective dehydration of fructose to 5-hydroxymethylfurfural (HMF) that operates at high fructose concentrations (10 to 50 weight %), achieves high yields (80% HMF selectivity at 90% fructose conversion), and delivers HMF in a separation-friendly solvent. In a two-phase reactor system, fructose is dehydrated in the aqueous phase with the use of an acid catalyst (hydrochloric acid or an acidic ion-exchange resin) with dimethylsulfoxide and/or poly(1-vinyl-2-pyrrolidinone) added to suppress undesired side reactions. The HMF product is continuously extracted into an organic phase (methylisobutylketone) modified with 2-butanol to enhance partitioning from the reactive aqueous solution.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Roman-Leshkov, Yuriy/E-1387-2014	Roman-Leshkov, Yuriy/0000-0002-0025-4233				[Anonymous], 1956, U.S. Patent, Patent No. [US2750394A, 2750394, 2,750,394]; ANTAL MJ, 1990, CARBOHYD RES, V199, P91, DOI 10.1016/0008-6215(90)84096-D; Benvenuti F, 2000, APPL CATAL A-GEN, V193, P147, DOI 10.1016/S0926-860X(99)00424-X; Bicker M, 2003, GREEN CHEM, V5, P280, DOI 10.1039/b211468b; BROWN DW, 1982, J CHEM TECHNOL BIOT, V32, P920, DOI 10.1002/jctb.5030320730; Carlini C, 2004, APPL CATAL A-GEN, V275, P111, DOI 10.1016/j.apcata.2004.07.026; Carlini C, 1999, APPL CATAL A-GEN, V183, P295, DOI 10.1016/S0926-860X(99)00064-2; Dias AS, 2005, J CATAL, V229, P414, DOI 10.1016/j.jcat.2004.11.016; ELHAJJ T, 1987, B SOC CHIM FR, P855; GASET A, 1981, INF CHIM, V212, P179; Harris J.F., 1960, FOREST PROD J, V10, P125; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; HUNTER RH, 1965, Patent No. 3201331; JONES RE, 1958, Patent No. 2994645; KUSTER BFM, 1990, STARCH-STARKE, V42, P314, DOI 10.1002/star.19900420808; Lewkowski J, 2001, ARKIVOC, P17, DOI 10.3998/ark.5550190.0002.102; Moreau C, 2004, TOP CATAL, V27, P11, DOI 10.1023/B:TOCA.0000013537.13540.0e; Moreau C, 1996, APPL CATAL A-GEN, V145, P211, DOI 10.1016/0926-860X(96)00136-6; NAKAMURA Y, 1980, B CHEM SOC JPN, V53, P3705, DOI 10.1246/bcsj.53.3705; Pentz K.W., 1984, Bristish Patent, Patent No. [2131014, 2,131,014]; Rapp KM, 1987, US Patent, Patent No. [4,740,605., 4740605]; RIGAL L, 1981, IND ENG CHEM PROD RD, V20, P719, DOI 10.1021/i300004a025; RIVALIER P, 1995, CATAL TODAY, V24, P165, DOI 10.1016/0920-5861(95)00026-C; Seri K, 2001, B CHEM SOC JPN, V74, P1145, DOI 10.1246/bcsj.74.1145; SZMANT HH, 1981, J CHEM TECHNOL BIOT, V31, P135, DOI 10.1002/jctb.280310119; VANDAM HE, 1986, STARCH-STARKE, V38, P95, DOI 10.1002/star.19860380308; Werpy TA., 2004, DOEGO1020041992 NAT, V67, P21, DOI DOI 10.2172/15008859	27	1311	1393	32	809	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1933	1937		10.1126/science.1126337	http://dx.doi.org/10.1126/science.1126337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809536				2022-12-28	WOS:000238848100054
J	Khor, WB; Aung, T; Saw, SM; Wong, TY; Tambyah, PA; Tan, AL; Beuerman, R; Lim, L; Chan, WK; Heng, WJ; Lim, J; Loh, RSK; Lee, SB; Tan, DTH				Khor, Wei-Boon; Aung, Tin; Saw, Seang-Mei; Wong, Tien-Yin; Tambyah, Paul A.; Tan, Ai-Ling; Beuerman, Roger; Lim, Li; Chan, Wing-Kwong; Heng, Wee-Jin; Lim, Jimmy; Loh, Raymond S. K.; Lee, Sao-Bing; Tan, Donald T. H.			An outbreak of Fusarium keratitis associated with contact lens wear in Singapore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNGAL KERATITIS; MICROBIAL KERATITIS; ULCERATIVE KERATITIS; SOUTH FLORIDA; RISK-FACTORS; SPECTRUM; ENDOPHTHALMITIS; VORICONAZOLE; ULCERS	Context Fungal keratitis is a potentially blinding condition that is rarely seen with contact lens wear. Objective To describe a nationwide outbreak of fungal keratitis caused by Fusarium species among contact lens wearers in Singapore. Design, Setting, and Patients Nationwide, hospital-based case series. All cases of fungal keratitis among contact lens wearers in all ophthalmology departments in Singapore were reviewed along with the charts of all contact lens wearers with culture-proven fungal keratitis from March 2005 through May 2006. A standardized telephone interview was conducted to obtain additional clinical information. Main Outcome Measure Diagnosis of Fusarium keratitis associated with contact lens wear. Results During the study period, 66 patients ( 68 affected eyes) were diagnosed with Fusarium keratitis associated with contact lens wear; the estimated annual national incidence is 2.35 cases per 10 000 contact lens wearers (95% confidence interval, 0.62-7.22). Patients ranged in age from 13 to 44 years ( mean [SD], 27.1 [8.4] years), of which 32 (48.5%) were men. The vast majority ( 65 patients; 98.5%) wore soft, disposable contact lenses; 62 patients (93.9%) reported using 1 brand of contact lens cleaning solution (ReNu, Bausch & Lomb, Rochester, NY), including 42 patients (63.6%) who recalled using ReNu with MoistureLoc. Most patients (81.8%) reported poor contact lens hygiene practices, including overnight use of daily wear contact lenses (19.7%), and use of contact lenses past the replacement date (43.9%). The final best-corrected visual acuity ranged from 20/20 to 20/80. Five patients ( 5 eyes; 7.4%) required emergency therapeutic or tectonic corneal transplantation. Conclusions A new and evolving epidemic of Fusarium keratitis associated with contact lens wear was found in Singapore. Physicians and eye care practitioners worldwide need to be aware of the likelihood of similar outbreaks emerging among contact lens wearers.	Singapore Eye Res Inst, Singapore 168751, Singapore; Singapore Natl Eye Ctr, Singapore, Singapore; Natl Univ Singapore, Dept Ophthalmol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; Natl Univ Singapore, Dept Community Occupat & Family Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; Tan Tock Seng Hosp, Dept Ophthalmol, Singapore, Singapore; Changi Gen Hosp, Singapore, Singapore; Natl Univ Singapore Hosp, Dept Ophthalmol, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital; National University of Singapore	Tan, DTH (corresponding author), Singapore Eye Res Inst, 11 3rd Hosp Ave, Singapore 168751, Singapore.	snecdt@pacific.net.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Khor, Wei Boon/0000-0001-5450-9863				ALFONSO E, 1986, AM J OPHTHALMOL, V101, P429, DOI 10.1016/0002-9394(86)90641-0; ALFONSO E, 2005, ASS RES VIS OPHTH AN; *AM AC OPHTH, RENU MOISTURELOC ID; Bharathi M. Jayahar, 2003, Indian Journal of Ophthalmology, V51, P315; *CDCP, 2006, FUS KER MULT STAT; CHATTERJEE A, 1995, CORNEA, V14, P138; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; *CTR HLTH PROT, 2006, UPD CAS FUNG CORN IN; DART JKG, 1991, LANCET, V338, P650, DOI 10.1016/0140-6736(91)91231-I; Fong CF, 2004, AM J OPHTHALMOL, V137, P329, DOI 10.1016/j.ajo.2003.09.001; Fridkin SK, 1996, CLIN INFECT DIS, V22, P222, DOI 10.1093/clinids/22.2.222; Hariprasad SM, 2004, ARCH OPHTHALMOL-CHIC, V122, P42, DOI 10.1001/archopht.122.1.42; Hennequin C, 1999, J CLIN MICROBIOL, V37, P3586, DOI 10.1128/JCM.37.11.3586-3589.1999; Lam DSC, 2002, EYE, V16, P608, DOI 10.1038/sj.eye.6700151; Lee Yoon-Chiang Kelvin, 2000, CLAO Journal, V26, P21; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; Mah-Sadorra JH, 2005, CORNEA, V24, P51, DOI 10.1097/01.ico.0000138839.29823.57; Marangon FB, 2004, AM J OPHTHALMOL, V137, P820, DOI 10.1016/j.ajo.2003.11.078; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; PETTIT TH, 1980, ARCH OPHTHALMOL-CHIC, V98, P1025, DOI 10.1001/archopht.1980.01020031015002; ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005; SCHEIN OD, 1994, ARCH OPHTHALMOL-CHIC, V112, P186, DOI 10.1001/archopht.1994.01090140062024; SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201; SCHEIN OD, 1989, CORNEA, V8, P281; Seal D V, 1999, Cont Lens Anterior Eye, V22, P49, DOI 10.1016/S1367-0484(99)80003-4; *SING DEP STAT, 2005, SING RES AG GROUP ET; *SING DEP STAT, POP CENS 2000 CONC D; Sponsel W, 2006, ANTIMICROB AGENTS CH, V50, P262, DOI 10.1128/AAC.50.1.262-268.2006; Srinivasan M, 1997, BRIT J OPHTHALMOL, V81, P965, DOI 10.1136/bjo.81.11.965; STEHRGREEN JK, 1987, JAMA-J AM MED ASSOC, V258, P57, DOI 10.1001/jama.258.1.57; Szklo M, 2004, EPIDEMIOLOGY BASICS; Tabbara KF, 1998, OPHTHALMOLOGY, V105, P522, DOI 10.1016/S0161-6420(98)93037-8; Tan D. T. H., 1995, Annals Academy of Medicine Singapore, V24, P823; Tanure MAG, 2000, CORNEA, V19, P307, DOI 10.1097/00003226-200005000-00010; Thomas PA, 2003, CLIN MICROBIOL REV, V16, P730, DOI 10.1128/CMR.16.4.730-797.2003; *US FDA, 2006, INV SER EYE INF ASS; WILHELMUS K R, 1987, CLAO Journal, V13, P211; WILHELMUS KR, 1988, AM J OPHTHALMOL, V106, P708, DOI 10.1016/0002-9394(88)90705-2; Wong Tien-Yin, 1997, CLAO Journal, V23, P275; Wong TY, 1997, INT OPHTHALMOL, V21, P127, DOI 10.1023/A:1026462631716; Xie LX, 2001, BRIT J OPHTHALMOL, V85, P1070, DOI 10.1136/bjo.85.9.1070	41	178	184	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2867	2873		10.1001/jama.295.24.2867	http://dx.doi.org/10.1001/jama.295.24.2867			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057DY	16804153	Bronze			2022-12-28	WOS:000238577700024
J	Gordon, JJ				Gordon, JJ			Commentary: Australian perspective	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sydney, No Clin Sch, Sydney, NSW 2006, Australia	University of Sydney	Gordon, JJ (corresponding author), Univ Sydney, No Clin Sch, Sydney, NSW 2006, Australia.	jill.gordon@arts.usyd.edu.au						*AUSTR SAF QUAL CO, 2005, NAT PAT SAF ED FRAM; Dowton SB, 2005, MED J AUSTRALIA, V182, P177, DOI 10.5694/j.1326-5377.2005.tb06649.x; Hutchinson L, 2006, BMJ-BRIT MED J, V332, P1502, DOI 10.1136/bmj.332.7556.1502; McNair Ruth, 2005, J Interprof Care, V19, P579, DOI 10.1080/13561820500412452; Productivity Commission, 2005, AUSTR HLTH WORKF RES	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 24	2006	332	7556					1505	1506		10.1136/bmj.332.7556.1505	http://dx.doi.org/10.1136/bmj.332.7556.1505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793818	Green Published			2022-12-28	WOS:000238820200025
J	Mirabel, IF				Mirabel, IF			Very energetic gamma-rays from microquasars and binary pulsars	SCIENCE			English	Editorial Material							DISCOVERY; GALAXY; JETS		European So Observ, Santiago, Chile; CEA Saclay, F-91191 Gif Sur Yvette, France	European Southern Observatory; CEA; UDICE-French Research Universities; Universite Paris Saclay	Mirabel, IF (corresponding author), European So Observ, Alonso Cordova 3107, Santiago, Chile.	fmirabel@eso.org						Aharonian F, 2005, ASTRON ASTROPHYS, V442, P1, DOI 10.1051/0004-6361:20052983; Aharonian F, 2005, SCIENCE, V309, P746, DOI 10.1126/science.1113764; Albert J, 2006, SCIENCE, V312, P1771, DOI 10.1126/science.1128177; Atoyan AM, 1999, MON NOT R ASTRON SOC, V302, P253, DOI 10.1046/j.1365-8711.1999.02172.x; Bosch-Ramon V, 2006, ASTRON ASTROPHYS, V447, P263, DOI 10.1051/0004-6361:20053633; Corbel S, 2002, SCIENCE, V298, P196, DOI 10.1126/science.1075857; Gallo E, 2005, NATURE, V436, P819, DOI 10.1038/nature03879; Maraschi L., 1981, MNRAS, V194, P1; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; Mirabel IF, 2004, ASTRON ASTROPHYS, V422, pL29, DOI 10.1051/0004-6361:200400016; Mirabel IF, 1998, NATURE, V392, P673, DOI 10.1038/33603; Ribo M, 2002, ASTRON ASTROPHYS, V384, P954, DOI 10.1051/0004-6361:20020093	12	32	32	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1759	1760		10.1126/science.1129815	http://dx.doi.org/10.1126/science.1129815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794071				2022-12-28	WOS:000238452800045
J	Penalver, E; Grimaldi, DA; Delclos, X				Penalver, Enrique; Grimaldi, David. A.; Delclos, Xavier			Early Cretaceous spider web with its prey	SCIENCE			English	Article									Amer Museum Nat Hist, Dept Entomol, New York, NY 10024 USA; Univ Barcelona, Dept Estratig Paleontol & Geociencies Marines, Fac Geol, E-08028 Barcelona, Spain	American Museum of Natural History (AMNH); University of Barcelona	Grimaldi, DA (corresponding author), Amer Museum Nat Hist, Dept Entomol, New York, NY 10024 USA.	grimaldi@amnh.org	Peñalver, Enrique/AAB-5470-2022; DELCLOS, Xavier/N-1652-2019; DELCLOS, Xavier/D-4363-2014	Peñalver, Enrique/0000-0001-8312-6087; DELCLOS, Xavier/0000-0002-2233-5480; DELCLOS, Xavier/0000-0002-2233-5480				Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x; Grimaldi David, 2005, pi; NENTWIG W, 1985, OECOLOGIA, V66, P580, DOI 10.1007/BF00379353; Penney D, 2004, T ROY SOC EDIN-EARTH, V94, P275, DOI 10.1017/S0263593300000675; Zschokke S, 2003, NATURE, V424, P636, DOI 10.1038/424636a; ZSCHOKKE S, 2004, EUROPEAN ARACHNOLOGY, P367	6	50	51	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1761	1761		10.1126/science.1126628	http://dx.doi.org/10.1126/science.1126628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794072				2022-12-28	WOS:000238452800046
J	Holtmaat, A; Wilbrecht, L; Knott, GW; Welker, E; Svoboda, K				Holtmaat, Anthony; Wilbrecht, Linda; Knott, Graham W.; Welker, Egbert; Svoboda, Karel			Experience-dependent and cell-type-specific spine growth in the neocortex	NATURE			English	Article							RAT BARREL CORTEX; DENDRITIC SPINES; PYRAMIDAL NEURONS; VISUAL-CORTEX; IN-VIVO; CORTICAL PLASTICITY; ADULT CORTEX; SYNAPSES; AMPA; HIPPOCAMPUS	Functional circuits in the adult neocortex adjust to novel sensory experience, but the underlying synaptic mechanisms remain unknown(1). Growth and retraction of dendritic spines with synapse formation and elimination could change brain circuits(2-7). In the apical tufts of layer 5B (L5B) pyramidal neurons in the mouse barrel cortex, a subset of dendritic spines appear and disappear over days, whereas most spines are persistent for months(4-6,8,9). Under baseline conditions, new spines are mostly transient and rarely survive for more than a week. Transient spines tend to be small(4,5,9), whereas persistent spines are usually large(4-6,8,9). Because most excitatory synapses in the cortex occur on spines, and because synapse size(10) and the number of alpha-amino-3- hydroxy-5-methyl-4-isoxazole propionic acid ( AMPA) receptors(11-13) are proportional to spine volume, the excitation of pyramidal neurons is probably driven through synapses on persistent spines. Here we test whether the generation and loss of persistent spines are enhanced by novel sensory experience. We repeatedly imaged dendritic spines for one month after trimming alternate whiskers, a paradigm that induces adaptive functional changes in neocortical circuits(14,15). Whisker trimming stabilized new spines and destabilized previously persistent spines. New-persistent spines always formed synapses. They were preferentially added on L5B neurons with complex apical tufts rather than simple tufts. Our data indicate that novel sensory experience drives the stabilization of new spines on subclasses of cortical neurons. These synaptic changes probably underlie experience-dependent remodelling of specific neocortical circuits.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, IBCM, CH-1005 Lausanne, Switzerland	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; GlaxoSmithKline; University of Lausanne	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Wilbrecht, Linda/J-7988-2013	Knott, Graham W/0000-0002-2956-9052; Holtmaat, Anthony/0000-0002-7577-0769				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; LARKMAN A, 1990, J NEUROSCI, V10, P1407; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	30	461	466	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					979	983		10.1038/nature04783	http://dx.doi.org/10.1038/nature04783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791195				2022-12-28	WOS:000238422300042
J	Miyai, E; Sakai, K; Okano, T; Kunishi, W; Ohnishi, D; Noda, S				Miyai, Eiji; Sakai, Kyosuke; Okano, Takayuki; Kunishi, Wataru; Ohnishi, Dai; Noda, Susumu			Photonics: Lasers producing tailored beams	NATURE			English	Article							DISTRIBUTED-FEEDBACK; LATTICE	Compact lasers that can produce a range of beam patterns are important for progress in several areas, including the improvement of optical tweezers, ultra-high-density optical memory and microfluidics. Here we engineer photonic crystals to generate semiconductor lasers that produce a range of beam patterns while maintaining stable single-mode oscillation. Our results could contribute to the realization of compact lasers that are capable of producing diverse beam patterns on demand.	Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyotodaigaku Katsura, Kyoto 6158510, Japan; ROHM, Opt Device Res & Dev Ctr, Ukyo Ku, Saiin, Kyoto 6158585, Japan	Kyoto University	Noda, S (corresponding author), Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyotodaigaku Katsura, Kyoto 6158510, Japan.	snoda@kuee.kyoto-u.ac.jp						Ashkin A, 2000, IEEE J SEL TOP QUANT, V6, P841, DOI 10.1109/2944.902132; Dorn R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233901; Imada M, 1999, APPL PHYS LETT, V75, P316, DOI 10.1063/1.124361; Letartre X, 2005, J OPT SOC AM B, V22, P2581, DOI 10.1364/JOSAB.22.002581; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; Meier M, 1999, APPL PHYS LETT, V74, P7, DOI 10.1063/1.123116; Miyai E, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1885182; Noda S, 2001, SCIENCE, V293, P1123, DOI 10.1126/science.1061738; Raftery JJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1929074; Witjaksono G, 2001, APPL PHYS LETT, V78, P4088, DOI 10.1063/1.1382633	10	224	236	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					946	946		10.1038/441946a	http://dx.doi.org/10.1038/441946a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791186	Bronze			2022-12-28	WOS:000238422300030
J	Tirosh, A; Mandel, D; Mimouni, FB; Zimlichman, E; Shochat, T; Kochba, I				Tirosh, Amir; Mandel, Dror; Mimouni, Francis B.; Zimlichman, Eyal; Shochat, Tzippora; Kochba, Ilan			Autoimmune diseases in asthma	ANNALS OF INTERNAL MEDICINE			English	Article							HYGIENE HYPOTHESIS; CHILDREN; ALLERGY; TH1; SUPPRESSION; DISORDERS; CHILDHOOD	Background: Previous research has suggested an inverse relationship between T-helper 2-related atopic disorders, such as asthma, and T-helper 1-related autoimmune diseases. One controversial hypothesis postulates that asthma provides a protective effect for the development of autoimmune-related disorders. Objective: To assess the rate of newly diagnosed. autoimmune disorders in a large cohort of young adults. Design: Using cross-sectional data from the Israeli Defense Force database, the authors analyzed the prevalence of auto immune disorders in asthmatic and nonasthmatic military personnel between 1980 and 2003. A follow-up study traced newly diagnosed auto-immune disorders among asthmatic and nonasthmatic individuals from the time of enrollment in military service until discharge (22 and 36 months for women and men, respectively). Setting: General community Patients: 307 367 male and 181 474 female soldiers in compulsory military service who were between 18 and 21 years of age. Measurements: Cases of type 1 diabetes mellitus, vasculitis, immune thrombocytopenic purpura, inflammatory bowel disease, rheumatoid arthritis, and the antiphospholipid syndrome. Results: Of 488 841 participants at enrollment, significantly more women than men had autoimmune disorders. Compared with asthmatic women, nonasthmatic women had a significantly higher prevalence of all autoimmune disorders except for the antiphospholipid syndrome. Type 1 diabetes mellitus, vasculitis, and rheumatoid arthritis were less prevalent in men with asthma than in those without. During the follow-up period, vasculitis and rheumatoid arthritis were more frequently diagnosed in nonasthmatic persons of both sexes. There was a significantly higher incidence of immune thrombocytopenic purpura, inflammatory bowel disease, and the anti phospholipid syndrome in nonasthmatic women and a statistically significantly higher incidence of type 1 diabetes mellitus in nonasthmatic men. Limitations: The study was limited to a population of young military recruits; therefore, its findings are not necessarily applicable to the general population. Because of the noninterventional nature of the study, it describes associations but cannot prove causality. Conclusions: Asthma status may affect the prevalence of. major autoimmune disorders. Preexisting asthma seems to protect against the development of autoimmune disorders to varying degrees in men and women.	Sheba Med Ctr, Dept Internal Med A&C, IL-52662 Tel Hashomer, Israel	Chaim Sheba Medical Center	Tirosh, A (corresponding author), Sheba Med Ctr, Dept Internal Med A&C, IL-52662 Tel Hashomer, Israel.	amirt@bgumail.bgu.ac.il	Mandel, Dror/GRR-6881-2022	Tirosh, Amir/0000-0003-2210-5906				[Anonymous], 2000, Diabetes Care, V23 Suppl 1, pS1; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Caffarelli C, 2004, INT ARCH ALLERGY IMM, V134, P288, DOI 10.1159/000079166; Celedon Juan C, 2004, Treat Respir Med, V3, P291, DOI 10.2165/00151829-200403050-00003; Cutolo M, 2004, LUPUS, V13, P635, DOI 10.1191/0961203304lu1094oa; Cutolo Maurizio, 2002, Autoimmunity Reviews, V1, P284, DOI 10.1016/S1568-9972(02)00064-2; Ente G, 2003, JAMA-J AM MED ASSOC, V289, P842, DOI 10.1001/jama.289.7.842-a; Eskola V, 2003, HORM RES, V59, P195, DOI 10.1159/000069327; *EXP PAN REP 2, 1997, NIH PUBL; Kannisto S, 2000, J CLIN ENDOCR METAB, V85, P652, DOI 10.1210/jc.85.2.652; Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; Sheikh A, 2003, J ALLERGY CLIN IMMUN, V111, P131, DOI 10.1067/mai.2003.8; Simpson CR, 2002, CLIN EXP ALLERGY, V32, P37, DOI 10.1046/j.0022-0477.2001.01250.x; Singh VK, 1999, IMMUNOL RES, V20, P147, DOI 10.1007/BF02786470; Smit JJ, 2004, CURR OPIN ALLERGY CL, V4, P57, DOI [10.1097/00130832-200402000-00012, 10.1097/01.all.0000113680.18759.17]; Stene LC, 2004, CLIN EXP ALLERGY, V34, P201, DOI 10.1111/j.1365-2222.2004.01864.x; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Tulic MK, 2004, LANCET, V363, P1689, DOI 10.1016/S0140-6736(04)16253-3; Weiss ST, 2002, NEW ENGL J MED, V347, P930, DOI 10.1056/NEJMe020092; Wen Jr, 2004, NETWORK THEORY APPLI, V11, P195; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255	23	53	55	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					877	883		10.7326/0003-4819-144-12-200606200-00004	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785476				2022-12-28	WOS:000238555500002
J	Oransky, I				Oransky, I			Charles Schepens - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2006	367	9527					1974	1974		10.1016/S0140-6736(06)68869-7	http://dx.doi.org/10.1016/S0140-6736(06)68869-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16810776	Bronze			2022-12-28	WOS:000238488900014
J	Geballe, TR; Oka, T				Geballe, T. R.; Oka, T.			A key molecular ion in the universe and in the laboratory	SCIENCE			English	Editorial Material							GALACTIC-CENTER; H-3(+); LINES; H-3+		Gemini Observ, Hilo, HI 96720 USA; Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA	University of Chicago	Geballe, TR (corresponding author), Gemini Observ, Hilo, HI 96720 USA.	tgeballe@gemini.edu; t-oka@uchicago.edu						Amano T, 2005, J MOL SPECTROSC, V233, P7, DOI 10.1016/j.jms.2005.05.008; Blythe P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.183002; DROSSART P, 1989, NATURE, V340, P539, DOI 10.1038/340539a0; GEBALLE TR, 1993, ASTROPHYS J, V408, pL109, DOI 10.1086/186843; Geballe TR, 1999, ASTROPHYS J, V510, P251, DOI 10.1086/306580; Geballe TR, 1996, NATURE, V384, P334, DOI 10.1038/384334a0; Gerlich D, 2002, PLANET SPACE SCI, V50, P1275, DOI 10.1016/S0032-0633(02)00094-6; Gottfried JL, 2003, J CHEM PHYS, V118, P10890, DOI 10.1063/1.1575737; HERBST E, 1973, ASTROPHYS J, V185, P505, DOI 10.1086/152436; Hogness TR, 1925, PHYS REV, V26, P0044, DOI 10.1103/PhysRev.26.44; Kokoouline V, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.012703; McCall BJ, 2003, NATURE, V422, P500, DOI 10.1038/nature01498; McCall BJ, 2002, ASTROPHYS J, V567, P391, DOI 10.1086/338380; Miller S, 2005, SPACE SCI REV, V116, P319, DOI 10.1007/s11214-005-1960-4; Oka T, 2005, ASTROPHYS J, V632, P882, DOI 10.1086/432679; OKA T, 1980, PHYS REV LETT, V45, P531, DOI 10.1103/PhysRevLett.45.531; Roberts H, 2003, ASTROPHYS J, V591, pL41, DOI 10.1086/376962; Schiffels P, 2003, MOL PHYS, V101, P189, DOI 10.1080/00268970210158713; Thomson JJ, 1911, PHILOS MAG, V21, P225, DOI 10.1080/14786440208637024; TRAFTON LM, 1993, ASTROPHYS J, V405, P761, DOI 10.1086/172404; Vastel C, 2004, ASTROPHYS J, V606, pL127, DOI 10.1086/421265; WATSON WD, 1973, ASTROPHYS J, V183, pL17, DOI 10.1086/181242; IN PRESS PHILOS T R	23	50	50	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1610	1612		10.1126/science.1126279	http://dx.doi.org/10.1126/science.1126279			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053EO	16778045				2022-12-28	WOS:000238288600033
J	You, HL; Lamanna, MC; Harris, JD; Chiappe, LM; O'Connor, J; Ji, SA; Lu, JC; Yuan, CX; Li, DQ; Zhang, X; Lacovara, KJ; Dodson, P; Ji, Q				You, Hai-lu; Lamanna, Matthew C.; Harris, Jerald D.; Chiappe, Luis M.; O'Connor, Jingmai; Ji, Shu-an; Lu, Jun-chang; Yuan, Chong-xi; Li, Da-qing; Zhang, Xing; Lacovara, Kenneth J.; Dodson, Peter; Ji, Qiang			A nearly modern amphibious bird from the early Cretaceous of Northwestern China	SCIENCE			English	Article								Three-dimensional specimens of the volant fossil bird Gansus yumenensis from the Early Cretaceous Xiagou Formation of northwestern China demonstrate that this taxon possesses advanced anatomical features previously known only in Late Cretaceous and Cenozoic ornithuran birds. Phylogenetic analysis recovers Gansus within the Ornithurae, making it the oldest known member of the clade. The Xiagou Formation preserves the oldest known ornithuromorph-dominated avian assemblage. The anatomy of Gansus, like that of other non-neornithean (nonmodern) ornithuran birds, indicates specialization for an amphibious life-style, supporting the hypothesis that modern birds originated in aquatic or littoral niches.	Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; Dixie State Coll, Dept Sci, St George, UT 84770 USA; Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA; Third Geol & Mineral Resources Explorat Acad Gans, Fossil Res & Dev Ctr, Lanzhou 730050, Gansu, Peoples R China; Prov Museum Gansu Prov, Nat Dept, Lanzhou 730050, Peoples R China; Drexel Univ, Dept Biosci & Biotechnol, Geol & Paleontol Program, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	Chinese Academy of Geological Sciences; Utah System of Higher Education; Dixie State University; Drexel University; University of Pennsylvania	Lamanna, MC (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, 4400 Forbes Ave, Pittsburgh, PA 15213 USA.	lamannam@carnegiemnh.org; jharris@dixie.edu	Dodson, Peter/A-9544-2009	You, Hai-Lu/0000-0003-2203-6461; Chiappe, Luis/0000-0001-9661-0601				Chatterjee Sankar, 2002, P125; Chiappe Luis M., 2002, P281; Chiappe Luis M., 2002, P448; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clarke JA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)387<0001:TMAPPO>2.0.CO;2; CRACRAFT J, 1982, SYST ZOOL, V31, P35, DOI 10.2307/2413412; de Buffrenil V., 2001, SECONDARY ADAPTATION, P91; Dyke GJ, 2002, NATURWISSENSCHAFTEN, V89, P408, DOI 10.1007/s00114-002-0352-9; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; Galton Peter M., 2002, P317; Gill F. B., 1995, ORNITHOLOGY; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hope Sylvia, 2002, P339; Hou L., 1997, MESOZOIC BIRDS CHINA; Hou L.H, 2002, MESOZOIC BIRDS W LIA; HOU LH, 1984, SCI SIN B-CHEM B A M, V27, P1296; Kurochkin EN, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)386<0001:ANPBAA>2.0.CO;2; Kurochkin EN, 1999, SM C PALEOB, P275; Lim JD, 2000, NATURWISSENSCHAFTEN, V87, P256, DOI 10.1007/s001140050715; Marsh OC., 1880, REPORT GEOLOGICAL EX, V18, P1; Parris David C., 2002, P113; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Sanz Jose L., 2002, P209; SHUFELDT RW, 1909, NY STATE MUS B, V130, P5; [袁崇喜 Yuan Chongxi], 2004, [地质学报, Acta Geologica Sinica], V78, P464; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2001, CHINESE SCI BULL, V46, P1258, DOI 10.1007/BF03184320; Zhou ZY, 2002, P SOC PHOTO-OPT INS, V4928, P160, DOI 10.1117/12.483166	28	111	123	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1640	1643		10.1126/science.1126377	http://dx.doi.org/10.1126/science.1126377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778053				2022-12-28	WOS:000238288600042
J	Currie, GP; Douglas, JG				Currie, Graeme P.; Graham Douglas, J.			ABC of chronic obstructive pulmonary disease - Non-pharmacological management	BRITISH MEDICAL JOURNAL			English	Editorial Material							LUNG-VOLUME-REDUCTION; REHABILITATION; METAANALYSIS; EMPHYSEMA		Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland	University of Aberdeen	Currie, GP (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland.			Currie, Graeme P/0000-0002-5711-9147				Ferreira IM, 2000, CHEST, V117, P672, DOI 10.1378/chest.117.3.672; Fishman A, 2003, NEW ENGL J MED, V348, P2059; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hopkinson NS, 2005, AM J RESP CRIT CARE, V171, P453, DOI 10.1164/rccm.200407-961OC; Man WDC, 2004, BMJ-BRIT MED J, V329, P1209, DOI 10.1136/bmj.38258.662720.3A; Morgan MDL, 2001, THORAX, V56, P827; POOLE PJ, 2000, COCHRANE DB SYST REV, V4	7	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 10	2006	332	7554					1379	1381		10.1136/bmj.332.7554.1379	http://dx.doi.org/10.1136/bmj.332.7554.1379			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763252	Green Published			2022-12-28	WOS:000238587000025
J	Dave, SS; Fu, K; Wright, GW; Lam, LT; Kluin, P; Boerma, EJ; Greiner, TC; Weisenburger, DD; Rosenwald, A; Ott, G; Muller-Hermelink, H; Gascoyne, RD; Delabie, J; Rimsza, LM; Braziel, RM; Grogan, TM; Campo, E; Jaffe, ES; Dave, BJ; Sanger, W; Bast, M; Vose, JM; Armitage, JO; Connors, JM; Smeland, EB; Kvaloy, S; Holte, H; Fisher, RI; Miller, TP; Montserrat, E; Wilson, WH; Bahl, M; Zhao, H; Yang, LM; Powell, J; Simon, R; Chan, WC; Staudt, LM				Dave, Sandeep S.; Fu, Kai; Wright, George W.; Lam, Lloyd T.; Kluin, Philip; Boerma, Evert-Jan; Greiner, Timothy C.; Weisenburger, Dennis D.; Rosenwald, Andreas; Ott, German; Mueller-Hermelink, Hans-Konrad; Gascoyne, Randy D.; Delabie, Jan; Rimsza, Lisa M.; Braziel, Rita M.; Grogan, Thomas M.; Campo, Elias; Jaffe, Elaine S.; Dave, Bhavana J.; Sanger, Warren; Bast, Martin; Vose, Julie M.; Armitage, James O.; Connors, Joseph M.; Smeland, Erlend B.; Kvaloy, Stein; Holte, Harald; Fisher, Richard I.; Miller, Thomas P.; Montserrat, Emilio; Wilson, Wyndham H.; Bahl, Manisha; Zhao, Hong; Yang, Liming; Powell, John; Simon, Richard; Chan, Wing C.; Staudt, Louis M.		Lymphoma Leukemia Molecular Profil	Molecular diagnosis of Burkitt's lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; GENE-EXPRESSION; ADULTS; CHEMOTHERAPY; EXPERIENCE; SUBGROUPS; PATTERNS; SURVIVAL; REGIMENS	Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is crucial because these two types of lymphoma require different treatments. We examined whether gene-expression profiling could reliably distinguish Burkitt's lymphoma from diffuse large-B-cell lymphoma. Methods: Tumor-biopsy specimens from 303 patients with aggressive lymphomas were profiled for gene expression and were also classified according to morphology, immunohistochemistry, and detection of the t(8;14) c-myc translocation. Results: A classifier based on gene expression correctly identified all 25 pathologically verified cases of classic Burkitt's lymphoma. Burkitt's lymphoma was readily distinguished from diffuse large-B-cell lymphoma by the high level of expression of c-myc target genes, the expression of a subgroup of germinal-center B-cell genes, and the low level of expression of major-histocompatibility-complex class I genes and nuclear factor-kappa B target genes. Eight specimens with a pathological diagnosis of diffuse large-B-cell lymphoma had the typical gene-expression profile of Burkitt's lymphoma, suggesting they represent cases of Burkitt's lymphoma that are difficult to diagnose by current methods. Among 28 of the patients with a molecular diagnosis of Burkitt's lymphoma, the overall survival was superior among those who had received intensive chemotherapy regimens instead of lower-dose regimens. Conclusions: Gene-expression profiling is an accurate, quantitative method for distinguishing Burkitt's lymphoma from diffuse large-B-cell lymphoma.	NCI, Metab Branch, CCR, NIH, Bethesda, MD 20892 USA; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; Univ Nebraska, Med Ctr, Omaha, NE USA; Univ Groningen, Med Ctr, Groningen, Netherlands; Univ Wurzburg, Wurzburg, Germany; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Norwegian Radium Hosp, Norway Hosp Clin, Oslo, Norway; SW Oncol Grp, Seattle, WA USA; Univ Arizona, Ctr Canc, Tucson, AZ USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Univ Barcelona, Barcelona, Spain; Univ Oslo, Oslo, Norway; Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Nebraska System; University of Nebraska Medical Center; University of Groningen; University of Wurzburg; British Columbia Cancer Agency; University of Oslo; Southwest Oncology Group; University of Arizona; Oregon Health & Science University; University of Barcelona; University of Oslo; University of Rochester	Staudt, LM (corresponding author), NCI, Metab Branch, CCR, NIH, Bldg 10,Rm 4N114,9000 Rockville Pike, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Holte, Harald/AAO-5647-2020; Smeland, Erlend/AAO-3214-2020; Gascoyne, Randy D/A-6009-2013; Connors, Joseph/AAF-5284-2019; Campo, Elias/AAC-5593-2019; Jaffe, Elaine/G-8981-2014; Wright, George W/M-1660-2017	Gascoyne, Randy D/0000-0002-2610-5690; Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Delabie, Jan/0000-0001-5023-0689	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [UO1-CA84967] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC000550, U01CA084967, Z01SC004024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bishop PC, 2000, CANCER INVEST, V18, P574, DOI 10.3109/07357900009012197; Butler R D, 1993, Cancer Treat Res, V66, P65; Divine M, 2005, ANN ONCOL, V16, P1928, DOI 10.1093/annonc/mdi403; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Gerbitz A, 1999, ONCOGENE, V18, P1745, DOI 10.1038/sj.onc.1202468; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; HILLS M, 1966, J ROY STAT SOC B, V28, P1; Jaffe ES, 2001, TUMOURS HAEMATOPOIET; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Lam LT, 2005, CLIN CANCER RES, V11, P28; Macpherson N, 1999, J CLIN ONCOL, V17, P1558, DOI 10.1200/JCO.1999.17.5.1558; Magrath I, 1996, J CLIN ONCOL, V14, P925, DOI 10.1200/JCO.1996.14.3.925; MANN RB, 1976, NEW ENGL J MED, V295, P685, DOI 10.1056/NEJM197609232951301; Mead GM, 2002, ANN ONCOL, V13, P1961, DOI 10.1093/annonc/mdf353; Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; PEES HW, 1992, ANN HEMATOL, V65, P201, DOI 10.1007/BF01703945; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Smeland S, 2004, ANN ONCOL, V15, P1072, DOI 10.1093/annonc/mdh262; SOUSSAIN C, 1995, BLOOD, V85, P664, DOI 10.1182/blood.V85.3.664.bloodjournal853664; Thomas DA, 1999, J CLIN ONCOL, V17, P2461, DOI 10.1200/JCO.1999.17.8.2461; Voltz R, 1989, Haematol Blood Transfus, V32, P289; Vose JM, 2002, LEUKEMIA LYMPHOMA, V43, P799, DOI 10.1080/10428190290016917; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	33	577	621	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2431	2442		10.1056/NEJMoa055759	http://dx.doi.org/10.1056/NEJMoa055759			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760443	Green Submitted			2022-12-28	WOS:000238100800005
J	Taddei, A; Van Houwe, G; Hediger, F; Kalck, V; Cubizolles, F; Schober, H; Gasser, SM				Taddei, Angela; Van Houwe, Griet; Hediger, Florence; Kalck, Veronique; Cubizolles, Fabien; Schober, Heiko; Gasser, Susan M.			Nuclear pore association confers optimal expression levels for an inducible yeast gene	NATURE			English	Article							LOCALIZATION; TELOMERES; REPRESSION; PROTEINS; DYNAMICS; SIR4	The organization of the nucleus into subcompartments creates microenvironments that are thought to facilitate distinct nuclear functions(1). In budding yeast, regions of silent chromatin, such as those at telomeres and mating-type loci, cluster at the nuclear envelope creating zones that favour gene repression(1,2). Other reports indicate that gene transcription occurs at the nuclear periphery, apparently owing to association of the gene with nuclear pore complexes(3-5). Here we report that transcriptional activation of a subtelomeric gene, HXK1 ( hexokinase isoenzyme 1), by growth on a non-glucose carbon source led to its relocalization to nuclear pores. This relocation required the 30 untranslated region ( UTR), which is essential for efficient messenger RNA processing and export, consistent with an accompanying report(6). However, activation of HXK1 by an alternative pathway based on the transactivator VP16 moved the locus away from the nuclear periphery and abrogated the normal induction of HXK1 by galactose. Notably, when we interfered with HXK1 localization by either antagonizing or promoting association with the pore, transcript levels were reduced or enhanced, respectively. From this we conclude that nuclear position has an active role in determining optimal gene expression levels.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Inst Curie, CNRS, Sect Rech, UMR 218, F-75231 Paris 05, France; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva 4, Switzerland	Friedrich Miescher Institute for Biomedical Research; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	taddei, angela/AAL-2413-2021	taddei, angela/0000-0002-3217-0739; Gasser, Susan/0000-0003-3610-9123; Cubizolles, Fabien/0000-0002-9822-4074				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; de la Cera T, 2002, J MOL BIOL, V319, P703, DOI 10.1016/S0022-2836(02)00377-7; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hediger F, 2006, EMBO J, V25, P857, DOI 10.1038/sj.emboj.7600976; Hediger F, 2004, METHOD ENZYMOL, V375, P345; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Tham WH, 2001, MOL CELL, V8, P189, DOI 10.1016/S1097-2765(01)00287-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	27	299	305	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					774	778		10.1038/nature04845	http://dx.doi.org/10.1038/nature04845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760983				2022-12-28	WOS:000238095100060
J	McKenna, D				McKenna, D			That's our drip counter!	LANCET			English	Editorial Material									Royal Jubilee Matern Serv, Belfast BT12 6BB, Antrim, North Ireland		McKenna, D (corresponding author), Royal Jubilee Matern Serv, Grosvenor Rd, Belfast BT12 6BB, Antrim, North Ireland.	d.mckenna485@btinternet.com							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1873	1873		10.1016/S0140-6736(06)68810-7	http://dx.doi.org/10.1016/S0140-6736(06)68810-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753491				2022-12-28	WOS:000238194200034
J	Parker, M; Johansen, A				Parker, Martyn; Johansen, Antony			Hip fracture	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELDERLY-PATIENTS; FEMORAL-NECK; POSTMENOPAUSAL WOMEN; CONTROLLED-TRIAL; PRESSURE ULCERS; RISK-FACTORS; MORTALITY; SURGERY; POPULATION; REDUCTION		Peterborough & Stamford NHS Fdn Trust, Dept Orthopaed, Peterborough PE3 6DA, England; Cardiff & Vale NHS Trust, Trauma Unit, Cardiff CF14 4XW, Wales	Cardiff University	Parker, M (corresponding author), Peterborough & Stamford NHS Fdn Trust, Dept Orthopaed, Peterborough PE3 6DA, England.	Martyn.Parker@pbh-tr.nhs.uk		Johansen, Antony/0000-0003-4726-9106				*AM GER SOC BRIT G, 2001, NAT GUID PREV FALLS; Avenell A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub2; AVENELL A, 2005, COCHRANE LIB; Baumgarten M, 2003, WOUND REPAIR REGEN, V11, P96, DOI 10.1046/j.1524-475X.2003.11204.x; BEDAT B, 1997, J BONE JOINT SURG BR, V79, P243; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Boonen S, 2004, J AM GERIATR SOC, V52, P1832, DOI 10.1111/j.1532-5415.2004.52506.x; Brennan J, 2003, OSTEOPOROSIS INT, V14, P515, DOI 10.1007/s00198-003-1404-5; Cameron I., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4020, DOI 10.3310/HTA4020]; Cameron ID, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000106; Chana R, 2006, INJURY, V37, P185, DOI 10.1016/j.injury.2005.07.012; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Conn K. S., 2004, CLIN ORTHOP RELAT R, V421, P249; Cserhati P, 1996, INJURY, V27, P583, DOI 10.1016/S0020-1383(96)00073-3; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Department of Health, 2001, NAT SERV FRAM OLD PE; Dinah AF, 2003, INJURY, V34, P839, DOI 10.1016/S0020-1383(03)00030-5; Duncn DG, 2006, AGE AGEING, V35, P148, DOI 10.1093/ageing/afj011; FITZGERALD JF, 1988, NEW ENGL J MED, V319, P1392, DOI 10.1056/NEJM198811243192106; GILCHRIST WJ, 1988, BRIT MED J, V297, P1116, DOI 10.1136/bmj.297.6656.1116; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; GILLESPIE W, 2001, COCHRANE LIB; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; HANDOLL HHG, 2002, COCHRANE LIB; HAYES WC, 1993, CALCIFIED TISSUE INT, V52, P192, DOI 10.1007/BF00298717; Hopkinson-Woolley JA, 1998, INJURY, V29, P585, DOI 10.1016/S0020-1383(98)00133-8; HORNBY R, 1989, J BONE JOINT SURG BR, V71, P619, DOI 10.1302/0301-620X.71B4.2670950; Irvine R.E., 1963, J BONE JOINT SURG BR, V49, P186; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Johansen A, 1997, INJURY, V28, P655, DOI 10.1016/S0020-1383(97)00144-7; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; Koval KJ, 2004, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000132266.59787.d2; March LM, 1999, MED J AUSTRALIA, V170, P489, DOI 10.5694/j.1326-5377.1999.tb127852.x; MASSON M, 2003, COCHRANE LIB; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; *NAT I HLTH CLIN A, 2004, CLIN PRACT GUID ASS; *NAT I HLTH CLIN E, 2005, BISPH AL ET RIS SEL; Nixon J, 2006, BMJ-BRIT MED J, V332, P1413, DOI 10.1136/bmj.38849.478299.7C; *NZ GUID GROUP, AC MAN IMM REH HIP F; O'Brien J, 2000, LANCET, V355, P1295; OKAMAYUMI, 2004, AM J ROENTGENOLOG, V182, P283; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Pammi M., 2020, COCHRANE DATABASE SY, V3, pCD007137, DOI 10.1002/14651858.CD007137.pub6; Parker MJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub3; Parker MJ, 2006, BMJ-BRIT MED J, V332, P571, DOI 10.1136/bmj.38753.375324.7C; Parker MJ, 1999, CLASSIFICATION OF MUSCULOSKELETAL TRAUMA, P184; Parker MJ, 1997, ACTA ORTHOP SCAND, V68, P325, DOI 10.3109/17453679708996170; PARKER MJ, 1991, PUBLIC HEALTH, V105, P443, DOI 10.1016/S0033-3506(05)80614-6; PARKER MJ, 2001, OXFORD TXB ORTHOPAED; PARKER MJ, 2002, COCHRANE LIB; PARKER MJ, 2004, COCHRANE LIB; PARKER MJ, 2000, COCHRANE LIB; PARKER MJ, 2005, CLIN EVIDENCE; PARKER MJ, 2003, COCHRANE LIB; PARKER MJ, 2005, COCHRANE LIB; PARKER MJ, 1997, HDB HIP FRACTURE SUR; Pathak G, 1997, INJURY, V28, P299, DOI 10.1016/S0020-1383(96)00198-2; PRYOR GA, 1989, J BONE JOINT SURG BR, V71, P471, DOI 10.1302/0301-620X.71B3.2722942; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salkeld G, 2000, BMJ-BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; Schwartz AV, 1998, OSTEOPOROSIS INT, V8, P240, DOI 10.1007/s001980050060; Siegmeth AW, 2005, J BONE JOINT SURG BR, V87B, P1123, DOI 10.1302/0301-620X.87B8; *SIGN, 2002, SIGN PUBL, V56; *SIGN, SIGN PUBL, V56; Sikand M, 2004, INJURY, V35, P1015, DOI 10.1016/j.injury.2004.01.004; Souverein PC, 2006, NEUROLOGY, V66, P1318, DOI 10.1212/01.wnl.0000210503.89488.88; TORGERSON DJ, 2001, EFFECTIVE MANAGEMENT; VERSLUYSEN M, 1986, BRIT MED J, V292, P1311, DOI 10.1136/bmj.292.6531.1311; 2006, BMJ, V332, P1282	75	288	318	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2006	333	7557					27	30C		10.1136/bmj.333.7557.27	http://dx.doi.org/10.1136/bmj.333.7557.27			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16809710	Green Published			2022-12-28	WOS:000238922900024
J	Heckman, JJ				Heckman, James J.			Skill formation and the economics of investing in disadvantaged children	SCIENCE			English	Editorial Material								This paper summarizes evidence on the effects of early environments on child, adolescent, and adult achievement. Life cycle skill formation is a dynamic process in which early inputs strongly affect the productivity of later inputs.	Univ Chicago, Dept Econ, Chicago, IL 60637 USA; Natl Univ Ireland Univ Coll Dublin, Dept Econ, Dublin 4, Ireland	University of Chicago; University College Dublin	Heckman, JJ (corresponding author), Univ Chicago, Dept Econ, Chicago, IL 60637 USA.	jjh@uchicago.edu			NICHD NIH HHS [R01HD043411] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043411] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson DA, 1999, J LAW ECON, V42, P611, DOI 10.1086/467436; BARNETT WS, 2004, BENEFIT COST ANAL PR; Carneiro P, 2003, INEQUALITY IN AMERICA, P77; Coleman J., 1966, EQUALITY ED OPPORTUN; CUNHA F, IN PRESS HDB EC ED; CUNHA F, IN PRESS J HUM RESOU; DeLong J. Bradford, 2003, AGENDA NATION, P17; ELLWOOD DT, 2001, ROARING 90S CAN FULL, P421; HECKMAN J, 2004, 5 COMM EC DEV; HECKMAN JJ, UNPUB; HECKMAN JJ, IN PRESS J LAB EC; Karoly L. A., 1998, INVESTING OUR CHILDR; KNUDSEN EI, IN PRESS P NATL ACAD; Krueger AB, 2001, ECON J, V111, P1, DOI 10.1111/1468-0297.00586; KRUEGER B, 2002, BRIDGING ACHIEVEMENT; NEAL DA, IN PRESS HDB EC ED; Ramey CT, 1998, PREV MED, V27, P224, DOI 10.1006/pmed.1998.0279; Ramey CT, 1998, AM PSYCHOL, V53, P109, DOI 10.1037/0003-066X.53.2.109; RAMEY CT, 2000, APPL DEV SCI, V0004; RAUDENBUSH SW, 2006, SCH STAT POVERTY MEA; Reynolds A., 2003, EARLY CHILDHOOD PROG; Rolnick A., 2003, EARLY CHILDHOOD DEV; Schweinhart L.J., 2005, LIFETIME EFFECTS HIG; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; *STAT CAN SPEC SUR, 2002, INT AD LIT SURV 2002; Steven B., 2002, BENEFIT COST ANAL AB; *WEST LEARN CORP O, 1969, IMP HEAD START EV EF, V1; *WEST LEARN CORP O, 1969, IMP HEAD START EV EF, V2	28	1644	1668	9	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1900	1902		10.1126/science.1128898	http://dx.doi.org/10.1126/science.1128898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061CF	16809525				2022-12-28	WOS:000238848100043
J	Hsu, YJ; Simons, M; Avouac, JP; Galetzka, J; Sieh, K; Chlieh, M; Natawidjaja, D; Prawirodirdjo, L; Bock, Y				Hsu, Ya-Ju; Simons, Mark; Avouac, Jean-Philippe; Galetzka, John; Sieh, Kerry; Chlieh, Mohamed; Natawidjaja, Danny; Prawirodirdjo, Linette; Bock, Yehuda			Frictional afterslip following the 2005 Nias-Simeulue earthquake, Sumatra	SCIENCE			English	Article							SLIP; DEFORMATION; FAULT; ZONE	Continuously recording Global Positioning System stations near the 28 March 2005 rupture of the Sunda megathrust [moment magnitude (M-w) 8.7] show that the earthquake triggered aseismic frictional afterstip on the subduction megathrust, with a major fraction of this slip in the up-dip direction from the main rupture. Eleven months after the main shock, afterstip continues at rates several times the average interseismic rate, resulting in deformation equivalent to at least a M-w 8.2 earthquake. In general, along-strike variations in frictional behavior appear to persist over multiple earthquake cycles. Aftershocks cluster along the boundary between the region of coseismic slip and the up-dip creeping zone. We observe that the cumulative number of aftershocks increases linearly with postseismic displacements; this finding suggests that the temporal evolution of aftershocks is governed by afterslip.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Indonesian Inst Sci, Res Ctr Geotechnol, Bandung 40135, Indonesia; Univ Calif San Diego, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	California Institute of Technology; Indonesian Institute of Sciences; University of California System; University of California San Diego	Hsu, YJ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	yaru@gps.caltech.edu	Simons, Mark/N-4397-2015; Hsu, Ya-Ju/O-2709-2016; Avouac, Jean-Philippe/B-5699-2015	Simons, Mark/0000-0003-1412-6395; Hsu, Ya-Ju/0000-0003-1389-9994; Avouac, Jean-Philippe/0000-0002-3060-8442; Chlieh, Mohamed/0000-0003-2252-2187				Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; BARRIENTOS SE, 1992, GEOPHYS RES LETT, V19, P701, DOI 10.1029/92GL00210; BLANPIED ML, 1995, J GEOPHYS RES-SOL EA, V100, P13045, DOI 10.1029/95JB00862; Bock Y, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000324; Briggs RW, 2006, SCIENCE, V311, P1897, DOI 10.1126/science.1122602; CHLIEH M, 2005, AM GEOPH UN FALL M S; Cohen SC, 1999, ADV GEOPHYS, V41, P133, DOI 10.1016/S0065-2687(08)60027-8; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; ENGDAHL ER, IN PRESS B SEISMOL S; FITCH TJ, 1972, J GEOPHYS RES, V77, P4432, DOI 10.1029/JB077i023p04432; Genrich JF, 2000, J GEOPHYS RES-SOL EA, V105, P28327, DOI 10.1029/2000JB900158; Hyndman RD, 1997, ISL ARC, V6, P244, DOI 10.1111/j.1440-1738.1997.tb00175.x; KARIG DE, 1980, J GEOL SOC LONDON, V137, P77, DOI 10.1144/gsjgs.137.1.0077; KONCA O, IN PRESS B SEISMOL S; MCCAFFREY R, 1991, GEOLOGY, V19, P881, DOI 10.1130/0091-7613(1991)019<0881:SVASOT>2.3.CO;2; McGuire JJ, 2003, GEOPHYS J INT, V155, P778, DOI 10.1111/j.1365-246X.2003.02022.x; Miyazaki S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021457; Miyazaki S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019410; NATAWIDJAJA D, 2003, THESIS CALTECH; Natawidjaja DH, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002398; NEWCOMB KR, 1987, J GEOPHYS RES-SOLID, V92, P421, DOI 10.1029/JB092iB01p00421; Oleskevich DA, 1999, J GEOPHYS RES-SOL EA, V104, P14965, DOI 10.1029/1999JB900060; PACHECO JF, 1993, J GEOPHYS RES-SOL EA, V98, P14133, DOI 10.1029/93JB00349; Peacock SM, 1999, GEOPHYS RES LETT, V26, P2517, DOI 10.1029/1999GL900558; Perfettini H, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002917; Perfettini H, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003522; Perfettini H, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002488; Prawirodirdjo L, 1997, GEOPHYS RES LETT, V24, P2601, DOI 10.1029/97GL52691; PRITCHARD ME, IN PRESS J GEOPHYS R; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Schaff DP, 1998, GEOPHYS RES LETT, V25, P4549, DOI 10.1029/1998GL900192; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Segall P, 1997, J GEOPHYS RES-SOL EA, V102, P22391, DOI 10.1029/97JB01795; Sieh K, 1999, GEOPHYS RES LETT, V26, P3141, DOI 10.1029/1999GL005409; Sieh K, 2000, J GEOPHYS RES-SOL EA, V105, P28295, DOI 10.1029/2000JB900120; Simoes M, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002958; Song TRA, 2003, SCIENCE, V301, P630, DOI 10.1126/science.1085557; Subarya C, 2006, NATURE, V440, P46, DOI 10.1038/nature04522; Wells RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002072; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Zweck C, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000409	42	387	401	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1921	1926		10.1126/science.1126960	http://dx.doi.org/10.1126/science.1126960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809533	Green Published			2022-12-28	WOS:000238848100051
J	Mas-Balleste, R; Que, L				Mas-Balleste, Ruben; Que, Lawrence, Jr.			Targeting specific C-H bonds for oxidation	SCIENCE			English	Editorial Material							METHANE MONOOXYGENASE; METALLOPORPHYRINS; HYDROXYLATION; ACTIVATION; CATALYSIS		Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mas-Balleste, R (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	que@chem.umn.edu	Mas-Balleste, Ruben/G-5341-2013	Mas-Balleste, Ruben/0000-0003-1988-8700				Bhyrappa P, 1996, J AM CHEM SOC, V118, P5708, DOI 10.1021/ja953474k; Brazeau BJ, 2000, BIOCHEMISTRY-US, V39, P13503, DOI 10.1021/bi001473l; BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002; Breslow R, 1997, P NATL ACAD SCI USA, V94, P11156, DOI 10.1073/pnas.94.21.11156; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; GROVES JT, 1987, J AM CHEM SOC, V109, P5045, DOI 10.1021/ja00250a059; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; STUK TL, 1991, J ORG CHEM, V56, P2957, DOI 10.1021/jo00009a006; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u; Zheng H, 2006, BIOCHEMISTRY-US, V45, P1685, DOI 10.1021/bi051605g	11	32	33	6	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1885	1886		10.1126/science.1129814	http://dx.doi.org/10.1126/science.1129814			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809517				2022-12-28	WOS:000238848100035
J	Soares, LMM; Zanier, K; Mackereth, C; Sattler, M; Valcarcel, J				Mendes Soares, Luis Miguel; Zanier, Katia; Mackereth, Cameron; Sattler, Michael; Valcarcel, Juan			Intron removal requires proofreading of U2AF/3 ' splice site recognition by DEK	SCIENCE			English	Article							PROTEIN	Discrimination between splice sites and similar, nonsplice sequences is essential for correct intron removal and messenger RNA formation in eukaryotes. The 65- and 35-kD subunits of the splicing factor U2AF, U2AF(65) and U2AF(35), recognize, respectively, the pyrimidine-rich tract and the conserved terminal AG present at metazoan 3' splice sites. We report that DEK, a chromatin- and RNA-associated protein mutated or overexpressed in certain cancers, enforces 3' splice site discrimination by U2AF. DEK phosphorylated at serines 19 and 32 associates with U2AF(35), facilitates the U2AF(35)-AG interaction and prevents binding of U2AF(65) to pyrimidine tracts not followed by AG. DEK and its phosphorylation are required for intron removal, but not for splicing complex assembly, which indicates that proofreading of early 3' splice site recognition influences catalytic activation of the spliceosome.	Ctr Regulacio Genom, Barcelona 08003, Spain; Inst Catalana Rec & Estudis Avancats, Barcelona 08003, Spain; Univ Pompeu Fabra, Barcelona 08003, Spain; European Mol Biol Lab, D-69117 Heidelberg, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Pompeu Fabra University; European Molecular Biology Laboratory (EMBL)	Valcarcel, J (corresponding author), Ctr Regulacio Genom, Passeig Maritim 37-49, Barcelona 08003, Spain.	juan.vatcarcel@crg.es	Valcarcel, Juan/O-9814-2014; Mackereth, Cameron D./F-7946-2013; Sattler, Michael/A-2407-2012; Sattler, Michael/C-1169-2010	Valcarcel, Juan/0000-0001-5398-3571; Mackereth, Cameron D./0000-0002-0776-7947; Sattler, Michael/0000-0002-1594-0527; 	ICREA Funding Source: Custom	ICREA(ICREA)		FORNEROD M, 1995, ONCOGENE, V10, P1739; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kappes F, 2004, MOL CELL BIOL, V24, P6011, DOI 10.1128/MCB.24.13.6011-6020.2004; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; SCHERLY D, 1990, NATURE, V345, P502, DOI 10.1038/345502a0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	14	116	119	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1961	1965		10.1126/science.1128659	http://dx.doi.org/10.1126/science.1128659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809543				2022-12-28	WOS:000238848100062
J	Mesot, J				Mesot, J			The neutron spin-echo technique at full strength	SCIENCE			English	Editorial Material							SPECTROMETER; NRSE		ETH, Neutron Scattering Lab, CH-5232 Villigen, Switzerland; Paul Scherrer Inst, CH-5232 Villigen, Switzerland	ETH Zurich; Paul Scherrer Institute	Mesot, J (corresponding author), ETH, Neutron Scattering Lab, CH-5232 Villigen, Switzerland.	joel.mesot@psi.ch						Bayrakci SP, 2006, SCIENCE, V312, P1926, DOI 10.1126/science.1127756; BLEUEL M, 2003, LECT NOTES PHYS, V601; Campuzano JC, 2004, PHYSICS OF SUPERCONDUCTORS, VOL II, P167; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Keller T, 2002, APPL PHYS A-MATER, V74, pS332, DOI 10.1007/s003390201612; Keller T, 1997, PHYSICA B, V234, P1126, DOI 10.1016/S0921-4526(97)00131-2; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; MEZEI F, 1972, Z PHYS, V255, P146, DOI 10.1007/BF01394523	8	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2006	312	5782					1888	1889		10.1126/science.1129459	http://dx.doi.org/10.1126/science.1129459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809519				2022-12-28	WOS:000238848100037
J	Vaupel, JW; Loichinger, E				Vaupel, James W.; Loichinger, Elke			Redistributing work in aging Europe	SCIENCE			English	Editorial Material								As Europe ages, the proportion of people who work wilt decline unless older individuals remain in the labor force. Such reform could be part of a more general redistribution of work. If a greater share of the population worked, then the average number of hours worked per week could be reduced. This could particularly help younger people and increase Europe's low birth rates. The challenges facing Germany, Europe's most populous country, are highlighted, but statistics are also given for five other European countries and, for comparison, the United States. Social science research is needed to provide policy-relevant knowledge about life-course options.	Rostocker Zentrum Study Demog Change, D-18057 Rostock, Germany; Max Planck Inst Demog Res, D-18057 Rostock, Germany; Duke Univ, Terry Sanford Inst Publ Policy, Durham, NC 27708 USA	Max Planck Society; Duke University	Vaupel, JW (corresponding author), Rostocker Zentrum Study Demog Change, Konrad Zuse Str 1, D-18057 Rostock, Germany.	jwv@demogr.mpg.de		Vaupel, James/0000-0003-0783-3905	NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER; NIA NIH HHS [AG-08761] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALHO J, 2005, CHANGING POPULATION; ANDREEV K, 2005, FORECASTS COHORT MOR; Blekesaune M, 2003, EUR SOCIOL REV, V19, P415, DOI 10.1093/esr/19.5.415; Borsch-Supan A., 2003, Labour, V17, P5, DOI 10.1111/1467-9914.17.specialissue.2; Browning Don S., 2000, CULTURE WARS COMMON; Butz WP, 2006, SCIENCE, V312, P1898, DOI 10.1126/science.1130121; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; George L.K., 2001, HDB AGING SOCIAL SCI, P333; Gruber J., 2004, SOCIAL SECURITY PROG; Lee R, 2004, POPUL DEV REV, V30, P153; MARSHALL VW, 2003, RESTRUCTURING WORK L; NEYER G, 2004, CONT RES EUROPEAN FE; *OECD, 2001, REF AG SOC; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; *OFF OFF PUBL EUR, 2003, EUR FDN IMPR LIV WOR; RedayMulvey G, 2005, WORKING BEYOND 60: KEY POLICIES AND PRACTICES IN EUROPE, P1, DOI 10.1057/9780230504981; Sobotka T, 2004, POSTPONEMENT CHILDBE; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; VAUPEL JW, 2004, FRANKFURTER ALL 0408, P41; WAITE LJ, 2004, POPUL DEV REV S, V30; WHEELOCK J, 1999, WORK IDLENESS POLITI	21	63	65	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1911	1913		10.1126/science.1127487	http://dx.doi.org/10.1126/science.1127487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061CF	16809529				2022-12-28	WOS:000238848100047
J	Lindvall, O; Kokaia, Z				Lindvall, O; Kokaia, Z			Stem cells for the treatment of neurological disorders	NATURE			English	Article							NEURAL PROGENITOR CELLS; SPINAL-CORD-INJURY; RAT MODEL; DIRECTED DIFFERENTIATION; FUNCTIONAL RECOVERY; PARKINSONS-DISEASE; MOTOR FUNCTION; ADULT RATS; TRANSPLANTATION; NEURONS	Many common neurological disorders, such as Parkinson's disease, stroke and multiple sclerosis, are caused by a loss of neurons and glial cells. In recent years, neurons and glia have been generated successfully from stem cells in culture, fuelling efforts to develop stem-cell-based transplantation therapies for human patients. More recently, efforts have been extended to stimulating the formation and preventing the death of neurons and glial cells produced by endogenous stem cells within the adult central nervous system. The next step is to translate these exciting advances from the laboratory into clinically useful therapies.	Univ Lund Hosp, Wallenberg Neurosci Ctr, Sect Restorat Neurol, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden; Univ Lund Hosp, Stem Cell Inst, Sect Restorat Neurol, Lab Neural Stem Cell Biol, SE-22184 Lund, Sweden; Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University	Lindvall, O (corresponding author), Univ Lund Hosp, Wallenberg Neurosci Ctr, Sect Restorat Neurol, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden.	olle.lindvall@med.lu.se	Kokaia, Zaal/AAL-6009-2020	Kokaia, Zaal/0000-0003-2296-2449				Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; HAYASHI J, J CEREB BLOOD F 0104; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Ikeda R, 2005, NEUROBIOL DIS, V20, P38, DOI 10.1016/j.nbd.2005.01.031; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kerr DA, 2003, J NEUROSCI, V23, P5131; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005	32	616	665	2	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2006	441	7097					1094	1096		10.1038/nature04960	http://dx.doi.org/10.1038/nature04960			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810245				2022-12-28	WOS:000238615500037
J	Foster, MA; Turner, AC; Sharping, JE; Schmidt, BS; Lipson, M; Gaeta, AL				Foster, Mark A.; Turner, Amy C.; Sharping, Jay E.; Schmidt, Bradley S.; Lipson, Michal; Gaeta, Alexander L.			Broad-band optical parametric gain on a silicon photonic chip	NATURE			English	Article							STIMULATED RAMAN-SCATTERING; INSULATOR WAVE-GUIDES; WAVELENGTH CONVERSION; 2-PHOTON ABSORPTION; AMPLIFICATION; DISPERSION; MODULATION; LASER	Developing an optical amplifier on silicon is essential for the success of silicon-on-insulator (SOI) photonic integrated circuits. Recently, optical gain with a 1-nm bandwidth was demonstrated using the Raman effect(1-9), which led to the demonstration of a Raman oscillator(10,11), lossless optical modulation(12) and optically tunable slow light(13). A key strength of optical communications is the parallelism of information transfer and processing onto multiple wavelength channels. However, the relatively narrow Raman gain bandwidth only allows for amplification or generation of a single wavelength channel. If broad gain bandwidths were to be demonstrated on silicon, then an array of wavelength channels could be generated and processed, representing a critical advance for densely integrated photonic circuits. Here we demonstrate net on/off gain over a wavelength range of 28 nm through the optical process of phase-matched four-wave mixing in suitably designed SOI channel waveguides. We also demonstrate wavelength conversion in the range 1,511 - 1,591 nm with peak conversion efficiencies of +15.2 dB, which represents more than 20 times improvement on previous four-wave-mixing efficiencies in SOI waveguides(14-17). These advances allow for the implementation of dense wavelength division multiplexing in an all-silicon photonic integrated circuit. Additionally, all-optical delays(18), all-optical switches(19), optical signal regenerators(20) and optical sources for quantum information technology(21), all demonstrated using four-wave mixing in silica fibres, can now be transferred to the SOI platform.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Gaeta, AL (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	a.gaeta@cornell.edu	Foster, Mark/E-8011-2010; Foster, Amy C/E-8009-2010; Gaeta, Alexander/AAE-2095-2019	Foster, Mark/0000-0002-4524-141X; 				Almeida VR, 2003, OPT LETT, V28, P1302, DOI 10.1364/OL.28.001302; Boyraz O., 2004, IEICE Electronics Express, V1, DOI 10.1587/elex.1.429; Ciaramella E, 2000, IEEE PHOTONIC TECH L, V12, P849, DOI 10.1109/68.853523; Claps R, 2003, OPT EXPRESS, V11, P1731, DOI 10.1364/OE.11.001731; Dimitropoulos D, 2004, OPT EXPRESS, V12, P149, DOI 10.1364/OPEX.12.000149; Dinu M, 2003, APPL PHYS LETT, V82, P2954, DOI 10.1063/1.1571665; Espinola RL, 2005, OPT EXPRESS, V13, P4341, DOI 10.1364/OPEX.13.004341; Espinola RL, 2004, OPT EXPRESS, V12, P3713, DOI 10.1364/OPEX.12.003713; Foster MA, 2004, OPT EXPRESS, V12, P2880, DOI 10.1364/OPEX.12.002880; Fukuda H, 2005, OPT EXPRESS, V13, P4629, DOI 10.1364/OPEX.13.004629; Hansryd J, 2002, IEEE J SEL TOP QUANT, V8, P506, DOI 10.1109/JSTQE.2002.1016354; Jones R, 2005, OPT EXPRESS, V13, P1716, DOI 10.1364/OPEX.13.001716; Jones R, 2005, OPT EXPRESS, V13, P519, DOI 10.1364/OPEX.13.000519; Li XY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.053601; Liang TK, 2004, APPL PHYS LETT, V84, P2745, DOI 10.1063/1.1702133; Liang TK, 2004, APPL PHYS LETT, V85, P3343, DOI 10.1063/1.1807960; Lin Q, 2005, IEEE PHOTONIC TECH L, V17, P2376, DOI 10.1109/LPT.2005.858155; Liu AS, 2004, OPT EXPRESS, V12, P4261, DOI 10.1364/OPEX.12.004261; Okawachi Y, 2006, OPT EXPRESS, V14, P2317, DOI 10.1364/OE.14.002317; Raghunathan V, 2005, J LIGHTWAVE TECHNOL, V23, P2094, DOI 10.1109/JLT.2005.849895; Rong HS, 2005, NATURE, V433, P292, DOI 10.1038/nature03273; Rong HS, 2004, APPL PHYS LETT, V85, P2196, DOI 10.1063/1.1794862; Rong HS, 2006, OPT EXPRESS, V14, P1182, DOI 10.1364/OE.14.001182; Rong HS, 2005, NATURE, V433, P725, DOI 10.1038/nature03346; Sharping JE, 2005, OPT EXPRESS, V13, P7872, DOI 10.1364/OPEX.13.007872; Tsang HK, 2002, APPL PHYS LETT, V80, P416, DOI 10.1063/1.1435801; Turner AC, 2006, OPT EXPRESS, V14, P4357, DOI 10.1364/OE.14.004357; Xu QF, 2005, OPT LETT, V30, P35, DOI 10.1364/OL.30.000035; Xu QF, 2004, OPT EXPRESS, V12, P4437, DOI 10.1364/OPEX.12.004437; Yamada K, 2006, IEEE PHOTONIC TECH L, V18, P1046, DOI 10.1109/LPT.2006.873469	30	704	720	16	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					960	963		10.1038/nature04932	http://dx.doi.org/10.1038/nature04932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791190				2022-12-28	WOS:000238422300037
J	Klein, BEK; Klein, R; Lee, KE; Grady, LM				Klein, BEK; Klein, R; Lee, KE; Grady, LM			Statin use and incident nuclear cataract	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEAVER-DAM EYE; AGE-RELATED MACULOPATHY; OPACITIES CASE-CONTROL; LENS OPACITIES; RISK-FACTORS; CORTICAL CATARACT; CIGARETTE-SMOKING; VISUAL-ACUITY; VITAMIN-E; MACULAR DEGENERATION	Context Statins are widely prescribed for their lipid-lowering effects but also have putative antioxidant properties. Oxidative stress is believed to play a role in the development of nuclear cataract, but little is known regarding the relationship of statin use and cataract incidence. Objective To evaluate the relationship of use of statins and incident cataract in adults in a midwestern community in the United States. Design, Setting, and Participants The Beaver Dam Eye Study, an observational, longitudinal, population-based study of age-related eye disease in Beaver Dam, Wis. There were 1299 persons who were seen at the third examination in 1998-2000, had gradable photographs in both eyes, and were deemed to be at risk of developing nuclear cataract within 5 years. Main Outcome Measure Five-year incidence of cataract with respect to statin use. Cataracts were graded from photographs taken through the participant's dilated pupil. Results A total of 210 persons developed incident nuclear cataract in the interval from 1998-2000 to 2003-2005. Five-year incidence of nuclear cataract was 12.2% in statin users compared with 17.2% in nonusers ( odds ratio [ OR], 0.55; 95% confidence interval [CI], 0.36-0.84), controlling for age. When only never smokers without diabetes were assessed, the age-, lipid level -, and sex-adjusted OR was 0.40 ( 95% CI, 0.18-0.90). Five-year incidence of cortical cataract was 9.9% in statin users and 7.5% in nonusers ( OR, 1.28; 95% CI, 0.79-2.08); posterior subcapsular cataract occurred in 3.0% of statin users and 3.4% of nonusers ( OR, 0.82; 95% CI, 0.39-1.71). Conclusion Statin use in a general population appears to be associated with lower risk of nuclear cataract, the most common type of age- related cataract.	Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison	Klein, BEK (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, 610 N Walnut St,4th Floor WARF, Madison, WI 53726 USA.	kleinb@epi.ophth.wisc.edu			NEI NIH HHS [EY06594] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; ALLAIN CC, 1974, CLIN CHEM, V20, P475; [Anonymous], [No title captured]; Behrens-Baumann W, 1990, Lens Eye Toxic Res, V7, P311; BERMAN ER, 1991, BIOCH EYE; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; GERSON RJ, 1990, EXP EYE RES, V50, P65, DOI 10.1016/0014-4835(90)90012-J; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; GUPTA PP, 1984, INDIAN J EXP BIOL, V22, P620; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; HARRIS ML, 1995, BRIT J OPHTHALMOL, V79, P996, DOI 10.1136/bjo.79.11.996; HEIBA IM, 1993, AM J MED GENET, V47, P1208, DOI 10.1002/ajmg.1320470816; HEIBA IM, 1995, INVEST OPHTH VIS SCI, V36, P227; HSU I, 1995, ANN PHARMACOTHER, V29, P743, DOI 10.1177/106002809502907-818; Iyengar SK, 2004, P NATL ACAD SCI USA, V101, P14485, DOI 10.1073/pnas.0400778101; JACQUES PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P337, DOI 10.1001/archopht.1988.01060130363022; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Klein AP, 2005, AM J EPIDEMIOL, V161, P707, DOI 10.1093/aje/kwi102; Klein B E, 1995, Ophthalmic Epidemiol, V2, P49, DOI 10.3109/09286589509071451; Klein BEK, 2006, AM J OPHTHALMOL, V141, P116, DOI 10.1016/j.ajo.2005.08.021; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; KLEIN BEK, 1995, AM J OPHTHALMOL, V119, P640, DOI 10.1016/S0002-9394(14)70223-5; KLEIN BEK, 1993, AM J PREV MED, V9, P27, DOI 10.1016/S0749-3797(18)30763-3; KLEIN BEK, 1995, DOC OPHTHALMOL, V88, P295; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P1151, DOI 10.1001/archopht.121.8.1151; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 1996, OPHTHALMOLOGY, V103, P1169, DOI 10.1016/S0161-6420(96)30526-5; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; KLEIN R, 1995, BEAVER DAM EYE STUDY, V2; KLEIN R, 1991, BEAVER DAM EYE STUDY; KORNZWEIG AL, 1977, ANN OPHTHALMOL, V9, P753; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P1113, DOI 10.1001/archopht.1995.01100090039020; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1; Leske MC, 1998, OPHTHALMOLOGY, V105, P831, DOI 10.1016/S0161-6420(98)95021-7; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Lyle BJ, 1999, AM J EPIDEMIOL, V149, P801, DOI 10.1093/oxfordjournals.aje.a009895; Lyle BJ, 1999, AM J CLIN NUTR, V69, P272; MARAINI G, 1991, AM J EPIDEMIOL, V133, P541; MARESPERLMAN JA, 1994, OPHTHALMOLOGY, V101, P315; MARESPERLMAN JA, 1995, INVEST OPHTH VIS SCI, V36, P276; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; ROSS WM, 1983, EXP EYE RES, V36, P645, DOI 10.1016/0014-4835(83)90102-1; Rowe N G, 2000, Ophthalmic Epidemiol, V7, P103; SAS Institute Inc, 2004, SAS STAT US GUID VER; Schmidt J, 1990, Lens Eye Toxic Res, V7, P643; Shishehbor MH, 2003, CIRCULATION, V108, P426, DOI 10.1161/01.CIR.0000080895.05158.8B; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Smeeth L, 2003, QJM-INT J MED, V96, P337, DOI 10.1093/qjmed/hcg064; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Stoll LL, 2004, DRUG TODAY, V40, P975, DOI 10.1358/dot.2004.40.12.872573; Stuve O, 2002, NEUROLOGIST, V8, P290, DOI 10.1097/01.nrl.0000031007.85777.18; URBAN RC, 1986, SURV OPHTHALMOL, V31, P102, DOI 10.1016/0039-6257(86)90077-9; VARMA SD, 1982, PHOTOCHEM PHOTOBIOL, V36, P623, DOI 10.1111/j.1751-1097.1982.tb09481.x; VARMA SD, 1991, AM J CLIN NUTR, V53, P335; VITALE S, 1993, EPIDEMIOLOGY, V4, P195, DOI 10.1097/00001648-199305000-00003; WEST S, 1989, ARCH OPHTHALMOL-CHIC, V107, P1166, DOI 10.1001/archopht.1989.01070020232031; YATA K, 1990, OPHTHALMIC RES, V22, P78, DOI 10.1159/000267071	64	62	66	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2752	2758		10.1001/jama.295.23.2752	http://dx.doi.org/10.1001/jama.295.23.2752			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16788130				2022-12-28	WOS:000238389700030
J	Harle, P; Schlottmann, K; Ehrenstein, BP; Fleck, M; Gluck, T; Herold, T; Schubert, TEO; Straub, RH; Scholmerich, J				Harle, Peter; Schlottmann, Klaus; Ehrenstein, Boris P.; Fleck, Martin; Gluck, Thomas; Herold, Thomas; Schubert, Thomas E. O.; Straub, Rainer H.; Schoelmerich, Juergen			A patient with arthritis, severe back pain, impaired wound healing, and perforated sigmoid colon	LANCET			English	Editorial Material									Univ Regensburg, Dept Internal Med 1, D-93042 Regensburg, Germany; Univ Regensburg, Inst Radiol, D-93042 Regensburg, Germany; Univ Regensburg, Dept Pathol, D-93042 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Harle, P (corresponding author), Univ Regensburg, Dept Internal Med 1, D-93042 Regensburg, Germany.	peter.haerle@klinik.uni-regensburg.de		Straub, Rainer H/0000-0003-1165-4555				Ganson NJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1861; Reinders MK, 2005, ANN RHEUM DIS, V64, P516; Schumacher HR, 2005, EXPERT OPIN INV DRUG, V14, P893, DOI 10.1517/13543784.14.7.893	3	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					2032	2032		10.1016/S0140-6736(06)68894-6	http://dx.doi.org/10.1016/S0140-6736(06)68894-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16782495				2022-12-28	WOS:000238488900039
J	Ashfold, MNR; Cronin, B; Devine, AL; Dixon, RN; Nix, MGD				Ashfold, MNR; Cronin, B; Devine, AL; Dixon, RN; Nix, MGD			The role of pi sigma* excited states in the photodissociation of heteroaromatic molecules	SCIENCE			English	Article							H ATOM ELIMINATION; HYDROGEN-TRANSFER; PHENOL; PYRROLE; SPECTROSCOPY; DYNAMICS; CLUSTERS; PHOTOCHEMISTRY; TRANSITIONS; SPECTRA	High-resolution measurements of the kinetic energies of hydrogen atom fragments formed during ultraviolet photolysis of imidazole, pyrrole, and phenol in the gas phase confirm that N(O)-H bond fission is an important nonradiative decay process from their respective (1)pi sigma* excited states. The measurements also reveal that the respective cofragments ( imidazolyl, pyrrolyl, and phenoxyl) are formed in very limited subsets of their available vibrational states. Identification of these product states yields uniquely detailed insights into the vibronic couplings involved in the photoinduced evolution from parent molecule to ultimate fragments.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Ashfold, MNR (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	mike.ashfold@bris.ac.uk	Nix, Michael/G-9447-2013	Nix, Michael/0000-0001-7228-7344; Cronin, Brid/0000-0002-3271-5145; ashfold, michael/0000-0001-5762-7048				BIST HD, 1967, J MOL SPECTROSC, V24, P413, DOI 10.1016/0022-2852(67)90105-1; BLANK DA, 1994, CHEM PHYS, V187, P35, DOI 10.1016/0301-0104(94)00230-4; Cronin B, 2004, PHYS CHEM CHEM PHYS, V6, P5031, DOI 10.1039/b411589a; Daigoku K, 2003, J CHEM PHYS, V119, P5149, DOI 10.1063/1.1597492; FRISCH MJ, 2003, EQUILIBRIUM STRUCTUR; Gianola AJ, 2005, J PHYS CHEM A, V109, P11504, DOI 10.1021/jp053566o; Ishiuchi S, 2002, J CHEM PHYS, V117, P7077, DOI 10.1063/1.1508103; KIMURA K, 1965, MOL PHYS, V9, P117, DOI 10.1080/00268976500100141; Lan ZG, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1906218; LIPERT RJ, 1989, J PHYS CHEM-US, V93, P135, DOI 10.1021/j100338a030; LORENTZON J, 1995, THEOR CHIM ACTA, V91, P91; Ratzer C, 2002, CHEM PHYS, V283, P153, DOI 10.1016/S0301-0104(02)00591-8; Roos BO, 2002, J CHEM PHYS, V116, P7526, DOI 10.1063/1.1465406; SCHNIEDER L, 1990, J CHEM PHYS, V92, P7027, DOI 10.1063/1.458243; SerranoAndres L, 1996, J PHYS CHEM-US, V100, P6484, DOI 10.1021/jp952809h; Sobolewski AL, 2002, PHYS CHEM CHEM PHYS, V4, P1093, DOI 10.1039/b110941n; Sobolewski AL, 2001, J PHYS CHEM A, V105, P9275, DOI 10.1021/jp011260l; SUR A, 1986, J CHEM PHYS, V84, P1206, DOI 10.1063/1.450512; Tseng CM, 2004, J CHEM PHYS, V121, P2459, DOI 10.1063/1.1781153; Wei J, 2004, FARADAY DISCUSS, V127, P267, DOI 10.1039/b403191c; Wei J, 2003, PHYS CHEM CHEM PHYS, V5, P315, DOI 10.1039/b208132f; ZARE RN, 1988, ANGULAR MOMENTUM	22	313	313	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1637	1640		10.1126/science.1125436	http://dx.doi.org/10.1126/science.1125436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778052				2022-12-28	WOS:000238288600041
J	Stuber, N; Forster, P; Radel, G; Shine, K				Stuber, N; Forster, P; Radel, G; Shine, K			The importance of the diurnal and annual cycle of air traffic for contrail radiative forcing	NATURE			English	Article							UPPER TROPOSPHERE; CIRRUS CLOUDS; PARAMETERIZATION; STRATOSPHERE; HUMIDITY; AVIATION; IMPACTS	Air traffic condensation trails, or contrails, are believed to have a net atmospheric warming effect(1), although one that is currently small compared to that induced by other sources of human emissions. However, the comparably large growth rate of air traffic requires an improved understanding of the resulting impact of aircraft radiative forcing on climate(2). Contrails have an effect on the Earth's energy balance similar to that of high thin ice clouds(3). Their trapping of outgoing longwave radiation emitted by the Earth and atmosphere (positive radiative forcing) is partly compensated by their reflection of incoming solar radiation (negative radiative forcing). On average, the longwave effect dominates and the net contrail radiative forcing is believed to be positive(1,2,4). Over daily and annual timescales, varying levels of air traffic, meteorological conditions, and solar insolation influence the net forcing effect of contrails. Here we determine the factors most important for contrail climate forcing using a sophisticated radiative transfer model(5,6) for a site in southeast England, located in the entrance to the North Atlantic flight corridor. We find that night-time flights during winter (December to February) are responsible for most of the contrail radiative forcing. Night flights account for only 25 per cent of daily air traffic, but contribute 60 to 80 per cent of the contrail forcing. Further, winter flights account for only 22 per cent of annual air traffic, but contribute half of the annual mean forcing. These results suggest that flight rescheduling could help to minimize the climate impact of aviation.	Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England	University of Reading	Stuber, N (corresponding author), Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England.	n.stuber@reading.ac.uk	Forster, Piers M/F-9829-2010; Shine, Keith P/D-9093-2012	Forster, Piers M/0000-0002-6078-0171; Shine, Keith P/0000-0003-2672-9978				Appleman H., 1953, B AM METEOROL SOC, V34, P14, DOI [10.1175/1520-0477-34.1.14, DOI 10.1175/1520-0477-34.1.14]; BAKAN S, 1994, ANN GEOPHYS-ATM HYDR, V12, P962, DOI 10.1007/s00585-994-0962-y; Detwiler A., 1984, J WEA MOD, V16, P46; Eyers C J, 2004, AERO2K GLOBAL AVIATI; FU Q, 1993, J ATMOS SCI, V50, P2008, DOI 10.1175/1520-0469(1993)050<2008:POTRPO>2.0.CO;2; FU Q, 1992, J ATMOS SCI, V49, P2139, DOI 10.1175/1520-0469(1992)049<2139:OTCDMF>2.0.CO;2; Gierens K, 2000, ANN GEOPHYS-ATM HYDR, V18, P499, DOI 10.1007/s00585-000-0499-7; Gierens K, 1999, ANN GEOPHYS-ATM HYDR, V17, P1218, DOI 10.1007/s00585-999-1218-7; Gierens KM, 1996, J ATMOS SCI, V53, P3333, DOI 10.1175/1520-0469(1996)053<3333:NSOPC>2.0.CO;2; HARTMANN DL, 1992, J CLIMATE, V5, P1281, DOI 10.1175/1520-0442(1992)005<1281:TEOCTO>2.0.CO;2; Jensen EJ, 1998, J GEOPHYS RES-ATMOS, V103, P3929, DOI 10.1029/97JD02808; Kley D., 2000, SPARC ASSESSMENT UPP; Lister D, 1999, AVIATION GLOBAL ATMO; Mannstein H, 1999, INT J REMOTE SENS, V20, P1641, DOI 10.1080/014311699212650; Marquart S, 2003, J CLIMATE, V16, P2890, DOI 10.1175/1520-0442(2003)016<2890:FDOCCO>2.0.CO;2; Meyer R, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000426; Minnis P, 1999, GEOPHYS RES LETT, V26, P1853, DOI 10.1029/1999GL900358; Myhre G, 2001, GEOPHYS RES LETT, V28, P3119, DOI 10.1029/2001GL013193; Ponater M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000429; ROSSOW WB, 1988, 266 WMOTD WORLD CLIM; Sausen R, 2005, METEOROL Z, V14, P555, DOI 10.1127/0941-2948/2005/0049; SAUSEN R, 1996, 9613 DLR; Schmidt E., 1941, SCHRIFTEN DTSCH AKAD, V44, P1; Schumann U, 2000, AEROSP SCI TECHNOL, V4, P391, DOI 10.1016/S1270-9638(00)01062-2; SCHUMANN U, 1994, ANN GEOPHYS, V12, P365, DOI 10.1007/s00585-994-0365-0; Schumann U., 1996, Meteorologische Zeitschrift, V5, P4; Stephenson DB, 2000, WEATHER FORECAST, V15, P221, DOI 10.1175/1520-0434(2000)015<0221:UOTORF>2.0.CO;2; Strauss B, 1997, ANN GEOPHYS-ATM HYDR, V15, P1457, DOI 10.1007/s00585-997-1457-4; Wang JH, 2002, J ATMOS OCEAN TECH, V19, P981, DOI 10.1175/1520-0426(2002)019<0981:COHMEF>2.0.CO;2; Williams V, 2005, TRANSPORT RES D-TR E, V10, P269, DOI 10.1016/j.trd.2005.04.003	30	68	69	5	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2006	441	7095					864	867		10.1038/nature04877	http://dx.doi.org/10.1038/nature04877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778887				2022-12-28	WOS:000238254100040
J	Shmerling, RH				Shmerling, Robert H.			An 81-year-old woman with temporal arteritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GIANT-CELL ARTERITIS; PLACEBO-CONTROLLED TRIAL; LARGE-VESSEL VASCULITIS; POLYMYALGIA-RHEUMATICA; CORTICOSTEROID TREATMENT; GLUCOCORTICOID THERAPY; INITIAL TREATMENT; DOUBLE-BLIND; VISUAL-LOSS; BIOPSY		Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Shmerling, RH (corresponding author), Beth Israel Deaconess Med Ctr, Div Rheumatol, 110 Francis St,Suite 4B, Boston, MA 02215 USA.	rshmerli@bidmc.harvard.edu		Shmerling, Robert/0000-0001-7560-1589				ACHKAR AA, 1994, ANN INTERN MED, V120, P987, DOI 10.7326/0003-4819-120-12-199406150-00003; AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550; Bhatti MT, 2001, DERMATOL SURG, V27, P15, DOI 10.1046/j.1524-4725.2001.00258.x; Bley TA, 2005, AM J ROENTGENOL, V184, P283, DOI 10.2214/ajr.184.1.01840283; Bongartz T, 2006, CURR OPIN RHEUMATOL, V18, P10, DOI 10.1097/01.bor.0000197996.04709.4e; Boyev LR, 1999, AM J OPHTHALMOL, V128, P211, DOI 10.1016/S0002-9394(99)00101-4; Brodmann M, 2004, RHEUMATOLOGY, V43, P241, DOI 10.1093/rheumatology/keh025; BUCHBINDER R, 1992, J RHEUMATOL, V19, P1220; Buckley L, 2001, ARTHRITIS RHEUM, V44, P1496; Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y; Evans RW, 2001, MED CLIN N AM, V85, P865, DOI 10.1016/S0025-7125(05)70348-5; Foroozan R, 2003, OPHTHALMOLOGY, V110, P539, DOI 10.1016/S0161-6420(02)01775-X; Frauman AG, 1996, ADVERSE DRUG REACT T, V15, P203; Gabriel SE, 1999, ARTHRITIS RHEUM, V42, P1255, DOI 10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P; Genereau T, 1999, ARTHRITIS RHEUM, V42, P2674, DOI 10.1002/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A; Gonzalez-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z; Goronzy JJ, 2002, CLEV CLIN J MED, V69, P91, DOI 10.3949/ccjm.69.Suppl_2.SII91; Hachulla E, 2001, CLIN EXP RHEUMATOL, V19, P171; Hall JK, 2003, OPHTHALMOLOGY, V110, P543, DOI 10.1016/S0161-6420(02)01758-X; HALL S, 1983, LANCET, V2, P1217; HAZLEMAN BL, 2003, RHEUMATOLOGY, P1623; HEALEY LA, 1991, BAILLIERE CLIN RHEUM, V5, P371, DOI 10.1016/S0950-3579(05)80059-7; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; Horton BM., 1932, PROC STAFF MEET MAYO, V7, P700; Horton BT, 1934, ARCH INTERN MED, V53, P400, DOI 10.1001/archinte.1934.00160090077007; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Hwang JM, 1999, AM J OPHTHALMOL, V127, P102, DOI 10.1016/S0002-9394(98)00313-4; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Karassa FB, 2005, ANN INTERN MED, V142, P359, DOI 10.7326/0003-4819-142-5-200503010-00011; KYLE V, 1993, ANN RHEUM DIS, V52, P847, DOI 10.1136/ard.52.12.847; Levin Morris, 2005, Curr Pain Headache Rep, V9, P259, DOI 10.1007/s11916-005-0033-4; MAKRUPA W, 2005, CLIN IMMUNOL, V15, P38; Mazlumzadeh M, 2004, ARTHRITIS RHEUM, V50, pS269; MILLER A, 1983, BRIT MED J, V286, P266, DOI 10.1136/bmj.286.6361.266; Myklebust G, 1996, BRIT J RHEUMATOL, V35, P1161; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Nordborg E, 2003, RHEUMATOLOGY, V42, P413, DOI 10.1093/rheumatology/keg116; PASCUAL J, 1994, J NEUROL NEUROSUR PS, V57, P1255, DOI 10.1136/jnnp.57.10.1255; Poller DN, 2000, J CLIN PATHOL, V53, P137, DOI 10.1136/jcp.53.2.137; Powers JF, 2005, AM J CLIN PATHOL, V123, P261, DOI 10.1309/2996TT2CTLTKN0KT; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; Rao JK, 1998, ANN INTERN MED, V129, P345, DOI 10.7326/0003-4819-129-5-199809010-00001; Rimenti G, 2000, J RHEUMATOL, V27, P2718; Sailler L, 2001, REV MED INTERNE, V22, P1032, DOI 10.1016/S0248-8663(01)00468-4; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P293, DOI 10.1002/art.21075; Salvarani C, 2004, ARTHRIT RHEUM-ARTHR, V51, P264, DOI 10.1002/art.20227; Salvarani C, 2003, CLIN EXP RHEUMATOL, V21, pS23; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; SCOTT KR, 1991, OPHTHALMIC SURG LAS, V22, P519; Seo P, 2004, ARTHRIT RHEUM-ARTHR, V51, P128, DOI 10.1002/art.20083; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; Taylor-Gjevre R, 2005, J RHEUMATOL, V32, P1279; Weyand CM, 2003, ANN INTERN MED, V139, P505, DOI 10.7326/0003-4819-139-6-200309160-00015; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Weyand CM, 2002, CLEV CLIN J MED, V69, P28; Younge BR, 2004, MAYO CLIN PROC, V79, P483, DOI 10.4065/79.4.483	56	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2525	2534		10.1001/jama.295.21.2525	http://dx.doi.org/10.1001/jama.295.21.2525			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZQ	16757725				2022-12-28	WOS:000238057300028
J	Lasorella, A; Stegmuller, J; Guardavaccaro, D; Liu, GC; Carro, MS; Rothschild, G; de la Torre-Ubieta, L; Pagano, M; Bonni, A; Iavarone, A				Lasorella, Anna; Stegmueller, Judith; Guardavaccaro, Daniele; Liu, Guangchao; Carro, Maria S.; Rothschild, Gerson; de la Torre-Ubieta, Luis; Pagano, Michele; Bonni, Azad; Iavarone, Antonio			Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth	NATURE			English	Article							PROTEINS; DIFFERENTIATION; PROLIFERATION; REGULATOR; CDH1-APC; FAMILY; ROLES	In the developing nervous system, Id2 ( inhibitor of DNA binding 2, also known as inhibitor of differentiation 2) enhances cell proliferation, promotes tumour progression and inhibits the activity of neurogenic basic helix - loop - helix ( bHLH) transcription factors(1,2). The anaphase promoting complex/cyclosome and its activator Cdh1 (APC/C-Cdh1) restrains axonal growth but the targets of APC/C-Cdh1 in neurons are unknown(3-5). Id2 and other members of the Id family are very unstable proteins that are eliminated as cells enter the quiescent state, but how they are targeted for degradation has remained elusive(6,7). Here we show that Id2 interacts with the core subunits of APC/C and Cdh1 in primary neurons. APC/C-Cdh1 targets Id2 for degradation through a destruction box motif ( D box) that is conserved in Id1 and Id4. Depletion of Cdh1 stabilizes Id proteins in neurons, whereas Id2 D-box mutants are impaired for Cdh1 binding and remain stable in cells that exit from the cell cycle and contain active APC/C-Cdh1. Mutants of the Id2 D box enhance axonal growth in cerebellar granule neurons in vitro and in the context of the cerebellar cortex, and overcome the myelin inhibitory signals for growth. Conversely, activation of bHLH transcription factors induces a cluster of genes with potent axonal inhibitory functions including the gene coding for the Nogo receptor, a key transducer of myelin inhibition. Degradation of Id2 in neurons permits the accumulation of the Nogo receptor, thereby linking APC/C-Cdh1 activity with bHLH target genes for the inhibition of axonal growth. These findings indicate that deregulated Id activity might be useful to reprogramme quiescent neurons into the axonal growth mode.	Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; NYU, Sch Med, NYU Canc Inst, Dept Pathol, New York, NY 10016 USA	Columbia University; Columbia University; Columbia University; Columbia University; Harvard University; Harvard Medical School; New York University	Iavarone, A (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA.	ai2102@columbia.edu	Stella, Maria Stella/GVS-1585-2022	Guardavaccaro, Daniele/0000-0002-4517-1765; de la Torre-Ubieta, Luis/0000-0001-8059-6243; pagano, michele/0000-0003-3210-2442; Carro, Maria Stella/0000-0002-8570-7691; Iavarone, Antonio/0000-0002-0683-4634				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Baghdoyan S, 2005, J BIOL CHEM, V280, P15836, DOI 10.1074/jbc.M414216200; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Chaudhary J, 2005, BIOL REPROD, V72, P1205, DOI 10.1095/biolreprod.104.035717; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Fiore R, 2003, FRONT BIOSCI-LANDMRK, V8, pS484, DOI 10.2741/1080; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Iavarone A, 2004, CANCER LETT, V204, P189, DOI 10.1016/S0304-3835(03)00455-5; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Lasorella A, 2002, CANCER RES, V62, P301; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Stegmuller J, 2005, TRENDS NEUROSCI, V28, P596, DOI 10.1016/j.tins.2005.09.003; Wainwright LJ, 2001, P NATL ACAD SCI USA, V98, P9396, DOI 10.1073/pnas.161288698; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	26	221	232	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					471	474		10.1038/nature04895	http://dx.doi.org/10.1038/nature04895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16810178				2022-12-28	WOS:000239278900047
J	Lau, NC; Seto, AG; Kim, J; Kuramochi-Miyagawa, S; Nakano, T; Bartel, DP; Kingston, RE				Lau, Nelson C.; Seto, Anita G.; Kim, Jinkuk; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Bartel, David P.; Kingston, Robert E.			Characterization of the piRNA complex from rat testes	SCIENCE			English	Article							SMALL RNAS; DROSOPHILA; PIWI; GENE; DNA; SPERMATOGENESIS; HETEROCHROMATIN; MAINTENANCE; METHYLATION; TETRAHYMENA	Small noncoding RNAs regulate processes essential for cell growth and development, including mRNA degradation, translational repression, and transcriptional gene silencing (TGS). During a search for candidate mammalian factors for TGS, we purified a complex that contains small RNAs and Riwi, the rat homolog to human Piwi. The RNAs, frequently 29 to 30 nucleotides in length, are called Piwi-interacting RNAs (piRNAs), 94% of which map to 100 defined (<= 101 kb) genomic regions. Within these regions, the piRNAs generally distribute across only one genomic strand or distribute on two strands but in a divergent, nonoverlapping manner. Preparations of piRNA complex ( piRC) contain rRecQ1, which is homologous to qde-3 from Neurospora, a gene implicated in silencing pathways. Piwi has been genetically linked to TGS in flies, and slicer activity cofractionates with the purified complex. These results are consistent with a gene-silencing role for piRC in mammals.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Osaka Univ, Microbial Dis Res Inst, Dept Mol Cell Biol, Suita, Osaka 5650871, Japan; MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Osaka University; Massachusetts Institute of Technology (MIT)	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu	Kim, Jinkuk/AAJ-1999-2020	Lau, Nelson/0000-0001-9907-1404				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	26	703	778	7	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					363	367		10.1126/science.1130164	http://dx.doi.org/10.1126/science.1130164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16778019				2022-12-28	WOS:000239154300048
J	Girard, A; Sachidanandam, R; Hannon, GJ; Carmell, MA				Girard, Angelique; Sachidanandam, Ravi; Hannon, Gregory J.; Carmell, Michelle A.			A germline-specific class of small RNAs binds mammalian Piwi proteins	NATURE			English	Article							DOUBLE-STRANDED-RNA; STEM-CELLS; DROSOPHILA; GENE; SPERMATOGENESIS; INTERFERENCE; MECHANISMS; MACHINERY; DIVISION; ENCODES	Small RNAs associate with Argonaute proteins and serve as sequence-specific guides to regulate messenger RNA stability, protein synthesis, chromatin organization and genome structure(1-3). In animals, Argonaute proteins segregate into two subfamilies(4). The Argonaute subfamily acts in RNA interference and in microRNA-mediated gene regulation using 21 - 22-nucleotide RNAs as guides. The Piwi subfamily is involved in germline-specific events such as germline stem cell maintenance and meiosis. However, neither the biochemical function of Piwi proteins nor the nature of their small RNA guides is known. Here we show that MIWI, a murine Piwi protein, binds a previously uncharacterized class of similar to 29-30-nucleotide RNAs that are highly abundant in testes. We have therefore named these Piwi-interacting RNAs (piRNAs). piRNAs show distinctive localization patterns in the genome, being predominantly grouped into 20-90-kilobase clusters, wherein long stretches of small RNAs are derived from only one strand. Similar piRNAs are also found in human and rat, with major clusters occurring in syntenic locations. Although their function must still be resolved, the abundance of piRNAs in germline cells and the male sterility of Miwi mutants suggest a role in gametogenesis.	Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Ecole Natl Super Mines, F-75272 Paris, France	Cold Spring Harbor Laboratory; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Hannon, GJ (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	sachidanandam, ravi/Q-6916-2019; Hannon, Gregory/AAB-3568-2019	sachidanandam, ravi/0000-0001-9844-4459; 				Ambros Victor, 2004, Methods Mol Biol, V265, P131; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lin HF, 1997, DEVELOPMENT, V124, P2463; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; VAGIN VV, 2004, RNA BIOL, V1, P51; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102	25	1166	1280	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					199	202		10.1038/nature04917	http://dx.doi.org/10.1038/nature04917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16751776				2022-12-28	WOS:000238979700047
J	Iglehart, JK				Iglehart, JK			The new era of medical imaging - Progress and pitfalls	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOSPITALS; SPECIALTY; QUALITY											ABELSON R, 2004, NY TIMES        0718, pBU1; ABELSON R, 2004, NY TIMES        1101, pA1; ARMSTRONG D, 2005, WALL STREET J   1212, pA1; Brickner ME, 2000, NEW ENGL J MED, V342, P988; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fuchs VR, 2001, HEALTH AFFAIR, V20, P30, DOI 10.1377/hlthaff.20.5.30; FUHRMANS V, 2005, WALL ST J       0818, pD1; GOLDSTEIN J, 2005, PHILADELPHIA IN 0819, pA1; Greenwald L, 2006, HEALTH AFFAIR, V25, P106, DOI 10.1377/hlthaff.25.1.106; GULLO K, 2005, WALL STREET J   1014; Guterman S, 2006, HEALTH AFFAIR, V25, P95, DOI 10.1377/hlthaff.25.1.95; HADLEY J, 2005, HLTH AFF MILLWOOD S3, V24; Iglehart JK, 2005, NEW ENGL J MED, V352, P638; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Kouri BE, 2002, AM J ROENTGENOL, V179, P843, DOI 10.2214/ajr.179.4.1790843; Levin David C, 2004, J Am Coll Radiol, V1, P169, DOI 10.1016/j.jacr.2003.12.009; LEVIN DC, 2004, NY TIMES        0706, pA19; *MED PAYM ADV COMM, 2003, REP C VAR INN MED; *MED PAYM ADV COMM, 2006, REP C MED PAYM POL; Medicare Payment Advisory Commission, 2005, REP C ISS MOD MED PR; Medicare Payment Advisory Committee, 2005, REP C MED PAYM POL; MITCHELL JM, 2005, HLTH AFF MILLWOOD S3, V24; Morgan Dan, 2000, WASH POST, pA1; Pham HH, 2004, HEALTH AFFAIR, V23, P70, DOI 10.1377/hlthaff.23.2.70; Raman SS, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781319; Stensland J, 2006, HEALTH AFFAIR, V25, P119, DOI 10.1377/hlthaff.25.1.119; *TIB GROUP, 2003, SPEC REP IM RAC; VANDEWATER J, 2004, ST LOUIS POST D 0925, pA11; 2000, N ENGL J MED, V342, P448; 2000, N ENGL J MED, V342, P42	30	190	191	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2822	2828		10.1056/NEJMhpr061219	http://dx.doi.org/10.1056/NEJMhpr061219			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807422				2022-12-28	WOS:000238584700014
J	Sosnay, PR; Kim, S				Sosnay, PR; Kim, S			Hypothyroid-induced hyporeflexia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Sosnay, PR (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					E27	E27		10.1056/NEJMicm050622	http://dx.doi.org/10.1056/NEJMicm050622			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807409				2022-12-28	WOS:000238584700009
J	Hewitt, CE; Torgerson, DJ				Hewitt, Catherine E.; Torgerson, David J.			Research methods - Is restricted randomisation necessary?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED TRIAL; CLINICAL-TRIALS; ALLOCATION; PHYSIOTHERAPY; MINIMIZATION; MULTICENTER; PATIENT		Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England	University of York - UK	Torgerson, DJ (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England.	djt6@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Hewitt, Catherine Elizabeth/0000-0002-0415-3536				Altman DG, 2000, LANCET, V356, P1521, DOI 10.1016/S0140-6736(05)73268-2; Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Brown S, 2005, STAT MED, V24, P3715, DOI 10.1002/sim.2391; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3; GRIZZLE JE, 1982, CONTROL CLIN TRIALS, V3, P365, DOI 10.1016/0197-2456(82)90026-5; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Kennedy A, 1997, CONTROL CLIN TRIA S3, V18, pS77; Kinley H, 2002, BRIT MED J, V325, P1323, DOI 10.1136/bmj.325.7376.1323; Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO;2-6; MacArthur C, 2001, LANCET, V358, P19; Macfarlane J, 2002, BRIT MED J, V324, P91, DOI 10.1136/bmj.324.7329.91; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rosenberger WF, 2002, RANDOMIZATION CLIN T; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456, DOI DOI 10.1001/JAMA.1995.03530180050029; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115	32	52	52	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1506	1508B		10.1136/bmj.332.7556.1506	http://dx.doi.org/10.1136/bmj.332.7556.1506			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793819	Green Published			2022-12-28	WOS:000238820200026
J	Inojosa, WO; Augusto, I; Bisoffi, Z; Josenado, T; Abel, PM; Stich, A; Whitty, CJM				Inojosa, Walter O.; Augusto, Inacio; Bisoffi, Zeno; Josenado, Teofile; Abel, Paolo M.; Stich, August; Whitty, Christopher J. M.			Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SLEEPING SICKNESS CONTROL; BRUCEI-GAMBIENSE; CATT	Objective To assess the operational feasibility of detecting human African trypanosomiasis by active and passive case finding using the card agglutination test with serial dilution of serum to guide treatment. Setting Trypanosomiasis control programme in the Negage focus, northern Angola, during a period of civil war. Design Observational study. Participants 359 patients presenting themselves to health centres with symptoms (passive case finding) and 14 446 people actively screened in villages. Main outcome measures Whole blood and serological tests at different dilutions using the card agglutination test, and detection of parasites by microscopy. Results Active case finding identified 251 people with a positive card agglutination test result, 10 of whom had confirmed parasites. In those presenting for investigation 34 of 51 with a positive card agglutination test result at the dilution of 1:8 or more used to guide treatment had parasites in blood, lymph node fluid, or cerebrospinal fluid compared with 10 of 76 in those detected by active case finding: positive predictive values of 67% for passive case detection and 13% for active case detection. Only at a cut-off dilution of more than 1:32 was the positive predictive value in active case detection reasonable (46%) and at this dilution 40% of microscopically proved cases were missed. Conclusions The card agglutination test is useful for initial screening in active detection of cases with human African trypanosomiasis but, given the toxicity of the drugs, serology using the card agglutination test should be not used alone to guide treatment after active case finding. A second confirmatory test is needed.	CUAMM Angola & Angotrip Project, Caritas, Luanda, Angola; Osped S Cuore, Ctr Malattie Trop, Verona, Italy; Minist Saude, Inst Combate Controlo Tripanossomoiases, Luanda, Angola; Mission Inst, Dept Trop Med & Epidem Control, Wurzburg, Germany; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1B 3DP, England	University of London; London School of Hygiene & Tropical Medicine	Inojosa, WO (corresponding author), Univ Catolica Mocambique Ponta, Gea Rua Marques Soveral,960 CP 821, Beira, Mozambique.	inojosawalter@hotmail.com	Bisoffi, Zeno/B-6438-2013; Whitty, Christopher/C-7740-2012	Bisoffi, Zeno/0000-0001-9530-8742; Whitty, Christopher/0000-0002-6076-5027				Abel PM, 2004, TROP MED INT HEALTH, V9, P141, DOI 10.1046/j.1365-3156.2003.01152.x; CATTAND P, 1988, B WORLD HEALTH ORGAN, V66, P83; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Garcia A, 2000, TROP MED INT HEALTH, V5, P786, DOI 10.1046/j.1365-3156.2000.00623.x; JHA TK, 1984, T ROY SOC TROP MED H, V78, P252, DOI 10.1016/0035-9203(84)90289-X; KEGELS G, 1992, ANN SOC BELG MED TR, V72, P271; Lejon V, 2003, LANCET INFECT DIS, V3, P804, DOI 10.1016/S1473-3099(03)00834-X; Lutumba P, 2005, TROP MED INT HEALTH, V10, P347, DOI 10.1111/j.1365-3156.2005.01391.x; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; NOIREAU F, 1988, T ROY SOC TROP MED H, V82, P237, DOI 10.1016/0035-9203(88)90430-0; Odiit M, 2004, ANN TROP MED PARASIT, V98, P339, DOI 10.1179/000349804225003389; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Pepin J, 2001, ADV PARASIT, V49, P71, DOI 10.1016/S0065-308X(01)49038-5; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; Stich A, 2002, BRIT MED J, V325, P203, DOI 10.1136/bmj.325.7357.203; Truc P, 2002, B WORLD HEALTH ORGAN, V80, P882; Van Meirvenne N., 1999, PROGR HUMAN AFRICAN; Van Nieuwenhove S., 1999, PROGR HUMAN AFRICAN; *WHO, 1983, TRYP CONTR MAN; WHO, 1998, CONTR SURV AFR TRYP, P881; Woo P. T. K., 1970, Acta trop., V27, P384	25	22	22	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1479	1481		10.1136/bmj.38859.531354.7C	http://dx.doi.org/10.1136/bmj.38859.531354.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16777858	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000238820200016
J	Riley, J; Ross, JR				Riley, J; Ross, JR			Reforming drug-control policy for palliative care in Romania	LANCET			English	Editorial Material									Royal Marsden Hosp Fdn Trust, Dept Palliat Med, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Riley, J (corresponding author), Royal Marsden Hosp Fdn Trust, Dept Palliat Med, London SW3 6JJ, England.	Julia.riley@rmh.nhs.uk						[Anonymous], 2000, ACH BAL NAT OP CONTR; *IARC, 2006, CANCERMONDIAL   0119; International Narcotics Control Board, 1996, REP INT NARC CONTR B; International Narcotics Control Board, 2005, REP INT NARC CONTR B; Mosoiu D, 2006, LANCET, V367, P2110, DOI 10.1016/S0140-6736(06)68482-1; Stewart B.W., 2003, WORLD CANC REPORT; *WHO, 2002, REG OFF EUR ASS AV O; World Health Organization, 1996, CANC PAIN REL; World Health Organization (WHO), 2005, ESS MED	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2040	2041		10.1016/S0140-6736(06)68483-3	http://dx.doi.org/10.1016/S0140-6736(06)68483-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798370				2022-12-28	WOS:000238657400007
J	Mitchell-Olds, T; Schmitt, J				Mitchell-Olds, Thomas; Schmitt, Johanna			Genetic mechanisms and evolutionary significance of natural variation in Arabidopsis	NATURE			English	Review							QUANTITATIVE TRAIT LOCUS; FLOWERING-TIME; POPULATION-GENETICS; BALANCING SELECTION; C ACTIVITY; THALIANA; POLYMORPHISM; FITNESS; FRIGIDA; RESISTANCE	Genomic studies of natural variation in model organisms provide a bridge between molecular analyses of gene function and evolutionary investigations of adaptation and natural selection. In the model plant species Arabidopsis thaliana, recent studies of natural variation have led to the identification of genes underlying ecologically important complex traits, and provided new insights about the processes of genome evolution, geographic population structure, and the selective mechanisms shaping complex trait variation in natural populations. These advances illustrate the potential for a new synthesis to elucidate mechanisms for the adaptive evolution of complex traits from nucleotide sequences to real-world environments.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Duke University; Brown University	Mitchell-Olds, T (corresponding author), Duke Univ, Dept Biol, POB 91000, Durham, NC 27708 USA.	tmo1@duke.edu	Bruening, Stefan/B-8505-2011; Mitchell-Olds, Thomas/K-8121-2012	Mitchell-Olds, Thomas/0000-0003-3439-9921				ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Bouche N, 2001, CURR OPIN PLANT BIOL, V4, P111, DOI 10.1016/S1369-5266(00)00145-X; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Callahan HS, 2005, NEW PHYTOL, V166, P129, DOI 10.1111/j.1469-8137.2005.01368.x; Callahan HS, 2002, ECOLOGY, V83, P1965, DOI 10.1890/0012-9658(2002)083[1965:SIPAIE]2.0.CO;2; Cork JM, 2005, GENETICS, V170, P1897, DOI 10.1534/genetics.104.036152; de Meaux J, 2005, PLANT CELL, V17, P676, DOI 10.1105/tpc.104.027839; DeCook R, 2006, GENETICS, V172, P1155, DOI 10.1534/genetics.105.042275; Dilda CL, 2002, GENETICS, V162, P1655; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Gachon CMM, 2005, PLANT MOL BIOL, V58, P229, DOI 10.1007/s11103-005-5346-5; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Hausmann NJ, 2005, EVOLUTION, V59, P81; Hoffmann MH, 2005, EVOLUTION, V59, P1425; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jorgensen S, 2004, MOL ECOL, V13, P3403, DOI 10.1111/j.1365-294X.2004.02329.x; Juenger TE, 2005, GENETICA, V123, P87, DOI 10.1007/s10709-003-2717-1; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kearsey MJ, 2003, HEREDITY, V91, P456, DOI 10.1038/sj.hdy.6800306; Kliebenstein DJ, 2006, GENETICS, V172, P1179, DOI 10.1534/genetics.105.049353; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Korves T, 2004, AM NAT, V163, P489, DOI 10.1086/382552; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Le Corre V, 2005, MOL ECOL, V14, P4181, DOI 10.1111/j.1365-294X.2005.02722.x; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Malmberg RL, 2005, GENETICS, V171, P2013, DOI 10.1534/genetics.105.046078; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mauricio R, 2003, GENETICS, V163, P735; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; PIGLIUCCI M, 2002, ARABIDOPSIS BOOK, DOI DOI 10.1199/TAB.0009; PLAGNOL V, 2005, GENETICS, V172, P2441; Puchta H, 2005, P NATL ACAD SCI USA, V102, P11961, DOI 10.1073/pnas.0505202102; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Siegal ML, 1996, GENETICS, V144, P715; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Stenoien HK, 2005, MOL ECOL, V14, P137, DOI 10.1111/j.1365-294X.2004.02359.x; Stenoien HK, 2002, AM J BOT, V89, P1604, DOI 10.3732/ajb.89.10.1604; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Syed NH, 2005, HEREDITY, V94, P295, DOI 10.1038/sj.hdy.6800558; THOMPSON L, 1994, J ECOL, V82, P63, DOI 10.2307/2261386; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; Ungerer MC, 2003, GENETICS, V165, P353; Verhoeven KJF, 2004, EVOLUTION, V58, P270, DOI 10.1111/j.0014-3820.2004.tb01644.x; WADE MJ, 1990, EVOLUTION, V44, P1947, DOI [10.2307/2409605, 10.1111/j.1558-5646.1990.tb04301.x]; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157; Weinig C, 2003, GENETICS, V165, P321; Weinreich DM, 2005, EVOLUTION, V59, P1165; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	75	304	319	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					947	952		10.1038/nature04878	http://dx.doi.org/10.1038/nature04878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791187				2022-12-28	WOS:000238422300034
J	Montan, S; Arulkumaran, S				Montan, Sven; Arulkumaran, Sabaratnam			Neonatal respiratory distress syndrome	LANCET			English	Editorial Material							ANTENATAL GLUCOCORTICOID TREATMENT; PREMATURE-INFANTS; CORTICOSTEROIDS; COURSES; EXPOSURE; SINGLE		Malmo Univ Hosp, Dept Obstet & Gynaecol, SE-20502 Malmo, Sweden; St George Hosp, Dept Obstet & Gynaecol, London, England	Lund University; Skane University Hospital; St Georges University London	Montan, S (corresponding author), Malmo Univ Hosp, Dept Obstet & Gynaecol, SE-20502 Malmo, Sweden.	sven.montan@skane.se						Baud O, 2004, ARCH DIS CHILD-FETAL, V89, P96, DOI 10.1136/adc.2003.028696; Baud O, 1999, NEW ENGL J MED, V341, P1190, DOI 10.1056/NEJM199910143411604; Burlet G, 2005, NEUROSCIENCE, V133, P221, DOI 10.1016/j.neuroscience.2005.01.018; CROWLEY P, 1996, COCHRANE DB SYST REV, V1; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; Davis EP, 2004, PSYCHONEUROENDOCRINO, V29, P1028, DOI 10.1016/j.psyneuen.2003.10.005; Figueras-Aloy J, 2005, AM J PERINAT, V22, P441, DOI 10.1055/s-2005-916332; Glover V, 2005, PEDIATR RES, V58, P1233, DOI 10.1203/01.pdr.0000185132.38209.73; Halliday HL, 2002, PEDIATRICS, V109, P1168, DOI 10.1542/peds.109.6.1168; Lee M, 2004, OBSTET GYNECOL, V103, P274, DOI 10.1097/01.AOG.0000110249.84858.90; Rotmensch S, 2005, FETAL DIAGN THER, V20, P371, DOI 10.1159/000086815; Spinillo A, 2004, AM J OBSTET GYNECOL, V191, P217, DOI 10.1016/j.ajog.2003.12.023; Stonestreet BS, 2004, J SOC GYNECOL INVEST, V11, P166, DOI 10.1016/j.jsgi.2003.10.006	13	10	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1878	1879		10.1016/S0140-6736(06)68820-X	http://dx.doi.org/10.1016/S0140-6736(06)68820-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765741				2022-12-28	WOS:000238194400005
J	Nylenna, M; Simonsen, S				Nylenna, Magne; Simonsen, Sigmund			Scientific misconduct: a new approach to prevention	LANCET			English	Editorial Material							INDIVIDUALS; MEDICINE		Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Nylenna, M (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7489 Trondheim, Norway.	magne.nylenna@helsebiblioteket.no						Charlton BG, 1995, J ROY SOC MED, V88, P607; Farthing M, 2000, LANCET, V356, P2030, DOI 10.1016/S0140-6736(00)03398-5; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Lock S, 2001, FRAUD MISCONDUCT BIO; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Parry J, 2006, BRIT MED J, V332, P67, DOI 10.1136/bmj.332.7533.67-a; ROSE G, 1990, BRIT MED J, V301, P1031, DOI 10.1136/bmj.301.6759.1031; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Rose G., 1992, STRATEGY PREVENTIVE	10	26	29	2	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1882	1884		10.1016/S0140-6736(06)68821-1	http://dx.doi.org/10.1016/S0140-6736(06)68821-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XG	16765743				2022-12-28	WOS:000238194400007
J	Pegrum, CM				Pegrum, Colin M.			Applied physics - Can a fraction of a quantum be better than a whole one?	SCIENCE			English	Editorial Material							JOSEPHSON-JUNCTIONS; FLUX-QUANTIZATION; PAIRING SYMMETRY		Univ Strathclyde, Dept Phys, Glasgow G4 0NG, Lanark, Scotland	University of Strathclyde	Pegrum, CM (corresponding author), Univ Strathclyde, Dept Phys, Glasgow G4 0NG, Lanark, Scotland.	colin@phys.strath.ac.uk						ANDERSON PW, 1963, PHYS REV LETT, V10, P230, DOI 10.1103/PhysRevLett.10.230; Baselmans JJA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224513; Blatter G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.174511; Brock DK, 2000, IEEE SPECTRUM, V37, P40, DOI 10.1109/6.887595; DEAVER BS, 1961, PHYS REV LETT, V7, P43, DOI 10.1103/PhysRevLett.7.43; DOLL R, 1961, PHYS REV LETT, V7, P51, DOI 10.1103/PhysRevLett.7.51; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Kirtley JR, 2002, PHYSICA C, V368, P55, DOI 10.1016/S0921-4534(01)01140-6; Kleiner R, 2004, P IEEE, V92, P1534, DOI 10.1109/JPROC.2004.833655; Krasnov VM, 2005, PHYSICA C, V418, P16, DOI 10.1016/j.physc.2004.11.004; Mukhanov OA, 2004, P IEEE, V92, P1564, DOI 10.1109/JPROC.2004.833660; Ortlepp T, 2006, SCIENCE, V312, P1495, DOI 10.1126/science.1126041; ROSA J, 2005, RF DESIGN, P40; Smilde HJH, 2002, APPL PHYS LETT, V80, P4579, DOI 10.1063/1.1485305; Tafuri F, 2004, PHYSICA C, V404, P367, DOI 10.1016/j.physc.2003.10.028; TSUEI CC, 1994, PHYS REV LETT, V73, P593, DOI 10.1103/PhysRevLett.73.593; van Harlingen DJ, 1999, PHYSICA C, V317, P410, DOI 10.1016/S0921-4534(99)00088-X	18	11	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1483	1484		10.1126/science.1128569	http://dx.doi.org/10.1126/science.1128569			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763139				2022-12-28	WOS:000238124100035
J	Bjork, A; Pitnick, S				Bjork, Adam; Pitnick, Scott			Intensity of sexual selection along the anisogamy-isogamy continuum	NATURE			English	Article							SPERM COMPETITION; EVOLUTION; SIZE; EJACULATE; TESTES; COST; LONG	Research into the evolution of giant sperm has uncovered a paradox within the foundations of sexual selection theory. Post-copulatory sexual selection on males ( that is, sperm competition and cryptic female choice) can lead to decreased sperm numbers by favouring the production of larger sperm(1). However, a decline in sperm numbers is predicted to weaken selection on males and increase selection on females(2,3). As isogamy is approached ( that is, as investment per gamete by males approaches that by females), sperm become less abundant, ova become relatively less rare, and competition between males for fertilization success is predicted to weaken. Sexual selection for longer sperm, therefore, is expected to be self limiting. Here we examine this paradox in Drosophila along the anisogamy-isogamy continuum using intraspecific experimental evolution techniques and interspecific comparative techniques. Our results confirm the big-sperm paradox by showing that the sex difference in sexual selection gradients(4) decreases as sperm size increases. However, a resolution to the paradox is provided when this finding is interpreted in concert with the 'opportunity for selection' and the 'opportunity for sexual selection'(5,6). Furthermore, we show that most of the variation in measures of selection intensity is explained by sperm length and relative investment in sperm production.	Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Bjork, A (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	acbjork@syr.edu		Bjork, Adam/0000-0001-7544-2987				Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Joly D., 1991, DROSOPHILA INFORMATI, V70, P104; Jones AG, 2004, AM NAT, V164, P444, DOI 10.1086/423826; Jones AG, 2000, P ROY SOC B-BIOL SCI, V267, P677, DOI 10.1098/rspb.2000.1055; Jones AG, 2002, P ROY SOC B-BIOL SCI, V269, P2533, DOI 10.1098/rspb.2002.2177; Karr TL, 1996, NATURE, V379, P405, DOI 10.1038/379405a0; Kokko H, 2003, TRENDS ECOL EVOL, V18, P103, DOI 10.1016/S0169-5347(03)00009-0; LaMunyon CW, 2002, P ROY SOC B-BIOL SCI, V269, P1125, DOI 10.1098/rspb.2002.1996; Lorch PD, 2002, AM NAT, V159, P645, DOI 10.1086/339992; MARKOW TA, 1992, J INSECT BEHAV, V5, P375, DOI 10.1007/BF01049845; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PITNICK S, 1995, NATURE, V375, P109, DOI 10.1038/375109a0; Pitnick S, 1997, EVOLUTION, V51, P833, DOI [10.2307/2411158, 10.1111/j.1558-5646.1997.tb03665.x]; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; PITNICK S, 1994, AM NAT, V143, P785, DOI 10.1086/285633; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; SHUSTER SM, 2003, MG BEH ECOL, pR7; Trivers R. L, 1972, SEXUAL SELECTION DES, P52; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2	29	84	85	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					742	745		10.1038/nature04683	http://dx.doi.org/10.1038/nature04683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760976	Green Published			2022-12-28	WOS:000238095100052
J	Horton, R				Horton, R			WHO: strengthening the road to renewal	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							ATTARAN A, 2006, LANCET          0425; Christian Aid, 2006, CLIM POV; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Lawn JE, 2006, LANCET, V367, P1541, DOI 10.1016/S0140-6736(06)68587-5; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; STEPHENS C, IN PRESS LANCET; 2006, LANCET, V367, P1704; 2005, UNESCO SCI REPORT 20	9	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1793	1795		10.1016/S0140-6736(06)68779-5	http://dx.doi.org/10.1016/S0140-6736(06)68779-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753466				2022-12-28	WOS:000238194200004
J	Shultis, DD; Purdy, MD; Banchs, CN; Wiener, MC				Shultis, David D.; Purdy, Michael D.; Banchs, Christian N.; Wiener, Michael C.			Outer membrane active transport: Structure of the BtuB : TonB complex	SCIENCE			English	Article							C-TERMINAL DOMAIN; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; IRON TRANSPORT; RECEPTOR; FHUA; REVEALS; GENE; PROTEINS	In Gram-negative bacteria, the import of essential micronutrients across the outer membrane requires a transporter, an electrochemical gradient of protons across the inner membrane, and an inner membrane protein complex (ExbB, ExbD, TonB) that couples the proton-motive force to the outer membrane transporter. The inner membrane protein TonB binds directly to a conserved region, called the Ton-box, of the transporter. We solved the structure of the cobalamin transporter BtuB in complex with the C-terminal domain of TonB. In contrast to its conformations in the absence of TonB, the Ton-box forms a beta strand that is recruited to the existing b sheet of TonB, which is consistent with a mechanical pulling model of transport.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Interdisciplinary Grad Program Biophys, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Wiener, MC (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	mwiener@virginia.edu			NIDDK NIH HHS [DK59999] Funding Source: Medline; NIGMS NIH HHS [GM00Z055] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059999] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Braun V, 2002, FEBS LETT, V529, P78, DOI 10.1016/S0014-5793(02)03185-X; Braun Volkmar, 2005, V12, P210, DOI 10.1159/000081697; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416; DeLano W.L, PYMOL MOL GRAPHICS S; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eisenhauer HA, 2005, J BIOL CHEM, V280, P30574, DOI 10.1074/jbc.M506708200; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Ghosh J, 2005, MOL MICROBIOL, V55, P276, DOI 10.1111/j.1365-2958.2004.04384.x; HELLER KJ, 1988, GENE, V64, P147, DOI 10.1016/0378-1119(88)90488-X; Howard SP, 2001, J BACTERIOL, V183, P5885, DOI 10.1128/JB.183.20.5885-5895.2001; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; Khursigara CM, 2004, J BIOL CHEM, V279, P7405, DOI 10.1074/jbc.M311784200; Klebba PE, 2003, FRONT BIOSCI, V8, pS1422, DOI 10.2741/1233; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; LUNDRIGAN MD, 1986, J BIOL CHEM, V261, P797; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Ogierman M, 2003, J BACTERIOL, V185, P1870, DOI 10.1128/JB.185.6.1870-1885.2003; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Sauter A, 2003, J BACTERIOL, V185, P5747, DOI 10.1128/JB.185.19.5747-5754.2003; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; TUCKMAN M, 1992, J BACTERIOL, V174, P320, DOI 10.1128/jb.174.1.320-323.1992; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7	31	226	234	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1396	1399		10.1126/science.1127694	http://dx.doi.org/10.1126/science.1127694			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741124				2022-12-28	WOS:000237961600060
J	Kamei, M; Saunders, WB; Bayless, KJ; Dye, L; Davis, GE; Weinstein, BM				Kamei, Makoto; Saunders, W. Brian; Bayless, Kayla J.; Dye, Louis; Davis, George E.; Weinstein, Brant M.			Endothelial tubes assemble from intracellular vacuoles in vivo	NATURE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; CAPILLARY LUMEN FORMATION; CELL MORPHOGENESIS; FIBRIN MATRICES; ZEBRAFISH; ANGIOGENESIS; MECHANISM; COLLAGEN; INTEGRIN; CAVEOLAE	The formation of epithelial tubes is crucial for the proper development of many different tissues and organs, and occurs by means of a variety of different mechanisms(1). Morphogenesis of seamless, properly patterned endothelial tubes is essential for the development of a functional vertebrate circulatory system, but the mechanism of vascular lumenization in vivo remains unclear. Evidence dating back more than 100 years has hinted at an important function for endothelial vacuoles in lumen formation(2). More than 25 years ago, in some of the first endothelial cell culture experiments in vitro, Folkman and Haudenschild described "longitudinal vacuoles" that "appeared to be extruded and connected from one cell to the next"(3,4), observations confirmed and extended by later studies in vitro showing that intracellular vacuoles arise from integrin-dependent and cdc42/Rac1-dependent pinocytic events downstream of integrin - extracellular-matrix signalling interactions(5-10). Despite compelling data supporting a model for the assembly of endothelial tubes in vitro through the formation and fusion of vacuoles, conclusive evidence in vivo has been lacking, primarily because of difficulties associated with imaging the dynamics of subcellular endothelial vacuoles deep within living animals. Here we use high-resolution time-lapse two-photon imaging of transgenic zebrafish to examine how endothelial tubes assemble in vivo, comparing our results with time-lapse imaging of human endothelial-cell tube formation in three-dimensional collagen matrices in vitro. Our results provide strong support for a model in which the formation and intracellular and intercellular fusion of endothelial vacuoles drives vascular lumen formation.	NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Microscopy & Imaging Core, NIH, Bethesda, MD 20892 USA; Texas A&M Univ Syst, Hlth Sci Ctr, Dept Pathol, College Stn, TX 77843 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Weinstein, BM (corresponding author), NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA.	bw96w@nih.gov		Kamei, Makoto/0000-0002-1438-0783	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001011] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001011] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2002, J CELL SCI, V115, P1123; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Childs S, 2002, DEVELOPMENT, V129, P973; Davis GE, 2000, IN VITRO CELL DEV-AN, V36, P513; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Downs KM, 2003, MICROCIRCULATION, V10, P5, DOI 10.1038/sj.mn.7800171; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kamei M, 2004, METHOD CELL BIOL, V76, P51; Kamei M, 2005, ZEBRAFISH, V2, P113, DOI 10.1089/zeb.2005.2.113; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Manning Gerards, 1993, P609; Paul SM, 2003, SCIENCE, V302, P2077, DOI 10.1126/science.1093203; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Weinstein BM, 2002, TRENDS CELL BIOL, V12, P439, DOI 10.1016/S0962-8924(02)02358-9; WESTERFIELD M, 1995, ZEBRAFISH BOOK	30	356	372	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					453	456		10.1038/nature04923	http://dx.doi.org/10.1038/nature04923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16799567				2022-12-28	WOS:000239278900043
J	Currie, GP; Douglas, JG				Currie, Graeme P.; Douglas, J. Graham			ABC of chronic obstructive pulmonary disease - Oxygen and inhalers	BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPY		Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland	University of Aberdeen	Currie, GP (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland.			Currie, Graeme P/0000-0002-5711-9147				[Anonymous], 1997, THORAX S5, V52, pS1; Bateman NT, 1998, BRIT MED J, V317, P798, DOI 10.1136/bmj.317.7161.798; Coker RK, 2002, THORAX, V57, P289; Lacasse Y, 2006, THORAX, V61, P374, DOI 10.1136/thx.2006.060749; Seccombe LM, 2004, THORAX, V59, P966, DOI 10.1136/thx.2004.022210; Stevenson NJ, 2004, THORAX, V59, P668, DOI 10.1136/thx.2003.014209	6	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 1	2006	333	7557					34	36		10.1136/bmj.333.7557.34	http://dx.doi.org/10.1136/bmj.333.7557.34			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16809712	Green Published			2022-12-28	WOS:000238922900029
J	Wormser, GP				Wormser, Gary P.			Early Lyme disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; CONFIRMED ERYTHEMA MIGRANS; BORRELIA-BURGDORFERI; AMBLYOMMA-AMERICANUM; ANTIBIOTIC-THERAPY; CONTROLLED TRIAL; DOUBLE-BLIND; DURATION; MANIFESTATIONS; DOXYCYCLINE		New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA	New York Medical College	Wormser, GP (corresponding author), New York Med Coll, Dept Med, Div Infect Dis, Rm 245,Munger Pavil, Valhalla, NY 10595 USA.	gary_wormser@nymc.edu	Hug, Balthasar L./G-1568-2010					AGGER WA, 1992, ANTIMICROB AGENTS CH, V36, P1788, DOI 10.1128/AAC.36.8.1788; Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Armstrong PM, 2001, B WORLD HEALTH ORGAN, V79, P916; Belongia EA, 1999, CLIN INFECT DIS, V29, P1472, DOI 10.1086/313532; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Dattwyler RJ, 1997, NEW ENGL J MED, V337, P289, DOI 10.1056/NEJM199707313370501; Eckman MH, 1997, NEW ENGL J MED, V337, P357, DOI 10.1056/NEJM199707313370525; ENGSTROM SM, 1995, J CLIN MICROBIOL, V33, P419, DOI 10.1128/JCM.33.2.419-427.1995; Falco RC, 1996, AM J EPIDEMIOL, V143, P187, DOI 10.1093/oxfordjournals.aje.a008728; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; FALCO RC, 2005, 10 INT C LYM BORR OT, P120; HANSEN K, 1992, ACTA DERM-VENEREOL, V72, P297; Hayes EB, 2003, NEW ENGL J MED, V348, P2424, DOI 10.1056/NEJMra021397; Johnson BJB, 1996, J INFECT DIS, V174, P346, DOI 10.1093/infdis/174.2.346; Kaplan RF, 2003, NEUROLOGY, V60, P1916, DOI 10.1212/01.WNL.0000068030.26992.25; Keirans JE, 1998, J PARASITOL, V84, P629, DOI 10.2307/3284739; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; NADELMAN RB, 1992, ANN INTERN MED, V117, P273, DOI 10.7326/0003-4819-117-4-273; NADELMAN RB, 1995, AM J MED, V98, pS15, DOI 10.1016/S0002-9343(99)80040-0; Nowakowski J, 2000, ARCH FAM MED, V9, P563, DOI 10.1001/archfami.9.6.563; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; O'Connell S, 1998, ZBL BAKT-INT J MED M, V287, P229, DOI 10.1016/S0934-8840(98)80124-2; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; PIESMAN J, 1991, J INFECT DIS, V163, P895, DOI 10.1093/infdis/163.4.895; RYDER JW, 1992, J MED ENTOMOL, V29, P525, DOI 10.1093/jmedent/29.3.525; SCHULZE TL, 1984, SCIENCE, V224, P601, DOI 10.1126/science.6710158; Schwartz I, 1997, NEW ENGL J MED, V337, P49, DOI 10.1056/NEJM199707033370111; Shapiro ED, 2005, INT J EPIDEMIOL, V34, P1437, DOI 10.1093/ije/dyi241; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Sood SK, 1997, J INFECT DIS, V175, P996, DOI 10.1086/514009; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Steere AC, 2003, AM J MED, V114, P58, DOI 10.1016/S0002-9343(02)01440-7; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; Steere AC, 2003, CLIN INFECT DIS, V36, P1078, DOI 10.1086/368187; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; Wormser GP, 2005, ANN INTERN MED, V142, P751, DOI 10.7326/0003-4819-142-9-200505030-00011; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Wormser GP, 2005, CLIN INFECT DIS, V41, P958, DOI 10.1086/432935; WORMSER GP, 2003, THERAPY INFECT DIS, P697; 2004, MMWR MORB MORTAL WKL, V53, P365; 1997, MMWR RECOMM REP, V46, P20	51	103	109	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2794	2801		10.1056/NEJMcp061181	http://dx.doi.org/10.1056/NEJMcp061181			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807416				2022-12-28	WOS:000238584700007
J	Mora, C; Andrefouet, S; Costello, MJ; Kranenburg, C; Rollo, A; Veron, J; Gaston, KJ; Myers, RA				Mora, Camilo; Andrefouet, Serge; Costello, Mark J.; Kranenburg, Christine; Rollo, Audrey; Veron, John; Gaston, Kevin J.; Myers, Ransom A.			Coral reefs and the global network of marine protected areas	SCIENCE			English	Editorial Material							POPULATIONS		Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand; Dalhousie Univ, Dept Biol Sci, Halifax, NS B4H 4J1, Canada; Inst Rech Dev, Noumea, New Caledonia; Univ S Florida, Inst Marine Remote Sensing, St Petersburg, FL 33701 USA; Australian Inst Marine Sci, Townsville, Qld 4810, Australia; Univ Sheffield, Biodivers & Macroecol Grp, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Auckland; Dalhousie University; Institut de Recherche pour le Developpement (IRD); State University System of Florida; University of South Florida; Australian Institute of Marine Science; University of Sheffield	Mora, C (corresponding author), Univ Auckland, Leigh Marine Lab, POB 349, Warkworth, New Zealand.	moracamilo@hotmail.com	Costello, Mark/C-9267-2013	Costello, Mark/0000-0003-2362-0328				Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2002, REEFS RISK SE ASIA; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shanks AL, 2003, ECOL APPL, V13, pS159; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Wilkinson C, 2004, STATUS CORAL REEF WO	13	328	334	11	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1750	1751		10.1126/science.1125295	http://dx.doi.org/10.1126/science.1125295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055LS	16794065				2022-12-28	WOS:000238452800039
J	Silva, J; Chambers, I; Pollard, S; Smith, A				Silva, Jose; Chambers, Ian; Pollard, Steven; Smith, Austin			Nanog promotes transfer of pluripotency after cell fusion	NATURE			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME; SOMATIC-CELLS; IN-VITRO; TERATOCARCINOMA; NUCLEI; MAINTENANCE; INITIATION	Through cell fusion, embryonic stem (ES) cells can erase the developmental programming of differentiated cell nuclei and impose pluripotency(1,2). Molecules that mediate this conversion should be identifiable in ES cells. One candidate is the variant homeodomain protein Nanog, which has the capacity to entrain undifferentiated ES cell propagation(3,4). Here we report that in fusions between ES cells and neural stem (NS) cells, increased levels of Nanog stimulate pluripotent gene activation from the somatic cell genome and enable an up to 200-fold increase in the recovery of hybrid colonies, all of which show ES cell characteristics. Nanog also improves hybrid yield when thymocytes or fibroblasts are fused to ES cells; however, fewer colonies are obtained than from ES x NS cell fusions, consistent with a hierarchical susceptibility to reprogramming among somatic cell types. Notably, for NS x ES cell fusions elevated Nanog enables primary hybrids to develop into ES cell colonies with identical frequency to homotypic ES x ES fusion products. This means that in hybrids, increased Nanog is sufficient for the NS cell epigenome to be reset completely to a state of pluripotency. We conclude that Nanog can orchestrate ES cell machinery to instate pluripotency with an efficiency of up to 100% depending on the differentiation status of the somatic cell.	Univ Edinburgh, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Cambridge, Inst Stem Cell Biol, Cambridge CB2 1QT, England	University of Edinburgh; University of Cambridge	Smith, A (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Edinburgh EH9 3JQ, Midlothian, Scotland.	austin.smith@ed.ac.uk	Silva, Jose/G-1920-2014; Silva, Jose C R/X-5140-2019; Chambers, Ian/H-5416-2011; Pollard, Steven/B-7966-2010	Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Chambers, Ian/0000-0003-2605-1597; Pollard, Steven/0000-0001-6428-0492; Smith, Austin/0000-0002-3029-4682	Medical Research Council [G0300058, G9806702] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish; MRC [G9806702, G0300058] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; BLELLOCH R, 2006, STEM CELLS      0518, DOI DOI 10.1634/STEMCELLS.2006.0050; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Matveeva NM, 1998, MOL REPROD DEV, V50, P128, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;128::AID-MRD2&gt;3.0.CO;2-M; MILLER RA, 1977, DEV BIOL, V56, P157, DOI 10.1016/0012-1606(77)90159-2; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Mountford P, 1998, REPROD FERT DEVELOP, V10, P527, DOI 10.1071/RD98087; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; POLLARD SM, IN PRESS CEREBRAL CO; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Yates A, 2005, BIOCHEM SOC T, V33, P1518, DOI 10.1042/BST0331518; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	28	272	317	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					997	1001		10.1038/nature04914	http://dx.doi.org/10.1038/nature04914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791199				2022-12-28	WOS:000238422300046
J	Stafford, N				Stafford, N			Angling Saxons	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					931	931		10.1038/441931a	http://dx.doi.org/10.1038/441931a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791170				2022-12-28	WOS:000238422300015
J	Mercer, J; Erickson-Owens, D				Mercer, Judith; Erickson-Owens, Debra			Delayed cord clamping increases infants' iron stores	LANCET			English	Editorial Material							PLACENTAL TRANSFUSION; CONTROLLED-TRIAL; 3RD STAGE; BLOOD; MANAGEMENT; LABOR		Univ Rhode Isl Coll, Coll Nursing, Kingston, RI 02881 USA	University of Rhode Island	Mercer, J (corresponding author), Univ Rhode Isl Coll, Coll Nursing, Kingston, RI 02881 USA.	jmercer@uri.edu						[Anonymous], 1999, Pediatrics, V104, P116; Chaparro CM, 2006, LANCET, V367, P1997, DOI 10.1016/S0140-6736(06)68889-2; Ende N, 2006, MED HYPOTHESES, V66, P1157, DOI 10.1016/j.mehy.2005.12.024; Grisaru D, 1999, AM J OBSTET GYNECOL, V180, P1240, DOI 10.1016/S0002-9378(99)70623-X; Mercer JS, 2006, PEDIATRICS, V117, P1235, DOI 10.1542/peds.2005-1706; PRENDIVILLE WJ, 1988, BMJ-BRIT MED J, V297, P1295, DOI 10.1136/bmj.297.6659.1295; Rabe H, 2004, COCHRANE DB SYST REV, V18, DOI [DOI 10.1002/14651858.CD003248.PUB2, 10.1002/14651858.CD003248.pub2]; Rogers J, 1998, LANCET, V351, P693, DOI 10.1016/S0140-6736(97)09409-9; Van Rheenen P, 2004, ANN TROP PAEDIATR, V24, P3, DOI 10.1179/027249304225013286; YAO AC, 1969, LANCET, V2, P505; YAO AC, 1968, LANCET, V1, P380	11	22	24	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					1956	1958		10.1016/S0140-6736(06)68858-2	http://dx.doi.org/10.1016/S0140-6736(06)68858-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16782466				2022-12-28	WOS:000238488900005
J	Tran, EJ; Wente, SR				Tran, Elizabeth J.; Wente, Susan R.			Dynamic nuclear pore complexes: Life on the edge	CELL			English	Review							MESSENGER-RNA EXPORT; VESICULAR STOMATITIS-VIRUS; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN IMPORT; NUCLEOPORIN NUP98; CRYOELECTRON TOMOGRAPHY; MOBILE NUCLEOPORIN; PROTEOMIC ANALYSIS; SUMO MODIFICATION; BINDING-PROTEINS	The exchange of molecules between the nucleus and cytoplasm is mediated through nuclear pore complexes (NPCs) embedded in the nuclear envelope. Altering the interactions between transport receptors and their cargo has been shown to be a major regulatory mechanism to control traffic through NPCs. New evidence now suggests that NPC proteins play active roles in translocation, and that transport is also controlled by dynamic changes in NPC composition and architecture. This view of ever-changing NPCs necessitates the re-evaluation of current models of nuclear transport and how this process is regulated.	Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Tran, EJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, U-3209 MRBIII,465 21st Ave S, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu	Tran, Elizabeth/G-7818-2018	Tran, Elizabeth/0000-0002-9541-004X	NCI NIH HHS [5T32CA009385] Funding Source: Medline; NIGMS NIH HHS [GM57438, 1F32GM075459-01, GM51219] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051219, R37GM051219, R01GM057438, F32GM075459] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Cai Y, 2002, MOL REPROD DEV, V61, P126, DOI 10.1002/mrd.1139; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Fan F, 1997, GENOMICS, V40, P444, DOI 10.1006/geno.1996.4557; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Mans BJ, 2004, CELL CYCLE, V3, P1612; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; MOORE PB, 1993, RIBOSOMES RNA WORLD; NEHRBASS U, 1993, EUR J CELL BIOL, V62, P1; Olsson M, 2004, EXP CELL RES, V292, P359, DOI 10.1016/j.yexcr.2003.09.014; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Patre M, 2006, J BIOL CHEM, V281, P1296, DOI 10.1074/jbc.M511717200; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Uv AE, 2000, GENE DEV, V14, P1945; Vassileva MT, 2004, MOL CELL BIOL, V24, P3623, DOI 10.1128/MCB.24.9.3623-3632.2004; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	79	394	401	2	47	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1041	1053		10.1016/j.cell.2006.05.027	http://dx.doi.org/10.1016/j.cell.2006.05.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777596	Bronze			2022-12-28	WOS:000238602700011
J	Canup, RM; Ward, WR				Canup, Robin M.; Ward, William R.			A common mass scaling for satellite systems of gaseous planets	NATURE			English	Article							DENSITY WAVES; 3-DIMENSIONAL INTERACTION; ORBITAL EVOLUTION; TILTING SATURN; GIANT PLANETS; SOLAR NEBULA; ACCRETION; DISK; JUPITER; PROTOPLANETS	The Solar System's outer planets that contain hydrogen gas all host systems of multiple moons, which notably each contain a similar fraction of their respective planet's mass (similar to 10(-4)). This mass fraction is two to three orders of magnitude smaller than that of the largest satellites of the solid planets (such as the Earth's Moon), and its common value for gas planets has been puzzling. Here we model satellite growth and loss as a forming giant planet accumulates gas and rock-ice solids from solar orbit. We find that the mass fraction of its satellite system is regulated to similar to 10(-4) by a balance of two competing processes: the supply of inflowing material to the satellites, and satellite loss through orbital decay driven by the gas. We show that the overall properties of the satellite systems of Jupiter, Saturn and Uranus arise naturally, and suggest that similar processes could limit the largest moons of extrasolar Jupiter-mass planets to Moon-to-Mars size.	SW Res Inst, Space Studies Dept, Boulder, CO 80302 USA		Canup, RM (corresponding author), SW Res Inst, Space Studies Dept, Boulder, CO 80302 USA.	robin@boulder.swri.edu		Canup, Robin/0000-0002-2342-3458				Agnor CB, 2006, NATURE, V441, P192, DOI 10.1038/nature04792; Alibert Y, 2005, ASTRON ASTROPHYS, V439, P1205, DOI 10.1051/0004-6361:20052841; Anderson JD, 2001, ICARUS, V153, P157, DOI 10.1006/icar.2001.6664; ARTYMOWICZ P, 1993, ASTROPHYS J, V419, P166, DOI 10.1086/173470; Barnes JW, 2002, ASTROPHYS J, V575, P1087, DOI 10.1086/341477; Brunini A, 2006, NATURE, V440, P1163, DOI 10.1038/nature04577; Burrows A, 2001, REV MOD PHYS, V73, P719, DOI 10.1103/RevModPhys.73.719; Calvet N., 2000, Protostars and planets 4, P377; Canup R., 2000, B AM ASTRON SOC, V32, P1105; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; CASSEN P, 1981, ICARUS, V48, P353, DOI 10.1016/0019-1035(81)90051-8; Chambers JE, 1996, ICARUS, V119, P261, DOI 10.1006/icar.1996.0019; Cuk M, 2005, ASTROPHYS J, V626, pL113, DOI 10.1086/431743; D'Angelo G, 2003, ASTROPHYS J, V599, P548, DOI 10.1086/379224; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; GOLDREICH P, 1989, SCIENCE, V245, P500, DOI 10.1126/science.245.4917.500; GOLDREICH P, 1965, ASTRON J, V70, P5, DOI 10.1086/109673; Hamilton DP, 2004, ASTRON J, V128, P2510, DOI 10.1086/424534; Jewitt D, 2005, SPACE SCI REV, V116, P441, DOI 10.1007/s11214-005-1965-z; Klahr HH, 2003, ASTROPHYS J, V582, P869, DOI 10.1086/344743; LISSAUER JJ, 1995, ICARUS, V114, P217, DOI 10.1006/icar.1995.1057; Lubow SH, 1999, ASTROPHYS J, V526, P1001, DOI 10.1086/308045; Lunine J. I, 1993, PROTOSTARS PLANETS, P749; Lunine JI, 2004, CAMB PLANET, P19; McKinnon WB, 1995, SPACE SCI S, P807; Mosqueira I, 2003, ICARUS, V163, P198, DOI 10.1016/S0019-1035(03)00076-9; Papaloizou JCB, 2000, MON NOT R ASTRON SOC, V315, P823, DOI 10.1046/j.1365-8711.2000.03466.x; Papaloizou JCB, 2005, ASTRON ASTROPHYS, V433, P247, DOI 10.1051/0004-6361:20042029; Pollack J. B., 1991, URANUS, P469; Saumon D, 2004, ASTROPHYS J, V609, P1170, DOI 10.1086/421257; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; SLATTERY WL, 1992, ICARUS, V99, P167, DOI 10.1016/0019-1035(92)90180-F; Stevenson DJ, 2001, SCIENCE, V294, P71, DOI 10.1126/science.1065306; Stevenson DJ, 1986, SATELLITES, P687; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713; Ward W. R., 2000, Protostars and planets 4, P1135; WARD WR, 1986, ICARUS, V67, P164, DOI 10.1016/0019-1035(86)90182-X; Ward WR, 2004, ASTRON J, V128, P2501, DOI 10.1086/424533; WARD WR, 1988, ICARUS, V73, P330, DOI 10.1016/0019-1035(88)90103-0; WARD WR, 1993, ICARUS, V106, P274, DOI 10.1006/icar.1993.1171; WARD WR, 2003, B AM ASTRON SOC, V35, P1046; Williams DM, 1997, NATURE, V385, P234, DOI 10.1038/385234a0	48	228	229	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					834	839		10.1038/nature04860	http://dx.doi.org/10.1038/nature04860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778883				2022-12-28	WOS:000238254100034
J	Mavarez, J; Salazar, CA; Bermingham, E; Salcedo, C; Jiggins, CD; Linares, M				Mavarez, Jesus; Salazar, Camilo A.; Bermingham, Eldredge; Salcedo, Christian; Jiggins, Chris D.; Linares, Mauricio			Speciation by hybridization in Heliconius butterflies	NATURE			English	Article							HYBRID ORIGIN; MELPOMENE; EVOLUTION; MIMICRY; POPULATION; SELECTION; CYDNO	Speciation is generally regarded to result from the splitting of a single lineage. An alternative is hybrid speciation, considered to be extremely rare, in which two distinct lineages contribute genes to a daughter species. Here we show that a hybrid trait in an animal species can directly cause reproductive isolation. The butterfly species Heliconius heurippa is known to have an intermediate morphology and a hybrid genome(1), and we have recreated its intermediate wing colour and pattern through laboratory crosses between H. melpomene, H. cydno and their F-1 hybrids. We then used mate preference experiments to show that the phenotype of H. heurippa reproductively isolates it from both parental species. There is strong assortative mating between all three species, and in H. heurippa the wing pattern and colour elements derived from H. melpomene and H. cydno are both critical for mate recognition by males.	Univ Los Andes, Inst Genet, Bogota, Colombia; Smithsonian Trop Res Inst, Panama City, Panama; Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian Tropical Research Institute; University of Edinburgh	Mavarez, J (corresponding author), Univ Los Andes, Inst Genet, Carrera 1E 18a-10,POB 4976, Bogota, Colombia.	mavarezj@sl.edu	Jiggins, Chris/T-4296-2019; C, Salazar/A-1647-2010; Jiggins, Chris D/B-9960-2008; Linares, Mauricio/I-3509-2016	Jiggins, Chris/0000-0002-7809-062X; C, Salazar/0000-0001-9217-6588; Jiggins, Chris D/0000-0002-7809-062X; Linares, Mauricio/0000-0002-1021-0226				BOGGS CL, 1979, SCIENCE, V206, P83, DOI 10.1126/science.206.4414.83; BROWN KS, 1992, HEREDITAS, V117, P109, DOI 10.1111/j.1601-5223.1992.tb00165.x; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Coyne J.A., 2004, SPECIATION; GILBERT LE, 2003, ECOLOGY EVOLUTION TA, P281; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Jiggins CD, 2004, J EVOLUTION BIOL, V17, P680, DOI 10.1111/j.1420-9101.2004.00675.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; LINARES M, 1989, THESIS U TEXAS AUSTI; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mallet J, 1998, ENDLESS FORMS, P390; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Mavarez J, 2006, MOL ECOL NOTES, V6, P20, DOI 10.1111/j.1471-8286.2005.01115.x; MCCARTHY EM, 1995, HEREDITY, V74, P502, DOI 10.1038/hdy.1995.71; McMillan WO, 1997, P NATL ACAD SCI USA, V94, P8628, DOI 10.1073/pnas.94.16.8628; Naisbit RE, 2003, EVOL DEV, V5, P269, DOI 10.1046/j.1525-142X.2003.03034.x; Naisbit RE, 2002, GENETICS, V161, P1517; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2000, EVOLUTION, V54, P859, DOI 10.1111/j.0014-3820.2000.tb00086.x; Salazar CA, 2005, J EVOLUTION BIOL, V18, P247, DOI 10.1111/j.1420-9101.2004.00839.x; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; SMILEY J, 1978, SCIENCE, V201, P745, DOI 10.1126/science.201.4357.745; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x	29	333	354	9	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					868	871		10.1038/nature04738	http://dx.doi.org/10.1038/nature04738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778888				2022-12-28	WOS:000238254100041
J	Davis, P; Lay-Yee, R; Dyall, L; Briant, R; Sporle, A; Brunt, D; Scott, A				Davis, Peter; Lay-Yee, Roy; Dyall, Lorna; Briant, Robin; Sporle, Andrew; Brunt, Deborah; Scott, Alastair			Quality of hospital care for Maori patients in New Zealand: retrospective cross-sectional assessment	LANCET			English	Article							DISPARITIES; MORTALITY; HEALTH; RELIABILITY	Background New Zealand has a substantial indigenous minority-the Maori-that has considerably worse health status than the majority population. We aimed to assess possible disparities in quality of hospital care for Maori with data on preventable adverse events as an indicator of suboptimum treatment. Methods We undertook 4 nationally representative cross-sectional survey of admissions to general public hospitals with more than 100 beds providing acute care. A sample of 6579 patients admitted in 1998 to 13 hospitals was selected by stratified systematic list sample. We did a two-stage retrospective assessment of records by structured implicit review. Outcome measures were occurrence, effect, and preventability of adverse events. Findings Maori accounted for just greater than 15% of admissions and were on average younger, were more likely to be from from deprived areas, had a different case mix, and were in hospital for a shorter stay compared with patients of non-Maori/non-Pacific origin. Overall, after age standardisation, 14% of admissions for Maori were associated with an adverse event, compared with 11% for non-Maori/non-Pacific patients (p=0.01 for difference between groups). For preventable, in-hospital events, this disparity persisted after controlling for age, other sociodemographic factors, and case mix (adjusted odds ratio 1.47; p=0.05). Analysis of potential causal factors showed no markedly or consistently different pattern between the groups. Interpretation Despite a predominantly publicly funded hospital system, our findings suggest that hospital care received by Maori is marginally poorer than that received by New Zealand citizens of non-Maori/non-Pacific origin. Although no cause specific to Maori was evident, various policy and system issues can be addressed.	Univ Auckland, Dept Sociol, Auckland 1020, New Zealand; Univ Auckland, Sch Populat Hlth, Auckland 1020, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Auckland 1020, New Zealand; Univ Auckland, Dept Stat, Auckland 1020, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Davis, P (corresponding author), Univ Auckland, Dept Sociol, Private Bag 92019, Auckland 1020, New Zealand.	pb.davis@auckland.ac.nz						AHMAD OB, 2002, GPE DISCUSSION PAPER, V31; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; Bramley D, 2005, AM J PUBLIC HEALTH, V95, P844, DOI 10.2105/AJPH.2004.040907; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; CRAMPTON PC, 1997, 8 HLTH SERV RES CTR; CUNNINGHAM C, 2005, HLTH SOC AOTEAROA NZ, P211; Davis P, 2001, 3 MIN HLTH; Davis P., 2002, NEW ZEAL MED J, V115, P271; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; French S., 2001, HLTH CARE SYSTEMS TR; GOLDMAN RL, 1992, JAMA-J AM MED ASSOC, V267, P958, DOI 10.1001/jama.267.7.958; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jha AK, 2001, JAMA-J AM MED ASSOC, V285, P297, DOI 10.1001/jama.285.3.297; Joe J., 2003, UNEQUAL TREATMENT CO; Korn EL., 1999, ANAL HLTH SURVEYS; Ministry of Health, 2002, HE KOR OR MAOR HLTH; Ministry of Health, 2002, WHAK MAOR HLTH ACT P; MITCHELL EA, 1991, SOC SCI MED, V32, P831, DOI 10.1016/0277-9536(91)90309-Z; Neale G, 2003, QUAL SAF HEALTH CARE, V12, P2, DOI 10.1136/qhc.12.1.2; *NZ HLTH INF SERV, 1998, DAT DICT NAT MIN DAT; PATERSON RJ, 2002, HLTH AFF, V21; SCHOEN C, 2002, NZ ADULTS HLTH CARE; Schoen Cathy, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Sporle A, 2002, NEW ZEAL MED J, V115, P127; *STAT NZ, 2004, NZ LIF TABL 2000 02; Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Tukuitonga CF, 2002, NEW ZEAL MED J, V115, P179; WEPA D, 2005, CULTURAL SAFETY AOTE; Westbrooke I, 2001, NEW ZEAL MED J, V114, P484; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	34	69	69	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1920	1925		10.1016/S0140-6736(06)68847-8	http://dx.doi.org/10.1016/S0140-6736(06)68847-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765761				2022-12-28	WOS:000238194400031
J	Motzer, RJ; Rini, BI; Bukowski, RM; Curti, BD; George, DJ; Hudes, GR; Redman, BG; Margolin, KA; Merchan, JR; Wilding, G; Ginsberg, MS; Bacik, J; Kim, ST; Baum, CM; Michaelson, MD				Motzer, Robert J.; Rini, Brian I.; Bukowski, Ronald M.; Curti, Brendan D.; George, Daniel J.; Hudes, Gary R.; Redman, Bruce G.; Margolin, Kim A.; Merchan, Jaime R.; Wilding, George; Ginsberg, Michelle S.; Bacik, Jennifer; Kim, Sindy T.; Baum, Charles M.; Michaelson, M. Dror			Sunitinib in patients with metastatic renal cell carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	41st Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 13-17, 2005	Orlando, FL	Amer Soc Clin Oncol			TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; ANTITUMOR-ACTIVITY; RANDOMIZED-TRIAL; SU11248; INTERLEUKIN-2; INTERFERON; SURVIVAL; CANCER	Context Current treatment options for metastatic renal cell carcinoma (RCC) are limited and there is a need to identify novel and effective therapies. Sunitinib malate is an oral multitargeted tyrosine kinase inhibitor, which has shown activity in an initial study of cytokine-refractory metastatic RCC patients. Objective To confirm the antitumor efficacy of sunitinib as second-line treatment in patients with metastatic clear-cell RCC, the predominant cell type of this malignancy. Design, Setting, and Patients Open-label, single-arm, multicenter clinical trial. Patients were enrolled between February and November 2004, with follow-up continuing until disease progression, unacceptable toxicity, or withdrawal of consent. The reported data apply through August 2005. Patients (N=106) had metastatic clear-cell RCC, which had progressed despite previous cytokine therapy. Intervention Repeated 6-week cycles of sunitinib, 50 mg per day given orally for 4 consecutive weeks followed by 2 weeks off per treatment cycle. Main Outcome Measures Assessment of clinical response, degree of tumor regression on imaging studies using the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines. Primary end point was overall objective response rate ( complete plus partial). Secondary end points were progression-free survival and safety. Response was evaluated by independent third-party core imaging laboratory and by treating physicians ( investigator assessment). Results All 106 patients received sunitinib and were included in the intent-to-treat population for safety analyses. Of these, 105 patients were evaluable for efficacy analyses. The objective response rate according to an independent third-party assessment resulted in 36 patients with partial response (34%; 95% confidence interval, 25%-44%), and a median progression-free survival of 8.3 months ( 95% confidence interval, 7.8-14.5 months). The most common adverse events experienced by patients were fatigue in 30 (28%) and diarrhea 21 (20%). Neutropenia, elevation of lipase, and anemia were the most common laboratory abnormalities observed in 45 (42%), 30 (28%), and 27 (26%) patients, respectively. Conclusion The results of this trial demonstrate the efficacy and manageable adverse-event profile of sunitinib as a single agent in second-line therapy for patients with cytokine-refractory metastatic clear-cell RCC.	Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY 10021 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Cleveland Clin Fdn, Expt Therapeut Program, Cleveland, OH 44195 USA; Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA; Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA; Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; City Hope Natl Med Ctr, Div Med Oncol, Duarte, CA 91010 USA; Mayo Clin, Dept Oncol, Rochester, MN USA; Univ Wisconsin, Ctr Comprehens Canc, Dept Med, Madison, WI USA; Pfizer Inc, Oncol Clin Dev, La Jolla, CA USA; Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Cleveland Clinic Foundation; Duke University; Fox Chase Cancer Center; University of Michigan System; University of Michigan; City of Hope; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison; Pfizer; Harvard University; Massachusetts General Hospital	Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	motzerr@mskcc.org		Margolin, Kim/0000-0002-5248-4356; Michaelson, Dror/0000-0001-9249-6338; Motzer, Robert/0000-0001-6925-2327				Abrams TJ, 2003, MOL CANCER THER, V2, P1011; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Curti BD, 2004, JAMA-J AM MED ASSOC, V292, P97, DOI 10.1001/jama.292.1.97; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Escudier B, 1999, J CLIN ONCOL, V17, P2039, DOI 10.1200/JCO.1999.17.7.2039; ESCUDIER B, 2005, 41 ANN M AM SOC CLIN; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Kondo K, 2002, GENE CHROMOSOME CANC, V34, P58, DOI 10.1002/gcc.10054; LAW TM, 1995, CANCER-AM CANCER SOC, V76, P824, DOI 10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; O'Farrell AM, 2003, CLIN CANCER RES, V9, P5465; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; VOGELZANG NJ, 1993, J CLIN ONCOL, V11, P1809, DOI 10.1200/JCO.1993.11.9.1809; WIRTH MP, 1993, UROL CLIN N AM, V20, P283; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	24	992	1048	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2516	2524		10.1001/jama.295.21.2516	http://dx.doi.org/10.1001/jama.295.21.2516			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	049ZQ	16757724	Bronze			2022-12-28	WOS:000238057300027
J	Lin, X; Duan, XY; Liang, YY; Su, Y; Wrighton, KH; Long, JY; Hu, M; Davis, CM; Wang, JR; Brunicardi, FC; Shi, YG; Chen, YG; Meng, AM; Feng, XH				Lin, Xia; Duan, Xueyan; Liang, Yao-Yun; Su, Ying; Wrighton, Katharine H.; Long, Jianyin; Hu, Min; Davis, Candi M.; Wang, Jinrong; Brunicardi, F. Charles; Shi, Yigong; Chen, Ye-Guang; Meng, Anming; Feng, Xin-Hua			PPM1A functions as a Smad phosphatase to terminate TGF beta signaling (Publication with Expression of Concern. See vol. 166, 2016) (Publication with Expression of Concern. See vol. 165, pg. 498, 2016)	CELL			English	Article; Publication with Expression of Concern							GROWTH-FACTOR-BETA; CYCLIN-DEPENDENT KINASES; C-MYC; DIRECT BINDING; INHIBITOR; RECEPTOR; EXPRESSION; TRANSCRIPTION; SPECIFICITY; P15(INK4B)	TGF beta signaling controls diverse normal developmental processes and pathogenesis of diseases including cancer and autoimmune and fibrotic diseases. TGF beta responses are generally mediated through transcriptional functions of Smads. A key step in TGF beta signaling is ligand-induced phosphorylation of receptor-activated Smads (R-Smads) catalyzed by the TGF beta type I receptor kinase. However, the potential of Smad dephosphorylation as a regulatory mechanism of TGF beta signaling and the identity of Smad-specific phosphatases remain elusive. Using a functional genomic approach, we have identified PPM1A/PP2C alpha as a bona fide Smad phosphatase. PPM1A dephosphorylates and promotes nuclear export of TGF beta-activated Smad2/3. Ectopic expression of PPM1A abolishes TGF beta-induced anti proliferative and transcriptional responses, whereas depletion of PPM1A enhances TGF beta signaling in mammalian cells. Smad-antagonizing activity of PPM1A is also observed during Nodal-dependent early embryogenesis in zebrafish. This work demonstrates that PPM1A/PP2C alpha, through dephosphorylation of Smad2/3, plays a critical role in terminating TGF beta signaling.	Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA	Baylor College of Medicine; Baylor College of Medicine; Tsinghua University; Tsinghua University; Princeton University	Lin, X (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	xialin@bcm.edu; xfeng@bcm.edu	Meng, Anming/A-4785-2012; Su, Ying/M-5825-2013; Long, Jianyin/H-8261-2013; Su, Ying/ABA-8545-2021	Su, Ying/0000-0002-8466-0043; Su, Ying/0000-0002-8466-0043; Wrighton, Katharine/0000-0001-7075-3399; Meng, Anming/0000-0001-7228-3431; Shi, Yigong/0000-0003-2030-168X	NCI NIH HHS [R21CA11293, R01CA108454, R01CA82171] Funding Source: Medline; NIAMS NIH HHS [R01 AR053591-05, R01 AR053591] Funding Source: Medline; NIDDK NIH HHS [R01DK073932] Funding Source: Medline; NIGMS NIH HHS [R01GM63773] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108454, R01CA082171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhurst RJ, 2004, NAT GENET, V36, P790, DOI 10.1038/ng0804-790; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Bennett D, 2002, NAT GENET, V31, P419, DOI 10.1038/ng938; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Coburn GA, 2001, GENE DEV, V15, P1194, DOI 10.1101/gad.888201; COHEN PTW, 2003, PROTEIN PHOSPHATASES, P1; Cullen Bryan R, 2004, Methods Mol Biol, V257, P85, DOI 10.1385/1-59259-750-5:085; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Jazag A, 2005, ONCOGENE, V24, P662, DOI 10.1038/sj.onc.1208102; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Lin Xia, 2005, J RNAi Gene Silencing, V1, P38; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; TAMURA S, 2003, PROTEIN PHOSPHATASES, P91; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Whitman M, 2005, DEVELOPMENT, V132, P4205, DOI 10.1242/dev.02023; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu JY, 2005, J IMMUNOL, V174, P6122, DOI 10.4049/jimmunol.174.10.6122; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	51	365	393	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					915	928		10.1016/j.cell.2006.03.044	http://dx.doi.org/10.1016/j.cell.2006.03.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751101	Green Accepted, Bronze			2022-12-28	WOS:000238116400018
J	Androutsellis-Theotokis, A; Leker, RR; Soldner, F; Hoeppner, DJ; Ravin, R; Poser, SW; Rueger, MA; Bae, SK; Kittappa, R; McKay, RDG				Androutsellis-Theotokis, Andreas; Leker, Ronen R.; Soldner, Frank; Hoeppner, Daniel J.; Ravin, Rea; Poser, Steve W.; Rueger, Maria A.; Bae, Soo-Kyung; Kittappa, Raja; McKay, Ronald D. G.			Notch signalling regulates stem cell numbers in vitro and in vivo	NATURE			English	Article							HEDGEHOG PATHWAY; NERVOUS-SYSTEM; ADULT BRAIN; DIFFERENTIATION; ACTIVATION; NEUROGENESIS; STAT3; AKT; MEDULLOBLASTOMA; EXPRESSION	The hope of developing new transplantation therapies for degenerative diseases is limited by inefficient stem cell growth and immunological incompatibility with the host(1,2). Here we show that Notch receptor activation induces the expression of the specific target genes hairy and enhancer of split 3 (Hes3) and Sonic hedgehog (Shh) through rapid activation of cytoplasmic signals, including the serine/threonine kinase Akt, the transcription factor STAT3 and mammalian target of rapamycin, and thereby promotes the survival of neural stem cells. In both murine somatic and human embryonic stem cells, these positive signals are opposed by a control mechanism that involves the p38 mitogen-activated protein kinase. Transient administration of Notch ligands to the brain of adult rats increases the numbers of newly generated precursor cells and improves motor skills after ischaemic injury. These data indicate that stem cell expansion in vitro and in vivo, two central goals of regenerative medicine, may be achieved by Notch ligands through a pathway that is fundamental to development and cancer(3-5).	Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McKay, RDG (corresponding author), Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	mckay@codon.nih.gov	Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002981, ZIANS002981, Z01NS002881, ZIANS002881] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GORIELY A, 1991, DEVELOPMENT, V113, P1395; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Leker RR, 2003, STROKE, V34, P2000, DOI 10.1161/01.STR.0000079817.68944.1E; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rajan P, 1998, J NEUROSCI, V18, P3620; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang J, 2005, CANCER RES, V65, P939; Zhao Y, 2005, EUR J NEUROSCI, V22, P278, DOI 10.1111/j.1460-9568.2005.04200.x	30	779	839	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					823	826		10.1038/nature04940	http://dx.doi.org/10.1038/nature04940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16799564	Green Published			2022-12-28	WOS:000239792700048
J	Cooper, AA; Gitler, AD; Cashikar, A; Haynes, CM; Hill, KJ; Bhullar, B; Liu, KN; Xu, KX; Strathearn, KE; Liu, F; Cao, SS; Caldwell, KA; Caldwell, GA; Marsischky, G; Kolodner, RD; LaBaer, J; Rochet, JC; Bonini, NM; Lindquist, S				Cooper, Antony A.; Gitler, Aaron D.; Cashikar, Anil; Haynes, Cole M.; Hill, Kathryn J.; Bhullar, Bhupinder; Liu, Kangning; Xu, Kexiang; Strathearn, Katherine E.; Liu, Fang; Cao, Songsong; Caldwell, Kim A.; Caldwell, Guy A.; Marsischky, Gerald; Kolodner, Richard D.; LaBaer, Joshua; Rochet, Jean-Christophe; Bonini, Nancy M.; Lindquist, Susan			alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models	SCIENCE			English	Article							CARBOXYPEPTIDASE-Y; DISEASE; YEAST; DEGRADATION; PROTEIN; TRANSPORT; REQUIRES; MUTATION; STRESS; NEURODEGENERATION	Alpha-synuclein (alpha Syn) misfolding is associated with several devastating neurodegenerative disorders, including Parkinson's disease (PD). In yeast cells and in neurons alpha Syn accumulation is cytotoxic, but little is known about its normal function or pathobiology. The earliest defect following alpha Syn expression in yeast was a block in endoplasmic reticulum (ER)-to-Golgi vesicular trafficking. In a genomewide screen, the largest class of toxicity modifiers were proteins functioning at this same step, including the Rab guanosine triphosphatase Ypt1p, which associated with cytoplasmic alpha Syn inclusions. Elevated expression of Rab1, the mammalian YPT1 homolog, protected against alpha Syn-induced dopaminergic neuron loss in animal models of PD. Thus, synucleinopathies may result from disruptions in basic cellular functions that interface with the unique biology of particular neurons to make them especially vulnerable.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; Harvard Univ, Inst Proteom, Cambridge, MA 02141 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Missouri System; University of Missouri Kansas City; Harvard University; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alabama System; University of Alabama Tuscaloosa; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Haynes, CM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Cashikar, Anil G/F-5968-2011	Gitler, Aaron/0000-0001-8603-1526; Caldwell, Guy/0000-0002-8283-9090; Cooper, Antony/0000-0002-6027-2353; Rochet, Jean-Christophe/0000-0002-6484-1541; Caldwell, Kim/0000-0003-1580-6122	NHGRI NIH HHS [R01-HG002923] Funding Source: Medline; NINDS NIH HHS [P50 NS038372] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	32	1037	1066	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					324	328		10.1126/science.1129462	http://dx.doi.org/10.1126/science.1129462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16794039	Green Accepted			2022-12-28	WOS:000239154300036
J	Vagin, VV; Sigova, A; Li, CJ; Seitz, H; Gvozdev, V; Zamore, PD				Vagin, Vasily V.; Sigova, Alla; Li, Chengjian; Seitz, Herve; Gvozdev, Vladimir; Zamore, Phillip D.			A distinct small RNA pathway silences selfish genetic elements in the germline	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; DROSOPHILA-MELANOGASTER; MICRORNA MATURATION; MESSENGER-RNA; INTERFERENCE; ENCODES; PROTEIN; LINE; PIWI; NUCLEOTIDE	In the Drosophila germline, repeat-associated small interfering RNAs (rasiRNAs) ensure genomic stability by silencing endogenous selfish genetic elements such as retrotransposons and repetitive sequences. Whereas small interfering RNAs (siRNAs) derive from both the sense and antisense strands of their double-stranded RNA precursors, rasiRNAs arise mainly from the antisense strand. rasiRNA production appears not to require Dicer-1, which makes microRNAs ( miRNAs), or Dicer-2, which makes siRNAs, and rasiRNAs lack the 2',3' hydroxy termini characteristic of animal siRNA and miRNA. Unlike siRNAs and miRNAs, rasiRNAs function through the Piwi, rather than the Ago, Argonaute protein subfamily. Our data suggest that rasiRNAs protect the fly germline through a silencing mechanism distinct from both the miRNA and RNA interference pathways.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; Russian Acad Sci, Inst Mol Genet, Dept Anim Mol Genet, Moscow 123182, Russia	University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Sciences	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Seitz, Hervé/AAE-6487-2019; Gvozdev, Vladimir/AAH-1730-2021; Zamore, Phillip D/A-8941-2013	Seitz, Hervé/0000-0001-8172-5393; Zamore, Phillip/0000-0002-4505-9618; Gvozdev, Vladimir/0000-0003-1694-1473	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62862, GM65236] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hoa NT, 2003, INSECT BIOCHEM MOLEC, V33, P949, DOI 10.1016/S0965-1748(03)00101-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Sahut-Barnola I, 1999, DEVELOPMENT, V126, P1917; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tritto P, 2003, GENETICA, V117, P247, DOI 10.1023/A:1022960632306; Vagin Vasily V, 2004, RNA Biol, V1, P54; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	36	927	989	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					320	324		10.1126/science.1129333	http://dx.doi.org/10.1126/science.1129333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16809489				2022-12-28	WOS:000239154300035
J	Sanders, J; Peters, TJ; Campbell, R				Sanders, Julia; Peters, Tim J.; Campbell, Rona			Effectiveness and acceptability of lidocaine spray in reducing perineal pain during spontaneous vaginal delivery: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITION	Objectives To evaluate the effectiveness and acceptability of a lidocaine spray in reducing perineal pain during spontaneous vaginal delivery. Design Randomised controlled trial. Setting Consultant led obstetric unit. Participants 185 women who had a spontaneous vaginal delivery without epidural analgesia. Interventions Topically applied local anaesthetic spray (93 women) and placebo spray (92 women). Main outcome measure Primary outcome measure was pain during delivery (0-100 scale). The 16 secondary outcome measures included second degree perineal trauma during delivery, trauma of the genital tract, and dyspareunia by two months. Results Lidocaine spray did not reduce pain during spontaneous vaginal delivery: mean 77 and 72 on a scale of 0-100 in the lidocaine and placebo groups, respectively (difference between means 4.8, 95% confidence interval - 1.7 to 11.2). Lidocaine spray may reduce genital tract trauma during delivery, in particular second degree perineal trauma. The intervention was highly acceptable to the women and midwives. Conclusions Although lidocaine spray applied to the perineum during spontaneous vaginal delivery did not reduce perineal pain, it was acceptable to both the women and the midwives.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1TH, Avon, England	University of Bristol; University of Bristol	Sanders, J (corresponding author), Univ Wales Hosp, Midwifery Led Unit, Cardiff CF14 4XN, Wales.	julia.sanders@cardiffandvale.wales.nhs.uk		Peters, Tim/0000-0003-2881-4180				Armitage P., 2002, STAT METHODS MED RES; BARKER DP, 1995, ARCH DIS CHILD-FETAL, V72, pF203, DOI 10.1136/fn.72.3.F203; BARRETT DA, 1994, ARCH DIS CHILD-FETAL, V71, pF122, DOI 10.1136/fn.71.2.F122; BLANKENBAKER WL, 1975, ANESTHESIOLOGY, V42, P325, DOI 10.1097/00000542-197503000-00016; GUPTA JK, 2000, DATABASE SYST REV; HODNETT ED, 1987, RES NURS HEALTH, V10, P301, DOI 10.1002/nur.4770100503; Johanson RBMB., 2000, COCHRANE DB SYST REV, V2, DOI 10.1002/14651858.CD000224; KUMAR R, 1984, J PSYCHOSOM RES, V28, P43, DOI 10.1016/0022-3999(84)90039-4; Labrecque H, 2000, AM J OBSTET GYNECOL, V182, P76, DOI 10.1016/S0002-9378(00)70493-5; McCandlish R, 1998, BRIT J OBSTET GYNAEC, V105, P1262, DOI 10.1111/j.1471-0528.1998.tb10004.x; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; *NAT PER EP UN, 1986, CLASS BIBL CONTR TRI; NIVEN C, 1984, SOC SCI MED, V19, P1347, DOI 10.1016/0277-9536(84)90023-6; PETRIE RH, 1974, AM J OBSTET GYNECOL, V120, P791, DOI 10.1016/0002-9378(74)90583-3; PHILIPSON EH, 1984, AM J OBSTET GYNECOL, V149, P403, DOI 10.1016/0002-9378(84)90154-6; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Renfrew MJ, 1998, BIRTH-ISS PERINAT C, V25, P143; Sanders J, 2005, MIDWIFERY, V21, P154, DOI 10.1016/j.midw.2004.12.003; Shipman MK, 1997, BRIT J OBSTET GYNAEC, V104, P787, DOI 10.1111/j.1471-0528.1997.tb12021.x; SIKORSKI J, 1995, ANTENATAL CARE PROJE; STEWART P, 1989, BRIT J OBSTET GYNAEC, V96, P327, DOI 10.1111/j.1471-0528.1989.tb02393.x; THOMAS J, 1969, BRIT J ANAESTH, V41, P442, DOI 10.1093/bja/41.5.442; WALDENSTROM U, 1991, BIRTH-ISS PERINAT C, V18, P5, DOI 10.1111/j.1523-536X.1991.tb00045.x; ZANDOR G, 1974, ACTA OBSTET GYNECO S, V34, P51; 2004, COCHRANE DATABASE SY	25	9	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2006	333	7559					117	119		10.1136/bmj.38878.833241.7C	http://dx.doi.org/10.1136/bmj.38878.833241.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16807257	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000239155900014
J	Chewning, B				Chewning, B			Commentary: The healthy adherer and the placebo effect	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Wisconsin, Sch Pharm, Sonderegger Res Inst, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Chewning, B (corresponding author), Univ Wisconsin, Sch Pharm, Sonderegger Res Inst, Madison, WI 53705 USA.	bachewning@pharmacy.wisc.edu						Barrett B, 2006, PERSPECT BIOL MED, V49, P178, DOI 10.1353/pbm.2006.0019; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; SIMPSON SH, 1996, BRIT MED J, V333, P15	4	20	20	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 1	2006	333	7557					18	19		10.1136/bmj.333.7557.18	http://dx.doi.org/10.1136/bmj.333.7557.18			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16809709	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000238922900020
J	Kahneman, D; Krueger, AB; Schkade, D; Schwarz, N; Stone, AA				Kahneman, Daniel; Krueger, Alan B.; Schkade, David; Schwarz, Norbert; Stone, Arthur A.			Would you be happier if you were richer? A focusing illusion	SCIENCE			English	Editorial Material							JUDGMENTS; INCREASE	The belief that high income is associated with good mood is widespread but mostly illusory. People with above-average income are relatively satisfied with their lives but are barely happier than others in moment-to-moment experience, tend to be more tense, and do not spend more time in particularly enjoyable activities. Moreover, the effect of income on life satisfaction seems to be transient. We argue that people exaggerate the contribution of income to happiness because they focus, in part, on conventional achievements when evaluating their life or the lives of others.	Princeton Univ, Princeton, NJ 08544 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Univ Calif San Diego, Rady Sch Management, San Diego, CA 92093 USA; Univ Michigan, Dept Psychol, Ann Arbor, MI 48106 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA	Princeton University; National Bureau of Economic Research; University of California System; University of California San Diego; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krueger, AB (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	akrueger@princeton.edu	Stone, Arthur A./AAC-3610-2019; Schwarz, Norbert/B-3591-2008	Schwarz, Norbert/0000-0002-8868-7067				[Anonymous], 1999, LUXURY FEVER; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; Duesenberry J.S., 1949, INCOME SAVING THEORY, DOI 10.2307/2226615; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Easterlin RA, 2003, IZA DISCUSSION PAPER, V172; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Frederick S., 1999, WELL BEING FDN HEDON, P302; Frey B.S., 2002, HAPPINESS EC EC I AF; Gilbert D, 2006, STUMBLING HAPPINESS; Kahneman D, 2006, J ECON PERSPECT, V20, P221, DOI 10.1257/089533006776526076; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; KAHNEMAN D, 2006, 53 CTR HLTH WELLB; Layard R., 2002, HAPPINESS LESSONS NE; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1162/003355305774268255; Runciman Walter Garrison, 1966, RELATIVE DEPRIVATION; Schkade DA, 1998, PSYCHOL SCI, V9, P340, DOI 10.1111/1467-9280.00066; Schnall PL, 1998, PSYCHOSOM MED, V60, P697, DOI 10.1097/00006842-199811000-00007; SCHWARZ N, 1991, PUBLIC OPIN QUART, V55, P3, DOI 10.1086/269239; Schwarz N., 1999, WELL BEING FDN HEDON, P61, DOI DOI 10.7758/9781610443258; Scitovsky T, 1976, JOYLESS EC; Smith DM, 2006, QUAL LIFE RES, V15, P621, DOI 10.1007/s11136-005-4529-5; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; STRACK F, 1988, EUR J SOC PSYCHOL, V18, P429, DOI 10.1002/ejsp.2420180505; STUTZER A, 2004, 127 IZA; *USDL, 041797 USDL; Van Praag B.M.S., 1999, WELL BEING FDN HEDON, P413	27	567	592	9	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1908	1910		10.1126/science.1129688	http://dx.doi.org/10.1126/science.1129688			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061CF	16809528	Green Submitted			2022-12-28	WOS:000238848100046
J	Moll, E; Bossuyt, PMM; Korevaar, JC; Lambalk, CB; van der Veen, F				Moll, Etelka; Bossuyt, Patrick M. M.; Korevaar, Johanna C.; Lambalk, Cornelis B.; van der Veen, Fulco			Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial	BRITISH MEDICAL JOURNAL			English	Article							INSULIN-RESISTANCE; SPONTANEOUS-ABORTION; PREGNANCY; HYPERANDROGENISM; PROGRESS	Objective To compare the effectiveness of clomifene citrate plus metformin and clomifene citrate plus placebo in women with newly diagnosed polycystic ovary syndrome. Design Randomised clinical trial. Setting Multicentre trial in 20 Dutch hospitals. Participants 228 women with polycystic ovary syndrome. Interventions Clomifene citrate plus metformin or clomifene citrate plus placebo. Main outcome measure The primary outcome measure was ovulation. Secondary outcome measures were ongoing pregnancy, spontaneous abortion, and clomifene resistance. Results 111 women were allocated to clomifene citrate plus metformin (metformin group) and 114 women were allocated to clomifene citrate plus placebo (placebo group). The ovulation rate in die metformin group was 64% compared with 72% in the placebo group, a non-significant difference (risk difference - 8%, 95% confidence interval - 20% to 4%). There were no significant differences in either rate of ongoing pregnancy (40% v 46%; - 6%, - 20% to 7%) or rate of spontaneous abortion (12% v 11%; 1%, - 7% to 10%). A significantly larger proportion of women in the metformin group discontinued treatment because of side effects (16% v 5%; 11%, 5% to 16%). Conclusion Metformin is not an effective addition to clomifene citrate as the primary method of inducing ovulation in women with polycystic ovary syndrome.	Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynaecol, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Div Reprod Med, NL-1007 MB Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Moll, E (corresponding author), Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynaecol, POB 22700, NL-1100 DE Amsterdam, Netherlands.	e.moll@amc.uva.nl	Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; Lambalk, Cornelis/0000-0003-3947-5129				Alberman E., 1992, SPONTANEOUS ABORTION, P9; [Anonymous], 2003, FERTIL STERIL, V80, P1302; BARBIERI RL, 1994, J REPROD MED, V39, P327; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Eijkemans MJC, 2003, HUM REPROD, V18, P2357, DOI 10.1093/humrep/deg459; El-Biely MM, 2001, MIDDLE E FERTIL SOC, V6, P43; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Glueck CJ, 2001, FERTIL STERIL, V75, P46, DOI 10.1016/S0015-0282(00)01666-6; Heard MJ, 2002, FERTIL STERIL, V77, P669, DOI 10.1016/S0015-0282(01)03266-6; Homburg R, 2002, HUM REPROD, V17, P2495, DOI 10.1093/humrep/17.10.2495; IMARI B, 2002, FERTIL STERIL, V77, P91; Jakubowicz DJ, 2002, J CLIN ENDOCR METAB, V87, P524, DOI 10.1210/jc.87.2.524; Lord JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003053; Nestler JE, 1996, NEW ENGL J MED, V335, P617, DOI 10.1056/NEJM199608293350902; Nestler JE, 1998, NEW ENGL J MED, V338, P1876, DOI 10.1056/NEJM199806253382603; NESTLER JE, 1989, J CLIN ENDOCR METAB, V68, P10247; Nestler John E., 1997, Human Reproduction (Oxford), V12, P53; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P1241, DOI 10.1210/jc.76.5.1241; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; VELAZQUEZ EM, 1994, METABOLISM, V43, P647, DOI 10.1016/0026-0495(94)90209-7; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	24	167	178	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 24	2006	332	7556					1485	1488A		10.1136/bmj.38867.631551.55	http://dx.doi.org/10.1136/bmj.38867.631551.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16769748	Green Published, Bronze			2022-12-28	WOS:000238820200018
J	Scherpbier, AJJA				Scherpbier, AJJA			Commentary: Dutch perspective	BRITISH MEDICAL JOURNAL			English	Editorial Material									Maastricht Univ, Inst Med Educ, NL-6200 MD Maastricht, Netherlands	Maastricht University	Scherpbier, AJJA (corresponding author), Maastricht Univ, Inst Med Educ, POB 616, NL-6200 MD Maastricht, Netherlands.	a.scherpbier@oifdg.unimaas.nl						Dornan T, 2005, MED EDUC, V39, P163, DOI 10.1111/j.1365-2929.2004.01914.x; Hutchinson L, 2006, BMJ-BRIT MED J, V332, P1502, DOI 10.1136/bmj.332.7556.1502; van der Vleuten CPM, 2000, MED TEACH, V22, P592, DOI 10.1080/01421590050175587	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 24	2006	332	7556					1504	1505		10.1136/bmj.332.7556.1504	http://dx.doi.org/10.1136/bmj.332.7556.1504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793817	Green Published			2022-12-28	WOS:000238820200024
J	White, PM; Doetzlhofer, A; Lee, YS; Groves, AK; Segil, N				White, Patricia M.; Doetzlhofer, Angelika; Lee, Yun Shain; Groves, Andrew K.; Segil, Neil			Mammalian cochlear supporting cells can divide and trans-differentiate into hair cells	NATURE			English	Article							INNER-EAR; ACOUSTIC TRAUMA; REGENERATION; EXPRESSION; MATH1; GENE; MICE; PROLIFERATION; PROGENITORS; PROTEINS	Sensory hair cells of the mammalian organ of Corti in the inner ear do not regenerate when lost as a consequence of injury, disease, or age-related deafness. This contrasts with other vertebrates such as birds, where the death of hair cells causes surrounding supporting cells to re-enter the cell cycle and give rise to both new hair cells and supporting cells(1,2). It is not clear whether the lack of mammalian hair cell regeneration is due to an intrinsic inability of supporting cells to divide and differentiate or to an absence or blockade of regenerative signals. Here we show that post-mitotic supporting cells(3) purified from the postnatal mouse cochlea retain the ability to divide and trans-differentiate into new hair cells in culture. Furthermore, we show that age-dependent changes in supporting cell proliferative capacity are due in part to changes in the ability to downregulate the cyclin-dependent kinase inhibitor p27(Kip1) ( also known as Cdkn1b). These results indicate that postnatal mammalian supporting cells are potential targets for therapeutic manipulation.	House Ear Res Inst, Gonda Dept Cell & Mol Biol, Los Angeles, CA 90057 USA; Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	House Research Institute; University of Southern California	Groves, AK (corresponding author), House Ear Res Inst, Gonda Dept Cell & Mol Biol, 2100 W 3rd St, Los Angeles, CA 90057 USA.	agroves@hei.org; nsegil@hei.org		Groves, Andrew/0000-0002-0784-7998	NIDCD NIH HHS [F32 DC005282, R01 DC004189] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC005282, R01DC004189] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; CHARDIN S, 1995, SCIENCE, V267, P707, DOI 10.1126/science.7839151; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Coppens AG, 2001, DEV BRAIN RES, V126, P191, DOI 10.1016/S0165-3806(00)00153-X; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; DECHESNE CJ, 1994, J COMP NEUROL, V346, P517, DOI 10.1002/cne.903460405; Doetzlhofer A, 2004, DEV BIOL, V272, P432, DOI 10.1016/j.ydbio.2004.05.013; DOETZLHOFER A, 2006, BRAIN RES       0406; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gestwa G, 1999, J COMP NEUROL, V414, P33, DOI 10.1002/(SICI)1096-9861(19991108)414:1<33::AID-CNE3>3.0.CO;2-M; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Helms AW, 2000, DEVELOPMENT, V127, P1185; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyers JR, 2003, J NEUROSCI, V23, P4054; PUJOL R, 1973, ACTA OTO-LARYNGOL, V76, P1, DOI 10.3109/00016487309121476; Roberson DW, 1996, AUDIT NEUROSCI, V2, P195; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Stone JS, 2000, P NATL ACAD SCI USA, V97, P11714, DOI 10.1073/pnas.97.22.11714; Warchol ME, 1996, J NEUROSCI, V16, P5466; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	30	310	342	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					984	987		10.1038/nature04849	http://dx.doi.org/10.1038/nature04849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791196				2022-12-28	WOS:000238422300043
J	Wachter, RM				Wachter, Robert M.			Expected and unanticipated consequences of the quality and information technology revolutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIAN ORDER ENTRY; OF-CARE; SAFETY; IMPLEMENTATION; BAR		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wachter, RM (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus,Box 0120, San Francisco, CA 94143 USA.	bobw@medicine.ucsf.edu	Tao, Youyou/D-2367-2014					Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Berner ES, 2005, J AM MED INFORM ASSN, V12, P3, DOI 10.1197/jamia.M1664; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Connolly Ceci, 2005, Washington Post, pA4; *CTR MED MED SERV, MED PAY FOR PERF DEM; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; FLANDERS SD, 2001, AHRQ PUBLICATION, P1; Fuchs VR, 2005, HEALTH AFFAIR, V24, P1399, DOI 10.1377/hlthaff.24.6.1399; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; *I MED, 2002, UN TREATM CONFR RAC; Issenberg SB, 1999, JAMA-J AM MED ASSOC, V282, P861, DOI 10.1001/jama.282.9.861; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Li GH, 2003, AM J EPIDEMIOL, V157, P874, DOI 10.1093/aje/kwg071; McDonald CJ, 2006, ANN INTERN MED, V144, P510, DOI 10.7326/0003-4819-144-7-200604040-00010; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; ORNSTEIN C, 2003, LOS ANGELES TIM 0122, pB1; RELMAN AS, 1988, NEW ENGL J MED, V319, P1220, DOI 10.1056/NEJM198811033191810; Revere D, 2001, J AM MED INFORM ASSN, V8, P62, DOI 10.1136/jamia.2001.0080062; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Shojania K G, 2001, Eff Clin Pract, V4, P82; Wachter RM, 2006, NEW ENGL J MED, V354, P661, DOI 10.1056/NEJMp058258; WACHTER RM, 2004, INTERNAL BLEEDING TR, P74; Weiner BJ, 2006, MED CARE RES REV, V63, P29, DOI 10.1177/1077558705283122; Wennberg JE, 1999, NEW ENGL J MED, V340, P52, DOI 10.1056/NEJM199901073400111; WOLFE T, 1979, RIGHT STUFF, P22	29	76	77	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2780	2783		10.1001/jama.295.23.2780	http://dx.doi.org/10.1001/jama.295.23.2780			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	054OZ	16788133				2022-12-28	WOS:000238389700033
J	Lee, MM				Lee, MM			Idiopathic short stature	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-HORMONE TREATMENT; QUALITY-OF-LIFE; ADULT HEIGHT; THERAPEUTICS-COMMITTEE; RESEARCH SOCIETY; FINAL HEIGHT; CHILDREN; THERAPY; DEFICIENCY; SAFETY	A healthy, active 12-year-old boy is in the first percentile for height (133.0 cm [52.4 in.]; 2.25 SD below the mean for age and sex) and in the third percentile for weight ( 29 kg [ 64 lb]) ( Fig. 1). He is the same size as his 10-year-old sister and is the shortest boy in his seventh-grade class. His father's height is 168.0 cm (66.1 in.; - 1.28 SD), and his mother's height is 148.0 cm (58.3 in.; - 2.25 SD). His physical examination is unremarkable, with normal proportions and no signs of puberty. His bone age is 10 years. His evaluation reveals no systemic disease ( e. g., growth hormone deficiency or gastrointestinal or thyroid disorder) and no skeletal dysplasia. His midparental height is 164.5 cm (64.8 in.), and his predicted height is 163.8 cm (64.5 in.). Is growth hormone therapy indicated?	Univ Massachusetts, Sch Med, Dept Pediat, Pediat Endocrine Div, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Lee, MM (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Pediat Endocrine Div, 55 Lake Ave N, Worcester, MA 01655 USA.	mary.lee@umassmed.edu		Lee, Mary/0000-0002-7204-4884; Lee, Mary Min-chin/0000-0003-1985-4594				Allen DB, 2004, J PEDIATR-US, V144, P648, DOI 10.1016/j.jpeds.2004.02.028; Attie KM, 2000, CURR OPIN PEDIATR, V12, P400, DOI 10.1097/00008480-200008000-00021; Badaru A, 2004, TRENDS ENDOCRIN MET, V15, P252, DOI 10.1016/j.tem.2004.06.004; Berlin CM, 1997, PEDIATRICS, V99, P122; Blair JC, 2002, TRENDS ENDOCRIN MET, V13, P325, DOI 10.1016/S1043-2760(02)00631-8; Blethen SL, 1997, J CLIN ENDOCR METAB, V82, P418, DOI 10.1210/jc.82.2.418; BRAMSWIG JH, 1990, J PEDIATR-US, V117, P886, DOI 10.1016/S0022-3476(05)80127-1; BRYANT J, 2003, COCHRANE DB SYST REV, V4; Carel JC, 1997, J CLIN ENDOCR METAB, V82, P2117, DOI 10.1210/jc.82.7.2117; Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868; Clayton PE, 2000, GROWTH HORM IGF RES, V10, P306, DOI 10.1054/ghir.2000.0175; Cuttler L, 2004, ARCH PEDIAT ADOL MED, V158, P108, DOI 10.1001/archpedi.158.2.108; Downie AB, 1997, BMJ-BRIT MED J, V314, P97, DOI 10.1136/bmj.314.7074.97; Finkelstein BS, 2002, ARCH PEDIAT ADOL MED, V156, P230, DOI 10.1001/archpedi.156.3.230; Food and Drug Administration, 2003, FED REGISTER, V68, P24003; FRADKIN JE, 1991, JAMA-J AM MED ASSOC, V265, P880, DOI 10.1001/jama.265.7.880; FURLANETTO RW, 1995, J PEDIATR-US, V127, P857; Ghigo E, 1996, J CLIN ENDOCR METAB, V81, P3323, DOI 10.1210/jc.81.9.3323; GODDARD AD, 1995, NEW ENGL J MED, V333, P1093, DOI 10.1056/NEJM199510263331701; Greulich WW., 1959, CALIF MED, V91, P53; Grumbach MM, 1998, HORM RES, V49, P41, DOI 10.1159/000053087; Gubitosi-Klug RA, 2005, ENDOCRIN METAB CLIN, V34, P565, DOI 10.1016/j.ecl.2005.04.003; Guyda HJ, 1999, J CLIN ENDOCR METAB, V84, P4307, DOI 10.1210/jc.84.12.4307; HINDMARSH PC, 1995, ARCH DIS CHILD, V72, P362, DOI 10.1136/adc.72.4.362; Hintz RL, 1999, NEW ENGL J MED, V340, P502, DOI 10.1056/NEJM199902183400702; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Kamp GA, 2002, ARCH DIS CHILD, V87, P215, DOI 10.1136/adc.87.3.215; Kant SG, 2003, HORM RES, V60, P157, DOI 10.1159/000073226; Kawai M, 1997, J PEDIATR-US, V130, P205, DOI 10.1016/S0022-3476(97)70344-5; Kemp SF, 2005, J CLIN ENDOCR METAB, V90, P5247, DOI 10.1210/jc.2004-2513; Lampit M, 2002, J CLIN ENDOCR METAB, V87, P3573, DOI 10.1210/jc.87.8.3573; Lee JM, 2006, ARCH PEDIAT ADOL MED, V160, P263, DOI 10.1001/archpedi.160.3.263; Leschek EW, 2004, J CLIN ENDOCR METAB, V89, P3140, DOI 10.1210/jc.2003-031457; Nagel BHP, 1997, EUR J PEDIATR, V156, P758, DOI 10.1007/s004310050707; National Center for Health Statistics. Centers for Disease Control and Prevention (CDC), CLIN GROWTH CHARTS; Quigley CA, 2005, J CLIN ENDOCR METAB, V90, P5188, DOI 10.1210/jc.2004-2543; REITER EO, 1990, HORM RES, V33, P121, DOI 10.1159/000181495; Rosenfeld RG, 2005, GROWTH HORM IGF RES, V15, pS3, DOI 10.1016/j.ghir.2005.06.014; Ross JL, 2004, J CLIN ENDOCR METAB, V89, P4873, DOI 10.1210/jc.2004-0791; Sandberg DE, 2005, HORM RES, V63, P275, DOI 10.1159/000086593; Sandberg DE, 2002, BEST PRACT RES CL EN, V16, P449, DOI 10.1053/beem.2002.0211; Schwartz I D, 1997, Curr Probl Pediatr, V27, P14; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; Theunissen NCM, 2002, J PEDIATR-US, V140, P507, DOI 10.1067/mpd.2002.123766; Voss LD, 2000, J PEDIATR-US, V136, P103, DOI 10.1016/S0022-3476(00)90058-1; Werther GA, 1996, J PEDIATR-US, V128, pS47, DOI 10.1016/S0022-3476(96)70011-2; Wheeler PG, 2004, ARCH PEDIAT ADOL MED, V158, P236, DOI 10.1001/archpedi.158.3.236; WILSON DM, 1986, PEDIATRICS, V78, P646; Wilson TA, 2003, J PEDIATR-US, V143, P415, DOI 10.1067/S0022-3476(03)00246-4; Wit JM, 2005, J PEDIATR-US, V146, P45, DOI 10.1016/j.jpeds.2004.08.055; Zimet GD, 1997, ARCH PEDIAT ADOL MED, V151, P1017, DOI 10.1001/archpedi.1997.02170470051010	51	30	32	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2576	2582		10.1056/NEJMcp060828	http://dx.doi.org/10.1056/NEJMcp060828			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775237				2022-12-28	WOS:000238233400007
J	Letvin, NL; Mascola, JR; Sun, Y; Gorgone, DA; Buzby, AP; Xu, L; Yang, ZY; Chakrabarti, B; Rao, SS; Schmitz, JE; Montefiori, DC; Barker, BR; Bookstein, FL; Nabel, GJ				Letvin, NL; Mascola, JR; Sun, Y; Gorgone, DA; Buzby, AP; Xu, L; Yang, ZY; Chakrabarti, B; Rao, SS; Schmitz, JE; Montefiori, DC; Barker, BR; Bookstein, FL; Nabel, GJ			Preserved CD4(+) central memory T cells and survival in vaccinated SIV-challenged monkeys	SCIENCE			English	Article							IMMUNODEFICIENCY VIRUS SIVMAC239; RHESUS-MONKEYS; ANTIRETROVIRAL THERAPY; VIRAL REPLICATION; IMMUNE-RESPONSES; INFECTION; LYMPHOCYTES; ENVELOPE; AIDS; GAG	Vaccine-induced cellular immunity controls virus replication in simian immunodeficiency virus (SIV) - infected monkeys only transiently, leading to the question of whether such vaccines for AIDS will be effective. We immunized monkeys with plasmid DNA and replication-defective adenoviral vectors encoding SIV proteins and then challenged them with pathogenic SIV. Although these monkeys demonstrated a reduction in viremia restricted to the early phase of SIV infection, they showed a prolonged survival. This survival was associated with preserved central memory CD4(+) T lymphocytes and could be predicted by the magnitude of the vaccine-induced cellular immune response. These immune correlates of vaccine efficacy should guide the evaluation of AIDS vaccines in humans.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Vienna, Dept Anthropol, A-1010 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vienna	Letvin, NL (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	nletvin@bidmc.harvard.edu	Mascola, John/AAI-7193-2021; Schmitz, Joern/A-4929-2018; Barker, Brianne/AAW-2583-2020	Schmitz, Joern/0000-0001-8803-0922; Barker, Brianne/0000-0001-6932-479X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005002, Z01AI005001, Z01AI005011, Z01AI005009] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Gilbert PB, 2005, J INFECT DIS, V192, P974, DOI 10.1086/432734; Hulgan T, 2005, J INFECT DIS, V192, P950, DOI 10.1086/432955; Letvin NL, 2004, J VIROL, V78, P7490, DOI 10.1128/JVI.78.14.7490-7497.2004; Letvin NL, 2005, ANNU REV MED, V56, P213, DOI 10.1146/annurev.med.54.101601.152349; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Nishimura Y, 2004, P NATL ACAD SCI USA, V101, P12324, DOI 10.1073/pnas.0404620101; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Polacino P, 1999, J VIROL, V73, P618, DOI 10.1128/JVI.73.1.618-630.1999; Polacino PS, 1999, J VIROL, V73, P8201, DOI 10.1128/JVI.73.10.8201-8215.1999; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Seaman MS, 2005, J VIROL, V79, P4580, DOI 10.1128/JVI.79.8.4580-4588.2005; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sun Y, 2005, J IMMUNOL, V174, P4753, DOI 10.4049/jimmunol.174.8.4753; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003	22	303	313	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1530	1533		10.1126/science.1124226	http://dx.doi.org/10.1126/science.1124226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763152	Green Accepted			2022-12-28	WOS:000238124100050
J	Allwood, AC; Walter, MR; Kamber, BS; Marshall, CP; Burch, IW				Allwood, Abigail C.; Walter, Malcolm R.; Kamber, Balz S.; Marshall, Craig P.; Burch, Ian W.			Stromatolite reef from the Early Archaean era of Australia	NATURE			English	Article							WARRAWOONA GROUP; GEOCHEMISTRY; CARBONATES; ORIGIN; CHERT	The 3,430-million-year-old Strelley Pool Chert ( SPC) ( Pilbara Craton, Australia) is a sedimentary rock formation containing laminated structures of probable biological origin ( stromatolites). Determining the biogenicity of such ancient fossils is the subject of ongoing debate. However, many obstacles to interpretation of the fossils are overcome in the SPC because of the broad extent, excellent preservation and morphological variety of its stromatolitic outcrops - which provide comprehensive palaeontological information on a scale exceeding other rocks of such age. Here we present a multi-kilometre-scale palaeontological and palaeoenvironmental study of the SPC, in which we identify seven stromatolite morphotypes - many previously undiscovered - in different parts of a peritidal carbonate platform. We undertake the first morphotype-specific analysis of the structures within their palaeoenvironment and refute contemporary abiogenic hypotheses for their formation. Finally, we argue that the diversity, complexity and environmental associations of the stromatolites describe patterns that - in similar settings throughout Earth's history reflect the presence of organisms.	Macquarie Univ, Australian Ctr Astrobiol, Biotechnol Res Inst, Sydney, NSW 2109, Australia; Macquarie Univ, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia; Laurentian Univ, Dept Earth Sci, Sudbury, ON P3E 6B5, Canada; Univ Sydney, Sch Chem, Vibrat Spect Facil, Sydney, NSW 2006, Australia	Macquarie University; Macquarie University; Laurentian University; University of Sydney	Allwood, AC (corresponding author), Macquarie Univ, Australian Ctr Astrobiol, Biotechnol Res Inst, Herring Rd, Sydney, NSW 2109, Australia.	aallwood@els.mq.edu.au	Burch, Ian/AAW-1627-2020; Kamber, Balz S/A-1823-2008	Kamber, Balz S/0000-0002-8720-0608				Awramik S.M., 1976, DEV SEDIMENTOLOGY ST, P149; BACHELOR MT, 2000, PHYSICA A, V282, P123; Banerjee NR, 2006, EARTH PLANET SC LETT, V241, P707, DOI 10.1016/j.epsl.2005.11.011; Corliss J. B., 1981, Oceanologica Acta, V4, P59; Flugel E., 1982, INTRO FACIES ANAL BT, P1, DOI [10.1007/978-3-642-68423-4_1, DOI 10.1007/978-3-642-68423-4_1]; GOLOVANOV NP, 1970, OPORNYI RAZREZ VERKH, P60; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Hofmann HJ, 1999, GEOL SOC AM BULL, V111, P1256, DOI 10.1130/0016-7606(1999)111<1256:OOGCSI>2.3.CO;2; Jogi P. M., 2005, ASTROBIOLOGY, V5, P293; Kamber BS, 2001, GEOCHIM COSMOCHIM AC, V65, P2509, DOI 10.1016/S0016-7037(01)00613-5; Knight J, 2005, SEDIMENT GEOL, V181, P207, DOI 10.1016/j.sedgeo.2005.09.004; Komar V.A., 1964, UCH ZAP NAUCHNO ISSL, V6, P84; KOMAR VA, 1965, T GEOL I MOSCOW, V131, P1; KOROLYUK I.K., 1960, T I GEOL RAZRABOTKI, V1, P112; Lindsay JF, 2005, PRECAMBRIAN RES, V143, P1, DOI 10.1016/j.precamres.2005.09.003; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; LOWE DR, 1983, PRECAMBRIAN RES, V19, P239, DOI 10.1016/0301-9268(83)90016-5; Nothdurft LD, 2004, GEOCHIM COSMOCHIM AC, V68, P263, DOI 10.1016/S0016-7037(03)00422-8; POPE M. C., 2000, SOC SEDIMENTARY GEOL, V67, P103; Van Kranendonk MJ, 2003, GEOBIOLOGY, V1, P91, DOI 10.1046/j.1472-4669.2003.00014.x; Van Kranendonk MJ, 2004, GEOCHEM-EXPLOR ENV A, V4, P253, DOI 10.1144/1467-7873/04-205; VANKRANENDONK MJ, 2002, ECON GEOL, V97, P605; Vlasov F.Y., 1977, MAT PALEONTOLOGII SR, P101; Walter M.R., 1976, STROMATOLITES, P273; Webb GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1557, DOI 10.1016/S0016-7037(99)00400-7	27	548	588	4	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					714	718		10.1038/nature04764	http://dx.doi.org/10.1038/nature04764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760969				2022-12-28	WOS:000238095100045
J	Richter, LM				Richter, Linda M.			Studying adolescence	SCIENCE			English	Editorial Material							CHILDHOOD; GIRLS; VULNERABILITY; MENARCHE; BEHAVIOR; BIRTH; AGE	Young people in their teens constitute the largest age group in the world, in a special stage recognized across the globe as the link in the life cycle between childhood and adulthood. Longitudinal studies in both developed and developing countries and better measurements of adolescent behavior are producing new insights. The physical and psychosocial changes that occur during puberty make manifest generational and early-childhood risks to development, in the form of individual differences in aspects such as growth, educational attainment, self-esteem, peer influences, and closeness to family. They also anticipate threats to adult health and well-being. Multidisciplinary approaches, especially links between the biological and the social sciences, as well as studies of socioeconomic and cultural diversity and determinants of positive outcomes, are needed to advance knowledge about this stage of development.	Human Sci Res Council, ZA-4014 Dalbridge, South Africa; Univ KwaZulu Natal, Natal, RN, Brazil		Richter, LM (corresponding author), Human Sci Res Council, Private Bag X07, ZA-4014 Dalbridge, South Africa.	trichter@hsrc.ac.za			Wellcome Trust [077210, 068599] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barbarin O.A., 2001, MANDELAS CHILDREN GR; BAUMAN KE, 1989, AM J EPIDEMIOL, V130, P327, DOI 10.1093/oxfordjournals.aje.a115339; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.2307/1131166; Berkey CS, 2000, AM J EPIDEMIOL, V152, P446, DOI 10.1093/aje/152.5.446; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BROWN BB, 2002, WORLDS YOUTH ADOLESC; CAMERON N, 1990, S AFR MED J, V78, P536; Crowther NJ, 2000, DIABETOLOGIA, V43, P978, DOI 10.1007/s001250051479; Dasen P.R., 2000, INT J GROUP TENSIONS, V29, P17, DOI DOI 10.1023/A:1005126629553; DELANEY CH, 1995, ADOLESCENCE, V30, P891; Elder G.H., 1974, CHILDREN GREAT DEPRE; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Fuchs Estelle, 1976, YOUTH CHANGING WORLD; Galambos NL, 2000, INT J BEHAV DEV, V24, P289, DOI 10.1080/01650250050118268; GARMEZY N, 1971, AM J ORTHOPSYCHIAT, V41, P101, DOI 10.1111/j.1939-0025.1971.tb01111.x; Ge XJ, 2001, DEV PSYCHOL, V37, P404, DOI 10.1037//0012-1649.37.3.404; Giddens MEH, 2001, PEDIATRICS, V107, P609, DOI 10.1542/peds.107.3.609; Haynie DL, 2003, SOC FORCES, V82, P355, DOI 10.1353/sof.2003.0093; HOOVER J, 1998, REACHING TODAYS YOUT, V3, P2; KETT J, RITES PASSAGE ADOLES, P77; LUTHAR SS, 1991, AM J ORTHOPSYCHIAT, V61, P6, DOI 10.1037/h0079218; Marrazzo JM, 1997, ANN INTERN MED, V127, P796, DOI 10.7326/0003-4819-127-9-199711010-00004; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Norris SA, 2005, J RES ADOLESCENCE, V15, P609, DOI 10.1111/j.1532-7795.2005.00113.x; Richter L., 2006, BABA MEN FATHERHOOD; RICHTER L, 2004, PSYCHOSOCIAL STUDIES; RICHTER L, 2004, PAEDIATR PERINAT EP, V18, P572; Richter L.M., 2000, INT PERSPECTIVES CHI, V1, P159; RINDFUSS RR, 1991, DEMOGRAPHY, V28, P493, DOI 10.2307/2061419; Schlegel A., 1991, ADOLESCENCE ANTHROPO; STEINBERG LD, 1978, DEV PSYCHOL, V14, P683; Susman EJ, 1997, J RES ADOLESCENCE, V7, P283, DOI 10.1207/s15327795jra0703_3; Thomas A., 1968, TEMPERAMENT BEHAV DI; UDRY JR, 1979, J BIOL SCI, V11, P411; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; WADSWORTH MEJ, 1991, IMPRINT TIME; Williams JM, 2000, J EARLY ADOLESCENCE, V20, P129, DOI 10.1177/0272431600020002002	37	42	45	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1902	1905		10.1126/science.1127489	http://dx.doi.org/10.1126/science.1127489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061CF	16809526	Green Accepted			2022-12-28	WOS:000238848100044
J	Eggan, K; Jurga, S; Gosden, R; Min, IM; Wagers, AJ				Eggan, Kevin; Jurga, Sara; Gosden, Roger; Min, Irene M.; Wagers, Amy J.			Ovulated oocytes in adult mice derive from non-circulating germ cells	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; FOLLICLE NUMBER; CYCLOPHOSPHAMIDE; OVARY; BLOOD	Decades of research in reproductive biology have led to the generally accepted belief that in female mammals, all surviving germ cells enter meiosis at the end of fetal development and as a result, the postnatal ovary harbours a limited supply of oocytes that cannot be replenished or regenerated if lost to injury or disease. However, recent reports have challenged this view, suggesting instead that oocyte production is maintained through continual seeding of the ovary by circulating, bone-marrow-derived germ cells. To test directly the physiological relevance of circulating cells for female fertility, we established transplantation and parabiotic mouse models to assess the capacity of circulating bone marrow cells to generate ovulated oocytes, both in the steady state and after induced damage. Our studies showed no evidence that bone marrow cells, or any other normally circulating cells, contribute to the formation of mature, ovulated oocytes. Instead, cells that travelled to the ovary through the bloodstream exhibited properties characteristic of committed blood leukocytes.	Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA; Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; Cornell Univ, Weill Med Coll, Ctr Reprod Med & Infertil, New York, NY 10021 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Stowers Institute for Medical Research; Harvard University; Harvard University; Harvard Medical School; Cornell University	Wagers, AJ (corresponding author), Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA.	amy.wagers@joslin.harvard.edu	Min, Irene/AAQ-4186-2021; Eggan, Kevin/P-7119-2018; Jurga, Stefan/E-8862-2017	Min, Irene/0000-0002-1057-4804; Jurga, Stefan/0000-0002-1665-6077				Barlow C, 1998, DEVELOPMENT, V125, P4007; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; BURKL W, 1978, CELL TISSUE RES, V186, P351; Byskov AG, 2005, DIFFERENTIATION, V73, P438, DOI 10.1111/j.1432-0436.2005.00045.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; FRANCHI LL, 1962, DEV OVARY PROCESS OO; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Johnson J, 2005, CELL CYCLE, V4, P1471; MATTISON DR, 1981, RES COMMUN CHEM PATH, V31, P155; Meirow D, 2001, HUM REPROD, V16, P632, DOI 10.1093/humrep/16.4.632; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PETERS H, 1962, NATURE, V195, P915, DOI 10.1038/195915a0; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; SHIROMIZU K, 1984, PEDIATR PHARMACOL, V4, P213; Telfer EE, 2005, CELL, V122, P821, DOI 10.1016/j.cell.2005.09.004; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	21	187	205	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1109	1114		10.1038/nature04929	http://dx.doi.org/10.1038/nature04929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16799565				2022-12-28	WOS:000238615500041
J	Bathgate, AJ				Bathgate, AJ		UK Liver Transplant Units Working	Recommendations for alcohol-related liver disease	LANCET			English	Editorial Material							FOLLOW-UP; TRANSPLANTATION; RELAPSE		Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Bathgate, AJ (corresponding author), Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, Edinburgh EH3 9YW, Midlothian, Scotland.	andybathgate@luht.scot.nhs.uk						Anand AC, 1997, HEPATOLOGY, V25, P1478, DOI 10.1002/hep.510250628; Cuadrado A, 2005, LIVER TRANSPLANT, V11, P420, DOI 10.1002/lt.20386; DiMartini A, 2001, PSYCHOSOMATICS, V42, P55, DOI 10.1176/appi.psy.42.1.55; Foster PF, 1997, HEPATOLOGY, V25, P1469, DOI 10.1002/hep.510250627; GISH RG, 1993, AM J GASTROENTEROL, V88, P1337; Gish RG, 2001, LIVER TRANSPLANT, V7, P581, DOI 10.1053/jlts.2001.25455; Jauhar S, 2004, LIVER TRANSPLANT, V10, P408, DOI 10.1002/lt.20086; Miguet M, 2004, GASTROEN CLIN BIOL, V28, P845, DOI 10.1016/S0399-8320(04)95146-9; Zibari GB, 1996, CLIN TRANSPLANT, V10, P676	9	53	53	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2045	2046		10.1016/S0140-6736(06)68904-6	http://dx.doi.org/10.1016/S0140-6736(06)68904-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798373				2022-12-28	WOS:000238657400010
J	Currie, GP; Lee, DKC; Lipworth, BJ				Currie, Graeme P.; Lee, Daniel K. C.; Lipworth, Brian J.			ABC of chronic obstructive pulmonary disease - Pharmacological management - oral treatment	BRITISH MEDICAL JOURNAL			English	Editorial Material									Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland; Papworth Everard, Papworth Hosp, Dept Resp Med, Cambridge, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Dundee DD1 9SY, Scotland	University of Aberdeen; Papworth Hospital; University of Dundee	Currie, GP (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland.			Currie, Graeme P/0000-0002-5711-9147				Barnes PJ, 2003, AM J RESP CRIT CARE, V167, P813, DOI 10.1164/rccm.200210-1142PP; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Poole PJ, 2001, BMJ-BRIT MED J, V322, P1271, DOI 10.1136/bmj.322.7297.1271; Ram FSF., 2002, COCHRANE DB SYST REV, V2002, pCD003902, DOI DOI 10.1002/14651858.CD003902; Rennard SI, 2004, LANCET, V364, P791, DOI 10.1016/S0140-6736(04)16941-9	5	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 24	2006	332	7556					1497	1499		10.1136/bmj.332.7556.1497	http://dx.doi.org/10.1136/bmj.332.7556.1497			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793814	Green Published			2022-12-28	WOS:000238820200022
J	Moayyedi, P; Talley, NJ				Moayyedi, Paul; Talley, Nicholas J.			Gastro-oesophageal reflux disease	LANCET			English	Review							PROTON-PUMP INHIBITORS; SHORT-TERM TREATMENT; QUALITY-OF-LIFE; HELICOBACTER-PYLORI INFECTION; ESOPHAGEAL CAPSULE ENDOSCOPY; NONCARDIAC CHEST-PAIN; OMEPRAZOLE 40 MG; DOUBLE-BLIND; EROSIVE ESOPHAGITIS; FOLLOW-UP	Gastro-oesophageal reflux disease refers to reflux of gastric contents into the oesophagus leading to oesophagitis, reflux: symptoms sufficient to impair quality of life, or long-term complications. Transient relaxation of the lower oesophageal sphincter is believed to be the primary mechanism of the disease although the underlying cause remains uncertain. Obesity and smoking are weakly associated with the disease and genetic factors might be important. A negative association with Helicobacter pylori exists, but eradication of H pylori does not seem to cause reflux disease. Diagnosis is imprecise as there is no gold standard. Reflux: symptoms are helpful in diagnosis but they lack sensitivity. Ambulatory oesophageal pH monitoring also seems to be insensitive despite high specificity Empirical acid suppression with a proton-pump inhibitor (PPI) has reasonable sensitivity but poor specificity. Some evidence suggests that once patients develop the disease, severity is determined early and patients seem to continue with that phenotype long term. Unfortunately, most patients do not respond to life-style advice and require further therapy. H. receptor antagonists and PPIs are better than placebo in oesophagitis, with a number needed to treat of five and two, respectively. In non-erosive reflux: disease, acid suppression is better than placebo but the response rate is lower. Most patients need long-term treatment because the disease usually relapses. The role of endoscopic therapy is uncertain. Anti-reflux surgery is probably as effective as PPI therapy although there is a low operative mortality and morbidity.	Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Motil Interest Grp, Rochester, MN 55905 USA; McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada	Mayo Clinic; McMaster University	Talley, NJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Motil Interest Grp, Rochester, MN 55905 USA.	talley.nicholas@mayo.edu	Beets, Geerard/G-2682-2013; Talley, Nicholas J/D-5399-2013; Moayyedi, Paul/M-6178-2014	Beets, Geerard/0000-0002-1671-9912; Talley, Nicholas J/0000-0003-2537-3092; Moayyedi, Paul/0000-0002-3616-9292	NIDDK NIH HHS [R01DK 65713-1 A1] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGHAZAHEDI M, IN PRESS COCHRANE DA; Agreus L, 2001, AM J GASTROENTEROL, V96, P2905; Allgood PC, 2000, EUR J SURG, V166, P713; Armbrecht U, 1997, ALIMENT PHARM THERAP, V11, P959, DOI 10.1046/j.1365-2036.1997.00195.x; Armstrong D, 2001, AM J GASTROENTEROL, V96, P2849; Avidan B, 2001, AM J GASTROENTEROL, V96, P41; Barak N, 2002, Obes Rev, V3, P9, DOI 10.1046/j.1467-789X.2002.00049.x; BARDHAN KD, 1995, ALIMENT PHARM THERAP, V9, P145; Barenys M, 2000, EUR J GASTROEN HEPAT, V12, P1275, DOI 10.1097/00042737-200012120-00003; Barlow WJ, 2005, GASTROENTEROLOGY, V128, P771, DOI 10.1053/j.gastro.2004.08.014; BREEN KJ, 1983, MED J AUSTRALIA, V2, P555, DOI 10.5694/j.1326-5377.1983.tb122675.x; BROWN P, 1979, MED J AUSTRALIA, V2, P96, DOI 10.5694/j.1326-5377.1979.tb112743.x; Bytzer P, 1996, EUR J GASTROEN HEPAT, V8, P359, DOI 10.1097/00042737-199604000-00014; Cameron AJ, 2002, GASTROENTEROLOGY, V122, P55, DOI 10.1053/gast.2002.30301; Catarci M, 2004, ANN SURG, V239, P325, DOI 10.1097/01.sla.0000114225.46280.fe; Caviglia R, 2005, AM J GASTROENTEROL, V100, P543, DOI 10.1111/j.1572-0241.2005.40978.x; Chang AB, 2005, COCHRANE DB SYST REV, V2; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Cloud ML, 1998, DIGEST DIS SCI, V43, P993, DOI 10.1023/A:1018822532736; Corley DA, 2003, GASTROENTEROLOGY, V125, P668, DOI 10.1016/S0016-5085(03)01052-7; Cremonini F, 2005, AM J GASTROENTEROL, V100, P1226, DOI 10.1111/j.1572-0241.2005.41657.x; Dean BB, 2004, CLIN GASTROENTEROL H, V2, P656, DOI 10.1016/S1542-3565(04)00288-5; DEHN TCB, 1990, GUT, V31, P509, DOI 10.1136/gut.31.5.509; Delaney B, 2004, BRIT MED J, V328, P1388, DOI 10.1136/bmj.328.7453.1388; Deng J, 2001, BRIT MED J, V322, P344, DOI 10.1136/bmj.322.7282.344; Dent J, 1997, AM J MED, V103, p29S, DOI 10.1016/S0002-9343(97)00317-3; Dent J, 2004, GUT, V53, P1, DOI 10.1136/gut.2003.034272; Dent J, 1999, GUT, V44, pS1, DOI 10.1136/gut.44.2008.S1; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Dettmer A, 1998, ALIMENT PHARM THER, V12, P865, DOI 10.1046/j.1365-2036.1998.00381.x; DeVault KR, 2005, AM J GASTROENTEROL, V100, P190, DOI 10.1111/j.1572-0241.2005.41217.x; Deviere J, 2005, GASTROENTEROLOGY, V128, pA45; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; DOBRILLA G, 1992, ITAL J GASTROENTEROL, V24, P338; DONNELLAN C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003245.PUB2; DUVNJAK M, 2002, PHARMACA, V40, P199; Earnest DL, 1998, AM J GASTROENTEROL, V93, P238, DOI 10.1016/S0002-9270(97)00052-X; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; El-Serag HB, 2005, GUT, V54, P11, DOI 10.1136/gut.2004.040337; El-Serag HB, 1999, AM J GASTROENTEROL, V94, P1771; Eliakim R, 2005, J CLIN GASTROENTEROL, V39, P572, DOI 10.1097/01.mcg.0000170764.29202.24; Farley A, 2000, AM J GASTROENTEROL, V95, P1894; Farrow DC, 2000, CANCER CAUSE CONTROL, V11, P231, DOI 10.1023/A:1008913828105; FELDMAN M, 1993, AM J GASTROENTEROL, V88, P1212; Fennerty M Brian, 2003, Cleve Clin J Med, V70 Suppl 5, pS33; FESTEN HPM, 1980, NETH J MED, V23, P237; Finlayson SRG, 2003, SURG ENDOSC, V17, P864, DOI 10.1007/s00464-002-8965-9; FJOSNE U, 1986, SCAND J GASTROENTERO, V21, P433, DOI 10.3109/00365528609015159; Fletcher J, 2004, GUT, V53, P168, DOI 10.1136/gut.2003.022160; Flum DR, 2002, J AM COLL SURGEONS, V195, P611, DOI 10.1016/S1072-7515(02)01490-4; Fock KM, 2004, J GASTROEN HEPATOL, V19, P357, DOI 10.1111/j.1440-1746.2004.03419.x; Ford AC, 2005, AM J EPIDEMIOL, V162, P454, DOI 10.1093/aje/kwi218; FRAME MH, 1991, EUR J GASTROEN HEPAT, V3, P511; GIBSON PG, 2003, COCHRANE DB SYST REV, V1; GOY JA, 1983, MED J AUSTRALIA, V2, P558, DOI 10.5694/j.1326-5377.1983.tb122676.x; GREEN JRB, 1995, BR J CLIN RES, V6, P63; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Hansen JM, 1998, SCAND J GASTROENTERO, V33, P799; Haque M, 2000, NEW ZEAL MED J, V113, P178; Harvey RF, 2004, BMJ-BRIT MED J, V328, P1417, DOI 10.1136/bmj.38082.626725.EE; HAVELUND T, 1988, BRIT MED J, V296, P89, DOI 10.1136/bmj.296.6615.89; HEIKKINEN M, 1995, SCAND J GASTROENTERO, V30, P519, DOI 10.3109/00365529509089783; HETZEL DJ, 1988, GASTROENTEROLOGY, V95, P903, DOI 10.1016/0016-5085(88)90162-X; HINE KR, 1984, DIGESTION, V29, P119, DOI 10.1159/000199020; Holloway RH, 1997, GUT, V40, P449, DOI 10.1136/gut.40.4.449; Hu WHC, 1997, GASTROENTEROLOGY, V112, pA153; Inadomi JM, 2003, AM J GASTROENTEROL, V98, P1940, DOI 10.1016/S0002-9270(03)00628-2; Jankowski JA, 2000, LANCET, V356, P2079, DOI 10.1016/S0140-6736(00)03411-5; Jankowski JA, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31599; Jansen JBMJ, 1999, ALIMENT PHARM THERAP, V13, P1611; JOHANSSON KE, 1986, SCAND J GASTROENTERO, V21, P769, DOI 10.3109/00365528609011116; Johnson DA, 2005, AM J GASTROENTEROL, V100, P1914, DOI 10.1111/j.1572-0241.2005.00285.x; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; Johnson DA, 2002, AM J GASTROENTEROL, V97, pS12, DOI 10.1016/S0002-9270(02)04470-2; Johnston BT, 1996, AM J GASTROENTEROL, V91, P1181; Jones BH, 2005, AM J GASTROENTEROL, V100, P1058, DOI 10.1111/j.1572-0241.2005.40722.x; Jones MP, 2001, AM J GASTROENTEROL, V96, P1711, DOI 10.1016/S0002-9270(01)02489-3; Junghard O, 2003, SCAND J GASTROENTERO, V38, P1197, DOI 10.1080/00365520310004920; Kahrilas Peter J, 2003, Cleve Clin J Med, V70 Suppl 5, pS4; Kahrilas PJ, 2000, GASTROENTEROLOGY, V118, P688, DOI 10.1016/S0016-5085(00)70138-7; Kahrilas PJ, 2003, AM J GASTROENTEROL, V98, pS15, DOI 10.1016/S0002-9270(03)00011-X; KAHRILAS PJ, 1988, GASTROENTEROLOGY, V94, P73, DOI 10.1016/0016-5085(88)90612-9; Kahrilas PJ, 1996, GASTROENTEROLOGY, V110, P1982, DOI 10.1053/gast.1996.1101982; KAHRILAS PJ, 1990, GUT, V31, P4, DOI 10.1136/gut.31.1.4; Kang JY, 2004, ALIMENT PHARM THER, V20, P705, DOI 10.1111/j.1365-2036.2004.02165.x; Kang JY, 1999, EUR J GASTROEN HEPAT, V11, P845, DOI 10.1097/00042737-199908000-00006; KAR P, 1990, CURR THER RES CLIN E, V47, P731; Katelaris P, 2002, J GASTROEN HEPATOL, V17, P825; Kawano S, 2002, J GASTROEN HEPATOL, V17, P955, DOI 10.1046/j.1440-1746.2002.02785.x; Kennedy T, 2000, ALIMENT PHARM THER, V14, P1589, DOI 10.1046/j.1365-2036.2000.00884.x; KHAN M, IN PRESS COCHRANE DA; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; KLINKENBERGKNOL EC, 1987, LANCET, V1, P349; KOOP H, 1995, J CLIN GASTROENTEROL, V20, P192, DOI 10.1097/00004836-199504000-00005; Kovacs TOG, 2002, ALIMENT PHARM THER, V16, P2043, DOI 10.1046/j.1365-2036.2002.01366.x; Lagergren J, 2000, JAMA-J AM MED ASSOC, V284, P961, DOI 10.1001/jama.284.8.961; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2000, GUT, V47, P26, DOI 10.1136/gut.47.1.26; Lee SJ, 2001, J GASTROEN HEPATOL, V16, P373, DOI 10.1046/j.1440-1746.2001.02464.x; Lee TJ, 2004, ALIMENT PHARM THER, V20, P1241, DOI 10.1111/j.1365-2036.2004.02289.x; LEHTOLA J, 1986, SCAND J GASTROENTERO, V21, P175, DOI 10.3109/00365528609034643; Lieberman DA, 1997, AM J GASTROENTEROL, V92, P1293; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Locke GR, 1999, AM J MED, V106, P642, DOI 10.1016/S0002-9343(99)00121-7; Lundell L, 2001, J AM COLL SURGEONS, V192, P172, DOI 10.1016/S1072-7515(00)00797-3; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Mahmood Z, 2003, GUT, V52, P34, DOI 10.1136/gut.52.1.34; Mahmood Z, 2006, AM J GASTROENTEROL, V101, P431, DOI 10.1111/j.1572-0241.2006.00534.x; Menchen P, 2000, GASTROENTEROLOGY, V118, pA1274; Meneghelli UG, 2002, DIS ESOPHAGUS, V15, P50, DOI 10.1046/j.1442-2050.2002.00225.x; Moayyedi P, 2006, JAMA-J AM MED ASSOC, V295, P1566, DOI 10.1001/jama.295.13.1566; Moayyedi P, 2005, ALIMENT PHARM THER, V22, P11, DOI 10.1111/j.1365-2036.2005.02605.x; Moayyedi P, 2000, LANCET, V355, P1665, DOI 10.1016/S0140-6736(00)02236-4; Moayyedi P, 2004, GUT, V53, P55, DOI 10.1136/gut.2003.034363; Moayyedi P, 1999, AM J GASTROENTEROL, V94, P3122, DOI 10.1111/j.1572-0241.1999.01502.x; MOAYYEDI P, 2004, CLIN EVIDENCE, V11, P583; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; MURPHY DW, 1988, AM J GASTROENTEROL, V83, P633; Nakamura T, 2005, ALIMENT PHARM THER, V21, P19, DOI 10.1111/j.1365-2036.2005.02469.x; Napierkowski J, 2003, AM J MED SCI, V326, P285, DOI 10.1097/00000441-200311000-00005; *NAT I CLIN EXC, DYSP MAN DYSP AD PRI; Neu B, 2003, ENDOSCOPY, V35, P957; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Numans ME, 2003, ALIMENT PHARM THER, V17, P1049, DOI 10.1046/j.1365-2036.2003.01549.x; Orlando RC, 1997, AM J GASTROENTEROL, V92, pS3; Pace F, 2005, ALIMENT PHARM THER, V22, P349, DOI 10.1111/j.1365-2036.2005.02558.x; PALMER RH, 1990, J CLIN GASTROENTEROL, V12, pS29, DOI 10.1097/00004836-199000000-00006; Pandolfino JE, 2003, GASTROENTEROLOGY, V125, P1018, DOI 10.1016/S0016-5085(03)01210-1; Pandolfino John E, 2005, Gastrointest Endosc Clin N Am, V15, P307, DOI 10.1016/j.giec.2004.10.005; Pare P, 2003, J CLIN GASTROENTEROL, V37, P132, DOI 10.1097/00004836-200308000-00008; Park PO, 2005, GASTROENTEROLOGY, V128, pA95; Pehlivanov N, 2001, AM J PHYSIOL-GASTR L, V281, pG743, DOI 10.1152/ajpgi.2001.281.3.G743; PETITE JP, 1991, MED CHIRURGIE DIGEST, V20, P462; QUIK RFP, 1990, ALIMENT PHARM THERAP, V4, P201; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Raghunath AS, 2004, ALIMENT PHARM THER, V20, P733, DOI 10.1111/j.1365-2036.2004.02172.x; Remes-Troche JM, 2005, AM J GASTROENTEROL, V100, P2382, DOI 10.1111/j.1572-0241.2005.00292.x; Richter J, 1999, EUR J GASTROEN HEPAT, V11, pS3; Richter JE, 2003, AM J MED SCI, V326, P300, DOI 10.1097/00000441-200311000-00006; Richter JE, 2000, AM J GASTROENTEROL, V95, P3071; Riddell RH, 1996, AM J SURG PATHOL, V20, pS31; ROBINSON M, 1993, ALIMENT PHARM THER, V7, P67; ROBINSON M, 1995, ALIMENT PHARM THERAP, V9, P25; Romero Y, 1997, GASTROENTEROLOGY, V113, P1449, DOI 10.1053/gast.1997.v113.pm9352846; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Rothstein RI, 2004, GASTROINTEST ENDOSC, V59, pAB111; ROUFAIL W, 1992, ALIMENT PHARM THERAP, V6, P597; Ruhl CE, 1999, ANN EPIDEMIOL, V9, P424, DOI 10.1016/S1047-2797(99)00020-4; Rune S, 2001, AM J GASTROENTEROL, V96, P1417; SABESIN SM, 1991, ARCH INTERN MED, V151, P2394, DOI 10.1001/archinte.151.12.2394; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; SANDMARK S, 1988, SCAND J GASTROENTERO, V23, P625, DOI 10.3109/00365528809093923; Schwartz MP, 2005, GASTROINTEST ENDOSC, V61, pAB95, DOI 10.1016/S0016-5107(05)00641-3; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen N, 2003, AM J MED SCI, V326, P264, DOI 10.1097/00000441-200311000-00002; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; SHERBANIUK R, 1984, J CLIN GASTROENTEROL, V6, P9; Silver MT, 1996, ALIMENT PHARM THERAP, V10, P373, DOI 10.1111/j.0953-0673.1996.00373.x; SIMON TJ, 1994, ALIMENT PHARM THER, V8, P71; Sjostedt S, 2005, ALIMENT PHARM THER, V22, P183, DOI 10.1111/j.1365-2036.2005.02553.x; Smith KJ, 2005, CANCER EPIDEM BIOMAR, V14, P2481, DOI 10.1158/1055-9965.EPI-05-0370; Sonnenberg A, 1999, YALE J BIOL MED, V72, P81; SONTAG S, 1987, ARCH INTERN MED, V147, P1485, DOI 10.1001/archinte.147.8.1485; SONTAG SJ, 1992, GASTROENTEROLOGY, V102, P109, DOI 10.1016/0016-5085(92)91790-B; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; STENELARSEN G, 1988, SCAND J GASTROENTERO, V23, P427, DOI 10.3109/00365528809093890; Suzuki H, 2005, GUT, V54, P1527, DOI 10.1136/gut.2005.066043; Terry P, 2000, NUTR CANCER, V38, P186, DOI 10.1207/S15327914NC382_7; THOMAS FB, 1980, GASTROENTEROLOGY, V79, P1262; Thomson ABR, 2003, ALIMENT PHARM THER, V17, P1481, DOI 10.1046/j.1365-2036.2003.01646.x; Tran T, 2005, AM J GASTROENTEROL, V100, P162, DOI [10.1111/j.1572-0241.2005.40709.x, 10.1111/j.1572-0241.2005.41007.x]; Triadafilopoulos G, 2002, GASTROINTEST ENDOSC, V55, P149, DOI 10.1067/mge.2002.121227; TRIMBLE KC, 1995, GUT, V37, P7, DOI 10.1136/gut.37.1.7; Trudgill NJ, 1999, AM J GASTROENTEROL, V94, P1172, DOI 10.1016/S0002-9270(99)00116-1; *US FDA, CTR DEV RAD HLTH; Vaezi MF, 2004, AM J GASTROENTEROL, V99, P989, DOI 10.1111/j.1572-0241.2004.04166.x; Vaezi MF, 1996, GASTROENTEROLOGY, V111, P1192, DOI 10.1053/gast.1996.v111.pm8898632; Vakil N, 2005, GASTROENTEROLOGY, V128, pA80; Vakil N, 2003, ALIMENT PHARM THERAP, V17, P1427, DOI 10.1046/j.1365-2036.2003.01601.x; van Zanten SJOV, 2005, CAN J GASTROENTEROL, V19, P285, DOI 10.1155/2005/674607; van Zyl JH, 2000, EUR J GASTROEN HEPAT, V12, P197, DOI 10.1097/00042737-200012020-00011; VANPINXTEREN B, 2004, COCHRANE DB SYST REV, V3; VANTRAPPEN G, 1988, DIGEST DIS SCI, V33, P523, DOI 10.1007/BF01798351; Vela MF, 2001, GASTROENTEROLOGY, V120, P1599, DOI 10.1053/gast.2001.24840; VITALE GC, 1987, JAMA-J AM MED ASSOC, V258, P2077, DOI 10.1001/jama.258.15.2077; Wajed SA, 2001, ARCH SURG-CHICAGO, V136, P1014, DOI 10.1001/archsurg.136.9.1014; Wang WH, 2005, ARCH INTERN MED, V165, P1222, DOI 10.1001/archinte.165.11.1222; WESDORP E, 1978, GASTROENTEROLOGY, V74, P821; WIENBECK M, 1989, SCAND J GASTROENTERO, V24, P7, DOI 10.3109/00365528909091032; Wong WM, 2004, J GASTROEN HEPATOL, V19, pS26, DOI 10.1111/j.1440-1746.2004.03588.x; Zacny J, 2005, ALIMENT PHARM THER, V21, P1299, DOI 10.1111/j.1365-2036.2005.02490.x; Zaman A, 1998, AM J GASTROENTEROL, V93, P1260; ZEITOUN P, 1987, LANCET, V2, P621	193	266	279	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2086	2100		10.1016/S0140-6736(06)68932-0	http://dx.doi.org/10.1016/S0140-6736(06)68932-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798392				2022-12-28	WOS:000238657400034
J	Qi, L; Heredia, JE; Altarejos, JY; Screaton, R; Goebel, N; Niessen, S; MacLeod, IX; Liew, CW; Kulkarni, RN; Bain, J; Newgard, C; Nelson, M; Evans, RM; Yates, J; Montminy, M				Qi, Ling; Heredia, Jose E.; Altarejos, Judith Y.; Screaton, Robert; Goebel, Naomi; Niessen, Sherry; MacLeod, Ian X.; Liew, Chong Wee; Kulkarni, Rohit N.; Bain, James; Newgard, Christopher; Nelson, Michael; Evans, Ronald M.; Yates, John; Montminy, Marc			TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism	SCIENCE			English	Article							NEGATIVE REGULATOR; INSULIN-RESISTANCE; TRIBBLES HOMOLOG; GENE-EXPRESSION; ARABIDOPSIS; PHOTOMORPHOGENESIS; MORPHOGENESIS; DROSOPHILA; PROTEIN; COA	During fasting, increased concentrations of circulating catecholamines promote the mobilization of lipid stores from adipose tissue in part by phosphorylating and inactivating acetyl-coenzyme A carboxylase (ACC), the rate-limiting enzyme in fatty acid synthesis. Here, we describe a parallel pathway, in which the pseudokinase Tribbles 3 (TRB3), whose abundance is increased during fasting, stimulates lipolysis by triggering the degradation of ACC in adipose tissue. TRB3 promoted ACC ubiquitination through an association with the E3 ubiquitin ligase constitutive photomorphogenic protein 1 (COP1). Indeed, adipocytes deficient in TRB3 accumulated larger amounts of ACC protein than did wild-type cells. Because transgenic mice expressing TRB3 in adipose tissue are protected from diet-induced obesity due to enhanced fatty acid oxidation, these results demonstrate how phosphorylation and ubiquitination pathways converge on a key regulator of lipid metabolism to maintain energy homeostasis.	Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA	Salk Institute; Salk Institute; Scripps Research Institute; Harvard University; Joslin Diabetes Center, Inc.; Duke University	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Nelson, Michael Shawn/GXF-4934-2022; Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Qi, Ling/0000-0001-8229-0184; Liew, Chong Wee/0000-0001-9904-0958; Bain, James R./0000-0002-8917-9187	NIDDK NIH HHS [DK064142] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064142] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; ENG J, SEQUEST; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Hu JP, 2002, SCIENCE, V297, P405, DOI 10.1126/science.1073633; Kahn C Ronald, 2003, Trans Am Clin Climatol Assoc, V114, P125; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; PEPPER A, 1994, CELL, V78, P109, DOI 10.1016/0092-8674(94)90577-0; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Rorth P, 2000, MOL CELL, V6, P23; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	26	241	255	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1763	1766		10.1126/science.1123374	http://dx.doi.org/10.1126/science.1123374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794074				2022-12-28	WOS:000238452800048
J	Bshary, R; Grutter, AS				Bshary, Redouan; Grutter, Alexandra S.			Image scoring and cooperation in a cleaner fish mutualism	NATURE			English	Article							EVOLUTION; ALTRUISM; RECIPROCITY; PUNISHMENT; HANDICAP; DIET	Humans are highly social animals and often help unrelated individuals that may never reciprocate the altruist's favour(1-5). This apparent evolutionary puzzle may be explained by the altruist's gain in social image: image-scoring bystanders, also known as eavesdroppers, notice the altruistic act and therefore are more likely to help the altruist in the future(5-7). Such complex indirect reciprocity based on altruistic acts may evolve only after simple indirect reciprocity has been established, which requires two steps. First, image scoring evolves when bystanders gain personal benefits from information gathered, for example, by finding cooperative partners(8-10). Second, altruistic behaviour in the presence of such bystanders may evolve if altruists benefit from access to the bystanders. Here, we provide experimental evidence for both of the requirements in a cleaning mutualism involving the cleaner fish Labroides dimidiatus. These cleaners may cooperate and remove ectoparasites from clients or they may cheat by feeding on client mucus(11,12). As mucus may be preferred over typical client ectoparasites(13), clients must make cleaners feed against their preference to obtain a cooperative service. We found that eavesdropping clients spent more time next to 'cooperative' than 'unknown cooperative level' cleaners, which shows that clients engage in image-scoring behaviour. Furthermore, trained cleaners learned to feed more cooperatively when in an `image-scoring' than in a 'non-image-scoring' situation.	Univ Neuchatel, Dept Zool, CH-2009 Neuchatel, Switzerland; Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia	University of Neuchatel; University of Queensland	Bshary, R (corresponding author), Univ Neuchatel, Dept Zool, Rue Emile Argand 11,Case Postale 158, CH-2009 Neuchatel, Switzerland.	redouan.bshary@unine.ch	Grutter, Alexandra S/J-2737-2013	Grutter, Alexandra S/0000-0003-1688-2821; Bshary, Redouan/0000-0001-7198-8472	Natural Environment Research Council [NER/A/S/2002/00898] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alexander R., 1987, BIOL MORAL SYSTEMS; Arnal C, 2000, J FISH BIOL, V57, P1075, DOI 10.1006/jfbi.2000.1371; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Bshary R, 2004, ADV STUD BEHAV, V34, P59, DOI 10.1016/S0065-3454(04)34002-7; Bshary R, 2003, DAHL WS ENV, P167; Bshary R, 2002, P ROY SOC B-BIOL SCI, V269, P2087, DOI 10.1098/rspb.2002.2084; Bshary R., 2005, COMMUNICATION NETWOR, P521; Bshary Redouan, 2001, P146, DOI 10.1017/CBO9780511752421.010; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Dugatkin L.A., 1997, COOPERATION ANIMALS; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Grutter AS, 1997, COPEIA, P346, DOI 10.2307/1447754; Johnstone RA, 2004, P ROY SOC B-BIOL SCI, V271, P1917, DOI 10.1098/rspb.2003.2581; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Lotem A, 2003, P ROY SOC B-BIOL SCI, V270, P199, DOI 10.1098/rspb.2002.2225; MATOS RJ, 2005, ANIMAL COMMUNICATION, P84; McGregor P., 2005, ANIMAL COMMUNICATION; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	28	253	260	0	139	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					975	978		10.1038/nature04755	http://dx.doi.org/10.1038/nature04755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791194	Green Submitted			2022-12-28	WOS:000238422300041
J	Fialko, Y				Fialko, Yuri			Interseismic strain accumulation and the earthquake potential on the southern San Andreas fault system	NATURE			English	Article							AMERICA PLATE BOUNDARY; HECTOR MINE EARTHQUAKE; NORTHERN CALIFORNIA; CRUSTAL DEFORMATION; FRANCISCO; SLIP; RECURRENCE; CHRONOLOGY; PACIFIC; RATES	The San Andreas fault in California is a mature continental transform fault that accommodates a significant fraction of motion between the North American and Pacific plates. The two most recent great earthquakes on this fault ruptured its northern and central sections in 1906 and 1857, respectively. The southern section of the fault, however, has not produced a great earthquake in historic times ( for at least 250 years). Assuming the average slip rate of a few centimetres per year, typical of the rest of the San Andreas fault, the minimum amount of slip deficit accrued on the southern section is of the order of 7 - 10 metres, comparable to the maximum co-seismic offset ever documented on the fault(1,2). Here I present high-resolution measurements of interseismic deformation across the southern San Andreas fault system using a well-populated catalogue of space-borne synthetic aperture radar data. The data reveal a nearly equal partitioning of deformation between the southern San Andreas and San Jacinto faults, with a pronounced asymmetry in strain accumulation with respect to the geologically mapped fault traces. The observed strain rates confirm that the southern section of the San Andreas fault may be approaching the end of the interseismic phase of the earthquake cycle.	Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Fialko, Y (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	yfialko@ucsd.edu	Fialko, Yuri/B-9567-2012	Fialko, Yuri/0000-0002-6161-8467				Ben-Zion Y, 1998, B SEISMOL SOC AM, V88, P1085; Bennett RA, 2004, GEOLOGY, V32, P961, DOI 10.1130/G20806.1; Bennett RA, 1996, J GEOPHYS RES-SOL EA, V101, P21943, DOI 10.1029/96JB02488; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; Fialko Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002756; Fialko Y, 2005, NATURE, V435, P295, DOI 10.1038/nature03425; Fialko Y, 2005, GEOPHYS J INT, V160, P527, DOI 10.1111/j.1365-246X.2004.02511.x; Fialko Y, 2002, SCIENCE, V297, P1858, DOI 10.1126/science.1074671; Fialko Y, 2001, GEOPHYS RES LETT, V28, P3063, DOI 10.1029/2001GL013174; Freymueller JT, 1999, J GEOPHYS RES-SOL EA, V104, P7419, DOI 10.1029/1998JB900118; Hauksson E, 2000, J GEOPHYS RES-SOL EA, V105, P13875, DOI 10.1029/2000JB900016; JACKSON DD, 1995, B SEISMOL SOC AM, V85, P379; JOHNSON HO, 1994, J GEOPHYS RES-SOL EA, V99, P23951, DOI 10.1029/94JB01902; Kenner SJ, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000189; Le Pichon X, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003343; LI VC, 1987, J GEOPHYS RES-SOLID, V92, P11533, DOI 10.1029/JB092iB11p11533; LISOWSKI M, 1991, J GEOPHYS RES-SOLID, V96, P8369, DOI 10.1029/91JB00199; LYONS S, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2002JB001831; Murray J, 2002, NATURE, V419, P287, DOI 10.1038/nature00984; PRESCOTT WH, 1986, J GEOPHYS RES-SOLID, V91, P7475, DOI 10.1029/JB091iB07p07475; Richards-Dinger KB, 2000, J GEOPHYS RES-SOL EA, V105, P10939, DOI 10.1029/2000JB900014; SHARP RV, 1967, GEOL SOC AM BULL, V78, P705, DOI 10.1130/0016-7606(1967)78[705:SJFZIT]2.0.CO;2; SIEH K, 1989, J GEOPHYS RES-SOLID, V94, P603, DOI 10.1029/JB094iB01p00603; THATCHER W, 1995, J GEOPHYS RES-SOL EA, V100, P3885, DOI 10.1029/94JB03064; THATCHER W, 1987, J GEOPHYS RES-SOLID, V92, P4771, DOI 10.1029/JB092iB06p04771; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; van der Woerd J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003559; WATERS MR, 1983, QUATERNARY RES, V19, P373, DOI 10.1016/0033-5894(83)90042-X; Weldon R., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)014%3C4:watecw%3E2.0.co;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2,2004]; WELDON RJ, 1985, GEOL SOC AM BULL, V96, P793, DOI 10.1130/0016-7606(1985)96<793:HROSAT>2.0.CO;2; Weldon RJ, 2005, SCIENCE, V308, P966, DOI 10.1126/science.1111707; YULE D, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2001JB000451	33	302	316	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					968	971		10.1038/nature04797	http://dx.doi.org/10.1038/nature04797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791192	Green Submitted			2022-12-28	WOS:000238422300039
J	Gnone, G; Moriconi, T; Gambini, G				Gnone, G; Moriconi, T; Gambini, G			Activity and sleep in dolphins	NATURE			English	Letter									Acquario Genova, Area Porto Antico Ponte Spinola, I-16128 Genoa, Italy		Gnone, G (corresponding author), Acquario Genova, Area Porto Antico Ponte Spinola, I-16128 Genoa, Italy.	ggnone@acquariodigenova.it						FLANIGAN WF, 1974, SLEEP RES, V3, P84; Gnone Guido, 2001, Aquatic Mammals, V27, P29; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; Mukhametov L. M., 1994, Journal of Sleep Research, V3, P174; Mukhametov L. M., 1984, EXPT BRAIN RES S, P227, DOI [10.1007/978-3-[ 642-69554-4_17spinal, DOI 10.1007/978-3-642-69554-E]; MUKHAMETOV LM, 1988, NEUROPHYSIOLOGY+, V20, P398, DOI 10.1007/BF02198450; MUKHAMETOV LM, 1977, BRAIN RES, V134, P581, DOI 10.1016/0006-8993(77)90835-6; MUKHAMETOV LM, 1995, SLEEP RES A, V24, P202; Sekiguchi Y, 2003, PHYSIOL BEHAV, V79, P643, DOI 10.1016/S0031-9384(03)00119-7	9	19	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					E10	E11		10.1038/nature04899	http://dx.doi.org/10.1038/nature04899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791148				2022-12-28	WOS:000238422300032
J	Marinov, I; Gnanadesikan, A; Toggweiler, JR; Sarmiento, JL				Marinov, I; Gnanadesikan, A; Toggweiler, JR; Sarmiento, JL			The Southern Ocean biogeochemical divide	NATURE			English	Article							ATMOSPHERIC CO2; THERMOHALINE CIRCULATION; CARBON-DIOXIDE; HIGH-LATITUDE; MODELS; VENTILATION; THERMOCLINE; WATER; PUMP	Modelling studies have demonstrated that the nutrient and carbon cycles in the Southern Ocean play a central role in setting the air - sea balance of CO2 and global biological production(1-8). Box model studies(1-4) first pointed out that an increase in nutrient utilization in the high latitudes results in a strong decrease in the atmospheric carbon dioxide partial pressure (p(CO2)). This early research led to two important ideas: high latitude regions are more important in determining atmospheric p(CO2) than low latitudes, despite their much smaller area, and nutrient utilization and atmospheric p(CO2) are tightly linked. Subsequent general circulation model simulations show that the Southern Ocean is the most important high latitude region in controlling preindustrial atmospheric CO2 because it serves as a lid to a larger volume of the deep ocean(5,6). Other studies point out the crucial role of the Southern Ocean in the uptake and storage of anthropogenic carbon dioxide(7) and in controlling global biological production(8). Here we probe the system to determine whether certain regions of the Southern Ocean are more critical than others for air - sea CO2 balance and the biological export production, by increasing surface nutrient drawdown in an ocean general circulation model. We demonstrate that atmospheric CO2 and global biological export production are controlled by different regions of the Southern Ocean. The air - sea balance of carbon dioxide is controlled mainly by the biological pump and circulation in the Antarctic deep-water formation region, whereas global export production is controlled mainly by the biological pump and circulation in the Subantarctic intermediate and mode water formation region. The existence of this biogeochemical divide separating the Antarctic from the Subantarctic suggests that it may be possible for climate change or human intervention to modify one of these without greatly altering the other.	Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08540 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA	Marinov, I (corresponding author), MIT, Program Atmospheres Oceans & Climate, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	imarinov@mit.edu	Toggweiler, J. R./O-5883-2019; Gnanadesikan, Anand/A-2397-2008	Toggweiler, J. R./0000-0001-6345-5756; Gnanadesikan, Anand/0000-0001-5784-1116				Caldeira K, 2000, SCIENCE, V287, P620, DOI 10.1126/science.287.5453.620; Dutkiewicz S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002342; Gnanadesikan A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018036; Gnanadesikan A, 2001, DEEP-SEA RES PT II, V49, P363; Gordon A. L., 1971, ANTARCTIC RES SERIES, VI, DOI 10.1029/AR015p0169; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; JOOS F, 1991, NATURE, V349, P772, DOI 10.1038/349772a0; KNOX F, 1984, J GEOPHYS RES-ATMOS, V89, P4629, DOI 10.1029/JD089iD03p04629; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; MARINOV I, 2005, THESIS PRINCETON U; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Najjar R., 1998, DESIGN OCMIP 2 SIMUL; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SARMIENTO JL, 1984, NATURE, V308, P620; SCHMITZ WJ, 1995, REV GEOPHYS, V33, P151, DOI 10.1029/95RG00879; SIEGENTHALER U, 1984, NATURE, V308, P624, DOI 10.1038/308624a0; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P143, DOI 10.1175/1520-0485(2001)031<0143:TSOLOT>2.0.CO;2; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Sverdrup H.U., 1942, OCEANS THEIR PHYS CH, P1065; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001841; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; WYRTKI K, 1961, DEEP-SEA RES, V8, P39, DOI 10.1016/0146-6313(61)90014-4	28	216	223	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					964	967		10.1038/nature04883	http://dx.doi.org/10.1038/nature04883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791191				2022-12-28	WOS:000238422300038
J	Herbert, KM; La Porta, A; Wong, BJ; Mooney, RA; Neuman, KC; Landick, R; Block, SM				Herbert, Kristina M.; La Porta, Arthur; Wong, Becky J.; Mooney, Rachel A.; Neuman, Keir C.; Landick, Robert; Block, Steven M.			Sequence-resolved detecton of pausing by single RNA polymerase molecules	CELL			English	Article							TRANSCRIPTION ELONGATION; II ELONGATION; DNA HYBRID; IN-VIVO; TERMINATION; PROMOTER; SITE; REGULATOR; COMPLEXES; ARREST	Transcriptional pausing by RNA polymerase (RNAP) plays an important role in the regulation of gene expression. Defined, sequence-specific pause sites have been identified biochemically. Single-molecule studies have also shown that bacterial RNAP pauses frequently during transcriptional elongation, but the relationship of these "ubiquitous" pauses to the underlying DNA sequence has been uncertain. We employed an ultrastable optical-trapping assay to follow the motion of individual molecules of RNAP transcribing templates engineered with repeated sequences carrying imbedded, sequence-specific pause sites of known regulatory function. Both the known and ubiquitous pauses appeared at reproducible locations, identified with base-pair accuracy. Ubiquitous pauses were associated with DNA sequences that show similarities to regulatory pause sequences. Data obtained for the lifetimes and efficiencies of pauses support a model where the transition to pausing branches off of the normal elongation pathway and is mediated by a common elemental state, which corresponds to the ubiquitous pause.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Biophys Program, Stanford, CA 94305 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Herbert, KM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	sblock@stanford.edu	Neuman, Keir C./F-7400-2011; Herbert, Kristina/A-3105-2010	Neuman, Keir C./0000-0002-0863-5671; Herbert, Kristina/0000-0002-5288-3381	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057035] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; AIVAZASHVILI V A, 1981, Molekulyarnaya Biologiya (Moscow), V15, P653; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bailey MJA, 1997, MOL MICROBIOL, V26, P845, DOI 10.1046/j.1365-2958.1997.6432014.x; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chamberlin M., 1976, RNA POLYMERASE, V6, P193; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DEMERCOYROL L, 1990, BIOCHEM J, V269, P651, DOI 10.1042/bj2690651; Erie DA, 2002, BBA-GENE STRUCT EXPR, V1577, P224, DOI 10.1016/S0167-4781(02)00454-2; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; Harrington KJ, 2001, P NATL ACAD SCI USA, V98, P5019, DOI 10.1073/pnas.240431598; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Landick R, 1996, ESCHERICHIA COLI SAL, P1263; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Pasman Z, 2002, J MOL BIOL, V322, P505, DOI 10.1016/S0022-2836(02)00814-8; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Tang HB, 2000, MOL CELL BIOL, V20, P2569, DOI 10.1128/MCB.20.7.2569-2580.2000; Tolic-Norrelykke SF, 2004, J BIOL CHEM, V279, P3292, DOI 10.1074/jbc.M310290200; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; VONHIPPEL PH, 1991, P NATL ACAD SCI USA, V88, P2307, DOI 10.1073/pnas.88.6.2307; VONHIPPEL PH, 1992, SCIENCE, V255, P809, DOI 10.1126/science.1536005; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	221	232	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1083	1094		10.1016/j.cell.2006.04.032	http://dx.doi.org/10.1016/j.cell.2006.04.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777599	Bronze, Green Accepted			2022-12-28	WOS:000238602700014
J	Sabeti, PC; Schaffner, SF; Fry, B; Lohmueller, J; Varilly, P; Shamovsky, O; Palma, A; Mikkelsen, TS; Altshuler, D; Lander, ES				Sabeti, P. C.; Schaffner, S. F.; Fry, B.; Lohmueller, J.; Varilly, P.; Shamovsky, O.; Palma, A.; Mikkelsen, T. S.; Altshuler, D.; Lander, E. S.			Positive natural selection in the human lineage	SCIENCE			English	Review							BLOOD-GROUP LOCUS; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; DARWINIAN SELECTION; NUCLEOTIDE SUBSTITUTION; MOLECULAR EVOLUTION; POPULATION-GENETICS; HAPLOTYPE STRUCTURE; ADAPTIVE EVOLUTION; PROTEIN EVOLUTION	Positive natural selection is the force that drives the increase in prevalence of advantageous traits, and it has played a central role in our development as a species. Until recently, the study of natural selection in humans has largely been restricted to comparing individual candidate genes to theoretical expectations. The advent of genome-wide sequence and polymorphism data brings fundamental new tools to the study of natural selection. It is now possible to identify new candidates for selection and to reevaluate previous claims by comparison with empirical distributions of DNA sequence variation across the human genome and among populations. The flood of data and analytical methods, however, raises many new challenges. Here, we review approaches to detect positive natural selection, describe results from recent analyses of genomewide data, and discuss the prospects and challenges ahead as we expand our understanding of the role of natural selection in shaping the human genome.	Harvard Univ, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Brown Univ, Providence, RI 02912 USA; Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School	Schaffner, SF (corresponding author), MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sfs@broad.mit.edu	Schaffner, Stephen F/D-1189-2011; Mikkelsen, Tarjei S/A-1306-2007; Sabeti, Pardis/GQH-8610-2022; Altshuler, David M/A-4476-2009; Varilly, Patrick/C-8118-2013	Mikkelsen, Tarjei S/0000-0002-8133-3135; Altshuler, David M/0000-0002-7250-4107; Varilly, Patrick/0000-0003-4619-8174; Schaffner, Stephen/0000-0001-6699-3568				Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arya R, 2004, AM J HUM GENET, V74, P272, DOI 10.1086/381717; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; CAVALLISFORZA L, 1994, HIST GEOGRAPHY HUMA; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Darwin C., 1858, J P LINNEAN SOC LOND, V3, P45, DOI DOI 10.1111/J.1096-3642.1858.TB02500.X; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hanchard NA, 2006, AM J HUM GENET, V78, P153, DOI 10.1086/499252; Hartl D., 1989, PRINCIPLES POPULATIO; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1987, GENETICS, V116, P153; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; INGRAM VM, 1959, BIOCHIM BIOPHYS ACTA, V36, P402, DOI 10.1016/0006-3002(59)90183-0; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEWONTIN RC, 1973, GENETICS, V74, P175; LI WH, 1985, MOL BIOL EVOL, V2, P150; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2005, PLOS GENET, V1, P413, DOI 10.1371/journal.pgen.0010054; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; NEI M, 1987, MOL EVOLUTIONARY ENE; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; NIELSEN R, 2005, ANN REV GENET   0831; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Przeworski M, 2002, GENETICS, V160, P1179; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Ronald James, 2005, Human Genomics, V2, P113; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; TAJIMA F, 1989, GENETICS, V123, P585; TESHIMA KM, 2006, GENOME RES      0510; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Toomajian C, 2003, GENETICS, V165, P287; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yauk CL, 2003, EMBO J, V22, P1389, DOI 10.1093/emboj/cdg136; Zhang JZ, 2002, GENETICS, V162, P1825	73	772	790	7	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1614	1620		10.1126/science.1124309	http://dx.doi.org/10.1126/science.1124309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778047				2022-12-28	WOS:000238288600035
J	Walsh, BT; Kaplan, AS; Attia, E; Olmsted, M; Parides, M; Carter, JC; Pike, KM; Devlin, MJ; Woodside, B; Roberto, CA; Rockert, W				Walsh, B. Timothy; Kaplan, Allan S.; Attia, Evelyn; Olmsted, Marion; Parides, Michael; Carter, Jacqueline C.; Pike, Kathleen M.; Devlin, Michael J.; Woodside, Blake; Roberto, Christina A.; Rockert, Wendi			Fluoxetine after weight restoration in anorexia nervosa - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EATING-DISORDERS; FOLLOW-UP; AMENORRHEA; INVENTORY; THERAPY; FEAR	Context Antidepressant medication is frequently prescribed for patients with anorexia nervosa. Objective To determine whether fluoxetine can promote recovery and prolong time-to-relapse among patients with anorexia nervosa following weight restoration. Design, Setting, and Participants Randomized, double-blind, placebo-controlled trial. From January 2000 until May 2005, 93 patients with anorexia nervosa received intensive inpatient or day-program treatment at the New York State Psychiatric Institute or Toronto General Hospital. Participants regained weight to a minimum body mass index ( calculated as weight in kilograms divided by the square of height in meters) of 19.0 and were then eligible to participate in the randomized phase of the trial. Interventions Participants were randomly assigned to receive fluoxetine or placebo and were treated for up to 1 year as outpatients in double-blind fashion. All patients also received individual cognitive behavioral therapy. Main Outcome Measures The primary outcome measures were time-to-relapse and the proportion of patients successfully completing 1 year of treatment. Results Forty-nine patients were assigned to fluoxetine and 44 to placebo. Similar percentages of patients assigned to fluoxetine and to placebo maintained a body mass index of at least 18.5 and remained in the study for 52 weeks ( fluoxetine, 26.5%; placebo, 31.5%; P=. 57). In a Cox proportional hazards analysis, with prerandomization body mass index, site, and diagnostic subtype as covariates, there was no significant difference between fluoxetine and placebo in time-to-relapse ( hazard ratio, 1.12; 95% CI, 0.65- 2.01; P=. 64). Conclusions This study failed to demonstrate any benefit from fluoxetine in the treatment of patients with anorexia nervosa following weight restoration. Future efforts should focus on developing new models to understand the persistence of this illness and on exploring new psychological and pharmacological treatment approaches.	Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Univ Toronto, Toronto, ON, Canada; Toronto Gen Hosp, Toronto, ON, Canada	Columbia University; New York State Psychiatry Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Walsh, BT (corresponding author), Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr,Unit 98, New York, NY 10032 USA.	btw1@columbia.edu	Parides, Michael/GON-8474-2022		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060271, R01MH060336] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60336, MH060271] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Attia E, 1998, AM J PSYCHIAT, V155, P548, DOI 10.1176/ajp.155.4.548; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Cachelin FM, 1998, J PSYCHOSOM RES, V44, P435, DOI 10.1016/S0022-3999(97)00268-7; ECKERT ED, 1995, PSYCHOL MED, V25, P143, DOI 10.1017/S0033291700028166; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Garfinkel PE, 1996, BRIT J PSYCHIAT, V168, P500, DOI 10.1192/bjp.168.4.500; Garner D. M., 1984, EATING DISORDER INVE; HALMI KA, 1991, ARCH GEN PSYCHIAT, V48, P712; Holtkamp K, 2005, J PSYCHIATR RES, V39, P303, DOI 10.1016/j.jpsychires.2004.08.001; JONES LM, 1993, BEHAV CHANGE, V10, P93; KAYE WH, 1991, J CLIN PSYCHIAT, V52, P464; Kaye WH, 2001, BIOL PSYCHIAT, V49, P644, DOI 10.1016/S0006-3223(00)01013-1; Koran LM, 1996, AM J PSYCHIAT, V153, P1450; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Lock J, 2005, INT J EAT DISORDER, V37, pS64, DOI 10.1002/eat.20122; MAZURE CM, 1994, J PSYCHIATR RES, V28, P425, DOI 10.1016/0022-3956(94)90002-7; McIntosh VVW, 2005, AM J PSYCHIAT, V162, P741, DOI 10.1176/appi.ajp.162.4.741; Pike KM, 2003, AM J PSYCHIAT, V160, P2046, DOI 10.1176/appi.ajp.160.11.2046; Pike KM, 1998, CLIN PSYCHOL REV, V18, P447, DOI 10.1016/S0272-7358(98)00014-2; Powers PS, 2002, INT J EAT DISORDER, V32, P146, DOI 10.1002/eat.10084; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Rosenberg M., 1979, CONCEIVING SELF; RUSSELL GFM, 1987, ARCH GEN PSYCHIAT, V44, P1047; STEINGLASS JE, IN PRESS J INT NEURO; Strober M, 2004, INT J EAT DISORDER, V35, P504, DOI 10.1002/eat.20029; Strober M, 1997, PSYCHOPHARMACOL BULL, V33, P425; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Tchanturia K, 2002, Eat Weight Disord, V7, P312; Watson TL, 2003, ACTA PSYCHIAT SCAND, V108, P175, DOI 10.1034/j.1600-0447.2003.00201.x; Zhu AJ, 2002, CAN J PSYCHIAT, V47, P227, DOI 10.1177/070674370204700302	31	240	251	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2605	2612		10.1001/jama.295.22.2605	http://dx.doi.org/10.1001/jama.295.22.2605			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HI	16772623	Bronze			2022-12-28	WOS:000238224000022
J	Connolly, S; Pogue, J; Hart, R; Pfeffer, M; Hohnloser, S; Chrolavicius, S; Yusuf, S				Connolly, S.; Pogue, J.; Hart, R.; Pfeffer, M.; Hohnloser, S.; Chrolavicius, S.; Yusuf, S.		Active Writing Grp; ACTIVE Investigators	Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial	LANCET			English	Article							MYOCARDIAL-INFARCTION; STROKE; THERAPY; WARFARIN	Background Oral anticoagulation therapy reduces risk of vascular events in patients with atrial fibrillation. However, long-term monitoring is necessary and many patients cannot achieve optimum anticoagulation. We assessed whether clopidogrel plus aspirin was non-inferior to oral anticoagulation therapy for prevention of vascular events. Methods Patients were enrolled if they had atrial fibrillation plus one or more risk factor for stroke, and were randomly allocated to receive oral anticoagulation therapy (target international normalised ratio of 2.0-3.0; n=3371) or clopidogrel (75 mg per day) plus aspirin (75-100 mg per day recommended; n=3335). Outcome events were adjudicated by a blinded committee. Primary outcome was first occurrence of stroke, non-CNS systemic embolus, myocardial infarction, or vascular death. Analyses were by intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT00243178. Results The study was stopped early because of clear evidence of superiority of oral anticoagulation therapy. There were 165 primary events in patients on oral anticoagulation therapy (annual risk 3.93%) and 234 in those on clopidogrel plus aspirin (annual risk 5.60%; relative risk 1.44 (1.18-1.76; p=0.0003). Patients on oral anticoagulation therapy who were already receiving this treatment at study entry had a trend towards a greater reduction in vascular events (relative risk 1.50, 95% CI 1.19-1.80) and a significantly (p=0.03 for interaction) lower risk of major bleeding with oral anticoagulation therapy (1.30; 0.94-1.79) than patients not on this treatment at study entry (1.27, 0.85-1.89 and 0.59, 0.32-1.08, respectively). Conclusion Oral anticoagulation therapy is superior to clopidogrel plus aspirin for prevention of vascular events in patients with atrial fibrillation at high risk of stroke, especially in those already taking oral anticoagulation therapy.	Populat Hlth Res Inst, Hamilton, ON, Canada; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Johann Wolfgang Goethe Univ Hosp, Dept Med, Frankfurt, Germany	Population Health Research Institute; University of Texas System; University of Texas Health San Antonio; Harvard University; Brigham & Women's Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Connolly, S (corresponding author), Hamilton Hlth Sci Corp, Hamilton Gen Site,237 Barton St E, Hamilton, ON L8L 2X2, Canada.		Manolis, Antonis/F-5003-2014	Manolis, Antonis/0000-0002-0336-4745; Yusuf, Salim/0000-0003-4776-5601				Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Blackshear JL, 1996, LANCET, V348, P633; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Chen ZM, 2005, LANCET, V366, P1622; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Krumholz HM, 2006, J AM COLL CARDIOL, V47, P236, DOI 10.1016/j.jacc.2005.10.020; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Patrono C, 1998, CHEST, V114, p470S, DOI 10.1378/chest.114.5_Supplement.470S; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yusuf S, 2001, NEW ENGL J MED, V345, P494	19	1469	1535	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1903	1912		10.1016/s0140-6736(06)68845-4	http://dx.doi.org/10.1016/s0140-6736(06)68845-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765759				2022-12-28	WOS:000238194400029
J	Davis, CS; McGillicuddy, DJ				Davis, Cabell S.; McGillicuddy, Dennis J., Jr.			Transatlantic abundance of the N-2-fixing colonial cyanobacterium Trichodesmium	SCIENCE			English	Article							NITROGEN-FIXATION; OSCILLATORIA TRICHODESMIUM; WESTERN SARGASSO; N-2 FIXATION; ATLANTIC; SPP.; THIEBAUTII; TAXA	Colonial diazotrophic cyanobacteria of the genus Trichodesmium are thought to play a significant role in the input of new nitrogen to upper layers of the tropical and subtropical oceanic ecosystems that cover nearly half of Earth's surface. Here we describe results of a transatlantic survey in which a noninvasive underwater digital microscope ( the video plankton recorder), was towed across the North Atlantic at 6 meters per second while undulating between the surface and 130 meters. Colony abundance had a basin-scale trend, a clear association with anticyclonic eddies, and was not affected by hurricane-forced mixing. Subsurface abundance was higher than previously reported, which has important implications for the global ocean nitrogen cycle.	Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Davis, CS (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	cdavis@whoi.edu		McGillicuddy, Dennis/0000-0002-1437-2425				Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 1998, MAR ECOL PROG SER, V172, P281, DOI 10.3354/meps172281; Carpenter E. J., 1983, NITROGEN MARINE ENV, P65; CARPENTER EJ, 1976, SCIENCE, V191, P1278, DOI 10.1126/science.1257749; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; CARPENTER EJ, 1995, MAR ECOL PROG SER, V118, P267, DOI 10.3354/meps118267; CARPENTER EJ, 1975, LIMNOL OCEANOGR, V20, P389, DOI 10.4319/lo.1975.20.3.0389; CARPENTER EJ, 1977, LIMNOL OCEANOGR, V22, P60, DOI 10.4319/lo.1977.22.1.0060; Chang J, 2000, J EXP MAR BIOL ECOL, V245, P215, DOI 10.1016/S0022-0981(99)00163-X; COLES VJ, 2004, J GEOPHYS RES-OCEANS, V109, P1; Davis CS, 2005, LIMNOL OCEANOGR-METH, V3, P59, DOI 10.4319/lom.2005.3.59; Davis CS, 2004, MAR ECOL PROG SER, V284, P77, DOI 10.3354/meps284077; DAVIS CS, 1992, SCIENCE, V257, P230, DOI 10.1126/science.257.5067.230; Falcon LI, 2004, APPL ENVIRON MICROB, V70, P765, DOI 10.1128/AEM.70.2.765-770.2004; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Hood R. R., 2004, J GEOPHYS RES, V109, P1; Hood RR, 2001, DEEP-SEA RES PT II, V49, P123; JENKINS WJ, 1988, NATURE, V331, P521, DOI 10.1038/331521a0; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; MCCARTHY JJ, 1979, J PHYCOL, V15, P75, DOI 10.1111/j.0022-3646.1979.00075.x; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Orcutt KM, 2001, DEEP-SEA RES PT II, V48, P1583, DOI 10.1016/S0967-0645(00)00157-0; Post AF, 2002, MAR ECOL PROG SER, V239, P241, DOI 10.3354/meps239241; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; SATHYENDRANATH S, 1991, NATURE, V349, P54, DOI 10.1038/349054a0; Tyrrell T, 2003, J PLANKTON RES, V25, P405, DOI 10.1093/plankt/25.4.405	29	138	147	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1517	1520		10.1126/science.1123570	http://dx.doi.org/10.1126/science.1123570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763148				2022-12-28	WOS:000238124100046
J	Tokura, Y				Tokura, Yoshinori			Multiferroics as quantum electromagnets	SCIENCE			English	Editorial Material									Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; Japan Sci & Technol Corp, Spin Superstruct Project, Exploratory Res Adv Technol Off, Tsukuba, Ibaraki 3058562, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Tokura, Y (corresponding author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tokura@ap.t.u-tokyo.ac.jp	Tokura, Yoshinori/C-7352-2009	Tokura, Yoshinori/0000-0002-2732-4983				Curie P., 1894, J PHYS-PARIS, V3, P393, DOI DOI 10.1051/JPHYSTAP:018940030039300; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Hur N, 2004, NATURE, V429, P392, DOI 10.1038/nature02572; Jung JH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.037403; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Lawes G, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087205	7	382	391	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1481	+		10.1126/science.1125227	http://dx.doi.org/10.1126/science.1125227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763137				2022-12-28	WOS:000238124100033
J	Salvana, EMT				Salvana, EMT			Patent ductus arteriosus in an elderly man	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Salvana, EMT (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2484	2484		10.1056/NEJMicm050276	http://dx.doi.org/10.1056/NEJMicm050276			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760448				2022-12-28	WOS:000238100800010
J	Stevens, LA; Coresh, J; Greene, T; Levey, AS				Stevens, Lesley A.; Coresh, Josef; Greene, Tom; Levey, Andrew S.			Medical progress - Assessing kidney function - Measured and estimated glomerular filtration rate	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC RENAL-INSUFFICIENCY; COCKCROFT-GAULT EQUATIONS; SERUM CYSTATIN-C; CREATININE CLEARANCE; CARDIOVASCULAR-DISEASE; RISK-FACTOR; PREDICTIVE PERFORMANCE; PRACTICE GUIDELINES; ESTIMATING GFR; DIET		Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA	Tufts Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Cleveland Clinic Foundation	Stevens, LA (corresponding author), Tufts Univ New England Med Ctr, Div Nephrol, 750 Washington St,Box 391, Boston, MA 02111 USA.	lstevens1@tufts-nemc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK053869, U01DK067651, R21DK067651] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; Anavekar N, 2005, MED J AUSTRALIA, V183, P138, DOI 10.5694/j.1326-5377.2005.tb06958.x; [Anonymous], 2004, AM J KIDNEY DIS, V43, pS1; BERGLUND F, 1975, J UROLOGY, V114, P802, DOI 10.1016/S0022-5347(17)67149-0; Bokenkamp A, 1999, CLIN CHEM, V45, P1866; Bostom AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022011.35035.F3; *BRIT COL MIN HLTH, GUID PROT ADV COMM I; BROSIUS FC, IN PRESS CIRCULATION; Cameron JS, 1999, NEPHROL DIAL TRANSPL, V14, P61, DOI 10.1093/ndt/14.suppl_2.61; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cirillo M, 2005, NEPHROL DIAL TRANSPL, V20, P1791, DOI 10.1093/ndt/gfh962; Clase CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013291.78621.26; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2004, CURR OPIN NEPHROL HY, V13, P73, DOI 10.1097/00041552-200401000-00011; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2002, J AM SOC NEPHROL, V13, P2811, DOI 10.1097/01.ASN.0000037420.89149.C9; Coresh J, 1998, AM J KIDNEY DIS, V32, P32, DOI 10.1053/ajkd.1998.v32.pm9669421; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Fehrman-Ekholm I, 2004, SCAND J UROL NEPHROL, V38, P73, DOI 10.1080/00365590310015750; Filler G, 2003, PEDIATR NEPHROL, V18, P981, DOI 10.1007/s00467-003-1271-5; Finney H, 1997, CLIN CHEM, V43, P1016; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Gaspari F, 2004, AM J TRANSPLANT, V4, P1826, DOI 10.1111/j.1600-6143.2004.00579.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gonwa T, 2004, LIVER TRANSPLANT, V10, P301, DOI 10.1002/lt.20017; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; Grubb A, 2005, SCAND J CLIN LAB INV, V65, P153, DOI 10.1080/00365510510013596; Grubb A O, 2000, Adv Clin Chem, V35, P63; Hallan S, 2004, AM J KIDNEY DIS, V44, P84, DOI 10.1053/j.ajkd.2004.03.027; Ibrahim H, 2005, J AM SOC NEPHROL, V16, P1051, DOI 10.1681/ASN.2004080692; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; Jafar TH, 2003, KIDNEY INT, V64, P1437, DOI 10.1046/j.1523-1755.2003.00212.x; Jones, 2000, AM J KIDNEY DIS, V35, P178; Keevil BG, 1998, CLIN CHEM, V44, P1535; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Lamb EJ, 2003, J AM GERIATR SOC, V51, P1012, DOI 10.1046/j.1365-2389.2003.51330.x; Laterza OF, 2002, CLIN CHEM, V48, P699; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2003, ANN INTERN MED, V139, P605, DOI 10.7326/0003-4819-139-7-200310070-00029; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEVEY AS, 1990, KIDNEY INT, V38, P167, DOI 10.1038/ki.1990.182; Lewis J, 2001, AM J KIDNEY DIS, V38, P744, DOI 10.1053/ajkd.2001.27691; LEWIS J, 2002, AM J KIDNEY DIS, V39, P444; Lin J, 2005, J AM SOC NEPHROL, V16, P2814; Miller WG, 2005, ARCH PATHOL LAB MED, V129, P297; MOHANRAM A, 2005, CHRONIC KIDNEY DIS D, P20; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; *NAT KID FOUND, 2004, AM J KIDNEY DIS, V42, pS1; *NAT KIDN DIS ED P, LAB PROF CREAT STAND; *NAT KIDN FDN, 2000, AM J KIDNEY DIS S, V35, pS56; NILSSONEHLE P, 1996, SCAND J CLIN LA S225, V56, P16; Obrador GT, 1999, J AM SOC NEPHROL, V10, P1793; Obrador GT, 1998, AM J KIDNEY DIS, V31, P398, DOI 10.1053/ajkd.1998.v31.pm9506677; PERRONE RD, 1990, AM J KIDNEY DIS, V16, P224, DOI 10.1016/S0272-6386(12)81022-5; Poge U, 2005, AM J TRANSPLANT, V5, P1306, DOI 10.1111/j.1600-6143.2005.00861.x; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; Poggio ED, 2005, AM J KIDNEY DIS, V46, P242, DOI 10.1053/j.ajkd.2005.04.023; *REN DAT SYST, 2001, 2001 ANN DAT REP ATL; Renal Data System, 2005, 2005 ANN DAT REP ATL; Rigalleau V, 2005, DIABETES CARE, V28, P838, DOI 10.2337/diacare.28.4.838; Ross JW, 1998, ARCH PATHOL LAB MED, V122, P587; ROUBENOFF R, 1990, ANN INTERN MED, V113, P501, DOI 10.7326/0003-4819-113-7-501; Rule, 2005, AM J KIDNEY DIS, V46, P170; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; SIEGEL N, 2003, RENAL EXPRESS; Sjostrom P, 2005, SCAND J CLIN LAB INV, V65, P111, DOI 10.1080/00365510510013523; Skluzacek PA, 2003, AM J KIDNEY DIS, V42, P1169, DOI 10.1053/j.ajkd.2003.08.017; SMITH HW, 1951, KIDNEY STRUCTURE FUN, P520; SOKOLL LJ, 1994, CLIN CHEM, V40, P2276; Stevens LA, 2005, NEW ENGL J MED, V352, P2122, DOI 10.1056/NEJMe058035; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; STEVENS LA, 2004, FREQUENTLY ASKED QUE; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011; Vervoort G, 2002, NEPHROL DIAL TRANSPL, V17, P1909, DOI 10.1093/ndt/17.11.1909; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wesson LG., 1969, PHYSL HUMAN KIDNEY; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	92	2104	2188	6	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2473	2483		10.1056/NEJMra054415	http://dx.doi.org/10.1056/NEJMra054415			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760447				2022-12-28	WOS:000238100800009
J	Wansbrough-Jones, M; Phillips, R				Wansbrough-Jones, Mark; Phillips, Richard			Buruli ulcer: emerging from obscurity	LANCET			English	Review							MYCOBACTERIUM-BOVIS BCG; HOST IMMUNE-RESPONSE; IN-VITRO; MACROLIDE TOXIN; PCR ASSAY; DISEASE; INFECTION; SKIN; MYCOLACTONE; IDENTIFICATION	Buruli ulcer is a skin disease caused by infection with Mycobacterium ulcerans, which produces a potent toxin known as mycolactone, thus distinguishing itself from all other mycobacterial diseases. Mycolactone destroys cells in the subcutis, leading to the development of large ulcers with undermined edges. The genome sequence of M ulcerans has now been published and it transpires that two identical copies of a plasmid carry the genetic code for mycolactone. The mode of transmission of infection remains uncertain, although environmental sources of the organisms are now better understood. Considerable progress has been made in understanding the immune response to M ulcerans and there have been major advances in management of the disease with the introduction of rational antibiotic therapy. We summarise the current understanding of M ulcerans and its relations with human beings.	St Georges Univ London, Dept Infect Dis, London SW17 0RE, England; KNUST, Komfo Anokye Teaching Hosp, Kumasi, Ghana	St Georges University London; Kwame Nkrumah University Science & Technology	Wansbrough-Jones, M (corresponding author), St Georges Univ London, Dept Infect Dis, London SW17 0RE, England.	wansbrou@sgul.ac.uk	Phillips, Richard Odame/ABD-5394-2021	Phillips, Richard Odame/0000-0001-8992-0222	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adjei O, 1998, T ROY SOC TROP MED H, V92, P108, DOI 10.1016/S0035-9203(98)90977-4; Adusumilli S, 2005, CELL MICROBIOL, V7, P1295, DOI 10.1111/j.1462-5822.2005.00557.x; Aguiar J, 1997, Med Trop (Mars), V57, P83; Amofah G, 2002, EMERG INFECT DIS, V8, P167, DOI 10.3201/eid0802.010119; Amofah G, 1998, TROP DOCT, V28, P81, DOI 10.1177/004947559802800208; AMOFAH GK, 1993, T ROY SOC TROP MED H, V87, P644, DOI 10.1016/0035-9203(93)90272-R; [Anonymous], 1969, LANCET, V1, P111; [Anonymous], 1971, T ROY SOC TROP MED H, V65, P763, DOI 10.1016/0035-9203(71)90090-3; Asiedu K, 2000, BURULI ULCER MYCOBAC; Bafende AE, 2002, SAMJ S AFR MED J, V92, P437; BARKER DJP, 1973, T ROY SOC TROP MED H, V67, P43, DOI 10.1016/0035-9203(73)90317-9; BAYLEY AC, 1971, BRIT MED J, V2, P401, DOI 10.1136/bmj.2.5758.401-c; Bentoucha A, 2001, ANTIMICROB AGENTS CH, V45, P3109, DOI 10.1128/AAC.45.11.3109-3112.2001; Buntine J, BURULI ULCER MANAGEM; BURCHARD GD, 1986, TROP MED PARASITOL, V37, P1; CHAUTY A, 2005, 8 WHO ADV GROUP M BU; CLANCEY J., 1962, ANN SOC BELGE MED TROP, V42, P585; CLANCEY JK, 1964, J PATHOL BACTERIOL, V88, P175, DOI 10.1002/path.1700880123; Connor D. H., 1965, INT J LEPROSY, V33, P698; Cook A., 1970, BRIT MED J, V2, P378; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; Debacker M, 2005, EMERG INFECT DIS, V11, P584, DOI 10.3201/eid1104.041000; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Dega H, 2000, ANTIMICROB AGENTS CH, V44, P2367, DOI 10.1128/AAC.44.9.2367-2372.2000; DODGE OG, 1964, J PATHOL BACTERIOL, V88, P167, DOI 10.1002/path.1700880122; Espey David K., 2002, International Journal of Infectious Diseases, V6, P60, DOI 10.1016/S1201-9712(02)90138-4; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Evans MRW, 2003, T ROY SOC TROP MED H, V97, P159, DOI 10.1016/S0035-9203(03)90105-2; FEHR H, 1994, TROP DOCT, V24, P61, DOI 10.1177/004947559402400206; FINE PEM, 1989, B WORLD HEALTH ORGAN, V67, P35; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; George KM, 1998, INFECT IMMUN, V66, P587, DOI 10.1128/IAI.66.2.587-593.1998; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; GLYNN PJ, 1972, AUST NZ J SURG, V41, P312, DOI 10.1111/j.1445-2197.1969.tb06534.x; Gooding TM, 2002, INFECT IMMUN, V70, P5562, DOI 10.1128/IAI.70.10.5562-5567.2002; Gooding TM, 2001, INFECT IMMUN, V69, P1704, DOI 10.1128/IAI.69.3.1704-1707.2001; GOTO M, 2005, 8 WHO ADV GROUP M BU; Guimaraes-Peres A, 1999, J CLIN MICROBIOL, V37, P206, DOI 10.1128/JCM.37.1.206-208.1999; Havel A, 1975, Ann Soc Belg Med Trop, V55, P105; Jenkin GA, 2003, J BACTERIOL, V185, P6870, DOI 10.1128/JB.185.23.6870-6882.2003; JOHNSON PD, 2000, 8 WHO ADV GROUP M BU; Johnson PDR, 1996, MED J AUSTRALIA, V164, P76, DOI 10.5694/j.1326-5377.1996.tb101352.x; Johnson RC, 2002, AIDS, V16, P1704, DOI 10.1097/00002030-200208160-00027; KRIEG RE, 1975, AVIAT SPACE ENVIR MD, V46, P1241; KRIEG RE, 1979, AVIAT SPACE ENVIR MD, V50, P888; KRIEG RE, 1974, ARCH DERMATOL, V110, P783, DOI 10.1001/archderm.110.5.783; LUNN H F, 1965, East Afr Med J, V42, P275; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P6296, DOI 10.1128/AEM.70.10.6296-6298.2004; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Marsollier L, 2003, INT J ANTIMICROB AG, V22, P562, DOI 10.1016/S0924-8579(03)00240-1; Marsollier L, 2003, ANTIMICROB AGENTS CH, V47, P1228, DOI 10.1128/AAC.47.4.1228-1232.2003; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; MEYERS WM, 1974, AM J TROP MED HYG, V23, P924, DOI 10.4269/ajtmh.1974.23.924; MONSON MH, 1984, ACTA TROP, V41, P165; MUELDER K, 1990, LANCET, V336, P1109, DOI 10.1016/0140-6736(90)92581-2; Mve-Obiang A, 2005, INFECT IMMUN, V73, P3307, DOI 10.1128/IAI.73.6.3307-3312.2005; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; OLUWASANMI JO, 1975, BRIT J PLAST SURG, V28, P111, DOI 10.1016/0007-1226(75)90170-8; OLUWASANMI JO, 1976, AM J TROP MED HYG, V25, P122, DOI 10.4269/ajtmh.1976.25.122; Pahlevan AA, 1999, J IMMUNOL, V163, P3928; Phillips R, 2006, INFECT IMMUN, V74, P2917, DOI 10.1128/IAI.74.5.2917-2924.2006; Phillips R, 2006, CLIN VACCINE IMMUNOL, V13, P253, DOI 10.1128/CVI.13.2.253-257.2006; Phillips R, 2005, J CLIN MICROBIOL, V43, P3650, DOI 10.1128/JCM.43.8.3650-3656.2005; Phillips R, 2004, ANTIMICROB AGENTS CH, V48, P3130, DOI 10.1128/AAC.48.8.3130-3132.2004; Phillips R, 2004, ANTIMICROB AGENTS CH, V48, P2866, DOI 10.1128/AAC.48.8.2866-2870.2004; PHILLIPS R, WHO REP 7 WHO ADV GR, P132; Portaels F, 2004, INFECT IMMUN, V72, P62, DOI 10.1128/IAI.72.1.62-65.2004; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Portaels F, 1997, J CLIN MICROBIOL, V35, P1097, DOI 10.1128/JCM.35.5.1097-1100.1997; Portaels F, 1998, ANTIMICROB AGENTS CH, V42, P2070, DOI 10.1128/AAC.42.8.2070; Portaels F, 2002, CLIN DIAGN LAB IMMUN, V9, P1389, DOI 10.1128/CDLI.9.6.1389-1391.2002; PORTAELS FJ, BURULI ULCER DIAGNOS; Prevot G, 2004, INFECT IMMUN, V72, P958, DOI 10.1128/IAI.72.2.958-965.2004; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; RAVISSE P, 1977, B SOC PATHOL EXOT, V70, P109; Reid I S, 1967, Med J Aust, V1, P427; REVILL WDL, 1970, BRIT MED J, V2, P390; REVILL WDL, 1972, BRIT J PREV SOC MED, V26, P23; REVILL WDL, 1973, LANCET, V2, P873; Rondini S, 2003, J CLIN MICROBIOL, V41, P4231, DOI 10.1128/JCM.41.9.4231-4237.2003; Ross BC, 1997, J CLIN MICROBIOL, V35, P1696, DOI 10.1128/JCM.35.7.1696-1700.1997; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135, DOI 10.1128/AEM.63.10.4135-4138.1997; Siegmund V, 2005, J CLIN MICROBIOL, V43, P271, DOI 10.1128/JCM.43.1.271-276.2005; SMITH PG, 1976, T ROY SOC TROP MED H, V70, P449, DOI 10.1016/0035-9203(76)90128-0; STANFORD JL, 1972, J MED MICROBIOL, V5, P39, DOI 10.1099/00222615-5-1-39; STANFORD JL, 1975, J HYG-CAMBRIDGE, V74, P7, DOI 10.1017/S0022172400046659; Stienstra Y, 2005, TROP MED INT HEALTH, V10, P1251, DOI 10.1111/j.1365-3156.2005.01519.x; Stienstra Y, 2005, AM J TROP MED HYG, V72, P449; Stienstra Y, 2003, J CLIN MICROBIOL, V41, P794, DOI 10.1128/JCM.41.2.794-797.2003; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018, DOI 10.1128/JCM.37.4.1018-1023.1999; Stinear T, 2000, APPL ENVIRON MICROB, V66, P3206, DOI 10.1128/AEM.66.8.3206-3213.2000; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stinear TP, 2005, MICROBIOL-SGM, V151, P683, DOI 10.1099/mic.0.27674-0; Stinear TP, 2005, J BACTERIOL, V187, P1668, DOI 10.1128/JB.187.5.1668-1676.2005; Tanghe A, 2001, INFECT IMMUN, V69, P5403, DOI 10.1128/IAI.69.9.5403-5411.2001; Thangaraj HS, 2000, J ANTIMICROB CHEMOTH, V45, P231, DOI 10.1093/jac/45.2.231; Townsend CA, 2004, P NATL ACAD SCI USA, V101, P1116, DOI 10.1073/pnas.0307310101; van der Werf TS, 2003, LANCET, V362, P1062, DOI 10.1016/S0140-6736(03)14417-0; Veitch MGK, 1997, EPIDEMIOL INFECT, V119, P313, DOI 10.1017/S0950268897008273; Walsh DS, 2005, AM J TROP MED HYG, V73, P410, DOI 10.4269/ajtmh.2005.73.410; Wansbrough-Jones M, 2005, BMJ-BRIT MED J, V330, P1402, DOI 10.1136/bmj.330.7505.1402; WHO, PROV GUID ROL SPEC A; *WHO, GLOB BUR ULC IN GBUI	110	108	110	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2006	367	9525					1849	1858		10.1016/S0140-6736(06)68807-7	http://dx.doi.org/10.1016/S0140-6736(06)68807-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753488				2022-12-28	WOS:000238194200031
J	Kislev, ME; Hartmann, A; Bar-Yosef, O				Kislev, ME; Hartmann, A; Bar-Yosef, O			Early domesticated fig in the Jordan Valley	SCIENCE			English	Article							FICUS-CARICA L; COMMON FIG; MORACEAE	It is generally accepted that the fig tree was domesticated in the Near East some 6500 years ago. Here we report the discovery of nine carbonized fig fruits and hundreds of drupelets stored in Gilgal I, an early Neolithic village, located in the Lower Jordan Valley, which dates to 11,400 to 11,200 years ago. We suggest that these edible fruits were gathered from parthenocarpic trees grown from intentionally planted branches. Hence, fig trees could have been the first domesticated plant of the Neolithic Revolution, which preceded cereal domestication by about a thousand years.	Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Land Israel Studies & Archaeol Dept, IL-52900 Ramat Gan, Israel; Harvard Univ, Peabody Museum, Dept Anthropol, Cambridge, MA 02138 USA	Bar Ilan University; Bar Ilan University; Harvard University	Kislev, ME (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	kislev@mail.biu.ac.il						[Anonymous], 1947, FIG; EREZ A, COMMUNICATION; FLAISHMAN M, COMMUNICATION; GALIL J, 1973, Gardens' Bulletin (Singapore), V26, P303; GALIL J, 1977, NEW PHYTOL, V79, P163, DOI 10.1111/j.1469-8137.1977.tb02192.x; Hopf M., 1983, EXCAVATIONS JERICHO, P576; Kislev M.E., EARLY NEOLITHIC VILL, V43, P209; KISLEV ME, IN PRESS GESHER PREP; KISLEV ME, IN PRESS GILGAL EARL; Miller N.F., 1991, PROGR OLD WORLD PALA, P133; NEEMAN G, 1978, NEW PHYTOL, V81, P375, DOI 10.1111/j.1469-8137.1978.tb02643.x; Noy T., 1989, PALEORIENT, V15, P11, DOI [10.3406/paleo.1989.4480, DOI 10.3406/paleo.1989.4480]; Parrish TL, 2004, SEX PLANT REPROD, V17, P17, DOI 10.1007/s00497-004-0208-x; RAMIREZB W, 1974, ANN MO BOT GARD, V61, P770, DOI 10.2307/2395028; Saleeb WF, 1965, THESIS U CALIFORNIA; Sauer C.O., 1969, SEEDS SPADES HEARTHS; Stager LE., 1985, PALESTINE BRONZE IRO, P172; Storey W. B., 1975, Advances in fruit breeding. Subtropical fruits., P568; VALDEYRON G, 1979, EVOLUTION, V33, P673, DOI 10.1111/j.1558-5646.1979.tb04720.x; VANZEIST W, 1986, PALAEOHISTORIA, V26, P171; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505; ZOHARY M., 1966, FLORA PALAESTINA, V1, P37	23	180	199	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1372	1374		10.1126/science.1125910	http://dx.doi.org/10.1126/science.1125910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741119				2022-12-28	WOS:000237961600053
J	Ober, EA; Verkade, H; Field, HA; Stainier, DYR				Ober, Elke A.; Verkade, Heather; Field, Holly A.; Stainier, Didier Y. R.			Mesodermal Wnt2b signalling positively regulates liver specification	NATURE			English	Article							WNT/BETA-CATENIN; ENDODERM; MORPHOGENESIS; GROWTH; GENE; ZEBRAFISH; ORGANOGENESIS; EXPRESSION; INITIATION; INDUCTION	Endodermal organs such as the lung, liver and pancreas emerge at precise locations along the primitive gut tube. Although several signalling pathways have been implicated in liver formation(1,2), so far no single gene has been identified that exclusively regulates liver specification. In zebrafish, the onset of liver specification is marked by the localized endodermal expression of hhex and prox1 at 22 hours post fertilization. Here we used a screen for mutations affecting endodermal organ morphogenesis to identify a unique phenotype: prometheus ( prt) mutants exhibit profound, though transient, defects in liver specification. Positional cloning reveals that prt encodes a previously unidentified Wnt2b homologue. prt/ wnt2bb is expressed in restricted bilateral domains in the lateral plate mesoderm directly adjacent to the liver- forming endoderm. Mosaic analyses show the requirement for Prt/ Wnt2bb in the lateral plate mesoderm, in agreement with the inductive properties of Wnt signalling. Taken together, these data reveal an unexpected positive role for Wnt signalling in liver specification, and indicate a possible common theme for the localized formation of endodermal organs along the gut tube.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Genet & Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ober, EA (corresponding author), Natl Inst Med Res, Div Dev Biol, Mill Hill, London NW7 1AA, England.	eober@nimr.mrc.ac.uk; didier_stainier@biochem.ucsf.edu	Verkade, Heather/J-2401-2013	Verkade, Heather/0000-0002-2817-0509; Ober, Elke/0000-0002-5195-1012; Stainier, Didier/0000-0002-0382-0026				Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Finley KR, 2003, GENE EXPR PATTERNS, V3, P681, DOI 10.1016/S1567-133X(03)00091-7; FUKUDATAIRA S, 1981, J EMBRYOL EXP MORPH, V63, P111; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Hussain SZ, 2004, EXP CELL RES, V292, P157, DOI 10.1016/j.yexcr.2003.08.020; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Landesman Y, 1997, MECH DEVELOP, V63, P199, DOI 10.1016/S0925-4773(97)00041-5; LEDOUARIN NM, 1975, MED BIOL, V53, P427; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; McBride HJ, 2003, DEV BIOL, V256, P18, DOI 10.1016/S0012-1606(02)00118-5; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Ng JK, 2002, DEVELOPMENT, V129, P5161; Pilcher Karen E., 2002, Gene Expression Patterns, V2, P369, DOI 10.1016/S1567-133X(02)00023-6; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Suksaweang S, 2004, DEV BIOL, V266, P109, DOI 10.1016/j.ydbio.2003.10.010; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Wells JM, 2000, DEVELOPMENT, V127, P1563; Zakin LDJ, 1998, MECH DEVELOP, V73, P107, DOI 10.1016/S0925-4773(98)00040-9; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zorn AM, 1999, DEV BIOL, V209, P282, DOI 10.1006/dbio.1999.9257	30	266	273	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					688	691		10.1038/nature04888	http://dx.doi.org/10.1038/nature04888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799568				2022-12-28	WOS:000239630200046
J	Elmusharaf, S; Elhadi, N; Alraroth, L				Elmusharaf, Susan; Elhadi, Nagla; Almroth, Lars			Reliability of self reported form of female genital mutilation and WHO classification: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							CIRCUMCISION; SUDAN; ERADICATION; ATTITUDES; TANZANIA	Objective To assess the reliability of self reported form of female genital mutilation (FGM) and to compare the extent of cutting verified by clinical examination with the corresponding World Health Organization classification. Design Cross sectional study. Settings One paediatric hospital and one gynaecological outpatient clinic in Khartoum, Sudan, 2003-4. Participants 255 girls aged 4-9 and 282 Women aged 17-35. Main outcome measures The women's reports of FGM,the actual anatomical extent of die mutilation and the corresponding types according to the WHO classification. Results All girls and women reported to have undergone FGM had this verified by genital inspection. None of those who said they had not undergone FGM Were found to have it. Many said to have undergone "sunna circumcision" (excision of prepuce and part or all of clitoris, equivalent to WHO type 1) had a form of FGM extending beyond the clitoris (10/23 (43%) girls and 20/35 (57%) women). Of those who said they had undergone this form, nine girls 39%) and 19 women (54%) actually had WHO type III (infibulation and excision of part or all of external genitalia). The anatomical extent of forms classified as WHO type Ell varies widely. In 12/32 girls (38%) and 27/245 women (11%) classified as having WHO type III, the labia majora were not involved. Thus there is a substantial overlap, in an anatomical sense, between WHO types U and Ell. Conclusion The reliability of reported form of FGM is low. There is considerable under-reporting of the extent. The WHO classification fails to relate the defined forms to the severity of the operation. It is important to be aware of these aspects in the conduct mid interpretation of epidemiological and clinical studies. WHO should revise its classification.	Karolinska Inst, Div Int Hlth, SE-17177 Stockholm, Sweden; Univ Khartoum, Fac Med, Dept Obstet & Gynaecol, Khartoum 102, Sudan	Karolinska Institutet; University of Khartoum	Elmusharaf, S (corresponding author), Karolinska Inst, Div Int Hlth, SE-17177 Stockholm, Sweden.	Sozan.Elmusharaf@ki.se	Zhang, Zhi-Qiang/C-4107-2009; Zhang, Zhi-Qiang/L-6079-2019	Zhang, Zhi-Qiang/0000-0003-4172-0592; Zhang, Zhi-Qiang/0000-0003-4172-0592				Ahlberg BM, 2004, CRIT SOC POLICY, V24, P50, DOI 10.1177/0261018304241003; Almroth L, 2001, INT J GYNECOL OBSTET, V74, P179, DOI 10.1016/S0020-7292(01)00392-7; Almroth L, 2005, LANCET, V366, P385, DOI 10.1016/S0140-6736(05)67023-7; Almroth L, 2005, AFR J REPROD HEALTH, V9, P127; Bosch X, 2001, LANCET, V358, P1177, DOI 10.1016/S0140-6736(01)06262-6; Department of Statistics and Institute for Resource Development/Macro International Inc, 1991, SUD DEM HLTH SURV 19; Dorkenoo E., 1994, CUTTING ROSE FEMALE; El Dareer A, 1982, WOMAN WHY DO YOU WEE; ELDAREER A, 1983, TROP DOCT, V13, P131, DOI 10.1177/004947558301300313; ELDAREER AA, 1983, TROP DOCT, V13, P41, DOI 10.1177/004947558301300114; Holmgren Helena, 2005, Lakartidningen, V102, P1637; Isa AR., 1999, REPROD HLTH MATTERS, V7, P137, DOI [10.1016/S0968-8080(99)90125-8, DOI 10.1016/S0968-8080(99)90125-8]; Islam MM, 2001, INT FAM PLAN PERSPEC, V27, P71, DOI 10.2307/2673817; Johnsdotter S., 2002, THESIS LUND U LUND; Klouman E, 2005, TROP MED INT HEALTH, V10, P105, DOI 10.1111/j.1365-3156.2004.01350.x; LOCKHAT H, 2004, FEMALE GENITAL MUTIL; Morison L, 2001, TROP MED INT HEALTH, V6, P643, DOI 10.1046/j.1365-3156.2001.00749.x; Morison LA, 2004, ETHNIC HEALTH, V9, P75, DOI 10.1080/1355785042000202763; Msuya SE, 2002, TROP MED INT HEALTH, V7, P159, DOI 10.1046/j.1365-3156.2002.00838.x; Mustafa AZ, 1966, J OBSTET GYNAECOL, V73, P302; Obermeyer CM, 1999, MED ANTHROPOL Q, V13, P79, DOI 10.1525/maq.1999.13.1.79; Population Council, 2003, FEM CIRC IND EXT IMP; Rahman A, 2000, FEMALE GENITAL MUTIL; Rushwan H, 1983, FEMALE CIRCUMCISION; SAMI IR, 1986, ANN TROP PAEDIATR, V6, P99, DOI 10.1080/02724936.1986.11748419; Shandall A A, 1967, Sudan Med J, V5, P178; Snow RC, 2002, TROP MED INT HEALTH, V7, P91, DOI 10.1046/j.1365-3156.2002.00829.x; TOUBIA N, 1994, NEW ENGL J MED, V331, P712, DOI 10.1056/NEJM199409153311106; Verzin J, 1975, TROPICAL DOCTOR, V5, P163; WHO Technical Working Group, 1996, FEM GEN MUT; World Health Organization, 1998, FEMALE GENITAL MUTIL	31	78	78	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 15	2006	333	7559					124	127		10.1136/bmj.38873.649074.55	http://dx.doi.org/10.1136/bmj.38873.649074.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16803943	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000239155900017
J	Gill, M; Goldacre, MJ; Yeates, DGR				Gill, Mike; Goldacre, Michael J.; Yeates, David G. R.			Changes in safety on England's roads: analysis of hospital statistics	BRITISH MEDICAL JOURNAL			English	Article								Objective To compare trends in the numbers of people with serious traffic injuries according to police statistics and hospital episode statistics (HES). Design Descriptive study based on two independent population based data sources. Setting Police statistics and hospital episode statistics in England. Main outcome measures Rates of injury and death and their change over time reported in each data source, for 1996 to 2004. Results According to police statistics, rates of people killed or seriously injured on the roads fell consistently from 85.9 per 100 000 in 1996 to 59.4 per 100 000 in 2004. Over the same time, however, hospital admission rates for traffic injuries were almost unchanged at 90.0 in 1996 and 91.1 in 2004. Both datasets showed a significant reduction in rates of injury in children aged <= 15, but the reduction in hospital admission rates was substantially less than the reduction shown in the police statistics. The definition of serious injury in police statistics includes every hospital admission; in each year, none the less, the number of admissions exceeded the number of injuries reported in the police system. Conclusions The overall fall seen in police statistics for non-fatal road traffic injuries probably represents a fall in completeness of reporting of these injuries.	Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England; Govt Off SE, SE Publ Hlth Grp, Surrey GU1 4GA, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.	michael.goldacre@dphpc.ox.ac.uk						*DEP TRANSP, 2004, TOM ROADS SAF EV 1 3; *DEP TRANSP NAT ST, ROAD ACC STAT STATS1; SIMPSON HF, 1996, COMP HOSP POLICE CAS; World Health Organization, EUR HLTH ALL DAT	4	20	20	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2006	333	7558					73	75		10.1136/bmj.38883.593831.4F	http://dx.doi.org/10.1136/bmj.38883.593831.4F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16798753	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000239133200016
J	Bayrakci, SP; Keller, T; Habicht, K; Keimer, B				Bayrakci, SP; Keller, T; Habicht, K; Keimer, B			Spin-wave lifetimes throughout the Brillouin zone	SCIENCE			English	Article							ANTIFERROMAGNETIC-RESONANCE LINEWIDTH; INELASTIC-SCATTERING; NEUTRON-SCATTERING; VECTOR MAGNONS; MNF2; TEMPERATURES; DYNAMICS; SPECTROMETER; SPECTRUM; WIDTHS	We used a neutron spin-echo method with microelectron-volt resolution to determine the lifetimes of spin waves in the prototypical antiferromagnet MnF2 over the entire Brillouin zone. A theory based on the interaction of spin waves (magnons) with longitudinal spin fluctuations provides an excellent, parameter-free description of the data, except at the lowest momenta and temperatures. This is surprising, given the prominence of alternative theories based on magnon-magnon interactions in the literature. The results and technique open up a new avenue for the investigation of fundamental concepts in magnetism. The technique also allows measurement of the lifetimes of other elementary excitations, such as lattice vibrations, throughout the Brillouin zone.	Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Tech Univ Munich, Zent Wissensch Einrichtung, D-85748 Garching, Germany; Hahn Meitner Inst Berlin GmbH, D-14109 Berlin, Germany	Max Planck Society; Technical University of Munich; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Bayrakci, SP (corresponding author), Max Planck Inst Festkorperforsch, Heisenbergstr 1, D-70569 Stuttgart, Germany.	bayrakci@fkf.mpg.de	Habicht, Klaus/K-3636-2013	Habicht, Klaus/0000-0002-9915-7221; Keimer, Bernhard/0000-0001-5220-9023				BARAK J, 1980, PHYS REV B, V21, P3015, DOI 10.1103/PhysRevB.21.3015; BARAK J, 1978, J MAGN MAGN MATER, V9, P323, DOI 10.1016/0304-8853(78)90087-2; COTTAM MG, 1974, J PHYS C SOLID STATE, V7, P2919, DOI 10.1088/0022-3719/7/16/019; COTTAM MG, 1971, J PHYS C SOLID STATE, V3, P2305; GOLUB R, 1987, PHYS LETT A, V123, P43, DOI 10.1016/0375-9601(87)90760-2; HARRIS AB, 1971, PHYS REV B, V3, P961, DOI 10.1103/PhysRevB.3.961; JONGERDEN GJ, 1989, PHYS REV B, V40, P9435, DOI 10.1103/PhysRevB.40.9435; KEFFER F, 1952, PHYS REV, V87, P608, DOI 10.1103/PhysRev.87.608; Keller T, 2002, APPL PHYS A-MATER, V74, pS332, DOI 10.1007/s003390201612; KOTTHAUS JP, 1973, PHYS LETT A, VA 42, P361, DOI 10.1016/0375-9601(73)90372-1; LOUDON R, 1963, PHYS REV, V132, P673, DOI 10.1103/PhysRev.132.673; MELCHER RL, 1970, PHYS REV B, V2, P733, DOI 10.1103/PhysRevB.2.733; MEZEI F, 1972, Z PHYS, V255, P146, DOI 10.1007/BF01394523; MONTGOMERY H, 1973, J PHYS C SOLID STATE, V6, P3156, DOI 10.1088/0022-3719/6/21/019; OKAZAKI A, 1964, PHYS LETT, V8, P9, DOI 10.1016/0031-9163(64)90774-7; REINECKE TL, 1980, PHYS REV B, V21, P5198, DOI 10.1103/PhysRevB.21.5198; ROTTER LD, 1990, J LUMIN, V45, P130, DOI 10.1016/0022-2313(90)90124-T; ROTTER LD, 1990, PHYS REV B, V42, P720, DOI 10.1103/PhysRevB.42.720; SCHULHOF MP, 1971, PHYS REV B, V4, P2254, DOI 10.1103/PhysRevB.4.2254; Schweika W, 2002, EUROPHYS LETT, V60, P446, DOI 10.1209/epl/i2002-00284-x; SMITH HG, 1977, DYNAMICS SOLIDS LIQU, P93; STINCHCO.RB, 1974, PHYS REV B, V9, P3786, DOI 10.1103/PhysRevB.9.3786; WHITE RM, 1974, PHYS REV B, V10, P1039, DOI 10.1103/PhysRevB.10.1039; Woolsey R. B., 1972, INT J MAGN, V2, P51; WOOLSEY RB, 1970, THESIS STANFORD U; WU AY, 1982, PHYS REV B, V25, P5230, DOI 10.1103/PhysRevB.25.5230; [No title captured]; [No title captured]	28	48	49	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2006	312	5782					1926	1929		10.1126/science.1127756	http://dx.doi.org/10.1126/science.1127756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809534	Green Submitted			2022-12-28	WOS:000238848100052
J	Kutnjak, Z; Petzelt, J; Blinc, R				Kutnjak, Z.; Petzelt, J.; Blinc, R.			The giant electromechanical response in ferroelectric relaxors as a critical phenomenon	NATURE			English	Article							NEUTRON-DIFFRACTION; CRITICAL-POINT	The direct conversion of electrical energy to mechanical work by a material is relevant to a number of applications. This is illustrated by ferroelectric 'relaxors'(1-4) such as Pb(Mg1/3Nb2/3) O-3-PbTiO3 (PMN-PT; refs 5, 6): these materials exhibit a giant electromechanical ( piezoelectric) response that is finding use in ultrasonic(4) and medical applications, as well as in telecommunications. The origins of this effect are, however, still unclear. Here we show that the giant electromechanical response in PMN-PT ( and potentially other ferroelectric relaxors) is the manifestation of critical points that define a line in the phase diagram of this system. Specifically, in the electric-field -temperature-composition phase diagram of PMN-PT ( the composition being varied by changing the PT concentration), a first-order paraelectric ferroelectric phase transition terminates in a line of critical points where the piezoelectric coefficient is maximum. Above this line, supercritical evolution is observed. On approaching the critical point, both the energy cost and the electric field necessary to induce ferroelectric polarization rotations decrease significantly, thus explaining the giant electromechanical response of these relaxors.	Jozef Stefan Inst, Ljubljana, Slovenia; Acad Sci Czech Republ, Inst Phys, Prague, Czech Republic	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences	Kutnjak, Z (corresponding author), Jozef Stefan Inst, Ljubljana, Slovenia.	zdravko.kutnjak@ijs.si	Kutnjak, Zdravko/B-4412-2013; Petzelt, Jan/G-6142-2014	Petzelt, Jan/0000-0001-8562-2148				Bai FM, 2004, J APPL PHYS, V96, P1620, DOI 10.1063/1.1766087; Colla EV, 1998, J APPL PHYS, V83, P3298, DOI 10.1063/1.367098; CROSS IE, 1993, FERROELECTRIC CERAMI, P1; CROSS LE, 1987, FERROELECTRICS, V76, P241, DOI 10.2109/jcersj.99.829; Davis M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014115; DURAND D, 1983, J PHYS LETT-PARIS, V44, pL207, DOI 10.1051/jphyslet:01983004405020700; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; HOCHLI UT, 1990, ADV PHYS, V39, P405, DOI 10.1080/00018739000101521; Kutnjak Z, 1996, PHYS REV E, V53, P4955, DOI 10.1103/PhysRevE.53.4955; Li JY, 2005, NAT MATER, V4, P776, DOI 10.1038/nmat1485; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Samara GA, 2003, J PHYS-CONDENS MAT, V15, pR367, DOI 10.1088/0953-8984/15/9/202; Uchino K, 1996, PIEZOELECTRIC ACTUAT; Wu ZG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.037601; Xu GY, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.212410; Yao H, 1998, REV SCI INSTRUM, V69, P172, DOI 10.1063/1.1148492; YAO H, 1995, PHYS REV E, V51, P4585, DOI 10.1103/PhysRevE.51.4585	17	575	582	5	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					956	959		10.1038/nature04854	http://dx.doi.org/10.1038/nature04854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791189				2022-12-28	WOS:000238422300036
J	Liu, KW; Liu, ZJ; Huang, LQ; Li, LQ; Chen, LJ; Tang, GD				Liu, Ke-Wei; Liu, Zhong-Jian; Huang, LaiQiang; Li, Li-Qiang; Chen, Li-Jun; Tang, Guang-Da			Pollination: Self-fertilization strategy in an orchid	NATURE			English	Article							REPRODUCTIVE ASSURANCE; EVOLUTION; PLANTS; SYSTEMS	Mating in flowering plants normally relies on animals, wind, gravity or secretion to convey pollen grains from the male (anther) to the female (stigma) organ. Here we describe a new type of self-pollination mechanism in the tree-living orchid Holcoglossum amesianum, in which the bisexual flower turns its anther against gravity through 360-degrees in order to insert pollen into its own stigma cavity - without the aid of any pollinating agent or medium. This mode of self-pollination, which occurs under windless, drought conditions when insects are scarce, adds to the variety of mechanisms that have evolved in angiosperms to ensure their reproductive success.	Tsing Hua Univ, Grad Sch Shenzhen, Ctr Biotechnol & Biomed, Shenzhen 518055, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; Natl Orchid Conservat Ctr, Shenzhen 518114, Peoples R China; S China Agr Univ, Coll Forestry, Guangzhou 510642, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese Academy of Sciences; University of Science & Technology of China, CAS; South China Agricultural University	Huang, LQ (corresponding author), Tsing Hua Univ, Grad Sch Shenzhen, Ctr Biotechnol & Biomed, Shenzhen 518055, Peoples R China.	huanglq@sz.tsinghua.edu.cn		Liu, Zhong-Jian/0000-0003-4390-3878				Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Darwin C., 1890, VARIOUS CONTRIVANCES; DOLE JA, 1992, AM J BOT, V79, P650, DOI 10.2307/2444881; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; LORD EM, 1981, BOT REV, V47, P421, DOI 10.1007/BF02860538; PIPER JG, 1984, NATURE, V310, P50, DOI 10.1038/310050a0; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Wang YQ, 2004, NATURE, V431, P39, DOI 10.1038/431039b	11	62	76	8	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					945	946		10.1038/441945a	http://dx.doi.org/10.1038/441945a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791185				2022-12-28	WOS:000238422300029
J	Sekiguchi, Y; Arai, K; Kohshima, S				Sekiguchi, Yuske; Arai, Kazutoshi; Kohshima, Shiro			Sleep in continuously active dolphins	NATURE			English	Letter							STATE; DEPRIVATION; CETACEANS		Toyohashi Univ Technol, Res Ctr Phys Fitness Sports & Hlth, Toyohashi, Aichi 4418580, Japan; Kamogawa Sea World, Kamogawa, Chiba 2960041, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Meguro Ku, Tokyo 1528551, Japan	Toyohashi University of Technology; Tokyo Institute of Technology	Sekiguchi, Y (corresponding author), Toyohashi Univ Technol, Res Ctr Phys Fitness Sports & Hlth, 1-1 Tempaku, Toyohashi, Aichi 4418580, Japan.	ysekiguc@coeprt.issrc.tut.ac.jp						Goley PD, 1999, MAR MAMMAL SCI, V15, P1054, DOI 10.1111/j.1748-7692.1999.tb00877.x; HOPPENBROUWERS T, 1975, EXP NEUROL, V49, P822, DOI 10.1016/0014-4886(75)90062-X; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; Lyamin OI, 2004, ARCH ITAL BIOL, V142, P557; Lyamin OI, 2002, BEHAV BRAIN RES, V129, P125, DOI 10.1016/S0166-4328(01)00346-1; Mukhametov L. M., 1984, EXPT BRAIN RES S, P227, DOI [10.1007/978-3-[ 642-69554-4_17spinal, DOI 10.1007/978-3-642-69554-E]; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Sekiguchi Y, 2003, PHYSIOL BEHAV, V79, P643, DOI 10.1016/S0031-9384(03)00119-7; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a	10	27	28	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					E9	E10		10.1038/nature04898	http://dx.doi.org/10.1038/nature04898			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791150				2022-12-28	WOS:000238422300031
J	Currie, GP; Lipworth, BJ				Currie, Graeme P.; Lipworth, Brian J.			ABC of chronic obstructive pulmonary disease - Pharmacological management - inhaled treatment	BRITISH MEDICAL JOURNAL			English	Editorial Material									Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland	University of Aberdeen; University of Dundee	Currie, GP (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland.			Currie, Graeme P/0000-0002-5711-9147				Altose MD, 2000, NEW ENGL J MED, V343, P1902; APPLETON S, 2002, COCHRANE DB SYST REV; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; CELLI BR, 2004, EUR RESP J, V23; Currie GP, 2006, PULM PHARMACOL THER, V19, P112, DOI 10.1016/j.pupt.2005.04.003; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; 2004, THORAX S1, V59, P1	7	5	5	1	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 17	2006	332	7555					1439	1441		10.1136/bmj.332.7555.1439	http://dx.doi.org/10.1136/bmj.332.7555.1439			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16777889	Green Published			2022-12-28	WOS:000238550800036
J	Foster, JL; Garcia, JV				Foster, John L.; Garcia, J. Victor			HIV pathogenesis: Nef loses control	CELL			English	Editorial Material								In this issue of Cell, Schindler et al. (2006) show that the Nef protein from nonpathogenic strains of simian immunodeficiency virus (SIV) induces the downregulation of host T cell receptor/CD3, whereas Nef from human immunodeficiency virus (HIV-1) does not. This loss of function in the Nef of HIV-1 may partly explain the pathogenicity of this virus.	Univ Texas, SW Med Ctr Dallas, Div Infect Dis, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Foster, JL (corresponding author), Univ Texas, SW Med Ctr Dallas, Div Infect Dis, Dept Internal Med, Dallas, TX 75390 USA.	john.foster@utsouthwestern.edu; victor.garcia@utsouthwestern.edu						Arora VK, 2002, MICROBES INFECT, V4, P189, DOI 10.1016/S1286-4579(01)01527-1; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Goldstein S, 2005, J VIROL, V79, P5153, DOI 10.1128/JVI.79.8.5153-5162.2005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Muller MC, 2003, FRONT BIOSCI-LANDMRK, V8, pD1170, DOI 10.2741/1130; Rey-Cuille MA, 1998, J VIROL, V72, P3872; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3	8	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1034	1035		10.1016/j.cell.2006.06.005	http://dx.doi.org/10.1016/j.cell.2006.06.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777594	Bronze			2022-12-28	WOS:000238602700009
J	Nathan, DG; Schechter, AN				Nathan, David G.; Schechter, Alan N.			NIH support for basic and clinical research - Biomedical researcher angst in 2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BUDGET		Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Nathan, DG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St,Room D1644, Boston, MA 02115 USA.	aschecht@helix.nih.gov		Schechter, Alan N/0000-0002-5235-9408	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025104, Z01DK025104] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bishop JM, 2006, SCIENCE, V312, P499, DOI 10.1126/science.1128904; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; Kotchen TA, 2006, J INVEST MED, V54, P13, DOI 10.2310/6650.2005.05026; Loscalzo J, 2006, NEW ENGL J MED, V354, P1665, DOI 10.1056/NEJMp068050; Marks AR, 2006, J CLIN INVEST, V116, P844, DOI 10.1172/JCI28364; Mervis J, 2006, SCIENCE, V311, P28, DOI 10.1126/science.311.5757.28; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; Nurse P, 2006, CELL, V124, P9, DOI 10.1016/j.cell.2005.12.029; Schechter AN, 1998, JAMA-J AM MED ASSOC, V280, P1440, DOI 10.1001/jama.280.16.1440; Shulman LE, 1996, ACAD MED, V71, P362, DOI 10.1097/00001888-199604000-00013; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Weissmann G, 2005, FASEB J, V19, P1761, DOI 10.1096/fj.05-1101ufm; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352	15	17	17	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2656	2658		10.1001/jama.295.22.2656	http://dx.doi.org/10.1001/jama.295.22.2656			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772630				2022-12-28	WOS:000238224000029
J	Taylor, CM; Riordan, FAI; Graham, C				Taylor, CM; Riordan, FAI; Graham, C			Lesson of the week - New football boots and toxic shock syndrome	BRITISH MEDICAL JOURNAL			English	Review							DIAGNOSIS		Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England; Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England	University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham	Taylor, CM (corresponding author), Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England.	cm.taylor@bch.nhs.uk						Arnold J, 2001, J Foot Ankle Surg, V40, P411; BACH MC, 1983, J AM ACAD DERMATOL, V8, P343, DOI 10.1016/S0190-9622(83)70037-X; Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002; DEETZ TR, 1981, NEW ENGL J MED, V304, P174; Takahashi N, 1998, LANCET, V351, P1614, DOI 10.1016/S0140-6736(97)11125-4; White MC, 2005, BURNS, V31, P193, DOI 10.1016/j.burns.2004.09.017	6	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 10	2006	332	7554					1376	1378		10.1136/bmj.332.7554.1376	http://dx.doi.org/10.1136/bmj.332.7554.1376			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763251	Green Published			2022-12-28	WOS:000238587000024
J	Flytzani-Stephanopoulos, M; Sakbodin, M; Wang, Z				Flytzani-Stephanopoulos, Maria; Sakbodin, Mann; Wang, Zheng			Regenerative adsorption and removal of H2S from hot fuel gas streams by rare earth oxides	SCIENCE			English	Article							HIGH-TEMPERATURE DESULFURIZATION; ZINC TITANATE; CERIUM OXIDE; SULFIDATION; SORBENTS	Sorbent materials that allow for high-temperature, regenerative desulfurization of fuel gas streams for the anode of a solid oxide fuel cell have been developed. Reversible adsorption of H2S on cerium and lanthanum oxide surfaces is demonstrated over many cycles at temperatures as high as 800 degrees C, on both fresh or presulfided sorbents, and at very high space velocities. The adsorption and desorption processes are very fast, and removal of H2S to sub-parts per million levels is achieved at very short ( millisecond) contact times. Any type of sulfur-free gas, including water vapor, can be used to regenerate the sorbent surface. Preferably, the anode off-gas stream is used to sweep the desorbed H2S to a burner.	Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA	Tufts University	Flytzani-Stephanopoulos, M (corresponding author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.	maria.flytzani-stephanopoulos@tufts.edu						Bakker WJW, 2003, CHEM ENG J, V96, P223, DOI 10.1016/j.cej.2003.08.022; Barbir F, 2005, SUSTAIN WORLD SER, P1; Barin I., 1973, THERMOCHEMICAL PROPE, Vfirst; Barin I., 1977, THERMOCHEMICAL PROPE; BARIN I, 1993, THERMOCHEMICAL DAT 1; Barin I, 1993, THERMOCHEMICAL DATA, V2nd, P271; FLYTZANISTEPHANOPOUL, 2005, Patent No. 0540488; Garcia E, 2000, ENERG FUEL, V14, P1296, DOI 10.1021/ef0001179; Kobayashi M, 2002, IND ENG CHEM RES, V41, P3115, DOI 10.1021/ie010815w; Kobayashi M, 2002, IND ENG CHEM RES, V41, P2903, DOI 10.1021/ie010846r; LEW S, 1992, IND ENG CHEM RES, V31, P1890, DOI 10.1021/ie00008a009; Li ZJ, 1997, IND ENG CHEM RES, V36, P187, DOI 10.1021/ie960245d; SIRIWARDANE RV, 1994, IND ENG CHEM RES, V33, P2810, DOI 10.1021/ie00035a034; SWISHER JH, 1995, IND ENG CHEM RES, V34, P4463, DOI 10.1021/ie00039a037; Wang Z, 2005, ENERG FUEL, V19, P2089, DOI 10.1021/ef049664a; Yi KB, 2005, IND ENG CHEM RES, V44, P7086, DOI 10.1021/ie050441x	16	207	219	2	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1508	1510		10.1126/science.1125684	http://dx.doi.org/10.1126/science.1125684			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763145				2022-12-28	WOS:000238124100043
J	Dickson, N; Dixon, J				Dickson, N; Dixon, J			Making the NHS cost effective	LANCET			English	Editorial Material									Kings Fund Inst, London W1G 0AN, England		Dickson, N (corresponding author), Kings Fund Inst, London W1G 0AN, England.	n.dickson@kingsfund.org.uk						[Anonymous], 2006, SECURING GOOD CARE O; APPLEBY J, 2006, KINGS FUND BRIE 0203; *DEP HLTH, 2006, NHS ENGL OP FRAM 200; Department of Health, 2003, INV GEN PRACT NEW GE; ELWYN GJ, 1994, BRIT MED J, V309, P576, DOI 10.1136/bmj.309.6954.576; St John of God Health Care, 2019, OUR VIS	6	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1802	1803		10.1016/S0140-6736(06)68784-9	http://dx.doi.org/10.1016/S0140-6736(06)68784-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753471				2022-12-28	WOS:000238194200009
J	Albertini, AAV; Wernimont, AK; Muziol, T; Ravelli, RBG; Clapier, CR; Schoehn, G; Weissenhorn, W; Ruigrok, RWH				Albertini, Aurelie A. V.; Wernimont, Amy K.; Muziol, Tadeusz; Ravelli, Raimond B. G.; Clapier, Cedric R.; Schoehn, Guy; Weissenhorn, Winfried; Ruigrok, Rob W. H.			Crystal structure of the rabies virus nucleoprotein-RNA complex	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; N-PROTEIN; VIRAL-RNA; PHOSPHOPROTEIN; BINDING; IDENTIFICATION; NUCLEOCAPSIDS; DOMAINS; SITE	Negative-strand RNA viruses condense their genome into a helical nucleoprotein-RNA complex, the nucleocapsid, which is packed into virions and serves as a template for the RNA-dependent RNA polymerase complex. The crystal structure of a recombinant rabies virus nucleoprotein-RNA complex, organized in an undecameric ring, has been determined at 3.5 angstrom resolution. Polymerization of the nucleoprotein is achieved by domain exchange between protomers, with flexible hinges allowing nucleocapsid formation. The two core domains of the nucleoprotein clamp around the RNA at their interface and shield it from the environment. RNA sequestering by nucleoproteins is likely a common mechanism used by negative-strand RNA viruses to protect their genomes from the innate immune response directed against viral RNA in human host cells at certain stages of an infectious cycle.	European Mol Biol Lab, F-38042 Grenoble, France; Univ Grenoble 1, Inst Virol Mol & Struct, CNRS, FRE 2854, F-38042 Grenoble, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Weissenhorn, W (corresponding author), European Mol Biol Lab, Boite Postale 181, F-38042 Grenoble, France.	weissen@embl-grenoble.fr	Muzioł, Tadeusz M./E-5944-2014; Muziol, Tadeusz Mikolaj/T-8919-2019	Muzioł, Tadeusz M./0000-0002-5220-4430; Muziol, Tadeusz Mikolaj/0000-0002-5220-4430; Ravelli, Raimond/0000-0001-6056-5888; Albertini, Aurelie/0000-0002-2076-1654; Schoehn, Guy/0000-0002-1459-3201				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ARNHEITER H, 1985, CELL, V41, P259, DOI 10.1016/0092-8674(85)90079-0; BLUMBERG BM, 1983, CELL, V32, P559, DOI 10.1016/0092-8674(83)90475-0; Dietzschold B, 2005, CURR TOP MICROBIOL, V292, P45; DIETZSCHOLD B, 1987, VIRUS RES, V8, P103, DOI 10.1016/0168-1702(87)90023-2; EMERSON SU, 1982, CELL, V31, P635, DOI 10.1016/0092-8674(82)90319-1; EMERSON SU, 1987, P NATL ACAD SCI USA, V84, P5655, DOI 10.1073/pnas.84.16.5655; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Iseni F, 2000, RNA, V6, P270, DOI 10.1017/S135583820099109X; Iseni F, 1998, J GEN VIROL, V79, P2909, DOI 10.1099/0022-1317-79-12-2909; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; KOLAKOFSKY D, 1982, J VIROL, V41, P566, DOI 10.1128/JVI.41.2.566-574.1982; Kouznetzoff A, 1998, J GEN VIROL, V79, P1005, DOI 10.1099/0022-1317-79-5-1005; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; LYNCH S, 1978, J VIROL, V28, P584, DOI 10.1128/JVI.28.2.584-589.1978; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Rudolph MG, 2003, STRUCTURE, V11, P1219, DOI 10.1016/j.str.2003.08.011; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Schoehn G, 2001, J VIROL, V75, P490, DOI 10.1128/JVI.75.1.490-498.2001; Spehner D, 1997, VIROLOGY, V232, P260, DOI 10.1006/viro.1997.8568; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; Toriumi H, 2005, MICROBIOL IMMUNOL, V49, P757, DOI 10.1111/j.1348-0421.2005.tb03666.x	25	255	269	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					360	363		10.1126/science.1125280	http://dx.doi.org/10.1126/science.1125280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16778023				2022-12-28	WOS:000239154300047
J							Amer Coll Phys	The health care response to pandemic influenza	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The threat of an H5N1 influenza virus (avian flu) pandemic is substantial. The success of the current U.S. influenza pandemic response plan depends on effective coordination among state and local public health authorities and individual health care providers. This article is a summary of a public policy paper developed by the American College of Physicians to address issues in the U.S. Department of Health and Human Services Pandemic Influenza Plan that involve physicians. The College's positions call for the following: 1) development of local public health task forces that include physicians representing all specialties and practice settings; 2) physician access to 2-way communication with public health authorities and to information technology tools for diagnosis and syndrome surveillance; 3) clear identification and authorization of agencies to process licensing and registration of volunteer physicians; 4) clear guidelines for overriding standard procedures for confidentiality and consent in the interest of the public's health; 5) clear and fair infection control measures that do not create barriers to care; 6) analysis of and solutions to current problems with seasonal influenza vaccination programs as a way of developing a maximally efficient pandemic flu vaccine program; 7) federal funding to provide pandemic flu vaccine for the entire U.S. population and antiviral drugs for 25% of the population; and 8) planning for health care in alternative, nonhospital settings to prevent a surge in demand for hospital care that exceeds supply.										[Anonymous], 2005, HHS PAND INFL PLAN; *US DEP HHS, 2005, HHS PAND INFL PLAN S, V1; *US DEP HHS, 2005, HHS PAND INFL PLAN S, V4; *US DEP HHS, 2005, HHS PAND INFL PLAN S, V2; *WHO, 2006, CUM NUMB CONF HUM CA	5	12	12	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					135	137		10.7326/0003-4819-145-2-200607180-00131	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00131			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16801625				2022-12-28	WOS:000239051400007
J	Starr, I				Starr, Isaac			Influenza in 1918: Recollections of the epidemic in Philadelphia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								When the great influenza epidemic struck Philadelphia in 1918, the author was just starting his third year at the University of Pennsylvania School of Medicine. After a single lecture on influenza, classes for the third and fourth year students were suspended while he and his mates manned an emergency hospital, in which they worked under little or no medical supervision and in the presence of an alarming patient mortality. This essay describes what happened in the hospital, and in the city as a whole, during the pandemic. Certain features of the clinical course of most patients permit the hope that modern therapy will prevent a repetition of the horrendous mortality.	Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Starr, I (corresponding author), Amer Coll Physicians, Consumer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Haldane JS, 1917, BRIT MED J, V1917, P181, DOI 10.1136/bmj.1.2928.181; 1964, CONCISE DICT AM BIOG, P1000	2	44	45	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					138	140		10.7326/0003-4819-145-2-200607180-00132	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00132			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16801626				2022-12-28	WOS:000239051400008
J	Hedrich, R; Kudla, J				Hedrich, Rainer; Kudla, Joerg			Calcium signaling plant K+ uptake networks channel	CELL			English	Editorial Material							ARABIDOPSIS	Potassium channel function is fundamental to many physiological processes in plants. In this issue of Cell, Xu et al. (2006) identify a protein complex in Arabidopsis consisting of a potassium channel, a protein kinase, and a calcium sensor. This study reveals that plants cope with limited soil potassium by coupling potassium channel activation to a cellular calcium signaling network.	Univ Wurzburg, Biozentrum, Julius von Sachs Inst, D-97082 Wurzburg, Germany; Univ Munster, Inst Bot & Bot Garten, Mol Entwicklungsbiol Pflanzen, D-48149 Munster, Germany	University of Wurzburg; University of Munster	Hedrich, R (corresponding author), Univ Wurzburg, Biozentrum, Julius von Sachs Inst, Julius von Sachs Pl 2, D-97082 Wurzburg, Germany.	hedrich@botanik.uni-wuerzburg.de; jkudla@uni-muenster.de	Hedrich, Rainer/G-8771-2011; Kudla, Jörg/C-2174-2012	Hedrich, Rainer/0000-0003-3224-1362; Kudla, Jörg/0000-0002-8238-767X				Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Bruggemann L, 1999, P NATL ACAD SCI USA, V96, P3298, DOI 10.1073/pnas.96.6.3298; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; XU J, 2006, CELL	12	40	45	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1221	1223		10.1016/j.cell.2006.06.017	http://dx.doi.org/10.1016/j.cell.2006.06.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814705	Bronze			2022-12-28	WOS:000239104500002
J	Jonzen, N; Linden, A; Ergon, T; Knudsen, E; Vik, JO; Rubolini, D; Piacentini, D; Brinch, C; Spina, F; Karlsson, L; Stervander, M; Andersson, A; Waldenstrom, J; Lehikoinen, A; Edvardsen, E; Solvang, R; Stenseth, NC				Jonzen, Niclas; Linden, Andreas; Ergon, Torbjorn; Knudsen, Endre; Vik, Jon Olav; Rubolini, Diego; Piacentini, Dario; Brinch, Christian; Spina, Fernando; Karlsson, Lennart; Stervander, Martin; Andersson, Arne; Waldenstrom, Jonas; Lehikoinen, Aleksi; Edvardsen, Erik; Solvang, Rune; Stenseth, Nils Chr.			Rapid advance of spring arrival dates in long-distance migratory birds	SCIENCE			English	Article							NORTH-ATLANTIC OSCILLATION; CLIMATE-CHANGE; MIGRANT; TRENDS; WINTER	Several bird species have advanced the timing of their spring migration in response to recent climate change. European short-distance migrants, wintering in temperate areas, have been assumed to be more affected by change in the European climate than long-distance migrants wintering in the tropics. However, we show that tong-distance migrants have advanced their spring arrival in Scandinavia more than short-distance migrants. By analyzing a long-term data set from southern Italy, we show that long-distance migrants also pass through the Mediterranean region earlier. We argue that this may reflect a climate-driven evolutionary change in the timing of spring migration.	Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; Univ Helsinki, Dept Biol & Environm Sci, Integrat Ecol Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Bird Ecol Unit, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; Univ Pavia, Dipartimento Biol Anim, I-27100 Pavia, Italy; Ist Nazl Fauna Selvat, I-40064 Ozzano Dell Emilia, BO, Italy; Falsterbo Bird Observ, SE-23940 Falsterbo, Sweden; Ottenby Bird Observ, SE-38065 Degerhamn, Sweden; Kalmar Univ, Dept Biol & Environm Sci, Sect Zoonot Ecol & Epidemiol, N-3704 Skien, Norway; Jomfruland Bird Observ, N-3704 Skien, Norway	University of Oslo; Lund University; University of Helsinki; University of Helsinki; University of Pavia; Italian Institute for Environmental Protection & Research (ISPRA)	Jonzen, N (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, POB 1066, N-0316 Oslo, Norway.	n.c.stenseth@bio.uio.no	Vik, Jon Olav/B-9350-2008; Lehikoinen, Aleksi/O-5444-2016; Rubolini, Diego/F-2851-2011; Stenseth, Nils Chr./G-5212-2016; Stervander, Martin/I-7907-2015; Waldenström, Jonas/E-4460-2013; Lindén, Andreas/D-9315-2017	Vik, Jon Olav/0000-0002-7778-4515; Rubolini, Diego/0000-0003-2703-5783; Stenseth, Nils Chr./0000-0002-1591-5399; Stervander, Martin/0000-0002-6139-7828; Waldenström, Jonas/0000-0002-1152-4235; Lindén, Andreas/0000-0002-5548-2671; Lehikoinen, Aleksi/0000-0002-1989-277X; Andersson, Arne/0000-0002-1363-4403				Berthold P, 1996, CONTROL BIRD MIGRATI; Both C, 2005, J AVIAN BIOL, V36, P368, DOI 10.1111/j.0908-8857.2005.03484.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Coppack T, 2003, P ROY SOC B-BIOL SCI, V270, pS43, DOI 10.1098/rsbl.2003.0005; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Dunn P, 2004, ADV ECOL RES, V35, P69, DOI 10.1016/S0065-2504(04)35004-X; Gordo O, 2005, GLOBAL CHANGE BIOL, V11, P12, DOI 10.1111/j.1365-2486.2004.00875.x; Gwinner E, 1996, J EXP BIOL, V199, P39; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Lack D., 1968, pvii; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Moller AP, 2001, P ROY SOC B-BIOL SCI, V268, P203; Pulido F, 2003, AVIAN MIGRATION, P53; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Stervander M, 2005, J AVIAN BIOL, V36, P210, DOI 10.1111/j.0908-8857.2005.03360.x; Stige LC, 2006, P NATL ACAD SCI USA, V103, P3049, DOI 10.1073/pnas.0600057103; Vahatalo AV, 2004, J AVIAN BIOL, V35, P210; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1	24	329	350	10	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1959	1961		10.1126/science.1126119	http://dx.doi.org/10.1126/science.1126119			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809542				2022-12-28	WOS:000238848100061
J	Wittlinger, M; Wehner, R; Wolf, H				Wittlinger, M; Wehner, R; Wolf, H			The ant odometer: Stepping on stilts and stumps	SCIENCE			English	Article							CATAGLYPHIS-FORTIS; DESERT ANTS; OPTIC FLOW; PATH-INTEGRATION; DISTANCE; PATTERNS	Desert ants, Catoglyphis, navigate in their vast desert habitat by path integration. They continuously integrate directions steered (as determined by their celestial compass) and distances traveled, gauged by as-yet-unknown mechanisms. Here we test the hypothesis that navigating ants measure distances traveled by using some kind of step integrator, or "step counter." We manipulated the lengths of the legs and, hence, the stride lengths, in freely walking ants. Animals with elongated ("stilts") or shortened legs ("stumps") take larger or shorter strides, respectively, and concomitantly misgauge travel distance. Travel distance is overestimated by experimental animals walking on stilts and underestimated by animals walking on stumps.	Univ Ulm, Dept Neurobiol, D-89069 Ulm, Germany; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	Ulm University; University of Zurich	Wittlinger, M (corresponding author), Univ Ulm, Dept Neurobiol, D-89069 Ulm, Germany.	matthias.wittlinger@gmx.de		Wolf, Harald/0000-0003-2715-3376				ESCH HE, 1995, NATURWISSENSCHAFTEN, V82, P38, DOI 10.1007/BF01167870; Franks NR, 2006, P ROY SOC B-BIOL SCI, V273, P165, DOI 10.1098/rspb.2005.3312; HERAN H, 1952, Z VERGL PHYSIOL, V34, P383, DOI 10.1007/BF00298052; Mittelstaedt H., 1973, FORTSCHR ZOOL, V21, P46; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; PIERON H, 1904, B I GEN PSYCHOL, V4, P168; Ronacher B, 2000, J EXP BIOL, V203, P1113; RONACHER B, 1995, J COMP PHYSIOL A, V177, P21; Sommer S, 2004, J COMP PHYSIOL A, V190, P1, DOI 10.1007/s00359-003-0465-4; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Thielin-Bescond M, 2005, NATURWISSENSCHAFTEN, V92, P193, DOI 10.1007/s00114-005-0609-1; Wehner R., 1983, Senckenbergiana Biologica, V64, P89; WEHNER R, 1981, NATURE, V293, P731, DOI 10.1038/293731a0; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Wehner R., 1992, P45; Wohlgemuth S, 2001, NATURE, V411, P795, DOI 10.1038/35081069; Zollikofer C.P.E., 1988, THESIS U ZURICH; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P107; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P95	20	291	293	7	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2006	312	5782					1965	1967		10.1126/science.1126912	http://dx.doi.org/10.1126/science.1126912			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16809544				2022-12-28	WOS:000238848100063
J	Hochedlinger, K; Jaenisch, R				Hochedlinger, Konrad; Jaenisch, Rudolf			Nuclear reprogramming and pluripotency	NATURE			English	Article							EMBRYONIC STEM-CELLS; PRIMORDIAL GERM-CELLS; SOMATIC-CELLS; CLONED MICE; GENE-EXPRESSION; MOUSE EMBRYOS; ES CELLS; DEVELOPMENTAL REGULATORS; ENUCLEATED OOCYTES; HYBRID-CELLS	The cloning of mammals from differentiated donor cells has refuted the old dogma that development is an irreversible process. It has demonstrated that the oocyte can reprogramme an adult nucleus into an embryonic state that can direct development of a new organism. The prospect of deriving patient-specific embryonic stem cells by nuclear transfer underscores the potential use of this technology in regenerative medicine. The future challenge will be to study alternatives to nuclear transfer in order to recapitulate reprogramming in a Petri dish without the use of oocytes.	MIT, Dept Biol, Cambridge, MA 02142 USA; Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), MIT, Dept Biol, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu						Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blau HM, 1999, SEMIN CELL DEV BIOL, V10, P267, DOI 10.1006/scdb.1999.0311; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; BRIGGS ROBERT, 1957, J MORPH, V100, P269, DOI 10.1002/jmor.1051000204; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; CHEONG HT, 1993, BIOL REPROD, V48, P958, DOI 10.1095/biolreprod48.5.958; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Cibelli J.B., 2001, J REGEN MED, V2, P25, DOI [10.1089/152489001753262168, DOI 10.1089/152489001753262168]; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Dey R, 2000, J BIOL CHEM, V275, P31520, DOI 10.1074/jbc.M004053200; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; DURCOVAHILLS G, IN PRESS STEM CELLS; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hakelien AM, 2002, NAT BIOTECHNOL, V20, P460, DOI 10.1038/nbt0502-460; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hernandez L, 2003, P NATL ACAD SCI USA, V100, P13344, DOI 10.1073/pnas.2234026100; Hiiragi T, 2005, MOL REPROD DEV, V70, P417, DOI 10.1002/mrd.20126; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kennedy Donald, 2006, Science, V311, P335; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kohda T, 2005, BIOL REPROD, V73, P1302, DOI 10.1095/biolreprod.105.044958; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lee J, 2002, DEVELOPMENT, V129, P1807; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li L, 2003, CANCER RES, V63, P2733; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meng L, 1997, BIOL REPROD, V57, P454, DOI 10.1095/biolreprod57.2.454; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; OSHIMA RG, 1981, J CELL PHYSIOL, V109, P195, DOI 10.1002/jcp.1041090202; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V70, P99; ROUSSET JP, 1983, DEV BIOL, V96, P331, DOI 10.1016/0012-1606(83)90170-7; Simerly C, 2004, DEV BIOL, V276, P237, DOI 10.1016/j.ydbio.2004.10.006; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; STEWART CL, 1994, DEV BIOL, V161, P626, DOI 10.1006/dbio.1994.1058; STEWART TA, 1982, J EXP ZOOL, V224, P465, DOI 10.1002/jez.1402240322; Tada M, 2003, DEV DYNAM, V227, P504, DOI 10.1002/dvdy.10337; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Wakayama S, 2005, BIOL REPROD, V72, P932, DOI 10.1095/biolreprod.104.035105; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamazaki Y, 2005, P NATL ACAD SCI USA, V102, P11361, DOI 10.1073/pnas.0504943102; Yu JY, 2006, STEM CELLS, V24, P168, DOI 10.1634/stemcells.2005-0292; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	100	359	421	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1061	1067		10.1038/nature04955	http://dx.doi.org/10.1038/nature04955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810240				2022-12-28	WOS:000238615500032
J	Ingelsson, E; Bjorklund-Bodegard, K; Lind, L; Arnlov, J; Sundstrom, J				Ingelsson, Erik; Bjorklund-Bodegard, Kristina; Lind, Lars; Arnlov, Johan; Sundstrom, Johan			Diurnal blood pressure pattern and risk of congestive heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL DYSFUNCTION; PROGNOSTIC-SIGNIFICANCE; NOCTURNAL DECLINE; SLEEP-APNEA; HYPERTENSION; RECOMMENDATIONS; VALIDITY; DISEASE	Context High blood pressure is the most important risk factor for congestive heart failure (CHF) at a population level, but the relationship of an altered diurnal blood pressure pattern to risk of subsequent CHF is unknown. Objectives To explore 24-hour ambulatory blood pressure characteristics as predictors of CHF incidence and to investigate whether altered diurnal blood pressure patterns confer any additional risk information beyond that provided by conventional office blood pressure measurements. Design, Setting, and Participants Prospective, community-based, observational cohort in Uppsala, Sweden, including 951 elderly men free of CHF, valvular disease, and left ventricular hypertrophy at baseline between 1990 and 1995, followed up until the end of 2002. Twenty-four-hour ambulatory blood pressure monitoring was performed at baseline, and the blood pressure variables were analyzed as predictors of subsequent CHF. Main Outcome Measure First hospitalization for CHF. Results Seventy men developed heart failure during follow-up, with an incidence rate of 8.6 per 1000 person-years at risk. In multivariable Cox proportional hazards models adjusted for antihypertensive treatment and established risk factors for CHF ( myocardial infarction, diabetes, smoking, body mass index, and serum cholesterol level), a 1-SD (9-mm Hg) increase in nighttime ambulatory diastolic blood pressure ( hazard ratio [HR], 1.26; 95% confidence interval [CI], 1.02-1.55) and the presence of "non-dipping" blood pressure (night-day ambulatory blood pressure ratio >= 1; HR, 2.29; 95% CI, 1.16-4.52) were associated with an increased risk of CHF. After adjusting for office-measured systolic and diastolic blood pressures, nondipping blood pressure remained a significant predictor of CHF ( HR, 2.21; 95% CI, 1.12-4.36 vs normal night-day pattern). Nighttime ambulatory diastolic blood pressure and nondipping blood pressure were also significant predictors of CHF after exclusion of all participants who had an acute myocardial infarction before baseline or during follow-up. Conclusions Nighttime blood pressure appears to convey additional risk information about CHF beyond office-measured blood pressure and other established risk factors for CHF. The clinical value of this association remains to be established in future studies.	Uppsala Univ, Dept Publ Hlth & Caring Sci, SE-75185 Uppsala, Sweden; Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden; AstraZeneca Res & Dev, Molndal, Sweden	Uppsala University; Uppsala University; AstraZeneca	Ingelsson, E (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	erik.ingelsson@pubcare.uu.se	Sundstrom, Johan/R-2139-2019; Ärnlöv, Johan/AAF-2746-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Ärnlöv, Johan/0000-0002-6933-4637; Sundström, Johan/0000-0003-2247-8454				Andersen NH, 2005, DIABETIC MED, V22, P1218, DOI 10.1111/j.1464-5491.2005.01589.x; APPEL LJ, 1990, AM J EPIDEMIOL, V132, P343, DOI 10.1093/oxfordjournals.aje.a115664; Bell DSH, 2003, DIABETES CARE, V26, P2433, DOI 10.2337/diacare.26.8.2433; Berry C, 2001, EUR J HEART FAIL, V3, P283, DOI 10.1016/S1388-9842(01)00123-4; Bjorklund K, 2004, J HYPERTENS, V22, P1691; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Byberg L, 1998, ARTERIOSCL THROM VAS, V18, P258, DOI 10.1161/01.ATV.18.2.258; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; Chong AY, 2004, CIRCULATION, V110, P1794, DOI 10.1161/01.CIR.0000143073.60937.50; CLELAND JG, 1995, EUR HEART J, V16, P741; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Galderisi M, 1996, AM J CARDIOL, V77, P597, DOI 10.1016/S0002-9149(97)89313-7; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Goyal D, 2005, EUR J HEART FAIL, V7, P149, DOI 10.1016/j.ejheart.2004.05.010; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Higashi Y, 2002, J AM COLL CARDIOL, V40, P2039, DOI 10.1016/S0735-1097(02)02535-4; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Javaheri S, 1998, CIRCULATION, V97, P2154, DOI 10.1161/01.CIR.97.21.2154; Lee KW, 2005, AM J HYPERTENS, V18, P104, DOI 10.1016/j.amjhyper.2004.09.003; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Ohkubo T, 1997, AM J HYPERTENS, V10, P1201, DOI 10.1016/S0895-7061(97)00274-4; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Prineas R., 1982, MINNESOTA CODE MANUA; Sherwood A, 2002, AM J HYPERTENS, V15, P111, DOI 10.1016/S0895-7061(01)02251-8; Sica D A, 1999, Blood Press Monit, V4 Suppl 2, pS9; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Staessen JA, 1997, HYPERTENSION, V29, P30, DOI 10.1161/01.HYP.29.1.30; Tousoulis D, 2005, INT J CARDIOL, V100, P347, DOI 10.1016/j.ijcard.2004.05.030; VERDECCHIA P, 1990, EUR HEART J, V11, P679, DOI 10.1093/oxfordjournals.eurheartj.a059783; Verdecchia P, 2002, J AM COLL CARDIOL, V39, P878, DOI 10.1016/S0735-1097(01)01827-7; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; von Kanel Roland, 2004, Journal of Hypertension, V22, P2087, DOI 10.1097/00004872-200411000-00009; Ziegler MG, 2003, CURR OPIN NEPHROL HY, V12, P97, DOI 10.1097/00041552-200301000-00016	39	222	239	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2859	2866		10.1001/jama.295.24.2859	http://dx.doi.org/10.1001/jama.295.24.2859			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057DY	16804152	Bronze			2022-12-28	WOS:000238577700023
J	Whooley, MA				Whooley, Mary A.			Depression and cardiovascular disease - Healing the broken-hearted	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Department of Medicine Grand Rounds Conference	JUL 21, 2006	San Francisco, CA	Univ Calif San Francisco			CORONARY-ARTERY-DISEASE; SEROTONIN REUPTAKE INHIBITORS; SUSTAINED-RELEASE BUPROPION; LATE-LIFE DEPRESSION; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; PRIMARY-CARE; CONTROLLED-TRIAL; RISK-FACTOR; COGNITIVE THERAPY	Major depressive disorder is a risk factor for the development of incident coronary heart disease events in healthy patients and for adverse cardiovascular outcomes in patients with established heart disease. Depression is present in 1 of 5 outpatients with coronary heart disease and in 1 of 3 outpatients with congestive heart failure, yet the majority of cases are not recognized or appropriately treated. It is not known whether treating depression improves cardiovascular outcomes, but antidepressant treatment with selective serotonin reuptake inhibitors is generally safe, alleviates depression, and improves quality of life. This article evaluates the importance of major depression in patients with cardiovascular disease, and provides practical guidance for identifying and treating this disorder.	Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Whooley, MA (corresponding author), Vet Affairs Med Ctr, 4150 Clement St 111A1, San Francisco, CA 94121 USA.	mary.whooley@ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079235, R01 HL079235-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abo-Zena RA, 2000, PHARMACOTHERAPY, V20, P476, DOI 10.1592/phco.20.5.476.35061; Abramson J, 2001, ARCH INTERN MED, V161, P1725, DOI 10.1001/archinte.161.14.1725; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barefoot John C, 2003, J Cardiopulm Rehabil, V23, P404, DOI 10.1097/00008483-200311000-00002; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Borowicz L, 2002, PSYCHOSOMATICS, V43, P464, DOI 10.1176/appi.psy.43.6.464; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Frasure-Smith N, 2006, PSYCHOSOM MED, V68, P87, DOI 10.1097/01.psy.0000195833.68482.27; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; FrasureSmith N, 1997, LANCET, V350, P473, DOI 10.1016/S0140-6736(97)02142-9; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Guck Thomas P, 2003, Congest Heart Fail, V9, P163, DOI 10.1111/j.1527-5299.2003.01356.x; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Havranek EP, 1999, AM J CARDIOL, V84, P348, DOI 10.1016/S0002-9149(99)00293-3; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; Hollon SD, 2005, J CLIN PSYCHIAT, V66, P455, DOI 10.4088/JCP.v66n0408; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Jiang W, 2005, AM HEART J, V150, P54, DOI 10.1016/j.ahj.2005.04.012; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Joynt KE, 2004, J CARD FAIL, V10, P258, DOI 10.1016/j.cardfail.2003.09.008; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Koike AK, 2002, AM J PSYCHIAT, V159, P1738, DOI 10.1176/appi.ajp.159.10.1738; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Kroenke K, 2002, JAMA-J AM MED ASSOC, V287, P1568, DOI 10.1001/jama.287.12.1568; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KUPFER DJ, 1989, ARCH GEN PSYCHIAT, V46, P771; Lane DA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003329.pub2; Lesperance F, 2000, J PSYCHOSOM RES, V48, P379, DOI 10.1016/S0022-3999(99)00102-6; Lesperance F, 2003, CAN J PSYCHIAT, V48, P695, DOI 10.1177/070674370304801009; Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Mason BJ, 1996, JAMA-J AM MED ASSOC, V275, P761, DOI 10.1001/jama.275.10.761; McCaffery JM, 2006, PSYCHOSOM MED, V68, P187, DOI 10.1097/01.psy.0000208630.79271.a0; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; MILLER MC, 1999, HARVARD MED SCH GUID, P520; Miller MD, 1996, AM J PSYCHIAT, V153, P1350; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Otte C, 2005, AM J PSYCHIAT, V162, P2139, DOI 10.1176/appi.ajp.162.11.2139; Otte C, 2004, BIOL PSYCHIAT, V56, P241, DOI 10.1016/j.biopsych.2004.06.003; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; ROOSE SP, 1991, AM J PSYCHIAT, V148, P512; Roose SP, 2003, BIOL PSYCHIAT, V54, P262, DOI 10.1016/S0006-3223(03)00320-2; Rozzini R, 2002, ARCH INTERN MED, V162, P362, DOI 10.1001/archinte.162.3.362-a; Ruo B, 2004, AM J CARDIOL, V94, P96, DOI 10.1016/j.amjcard.2004.03.035; Schins A, 2004, LIFE SCI, V76, P637, DOI 10.1016/j.lfs.2004.04.060; Schulberg HC, 1998, ARCH GEN PSYCHIAT, V55, P1121, DOI 10.1001/archpsyc.55.12.1121; Serebruany VL, 2003, CIRCULATION, V108, P939, DOI 10.1161/01.CIR.0000085163.21752.0A; Serebruany VL, 2003, BLOOD COAGUL FIBRIN, V14, P563, DOI 10.1097/00001721-200309000-00008; SKALA JA, 2005, ADV PSYCHOTHERAPY EV; Smith SC, 2001, CIRCULATION, V104, P1577, DOI 10.1161/hc3801.097475; Solai LKK, 2001, DRUG AGING, V18, P355, DOI 10.2165/00002512-200118050-00006; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stewart RAH, 2003, EUR HEART J, V24, P2027, DOI 10.1016/j.ehj.2003.08.017; Stimmel GL, 1997, PHARMACOTHERAPY, V17, P10; Strike PC, 2003, EUR HEART J, V24, P690, DOI 10.1016/S0195-668X(02)00615-2; Tamam L, 2002, ADV THER, V19, P17, DOI 10.1007/BF02850015; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Taylor MJ, 2005, J AFFECT DISORDERS, V88, P241, DOI 10.1016/j.jad.2005.07.006; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; *US DEP HHS, 1993, AHCPR PUBL; Vaccarino V, 2001, J AM COLL CARDIOL, V38, P199, DOI 10.1016/S0735-1097(01)01334-1; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; WELLS K, 1996, CARING DEPRESSION; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zajecka J, 1997, PSYCHOPHARMACOL BULL, V33, P755; Zellweger MJ, 2004, EUR HEART J, V25, P3, DOI 10.1016/j.ehj.2003.09.009; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; Ziegelstein RC, 2001, JAMA-J AM MED ASSOC, V286, P1621, DOI 10.1001/jama.286.13.1621	88	174	186	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2874	2881		10.1001/jama.295.24.2874	http://dx.doi.org/10.1001/jama.295.24.2874			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	057DY	16804154	Green Accepted			2022-12-28	WOS:000238577700025
J	Kim, BG; Li, CL; Qiao, WH; Mamura, M; Kasperczak, B; Anver, M; Wolfraim, L; Hong, S; Mushinski, E; Potter, M; Kim, SJ; Fu, XY; Deng, CX; Letterio, JJ				Kim, Byung-Gyu; li, Cuing Li; Qiao, Wenhui; Mamura, Mizuko; Kasperczak, Barbara; Anver, Miriam; Wolfraim, Lawrence; Hong, Suntaek; Mushinski, Elizabeth; Potter, Michael; Kim, Seong-Jin; Fu, Xin-Yuan; Deng, Chuxia; Letterio, John J.			Smad4 signalling in T cells is required for suppression of gastrointestinal cancer	NATURE			English	Article							CONDITIONAL KNOCKOUT MICE; TGF-BETA; JUVENILE POLYPOSIS; COLON-CANCER; TRANSGENIC MICE; TUMOR-GROWTH; GENE; STAT3; IL-6; INACTIVATION	SMAD4 (MAD homologue 4 (Drosophila)), also known as DPC4 ( deleted in pancreatic cancer), is a tumour suppressor gene that encodes a central mediator of transforming growth factor-beta signalling(1-4). Germline mutations in SMAD4 are found in over 50% of patients with familial juvenile polyposis, an autosomal dominant disorder characterized by predisposition to hamartomatous polyps and gastrointestinal cancer(5,6). Dense inflammatory cell infiltrates underlay grossly normal appearing, non-polypoid colonic and gastric mucosa of patients with familial juvenile polyposis(7). This prominent stromal component suggests that loss of SMAD4-dependent signalling in cells within the epithelial microenvironment has an important role in the evolution of intestinal tumorigenesis in this syndrome. Here we show that selective loss of Smad4-dependent signalling in T cells leads to spontaneous epithelial cancers throughout the gastrointestinal tract in mice, whereas epithelial-specific deletion of the Smad4 gene does not. Tumours arising within the colon, rectum, duodenum, stomach and oral cavity are stroma-rich with dense plasma cell infiltrates. Smad4(-/-) T cells produce abundant T(H)2-type cytokines including interleukin (IL)-5, IL-6 and IL-13, known mediators of plasma cell and stromal expansion. The results support the concept that cancer, as an outcome, reflects the loss of the normal communication between the cellular constituents of a given organ(8), and indicate that Smad4-deficient T cells ultimately send the wrong message to their stromal and epithelial neighbours.	NCI, Lab Cell Regulat & Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet Dis & Dev Branch, NIH, Bethesda, MD 20892 USA; NCI, SAIC, Frederick, MD 21702 USA; NIH, Genet Lab, Ctr Canc Res, Bethesda, MD 20892 USA; Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Indiana University System; Indiana University-Purdue University Indianapolis	Letterio, JJ (corresponding author), NCI, Lab Cell Regulat & Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	john.letterio@cwru.edu	deng, chuxia/N-6713-2016	Kim, Byung-Gyu/0000-0002-8921-5061; Mamura, Mizuko/0000-0003-4531-0144	NATIONAL CANCER INSTITUTE [Z01BC005617, ZIABC005596, Z01BC005596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056012, Z01DK056001, ZIADK056012, ZIADK056001] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2005, CELL CYCLE, V4, P217; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Corvinus FM, 2005, NEOPLASIA, V7, P545, DOI 10.1593/neo.04571; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2002, AM J HUM GENET, V70, P1357, DOI 10.1086/340258; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyaki M, 2003, BIOCHEM BIOPH RES CO, V306, P799, DOI 10.1016/S0006-291X(03)01066-0; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SUBRAMONY C, 1994, AM J CLIN PATHOL, V102, P91, DOI 10.1093/ajcp/102.1.91; Tsuchida K, 2003, KIDNEY INT, V63, P2000, DOI 10.1046/j.1523-1755.2003.00009.x; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Woodford-Richens K, 2000, CANCER RES, V60, P2477; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029	29	241	258	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					1015	1019		10.1038/nature04846	http://dx.doi.org/10.1038/nature04846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791201				2022-12-28	WOS:000238422300050
J	Okie, S				Okie, S			ADHD in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEFICIT HYPERACTIVITY DISORDER											Biederman J, 2006, LANCET, V367, P210; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; McCann BS, 2004, COMPR PSYCHIAT, V45, P175, DOI 10.1016/j.comppsych.2004.02.006	7	58	59	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2637	2641		10.1056/NEJMp068113	http://dx.doi.org/10.1056/NEJMp068113			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	054ZJ	16790695				2022-12-28	WOS:000238416900001
J	Sun, JM; Liu, TS				Sun, JM; Liu, TS			The age of the Taklimakan Desert	SCIENCE			English	Article									Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, Beijing 100029, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS	Sun, JM (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, POB 9825, Beijing 100029, Peoples R China.	jmsun@mail.igcas.ac.cn	Sun, Jimin/F-1240-2018	Sun, Jimin/0000-0003-3516-1413				CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Zhou Z.Y., 1990, BIOSTRATIGRAPHY GEOL; Zhu Z.D., 1980, OUTLINE CHINESE DESE; 郑洪波, 2002, [科学通报, Chinese science bulletin], V47, P226	6	189	259	6	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1621	1621		10.1126/science.1124616	http://dx.doi.org/10.1126/science.1124616			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778048				2022-12-28	WOS:000238288600036
J	Gewin, V				Gewin, V			Burst of energy	NATURE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2006	441	7095					810	811		10.1038/441810a	http://dx.doi.org/10.1038/441810a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778861				2022-12-28	WOS:000238254100015
J	Markovitsi, D; Talbot, F; Gustavsson, T; Onidas, D; Lazzarotto, E; Marguet, S				Markovitsi, Dimitra; Talbot, Francis; Gustavsson, Thomas; Onidas, Delphine; Lazzarotto, Elodie; Marguet, Sylvie			Molecular spectroscopy: Complexity of excited-state dynamics in DNA	NATURE			English	Article									CEA Saclay, DSM, DRECAM SPAM, Lab Francis Perrin,CNRS,URA 2453, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS)	Markovitsi, D (corresponding author), CEA Saclay, DSM, DRECAM SPAM, Lab Francis Perrin,CNRS,URA 2453, F-91191 Gif Sur Yvette, France.	dimitra.markovitsi@cea.fr	MARGUET, Sylvie/K-2750-2012; Gustavsson, Thomas/B-1702-2009	MARGUET, Sylvie/0000-0002-8670-1320; Gustavsson, Thomas/0000-0001-7030-6812; Markovitsi, Dimitra/0000-0002-2726-305X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064563] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064563-04, R01 GM064563] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouvier B, 2003, J PHYS CHEM B, V107, P13512, DOI 10.1021/jp036164u; Bouvier B, 2002, CHEM PHYS, V275, P75, DOI 10.1016/S0301-0104(01)00523-7; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; Crespo-Hernandez CE, 2004, J PHYS CHEM B, V108, P11182, DOI 10.1021/jp0496046; Emanuele E, 2005, J PHYS CHEM B, V109, P16109, DOI 10.1021/jp051833k; Emanuele E, 2005, CHEMPHYSCHEM, V6, P1387, DOI 10.1002/cphc.200500014; GE G, 1991, PHOTOCHEM PHOTOBIOL, V54, P301, DOI 10.1111/j.1751-1097.1991.tb02020.x; Hartmann B, 1996, Q REV BIOPHYS, V29, P309, DOI 10.1017/S0033583500005874; KOPKA ML, 1983, J MOL BIOL, V163, P129, DOI 10.1016/0022-2836(83)90033-5; Markovitsi D, 2005, J AM CHEM SOC, V127, P17130, DOI 10.1021/ja054955z; Markovitsi D, 2003, CHEMPHYSCHEM, V4, P303, DOI 10.1002/cphc.200390050; Starikov EB, 2005, INT J MOD PHYS B, V19, P4331, DOI 10.1142/S0217979205032802	12	121	121	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					E7	E7		10.1038/nature04903	http://dx.doi.org/10.1038/nature04903			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760929	Green Submitted, Bronze			2022-12-28	WOS:000238095100042
J	Roberge, A; Feldman, PD; Weinberger, AJ; Deleuil, M; Bouret, JC				Roberge, Aki; Feldman, Paul D.; Weinberger, Alycia J.; Deleuil, Magali; Bouret, Jean-Claude			Stabilization of the disk around beta Pictoris by extremely carbon-rich gas	NATURE			English	Article							CIRCUMSTELLAR DISK	The edge-on disk surrounding the nearby young star beta Pictoris is the archetype of `debris disks', which are composed of dust and gas produced by collisions between - and evaporation of - planetesimals, analogues of Solar System comets and asteroids. These disks may provide insight into the formation and early evolution of terrestrial planets. Previous work on beta Pic concluded that the disk gas has roughly solar abundances of elements(1), but this poses a problem because such gas should rapidly be blown away from the star, contrary to observations showing a stable gas disk in keplerian rotation(1,2). Here we report the detection of singly and doubly ionized carbon ( C II, C III) and neutral atomic oxygen ( O I) gas in the beta Pic disk. Carbon is extremely overabundant relative to every other measured element. This appears to solve the problem of the stable gas disk, because the carbon overabundance should keep the gas disk in keplerian rotation(3). The overabundance may indicate that the gas is produced from material more carbon-rich than expected of Solar System analogues.	NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Lab Astrophys Marseille, F-13376 Marseille 12, France	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Carnegie Institution for Science; UDICE-French Research Universities; Aix-Marseille Universite	Roberge, A (corresponding author), NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA.	akir@milkyway.gsfc.nasa.gov	Roberge, Aki/D-2782-2012	Roberge, Aki/0000-0002-2989-3725; Deleuil, Magali/0000-0001-6036-0225; Weinberger, Alycia/0000-0001-6654-7859				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; BEUST H, 1990, ASTRON ASTROPHYS, V236, P202; Bouret JC, 2002, ASTRON ASTROPHYS, V390, P1049, DOI 10.1051/0004-6361:20020741; Brandeker A, 2004, ASTRON ASTROPHYS, V413, P681, DOI 10.1051/0004-6361:20034326; Chen CH, 2003, ASTROPHYS J, V582, P443, DOI 10.1086/344589; CRAWFORD IA, 1994, MON NOT R ASTRON SOC, V266, pL65, DOI 10.1093/mnras/266.1.L65; Deleuil M, 2001, ASTROPHYS J, V557, pL67, DOI 10.1086/323005; FERNANDEZ R, 2006, IN PRESS ASTROPHYS J; FREUDLING W, 1995, ASTRON ASTROPHYS, V301, P231; Holweger H, 1997, ASTRON ASTROPHYS, V320, pL49; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; Lagrange AM, 1998, ASTRON ASTROPHYS, V330, P1091; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Olofsson G, 2001, ASTROPHYS J, V563, pL77, DOI 10.1086/338354; Roberge A, 2000, ASTROPHYS J, V538, P904, DOI 10.1086/309157; SLETTEBAK A, 1975, ASTROPHYS J SUPPL S, V29, P137, DOI 10.1086/190338; VIDALMADJAR A, 1994, ASTRON ASTROPHYS, V290, P245; Zuckerman B, 2001, ASTROPHYS J, V562, pL87, DOI 10.1086/337968	18	103	103	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					724	726		10.1038/nature04832	http://dx.doi.org/10.1038/nature04832			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760971	Green Submitted			2022-12-28	WOS:000238095100047
J	Boillee, S; Yamanaka, K; Lobsiger, CS; Copeland, NG; Jenkins, NA; Kassiotis, G; Kollias, G; Cleveland, DW				Boillee, Severine; Yamanaka, Koji; Lobsiger, Christian S.; Copeland, Neal G.; Jenkins, Nancy A.; Kassiotis, George; Kollias, George; Cleveland, Don W.			Onset and progression in inherited ALS determined by motor neurons and microglia	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; SPINAL-CORD TISSUE; FAMILIAL ALS; MOUSE MODEL; TRANSGENIC MODEL; DISEASE ONSET; DEGENERATION; MINOCYCLINE; MICE	Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non-cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; NCI, Mouse Canc Genet Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari 16672, Greece	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Alexander Fleming Biomedical Sciences Research Center	Yamanaka, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kyamanaka@ucsd.edu; dcleveland@ucsd.edu	Lobsiger, Christian/N-4369-2018; Boillee, Severine/J-4027-2017; Lobsiger, Christian S./AAA-5311-2019; Cleveland, Don/AAN-9783-2021; Yamanaka, Koji/ABD-1034-2020; Lobsiger, Christian S/B-2720-2017; Kollias, George/A-7079-2012; Yamanaka, Koji/H-5806-2011	Lobsiger, Christian S./0000-0002-4313-010X; Yamanaka, Koji/0000-0003-4655-0035; Kollias, George/0000-0003-1867-3150; Yamanaka, Koji/0000-0003-4655-0035; Kassiotis, George/0000-0002-8457-2633; Cleveland, Don/0000-0002-1934-3682; BOILLEE, Severine/0000-0001-5518-9005	NINDS NIH HHS [R37 NS027036, NS 27036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; HICKSTEIN DD, 1992, P NATL ACAD SCI USA, V89, P2105, DOI 10.1073/pnas.89.6.2105; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S., 2001, BMC DEV BIOL, V1; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	28	1192	1244	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1389	1392		10.1126/science.1123511	http://dx.doi.org/10.1126/science.1123511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741123				2022-12-28	WOS:000237961600058
J	Green, TJ; Zhang, X; Wertz, GW; Luo, M				Green, Todd J.; Zhang, Xin; Wertz, Gail W.; Luo, Ming			Structure of the vesicular stomatitis virus nucleoprotein-RNA complex	SCIENCE			English	Article							PROTEIN; POLYMERASE; NS	Vesicular stomatitis virus is a negative-stranded RNA virus. Its nucleoprotein (N) binds the viral genomic RNA and is involved in multiple functions including transcription, replication, and assembly. We have determined a 2.9 angstrom structure of a complex containing 10 molecules of the N protein and 90 bases of RNA. The RNA is tightly sequestered in a cavity at the interface between two lobes of the N protein. This serves to protect the RNA in the absence of polynucleotide synthesis. For the RNA to be accessed, some conformational change in the N protein should be necessary.	Univ Alabama, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Luo, M (corresponding author), Univ Alabama, Sch Med, Dept Microbiol, 1025 18th St S, Birmingham, AL 35294 USA.	mingluo@uab.edu		Green, Todd/0000-0003-1158-4710	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012464, R56AI050066, R01AI050066] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI012464-29, AI050066, R37 AI012464-28, R37 AI012464-31, R37 AI012464-30, R37 AI012464, R37AI012464] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chen Z, 2004, STRUCTURE, V12, P227, DOI 10.1016/j.str.2004.01.001; DeLano WL, 2002, PYMOL USERS MANUAL; EMERSON SU, 1972, J VIROL, V10, P297, DOI 10.1128/JVI.10.2.297-309.1972; EMERSON SU, 1975, J VIROL, V15, P1348, DOI 10.1128/JVI.15.6.1348-1356.1975; Green TJ, 2000, J VIROL, V74, P9515, DOI 10.1128/JVI.74.20.9515-9524.2000; Green TJ, 2006, ACTA CRYSTALLOGR D, V62, P498, DOI 10.1107/S0907444906006809; HOWARD M, 1989, J GEN VIROL, V70, P2683, DOI 10.1099/0022-1317-70-10-2683; HOWATSON AF, 1962, VIROLOGY, V16, P466, DOI 10.1016/0042-6822(62)90228-3; HUANG AS, 1966, J MOL BIOL, V22, P381, DOI 10.1016/0022-2836(66)90143-4; Iseni F, 2000, RNA, V6, P270, DOI 10.1017/S135583820099109X; KEENE JD, 1981, P NATL ACAD SCI-BIOL, V78, P6191, DOI 10.1073/pnas.78.10.6191; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; MCCOMBS RM, 1966, J BACTERIOL, V91, P803, DOI 10.1128/JB.91.2.803-812.1966; NAITO S, 1976, J BIOL CHEM, V251, P4307; NAKAI T, 1968, VIROLOGY, V35, P268, DOI 10.1016/0042-6822(68)90267-5; Schoehn G, 2001, J VIROL, V75, P490, DOI 10.1128/JVI.75.1.490-498.2001; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985	18	255	266	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					357	360		10.1126/science.1126953	http://dx.doi.org/10.1126/science.1126953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16778022				2022-12-28	WOS:000239154300046
J	Watson, N; Halamka, JD				Watson, N; Halamka, JD			For and against - Patients should have to opt out of national electronic care records	BRITISH MEDICAL JOURNAL			English	Editorial Material							LESSONS	Although some aspects of the NHS care record service have a broad consensus agreement, issues of consent and security are dividing health professionals, the public, and the national programme for information technology. Nigel Watson believes his experience of opting out shows it to be the most workable option, but John Halamka uses a US model to argue that opting in is the out), way to ensure confidentiality.	Wessex Local Med Comm, Winchester SO23 8TA, Hants, England		Watson, N (corresponding author), Wessex Local Med Comm, Winchester SO23 8TA, Hants, England.	nigelwatson@wessexlmcs.org.uk; jhalamka@caregroup.harvard.edu						Adams T, 2004, BRIT MED J, V328, P871, DOI 10.1136/bmj.328.7444.871; *BMA, 2006, STAT CONN HLTH; *CONN HLTH, NHS CAR REC SERV; Gottlieb LK, 2005, HEALTH AFFAIR, V24, P1197, DOI 10.1377/hlthaff.24.5.1197; Halamka J, 2005, J AM MED INFORM ASSN, V12, P596, DOI 10.1197/jamia.M1866; Hippisley-Cox J, 2003, BRIT MED J, V326, P1439, DOI 10.1136/bmj.326.7404.1439; Institute of Medicine, 2006, HOSP BASED EMERGENCY; 2006, EMERGENCY CARE S FEB	8	15	16	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 1	2006	333	7557					39	42		10.1136/bmj.333.7557.39	http://dx.doi.org/10.1136/bmj.333.7557.39			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16809714	Green Published			2022-12-28	WOS:000238922900030
J	Butz, WP; Torrey, BB				Butz, William P.; Torrey, Barbara Boyle			Some frontiers in social science	SCIENCE			English	Editorial Material							COOPERATION; POPULATION	The fundamental challenge in the social sciences is moving from complicated correlations to useful prediction. Progress usually reflects an interplay between theory, data, and toots. Six areas of innovation, principally data and tools, are now pushing at the frontiers of these sciences: longitudinal data, laboratory experimentation, improved statistical methods, geographic information tools, biosocial science, and international replication. These innovations are gaining power as they cross disciplinary boundaries, helping to attribute causality to observed relationships, to understand their nature, and thereby to improve the accuracy and usefulness of predictions.	Populat Reference Bur, Washington, DC 20009 USA		Butz, WP (corresponding author), Populat Reference Bur, 1875 Connecticut Ave, Washington, DC 20009 USA.	wbutz@prb.org						ABOWD JM, 2003, TP200310 US CENS BUR; Bainbridge W. S., 2002, COMPUTING SOCIAL SCI, P51; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; BERNDT E, 2005, 11288 NBER; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Bonham VL, 2005, AM PSYCHOL, V60, P9, DOI 10.1037/0003-066X.60.1.9; BRADURY B, 2001, DYNAMICS CHILD POVER; Camerer CF, 2004, ROUNDTABLE SER BEHAV, P1; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Dennett D. C., 2006, BREAKING SPELL RELIG; DEUTSCH KW, 1971, SCIENCE, V171, P450, DOI 10.1126/science.171.3970.450; Dillman D.A., 2007, MAIL INTERNET SURVEY, V2nd; Fearon JD, 1996, AM POLIT SCI REV, V90, P715, DOI 10.2307/2945838; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Henrich J, 2006, SCIENCE, V312, P60, DOI 10.1126/science.1126398; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Kagel John H., 1995, EC CHOICE THEORY EXP; Karlan DS, 2005, AM ECON REV, V95, P1688, DOI 10.1257/000282805775014407; LIVERMORE D, 1998, PEOPLE PIXELS; MARBERGER JH, 2006, C SCI TECHN POL ATL; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McFadden D, 2006, AM ECON REV, V96, P5, DOI 10.1257/000282806776157542; Milgrom P., 2004, PUTTING AUCTION THEO; Newman M., 2003, STRUCTURE DYNAMICS C; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; O'Neill B., 2001, POPULATION CLIMATE C, P114; SCHONLAU M, UNPUB; Smith PM, 1996, SCIENCE, V271, P611, DOI 10.1126/science.271.5249.611; Suzman R, 2004, POPUL DEV REV, V30, P239; Watts D.J., 2003, 6 DEGREES SCI CONNEC; Weber RA, 2006, AM ECON REV, V96, P114, DOI 10.1257/000282806776157588; Witte J., 2004, SOC ONLINE INTERNET, pxv	32	45	47	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1898	1900		10.1126/science.1130121	http://dx.doi.org/10.1126/science.1130121			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061CF	16809524				2022-12-28	WOS:000238848100042
J	Steinbrook, R				Steinbrook, R			For sale: Physician's prescribing data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*AM MED ASS, 2004, US PHYS PAT PRESCR D; *AM MED ASS, 2005 ANN REP; *HLTH IMS, 2005 ANN REP; MUSACCHIO RJ, 2006, PHARM EXECUTIVE 0501; SAUL S, 2006, NY TIMES        0504	5	29	30	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2745	2747		10.1056/NEJMp068125	http://dx.doi.org/10.1056/NEJMp068125			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807410				2022-12-28	WOS:000238584700001
J	Koh, K; Zheng, XZ; Sehgal, A				Koh, Kyunghee; Zheng, Xiangzhong; Sehgal, Amita			JETLAG resets the Drosophila circadian clock by promoting light-induced degradation of TIMELESS	SCIENCE			English	Article							CRYPTOCHROME; PROTEIN; PHOTORECEPTION; PERIOD; MELANOGASTER; ENTRAINMENT; EXPRESSION; SLIMB	Organisms ranging from bacteria to humans synchronize their internal clocks to daily cycles of light and dark. Photic entrainment of the Drosophila clock is mediated by proteasomal degradation of the clock protein TIMELESS (TIM). We have identified mutations in jetlag-a gene coding for an F-box protein with leucine-rich repeats-that result in reduced light sensitivity of the circadian clock. Mutant flies show rhythmic behavior in constant light, reduced phase shifts in response to light pulses, and reduced light-dependent degradation of TIM. Expression of JET along with the circadian photoreceptor cryptochrome (CRY) in cultured S2R+ cells confers light-dependent degradation onto TIM, thereby reconstituting the acute response of the circadian clock to light in a cell culture system. Our results suggest that JET is essential for resetting the clock by transmitting light signals from CRY to TIM.	Univ Penn, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Koh, Kyunghee/0000-0003-0847-8204	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS048471, R56NS048471, R01NS048471] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS048471, R37 NS048471, NS048471, R01 NS048471-02, R56 NS048471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashmore LJ, 2003, J BIOL RHYTHM, V18, P206, DOI [10.1177/0748730403018003003, 10.1177/0748730403253385]; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hendricks JC, 2004, SLEEP, V27, P334, DOI 10.1093/sleep/27.2.334; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Panda Satchidananda, 2003, Novartis Found Symp, V253, P73; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0	24	225	234	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1809	1812		10.1126/science.1124951	http://dx.doi.org/10.1126/science.1124951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794082	Green Accepted			2022-12-28	WOS:000238452800062
J	Vanhaeren, M; d'Errico, F; Stringer, C; James, SL; Todd, JA; Mienis, HK				Vanhaeren, Marian; d'Errico, Francesco; Stringer, Chris; James, Sarah L.; Todd, Jonathan A.; Mienis, Henk K.			Middle Paleolithic shell beads in Israel and Algeria	SCIENCE			English	Article							BURIAL SITE; U-SERIES; ES-SKHUL; ORIGIN; BEHAVIOR; DATES	Perforated marine gastropod shells at the western Asian site of Skhul and the North African site of Oued Djebbana indicate the early use of beads by modern humans in these regions. The remoteness of these sites from the seashore and a comparison of the shells to natural shell assemblages indicate deliberate selection and transport by humans for symbolic use. Elemental and chemical analyses of sediment matrix adhered to one Nassarius gibbosulus from Skhul indicate that the shell bead comes from a layer containing 10 human fossils and dating to 100,000 to 135,000 years ago, about 25,000 years earlier than previous evidence for personal decoration by modern humans in South Africa.	UCL, Ctr Evolut Cultural Divers, London WC1H 0PY, England; CNRS, UMR 7041, F-92023 Nanterre, France; Inst Prehist & Geol Quaternaire, CNRS, UMR 5199, F-33405 Talence, France; George Washington Univ, Dept Anthropol, Washington, DC USA; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); George Washington University; Natural History Museum London; Natural History Museum London; Tel Aviv University	Vanhaeren, M (corresponding author), UCL, Ctr Evolut Cultural Divers, 31-34 Gordon Sq, London WC1H 0PY, England.	m.vanhaeren@ucl.ac.uk; f.derrico@ipgq.u-bordeaux1.fr	Todd, Jonathan/M-7064-2019	Todd, Jonathan/0000-0002-0433-1611				Bar-Yosef O., 1992, MIDDLE PALEOLITHIC A, P163; Bate D., 1937, STONE AGE MOUNT CARM, V1, P134; CERNOHORSKY WO, 1984, B AUCKLAND I MUSEUM, V14; Claassen C., 1998, SHELLS; Cremaschi M., 1998, AFR ARCHAEOL REV, V15, P261; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; DEBENATH A, 1992, ANTHROPOLOGIE, V96, P711; Ferranti L, 2006, QUATERN INT, V145, P30, DOI 10.1016/j.quaint.2005.07.009; Garrod D.A.E., 1937, STONE AGE MOUNT CARM, VI; Gili C, 2000, LETHAIA, V33, P236, DOI 10.1080/00241160025100080; Grine FE, 2000, J HUM EVOL, V38, P755, DOI 10.1006/jhev.1999.0379; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Hublin J.J., 2001, HUMAN ROOTS AFRICA A, P99; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCown T, 1939, STONE AGE MOUNT CARM, V2; McCown T. D., 1937, STONE AGE MOUNT CARM, V1, P91; MCDERMOTT F, 1993, NATURE, V363, P252, DOI 10.1038/363252a0; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; MOREL J, 1974, ANTHROPOLOGIE, V78, P53; Morel J., 1974, B SOC PREH FR, V71, P103; MOSHKOVITZ S, 1968, THESIS HEBREW U JERU; Reygasse M., 1919, REC NOT MEM SOC ARCH, VLII, P513; REYGASSE M, 1919, RECL NOTES MEM SOC A, V52, P204; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; STEINER MC, 2003, CHRONOLOGY AURIGNACI, P49; Stringer C., 1989, PALEORIENT, V15, P99, DOI DOI 10.3406/paleo.1989.4512; STRINGER C, 2002, PHILOS T R SOC B, V357, P653; STRINGER CB, 1992, PHILOS T ROY SOC B, V337, P217, DOI 10.1098/rstb.1992.0099; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Taborin Y., 2003, ECHANGES DIFFUSION P, P113; Taborin Y., 1993, GALLIA PREHISTOI S29; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; VANDERMEERSCH B, 1989, HUMAN REVOLUTION, P155; Vanhaeren M., 2005, TOOLS SYMBOLS EARLY, P525; Wrinn PJ, 2003, J ARCHAEOL SCI, V30, P123, DOI 10.1006/jasc.2002.0813	40	286	298	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1785	1788		10.1126/science.1128139	http://dx.doi.org/10.1126/science.1128139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055LS	16794076				2022-12-28	WOS:000238452800055
J	Vogel, VG; Costantino, JP; Wickerham, DL; Cronin, WM; Cecchini, RS; Atkins, JN; Bevers, TB; Fehrenbacher, L; Pajon, ER; Wade, JL; Robidoux, A; Margolese, RG; James, J; Lippman, SM; Runowicz, CD; Ganz, PA; Reis, SE; McCaskill-Stevens, W; Ford, LG; Jordan, VC; Wolmark, N				Vogel, Victor G.; Costantino, Joseph P.; Wickerham, D. Lawrence; Cronin, Walter M.; Cecchini, Reena S.; Atkins, James N.; Bevers, Therese B.; Fehrenbacher, Louis; Pajon, Eduardo R., Jr.; Wade, James L., III; Robidoux, Andre; Margolese, Richard G.; James, Joan; Lippman, Scott M.; Runowicz, Carolyn D.; Ganz, Patricia A.; Reis, Steven E.; McCaskill-Stevens, Worta; Ford, Leslie G.; Jordan, V. Craig; Wolmark, Norman		NSABP	Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGICAL ADJUVANT BREAST; HEALTH SURVEY SF-36; ESTROGEN-RECEPTOR MODULATORS; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; MULTIPLE OUTCOMES; RANDOMIZED-TRIAL; PREVENTION; REDUCTION; PATIENT	Context Tamoxifen is approved for the reduction of breast cancer risk, and raloxifene has demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis. Objective To compare the relative effects and safety of raloxifene and tamoxifen on the risk of developing invasive breast cancer and other disease outcomes. Design, Setting, and Patients The National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial, a prospective, double-blind, randomized clinical trial conducted beginning July 1, 1999, in nearly 200 clinical centers throughout North America, with final analysis initiated after at least 327 incident invasive breast cancers were diagnosed. Patients were 19 747 postmenopausal women of mean age 58.5 years with increased 5-year breast cancer risk ( mean risk, 4.03% [SD, 2.17%]). Data reported are based on a cutoff date of December 31, 2005. Intervention Oral tamoxifen ( 20 mg/d) or raloxifene ( 60 mg/d) over 5 years. Main Outcome Measures Incidence of invasive breast cancer, uterine cancer, non-invasive breast cancer, bone fractures, thromboembolic events. Results There were 163 cases of invasive breast cancer in women assigned to tamoxifen and 168 in those assigned to raloxifene ( incidence, 4.30 per 1000 vs 4.41 per 1000; risk ratio [RR], 1.02; 95% confidence interval [CI], 0.82-1.28). There were fewer cases of noninvasive breast cancer in the tamoxifen group ( 57 cases) than in the raloxifene group ( 80 cases) ( incidence, 1.51 vs 2.11 per 1000; RR, 1.40; 95% CI, 0.98- 2.00). There were 36 cases of uterine cancer with tamoxifen and 23 with raloxifene ( RR, 0.62; 95% CI, 0.35-1.08). No differences were found for other invasive cancer sites, for ischemic heart disease events, or for stroke. Thromboembolic events occurred less often in the raloxifene group ( RR, 0.70; 95% CI, 0.54-0.91). The number of osteoporotic fractures in the groups was similar. There were fewer cataracts ( RR, 0.79; 95% CI, 0.68-0.92) and cataract surgeries ( RR, 0.82; 95% CI, 0.68-0.99) in the women taking raloxifene. There was no difference in the total number of deaths ( 101 vs 96 for tamoxifen vs raloxifene) or in causes of death. Conclusions Raloxifene is as effective as tamoxifen in reducing the risk of invasive breast cancer and has a lower risk of thromboembolic events and cataracts but a nonstatistically significant higher risk of noninvasive breast cancer. The risk of other cancers, fractures, ischemic heart disease, and stroke is similar for both drugs.	Univ Pittsburgh, Sch Med, Magee Womens Hosp, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; NSABP, Operat Ctr, Pittsburgh, PA USA; NSABP, Ctr Biostat, Pittsburgh, PA USA; Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; SE Canc Control Consortium, Winston Salem, NC USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Kaiser Permanente No Calif, Vallejo, CA USA; Denver Vet Med Ctr, Colorado CCOP, Denver, CO USA; Cent Illinois CCOP, Decatur, IL USA; Univ Montreal, Ctr Hosp, Montreal, PQ, Canada; McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; NCI, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Allegheny General Hospital; University of Texas System; UTMD Anderson Cancer Center; Kaiser Permanente; Universite de Montreal; McGill University; Fox Chase Cancer Center; University of Connecticut; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vogel, VG (corresponding author), Univ Pittsburgh, Sch Med, Magee Womens Hosp, 300 Halket St,Room 3524, Pittsburgh, PA 15213 USA.	vvogel@magee.edu	Cecchini, Rubens/D-9811-2013; Jordan, V. Craig/H-4491-2011; JORDAN, V.Craig/AAX-3562-2020; Reis, Steven E/J-3957-2014	Cecchini, Rubens/0000-0001-9941-2344; Reis, Steven/0000-0001-8023-0102; Cecchini, Reena/0000-0002-9075-9357; Runowicz, Carolyn D./0000-0002-6246-3743	NCI NIH HHS [U10-CA-37377, U10CA-69651, U10-CA-69974, U10CA-12027] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA037377, U10CA069651, U10CA012027, U10CA069974] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406; Bushnell CD, 2004, NEUROLOGY, V63, P1230, DOI 10.1212/01.WNL.0000140491.54664.50; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Clarke M, 1998, LANCET, V351, P1451; Cummings SR, 1999, JAMA-J AM MED ASSOC, V282, P2124; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 2002, JAMA-J AM MED ASSOC, V287, P216, DOI 10.1001/jama.287.2.216; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Decensi A, 2005, CIRCULATION, V111, P650, DOI 10.1161/01.CIR.0000154545.84124.AC; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fabian CJ, 2005, J CLIN ONCOL, V23, P1644, DOI 10.1200/JCO.2005.11.005; Fisher B, 2001, SEMIN ONCOL, V28, P400, DOI 10.1053/sonc.2001.26151; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2001, J NATL CANCER I, V93, P334, DOI 10.1093/jnci/93.5.334; Goldman NA, 2005, OBSTET GYNECOL, V105, P1278, DOI 10.1097/01.AOG.0000160480.55365.a8; Gorin MB, 1998, AM J OPHTHALMOL, V125, P493, DOI 10.1016/S0002-9394(99)80190-1; GOTTARDIS MM, 1990, CANCER RES, V50, P3189; GOTTARDIS MM, 1987, CANCER RES, V47, P4020; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grese TA, 1997, P NATL ACAD SCI USA, V94, P14105, DOI 10.1073/pnas.94.25.14105; Jordan VC, 2001, CANCER RES, V61, P5683; Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012; Kleinman D, 1996, ENDOCRINOLOGY, V137, P1089, DOI 10.1210/en.137.3.1089; KORN EL, 1992, STAT MED, V11, P813, DOI 10.1002/sim.4780110611; Lamb CA, 2003, BREAST CANCER RES TR, V79, P25, DOI 10.1023/A:1023324827225; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Lippman, 2002, J CLIN ONCOL, V20, P1430; Lippman ME, 2001, J CLIN ONCOL, V19, P3111, DOI 10.1200/JCO.2001.19.12.3111; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Namba R, 2005, BREAST CANCER RES, V7, pR881, DOI 10.1186/bcr1317; Powles T, 1998, LANCET, V352, P98; PREMKUMAR A, 2006, AJR AM J ROENTGEN S4, V186, pA121; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sherbourne CD, 1992, MEASURING FUNCTIONIN, P194; Sporn MB, 2004, CLIN THER, V26, P830, DOI 10.1016/S0149-2918(04)90127-0; Veronesi U, 1998, LANCET, V352, P93; Vogel VG, 2003, CLIN CANCER RES, V9, p495S; Vogel Victor G, 2002, Clin Breast Cancer, V3, P153, DOI 10.3816/CBC.2002.n.020; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WHITE SJ, 1978, BRIT J CANCER, V37, P849, DOI 10.1038/bjc.1978.124	53	1203	1249	2	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2727	2741		10.1001/jama.295.23.joc60074	http://dx.doi.org/10.1001/jama.295.23.joc60074			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16754727	Bronze			2022-12-28	WOS:000238389700028
J	Fitzgibbons, JP; Bordley, DR; Berkowitz, LR; Miller, BW; Henderson, MC				Fitzgibbons, John P.; Bordley, Donald R.; Berkowitz, Lee R.; Miller, Beth W.; Henderson, Mark C.			Redesigning residency education in internal medicine: A position paper from the Association of Program Directors in Internal Medicine	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICIAN-EDUCATORS; GENERAL INTERNISTS; HEALTH-CARE; TASK-FORCE; EVALUATION EXERCISE; NEW-MODEL; REFORM; SATISFACTION; PHYSICIAN; STUDENTS	There has been considerable change in the practice of internal medicine in the past quarter century, including the rise of specialization, increasing time pressure, the hospitalist movement, and the rapidly changing responsibilities of internists in inpatient and outpatient settings. Training programs have not adequately responded to these trends, and there is a consensus that the residency education system urgently needs redesign.	Lehigh Valley Hosp, Dept Med, Allentown, PA 18105 USA; Assoc Program Directors Internal Med, Washington, DC USA	Lehigh Valley Hospital	Fitzgibbons, JP (corresponding author), Lehigh Valley Hosp, Dept Med, POB 689, Allentown, PA 18105 USA.	John.fitzgibbons@lvh.com						*ACCR COUNC GRAD M, 2004, OUTC PROJ GEN COMP; *ACCR COUNC GRAD M, 2003, PROGR REQ INT MED; *ALL PHYS, 2004, PHYS SAL PHYS SAL SU; *AM BOARD INT MED, 2004, CROSS QUAL CHASM SHA; *AM COLL PHYS, 2003, 2003 MEMB SURV; *ASS AM MED COLL, 2004, AAMC FAC SAL SURV RE; *ASS AM MED COLL, 2004, HDB AC MED MED SCH T; *ASS AM MED COLL, 2004, AAMC DAT BOOK 2004; Bates DW, 2001, J AM MED INFORM ASSN, V8, P299, DOI 10.1136/jamia.2001.0080299; Blackwell TA, 2004, AM J MED, V117, P107, DOI 10.1016/j.amjmed.2004.04.007; Boex JR, 2003, ACAD MED, V78, P939, DOI 10.1097/00001888-200309000-00022; BUSH RW, 2005, 2005 ASS PROGR DIR I; CANTOR JC, 1993, JAMA-J AM MED ASSOC, V270, P1035, DOI 10.1001/jama.270.9.1035; Charap MH, 2005, AM J MED, V118, P1042, DOI 10.1016/j.amjmed.2005.06.009; Clayton CP, 2004, AM J MED, V117, P69, DOI 10.1016/j.amjmed.2004.04.006; Cohen JJ, 1999, ACAD MED, V74, P108, DOI 10.1097/00001888-199902000-00009; Donabedian A., 1980, EXPLORATIONS QUALITY; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; FALLON HJ, 1992, ANN INTERN MED, V116, P1041, DOI 10.7326/0003-4819-116-12-1041; Fleming VM, 2005, JAMA-J AM MED ASSOC, V294, P1101, DOI 10.1001/jama.294.9.1101; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Goldman L, 2004, AM J MED, V117, P133, DOI 10.1016/j.amjmed.2004.05.001; Goroll AH, 2004, ANN INTERN MED, V140, P902, DOI 10.7326/0003-4819-140-11-200406010-00012; GREGANTI MA, 1989, J GEN INTERN MED, V4, P136, DOI 10.1007/BF02602355; GROVER A, 2004, AC INT MED WEEK NASH; Hauer KE, 2004, ARCH INTERN MED, V164, P1866, DOI 10.1001/archinte.164.17.1866; Henderson MC, 2005, AM J MED, V118, P1061, DOI 10.1016/j.amjmed.2005.08.003; Henderson MC, 1996, AM J MED, V101, P648, DOI 10.1016/S0002-9343(96)00334-8; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hirshfeld J, 2004, J AM COLL CARDIOL, V44, P272, DOI 10.1016/j.jacc.2004.05.028; Holmboe ES, 2004, ACAD MED, V79, P16, DOI 10.1097/00001888-200401000-00006; Holmboe ES, 2005, J GEN INTERN MED, V20, P1165, DOI 10.1111/j.1525-1497.2005.0249.x; Holmboe ES, 2005, ACAD MED, V80, P571, DOI 10.1097/00001888-200506000-00012; Holmboe ES, 2004, J GEN INTERN MED, V19, P558, DOI 10.1111/j.1525-1497.2004.30134.x; Holmboe ES, 2004, ANN INTERN MED, V140, P874, DOI 10.7326/0003-4819-140-11-200406010-00008; Holmboe ES, 2003, ACAD MED, V78, P826, DOI 10.1097/00001888-200308000-00018; Huddle TS, 2003, J GEN INTERN MED, V18, P764, DOI 10.1046/j.1525-1497.2003.20717.x; HUMPHREY HJ, 2004, 2004 AM PROF MED WIN; Ibrahim T, 2004, AM J MED, V117, P365, DOI 10.1016/j.amjmed.2004.06.019; JOLLY P, 2004, MED SCH TUIT YOUNG P; Kulaga ME, 2004, J GEN INTERN MED, V19, P293, DOI 10.1111/j.1525-1497.2004.30552.x; Kuperman GJ, 2003, ANN INTERN MED, V139, P31, DOI 10.7326/0003-4819-139-1-200307010-00010; Larson EB, 2004, ANN INTERN MED, V140, P639, DOI 10.7326/0003-4819-140-8-200404200-00011; Leigh JP, 2002, ARCH INTERN MED, V162, P1577, DOI 10.1001/archinte.162.14.1577; Levinson W, 1999, NEW ENGL J MED, V341, P840, DOI 10.1056/NEJM199909093411111; Ludmerer K., 1999, TIME HEAL AM MED ED; Ludmerer KM, 2005, JAMA-J AM MED ASSOC, V294, P1083, DOI 10.1001/jama.294.9.1083; Ludmerer KM, 2004, NEW ENGL J MED, V351, P1163, DOI 10.1056/NEJMp048112; *NAT RES MATCH PRO, 2005, RES DAT 1975 2005; Nishimura RA, 2004, ACAD MED, V79, P426, DOI 10.1097/00001888-200405000-00011; NOLAN JP, 1992, ANN INTERN MED, V116, P1042, DOI 10.7326/0003-4819-116-12-1042; Odwazny Richard, 2005, Qual Manag Health Care, V14, P132; PETROZZI MC, 1992, J GEN INTERN MED, V7, P363, DOI 10.1007/BF02598096; Pham HH, 2004, ACAD MED, V79, P32, DOI 10.1097/00001888-200401000-00009; Plews-Ogan ML, 2004, J GEN INTERN MED, V19, P719, DOI 10.1111/j.1525-1497.2004.30386.x; SCHROEDER SA, 1986, ANN INTERN MED, V104, P554, DOI 10.7326/0003-4819-104-4-554; Schwartz MD, 2005, ANN INTERN MED, V142, P715, DOI 10.7326/0003-4819-142-8-200504190-00040; STEIN JH, 1991, ANN INTERN MED, V114, P79, DOI 10.7326/0003-4819-114-1-79; The Commonwealth Fund Task Force on Academic Health Centers, 2002, TRAIN TOM DOCT MED E; Whitcomb ME, 2004, NEW ENGL J MED, V351, P710, DOI 10.1056/NEJMsb045003; Whitcomb ME, 2003, ACAD MED, V78, P851, DOI 10.1097/00001888-200309000-00001; Wild D, 2005, JT COMM J QUAL PATIE, V31, P13, DOI 10.1016/S1553-7250(05)31003-8; Zuger A, 2004, NEW ENGL J MED, V350, P69, DOI 10.1056/NEJMsr031703	63	117	119	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					920	926		10.7326/0003-4819-144-12-200606200-00010	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785480				2022-12-28	WOS:000238555500007
J	Smylie, J; Anderson, I; Ratima, M; Crengle, S; Anderson, M				Smylie, Janet; Anderson, Ian; Ratima, Mihi; Crengle, Sue; Anderson, Marcia			Indigenous health performance measurement systems in Canada, Australia, and New Zealand	LANCET			English	Editorial Material									Univ Saskatchewan, Dept Epidemiol & Community Hlth, Saskatoon, SK S7N 0W0, Canada; Univ Melbourne, Sch Populat Hlth, Ctr Study Hlth & Soc, Parkville, Vic 3052, Australia; Univ Melbourne, Sch Populat Hlth, Onemda VicHlth Koori Hlth Unit, Parkville, Vic 3052, Australia; Cooperat Res Ctr Aboriginal Hlth, Darwin, NT, Australia; Auckland Univ Technol, Fac Hlth & Environm Sci, Taupua Waiora Ctr Maori Hlth Res, Auckland, New Zealand; Univ Auckland, Sch Populat Hlth, Dept Maori & Pacific Hlth, Auckland 1, New Zealand; Univ Saskatchewan, Coll Med, Dept Internal Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Melbourne; University of Melbourne; Auckland University of Technology; University of Auckland; University of Saskatchewan	Smylie, J (corresponding author), Univ Saskatchewan, Royal Univ Hosp Saskatoon, Dept Epidemiol & Community Hlth, Saskatoon, SK S7N 0W8, Canada.	jk.smylie@usask.ca	Anderson, Ian PS/C-1498-2008; Crengle, Sue/E-6774-2010	Crengle, Sue/0000-0001-9367-1492				*1 NAT UN REG HLTH, 1 NAT IN REG HLTH SU; AJWANI S, DECADES DISPARITY ET; ANDERSON I, 1999, HLTH POLICY MARKET S, P187; ANDERSON I, PERFORMANCE INDICATO; Anderson I., 2004, AUSTR NZ HLTH POLICY, V1, P1; ANDERSON I, 2003, HLTH SOCIAL CHANGE C, P224; ANDERSON I, 2004, NEGOTIATING SETTLEME, P254; Anderson I, 2005, GEN PRACTICE AUSTR 2, P302; ANDERSON M, 2006, 1 NAT MET IN HLTH IN; ANDERSON M, 2006, MEASURING HLTH ABORI; Australian Institute of Health and Welfare, 2015, 147 IHW; Castellano M.B., 2004, J ABORIG HLTH, V1, P98, DOI DOI 10.3138/IJIH.V1I1.28935; DURIE M, 2004, TE PAE MAHUTONGA; Durie M., 1998, WHAIORA MAORI HLTH D; HARREL J, ESSENTIAL SERVICES P; Health Council of Canada, 2005, HLTH STAT CAN 1 NAT; *IN TAP KAN, 2002, IN HLTH INF FRAM; *NAT AB TORR STRAI, 2000, ABORIG ISL HLTH WORK, V24, P17; National Aboriginal and Torres Strait Islander Health Council, 2004, NATL STRATEGIC FRAME; New Zealand Ministry of Health, 2002, HE KOR OR MAOR HLTH HE KOR OR MAOR HLTH; *NZ MIN HLTH, 2004, DEV MON FRAM STRAT R; RATIMA M, 2006, MAORI HLTH INDICATOR; Stephens C, 2005, LANCET, V366, P10, DOI 10.1016/S0140-6736(05)66801-8; Tukuitonga CF, 2002, NEW ZEAL MED J, V115, P179; *UK DEP HLTH, NAT STAND LOC ACT HL; *UN WORK GROUP IND, 1994, ECN4SUB2199456 UN WO; United Nations, 1966, INT COV EC SOC CULT; World Health Organization, 2000, WORLD HLTH REP 2000	28	44	46	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					2029	2031		10.1016/S0140-6736(06)68893-4	http://dx.doi.org/10.1016/S0140-6736(06)68893-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16782494				2022-12-28	WOS:000238488900038
J	Ikeda, H; Stark, J; Fischer, H; Wagner, M; Drdla, R; Jager, T; Sandkuhler, J				Ikeda, Hiroshi; Stark, Johanna; Fischer, Harald; Wagner, Matthias; Drdla, Ruth; Jager, Tino; Sandkuhler, Jurgen			Synaptic amplifier of inflammatory pain in the spinal dorsal horn	SCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSTANCE-P RECEPTOR; I PROJECTION NEURONS; LAMINA-I; SECONDARY HYPERALGESIA; BRAIN-STEM; HUMANS; CORD; SENSITIZATION; STIMULATION	Inflammation and trauma lead to enhanced pain sensitivity ( hyperalgesia), which is in part due to altered sensory processing in the spinal cord. The synaptic hypothesis of hyperalgesia, which postulates that hyperalgesia is induced by the activity-dependent long-term potentiation (LTP) in the spinal cord, has been challenged, because in previous studies of pain pathways, LTP was experimentally induced by nerve stimulation at high frequencies (similar to 100 hertz). This does not, however, resemble the real low-frequency afferent barrage that occurs during inflammation. We identified a synaptic amplifier at the origin of an ascending pain pathway that is switched-on by low-level activity in nociceptive nerve fibers. This model integrates known signal transduction pathways of hyperalgesia without contradiction.	Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria	Medical University of Vienna	Sandkuhler, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X; Drdla-Schutting, Ruth/0000-0003-0645-986X	Austrian Science Fund FWF [P 18129] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; CERVERO F, 1993, PAIN, V54, P181, DOI 10.1016/0304-3959(93)90207-6; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Khasabov SG, 2002, J NEUROSCI, V22, P9086; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Ruscheweyh R, 2004, J PHYSIOL-LONDON, V555, P527, DOI 10.1113/jphysiol.2003.054049; RUSCHEWEYH R, IN PRESS NEUROSCIENC; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Spike RC, 2003, EUR J NEUROSCI, V18, P2433, DOI 10.1046/j.1460-9568.2003.02981.x; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Willis WD, 2001, ANN NY ACAD SCI, V933, P142; Willis WD., 2004, SENSORY MECH SPINAL, V1; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	29	337	353	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1659	1662		10.1126/science.1127233	http://dx.doi.org/10.1126/science.1127233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778058				2022-12-28	WOS:000238288600048
J	Enders, D; Huttl, MRM; Grondal, C; Raabe, G				Enders, Dieter; Huettl, Matthias R. M.; Grondal, Christoph; Raabe, Gerhard			Control of four stereocentres in a triple cascade organocatalytic reaction	NATURE			English	Article							MICHAEL ADDITIONS; MULTICOMPONENT REACTIONS; DOMINO REACTIONS; ALDEHYDES; NITROALKENES; CATALYSIS; KETONES	Efficient and elegant syntheses of complex organic molecules with multiple stereogenic centres continue to be important in both academic and industrial laboratories(1). In particular, catalytic asymmetric multi-component 'domino' reactions, used during total syntheses of natural products and synthetic building blocks, are highly desirable(2,3). These reactions avoid time-consuming and costly processes, including the purification of intermediates and steps involving the protection and deprotection of functional groups, and they are environmentally friendly and often proceed with excellent stereoselectivities(4,5). Therefore, the design of new catalytic and stereoselective cascade reactions is a continuing challenge at the forefront of synthetic chemistry(6). In addition, catalytic cascade reactions can be described as biomimetic, as they are reminiscent of tandem reactions that may occur during biosyntheses of complex natural products(7,8). Here we report the development of an asymmetric organocatalytic triple cascade reaction for the synthesis of tetra-substituted cyclohexene carbaldehydes. This three-component domino reaction proceeds by way of a catalysed Michael/Michael/aldol condensation sequence affording the products with good to moderate yields (25-58 per cent). During this sequence, four stereogenic centres are formed with high diastereoselectivity and complete enantioselectivity. In addition, variation of the starting materials can be used to obtain diverse polyfunctional cyclohexene derivatives, which can be used as building blocks in organic synthesis.	Rhein Westfal TH Aachen, Inst Organ Chem, D-52074 Aachen, Germany	RWTH Aachen University	Enders, D (corresponding author), Rhein Westfal TH Aachen, Inst Organ Chem, Landoltweg 1, D-52074 Aachen, Germany.	Enders@RWTH-Aachen.de	Gais, Hans-Joachim/AAD-3810-2019					Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677; Berner OM, 2002, EUR J ORG CHEM, V2002, P1877; Dalko PI, 2004, ANGEW CHEM INT EDIT, V43, P5138, DOI 10.1002/anie.200400650; Enders D, 2002, SYNLETT, P26; ENDERS D, 1988, B SOC CHIM BELG, V97, P691; Franzen J, 2005, J AM CHEM SOC, V127, P18296, DOI 10.1021/ja056120u; Guo HC, 2006, ANGEW CHEM INT EDIT, V45, P354, DOI 10.1002/anie.200500195; Hayashi Y, 2005, ANGEW CHEM INT EDIT, V44, P4212, DOI 10.1002/anie.200500599; Huang Y, 2005, J AM CHEM SOC, V127, P15051, DOI 10.1021/ja055545d; Lehninger A., 1993, PRINCIPLES BIOCH; List B, 2001, ORG LETT, V3, P2423, DOI 10.1021/ol015799d; Mann J., 1999, CHEM ASPECTS BIOSYNT; Marigo M, 2005, J AM CHEM SOC, V127, P15710, DOI 10.1021/ja055291w; Nicolaou KC, 2003, CHEM COMMUN, P551, DOI 10.1039/b209440c; Prieto A, 2005, ORG LETT, V7, P3897, DOI 10.1021/ol051301m; Ramachary DB, 2004, CHEM-EUR J, V10, P5323, DOI 10.1002/chem.200400597; Ramon DJ, 2005, ANGEW CHEM INT EDIT, V44, P1602, DOI 10.1002/anie.200460548; Seayad J, 2005, ORG BIOMOL CHEM, V3, P719, DOI 10.1039/b415217b; Tietze L.F., 2000, STIMULATING CONCEPTS, P39, DOI [10.1002/3527605746.ch4, DOI 10.1002/3527605746.CH4]; Tietze LF, 1996, CHEM REV, V96, P115, DOI 10.1021/cr950027e; Wasilke JC, 2005, CHEM REV, V105, P1001, DOI 10.1021/cr020018n; Yang JW, 2005, J AM CHEM SOC, V127, P15036, DOI 10.1021/ja055735o	22	793	798	6	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					861	863		10.1038/nature04820	http://dx.doi.org/10.1038/nature04820			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	052SL	16778886				2022-12-28	WOS:000238254100039
J	Williams, MA; Tyznik, AJ; Bevan, MJ				Williams, Matthew A.; Tyznik, Aaron J.; Bevan, Michael J.			Interleukin-2 signals during priming are required for secondary expansion of CD8(+) memory T cells	NATURE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8-T-CELL MEMORY; IMMUNE-RESPONSES; CD4-T-CELL HELP; ACUTE INFECTION; IL-2; MICE; EXPRESSION; EFFECTOR; GENE	Although interleukin-2 (IL-2) was initially characterized as the primary T-cell growth factor following in vitro activation(1), less is known about its role in shaping T-cell responses to acute infections in vivo. The use of IL-2- or IL-2- receptor-deficient mice is problematic owing to their early development of autoimmunity(2-5), attributable to the central role of IL-2 in the generation, maintenance and function of CD4(+) CD25(+) regulatory T cells(6-9). To bypass these inherent difficulties, we have studied the effect of IL-2 on T-cell responses to acute infections by adopting a mixed chimaera strategy in which T cells lacking the high-affinity IL-2 receptor could be studied in an otherwise healthy mouse containing a full complement of regulatory T cells. Here we show that although IL-2 signalling to pathogen-specific CD8(+) T cells affects the number of developing effector and memory cells very little, it is required for the generation of robust secondary responses. This is not due to an altered T-cell-receptor repertoire development or selection, and does not reflect an acute requirement for IL-2 during secondary activation and expansion. Rather, we demonstrate a previously unappreciated role for IL-2 during primary infection in programming the development of CD8(+) memory T cells capable of full secondary expansion. These results have important implications for the development of vaccination or immunotherapeutic strategies aimed at boosting memory T-cell function.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	mbevan@u.washington.edu		Williams, Matthew/0000-0002-4721-4482	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335, R01 AI019335-19] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; COUSENS LP, 1995, J IMMUNOL, V155, P5690; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236	30	575	586	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					890	893		10.1038/nature04790	http://dx.doi.org/10.1038/nature04790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778891	Green Accepted			2022-12-28	WOS:000238254100046
J	Truog, RD; Christ, G; Browning, DM; Meyer, EC				Truog, Robert D.; Christ, Grace; Browning, David M.; Meyer, Elaine C.			Sudden traumatic death in children - "We did everything, but your child didn't survive"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; ORGAN DONATION; PARENTAL PERSPECTIVES; FAMILY PERSPECTIVES; HOSPITAL STAFF; BRAIN-DEATH; END; QUALITY; BEREAVEMENT; ETHICS	When caring for children who become suddenly and catastrophically ill, clinicians must simultaneously attend to a complex and rapidly evolving medical situation, as well as to the equally challenging demands of establishing compassionate relationships with family members and communicating well with colleagues. An 18-month-old toddler was brought to the hospital with severe head injury after being struck by a car. Over a period of hours, her condition evolved from prognostic uncertainty to the diagnosis of brain death and considerations of organ donation. Against this medical backdrop, the clinicians successfully established a trusting relationship with family members by careful attention to their emotional, informational, and care needs as they absorbed the devastating prognosis, took in the results of the brain death examination, and considered the option of organ donation. This case illustrates the importance of interdisciplinary communication, the vital role of social workers and other psychosocial providers with expertise in working with families, and the critical significance of mutual care and support for the clinicians who accompany families through these tragic life events.	Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Childrens Hosp Boston, Div Crit Care Med, Boston, MA USA; Educ Dev Ctr Inc, Initiat Pediat Palliat Care, Boston, MA USA; Columbia Univ, Sch Social Work, New York, NY USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Columbia University	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Social Med, 641 Huntington Ave, Boston, MA 02115 USA.	robert.truog@childrens.harvard.edu						Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; [Anonymous], 1998, Fed Regist, V63, P33856; Back AL, 2003, J CLIN ONCOL, V21, P2433, DOI 10.1200/JCO.2003.09.073; Back Anthony L, 2003, Ann Intern Med, V138, P439; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; BROWNING D, 2003, DIFFICULT CONVERSATI; Browning David, 2002, Bioethics Forum, V18, P23; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Chambliss D.F, 1996, CARING HOSP NURSES S; CHRIST G, IN PRESS INNOVATIVE; Contro N, 2002, ARCH PEDIAT ADOL MED, V156, P14, DOI 10.1001/archpedi.156.1.14; Contro NA, 2004, PEDIATRICS, V114, P1248, DOI 10.1542/peds.2003-0857-L; Cook P, 2002, ARCH DIS CHILD, V87, P36, DOI 10.1136/adc.87.1.36; Curtis JR, 2002, J CRIT CARE, V17, P147, DOI 10.1053/jcrc.2002.35929; Davies B, 2002, J NURS ADMIN, V32, P5, DOI 10.1097/00005110-200201000-00001; Davis CG, 2000, DEATH STUD, V24, P497; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; FALLOWFIELD L, 1993, LANCET, V341, P476, DOI 10.1016/0140-6736(93)90219-7; FIELD MJ, 2003, I MED CHILDREN DIE I; FINLAY I, 1991, BRIT MED J, V302, P1524, DOI 10.1136/bmj.302.6791.1524; FLEISCHMAN AR, 1994, PEDIATRICS, V94, P433; Frank AW, 2004, INTERN MED J, V34, P355, DOI 10.1111/j.1445-5994.2004.00622.x; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Harbaugh Bonnie Lee, 2004, Issues Compr Pediatr Nurs, V27, P163, DOI 10.1080/01460860490497985; Hurwitz CA, 2004, JAMA-J AM MED ASSOC, V292, P2141, DOI 10.1001/jama.292.17.2141; *I MED, 2003, CHILDR DIE IMPR PALL; Janzen L, 2003, OMEGA-J DEATH DYING, V48, P149; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kirschbaum MS, 1996, ADV NURS SCI, V19, P51, DOI 10.1097/00012272-199609000-00007; LEHMAN DR, 1987, J PERS SOC PSYCHOL, V52, P218, DOI 10.1037/0022-3514.52.1.218; Lipton H, 2000, Int J Emerg Ment Health, V2, P19; Lipton H, 2000, Int J Emerg Ment Health, V2, P181; Lock MM., 2002, TWICE DEAD ORGAN TRA, DOI DOI 10.1525/J.CTT1PN7PH; Macdonald ME, 2005, PEDIATRICS, V116, P884, DOI 10.1542/peds.2004-1980; Mack JW, 2005, J CLIN ONCOL, V23, P9155, DOI 10.1200/JCO.2005.04.010; Martinez R, 2002, THEOR MED BIOETH, V23, P185, DOI 10.1023/A:1020816824759; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Meert K L, 2001, Pediatr Crit Care Med, V2, P324, DOI 10.1097/00130478-200110000-00007; Meert K L, 2000, Pediatr Crit Care Med, V1, P179, DOI 10.1097/00130478-200010000-00017; Meyer EC, 2006, PEDIATRICS, V117, P649, DOI 10.1542/peds.2005-0144; Meyer EC, 2002, CRIT CARE MED, V30, P226, DOI 10.1097/00003246-200201000-00032; Murphy SA, 2003, J TRAUMA STRESS, V16, P17, DOI 10.1023/A:1022003126168; Nolen-Hoeksema S., 1999, COPING LOSS; OLIVER RC, 1995, J TRAUMA, V39, P303, DOI 10.1097/00005373-199508000-00019; Plum F, 1999, DEFINITION OF DEATH, P34; Rabow MW, 1999, WESTERN J MED, V171, P260; Rachmani R, 1999, TRANSPLANT P, V31, P1912, DOI 10.1016/S0041-1345(99)00152-9; Roter DL, 2000, ARCH INTERN MED, V160, P3477, DOI 10.1001/archinte.160.22.3477; Seecharan GA, 2004, ARCH PEDIAT ADOL MED, V158, P515, DOI 10.1001/archpedi.158.6.515; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Siminoff LA, 2001, CLIN TRANSPLANT, V15, P39, DOI 10.1034/j.1399-0012.2001.150107.x; Solomon MZ, 2005, PEDIATRICS, V116, P872, DOI 10.1542/peds.2004-0905; *SPEC TASK FORC, 1987, PEDIATRICS, V80, P298; Stack CG, 2003, PAEDIATR ANAESTH, V13, P651, DOI 10.1046/j.1460-9592.2003.01112.x; Truog R, 2003, J CLIN ETHIC, V14, P63; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Truog RD, 2003, CRIT CARE MED, V31, P2391, DOI 10.1097/01.CCM.0000090869.19410.3C; WALKER JA, 1990, CAN MED ASSOC J, V142, P1383; Wellesley A, 1997, J ACCID EMERG MED, V14, P24; Wheeler I, 2001, DEATH STUD, V25, P51, DOI 10.1080/07481180126147; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; WIJNGAARDSDEMEI.J, 2005, J CONSULT CLIN PSYCH, V73, P617; YOUNGNER SJ, 1989, JAMA-J AM MED ASSOC, V261, P2205, DOI 10.1001/jama.261.15.2205; 2003, J TRAUMA, V54, pS235	64	24	24	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2646	2654		10.1001/jama.295.22.2646	http://dx.doi.org/10.1001/jama.295.22.2646			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HI	16772628				2022-12-28	WOS:000238224000027
J	Hummel, M; Bentink, S; Berger, H; Klapper, W; Wessendorf, S; Barth, TFE; Bernd, HW; Cogliatti, SB; Dierlamm, J; Feller, AC; Hansmann, ML; Haralambieva, E; Harder, L; Hasenclever, D; Kuhn, M; Lenze, D; Lichter, P; Martin-Subero, JI; Moller, P; Muller-Hermelink, HK; Ott, G; Parwaresch, RM; Pott, C; Rosenwald, A; Rosolowski, M; Schwaenen, C; Sturzenhofecker, B; Szczepanowski, M; Trautmann, H; Wacker, HH; Spang, R; Loeffler, M; Trumper, L; Stein, H; Siebert, R				Hummel, Michael; Bentink, Stefan; Berger, Hilmar; Klapper, Wolfram; Wessendorf, Swen; Barth, Thomas F. E.; Bernd, Heinz-Wolfram; Cogliatti, Sergio B.; Dierlamm, Judith; Feller, Alfred C.; Hansmann, Martin-Leo; Haralambieva, Eugenia; Harder, Lana; Hasenclever, Dirk; Kuehn, Michael; Lenze, Dido; Lichter, Peter; Ignacio Martin-Subero, Jose; Moeller, Peter; Mueller-Hermelink, Hans-Konrad; Ott, German; Parwaresch, Reza M.; Pott, Christiane; Rosenwald, Andreas; Rosolowski, Maciej; Schwaenen, Carsten; Stuerzenhofecker, Benjamin; Szczepanowski, Monika; Trautmann, Heiko; Wacker, Hans-Heinrich; Spang, Rainer; Loeffler, Markus; Truemper, Lorenz; Stein, Harald; Siebert, Reiner		Molecular Mechanisms Malignant Lym	A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-MYC; CELL; TRANSLOCATIONS; CHEMOTHERAPY; CYTOGENETICS; SUBGROUPS; SURVIVAL; LEUKEMIA; BCL2	Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear. We used transcriptional and genomic profiling to define Burkitt's lymphoma more precisely and to distinguish subgroups in other types of mature aggressive B-cell lymphomas. Methods: We performed gene-expression profiling using Affymetrix U133A GeneChips with RNA from 220 mature aggressive B-cell lymphomas, including a core group of 8 Burkitt's lymphomas that met all World Health Organization (WHO) criteria. A molecular signature for Burkitt's lymphoma was generated, and chromosomal abnormalities were detected with interphase fluorescence in situ hybridization and array-based comparative genomic hybridization. Results: We used the molecular signature for Burkitt's lymphoma to identify 44 cases: 11 had the morphologic features of diffuse large-B-cell lymphomas, 4 were unclassifiable mature aggressive B-cell lymphomas, and 29 had a classic or atypical Burkitt's morphologic appearance. Also, five did not have a detectable IG-myc Burkitt's translocation, whereas the others contained an IG-myc fusion, mostly in simple karyotypes. Of the 176 lymphomas without the molecular signature for Burkitt's lymphoma, 155 were diffuse large-B-cell lymphomas. Of these 155 cases, 21 percent had a chromosomal breakpoint at the myc locus associated with complex chromosomal changes and an unfavorable clinical course. Conclusions: Our molecular definition of Burkitt's lymphoma clarifies and extends the spectrum of the WHO criteria for Burkitt's lymphoma. In mature aggressive B-cell lymphomas without a gene signature for Burkitt's lymphoma, chromosomal breakpoints at the myc locus were associated with an adverse clinical outcome.	Charite Univ Med Berlin, Inst Pathol, D-12200 Berlin, Germany; Max Planck Inst Mol Genet, Dept Computat Mol Biol, Computat Diagnost Grp, Berlin, Germany; Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-7010 Leipzig, Germany; Univ Klinikum Schleswig Holstein, Inst Hematopathol & Lymph Node Registry, Kiel, Germany; Univ Klinikum Schleswig Holstein, Inst Human Genet, Kiel, Germany; Univ Klinikum Schleswig Holstein, Dept Med 2, Kiel, Germany; Univ Ulm Klinikum, Inst Pathol, Ulm, Germany; Univ Klinikum Schleswig Holstein, Inst Pathol, Lubeck, Germany; Univ Hamburg, Klinikum Eppendorf, Dept Hematol & Oncol, Hamburg, Germany; Univ Frankfurt Klinikum, Inst Pathol, D-6000 Frankfurt, Germany; Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; German Canc Res Ctr, D-6900 Heidelberg, Germany; Interdisciplinary Ctr Bioinformat, Leipzig, Germany; Univ Gottingen, Dept Hematol & Oncol, D-3400 Gottingen, Germany; Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Leipzig University; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ulm University; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Wurzburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Gottingen; Kantonsspital St. Gallen	Stein, H (corresponding author), Charite Univ Med Berlin, Inst Pathol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	Harald.Stein@charite.de	Klapper, Wolfram/S-6314-2016; Siebert, Reiner/A-8049-2010; Klapper, Wolfram/D-2516-2010	Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Hummel, Michael/0000-0001-6717-605X; Spang, Rainer/0000-0002-1326-4297				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Au WY, 2000, HAEMATOLOGICA, V85, P1225; Au WY, 2004, LEUKEMIA LYMPHOMA, V45, P519, DOI 10.1080/10428190310001593120; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chan WC, 1997, BLOOD, V89, P3909; Coiffier B, 2005, J CLIN ONCOL, V23, P6387, DOI 10.1200/JCO.2005.05.015; DIEBOLD J, 2001, PATHOLOGY GENETICS T, V3, P181; Divine M, 2005, ANN ONCOL, V16, P1928, DOI 10.1093/annonc/mdi403; Dunphy CH, 2003, ARCH PATHOL LAB MED, V127, P610; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Gatter KC, 2001, PATHOLOGY GENETICS T, P171; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Knezevich S, 2005, LEUKEMIA, V19, P659, DOI 10.1038/sj.leu.2403661; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; LEVINE EG, 1989, BLOOD, V74, P1796; Macpherson N, 1999, J CLIN ONCOL, V17, P1558, DOI 10.1200/JCO.1999.17.5.1558; Magrath I, 2001, NEOPLASTIC HEMATOPAT, P953; Martin-Subero JI, 2003, ANTICANCER RES, V23, P1139; Martin-Subero JI, 2002, INT J CANCER, V98, P470, DOI 10.1002/ijc.10169; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; NACHEVA E, 1993, BLOOD, V82, P231, DOI 10.1182/blood.V82.1.231.bloodjournal821231; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; PFREUNDSCHUH M, 2004, 46 ANN M AM SOC HEM, P157; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schwaenen C, 2004, P NATL ACAD SCI USA, V101, P1039, DOI 10.1073/pnas.0304717101; SHIPP MA, 1994, BLOOD, V83, P1165; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	32	688	714	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2419	2430		10.1056/NEJMoa055351	http://dx.doi.org/10.1056/NEJMoa055351			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760442				2022-12-28	WOS:000238100800004
J	McCauley, DW; Bronner-Fraser, M				McCauley, DW; Bronner-Fraser, M			Importance of SoxE in neural crest development and the evolution of the pharynx	NATURE			English	Article							EARLY VERTEBRATE EVOLUTION; TRANSCRIPTION FACTOR SOX9; LAMPREY; ORIGIN; HEAD; EXPRESSION; INSIGHTS; GENES; JAW	The neural crest, a defining character of vertebrates(1), is of prime importance to their evolutionary origin(2). To understand neural crest evolution, we explored molecular mechanisms underlying craniofacial development in the basal jawless vertebrate, sea lamprey ( Petromyzon marinus), focusing on the SoxE ( Sox8, Sox9 and Sox10) gene family. In jawed vertebrates, these are important transcriptional regulators of the neural crest(3), and the loss of Sox9 causes abnormal craniofacial development(4,5). Here we report that two lamprey SoxE genes are expressed in migrating neural crest and crest-derived prechondrocytes in posterior branchial arches, whereas a third paralogue is expressed later in the perichondrium and mandibular arch. Morpholino knock-down of SoxE1 reveals that it is essential for posterior branchial arch development, although the mandibular arch is unaffected. The results show that chondrogenic function of SoxE regulators can be traced to the lamprey-gnathostome common ancestor and indicate that lamprey SoxE genes might have undergone independent duplication to have distinct functions in mandibular versus caudal branchial arches. This work sheds light on the homology of vertebrate branchial arches and supports their common origin at the base of vertebrates.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	McCauley, DW (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	dwmccauley@ou.edu		Bronner, Marianne/0000-0003-4274-1862				Cerny R, 2004, DEV BIOL, V276, P225, DOI 10.1016/j.ydbio.2004.08.046; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Coates MI, 1998, BIOESSAYS, V20, P371, DOI 10.1002/(SICI)1521-1878(199805)20:5<371::AID-BIES4>3.0.CO;2-R; DAMAS H., 1951, ARCH BIOL, V62, P65; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Graham A, 2001, J ANAT, V199, P133, DOI 10.1017/S0021878201008159; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Janvier P., 1996, EARLY VERTEBRATES; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; Kuratani S, 2004, J EXP ZOOL PART B, V302B, P458, DOI 10.1002/jez.b.21011; Kusakabe R, 2004, J EXP ZOOL PART B, V302B, P121, DOI 10.1002/jez.b.20009; LANGILLE RM, 1988, DEVELOPMENT, V102, P301; MALLATT J, 1984, J ZOOL, V204, P169; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; McCauley DW, 2002, GENE, V287, P129, DOI 10.1016/S0378-1119(01)00894-0; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; SCHULTZE M, 1956, ENTWICKELUNGSGESCHIC; Spokony RF, 2002, DEVELOPMENT, V129, P421; TAKIO Y, 2004, NATURE          0520; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomsa JM, 1999, DEV BIOL, V207, P26, DOI 10.1006/dbio.1998.9163; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9; Yan YL, 2002, DEVELOPMENT, V129, P5065	24	107	112	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					750	752		10.1038/nature04691	http://dx.doi.org/10.1038/nature04691			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760978				2022-12-28	WOS:000238095100054
J	Iimura, T; Pourquie, O				Iimura, Tadahiro; Pourquie, Olivier			Collinear activation of Hoxb genes during gastrulation is linked to mesoderm cell ingression	NATURE			English	Article							MOUSE EMBRYO; EXPRESSION; CHICK; COMPLEXES; PATTERN; MURINE	The vertebral column exhibits segmentation and regionalization along the antero-posterior axis. During embryogenesis, the rhythmic production of the precursors of the vertebrae, the somites, imposes a segmented aspect to the spine, whereas the spine's regional differentiation is controlled by Hox genes(1,2). Here we show that in the paraxial mesoderm, Hoxb genes are first activated in a temporal collinear fashion in precursors located in the epiblast lateral to the primitive streak. Our data suggest that collinear activation of Hoxb genes regulates the flux of cells from the epiblast to the streak and thus directly controls the establishment of the genes' characteristic nested expression domains in the somites. This suggests that establishment of the spatial co-linearity in the embryo is directly controlled by the Hox genes themselves.	Howard Hughes Med Inst, Kansas City, MO 64110 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	Howard Hughes Medical Institute; Stowers Institute for Medical Research	Pourquie, O (corresponding author), Howard Hughes Med Inst, 1000 E 50th St, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022; Iimura, Tadahiro/P-3550-2018	Pourquié, Olivier/0000-0001-5189-1227; Iimura, Tadahiro/0000-0002-1431-0689				Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kesselman MA, 2004, BOOK LIB IN, V67, P89; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Nicolet G., 1971, Adv Morphogen, V9, P231; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; STERN CD, 2004, GASTRULATION CELLS E, P219; STEWART CL, 1987, EMBO J, V6, P383, DOI 10.1002/j.1460-2075.1987.tb04766.x; TAM PPL, 1992, DEVELOPMENT, V115, P703; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3	24	162	167	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					568	571		10.1038/nature04838	http://dx.doi.org/10.1038/nature04838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16760928				2022-12-28	WOS:000239455900044
J	Brooks, JJ				Brooks, JJ			A patient's journey: living with breast cancer	BRITISH MEDICAL JOURNAL			English	Article												janbrooks@manx.net						Fox M, 2006, BRIT MED J, V332, P1438, DOI 10.1136/bmj.332.7555.1438	1	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 1	2006	333	7557					31	33		10.1136/bmj.333.7557.31	http://dx.doi.org/10.1136/bmj.333.7557.31			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16809711	Green Published			2022-12-28	WOS:000238922900028
J	Atroshi, I; Larsson, GU; Ornstein, E; Hofer, M; Johnsson, R; Ranstam, J				Atroshi, I; Larsson, GU; Ornstein, E; Hofer, M; Johnsson, R; Ranstam, J			Outcomes of endoscopic surgery compared with open surgery for carpal tunnel syndrome among employed patients: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							RELEASE; RELIABILITY; VALIDITY	Objectives To compare endoscopic and open carpal tunnel release surgery among employed patients with carpal tunnel syndrome. Design and setting Randomised controlled trial at a single orthopaedic department. Participants 128 employed patients aged 25-60 years with clinically diagnosed and electrophysiologically confirmed idiopathic carpal tunnel syndrome. Main outcome measures The primary outcome was severity of postoperative pain in the scar or proximal palm and the degree to which pain or tenderness limits activities, each rated on a 4 point scale, transformed into a combined score of 0 (none) to 100 (severe pain or tenderness causing severe activity limitation). The secondary outcomes were length of postoperative work absence, severity of symptoms of carpal tunnel syndrome and functional status scores, SF-12 quality of life score, and hand sensation and strength (blinded examiner); follow-up at three and six weeks and three and 12 months. Results 63 patients were allocated to endoscopic surgery and 65 patients to open surgery, with no withdrawals or dropouts. Pain hi the scar or proximal palm was less prevalent or severe after endoscopic surgery than after open surgery but die differences were generally small. At three months, pain in the scar or palm was reported by 33 patients (52%) in the endoscopic group and 53 patients (82%) in the open group (number needed to treat 3.4,95% confidence interval 2.3 to 7.7) and the mean score difference for severity of pain in scar or palm and limitation of activity was 13.3 (5.3 to 21.3). No differences between the groups were found in the other outcomes. The median length of work absence after surgery was 28 days in both groups. Quality of life measures improved substantially. Conclusions In carpal tunnel syndrome, endoscopic surgery was associated with less postoperative pain than open surgery, but the small size of the benefit and similarity in other outcomes make its cost effectiveness uncertain.	Hassleholm Hosp, Dept Orthopaed, SE-28125 Hasselholm, Sweden; Kristianstad Hosp, Dept Orthopaed, SE-28125 Hasselholm, Sweden; Kristianstad Hosp, Dept Phys & Occupat Therapy, SE-29185 Kristianstad, Sweden; Univ Lund Hosp, Dept Orthopaed, SE-22100 Lund, Sweden; Univ Lund Hosp, Natl Swedish Competence Ctr Musculoskeletal Disor, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Atroshi, I (corresponding author), Hassleholm Hosp, Dept Orthopaed, SE-28125 Hasselholm, Sweden.	Isam.Atroshi@skane.se	Ranstam, Jonas/A-4386-2009	Ranstam, Jonas/0000-0002-8287-7273				AGEE JM, 1992, J HAND SURG-AM, V17A, P987, DOI 10.1016/S0363-5023(09)91044-9; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Atroshi I, 1998, ACTA ORTHOP SCAND, V69, P82, DOI 10.3109/17453679809002363; BROWN RA, 1993, J BONE JOINT SURG AM, V75A, P1265, DOI 10.2106/00004623-199309000-00002; *BUR LAB STAT, 2003, 03138 USDL BUR LAB S; *BUR LAB STAT, 2003, LOST WORKT INJ ILLN; CHOW J C Y, 1989, Arthroscopy, V5, P19, DOI 10.1016/0749-8063(89)90085-6; ELASHOFF JD, 1995, NQUERY ADVISAR USERS; Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Katz JN, 2005, AM J IND MED, V47, P120, DOI 10.1002/ajim.20127; KATZMAN PL, 1990, J CARDIOVASC PHARM, V15, P360, DOI 10.1097/00005344-199003000-00003; Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd; Le AX, 2001, J ORTHOPAED RES, V19, P78, DOI 10.1016/S0736-0266(00)00006-1; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; MacDermid JC, 2003, J HAND SURG-AM, V28A, P475, DOI 10.1053/jhsu.2003.50080; OWINGS MR, 1998, VITAL HLTH STAT, P13; Thoma A, 2004, PLAST RECONSTR SURG, V114, P1137, DOI 10.1097/01.prs.0000135850.37523.d0; Trumble TE, 2002, J BONE JOINT SURG AM, V84A, P1107, DOI 10.2106/00004623-200207000-00003; Vasen AP, 1999, J HAND SURG-AM, V24A, P1109; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 1993, SF36 HLTH SURVEY MAN	22	131	138	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 24	2006	332	7556					1473	1476A		10.1136/bmj.38863.632789.1F	http://dx.doi.org/10.1136/bmj.38863.632789.1F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16777857	Green Published, Bronze			2022-12-28	WOS:000238820200014
J	Belsky, J; Melhuish, E; Barnes, J; Leyland, AH; Romaniuk, H				Belsky, Jay; Melhuish, Edward; Barnes, Jacqueline; Leyland, Alastair H.; Romaniuk, Helena		Natl Evaluation Sure Start Res	Effects of Sure Start local programmes on children and families: early findings from a quasi-experimental, cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate die effects of Sure Start local programmes (SSLPs) on children and their families. To assess whether variations in the effectiveness of SSLPs are due to differences in implementation. Design Quasi-experimental cross sectional study using interviews with mothers and cognitive assessment of children aged 36 months who speak English. Setting Socially deprived communities in England: 150 communities with ongoing SSLPs and 50 comparison communities. Participants Mothers of 12 575 children aged 9 months and 3927 children aged 36 months in SSLP areas; mothers of 1509 children aged 9 months and 110 1 children aged 36 months in comparison communities. Outcome measures Mothers' reports of community services and local area, family functioning and parenting skills, child health and development, and verbal ability at 36 months. Results Differences between SSLP areas and comparison areas were limited, small, and varied by degree of social deprivation. SSLPs had beneficial effects on non-teenage mothers (better parenting, better social functioning in children) and adverse effects on children of teenage mothers (poorer social functioning) and children of single parents or parents who did not work (lower verbal ability). SSLPs led by health services were slightly more effective than other SSLPs. Conclusion SSLPs seem to benefit relatively less socially deprived parents (who have greater personal resources) and their children but seem to have an adverse effect on the most disadvantaged children. Programmes led by health services seem to be more effective than programmes led by other agencies.	Univ London, Birkbeck, Inst Study Children Families & Social Issues, London WC1B 3RA, England; Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	University of London; Birkbeck University London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Belsky, J (corresponding author), Univ London, Birkbeck, Inst Study Children Families & Social Issues, London WC1B 3RA, England.	j.belsky@bbk.ac.uk	Leyland, Alastair/C-6069-2011	Leyland, Alastair/0000-0003-3741-7099; Romaniuk, Helena/0000-0002-5801-2077; Belsky, Jay/0000-0003-2191-2503	Medical Research Council [MC_U130059823] Funding Source: Medline; Chief Scientist Office [SPHSU2] Funding Source: Medline; MRC [MC_U130059823] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bachman J. G., 1978, ADOLESCENCE ADULTHOO; BARNES J, 2003, CHARACTERISTICS SURE; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Krull JL, 1999, EVALUATION REV, V23, P418, DOI 10.1177/0193841X9902300404; Love JM., 2002, MAKING DIFFERENCE LI, VI; McGuire JB, 1997, J COMMUNITY PSYCHOL, V25, P551; MEADOWS P, 2006, INTERIM REPORT COST; *NAT EV SUR START, 2005, 13 NAT EV SUR START; RAMEY CT, 2000, APPL DEV SCI, V0004; Rutter M., 1970, ED HLTH BEHAV; Schafer J., 1999, ANAL INCOMPLETE MULT; WEBSTERSTRATTON C, 1993, SCHOOL PSYCHOL REV, V22, P437	12	115	115	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1476	+		10.1136/bmj.38853.451748.2F	http://dx.doi.org/10.1136/bmj.38853.451748.2F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16782721	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-28	WOS:000238820200015
J	August, P; Suthanthiran, M				August, P; Suthanthiran, M			Transforming growth factor beta signaling, vascular remodeling, and hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLOOD-PRESSURE		Cornell Univ, Weill Med Coll, New York, NY 10021 USA; New York Hosp Queens, Theresa & Eugene Lang Ctr Res & Educ, Flushing, NY USA	Cornell University; NewYork-Presbyterian Hospital	August, P (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.		Suthanthiran, Manikkam/AAL-9104-2020					Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	5	53	54	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2721	2723		10.1056/NEJMcibr062143	http://dx.doi.org/10.1056/NEJMcibr062143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790709				2022-12-28	WOS:000238416900016
J	Wolpe, PR				Wolpe, PR			Reasons scientists avoid thinking about ethics	CELL			English	Editorial Material							SCIENCE	Science is a powerful force for change in modern society. As the professionals at its helm, scientists have a unique responsibility to shepherd that change with thoughtful advocacy of their research and careful ethical scrutiny of their own behavior.	Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Wolpe, PR (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	wolpep@mail.med.upenn.edu	Wolpe, Paul/A-1032-2007					Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Chadwick R, 2005, INTERDISCIPL SCI REV, V30, P247, DOI 10.1179/030801805X42054; Dreifus C., 2006, NY TIMES        0124, pF2; Kempner J, 2005, SCIENCE, V307, P854, DOI 10.1126/science.1107576; Kitcher P, 2004, BIOSCIENCE, V54, P331, DOI 10.1641/0006-3568(2004)054[0331:RB]2.0.CO;2; Mathews DJH, 2005, AM J MED GENET A, V137A, P161, DOI 10.1002/ajmg.a.30849; Pincock S, 2006, SCIENTIST	7	30	30	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1023	1025		10.1016/j.cell.2006.06.001	http://dx.doi.org/10.1016/j.cell.2006.06.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777590	Green Published, Bronze			2022-12-28	WOS:000238602700005
J	Sepkowitz, KA				Sepkowitz, Kent A.			One disease, two epidemics - AIDS at 25	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.							Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; *AVERT, WORLD EST HIV AIDS E; *DEP HHS, 2005, GUID US ANT AG HIV 1; GLYNN M, 2005, NAT HIV PREV C ATL J; Masquelier BND, 2005, JAIDS-J ACQ IMM DEF, V40, P505, DOI 10.1097/01.qai.0000186361.42834.61	5	21	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2411	2414		10.1056/NEJMp068084	http://dx.doi.org/10.1056/NEJMp068084			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	050PQ	16760440				2022-12-28	WOS:000238100800002
J	Chen, LC				Chen, LC			Philanthropic partnership for public health in India?	LANCET			English	Editorial Material									Harvard Univ, Global Equ Initiat, Cambridge, MA 02138 USA	Harvard University	Chen, LC (corresponding author), Harvard Univ, Global Equ Initiat, Cambridge, MA 02138 USA.	lcchen@fas.harvard.edu						Flexner Abraham, 1910, B CARNEGIE FDN ADV T, V4; Ministry of Health and Family Welfare Government of India, 2005, REP NAT COMM MACR HL; Ministry of Health & Family Welfare-Government of India, 2005, NAT RUR HLTH MISS 20; 1915, WELCH ROSE REPORT SC	4	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1800	1801		10.1016/S0140-6736(06)68783-7	http://dx.doi.org/10.1016/S0140-6736(06)68783-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753470				2022-12-28	WOS:000238194200008
J	Villar, J; Valladares, E; Wojdyla, D; Zavaleta, N; Carroli, G; Velazco, A; Shah, A; Campodonico, L; Bataglia, V; Faundes, A; Langer, A; Narvaez, A; Donner, A; Romero, M; Reynoso, S; de Padua, KS; Giordano, D; Kublickas, M; Acosta, A				Villar, Jose; Valladares, Eliette; Wojdyla, Daniel; Zavaleta, Nelly; Carroli, Guillermo; Velazco, Alejandro; Shah, Archana; Campodonico, Liana; Bataglia, Vicente; Faundes, Anibal; Langer, Ana; Narvaez, Alberto; Donner, Allan; Romero, Mariana; Reynoso, Sofia; Simonia de Padua, Karla; Giordano, Daniel; Kublickas, Marius; Acosta, Arnaldo		WHO 2005 global survey maternal pe	Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America	LANCET			English	Article							SECTION; RISK; OBSTETRICIANS	Background Caesarean delivery rates continue to increase worldwide. Our aim was to assess the association between Caesarean delivery and pregnancy outcome at the institutional level, adjusting for the pregnant population and institutional characteristics. Methods For the 2005 WHO global survey on maternal and perinatal health, we assessed a multistage stratified sample, comprising 24 geographic regions in eight countries in Latin America. We obtained individual data for all women admitted for delivery over 3 months to 120 institutions randomly selected from of 410 identified institutions. We also obtained institutional-level data. Findings We obtained data for 97095 of 106 546 deliveries (91% coverage). The median rate of Caesarean delivery was 33% (quartile range 24-43), with the highest rates of Caesarean delivery noted in private hospitals (51%, 43-57). Institution-specific rates of Caesarean delivery were affected by primiparity previous Caesarean delivery, and institutional complexity. Rate of Caesarean delivery was positively associated with postpartum antibiotic treatment and severe maternal morbidity and mortality; even after adjustment for risk factors. Increase in the rate of Caesarean delivery was associated with an increase in fetal mortality rates and higher numbers of babies admitted to intensive care for 7 days or longer even after adjustment for preterm, delivery. Rates of preterm delivery and neonatal mortality both rose at rates of Caesarean delivery of between 10% and 20%. Interpretation High rates of Caesarean delivery do not necessarily indicate better perinatal care and can be associated with harm.	WHO, UNDP UNFPA, World Bank Special Programme Res Dev & Res Traini, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; Univ Nacl Autonoma Nicaragua, Leon, Nicaragua; Ctr Rosarino Estud Perinatales, Rosario, Argentina; Inst Invest Nutr, Lima, Peru; Hosp Docente Ginecobstet Amer Arias, Havana, Cuba; Hosp Nacl Itaugua, Dept Obstet & Gynecol, Asuncion, Paraguay; Ctr Pesquisas Saude Reprod Campinas, Campinas, SP, Brazil; EngenderHlth, New York, NY USA; Fdn Salud Ambientey & Desarrollo, Quito, Ecuador; Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada; Consejo Nacl Invest Cient & Tecn, Ctr Estud Estado & Sociedad, RA-1033 Buenos Aires, DF, Argentina; Latin Amer Off, Populat Council, Mexico City, DF, Mexico; Karolinska Inst, Stockholm, Sweden; Univ Nacl Asuncion, Dept Obstet & Gynaecol, Asuncion, Paraguay	The World Bank; United Nations Population Fund; World Health Organization; Western University (University of Western Ontario); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Karolinska Institutet; Universidad Nacional de Asuncion	Villar, J (corresponding author), WHO, UNDP UNFPA, World Bank Special Programme Res Dev & Res Traini, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	villarj@who.int		Romero, Mariana/0000-0003-4272-3138; Zavaleta, Nelly/0000-0002-6929-5834				AlMufti R, 1996, LANCET, V347, P544, DOI 10.1016/S0140-6736(96)91176-9; Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 1997, LANCET, V349, P815; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Bonilla E, 1990, Jordemodern, V103, P24; CLEVELAND SW, 1993, VISUALIZING DATA; Cotzias CS, 2001, EUR J OBSTET GYN R B, V97, P15, DOI 10.1016/S0301-2115(00)00360-2; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df; Lavender T, 2005, BMJ-BRIT MED J, V331, P490, DOI 10.1136/bmj.38560.572639.3A; Li T, 2003, OBSTET GYNECOL, V101, P1204, DOI 10.1016/S0029-7844(03)00175-3; Linton A, 2004, BIRTH-ISS PERINAT C, V31, P3, DOI 10.1111/j.0730-7659.2004.0268.x; Magann EF, 2005, SOUTH MED J, V98, P681, DOI 10.1097/01.SMJ.0000163309.53317.B8; MARIESKIND H, 1979, EVALUATION CESAREAN; Merchant KM, 2001, BRIT J OBSTET GYNAEC, V108, P689, DOI 10.1111/j.1471-0528.2001.00181.x; Minkoff H, 2004, OBSTET GYNECOL, V103, P387, DOI 10.1097/01.AOG.0000107288.44622.2a; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY, P459; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; Ryan Kristi, 2005, Conn Med, V69, P139; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Turcotte Leo, 2005, Int J Health Care Finance Econ, V5, P255, DOI 10.1007/s10754-005-1789-0; US Department of Health and Human-Services Public Health Service National Institutes of Health., 1981, NIH PUBL, V82-2067; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; *WHO, 2004, WHO GLOB SURV MAT PE; Wilkinson C, 1998, BRIT J OBSTET GYNAEC, V105, P45, DOI 10.1111/j.1471-0528.1998.tb09349.x; Wu JM, 2005, OBSTET GYNECOL, V105, P301, DOI 10.1097/01.AOG.0000151110.05801.c0	30	597	643	0	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2006	367	9525					1819	1829		10.1016/S0140-6736(06)68704-7	http://dx.doi.org/10.1016/S0140-6736(06)68704-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753484				2022-12-28	WOS:000238194200027
J	Noma, KI; Cam, HP; Maraia, RJ; Grewal, SIS				Noma, Ken-ichi; Cam, Hugh P.; Maraia, Richard J.; Grewal, Shiv I. S.			A role for TFIIIC transcription factor complex in genome organization	CELL			English	Article							RNA-POLYMERASE-III; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; HETEROCHROMATIN DOMAIN; EPIGENETIC CONTROL; CHROMATIN DOMAINS; GENE-EXPRESSION; BOUNDARIES; MACHINERY	Eukaryotic genome complexity necessitates boundary and insulator elements to partition genomic content into distinct domains. We show that inverted repeat (IR) boundary elements flanking the fission yeast mating-type heterochromatin domain contain B-box sequences, which prevent heterochromatin from spreading into neighboring euchromatic regions by recruiting transcription factor TFIIIC complex without RNA polymerase III (Pol III). Genome-wide analysis reveals TFIIIC with Pol III at all tRNA genes, many of which cluster at pericentromeric heterochromatin domain boundaries. However, a single tRNA(phe), gene with modest TFIIIC enrichment is insufficient to serve as boundary and requires RNAi-associated element to restrain heterochromatin spreading. Remarkably, we found TFIIIC localization without Pol III at many sites located between divergent promoters. These sites appear to act as chromosome-organizing clamps by tethering distant loci to the nuclear periphery, at which TFIIIC: is concentrated into several distinct bodies. Our analyses uncover a general genome organization mechanism involving conserved TFIIIC complex.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Maraia, Richard/ABC-1442-2020	Maraia, Richard/0000-0002-5209-0066; Grewal, Shiv/0000-0002-4552-9261	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000412] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000412] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010523, Z01BC010523] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cavalli G, 2002, CURR OPIN CELL BIOL, V14, P269, DOI 10.1016/S0955-0674(02)00324-1; Deininger PL, 1989, MOBILE DNA, P619; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; Hsieh YJ, 1999, MOL CELL BIOL, V19, P7697; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Huang Y, 2000, J BIOL CHEM, V275, P31480, DOI 10.1074/jbc.M004635200; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kuhn AN, 2003, CURR GENET, V42, P241, DOI 10.1007/s00294-002-0355-2; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Partridge JF, 2000, GENE DEV, V14, P783; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sadaie M, 2003, GENE DEV, V17, P2271, DOI 10.1101/gad.1112103; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Thon G, 2002, GENETICS, V161, P611; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P1790, DOI 10.1073/pnas.71.5.1790; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	48	225	235	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					859	872		10.1016/j.cell.2006.04.028	http://dx.doi.org/10.1016/j.cell.2006.04.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751097	Bronze			2022-12-28	WOS:000238116400014
J	Pawelek, PD; Croteau, N; Ng-Thow-Hing, C; Khursigara, CM; Moiseeva, N; Allaire, M; Coulton, JW				Pawelek, Peter D.; Croteau, Nathalie; Ng-Thow-Hing, Christopher; Khursigara, Cezar M.; Moiseeva, Natalia; Allaire, Marc; Coulton, James W.			Structure of TonB in complex with FhuA, E-coli outer membrane receptor	SCIENCE			English	Article							C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; BOUND-STATES; TRANSPORT; PROTEIN; REVEALS; REGION; BTUB	The cytoplasmic membrane protein TonB spans the periplasm of the Gram-negative bacterial cell envelope, contacts cognate outer membrane receptors, and facilitates siderophore transport. The outer membrane receptor FhuA from Escherichia coli mediates TonB-dependent import of ferrichrome. We report the 3.3 angstrom resolution crystal structure of the TonB carboxyl-terminal domain in complex with FhuA. TonB contacts stabilize FhuA's amino-terminal residues, including those of the consensus Ton box sequence that form an interprotein beta sheet with TonB through strand exchange. The highly conserved TonB residue arginine-166 is oriented to form multiple contacts with the FhuA cork, the globular domain enclosed by the beta barrel.	McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA	McGill University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Coulton, JW (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	james.coulton@mcgill.ca	Pawelek, Peter/E-7950-2014	Pawelek, Peter/0000-0002-8361-6593				Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416; Faraldo-Gomez JD, 2003, BIOPHYS J, V85, P1406, DOI 10.1016/S0006-3495(03)74573-1; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Khursigara CM, 2005, PROTEIN SCI, V14, P1266, DOI 10.1110/ps.051342505; Khursigara CM, 2005, BIOCHEMISTRY-US, V44, P3441, DOI 10.1021/bi047882p; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; Larsen RA, 1996, J BACTERIOL, V178, P1363, DOI 10.1128/jb.178.5.1363-1373.1996; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	17	202	207	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1399	1402		10.1126/science.1128057	http://dx.doi.org/10.1126/science.1128057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741125				2022-12-28	WOS:000237961600061
J	Brinkhuis, H; Schouten, S; Collinson, ME; Sluijs, A; Damste, JSS; Dickens, GR; Huber, M; Cronin, TM; Onodera, J; Takahashi, K; Bujak, JP; Stein, R; van der Burgh, J; Eldrett, JS; Harding, IC; Lotter, AF; Sangiorgi, F; Cittert, HVV; de Leeuw, JW; Matthiessen, J; Backman, J; Moran, K				Brinkhuis, Henk; Schouten, Stefan; Collinson, Margaret E.; Sluijs, Appy; Damste, Jaap S. Sinninghe; Dickens, Gerald R.; Huber, Matthew; Cronin, Thomas M.; Onodera, Jonaotaro; Takahashi, Kozo; Bujak, Jonathan P.; Stein, Ruediger; van der Burgh, Johan; Eldrett, James S.; Harding, Ian C.; Lotter, Andre F.; Sangiorgi, Francesca; van Konijnenburg-van Cittert, Han; de Leeuw, Jan W.; Matthiessen, Jens; Backman, Jan; Moran, Kathryn		Expedition 302 Scientists	Episodic fresh surface waters in the Eocene Arctic Ocean	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; CRENARCHAEOTAL MEMBRANE-LIPIDS; CLIMATE; TEMPERATURE; CIRCULATION; SEDIMENTS; ISOTOPE; PROXY	It has been suggested, on the basis of modern hydrology and fully coupled palaeoclimate simulations, that the warm greenhouse conditions(1) that characterized the early Palaeogene period (55-45 Myr ago) probably induced an intensified hydrological cycle(2) with precipitation exceeding evaporation at high latitudes(3). Little field evidence, however, has been available to constrain oceanic conditions in the Arctic during this period. Here we analyse Palaeogene sediments obtained during the Arctic Coring Expedition, showing that large quantities of the free-floating fern Azolla grew and reproduced in the Arctic Ocean by the onset of the middle Eocene epoch (similar to 50 Myr ago). The Azolla and accompanying abundant freshwater organic and siliceous microfossils indicate an episodic freshening of Arctic surface waters during an similar to 800,000-year interval. The abundant remains of Azolla that characterize basal middle Eocene marine deposits of all Nordic seas(4-7) probably represent transported assemblages resulting from freshwater spills from the Arctic Ocean that reached as far south as the North Sea(8). The termination of the Azolla phase in the Arctic coincides with a local sea surface temperature rise from similar to 10 degrees C to 13 degrees C, pointing to simultaneous increases in salt and heat supply owing to the influx of waters from adjacent oceans. We suggest that onset and termination of the Azolla phase depended on the degree of oceanic exchange between Arctic Ocean and adjacent seas.	Univ Utrecht, Palaeobot & Palynol Lab, Inst Environm Biol, NL-3584 CD Utrecht, Netherlands; Royal Netherlands Inst Sea Res NIOZ, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Univ London, Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EX, Surrey, England; Univ Utrecht, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47906 USA; Purdue Univ, Purdue Climate Change Res Ctr, W Lafayette, IN 47906 USA; US Geol Survey, Natl Ctr, Reston, VA 20192 USA; Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan; Bujak Res Inst, Blackpool FY3 8NE, England; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; Shell UK Explorat & Prod Ltd, Aberdeen AB12 3FY, Scotland; Univ Southampton, Southampton Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Natl Museum Nat Hist, NL-2300 RA Leiden, Netherlands; Stockholm Univ, Dept Geol & Geochem, SE-10691 Stockholm, Sweden; Univ Rhode Isl, Narragansett, RI 02882 USA	Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of London; Royal Holloway University London; Utrecht University; Rice University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of the Interior; United States Geological Survey; Kyushu University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Royal Dutch Shell; NERC National Oceanography Centre; University of Southampton; Stockholm University; University of Rhode Island	Brinkhuis, H (corresponding author), Univ Utrecht, Palaeobot & Palynol Lab, Inst Environm Biol, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	H.Brinkhuis@bio.uu.nl	O'Regan, Matt/B-2157-2010; Huber, Matthew/A-7677-2008; Palike, Heiko/A-6560-2008; Sluijs, Appy/B-3726-2009; Jakobsson, Martin/F-6214-2010; de Leeuw, Jan W/F-6471-2011; Harding, Ian C/K-3320-2012; O'Regan, Matt/P-6277-2019; Damste, Jaap S Sinninghe/F-6128-2011; Gattacceca, Jerome/AAG-5651-2019; Brinkhuis, Henk/B-4223-2009; Dickens, Gerald R/G-1222-2011; Lotter, Andre F./C-3477-2008	Huber, Matthew/0000-0002-2771-9977; Palike, Heiko/0000-0003-3386-0923; Sluijs, Appy/0000-0003-2382-0215; O'Regan, Matt/0000-0002-6046-1488; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Gattacceca, Jerome/0000-0002-1639-7140; Lotter, Andre F./0000-0002-2954-8809; Brinkhuis, Henk/0000-0003-0253-6610; eldrett, james/0000-0001-5196-3112; Takahashi, Kozo/0000-0001-8660-4371; Onodera, Jonaotaro/0000-0001-6942-2285; Jakobsson, Martin/0000-0002-9033-3559; Eynaud, Frederique/0000-0003-1283-7425; Stein, Ruediger/0000-0002-4453-9564; Matthiessen, Jens/0000-0002-6952-2494; Jordan, Richard/0000-0002-8997-7349; Rea, Brice/0000-0002-9928-145X; Kaminski, Michael A/0000-0002-7344-5874; Harding, Ian/0000-0003-4281-0581; Dickens, Gerald/0000-0003-2869-4860	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arora A, 2003, BIOMASS BIOENERG, V24, P175, DOI 10.1016/S0961-9534(02)00133-2; Backman J., 2006, P IODP, V302, DOI [10.2204/iodp.proc.302.104.2006, DOI 10.2204/IODP.PROC.302.2006]; BARRON EJ, 1989, GLOBAL PLANET CHANGE, V75, P157; Boulter M.C., 1986, Journal of Micropalaeontology, V5, P75; BUJAK J, 1994, J GEOL SOC LONDON, V151, P449, DOI 10.1144/gsjgs.151.3.0449; COLLINSON ME, 1983, BOT J LINN SOC, V86, P177, DOI 10.1111/j.1095-8339.1983.tb00725.x; Collinson ME, 2002, REV PALAEOBOT PALYNO, V119, P51, DOI 10.1016/S0034-6667(01)00129-4; Collinson ME, 2001, BRITTONIA, V53, P173, DOI 10.1007/BF02812700; Eldrett JS, 2004, MAR GEOL, V204, P91, DOI 10.1016/S0025-3227(03)00357-8; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; GRADSTEIN FM, 1982, QUANTITATIVE STRATIG, P119; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; HEILMANNCLAUSEN C, 1996, EARLY PALEOGENE STAG, P19; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Huber M, 2006, PALAEOGEOGR PALAEOCL, V231, P9, DOI 10.1016/j.palaeo.2005.07.037; HUBER M, 2003, GEOL SOC AM SPEC PAP, V369, P25, DOI DOI 10.1130/0-8137-2369-8.25; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Powers LA, 2004, GEOLOGY, V32, P613, DOI 10.1130/G20434.1; Rai V, 1999, PLANT SOIL, V206, P79, DOI 10.1023/A:1004340005693; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; SWEET AR, 1976, CAN J BOT, V54, P334, DOI 10.1139/b76-031; Tripati A, 2001, PALAEOGEOGR PALAEOCL, V170, P101, DOI 10.1016/S0031-0182(01)00230-9; Wuchter C, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001041; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	28	226	234	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					606	609		10.1038/nature04692	http://dx.doi.org/10.1038/nature04692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16752440	Green Published			2022-12-28	WOS:000237920800040
J	Kleiner, K				Kleiner, K			Assault on batteries	NATURE			English	News Item																			0	14	14	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2006	441	7097					1046	1047		10.1038/4411046a	http://dx.doi.org/10.1038/4411046a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810221				2022-12-28	WOS:000238615500015
J	Sun, D; Riley, AE; Cadby, AJ; Richman, EK; Korlann, SD; Tolbert, SH				Sun, Dong; Riley, Andrew E.; Cadby, Ashley J.; Richman, Erik K.; Korlann, Scott D.; Tolbert, Sarah H.			Hexagonal nanoporous germanium through surfactant-driven self-assembly of Zintl clusters	NATURE			English	Article							FILMS; PHOTOLUMINESCENCE; CRYSTALLINE; EDGE; TCNQ	Surfactant templating is a method that has successfully been used to produce nanoporous inorganic structures from a wide range of oxide-based material(1-5). Co-assembly of inorganic precursor molecules with amphiphilic organic molecules is followed first by inorganic condensation to produce rigid amorphous frameworks and then, by template removal, to produce mesoporous solids. A range of periodic surfactant/semiconductor and surfactant/metal composites have also been produced by similar methods(6-11), but for virtually all the non-oxide semiconducting phases, the surfactant unfortunately cannot be removed to generate porous materials. Here we show that it is possible to use surfactant-driven self-organization of soluble Zintl clusters to produce periodic, nanoporous versions of classic semiconductors such as amorphous Ge or Ge/Si alloys. Specifically, we use derivatives of the anionic Ge-9(4-) cluster(12-14), a compound whose use in the synthesis of nanoscale materials is established(15). Moreover, because of the small size, high surface area, and flexible chemistry of these materials, we can tune optical properties in these nanoporous semiconductors through quantum confinement(16,17), by adsorption of surface species, or by altering the elemental composition of the inorganic framework. Because the semiconductor surface is exposed and accessible in these materials, they have the potential to interact with a range of species in ways that could eventually lead to new types of sensors or other novel nanostructured devices.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Tolbert, SH (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	tolbert@chem.ucla.edu	Tolbert, Sarah H./L-2321-2016; Cadby, Ashley/H-3679-2013	Cadby, Ashley/0000-0002-5472-8625				Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; [Anonymous], 1992, INTERMOLECULAR SURFA; Attard GS, 1997, SCIENCE, V278, P838, DOI 10.1126/science.278.5339.838; BELIN CHE, 1977, J AM CHEM SOC, V99, P7163, DOI 10.1021/ja00464a011; Braun PV, 1996, NATURE, V380, P325, DOI 10.1038/380325a0; BROEKHOFF JCP, 1979, J CHEM SOC FARAD T 1, V75, P42, DOI 10.1039/f19797500042; Crepaldi EL, 2003, J AM CHEM SOC, V125, P9770, DOI 10.1021/ja030070g; DALBA G, 1995, PHYS REV B, V52, P11034, DOI 10.1103/PhysRevB.52.11034; Djordjevic BR, 1997, J PHYS-CONDENS MAT, V9, P1983, DOI 10.1088/0953-8984/9/9/012; Downie C, 2000, ANGEW CHEM INT EDIT, V39, P338; EVANS DF, 1989, WATER SCI REV, V4, P1; GREGG S. J., 1982, AUFLAGE, V2nd; Grosso D, 2004, NAT MATER, V3, P787, DOI 10.1038/nmat1206; Guzelian AA, 1996, J PHYS CHEM-US, V100, P7212, DOI 10.1021/jp953719f; Korlann SD, 2005, J AM CHEM SOC, V127, P12516, DOI 10.1021/ja045446k; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; MacLachlan MJ, 1999, NATURE, V397, P681, DOI 10.1038/17776; MIYAZAKI S, 1995, THIN SOLID FILMS, V255, P99, DOI 10.1016/0040-6090(94)05630-V; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Nakata H, 2000, J NON-CRYST SOLIDS, V266, P1067, DOI 10.1016/S0022-3093(00)00025-9; Rivillon S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2142084; Taylor BR, 1998, CHEM MATER, V10, P22, DOI 10.1021/cm970576w; Trikalitis PN, 2002, J AM CHEM SOC, V124, P2604, DOI 10.1021/ja017245b; Trikalitis PN, 2001, NATURE, V410, P671, DOI 10.1038/35070533; Vogg G, 2000, ADV MATER, V12, P1278, DOI 10.1002/1521-4095(200009)12:17<1278::AID-ADMA1278>3.0.CO;2-Y; Xu L, 1999, J AM CHEM SOC, V121, P9245, DOI 10.1021/ja992269s; Yang PD, 1998, NATURE, V396, P152; Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E; Zakrzewski VG, 1996, J CHEM PHYS, V105, P5872, DOI 10.1063/1.472428; ZHANG JZ, 1992, J PHYS CHEM-US, V96, P2700, DOI 10.1021/j100185a054	30	196	199	4	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1126	1130		10.1038/nature04891	http://dx.doi.org/10.1038/nature04891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810251				2022-12-28	WOS:000238615500045
J	Burns, JA; Cuzzi, JN				Burns, JA; Cuzzi, JN			Our local astrophysical laboratory	SCIENCE			English	Editorial Material									Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	Cornell University; Cornell University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Burns, JA (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	jab16@cornell.edu						Colwell JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025163; COLWELL JH, COMMUNICATION; HEDMAN MM, 2005, AM GEOPH UN FALL M 5; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; LISSAUER JJ, 1985, PROTOSTARS PLANETS, V2, P920; SALO H, 1995, ICARUS, V117, P287, DOI 10.1006/icar.1995.1157; Several articles in Science and Nature issues of 2004 and 2005 describe in detail the CassinieHuygens mission first findings. In particular: Cassini arrives at Saturn, 2005, SCIENCE, V307; Tiscareno MS, 2006, NATURE, V440, P648, DOI 10.1038/nature04581; TISCARENO MS, 2005, AM GEOPH UN FALL M 5; [No title captured]	10	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1753	1755		10.1126/science.1114856	http://dx.doi.org/10.1126/science.1114856			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794067				2022-12-28	WOS:000238452800041
J	Annas, GJ				Annas, GJ			Bioterror and "bioart'' - A plague o' both your houses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas George J, 2005, J Health Law, V38, P319; Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats Institute of Medicine and National Research Council, 2006, GLOB BIOS FUT LIF SC; Enserink M, 2003, SCIENCE, V302, P2054, DOI 10.1126/science.302.5653.2054; Gaudioso J, 2004, SCIENCE, V305, P180; Gaudioso J, 2004, SCIENCE, V304, P687, DOI 10.1126/science.1096911; GOLD R, 2003, WALL STREET J   0414, pA1; HAUSER J, 2003, ART BIOTECH; Kwik Gigi, 2003, Biosecur Bioterror, V1, P27, DOI 10.1089/15387130360514805; Murray BE, 2005, CLIN INFECT DIS, V40, P1644, DOI 10.1086/431348; Mwengee W, 2006, CLIN INFECT DIS, V42, P614, DOI 10.1086/500137; National Research Council, 2004, BIOT RES AG TERR, DOI [10.17226/10827, DOI 10.17226/10827]; Relman DA, 2006, NEW ENGL J MED, V354, P113, DOI 10.1056/NEJMp058078; Shattuck R., 1996, FORBIDDEN KNOWLEDGE, P224; Somerville MA, 2005, SCIENCE, V307, P1881, DOI 10.1126/science.1109279; TANSEY B, 2004, SAN FRANCISCO C 1031, pA7; TURNER C, 2005, GUARDIAN LONDON 1020, P18; WHEELIF M, 2006, DEADLY CULTURES BIOL	17	9	10	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2715	2720		10.1056/NEJMlim060344	http://dx.doi.org/10.1056/NEJMlim060344			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	054ZJ	16790708	Green Published			2022-12-28	WOS:000238416900015
J	Chaparro, CM; Neufeld, LM; Alavez, GT; Cedilla, REL; Dewey, KG				Chaparro, Camila M.; Neufeld, Lynnette M.; Gilberto, Tena Alavez; Equia-Liz Cedilla, Raul; Dewey, Kathryn G.			Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomised controlled trial	LANCET			English	Article							BLOOD-VOLUME; BODY IRON; PLACENTAL TRANSFUSION; TERM INFANTS; DEFICIENCY; HEMOGLOBIN; FERRITIN; CHILDREN; AGE	Background Delayed clamping of the umbilical cord increases the infant's iron endowment at birth and haemoglobin concentration at 2 months of age. We aimed to assess whether a 2-minute delay in the clamping of the umbilical cord of normal-weight, full-term infants improved iron and haematological status up to 6 months of age. Methods 476 mother-infant pairs were recruited at a large obstetrics hospital in Mexico City, Mexico, randomly assigned to delayed clamping (2 min after delivery of the infant's shoulders) or early clamping (around 10 s after delivery), and followed up until 6 months postpartum. Primary outcomes were infant haematological status and iron status at 6 months of age, and analysis was by intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT00298051. Findings 358 (75%) mother-infant pairs completed the trial. At 6 months of age, infants who had delayed clamping had significantly higher mean corpuscular volume (81.0 CL vs 79.5 fL 95% CI -2.5 to -0.6, p=0.001), ferritin (50.7 mu g/L vs 34.4 mu g/L 95% C1 -30.7 to -1.9, p=0.0002), and total body iron. The effect of delayed clamping was significantly greater for infants born to mothers with low ferritin at delivery, breastfed infants not receiving iron-fortified milk or formula, and infants born with birthweight between 2500 g and 3000 g. A cord clamping delay of 2 minutes increased 6-month iron stores by about 27-47 mg. Interpretation Delay in cord clamping of 2 minutes could help prevent iron deficiency from developing before 6 months of age, when iron-fortified complementary foods could be introduced.	Univ Calif Davis, Dept Nutr, Program Int & Community Nutr, Davis, CA 95616 USA; Natl Inst Publ Hlth, Div Nutr Epidemiol, Cuernavaca, Morelos, Mexico; Inst Mexicano Seguro Social, Hosp Gineco Obstet Luis Castelazo Ayala 4, Mexico City, DF, Mexico	University of California System; University of California Davis; Instituto Nacional de Salud Publica; Instituto Mexicano del Seguro Social	Dewey, KG (corresponding author), Univ Calif Davis, Dept Nutr, Program Int & Community Nutr, 1 Shields Ave, Davis, CA 95616 USA.	kgdewey@ucdavis.edu						*ACC SCN, 2001, WHAT WORKS REV EFF E, P43; [Anonymous], 2000, HEMATOLOGIC PROBLEMS; Cook JD, 2005, BLOOD, V106, P1441, DOI 10.1182/blood-2004-12-4782; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dallman PR, 1990, PRESENT KNOWLEDGE NU; DIRREN H, 1994, EUR J CLIN NUTR, V48, P625; Domellof M, 2002, PEDIATRICS, V110, P545, DOI 10.1542/peds.110.3.545; Domellof M, 2002, J NUTR, V132, P3680, DOI 10.1093/jn/132.12.3680; Domellof M, 2001, J PEDIATR-US, V138, P679, DOI 10.1067/mpd.2001.112895; Emhamed MO, 2004, TROP DOCT, V34, P218, DOI 10.1177/004947550403400410; Geethanath R M, 1997, Indian Pediatr, V34, P103; Grajeda R, 1997, AM J CLIN NUTR, V65, P425, DOI 10.1093/ajcn/65.2.425; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Gupta Rajesh, 2002, Indian Pediatr, V39, P130; *I MED, 1990, NUTR PREGN, P272; *I MED, 2001, IR DIET REF INT VIT; *ICM FIGO, 2003, JOINT STAT MAN 3 STA; LANZKOWSKY P, 1960, BRIT MED J, V2, P1777, DOI 10.1136/bmj.2.5215.1777; LINDERKAMP O, 1992, ACTA PAEDIATR, V81, P745, DOI 10.1111/j.1651-2227.1992.tb12095.x; LINDERKAMP O, 1977, EUR J PEDIATR, V125, P227, DOI 10.1007/BF00493567; LOPEZ MXD, 2004, PRACTICAS ALIMENTACI, P185; Malope BI, 2001, BRIT J HAEMATOL, V115, P84, DOI 10.1046/j.1365-2141.2001.03063.x; OH W, 1966, ANN PAEDIATR-BASEL, V207, P147; *OXF MIDW RES GROU, 1991, MIDWIFERY, V7, P167; PAOCHEN W, 1960, CHIN MED J, V80, P351; Prendiville WJ, 2000, COCHRANE DB SYST REV, V3; SAARINEN UM, 1979, PEDIATR RES, V13, P143, DOI 10.1203/00006450-197903000-00001; USHER R, 1963, ACTA PAEDIATR, V52, P497, DOI 10.1111/j.1651-2227.1963.tb03809.x; Van Rheenen P, 2004, ANN TROP PAEDIATR, V24, P3, DOI 10.1179/027249304225013286; *WHO UN CHILDR FUN, 1998, IR DEF IND ASS STRAT; WILSON EE, 1941, AM J DIS CHILD, P320; YAO AJ, 1969, LANCET, V294, P871	32	196	209	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					1997	2004		10.1016/S0140-6736(06)68889-2	http://dx.doi.org/10.1016/S0140-6736(06)68889-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16782490				2022-12-28	WOS:000238488900034
J	Danel, C; Moh, R; Minga, A; Anzian, A; Ba-Gomis, O; Kanga, C; Nzunetu, G; Gabillard, D; Rouet, F; Sorho, S; Chaix, ML; Eholie, S; Menan, H; Sauvageot, D; Bissagnene, E; Salamon, R; Anglaret, X				Danel, Christine; Moh, Raoul; Minga, Albert; Anzian, Amani; Ba-Gomis, Olivier; Kanga, Constance; Nzunetu, Gustave; Gabillard, Delphine; Rouet, Francois; Sorho, Souleymane; Chaix, Marie-Laure; Eholie, Serge; Menan, Herve; Sauvageot, Delphine; Bissagnene, Emmanuel; Salamon, Roger; Anglaret, Xavier		Trivacan ANRS 1269 Trial Grp	CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial	LANCET			English	Article							T-CELLS; HIV-1-INFECTED PATIENTS; THERAPY; COHORT; COTRIMOXAZOLE; MUTATIONS; DYNAMICS; IMMUNITY; ABIDJAN; REGIMEN	Background Structured treatment interruptions of highly-active antiretroviral therapy (HAART) might be particularly relevant for sub-Saharan Africa, where cost-saving strategies could help to increase the number of patients on HAART. We did a randomised trial of structured treatment interruption in Abidjan, Cote d'Ivoire. Methods HIV-infected adults were randomised to receive continuous HAART (CT), CD4-guided HAART (CD4GT) with interruption and reintroduction thresholds at 350 and 250 cells per mm(3), respectively, or 2-months-off, 4-months-on HAART. Primary endpoints were death and severe morbidity (any WHO stage 3 or 4 events and any events leading to death) at month 24. We report data from the CT and CD4GT groups until Oct 31, 2005, when the data safety monitoring board recommended to prematurely stop the CD4GT arm. Analyses were intention-to-treat. This study is registered at ClinicalTrials.gov, number NCT00158405. Results 326 adults (median CD4 count nadir 272 per mm(3)) were randomised to the CT or CD4GT groups and followed up for median of 20 months. Incidence of mortality (per 100 person-years) was not different between groups (CT 0.6, CD4GT 1.2; p=0.57). Incidence of severe morbidity (per 100 person-years) was higher in the CDG4T group (17.6) than in the CT group (6.7; p=0.001). The most frequent severe events were invasive bacterial diseases. 79% of severe morbidity episodes occurred in patients with CD4 count 200-500 per mm(3). Conclusion Patients on CD4GT had severe morbidity rates 2.5-fold higher than those on CT This difference was mainly due to high rates of common diseases in patients with CD4 count 200-500 per mm(3). This CD4-guided structured treatment interruption strategy should not be recommended in Abidjan.	Univ Bordeaux 2, INSERM, U593, F-33076 Bordeaux, France; Programme PAC CI, Abidjan, Cote Ivoire; Ctr Hosp Univ Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire; Ctr Hosp Univ Treichville, Ctr Diagnost & Rech SIDA, Abidjan, Cote Ivoire; Ctr Hosp Univ Necker, Serv Virol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Anglaret, X (corresponding author), Univ Bordeaux 2, INSERM, U593, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	Xavier.Anglaret@isped.u-bordeaux2.fr	Anglaret, Xavier/T-2757-2019; Anglaret, Xavier/F-7333-2013; Eholie, Serge/T-6008-2019; Van de Perre, Philippe/B-9692-2008	Van de Perre, Philippe/0000-0002-3912-0427; Anglaret, Xavier/0000-0003-3319-8423; Moh, Desmorys Raoul/0000-0002-1678-3340				Ananworanich J, 2005, JAIDS-J ACQ IMM DEF, V39, P523; Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; ANANWORANICH J, 2006, 13 C RETR OPP INF; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Anglaret X, 2003, AIDS, V17, P575, DOI 10.1097/00002030-200303070-00013; [Anonymous], 13 C RETR OPP INF DE; Arnedo-Valero M, 2005, CLIN INFECT DIS, V41, P883, DOI 10.1086/432881; Boschi A, 2004, AIDS, V18, P2381; D'Offizi G, 2002, AIDS, V16, P2431, DOI 10.1097/00002030-200212060-00008; Danel C, 2006, JAIDS-J ACQ IMM DEF, V42, P29, DOI 10.1097/01.qai.0000219777.04927.50; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Dybul Mark, 2002, Curr Infect Dis Rep, V4, P175, DOI 10.1007/s11908-002-0059-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/00002030-200301240-00009; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Garcia F, 2001, AIDS, V15, pF29, DOI 10.1097/00002030-200106150-00002; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Hatano H, 2000, AIDS, V14, P1935, DOI 10.1097/00002030-200009080-00008; Hoen B, 2005, JAIDS-J ACQ IMM DEF, V40, P307, DOI 10.1097/01.qai.0000182628.66713.31; *INT AIDS SOC US, HIV DRUGS RES MUT; Lori F, 2001, JAMA-J AM MED ASSOC, V286, P2981, DOI 10.1001/jama.286.23.2981; Maggiolo F, 2004, AIDS, V18, P439, DOI 10.1097/00002030-200402200-00010; MARCHOU B, 2006, 13 C RETR OPP INF; Martinez-Picado J, 2002, AIDS, V16, P895, DOI 10.1097/00002030-200204120-00009; Martini F, 2002, J INFECT DIS, V186, P847, DOI 10.1086/342410; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Moh R, 2005, ANTIVIR THER, V10, P615; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; Pasquier C, 2001, J VIROL METHODS, V94, P45, DOI 10.1016/S0166-0934(01)00272-5; REID P, 2004, 15 INT AIDS C 11 16; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Ruiz L, 2000, AIDS, V14, P397, DOI 10.1097/00002030-200003100-00013; Ruiz L, 2001, AIDS, V15, pF19, DOI 10.1097/00002030-200106150-00001; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Tarwater PM, 2003, CLIN INFECT DIS, V37, P1541, DOI 10.1086/379514; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; *WHO, 2003, WHO EXP CONS COTR PR; Wit FWNM, 2005, AIDS, V19, P345	39	174	177	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2006	367	9527					1981	1989		10.1016/S0140-6736(06)68887-9	http://dx.doi.org/10.1016/S0140-6736(06)68887-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055ZC	16782488				2022-12-28	WOS:000238488900032
J	Alonso, JM				Alonso, JM			Neurons find strength through synchrony in the brain	SCIENCE			English	Editorial Material							LATERAL GENICULATE-NUCLEUS; CORTICAL RECEPTIVE-FIELDS; VISUAL-CORTEX; CAT; INNERVATION; AFFERENTS; CELL		SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	State University of New York (SUNY) System; SUNY Optometry	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA.	jalonso@sunyopt.edu						Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2002, J NEUROSCI, V22, P10966; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FREUND TF, 1985, J COMP NEUROL, V242, P275, DOI 10.1002/cne.902420209; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	14	4	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1604	1605		10.1126/science.1129705	http://dx.doi.org/10.1126/science.1129705			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778042				2022-12-28	WOS:000238288600029
J	Zhou, J; Long, S; Wang, Q; Dinsmore, AD				Zhou, J.; Long, S.; Wang, Q.; Dinsmore, A. D.			Measurement of forces inside a three-dimensional pile of frictionless droplets	SCIENCE			English	Article							LIQUID-LIQUID INTERFACES; GRANULAR-MATERIALS; BEAD PACKS; ELASTICITY; MODEL; FLUCTUATIONS; EMULSIONS; STRESS; SOLIDS; SYSTEM	We present systematic and detailed measurements of interparticle contact forces inside three-dimensional piles of frictionless liquid droplets. We measured long-range chainlike correlations of the directions and magnitudes of large forces, thereby establishing the presence of force chains in three dimensions. Our correlation definition provides a chain persistence length of 10 mean droplet diameters, decreasing as load is applied to the pile. We also measured the angles between contacts and showed that the chainlike arrangement arises from the balance of forces. Moreover, we found that piles whose height was comparable to the chain persistence length exhibited substantially greater strain hardening than did tall piles, which we attributed to the force chains. Together, the results establish a connection between the microscopic force network and the elastic response of meso- or macroscopic granular piles. The conclusions drawn here should be relevant in jammed systems generally, including concentrated emulsions and piles of sand or other heavy particles.	Univ Massachusetts, Hasbrouck Lab 411, Dept Phys, Amherst, MA 01003 USA; Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of Massachusetts System; University of Massachusetts Amherst; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Dinsmore, AD (corresponding author), Univ Massachusetts, Hasbrouck Lab 411, Dept Phys, 666 N Pleasant St, Amherst, MA 01003 USA.	dinsmore@physics.umass.edu		Wang, Qian/0000-0002-2149-384X				Blair DL, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041304; Brujic J, 2003, PHYSICA A, V327, P201, DOI 10.1016/S0378-4371(03)00477-1; Coppersmith SN, 1996, PHYS REV E, V53, P4673, DOI 10.1103/PhysRevE.53.4673; DRESCHER A, 1972, J MECH PHYS SOLIDS, V20, P337, DOI 10.1016/0022-5096(72)90029-4; Erikson JM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.040301; Geng JF, 2003, PHYSICA D, V182, P274, DOI 10.1016/S0167-2789(03)00137-4; Goldenberg C, 2005, NATURE, V435, P188, DOI 10.1038/nature03497; Goldenberg C, 2004, GRANUL MATTER, V6, P87, DOI 10.1007/s10035-004-0165-y; Goldenberg C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.084302; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616; LIU CH, 1995, SCIENCE, V269, P513, DOI 10.1126/science.269.5223.513; Lovoll G, 1999, PHYS REV E, V60, P5872, DOI 10.1103/PhysRevE.60.5872; Majmudar TS, 2005, NATURE, V435, P1079, DOI 10.1038/nature03805; Makse HA, 2000, PHYS REV LETT, V84, P4160, DOI 10.1103/PhysRevLett.84.4160; MASON TG, 1995, PHYS REV LETT, V75, P2051, DOI 10.1103/PhysRevLett.75.2051; Mueth DM, 1998, PHYS REV E, V57, P3164, DOI 10.1103/PhysRevE.57.3164; O'Hern CS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011306; O'Hern CS, 2001, PHYS REV LETT, V86, P111, DOI 10.1103/PhysRevLett.86.111; Ostojic S, 2006, NATURE, V439, P828, DOI 10.1038/nature04549; Ouaguenouni S, 1997, EUROPHYS LETT, V39, P117, DOI 10.1209/epl/i1997-00324-1; PRINCEN HM, 1983, J COLLOID INTERF SCI, V91, P160, DOI 10.1016/0021-9797(83)90323-5; Russell JT, 2005, ANGEW CHEM INT EDIT, V44, P2420, DOI 10.1002/anie.200462653; Silbert LE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061303; Snoeijer JH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054302; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; van Hecke M, 2005, NATURE, V435, P1041, DOI 10.1038/4351041a	27	98	101	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1631	1633		10.1126/science.1125151	http://dx.doi.org/10.1126/science.1125151			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778050				2022-12-28	WOS:000238288600039
J	Santoro, M; Gorelli, FA; Bini, R; Ruocco, G; Scandolo, S; Crichton, WA				Santoro, Mario; Gorelli, Federico A.; Bini, Roberto; Ruocco, Giancarlo; Scandolo, Sandro; Crichton, Wilson A.			Amorphous silica-like carbon dioxide	NATURE			English	Article							HIGH-PRESSURE; RAMAN-SPECTROSCOPY; CRYSTAL-STRUCTURE; CO2; PHASE; NITROGEN; QUARTZ	Among the group IV elements, only carbon forms stable double bonds with oxygen at ambient conditions. At variance with silica and germania, the non-molecular single-bonded crystalline form of carbon dioxide, phase V, only exists at high pressure(1-9). The amorphous forms of silica (a-SiO2) and germania (a-GeO2) are well known at ambient conditions; however, the amorphous, non-molecular form of CO2 has so far been described only as a result of first-principles simulations(9). Here we report the synthesis of an amorphous, silica-like form of carbon dioxide, a-CO2, which we call 'a-carbonia'. The compression of the molecular phase III of CO2 between 40 and 48 GPa at room temperature initiated the transformation to the non-molecular amorphous phase. Infrared spectra measured at temperatures up to 680 K show the progressive formation of C-O single bonds and the simultaneous disappearance of all molecular signatures. Furthermore, state-of-the-art Raman and synchrotron X-ray diffraction measurements on temperature-quenched samples confirm the amorphous character of the material. Comparison with vibrational and diffraction data for a-SiO2 and a-GeO2, as well as with the structure factor calculated for the a-CO2 sample obtained by first-principles molecular dynamics(9), shows that a-CO2 is structurally homologous to the other group IV dioxide glasses. We therefore conclude that the class of archetypal network-forming disordered systems, including a-SiO2, a-GeO2 and water, must be extended to include a-CO2.	European Lab Nonlinear Spect, LENS, I-50019 Florence, Italy; INFM, I-50019 Florence, Italy; Univ Roma La Sapienza, CNR, INFM, CRS,SOFT, I-00185 Rome, Italy; Univ Florence, Dipartimento Chim, I-50019 Florence, Italy; Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; INFM, Democritos Natl Smithsonian Ctr, I-34014 Trieste, Italy; European Synchrotron Res Facil, F-38043 Grenoble, France	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; University of Florence; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Gorelli, FA (corresponding author), European Lab Nonlinear Spect, LENS, Via N Carrara 1, I-50019 Florence, Italy.	gorelli@lens.unifi.it	Scandolo, Sandro/AAC-9081-2019; Ruocco, Giancarlo/A-6245-2010	Scandolo, Sandro/0000-0003-3826-4813; Ruocco, Giancarlo/0000-0002-2762-9533; Crichton, Wilson/0000-0001-6823-5509; Santoro, Mario/0000-0001-5693-4636; BINI, ROBERTO/0000-0002-6746-696X				AOKI K, 1994, SCIENCE, V263, P356, DOI 10.1126/science.263.5145.356; Dong J, 2000, SCIENCE, V287, p11a; Dong JJ, 2000, PHYS REV B, V62, P14685, DOI 10.1103/PhysRevB.62.14685; Dong JJ, 2000, PHYS REV B, V61, P5967, DOI 10.1103/PhysRevB.61.5967; DURBEN DJ, 1991, PHYS REV B, V43, P2355, DOI 10.1103/PhysRevB.43.2355; Eremets MI, 2004, NAT MATER, V3, P558, DOI 10.1038/nmat1146; Eremets ML, 2001, NATURE, V411, P170, DOI 10.1038/35075531; Goncharov AF, 2000, PHYS REV LETT, V85, P1262, DOI 10.1103/PhysRevLett.85.1262; Gorelli FA, 1999, PHYS REV LETT, V83, P4093, DOI 10.1103/PhysRevLett.83.4093; Gorelli FA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.205503; Gregoryanz E, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.052103; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; HEMLEY RJ, 1986, PHYS REV LETT, V57, P747, DOI 10.1103/PhysRevLett.57.747; HEMLEY RJ, 1988, NATURE, V334, P52, DOI 10.1038/334052a0; Holm B, 2000, PHYS REV LETT, V85, P1258, DOI 10.1103/PhysRevLett.85.1258; Iota V, 1999, SCIENCE, V283, P1510, DOI 10.1126/science.283.5407.1510; Kendall JL, 1999, CHEM REV, V99, P543, DOI 10.1021/cr9700336; LIANG Y, UNPUB PHYS REV LETT; MEADE C, 1992, PHYS REV LETT, V69, P1387, DOI 10.1103/PhysRevLett.69.1387; Miller SA, 2004, NATURE, V427, P724, DOI 10.1038/nature02251; Santoro M, 2004, J CHEM PHYS, V121, P2780, DOI 10.1063/1.1758936; Schettino V, 2005, ADV CHEM PHYS, V131, P105, DOI 10.1002/0471739464.ch4; Serra S, 1999, SCIENCE, V284, P788, DOI 10.1126/science.284.5415.788; Tschauner O, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.075701; WILLIAMS Q, 1988, SCIENCE, V239, P902, DOI 10.1126/science.239.4842.902; WILLIAMS Q, 1993, J GEOPHYS RES-SOL EA, V98, P22157, DOI 10.1029/93JB02171; Yoo CS, 1999, PHYS REV LETT, V83, P5527, DOI 10.1103/PhysRevLett.83.5527	27	130	132	4	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					857	860		10.1038/nature04879	http://dx.doi.org/10.1038/nature04879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778885				2022-12-28	WOS:000238254100038
J	Hannan, SA; Alusi, G				Hannan, SA; Alusi, G			Zenker's diverticulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Bartholomews Hosp, London EC1A 7BE, England	University of London; Queen Mary University London	Hannan, SA (corresponding author), St Bartholomews Hosp, London EC1A 7BE, England.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					E24	E24		10.1056/NEJMicm050445	http://dx.doi.org/10.1056/NEJMicm050445			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760438				2022-12-28	WOS:000238100800011
J	Quackenbush, J				Quackenbush, John			Current concepts - Microarray analysis and tumor classification	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENE-EXPRESSION PATTERNS; DNA MICROARRAY; CDNA MICROARRAY; BREAST-CANCER; OLIGONUCLEOTIDE ARRAYS; ALZHEIMERS-DISEASE; MUSCLE-CELLS; PLATFORMS; PROFILES; PREDICTION		Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Quackenbush, J (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu		Quackenbush, John/0000-0002-2702-5879				Agrawal D, 2002, J NATL CANCER I, V94, P513; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ball C, 2004, ENVIRON HEALTH PERSP, V112, pA666; Ball CA, 2004, PLOS BIOL, V2, P1276, DOI 10.1371/journal.pbio.0020317; Ball CA, 2002, BIOINFORMATICS, V18, P1409, DOI 10.1093/bioinformatics/18.11.1409; Ball CA, 2002, SCIENCE, V298, P539; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Barczak A, 2003, GENOME RES, V13, P1775, DOI 10.1101/gr.1048803; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carter MG, 2003, GENOME RES, V13, P1011, DOI 10.1101/gr.878903; Chin KV, 2002, FERTIL STERIL, V77, P1214, DOI 10.1016/S0015-0282(02)03114-X; DeRisi J, 1996, NAT GENET, V14, P457; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Erle DJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-232; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; Giudice LC, 2002, ANN NY ACAD SCI, V955, P252, DOI 10.1111/j.1749-6632.2002.tb02786.x; Giudice LC, 2002, ANN NY ACAD SCI, V955, P293; Giudice LC, 2002, ANN NY ACAD SCI, V955, P396; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Horcajadas JA, 2004, ANN NY ACAD SCI, V1034, P166, DOI 10.1196/annals.1335.019; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Irizarry RA, 2005, NAT METHODS, V2, P477, DOI 10.1038/nmeth0605-477b; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Khan J, 1998, CANCER RES, V58, P5009; Kihara C, 2001, CANCER RES, V61, P6474; Kothapalli R, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-22; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Li T, 2003, CIRC RES, V93, P1202, DOI 10.1161/01.RES.0000104085.76261.02; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; Loring JF, 2002, DNA CELL BIOL, V21, P241; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Moch H, 1999, Verh Dtsch Ges Pathol, V83, P225; Ohki R, 2005, INT J CARDIOL, V102, P233, DOI 10.1016/j.ijcard.2004.05.026; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pierce A, 2004, NEUROCHEM RES, V29, P1145, DOI 10.1023/B:NERE.0000023601.50101.7f; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Rolph MS, 2006, PHARMACOL THERAPEUT, V109, P284, DOI 10.1016/j.pharmthera.2005.08.009; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Syed F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-9; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang HY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r5; Welford SM, 1998, NUCLEIC ACIDS RES, V26, P3059, DOI 10.1093/nar/26.12.3059; Yang IV, 2002, GENOME BIOL, V3; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030; Zvara A, 2005, DIS MARKERS, V21, P61, DOI 10.1155/2005/275318	60	318	345	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2463	2472		10.1056/NEJMra042342	http://dx.doi.org/10.1056/NEJMra042342			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760446				2022-12-28	WOS:000238100800008
J	Saha, D; Karim, MM; Khan, WA; Ahmed, S; Salam, MA; Bennish, ML				Saha, Debasish; Karim, Mohammad M.; Khan, Wasif A.; Ahmed, Sabeena; Salam, Mohammed A.; Bennish, Michael L.			Single-dose azithromycin for the treatment of cholera in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND TRIAL; CHILDHOOD CHOLERA; CIPROFLOXACIN; TETRACYCLINE; DOXYCYCLINE; ERYTHROMYCIN; STRAINS; 12-DOSE	Background: Single-dose azithromycin is effective in the treatment of severe cholera in children, but its effectiveness in adults has not been evaluated. Methods: We conducted a double-blind, randomized trial comparing the equivalence of azithromycin and ciprofloxacin (each given in a single 1-g dose of two 500-mg tablets) among 195 men with severe cholera caused by Vibrio cholerae O1 or O139. Patients were hospitalized for five days. A stool culture was performed daily. Primary outcome measures were clinical success (the cessation of watery stools within 48 hours after drug administration) and bacteriologic success (the inability to isolate V. cholerae after 48 hours). Results: Therapy was clinically successful in 71 of 97 patients receiving azithromycin (73 percent) and in 26 of 98 patients receiving ciprofloxacin (27 percent) (P < 0.001) and bacteriologically successful in 76 of 97 patients receiving azithromycin (78 percent) and in 10 of 98 patients receiving ciprofloxacin (10 percent) (P < 0.001). Patients who were treated with azithromycin had a shorter duration of diarrhea than did patients treated with ciprofloxacin (median, 30 vs. 78 hours); a lower frequency of vomiting (43 percent vs. 67 percent); fewer stools (median, 36 vs. 52); and a lower stool volume (median, 114 vs. 322 ml per kilogram of body weight). The median minimal inhibitory concentration of ciprofloxacin for the 177 isolates of V. cholerae O1 was 0.25 microg per milliliter, which was 11 to 83 times as high as that in previous studies at this site. Conclusions: Single-dose azithromycin was effective in the treatment of severe cholera in adults. The lack of efficacy of ciprofloxacin may result from its diminished activity against V. cholerae O1 strains currently circulating in Bangladesh.	Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res B, Div Clin Sci, Dhaka 1000, Bangladesh; Univ KwaZulu Natal, Sch Family Med & Publ Hlth, Durban, South Africa; Univ Oxford, Nuffield Dept Clin Med, Oxford, England	International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; University of Oxford	Saha, D (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res B, Div Clin Sci, GPO Box 128, Dhaka 1000, Bangladesh.	dsaha@icddrb.org			NIAID NIH HHS [UO1 AI45508-01] Funding Source: Medline; PHS HHS [K24 AIHDO01671] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		ALAM AN, 1990, BRIT MED J, V300, P1619, DOI 10.1136/bmj.300.6740.1619; [Anonymous], 2005, HSB (Health Science Bulletin), V3, P1; BAKER CN, 1991, J CLIN MICROBIOL, V29, P533, DOI 10.1128/JCM.29.3.533-538.1991; BROWN DFJ, 1991, J ANTIMICROB CHEMOTH, V27, P185, DOI 10.1093/jac/27.2.185; CDC, 1999, GUIDELINE PREVENTION; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; Garg P, 2000, EPIDEMIOL INFECT, V124, P393, DOI 10.1017/S0950268899003957; GREENOUGH WB, 1964, LANCET, V1, P355; HOPKINS S, 1991, AM J MED, V91, pS40, DOI 10.1016/0002-9343(91)90401-I; ISLAM MR, 1987, GUT, V28, P1029, DOI 10.1136/gut.28.8.1029; Khan WA, 1996, LANCET, V348, P296, DOI 10.1016/S0140-6736(96)01180-4; Khan WA, 2002, LANCET, V360, P1722, DOI 10.1016/S0140-6736(02)11680-1; KNAPP JS, 1995, ANTIMICROB AGENTS CH, V39, P2442, DOI 10.1128/AAC.39.11.2442; LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871; MAKUCH RW, 1986, ARCH INTERN MED, V146, P986, DOI 10.1001/archinte.146.5.986; National Committee for Clinical Laboratory Standards, 1997, M2A6 NCCLS CLIN LAB, V6th; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; RABBANI GH, 1989, ANTIMICROB AGENTS CH, V33, P1447, DOI 10.1128/AAC.33.9.1447; SACK DA, 1978, ANTIMICROB AGENTS CH, V14, P462, DOI 10.1128/AAC.14.3.462; Saha D, 2005, LANCET, V366, P1085, DOI 10.1016/S0140-6736(05)67290-X; SCHENTAG JJ, 1991, AM J MED, V91, pS5, DOI 10.1016/0002-9343(91)90394-D; SIDDIQUE AK, 1989, LANCET, V2, P396; SIDDIQUE AK, 1995, LANCET, V345, P359, DOI 10.1016/S0140-6736(95)90344-5; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; *WHO, 2005, WEEKL EP REC CHOL 20; World Health Organization, 2005, TREATM DIARRH MAN PH	27	99	103	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2452	2462		10.1056/NEJMoa054493	http://dx.doi.org/10.1056/NEJMoa054493			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760445	Bronze			2022-12-28	WOS:000238100800007
J	Hochman, JS; Sleeper, LA; Webb, JG; Dzavik, V; Buller, CE; Aylward, P; Col, J; White, HD				Hochman, Judith S.; Sleeper, Lynn A.; Webb, John G.; Dzavik, Vladimir; Buller, Christopher E.; Aylward, Philip; Col, Jacques; White, Harvey D.		SHOCK Investigators	Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OCCLUDED CORONARIES; ELDERLY-PATIENTS; TRIAL REGISTRY; MORTALITY; OUTCOMES; TIME; ANGIOPLASTY; MANAGEMENT; TRENDS	Context Cardiogenic shock remains the major cause of death for patients hospitalized with acute myocardial infarction (MI). Although survival in patients with cardiogenic shock complicating acute MI has been shown to be significantly higher at 1 year in those receiving early revascularization vs initial medical stabilization, data demonstrating long-term survival are lacking. Objective To determine if early revascularization affects long-term survival of patients with cardiogenic shock complicating acute MI. Design, Setting, and Patients The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock ( SHOCK) trial, an international randomized clinical trial enrolling 302 patients from April 1993 through November 1998 with acute myocardial infarction complicated by cardiogenic shock ( mean [SD] age at randomization, 66 [ 11] years); long-term follow-up of vital status, conducted annually until 2005, ranged from 1 to 11 years ( median for survivors, 6 years). Main Outcome Measures All-cause mortality during long-term follow-up. Results The group difference in survival of 13 absolute percentage points at 1 year favoring those assigned to early revascularization remained stable at 3 and 6 years (13.1% and 13.2%, respectively; hazard ratio [HR], 0.74; 95% confidence interval [CI], 0.57-0.97; log-rank P=. 03). At 6 years, overall survival rates were 32.8% and 19.6% in the early revascularization and initial medical stabilization groups, respectively. Among the 143 hospital survivors, a group difference in survival also was observed ( HR, 0.59; 95% CI, 0.36-0.95; P=. 03). The 6-year survival rates for the hospital survivors were 62.4% vs 44.4% for the early revascularization and initial medical stabilization groups, respectively, with annualized death rates of 8.3% vs 14.3% and, for the 1-year survivors, 8.0% vs 10.7%. There was no significant interaction between any subgroup and treatment effect. Conclusions In this randomized trial, almost two thirds of hospital survivors with cardiogenic shock who were treated with early revascularization were alive 6 years later. A strategy of early revascularization resulted in a 13.2% absolute and a 67% relative improvement in 6-year survival compared with initial medical stabilization. Early revascularization should be used for patients with acute MI complicated by cardiogenic shock due to left ventricular failure.	NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA; New England Res Inst, Watertown, MA 02172 USA; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Univ Toronto, Toronto, ON, Canada; Vancouver Gen Hosp, Vancouver, BC, Canada; Flinders Med Ctr, Bedford Pk, SA, Australia; Clin Univ St Luc, B-1200 Brussels, Belgium; Green Lane Hosp, Auckland 3, New Zealand	New York University; HealthCore, Inc; St. Paul's Hospital; University of Saskatchewan; University of Toronto; University of British Columbia; Flinders Medical Centre; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Hochman, JS (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, 530 1st Ave,HCC 1173, New York, NY 10016 USA.	judith.hochman@med.nyu.edu		Hochman, Judith/0000-0002-5889-5981; Aylward, Philip/0000-0002-5358-8552	NHLBI NIH HHS [R01-HL49970, R01 HL049970, R01 HL050020] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050020, R01HL049970] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Alter DA, 2001, JAMA-J AM MED ASSOC, V285, P2101, DOI 10.1001/jama.285.16.2101; Antman EM, 2005, CIRCULATION, V111, P2013; Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Babaev A, 2002, CIRCULATION, V106, P364; Becker RC, 1996, J AM COLL CARDIOL, V27, P1321, DOI 10.1016/0735-1097(96)00008-3; Berger PB, 1999, CIRCULATION, V99, P873, DOI 10.1161/01.CIR.99.7.873; Brodie BR, 2003, AM HEART J, V145, P708, DOI 10.1067/mhj.2003.9; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; COX DR, 1972, J R STAT SOC B, V34, P187; Dauerman Harold L, 2003, J Invasive Cardiol, V15, P380; Dauerman HL, 2002, AM J CARDIOL, V90, P838, DOI 10.1016/S0002-9149(02)02704-2; Dauerman HL, 2001, AM J CARDIOL, V87, P844, DOI 10.1016/S0002-9149(00)01524-1; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Dzavik V, 2005, AM HEART J, V149, P1128, DOI 10.1016/j.ahj.2005.03.045; Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; GOLDBERG RJ, 1991, NEW ENGL J MED, V325, P1117, DOI 10.1056/NEJM199110173251601; Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2; Hochman JS, 1999, AM HEART J, V137, P313, DOI 10.1053/hj.1999.v137.95352; Holmes DR, 1997, J AM COLL CARDIOL, V30, P881, DOI 10.1016/S0735-1097(97)00249-0; Holmes DR, 2004, J AM COLL CARDIOL, V43, p274A, DOI 10.1016/S0735-1097(04)91167-9; Lindholm MG, 2003, EUR HEART J, V24, P258, DOI 10.1016/S0195-668X(02)00429-3; Sleeper LA, 2005, J AM COLL CARDIOL, V46, P266, DOI 10.1016/j.jacc.2005.01.061; Sleeper LA, 2000, CIRCULATION, V102, P795; Tedesco JV, 2003, AM HEART J, V146, P472, DOI 10.1016/S0002-8703(03)00308-9; White HD, 2005, CIRCULATION, V112, P1992, DOI 10.1161/CIRCULATIONAHA.105.540948	30	413	441	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2511	2515		10.1001/jama.295.21.2511	http://dx.doi.org/10.1001/jama.295.21.2511			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZQ	16757723	Bronze, Green Accepted			2022-12-28	WOS:000238057300026
J	Buhler, M; Verdel, A; Moazed, D				Buhler, Marc; Verdel, Andre; Moazed, Danesh			Tethering RITS to a nascent transcript initiates RNAi- and heterochromatin-dependent gene silencing	CELL			English	Article							DOUBLE-STRANDED-RNA; H3 LYSINE-9 METHYLATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; HISTONE H3; CHROMOSOME SEGREGATION; EPIGENETIC CONTROL; POLYMERASE-II; INTERFERENCE; MECHANISMS	In the fission yeast Schizosaccharomyces pombe, the RNA-Induced Transcriptional Silencing (RITS) complex has been proposed to target the chromosome via siRNA-dependent base-pairing interactions to initiate heterochromatin formation. Here we show that tethering of the RITS subunit, Tas3, to the RNA transcript of the normally active ura4(+) gene silences ura4(+) expression. This silencing depends on a functional RNAi pathway, requires the heterochromatin proteins, Swi6/HP1, CIr4/Suv39h, and Sir2, and is accompanied by the generation of ura4(+) siRNAs, histone H3-lysine 9 methylation, and Swi6 binding. Furthermore, the ability of the newly generated ura4(+) siRNAs; to silence a second ura4(+) allele in trans is strongly inhibited by the conserved siRNA nuclease, Eri1. Surprisingly, silencing of tethered ura4(+), or ura4(+) inserted within centromeric heterochromatin, or some of the endogenous centromeric repeat promoters, is not associated with changes in RNA polymerase II occupancy. These findings support a model in which targeting of nascent transcripts by RITS mediates chromatin modifications and suggest that cotranscriptional processing events play a primary role in the silencing mechanism.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Verdel, André/M-5201-2013; Buehler, Marc/S-5866-2019; Bühler, Marc/B-1134-2010	Buehler, Marc/0000-0001-6661-9795; Bühler, Marc/0000-0001-6661-9795; VERDEL, Andre/0000-0001-6048-3794				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATERMANN KB, 1989, MOL CELL BIOL, V9, P1526, DOI 10.1128/MCB.9.4.1526; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; KATO H, 2005, SCIENCE; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; MORRIS KV, 2004, SCIENCE; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Partridge JF, 2000, GENE DEV, V14, P783; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	60	299	317	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					873	886		10.1016/j.cell.2006.04.025	http://dx.doi.org/10.1016/j.cell.2006.04.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751098	Bronze			2022-12-28	WOS:000238116400015
J	Denton, MD; Digumarthy, SR; Chua, S; Colvin, RB; Weisberg, AD; Harris, NL; Haupert, GT				Denton, MD; Digumarthy, SR; Chua, S; Colvin, RB; Weisberg, AD; Harris, NL; Haupert, GT			An 84-year-old man with staphylococcal bacteremia and renal failure - Henoch-Schonlein purpura associated with Staphylococcus aureus sepsis. Acute tubular necrosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IGA NEPHROPATHY; SCHOENLEIN PURPURA; NEPHRITIS; GLOMERULONEPHRITIS; INFECTION; SUPERANTIGEN; ENDOCARDITIS; DEPOSITS; RECEPTOR; ADULTS		Derriford Hosp, Renal Unit, Plymouth PL6 8DH, Devon, England; Peninsula Med Sch, Dept Med, Plymouth, Devon, England; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Derriford Hospital; University of Plymouth; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Denton, MD (corresponding author), Derriford Hosp, Renal Unit, Plymouth PL6 8DH, Devon, England.							Algoet C, 2003, PEDIATR NEPHROL, V18, P471, DOI 10.1007/s00467-003-1132-2; Arrizabalaga P, 2003, ANN HEMATOL, V82, P526, DOI 10.1007/s00277-003-0698-x; Borras-Blasco J, 2003, INT J CLIN PHARM TH, V41, P420; Borras-Blasco J, 2003, INT J CLIN PHARM TH, V41, P213; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; Davin JC, 2001, EUR J PEDIATR, V160, P689, DOI 10.1007/s004310100841; DAVISON AM, 1998, OXFORD TXB CLIN NEPH, V1, P667; Garcia-Porrua C, 1999, J RHEUMATOL, V26, P1942; Haddad E, 2003, J AM SOC NEPHROL, V14, P327, DOI 10.1097/01.ASN.0000046961.04917.83; Handa Tomohiro, 2003, Clin Exp Nephrol, V7, P247, DOI 10.1007/s10157-003-0240-4; Hirayama K, 2001, J INTERN MED, V249, P289, DOI 10.1046/j.1365-2796.2001.00815.x; KOYAMA A, 1995, KIDNEY INT, V47, P207, DOI 10.1038/ki.1995.25; Koyama A, 2004, KIDNEY INT, V66, P121, DOI 10.1111/j.1523-1755.2004.00714.x; LOMAXSMITH JD, 1983, AM J PATHOL, V113, P359; Majumdar A, 2000, NEPHROL DIAL TRANSPL, V15, P1782, DOI 10.1093/ndt/15.11.1782; Michail S, 1998, SCAND J RHEUMATOL, V27, P233; MONTOLIU J, 1987, AM J NEPHROL, V7, P137, DOI 10.1159/000167450; Paynter HE, 1998, CLIN NEPHROL, V49, P121; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; SPECTOR DA, 1980, CLIN NEPHROL, V14, P256; Szeto CC, 2001, MODERN PATHOL, V14, P635, DOI 10.1038/modpathol.3880364; Takatani T, 2004, J NEPHROL, V17, P679; Yoh K, 2000, NEPHROL DIAL TRANSPL, V15, P1170, DOI 10.1093/ndt/15.8.1170	23	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2803	2813		10.1056/NEJMcpc069012	http://dx.doi.org/10.1056/NEJMcpc069012			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807418				2022-12-28	WOS:000238584700010
J	Tirichine, L; Imaizumi-Anraku, H; Yoshida, S; Murakami, Y; Madsen, LH; Miwa, H; Nakagawa, T; Sandal, N; Albrektsen, AS; Kawaguchi, M; Downie, A; Sato, S; Tabata, S; Kouchi, H; Parniske, M; Kawasaki, S; Stougaard, J				Tirichine, Leila; Imaizumi-Anraku, Haruko; Yoshida, Satoko; Murakami, Yasuhiro; Madsen, Lene H.; Miwa, Hiroki; Nakagawa, Tomomi; Sandal, Niels; Albrektsen, Anita S.; Kawaguchi, Masayoshi; Downie, Allan; Sato, Shusei; Tabata, Satoshi; Kouchi, Hiroshi; Parniske, Martin; Kawasaki, Shinji; Stougaard, Jens			Deregulation of a Ca2+/calmodulin-dependent kinase leads to spontaneous nodule development	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; LEGUME LOTUS-JAPONICUS; SYMBIOTIC MUTANTS; CALMODULIN; AUTOPHOSPHORYLATION; CALCIUM; ROOT; ABSENCE; DOMAIN; GENE	Induced development of a new plant organ in response to rhizobia is the most prominent manifestation of legume root-nodule symbiosis with nitrogen-fixing bacteria. Here we show that the complex root-nodule organogenic programme can be genetically deregulated to trigger de novo nodule formation in the absence of rhizobia or exogenous rhizobial signals. In an ethylmethane sulphonate-induced snf1 (spontaneous nodule formation) mutant of Lotus japonicus, a single amino-acid replacement in a Ca2+/calmodulin-dependent protein kinase (CCaMK) is sufficient to turn fully differentiated root cortical cells into meristematic founder cells of root nodule primordia. These spontaneous nodules are genuine nodules with an ontogeny similar to that of rhizobial-induced root nodules, corroborating previous physiological studies(1). Using two receptor-deficient genetic backgrounds we provide evidence for a developmentally integrated spontaneous nodulation process that is independent of lipochitin-oligosaccharide signal perception and oscillations in Ca2+ second messenger levels. Our results reveal a key regulatory position of CCaMK upstream of all components required for cell-cycle activation, and a phenotypically divergent series of mutant alleles demonstrates positive and negative regulation of the process.	Aarhus Univ, Dept Mol Biol, Gene Express Lab, DK-8000 Aarhus C, Denmark; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Univ Munich, Dept Biol 1, D-80638 Munich, Germany; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Kazusa DNA Res Inst, Chiba 2920818, Japan	Aarhus University; National Institute of Agrobiological Sciences - Japan; University of Munich; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Tokyo; Kazusa DNA Research Institute	Stougaard, J (corresponding author), Aarhus Univ, Dept Mol Biol, Gene Express Lab, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.	stougaard@mb.au.dk	Yoshida, Satoko/G-5003-2010; Yoshida, Satoko/AAZ-4757-2021; Parniske, Martin/M-3781-2019; Sato, Shusei/A-3616-2015; Downie, Allan/I-3487-2012; yoshida, satoko/AAO-4892-2020; Parniske, Martin/F-2202-2011	Yoshida, Satoko/0000-0002-9999-7861; Parniske, Martin/0000-0001-8561-747X; Sato, Shusei/0000-0002-0293-5366; yoshida, satoko/0000-0002-9999-7861; Parniske, Martin/0000-0001-8561-747X; Stougaard, Jens/0000-0002-9312-2685; Kawaguchi, Masayoshi/0000-0002-1032-6261; Downie, Allan/0000-0003-1011-4960				Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liu ZH, 1998, PLANT MOL BIOL, V38, P889, DOI 10.1023/A:1006019001200; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; PATIL S, 1995, P NATL ACAD SCI USA, V92, P4897, DOI 10.1073/pnas.92.11.4897; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Sathyanarayanan PV, 2000, J BIOL CHEM, V275, P30417, DOI 10.1074/jbc.M000771200; Sathyanarayanan PV, 2002, EUR J BIOCHEM, V269, P2457, DOI 10.1046/j.1432-1033.2002.02904.x; Sathyanarayanan PV, 2001, J BIOL CHEM, V276, P32940, DOI 10.1074/jbc.M009648200; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Senoo K, 2000, PLANT CELL PHYSIOL, V41, P726, DOI 10.1093/pcp/41.6.726; Takezawa D, 1996, J BIOL CHEM, V271, P8126, DOI 10.1074/jbc.271.14.8126; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373	17	320	339	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1153	1156		10.1038/nature04862	http://dx.doi.org/10.1038/nature04862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16810257				2022-12-28	WOS:000238615500051
J	Hutchinson, L				Hutchinson, Linda			Medical education - Challenges of training doctors in the new English NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Off Strateg Hlth Author, London SE1 6LN, England		Hutchinson, L (corresponding author), Off Strateg Hlth Author, London SE1 6LN, England.	linda.hutchinson@osha.nhs.uk						CARVEL J, 2005, GUARDIAN        1105; *DEP HLTH, FUND LEARN DEV HEALT; *DEP HLTH, 2005, COMM PAT LED NHS; *DEP HLTH, POL GUID; Department of Health, 2005, CREAT PAT LED NHS; HALL C, 2005, DAILY TELEGRAPH 0325; *JOINT CONS COMM, 2006, BREAK TRAD FUT ROL U; JONES M, 2005, CARE CRIT ILL, V20, P19; NEWMAN N, 2005, HOSP DOCTOR     0127; *POSTGR MED DENT E, WORK BAS ASS; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; Sastry T, 2005, ED TRAINING MED HLTH; TEMPLETON SK, 2006, SUNDAY TIMES    0312	13	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1502	1504		10.1136/bmj.332.7556.1502	http://dx.doi.org/10.1136/bmj.332.7556.1502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793816	Green Published			2022-12-28	WOS:000238820200023
J	Mosoiu, D; Ryan, KM; Joranson, DE; Garthwaite, JP				Mosoiu, Daniela; Ryan, Karen M.; Joranson, David E.; Garthwaite, Jody P.			Reform of drug control policy for palliative care in Romania	LANCET			English	Article							CANCER PAIN; CURRENT PERSPECTIVES; AIDS; UNDERTREATMENT; MORPHINE; OPIOIDS	Unrelieved pain from cancer and HIV/AIDS is a substantial worldwide public-health problem. Inadequate pain relief is partly due to excessively strict national drug-control policies that constrain medical use of essential medicines such as morphine. Romania's drug-control policies are more than 35 years old and impose an antiquated regulatory system that is based on inpatient post-surgical management of acute pain that restricts prescription authority and makes access to opioid treatment difficult for outpatients with severe chronic pain due to cancer or HIV/AIDS. A Ministry of Health palliative-care commission used WHO guidelines to assess and recommend changes to Romania's national drug control law and regulations. The Romanian parliament has adopted a new law that will simplify prescribing requirements and allow modern pain management. Achievement of adequate pain relief is a vital part of worldwide health and will be dependent on reform of antidrug regulations in many countries.	Univ Wisconsin, Ctr Comprehens Canc, Pain & Policy Studies Grp, Madison, WI 53711 USA; Hospice Casa Sperantei, Brasov 500074, Romania	University of Wisconsin System; University of Wisconsin Madison	Ryan, KM (corresponding author), Univ Wisconsin, Ctr Comprehens Canc, Pain & Policy Studies Grp, Madison, WI 53711 USA.	kmryan2@wisc.edu	Mosoiu, Daniela/AAB-9021-2020; Mosoiu, Daniela/AAR-4779-2021					[Anonymous], 1961, SINGL CONV NARC DRUG; [Anonymous], 2000, ACH BAL NAT OP CONTR; Blengini C, 2003, EUR J CANCER CARE, V12, P28, DOI 10.1046/j.1365-2354.2003.00325.x; BRASSEUR L, 1993, J PAIN SYMPTOM MANAG, V8, P412, DOI 10.1016/0885-3924(93)90066-5; Breitbart W, 2002, ONCOLOGY-NY, V16, P818; Breitbart W, 2002, ONCOLOGY-NY, V16, P964; Breitbart W, 1996, PAIN, V65, P243, DOI 10.1016/0304-3959(95)00217-0; Clark D, 2002, TRANSITIONS END LIFE; *COMM SPEC PAIN TH, 2003, REC MIN HLTH BUCH; *COUNC EUR COMM MI, REC 24 COMM MIN MEMB; Dale A, 2005, PALLIATIVE MED, V19, P177, DOI 10.1191/0269216305pm1012ed; De Conno F, 2005, PALLIATIVE MED, V19, P179, DOI 10.1191/0269216305pm1002oa; Dobrossy L, 2002, LANCET ONCOL, V3, P374, DOI 10.1016/S1470-2045(02)00778-7; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Hanks GW, 2001, BRIT J CANCER, V84, P587, DOI 10.1054/bjoc.2001.1680; *I MED COMM CAR EN, 1997, APPR DEATH IMPR CAR; *INT NARC CONTR BO, 2003, EUR REG GLOB CONS MO; *INT NARC CONTR BO, 1989, REP INT NARC CONTR B; International Narcotics Control Board, 2002, REP INT NARC CONTR B; International Narcotics Control Board, 1996, REP INT NARC CONTR B; International Narcotics Control Board, 2005, REP INT NARC CONTR B; *JOINT UN PROGR HI, 2005, AIDS EP UPD; Krizanova K, 2002, J PAIN SYMPTOM MANAG, V24, P231, DOI 10.1016/S0885-3924(02)00439-6; Larue F, 1997, BRIT MED J, V314, P23, DOI 10.1136/bmj.314.7073.23; LARUE F, 1997, REV PRAT MED GEN, V11, P11; Luczak J, 2002, J PAIN SYMPTOM MANAG, V24, P215, DOI 10.1016/S0885-3924(02)00464-5; Mosoiu D, 2002, J PAIN SYMPTOM MANAG, V24, P225, DOI 10.1016/S0885-3924(02)00446-3; Muszbek K, 2002, J PAIN SYMPTOM MANAG, V24, P188, DOI 10.1016/S0885-3924(02)00457-8; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Seskevicius A, 2002, J PAIN SYMPTOM MANAG, V24, P205, DOI 10.1016/S0885-3924(02)00438-4; SOHN W, 1998, MORPHINVERSCHREIBUNG; STEWART BW, 2003, WHO WORLD CANC REPOR; *UN AIDS PROGR, 2004, EP FACT SHEETS HIV A; *WHO, HIGHL HLTH ROM; *WHO, HIV AIDS PALL CAR; *WHO, ESS MED WHO MOD LIST; *WHO, 1990, WHO TECHN REP SER, V804; WHO, ESS MED; *WHO, 1996, ESS MED; *WHO REG OFF EUR, 2002, ASS AV OP AN PALL CA; World Health Assembly, 2005, CANC PREV CONTR; World Health Organization, 1996, CANC PAIN REL GUID O; ZENZ M, 1993, J PAIN SYMPTOM MANAG, V8, P416, DOI 10.1016/0885-3924(93)90067-6	43	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2110	2117		10.1016/S0140-6736(06)68482-1	http://dx.doi.org/10.1016/S0140-6736(06)68482-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798394				2022-12-28	WOS:000238657400036
J	Smithuis, F; Kyaw, MK; Phe, O; Aye, KZ; Htet, L; Barends, M; Lindegardh, N; Singtoroj, T; Ashley, E; Lwin, S; Stepniewska, K; White, NJ				Smithuis, Frank; Kyaw, Moe Kyaw; Phe, Ohn; Aye, Khin Zarli; Htet, Lhin; Barends, Marion; Lindegardh, Niklas; Singtoroj, Thida; Ashley, Elizabeth; Lwin, Saw; Stepniewska, Kasia; White, Nicholas J.			Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison	LANCET			English	Article							POPULATION PHARMACOKINETICS; UNCOMPLICATED FALCIPARUM; CAMBODIAN CHILDREN; ADULTS; CHLOROQUINE; COMBINATION; INFECTIONS; SAFETY; BORDER	Background Artemisinin-based combinations are judged the best treatments for multidrug-resistant Plasmodium falciparum malaria. Artesunate-mefloquine is widely recommended in southeast Asia, but its high cost and tolerability profile remain obstacles to widespread deployment. To assess whether dihydroartemisinin-piperaquine is a suitable alternative to artesunate-mefloquine, we compared the safety, tolerability, efficacy, and effectiveness of the two regimens for the treatment of uncomplicated falciparum in western Myanmar (Burma). Methods We did an open randomised comparison of 3-day regimens of artesunate-mefloquine (12/25 mg/kg) versus dihydroartemisinin-piperaquine (6.3/50 mg/kg) for the treatment of children aged 1 year or older and in adults with uncomplicated falciparum malaria in Rakhine State, western Myanmar. Within each group, patients were randomly assigned supervised or non-supervised treatment. The primary endpoint was the PCR-confirmed parasitological failure rate by day 42. Failure rates at day 42 were estimated by Kaplan-Meier survival analysis. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN27914471. Findings Of 652 patients enrolled, 327 were assigned dihydroartemisinin-piperaquine (156 supervised and 171 not supervised), and 325 artesunate-mefloquine (162 and 163, respectively). 16 patients were lost to follow-up, and one patient died 22 days after receiving dihydroartemisinin-piperaquine. Recrudescent parasitaemias were confirmed in only two patients; the day 42 failure rate was 0.6% (95% CI 0.2-2.5) for dihydroartemisinin-piperaquine and 0 (0-1.2) for artesunate-mefloquine. Whole-blood piperaquine concentrations at day 7 were similar for patients with observed and non-observed dihydroartemisinin-piperaquine treatment. Gametocytaemia developed more frequently in patients who had received dihydroartemisinin-piperaquine than in those on artesunate-mefloquine: day 7, 18 (10%) of 188 versus five (2%) of 218; relative risk 4.2 (1.6-11.0) p=0.011. Interpretation Dihydroarternisinin-piperaquine is a highly efficacious and inexpensive treatment of multidrug-resistant falciparum malaria and is well tolerated by all age groups. The effectiveness of the unsupervised treatment, as in the usual context of use, equalled its supervised efficacy, indicating good adherence without supervision. Dihydroartemisinin-piperaquine is a good alternative to artesunate-mefloquine.	Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; Med Sans Frontieres Holland, Yangon, Myanmar; Shoklo Malaria Res Unit, Mae Sot, Thailand; Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England; Dept Hlth, Yangon, Myanmar	Mahidol University; Mahidol University; University of Oxford	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	nickw@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Stepniewska, Kasia/0000-0002-1713-6209; Ashley, Elizabeth/0000-0002-7620-4822; smithuis, frank/0000-0002-4704-9915	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING, P1125; Karunajeewa H, 2004, BRIT J CLIN PHARMACO, V57, P93, DOI 10.1046/j.1365-2125.2003.01962.x; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Malm M, 2004, J CHROMATOGR B, V809, P43, DOI 10.1016/j.jchromb.2004.05.032; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; NOSTEN F, 1991, LANCET, V337, P1140, DOI 10.1016/0140-6736(91)92798-7; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; Smithuis F, 2004, TROP MED INT HEALTH, V9, P1184, DOI 10.1111/j.1365-3156.2004.01323.x; Smithuis F, 2004, T ROY SOC TROP MED H, V98, P182, DOI 10.1016/S0035-9203(03)00035-X; Smithuis FM, 1997, T ROY SOC TROP MED H, V91, P468, DOI 10.1016/S0035-9203(97)90288-1; terKuile FO, 1995, B WORLD HEALTH ORGAN, V73, P631; Tin F., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P51; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	23	114	117	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2075	2085		10.1016/S0140-6736(06)68931-9	http://dx.doi.org/10.1016/S0140-6736(06)68931-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798391				2022-12-28	WOS:000238657400033
J	Henrich, J; McElreath, R; Barr, A; Ensminger, J; Barrett, C; Bolyanatz, A; Cardenas, JC; Gurven, M; Gwako, E; Henrich, N; Lesorogol, C; Marlowe, FW; Tracer, D; Ziker, J				Henrich, Joseph; McElreath, Richard; Barr, Abigail; Ensminger, Jean; Barrett, Clark; Bolyanatz, Alexander; Camilo Cardenas, Juan; Gurven, Michael; Gwako, Edwins; Henrich, Natalie; Lesorogol, Carolyn; Marlowe, Frank W.; Tracer, David; Ziker, John			Costly punishment across human societies	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT; ULTIMATUM GAME; NEURAL BASIS; COOPERATION; FAIRNESS; NORMS; PERSPECTIVE; ENFORCEMENT; RECIPROCITY; EVOLUTION	Recent behavioral experiments aimed at understanding the evolutionary foundations of human cooperation have suggested that a willingness to engage in costly punishment, even in one-shot situations, may be part of human psychology and a key element in understanding our sociality. However, because most experiments have been confined to students in industrialized societies, generalizations of these insights to the species have necessarily been tentative. Here, experimental results from 15 diverse populations show that (i) all populations demonstrate some willingness to administer costly punishment as unequal behavior increases, (ii) the magnitude of this punishment varies substantially across populations, and (iii) costly punishment positively covaries with altruistic behavior across populations. These findings are consistent with models of the gene-culture coevolution of human altruism and further sharpen what any theory of human cooperation needs to explain.	Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; Univ Calif Davis, Dept Anthropol, Grad Grp Ecol, Anim Behav Grad Grp,Populat Biol Grad Grp, Davis, CA 95616 USA; Univ Oxford, Dept Econ, GPRG, Oxford OX1 3UQ, England; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; Coll DuPage, Dept Anthropol, Glen Ellyn, IL 60137 USA; Univ Los Andes, CEDE, Fac Econ, Bogota, Colombia; Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; Guilford Coll, Dept Sociol & Anthropol, Greensboro, NC 27410 USA; Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Univ Colorado, Dept Anthropol, Denver, CO 80217 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80217 USA; Boise State Univ, Dept Anthropol, Boise, ID 83725 USA	Emory University; University of California System; University of California Davis; University of Oxford; California Institute of Technology; University of California System; University of California Los Angeles; Universidad de los Andes (Colombia); University of California System; University of California Santa Barbara; Washington University (WUSTL); Harvard University; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Idaho; Boise State University	Henrich, J (corresponding author), Emory Univ, Dept Anthropol, 1557 Dickey Dr, Atlanta, GA 30322 USA.	jhenric@emory.edu	Marlowe, Frank/G-9752-2012; Ziker, John/H-4395-2019; cardenas, juan-camilo/B-4658-2009; Barrett, H Clark/AAE-2086-2019	cardenas, juan-camilo/0000-0003-0005-7595; Barrett, H Clark/0000-0002-4157-6511; McElreath, Richard/0000-0002-0387-5377; Ziker, John/0000-0001-9059-5594; Gurven, Michael/0000-0002-5661-527X	Economic and Social Research Council [M571255001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Andreoni J, 2003, AM ECON REV, V93, P672, DOI 10.1257/000282803322157034; Bahry DL, 2006, J ECON BEHAV ORGAN, V60, P37, DOI 10.1016/j.jebo.2004.07.005; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Camerer C., 2004, FDN HUMAN SOCIALITY, P55, DOI DOI 10.1093/0199262055.003.0003; Camerer C., 2004, FDN HUMAN SOCIALITY, P194, DOI DOI 10.1093/0199262055.003.0007; CARTER JR, 1991, J ECON PERSPECT, V5, P171, DOI 10.1257/jep.5.2.171; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gachter S, 2005, BEHAV BRAIN SCI, V28, P822, DOI 10.1017/S0140525X05290143; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Huck S, 1999, J ECON PSYCHOL, V20, P183, DOI 10.1016/S0167-4870(99)00004-5; Marlowe F. W., 2004, FDN HUMAN SOCIALITY, P168, DOI DOI 10.1093/0199262055.003.0006; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Price ME, 2002, EVOL HUM BEHAV, V23, P203, DOI 10.1016/S1090-5138(01)00093-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; SUTTER M, 2005, TRUST RECIPROCITY DI; Tracer D., 2004, FDN HUMAN SOCIALITY, P232, DOI DOI 10.1093/0199262055.003.0008; Tracer DP, 2003, CURR ANTHROPOL, V44, P432, DOI 10.1086/374904	34	906	918	11	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1767	1770		10.1126/science.1127333	http://dx.doi.org/10.1126/science.1127333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055LS	16794075				2022-12-28	WOS:000238452800049
J	Bleul, CC; Corbeaux, T; Reuter, A; Fisch, P; Monting, JS; Boehm, T				Bleul, Conrad C.; Corbeaux, Tatiana; Reuter, Alexander; Fisch, Paul; Moenting, Juergen Schulte; Boehm, Thomas			Formation of a functional thymus initiated by a postnatal epithelial progenitor cell	NATURE			English	Article							MOUSE; GENE; DIFFERENTIATION; MICROENVIRONMENT; EXPRESSION; PHENOTYPE; PROTEIN; STRAIN	The thymus is essential for the generation of self-tolerant effector and regulatory T cells. Intrathymic T-cell development requires an intact stromal microenvironment, of which thymic epithelial cells (TECs) constitute a major part(1-3). For instance, cell-autonomous genetic defects of forkhead box N1 (Foxn1)(4) and autoimmune regulator (Aire)(5) in thymic epithelial cells cause primary immunodeficiency and autoimmunity, respectively. During development, the thymic epithelial rudiment gives rise to two major compartments, the cortex and medulla. Cortical TECs positively select T cells(6), whereas medullary TECs are involved in negative selection of potentially autoreactive T cells(7). It has long been unclear whether these two morphologically and functionally distinct types of epithelial cells arise from a common bi-potent progenitor cell(8) and whether such progenitors are still present in the postnatal period. Here, using in vivo cell lineage analysis in mice, we demonstrate the presence of a common progenitor of cortical and medullary TECs after birth. To probe the function of postnatal progenitors, a conditional mutant allele of Foxn1 was reverted to wild-type function in single epithelial cells in vivo. This led to the formation of small thymic lobules containing both cortical and medullary areas that supported normal thymopoiesis. Thus, single epithelial progenitor cells can give rise to a complete and functional thymic microenvironment, suggesting that cell-based therapies could be developed for thymus disorders.	Max Planck Inst Immunobiol, Dept Dev Immunol, D-79108 Freiburg, Germany; Univ Freiburg, Dept Pathol, D-79110 Freiburg, Germany; Univ Freiburg, Inst Med Biometry & Informat, D-79104 Freiburg, Germany	Max Planck Society; University of Freiburg; University of Freiburg	Boehm, T (corresponding author), Max Planck Inst Immunobiol, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de						Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2002, TRENDS IMMUNOL, V23, P391, DOI 10.1016/S1471-4906(02)02265-2; Boehm T, 2003, IMMUNOL REV, V195, P15, DOI 10.1034/j.1600-065X.2003.00070.x; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Hogquist K A, 1996, Semin Immunol, V8, P63, DOI 10.1006/smim.1996.0009; Huth M, 1997, IMMUNOGENETICS, V45, P282, DOI 10.1007/s002510050206; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, CURR BIOL, V4, P983, DOI 10.1016/S0960-9822(00)00222-0; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NEHLS M, 1994, BIOTECHNIQUES, V17, P770; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563	29	283	286	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					992	996		10.1038/nature04850	http://dx.doi.org/10.1038/nature04850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791198				2022-12-28	WOS:000238422300045
J	Gollob, MH; Jones, DL; Krahn, AD; Danis, L; Gong, XQ; Shao, Q; Liu, XQ; Veinot, JP; Tang, ASL; Stewart, AFR; Tesson, F; Klein, GJ; Yee, R; Skanes, AC; Guiraudon, GM; Ebihara, L; Bai, D				Gollob, Michael H.; Jones, Douglas L.; Krahn, Andrew D.; Danis, Lynne; Gong, Xiang-Qun; Shao, Qing; Liu, Xiaoqin; Veinot, John P.; Tang, Anthony S. L.; Stewart, Alexandre F. R.; Tesson, Frederique; Klein, George J.; Yee, Raymond; Skanes, Allan C.; Guiraudon, Gerard M.; Ebihara, Lisa; Bai, Donglin			Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MARIE-TOOTH NEUROPATHY; GAP JUNCTION CHANNELS; PROLINE RESIDUE; RISK-FACTOR; IDENTIFICATION; CONDUCTION; DISEASE; VULNERABILITY; EXPRESSION; CATARACT	Background: Atrial fibrillation is the most common type of cardiac arrhythmia and a leading cause of cardiovascular morbidity, particularly stroke. The cardiac gap-junction protein connexin 40 is expressed selectively in atrial myocytes and mediates the coordinated electrical activation of the atria. We hypothesized that idiopathic atrial fibrillation has a genetic basis and that tissue-specific mutations in GJA5, the gene encoding connexin 40, may predispose the atria to fibrillation. Methods: We sequenced GJA5 from genomic DNA isolated from resected cardiac tissue and peripheral lymphocytes from 15 patients with idiopathic atrial fibrillation. Identified GJA5 mutations were transfected into a gap-junction-deficient cell line to assess their functional effects on protein transport and intercellular electrical coupling. Results: Four novel heterozygous missense mutations were identified in 4 of the 15 patients. In three patients, the mutations were found in the cardiac-tissue specimens but not in the lymphocytes, indicating a somatic source of the genetic defects. In the fourth patient, the sequence variant was detected in both cardiac tissue and lymphocytes, suggesting a germ-line origin. Analysis of the expression of mutant proteins revealed impaired intracellular transport or reduced intercellular electrical coupling. Conclusions: Mutations in GJA5 may predispose patients to idiopathic atrial fibrillation by impairing gap-junction assembly or electrical coupling. Our data suggest that common diseases traditionally considered to be idiopathic may have a genetic basis, with mutations confined to the diseased tissue.	Univ Ottawa, Inst Heart, Arrhythmia Res Lab, Dept Med, Ottawa, ON K1Y 4W7, Canada; Univ Western Ontario, Dept Med, London, ON, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, N Chicago, IL USA	University of Ottawa; University of Ottawa Heart Institute; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Rosalind Franklin University Medical & Science	Gollob, MH (corresponding author), Univ Ottawa, Inst Heart, Arrhythmia Res Lab, Dept Med, Rm H350,40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	mgollob@ottawaheart.ca	Skanes, Allan/G-3347-2011; Guiraudon, Gerard M/B-7811-2015; Klein, George/G-3313-2011; Bai, Donglin/ABB-9924-2021; Yee, Raymond/H-1323-2011; Stewart, Alexandre F.R./A-5677-2011; Tang, Anthony S/E-6203-2014; Jones, Douglas Lloyd/M-7806-2015; Tesson, Frederique/A-3218-2013; Bai, Donglin/A-5799-2008	Guiraudon, Gerard M/0000-0002-7418-2500; Bai, Donglin/0000-0003-1112-6947; Jones, Douglas Lloyd/0000-0002-5577-0091; Bai, Donglin/0000-0003-1112-6947; Gollob, Michael/0000-0003-0242-5208; Stewart, Alexandre/0000-0003-2673-9164				Barnes TM, 1997, J NEUROCHEM, V69, P2251; Bayazit YA, 2003, INT J PEDIATR OTORHI, V67, P1331, DOI 10.1016/j.ijporl.2003.08.003; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bort S, 1997, HUM GENET, V99, P746, DOI 10.1007/s004390050442; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; COX JL, 1991, J THORAC CARDIOV SUR, V101, P406, DOI 10.1016/s0022-5223(19)36723-6; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Ellinor PT, 2003, CIRCULATION, V107, P2880, DOI 10.1161/01.CIR.0000077910.80718.49; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Firouzi M, 2004, CIRC RES, V95, P29, DOI 10.1161/01.RES.0000141134.64811.0a; Fritz S, 2002, J CLIN ENDOCR METAB, V87, P1362, DOI 10.1210/jc.87.3.1362; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Hagendorff A, 1999, CIRCULATION, V99, P1508, DOI 10.1161/01.CIR.99.11.1508; Janssen EAM, 1997, HUM GENET, V99, P501, DOI 10.1007/s004390050396; Kanno S, 2001, CARDIOVASC PATHOL, V10, P169, DOI 10.1016/S1054-8807(01)00078-3; KONINGS KTS, 1994, CIRCULATION, V89, P1665, DOI 10.1161/01.CIR.89.4.1665; Krutovskikh V, 2000, MUTAT RES-REV MUTAT, V462, P197, DOI 10.1016/S1383-5742(00)00037-5; Kuntzer T, 2003, J NEUROL SCI, V207, P77, DOI 10.1016/S0022-510X(02)00394-5; Lerman BB, 1998, J CLIN INVEST, V101, P2862, DOI 10.1172/JCI1582; Nelis E, 1997, HUM MUTAT, V9, P47, DOI 10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.3.CO;2-N; Pal JD, 1999, AM J PHYSIOL-CELL PH, V276, pC1443, DOI 10.1152/ajpcell.1999.276.6.C1443; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Puck JM, 2004, NEW ENGL J MED, V351, P1388, DOI 10.1056/NEJMp048116; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Valiunas V, 2001, AM J PHYSIOL-HEART C, V281, pH1675, DOI 10.1152/ajpheart.2001.281.4.H1675; Waldo, 1996, ATRIAL FLUTTER, P248; Wattigney WA, 2003, CIRCULATION, V108, P711, DOI 10.1161/01.CIR.0000083722.42033.0A; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	35	381	408	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2677	2688		10.1056/NEJMoa052800	http://dx.doi.org/10.1056/NEJMoa052800			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790700				2022-12-28	WOS:000238416900006
J	Salpeter, SR; Buckley, NS; Ormiston, TM; Salpeter, EE				Salpeter, Shelley R.; Buckley, Nicholas S.; Ormiston, Thomas M.; Salpeter, Edwin E.			Meta-analysis: Effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths	ANNALS OF INTERNAL MEDICINE			English	Review							FORMOTEROL DRY POWDER; QUALITY-OF-LIFE; METERED-DOSE INHALER; NEAR-FATAL ASTHMA; PERSISTENT ASTHMA; DOUBLE-BLIND; SALMETEROL XINAFOATE; TERM TREATMENT; BRONCHIAL RESPONSIVENESS; IPRATROPIUM BROMIDE	Background: Long-acting beta-agonists may increase the risk for fatal and nonfatal asthma exacerbations. Purpose: To assess the risk for severe, life-threatening, or fatal asthma exacerbations associated with long-acting beta-agonists. Data Sources: English- and non-English-language searches of MEDLINE, EMBASE, and Cochrane databases; the U.S. Food and Drug Administration Web site; and references of selected reviews through December 2005. Study Selection: Randomized, placebo-controlled trials that lasted at least 3 months and evaluated long-acting P-agonist use in patients with asthma. All trials allowed the use of as-needed short-acting beta-agonists. Data Extraction: outcomes measured were Peto odds ratio (OR) and risk difference of severe exacerbations requiring hospitalization, life-threatening exacerbations requiring intubation and ventilation, and asthma-related deaths. The OR for asthma-related deaths was obtained from the Salmeterol Multi-center Asthma Research Trial (SMART). Data Synthesis: Pooled results from 19 trials with 33 826 participants found that long-acting beta-agonists increased exacerbations requiring hospitalization (OR, 2.6 [95% Cl, 1.6 to 4.3]) and life-threatening exacerbations (OR, 1.8 [Cl, 1.1 to 2.9]) compared with placebo. Hospitalizations were statistically significantly increased with salmeterol (OR, 1.7 [Cl, 1.1 to 2.7]) and formoterol (OR, 3.2 [Cl, 1.7 to 6.0]) and in children (OR, 3.9 [Cl, 1.7 to 8.8]) and adults (OR, 2.0 [Cl, 1.1 to 3.9]). The absolute increase in hospitalization was 0.7% (Cl, 0.1% to 1.3%) over 6 months. The risk for asthma-related deaths was increased (OR, 3.5 [Cl, 1.3 to 9.3]), with a pooled risk difference of 0.07% (Cl, 0.01% to 0.1%). Limitations: The small number of deaths limited the reliability in assessing this risk, and 28 studies did not report information on the outcomes of interest. Conclusions: Long-acting beta-agonists have been shown to increase severe and life-threatening asthma exacerbations, as well as asthma-related deaths.	Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; Cornell Univ, Ithaca, NY USA	Santa Clara Valley Medical Center; Cornell University	Salpeter, SR (corresponding author), Santa Clara Valley Med Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	Salpeter@stanford.edu						Adams N, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002310.pub3; ALDREY OE, 1995, J ASTHMA, V32, P21, DOI 10.3109/02770909509089496; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Anis AH, 2001, CAN MED ASSOC J, V164, P625; Arledge TE, 1996, J ALLERGY CLIN IMMUN, V98, P1116, DOI 10.1016/S0091-6749(96)80200-4; BEASLEY R, 1995, INT ARCH ALLERGY IMM, V107, P325, DOI 10.1159/000237016; Bensch G, 2002, ANN ALLERG ASTHMA IM, V89, P180, DOI 10.1016/S1081-1206(10)61935-7; Bensch G, 2001, ANN ALLERG ASTHMA IM, V86, P19, DOI 10.1016/S1081-1206(10)62351-4; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; Bijl-Hofland ID, 2001, AM J RESP CRIT CARE, V164, P764, DOI 10.1164/ajrccm.164.5.9910103; BOYD G, 1995, EUR RESPIR J, V8, P1494; Busse W, 2004, CLIN THER, V26, P1587, DOI 10.1016/j.clinthera.2004.10.004; Busse WW, 1998, AM J MANAG CARE, V4, P1579; *CENTR INT AG, 2005, WORLD FACTB; CHERVINSKY P, 1977, J ALLERGY CLIN IMMUN, V59, P22, DOI 10.1016/0091-6749(77)90172-5; CLARKE PS, 1982, ANN ALLERGY, V48, P180; Cloosterman SGM, 2001, CHEST, V119, P1306, DOI 10.1378/chest.119.5.1306; Creticos PS, 1999, INT ARCH ALLERGY IMM, V118, P345, DOI 10.1159/000024129; CROMPTON GK, 1975, BRIT MED J, V4, P458, DOI 10.1136/bmj.4.5994.458; Cunningham S.J., 1997, EMERG PEDIAT, V10, P33; D'Urzo AD, 2001, CHEST, V119, P714, DOI 10.1378/chest.119.3.714; DALONZO GE, 1994, JAMA-J AM MED ASSOC, V271, P1412, DOI 10.1001/jama.271.18.1412; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; DODDS WN, 1975, BRIT MED J, V4, P345, DOI 10.1136/bmj.4.5992.345-b; Eisner MD, 2001, EUR RESPIR J, V17, P233, DOI 10.1183/09031936.01.17202330; Ekstrom T, 1998, RESP MED, V92, P1040, DOI 10.1016/S0954-6111(98)90352-3; Ekstrom T, 1998, ANN ALLERG ASTHMA IM, V81, P225, DOI 10.1016/S1081-1206(10)62816-5; ERNST P, 1992, JAMA-J AM MED ASSOC, V268, P3462, DOI 10.1001/jama.268.24.3462; FAHY JV, 1995, CLIN CHEST MED, V16, P715; FitzGerald JM, 1999, J ALLERGY CLIN IMMUN, V103, P427, DOI 10.1016/S0091-6749(99)70467-7; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Hancox RJ, 1999, EUR RESPIR J, V14, P283, DOI 10.1034/j.1399-3003.1999.14b08.x; Hancox RJ, 1999, THORAX, V54, P482, DOI 10.1136/thx.54.6.482; Hussey PS, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.3.89; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kalra S, 1996, CHEST, V109, P953, DOI 10.1378/chest.109.4.953; Kavuru M, 2000, J ALLERGY CLIN IMMUN, V105, P1108, DOI 10.1067/mai.2000.105711; KELMAN GR, 1969, NATURE, V221, P1251, DOI 10.1038/2211251a0; Kemp JP, 1999, J ALLERGY CLIN IMMUN, V104, P1189, DOI 10.1016/S0091-6749(99)70012-6; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; Kips JC, 2001, AM J RESP CRIT CARE, V164, P923, DOI 10.1164/ajrccm.164.6.2010107; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; LaForce C, 2005, J ASTHMA, V42, P101, DOI 10.1081/JAS-51334; Lanes SF, 2002, THORAX, V57, P683, DOI 10.1136/thorax.57.8.683; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Levy Robyn, 2005, Pediatric Asthma Allergy & Immunology, V18, P25, DOI 10.1089/pai.2005.18.25; Li X, 1999, AM J RESP CRIT CARE, V160, P1493, DOI 10.1164/ajrccm.160.5.9811052; LIPWORTH BJ, 1992, DRUG SAFETY, V7, P54, DOI 10.2165/00002018-199207010-00007; Lockey RF, 1999, CHEST, V115, P666, DOI 10.1378/chest.115.3.666; MANTEL N, 1959, J NATL CANCER I, V22, P719; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; MEIJER GG, 1995, AM J RESP CRIT CARE, V152, P1887, DOI 10.1164/ajrccm.152.6.8520751; *NAT HEART LUNG BL, 2005, PROGR DESCR; Nathan RA, 1999, ANN ALLERG ASTHMA IM, V82, P521, DOI 10.1016/S1081-1206(10)63159-6; NATHAN RA, 1995, ANN ALLERG ASTHMA IM, V75, P243; National Heart Lung and Blood Institute, 1997, GUID DIAGN MAN ASTHM; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; NEWCOMB R, 1985, AM REV RESPIR DIS, V132, P12; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; OConnor BJ, 1996, AM J RESP CRIT CARE, V154, P876, DOI 10.1164/ajrccm.154.4.8887578; Orsida BE, 2001, AM J RESP CRIT CARE, V164, P117, DOI 10.1164/ajrccm.164.1.2006003; Price D, 2002, THORAX, V57, P791, DOI 10.1136/thorax.57.9.791; Ramsey SD, 2000, CHEST, V117, P33; Rodrigo GJ, 2005, THORAX, V60, P740, DOI 10.1136/thx.2005.040444; Rosenthal RR, 1999, CHEST, V116, P595, DOI 10.1378/chest.116.3.595; RUSSELL G, 1995, ANN ALLERG ASTHMA IM, V75, P423; Salpeter SR, 2004, ANN INTERN MED, V140, P802, DOI 10.7326/0003-4819-140-10-200405180-00010; SALPETER SR, 2006, UNPUB J GEN INT MED; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; Shapiro G, 2000, AM J RESP CRIT CARE, V161, P527, DOI 10.1164/ajrccm.161.2.9905091; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STEFFENSEN I, 1995, ALLERGY, V50, P657, DOI 10.1111/j.1398-9995.1995.tb02582.x; SUISSA S, 1994, EUR RESPIR J, V7, P1602, DOI 10.1183/09031936.94.07091602; Tashkin DP, 2005, CURR OPIN PULM MED, V11, P121, DOI 10.1097/00063198-200503000-00004; Taylor DR, 1996, MED CLIN N AM, V80, P719, DOI 10.1016/S0025-7125(05)70465-X; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; Taylor DR, 2000, THORAX, V55, P595, DOI 10.1136/thorax.55.7.595; Terzano C, 2004, Eur Rev Med Pharmacol Sci, V8, P259; *US FOOD DRUG ADM, 2001, SLD390 US FOOD DRUG; *US FOOD DRUG ADM, 020831 NDA US FOOD D; *US FOOD DRUG ADM, 2001, FOR FORM FUM INH A 5; *US FOOD DRUG ADM, 2005, SER ADV FO WITHD CON; *US FOOD DRUG ADM, FOR FORM FUM INH A 4; *US FOOD DRUG ADM, 2001, SERV SALM XIN INH 2; van Schayck CP, 2002, EUR RESPIR J, V19, P240, DOI 10.1183/09031936.02.00203602; van Schayck CP, 2002, RESP MED, V96, P155, DOI 10.1053/rmed.2001.1243; vanderMolen T, 1997, THORAX, V52, P535, DOI 10.1136/thx.52.6.535; VANESSENZANDVLIET EE, 1992, AM REV RESPIR DIS, V146, P547, DOI 10.1164/ajrccm/146.3.547; VANSCHAYCK CP, 1990, J ALLERGY CLIN IMMUN, V86, P793, DOI 10.1016/S0091-6749(05)80185-X; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; von Berg A, 2003, INT J CLIN PRACT, V57, P852; von Berg A, 1998, RESP MED, V92, P292, DOI 10.1016/S0954-6111(98)90112-3; WAHEDNA I, 1993, AM REV RESPIR DIS, V148, P707, DOI 10.1164/ajrccm/148.3.707; Weinstein SF, 1998, ANN ALLERG ASTHMA IM, V81, P51, DOI 10.1016/S1081-1206(10)63109-2; Westby M, 2004, Cochrane Database Syst Rev, pCD003269; Wilding P, 1997, BRIT MED J, V314, P1441, DOI 10.1136/bmj.314.7092.1441; Zimmerman B, 2004, PEDIATR PULM, V37, P122, DOI 10.1002/ppul.10404; 2004, PATTERNS MED USE US	102	375	389	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					904	912		10.7326/0003-4819-144-12-200606200-00126	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00126			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16754916				2022-12-28	WOS:000238555500005
J	Collier, J				Collier, J			First person - The price of independence	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Georges Hosp & Med Sch, London SW17 0RE, England	St Georges University London	Collier, J (corresponding author), St Georges Hosp & Med Sch, London SW17 0RE, England.	jcollier@sgul.ac.uk						BOSELEY S, 2005, GUARDIAN        1006; Chatham House, CHATH HOUS RUL; *COMM STAND PUBL L, 1996, 1 COMM STAND PUBL LI; *EUR MED AG, EMERA PROC HANDL CON; Wise MEJ, 2006, BRIT MED J, V332, P500, DOI 10.1136/bmj.332.7540.500; 1969, DRUG THERAPEUTICS B, V7, P99	6	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 17	2006	332	7555					1447	1449		10.1136/bmj.332.7555.1447	http://dx.doi.org/10.1136/bmj.332.7555.1447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16777892	Green Published			2022-12-28	WOS:000238550800038
J	Kumar, KR; Li, LN; Yan, M; Bhaskarabhatla, M; Mobley, AB; Nguyen, C; Mooney, JM; Schatzle, JD; Wakeland, EK; Mohan, C				Kumar, Kirthi Raman; Li, Liunan; Yan, Mei; Bhaskarabhatla, Madhavi; Mobley, Angela B.; Nguyen, Charles; Mooney, Jill M.; Schatzle, John D.; Wakeland, Edward K.; Mohan, Chandra			Regulation of B cell tolerance by the lupus susceptibility gene Ly108	SCIENCE			English	Article							REACTIVE LYMPHOCYTES-B; SLE PATHOGENESIS; SELF-ANTIGEN; ERYTHEMATOSUS; DISSECTION; ELIMINATION; EXPRESSION; CLUSTER; MICE	The susceptibility locus for the autoimmune disease lupus on murine chromosome 1, Sle1(z)/Sle1b(z), and the orthologous human locus are associated with production of autoantibody to chromatin. We report that the presence of Sle1(z)/Sle1b(z) impairs B cell anergy, receptor revision, and deletion. Members of the SLAM costimulatory molecule family constitute prime candidates for Sle1b(z), among which the Ly108.1 isoform of the Ly108 gene was most highly expressed in immature B cells from lupus-prone B6. Sle1(z) mice. The normal Ly108.2 allele, but not the lupus-associated Ly108.1 allele, was found to sensitize immature B cells to deletion and RAG reexpression. As a potential regulator of tolerance checkpoints, Ly108 may censor self-reactive B cells, hence safeguarding against autoimmunity.	Univ Texas, SW Med Ctr, Dept Internal Med Rheumatol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mohan, C (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med Rheumatol, Dallas, TX 75390 USA.	chandra.mohan@utsouthwestern.edu	Mohan, Chandra/GPX-8233-2022; yan, mei/AAA-1379-2022		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044894] Funding Source: NIH RePORTER; NIAID NIH HHS [AI54902] Funding Source: Medline; NIAMS NIH HHS [NIH RO1 AR44894] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HOLMAN HR, 1957, SCIENCE, V126, P162, DOI 10.1126/science.126.3265.162; Kono D H, 2000, Int Rev Immunol, V19, P367, DOI 10.3109/08830180009055504; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Mohan C, 1998, J CLIN INVEST, V101, P1362; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Raman K, 2003, CURR OPIN IMMUNOL, V15, P651, DOI 10.1016/j.coi.2003.09.007; RATHMELL JC, 1994, J IMMUNOL, V153, P2831; Rubio CF, 1996, J IMMUNOL, V157, P65; Sobel ES, 1999, J IMMUNOL, V162, P2415; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Tze LE, 2003, J IMMUNOL, V171, P678, DOI 10.4049/jimmunol.171.2.678; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	22	191	199	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1665	1669		10.1126/science.1125893	http://dx.doi.org/10.1126/science.1125893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778059				2022-12-28	WOS:000238288600050
J	Mervis, J				Mervis, J			Environmental science - Climate sensors dropped from US weather satellite package	SCIENCE			English	News Item																			0	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1580	1580		10.1126/science.312.5780.1580	http://dx.doi.org/10.1126/science.312.5780.1580			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778025				2022-12-28	WOS:000238288600002
J	Zhang, XW; Gureasko, J; Shen, K; Cole, PA; Kuriyan, J				Zhang, Xuewu; Gureasko, Jodi; Shen, Kui; Cole, Philip A.; Kuriyan, John			An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor	CELL			English	Article							PROTEIN-TYROSINE KINASE; CRYSTAL-STRUCTURE; EGF RECEPTOR; LUNG CANCERS; GENE-MUTATIONS; GEFITINIB; INHIBITOR; COMPLEX; PHOSPHORYLATION; DIMERIZATION	The mechanism by which the epidermal growth factor receptor (EGFR) is activated upon dimerization has eluded definition. We find that the EGFR kinase domain can be activated by increasing its local concentration or by mutating a leucine (L834R) in the activation loop, the phosphorylation of which is not required for activation. This suggests that the kinase domain is intrinsically autoinhibited, and an intermolecular interaction promotes its activation. Using further mutational analysis and crystallography we demonstrate that the autoinhibited conformation of the EGFR kinase domain resembles that of Src and cyclin-dependent kinases (CDKs). EGFR activation results from the formation of an asymmetric dimer in which the C-terminal lobe of one kinase domain plays a role analogous to that of cyclin in activated CDK/cyclin complexes. The CDK/cyclin-like complex formed by two kinase domains thus explains the activation of EGFR.-family receptors by homo- or heterodimerization.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Johns Hopkins University	Zhang, XW (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu			NCI NIH HHS [R01 CA96504, R01 CA74305] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074305, R01CA096504] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bishayee A, 1999, MOL BIOL CELL, V10, P525, DOI 10.1091/mbc.10.3.525; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; CHANG CM, 1995, J VIROL, V69, P1172, DOI 10.1128/JVI.69.2.1172-1180.1995; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dorn IT, 1998, J AM CHEM SOC, V120, P2753, DOI 10.1021/ja9735620; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Groenen LC, 1997, BIOCHEMISTRY-US, V36, P3826, DOI 10.1021/bi9614141; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shrout AL, 2003, BIOCHEMISTRY-US, V42, P13379, DOI 10.1021/bi0352769; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WEDEGAERTNER PB, 1989, J BIOL CHEM, V264, P11346; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	41	1112	1151	7	134	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1137	1149		10.1016/j.cell.2006.05.013	http://dx.doi.org/10.1016/j.cell.2006.05.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777603	Bronze			2022-12-28	WOS:000238602700018
J	Noubissi, FK; Elcheva, I; Bhatia, N; Shakoori, A; Ougolkov, A; Liu, JH; Minamoto, T; Ross, J; Fuchs, SY; Spiegelman, VS				Noubissi, Felicite K.; Elcheva, Irina; Bhatia, Neehar; Shakoori, Abbas; Ougolkov, Andrei; Liu, Jianghuai; Minamoto, Toshinari; Ross, Jeff; Fuchs, Serge Y.; Spiegelman, Vladimir S.			CRD-BP mediates stabilization of beta TrCP1 and c-myc mRNA in response to beta-catenin signalling	NATURE			English	Article							UBIQUITIN LIGASE RECEPTOR; NF-KAPPA-B; BINDING-PROTEIN; CODING REGION; IN-VITRO; EXPRESSION; CANCER; TARGET; TRCP; DETERMINANT	Although constitutive activation of beta-catenin/Tcf signalling is implicated in the development of human cancers(1), the mechanisms by which the beta-catenin/Tcf pathway promotes tumorigenesis are incompletely understood. Messenger RNA turnover has a major function in regulating gene expression and is responsive to developmental and environmental signals. mRNA decay rates are dictated by cis-acting elements within the mRNA and by trans-acting factors, such as RNA-binding proteins ( reviewed in refs 2, 3). Here we show that beta-catenin stabilizes the mRNA encoding the F-box protein beta TrCP1, and identify the RNA-binding protein CRD-BP ( coding region determinant-binding protein) as a previously unknown target of beta-catenin/Tcf transcription factor. CRD-BP binds to the coding region of bTrCP1 mRNA. Overexpression of CRD-BP stabilizes bTrCP1 mRNA and elevates beta TrCP1 levels ( both in cells and in vivo), resulting in the activation of the Skp1-Cullin1-F-box protein (SCF) beta TrCP E3 ubiquitin ligase and in accelerated turnover of its substrates including I kappa B and beta-catenin. CRD-BP is essential for the induction of both beta TrCP1 and c-Myc by beta-catenin signalling in colorectal cancer cells. High levels of CRD-BP that are found in primary human colorectal tumours exhibiting active beta-catenin/Tcf signalling implicates CRD-BP induction in the upregulation of beta TrCP1, in the activation of dimeric transcription factor NF-kappa B and in the suppression of apoptosis in these cancers.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA; Kanazawa Univ, Div Translat & Clin Oncol, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Kanazawa University; University of Pennsylvania; University of Wisconsin System; University of Wisconsin Madison	Spiegelman, VS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA.	spiegelman@dermatology.wisc.edu	Ugolkov, Andrey/T-3012-2019	Spiegelman, Vladimir S/0000-0003-4847-155X; shakoori, abbas/0000-0002-4363-1967; Liu, Jianghuai/0000-0002-2382-9140				Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ioannidis P, 2004, CANCER LETT, V209, P245, DOI 10.1016/j.canlet.2003.12.015; Ioannidis P, 2003, ANTICANCER RES, V23, P2179; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Ioannidis P, 2001, INT J CANCER, V94, P480, DOI 10.1002/ijc.1512; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Ross J, 1999, METH MOL B, V118, P459; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	28	172	176	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					898	901		10.1038/nature04839	http://dx.doi.org/10.1038/nature04839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778892				2022-12-28	WOS:000238254100048
J	Talpaz, M; Shah, NP; Kantarjian, H; Donato, N; Nicoll, J; Paquette, R; Cortes, J; O'Brien, S; Nicaise, C; Bleickardt, E; Blackwood-Chirchir, MA; Iyer, V; Chen, TT; Huang, F; Decillis, AP; Sawyers, CL				Talpaz, Moshe; Shah, Neil P.; Kantarjian, Hagop; Donato, Nicholas; Nicoll, John; Paquette, Ron; Cortes, Jorge; O'Brien, Susan; Nicaise, Claude; Bleickardt, Eric; Blackwood-Chirchir, M. Anne; Iyer, Vishwanath; Chen, Tai-Tsang; Huang, Fei; Decillis, Arthur P.; Sawyers, Charles L.			Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; ABL KINASE; CHRONIC-PHASE; ACQUIRED-RESISTANCE; TYROSINE KINASE; CYTOGENETIC RESPONSES; INHIBITOR; GENE; BMS-354825	BACKGROUND: The BCR-ABL tyrosine kinase inhibitor imatinib is effective in Philadelphia chromosome-positive (Ph-positive) leukemias, but relapse occurs, mainly as a result of the outgrowth of leukemic subclones with imatinib-resistant BCR-ABL mutations. We evaluated dasatinib, a BCR-ABL inhibitor that targets most imatinib-resistant BCR-ABL mutations, in patients with chronic myelogenous leukemia (CML) or Ph-positive acute lymphoblastic leukemia (ALL). METHODS: Patients with various phases of CML or with Ph-positive ALL who could not tolerate or were resistant to imatinib were enrolled in a phase 1 dose-escalation study. Dasatinib (15 to 240 mg per day) was administered orally in four-week treatment cycles, once or twice daily. RESULTS: A complete hematologic response was achieved in 37 of 40 patients with chronic-phase CML, and major hematologic responses were seen in 31 of 44 patients with accelerated-phase CML, CML with blast crisis, or Ph-positive ALL. In these two phases, the rates of major cytogenetic response were 45 percent and 25 percent, respectively. Responses were maintained in 95 percent of patients with chronic-phase disease and in 82 percent of patients with accelerated-phase disease, with a median follow-up more than 12 months and 5 months, respectively. Nearly all patients with lymphoid blast crisis and Ph-positive ALL had a relapse within six months. Responses occurred among all BCR-ABL genotypes, with the exception of the T315I mutation, which confers resistance to both dasatinib and imatinib in vitro. Myelosuppression was common but not dose-limiting. CONCLUSIONS: Dasatinib induces hematologic and cytogenetic responses in patients with CML or Ph-positive ALL who cannot tolerate or are resistant to imatinib.	Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Bristol Myers Squibb Co, Wallingford, CT 06492 USA; Bristol Myers Squibb Co, Lawrenceville, NJ USA; Howard Hughes Med Inst, Chevy Chase, MD USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Bristol-Myers Squibb; Bristol-Myers Squibb; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 11-934 Factor Bldg,10833 LeConte Ave, Los Angeles, CA 90095 USA.	csawyers@mednet.ucla.edu	Sawyers, Charles/G-5327-2016	Cortes, Jorge/0000-0002-8636-1071; Talpaz, Moshe/0000-0003-3361-3981; CHEN, TAI-TSANG/0000-0003-2524-0409	NCRR NIH HHS [M01-RR-00865] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; EVANS TRJ, 2005, J CLIN ONCOL, V23, P3034; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Guilhot F, 2004, BLOOD, V104, p10A, DOI 10.1182/blood.V104.11.21.21; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Silver RT, 2004, BLOOD, V104, p11A; Tokarski JS, 2004, BLOOD, V104, p160A, DOI 10.1182/blood.V104.11.553.553; Wardelmann E, 2005, LANCET ONCOL, V6, P249, DOI 10.1016/S1470-2045(05)70097-8; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Yamamoto M, 2005, CANCER GENET CYTOGEN, V157, P104, DOI 10.1016/j.cancergencyto.2004.06.014	31	1309	1374	1	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2531	2541		10.1056/NEJMoa055229	http://dx.doi.org/10.1056/NEJMoa055229			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775234				2022-12-28	WOS:000238233400003
J	Stott, R				Stott, R			Contraction and convergence - Healthy response to climate change	BRITISH MEDICAL JOURNAL			English	Editorial Material												stott@dircon.co.uk						*3 WORLD TRAV, WORLD OIL FACTS; *CAP INV UN, 2005, BUILD HLTH CAP SUST; Coote A., 2002, CLAIMING HLTH DIVIDE; *CORNW PARTN NHS T, CORNW FOOD PROGR; *DEP INT DEV, 2006, PRES STERN REV DEV C; *GERM ADV COUNC GL, CLIM PROT STRAT 21ST; Hanlon J, 2004, DEV CHANGE, V35, P375, DOI 10.1111/j.1467-7660.2004.00356.x; Houghton J, 2005, REP PROG PHYS, V68, P1343, DOI 10.1088/0034-4885/68/6/R02; *INT PAN CLIM CHAN, CILM CHANG SYNTH REP; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; PORRITT J, 2006, GUARDIAN SOC    1204, P9; Roberts I, 2006, BMJ-BRIT MED J, V332, P497, DOI 10.1136/bmj.332.7539.497; *ROYAL COMM ENV PO, 2000, EN CHANG CLIM, P47; Sachs JD, 2005, SCI AM, V293, P56, DOI 10.1038/scientificamerican0905-56; Simmons M. R., 2005, TWILIGHT DESERT; STARKEY R, 39 TYND CTR; TOOKE M, 2005, PEAK OIL; *US STAT DIV, 2006, MILL DEV GOAL IND DA; WHO, 2005, EC HUM WELL BEING HL	19	25	25	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 10	2006	332	7554					1385	1387		10.1136/bmj.332.7554.1385	http://dx.doi.org/10.1136/bmj.332.7554.1385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16763255	Green Published			2022-12-28	WOS:000238587000026
J	Verheugt, FWA				Verheugt, Freek W. A.			Good old warfarin for stroke prevention in atrial fibrillation	LANCET			English	Editorial Material							ASPIRIN; CLOPIDOGREL; THERAPY		Radboud Univ Nijmegen Med Ctr, Ctr Heart, Dept Cardiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Verheugt, FWA (corresponding author), Radboud Univ Nijmegen Med Ctr, Ctr Heart, Dept Cardiol, NL-6500 HB Nijmegen, Netherlands.	f.verheugt@cardio.umcn.nl	Verheugt, F.W.A./H-8105-2014					Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Blackshear JL, 1996, LANCET, V348, P633; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Lip GYH, 2002, BRIT MED J, V325, P1022, DOI 10.1136/bmj.325.7371.1022; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Verheugt FWA, 2003, LANCET, V362, P1686, DOI 10.1016/S0140-6736(03)14880-5; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; Yusuf S, 2001, NEW ENGL J MED, V345, P494	14	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1877	1878		10.1016/S0140-6736(06)68819-3	http://dx.doi.org/10.1016/S0140-6736(06)68819-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765740				2022-12-28	WOS:000238194400004
J	Fedorov, AV; Dekens, PS; McCarthy, M; Ravelo, AC; deMenocal, PB; Barreiro, M; Pacanowski, RC; Philander, SG				Fedorov, A. V.; Dekens, P. S.; McCarthy, M.; Ravelo, A. C.; deMenocal, P. B.; Barreiro, M.; Pacanowski, R. C.; Philander, S. G.			The Pliocene paradox (mechanisms for a permanent El Nino)	SCIENCE			English	Review							SEA-SURFACE TEMPERATURES; THERMAL STRUCTURE; CLIMATE; PACIFIC; CIRCULATION; WARMTH; ICE; IMPACT; PANAMA; PART	During the early Pliocene, 5 to 3 million years ago, globally averaged temperatures were substantially higher than they are today, even though the external factors that determine climate were essentially the same. In the tropics, El Nino was continual ( or "permanent'') rather than intermittent. The appearance of northern continental glaciers, and of cold surface waters in oceanic upwelling zones in low latitudes ( both coastal and equatorial), signaled the termination of those warm climate conditions and the end of permanent El Nino. This led to the amplification of obliquity ( but not precession) cycles in equatorial sea surface temperatures and in global ice volume, with the former leading the latter by several thousand years. A possible explanation is that the gradual shoaling of the oceanic thermocline reached a threshold around 3 million years ago, when the winds started bringing cold waters to the surface in low latitudes. This introduced feedbacks involving ocean-atmosphere interactions that, along with ice-albedo feedbacks, amplified obliquity cycles. A future melting of glaciers, changes in the hydrological cycle, and a deepening of the thermocline could restore the warm conditions of the early Pliocene.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Natl Ocean & Atmospher Adm, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	Yale University; University of California System; University of California Santa Cruz; Columbia University; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA	Fedorov, AV (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	fedorov@yale.edu	Barreiro, Marcelo/AAT-7377-2020; fedorov, alexey/F-1879-2010; demenocal, peter/B-1386-2013	demenocal, peter/0000-0002-7191-717X; Ravelo, Ana Christina/0000-0003-3929-677X				Barreiro M, 2006, CLIM DYNAM, V26, P349, DOI 10.1007/s00382-005-0086-4; Beaufort L, 2001, SCIENCE, V293, P2440, DOI 10.1126/science.293.5539.2440; Boccaletti G, 2004, J PHYS OCEANOGR, V34, P888, DOI 10.1175/1520-0485(2004)034<0888:TTSOTU>2.0.CO;2; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Crowley TJ, 1996, MAR MICROPALEONTOL, V27, P3, DOI 10.1016/0377-8398(95)00049-6; DASILVA AM, 1994, ATLAS SURFACE MARINE, V6; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; DEKENS PS, UNPUB; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Dijkstra HA, 1999, J CLIMATE, V12, P1630, DOI 10.1175/1520-0442(1999)012<1630:CPATTC>2.0.CO;2; Dowsett H, 1996, MAR MICROPALEONTOL, V27, P13, DOI 10.1016/0377-8398(95)00050-X; Dowsett HJ, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001133; Driscoll NW, 1998, SCIENCE, V282, P436, DOI 10.1126/science.282.5388.436; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Fedorov AV, 2004, J PHYS OCEANOGR, V34, P1949, DOI 10.1175/1520-0485(2004)034<1949:TEOSOT>2.0.CO;2; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Haywood AM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000799; Haywood AM, 2004, EARTH PLANET SC LETT, V218, P363, DOI 10.1016/S0012-821X(03)00685-X; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; Klocker A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021564; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; Marlow JR, 2000, SCIENCE, V290, P2288; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; RAVELO AC, 2006, GSA TODAY, V3, DOI DOI 10.1130/1052-5173; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Rickaby REM, 2005, SCIENCE, V307, P1948, DOI 10.1126/science.1104666; Sloan LC, 1996, MAR MICROPALEONTOL, V27, P51, DOI 10.1016/0377-8398(95)00063-1; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Winton M, 2003, J CLIMATE, V16, P2875, DOI 10.1175/1520-0442(2003)016<2875:OTCIOO>2.0.CO;2; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	44	279	294	5	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1485	1489		10.1126/science.1122666	http://dx.doi.org/10.1126/science.1122666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763140				2022-12-28	WOS:000238124100036
J	Rambach, P				Rambach, P			The spirit of writing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												prambach@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2453	2454		10.1001/jama.295.21.2453	http://dx.doi.org/10.1001/jama.295.21.2453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049ZQ	16757706				2022-12-28	WOS:000238057300001
J	Banks, E; Meirik, O; Farley, T; Akande, O; Bathija, H; Ali, M				Banks, Emily; Meirik, Olav; Farley, Tim; Akande, Oluwole; Bathija, Heli; Ali, Mohamed		WHO Study Grp Female Genital Mutil	Female genital mutilation and obstetric outcome: WHO collaborative prospective study in six African countries	LANCET			English	Article							CIRCUMCISION	Background Reliable evidence about the effect of female genital mutilation (FGM) on obstetric outcome is scarce. This study examines the effect of different types of FGM on obstetric outcome. Methods 28393 women attending for singleton delivery between November, 2001, and March, 2003, at 28 obstetric centres in Burkina Faso, Ghana, Kenya, Nigeria, Senegal, and Sudan were examined before delivery to ascertain whether or not they had undergone FGM, and were classified according to the WHO system: FGM 1, removal of the prepuce or clitoris, or both; FGM 11, removal of clitoris and labia minora; and FGM III, removal of part or all of the external genitalia with stitching or narrowing of the vaginal opening. Prospective information on demographic, health, and reproductive factors was gathered. Participants and their infants were followed up until maternal discharge from hospital. Findings Compared with women without FGM, the adjusted relative risks of certain obstetric complications were, in women with FGM I, II, and III, respectively: Caesarean section 1.03 (95% Cl 0.88-1.21), 1.29 (1.09-1.52), 1.31 (1.01-1.70); postpartum haemorrhage 1.03 (0.87-1.21), 1.21 (1.01-1.43), 1.69 (1.34-2.12); extended maternal hospital stay 1.15 (0.97-1.35), 1.51 (1.29-1.76), 1.98 (1.54-2.54); infant resuscitation 1.11 (0.95-1.28), 1.28 (1.10-1.49),1.66 (1.31-2.10), stillbirth or early neonatal death 1.15 (0.94-1.41),1.32 (1.08-1.62),1.55 (1.12-2.16), and low birthweight 0.94 (0.82-1.07), 1.03 (0.89-1.18), 0.91 (0.74-1.11). Parity did not significantly affect these relative risks. FGM is estimated to lead to an extra one to two perinatal deaths per 100 deliveries. Interpretation Women with FGM are significantly more likely than those without FGM to have adverse obstetric outcomes. Risks seem to be greater with more extensive FGM.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	Banks, E (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	FGMStudyGroup@who.int		Dhoundiyal, Bhavana/0000-0003-4107-7701				DESILVA S, 1989, EUR J OBSTET GYN R B, V32, P233, DOI 10.1016/0028-2243(89)90041-5; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hakim L Y, 2001, East Afr Med J, V78, P255; Jones H, 1999, STUD FAMILY PLANN, V30, P219, DOI 10.1111/j.1728-4465.1999.00219.x; Larsen U, 2002, INT J GYNECOL OBSTET, V77, P255, DOI 10.1016/S0020-7292(02)00028-0; Morison L, 2001, TROP MED INT HEALTH, V6, P643, DOI 10.1046/j.1365-3156.2001.00749.x; Shandall A A, 1967, Sudan Med J, V5, P178; Snow RC, 2002, TROP MED INT HEALTH, V7, P91, DOI 10.1046/j.1365-3156.2002.00829.x; *UNICEF INN RES CT, 2005, CHANG HARMF SOC CONV; World Health Organisation, 2005, WORLD HLTH REP MAK E; World Health Organization, 1998, FEMALE GENITAL MUTIL	11	370	374	1	67	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2006	367	9525					1835	1841						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753486				2022-12-28	WOS:000238194200029
J	Radford, SE				Radford, Sheena E.			GroEL: More than just a folding cage	CELL			English	Editorial Material							CHAPERONIN		Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039	Biotechnology and Biological Sciences Research Council [SF16972] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Zhou HX, 2004, J MOL RECOGNIT, V17, P368, DOI 10.1002/jmr.711	10	28	29	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					831	833		10.1016/j.cell.2006.05.021	http://dx.doi.org/10.1016/j.cell.2006.05.021			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751091	Bronze			2022-12-28	WOS:000238116400008
